note_id,text
10043750-DS-6," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: SURGERY
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
R colon cancer
 
Major Surgical or Invasive Procedure:
Open right colectomy

 
History of Present Illness:
The patient presented to clinic with a diagnosis of right colon 
cancer diagnosed after she underwent a colonoscopy.  This was a 
large cecal cancer. Staging investigations demonstrated no 
metastatic disease.
She was offered a right colectomy.  She opted to proceed with 
open right colectomy.  Risks and benefits of the procedure were 
explained to the patient prior to proceeding the operating.

 
Past Medical History:
PMH: DJD, sciatica, b/l blepharitis, diverticulosis, vit D 
deficiency, insomnia, HTN, HLD, LBBB, CKD III, vit B12 
deficiency

PSH: L knee arthroscopy
 
Social History:
Lives alone, but has daughter as support nearby.
 
Physical Exam:
Gen: AOx3, NAD, comfortable, pleasant
HEENT: anicteric sclera, EOMI OP clear with MMM
Resp: CTAB
CV: RRR S1S2
Abd: +BS, soft, minimally tender, non-distended, no masses
Wound: steristrips in place, c/d/i with no erythema, fluctuance 
or induration
Ext: WWP
 
Pertinent Results:
___ 06:38AM BLOOD WBC-7.9 RBC-3.14* Hgb-9.9* Hct-30.4* 
MCV-97 MCH-31.5 MCHC-32.5 RDW-12.8 Plt ___
___ 06:38AM BLOOD Glucose-72 UreaN-17 Creat-1.0 Na-143 
K-3.8 Cl-109* HCO3-22 AnGap-16
___ 06:38AM BLOOD Calcium-8.1* Phos-3.2 Mg-1.6

___ 07:35AM BLOOD Glucose-90 UreaN-15 Creat-1.0 Na-136 
K-3.8 Cl-105 HCO3-25 AnGap-10
___ 07:35AM BLOOD Calcium-7.8* Phos-1.8* Mg-2.3

PATHOLOGIC DIAGNOSIS:

Ileum, colon and appendix, ileocolectomy:

1. Mucinous adenocarcinoma invading into the muscularis propria 
(pT2, see synoptic report); the margins are negative for 
malignancy.
2. Sixteen lymph nodes with no malignancy identified ___, pN0, 
see synoptic report).
3. Colon with melanosis coli.
4. Unremarkable ileum and appendix.
 
Brief Hospital Course:
The patient was admitted to the General Surgical Service on 
___ after an open right colectomy for colon cancer. The 
procedure went well without complication (reader referred to the 
Operative Note for details). After a brief, uneventful stay in 
the PACU, the patient arrived on the floor.
 
Neuro: The patient had an epidural which was transitioned to  
oral pain medications on POD2 with good effect and adequate pain 
control.  
Cardiopulmonary: The patient remained stable from a 
cardiopulmonary standpoint; vital signs were routinely 
monitored. Good pulmonary toilet, early ambulation and incentive 
spirrometry were encouraged throughout hospitalization.
GI/GU/FEN: Post-operatively, the patient was made NPO with IV 
fluids. Diet was advanced when appropriate, which was well 
tolerated.  Patient's intake and output were closely monitored, 
and IV fluid was adjusted when necessary.  Electrolytes were 
routinely followed, and repleted when necessary.
ID: The patient's fever curves were closely watched for signs of 
infection.  The wound dressings were monitored daily.
Prophylaxis: The patient received subcutaneous heparin and 
venodyne boots were used during this stay; was encouraged to get 
up and ambulate as early as possible.
 
At the time of discharge, the patient was doing well, afebrile 
with stable vital signs.  The patient was tolerating a regular 
diet, ambulating, voiding without assistance, and pain was well 
controlled. She was evaluated by physical therapy and after 
discussion with the patient, family, and ___, she was discharged 
home with home ___. The patient received discharge teaching and 
follow-up instructions with understanding verbalized and 
agreement with the discharge plan.
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Atenolol 50 mg PO DAILY 
2. BuPROPion 75 mg PO BID 
3. Flunisolide Inhaler 2 sprays inhalation daily 
4. NIFEdipine CR 60 mg PO DAILY 
5. Ranitidine 300 mg PO DAILY 
6. Simvastatin 10 mg PO DAILY 
7. Tobramycin-Dexamethasone Ophth Susp 1 DROP BOTH EYES PRN dry 
eyes 
8. TraZODone 50 mg PO DAILY 
9. Triamcinolone Acetonide 0.1% Cream 1 Appl TP BID 
10. peg 400-propylene glycol 0.4-0.3 % ophthalmic 1 drop each 
eye 
11. DiphenhydrAMINE Dose is Unknown  PO Frequency is Unknown 

 
Discharge Medications:
1. Atenolol 50 mg PO DAILY 
2. BuPROPion 150 mg PO QAM 
3. BuPROPion 75 mg PO QPM 
4. NIFEdipine CR 60 mg PO DAILY 
5. Ranitidine 300 mg PO DAILY 
6. Simvastatin 10 mg PO DAILY 
7. TraZODone 50 mg PO HS:PRN insomnia 
8. Acetaminophen 1000 mg PO TID 
9. Aluminum-Magnesium Hydrox.-Simethicone ___ mL PO QID:PRN 
heartburn 
10. Cepastat (Phenol) Lozenge 1 LOZ PO Q4H:PRN throat irritation 

11. TraMADOL (Ultram) 25 mg PO Q6H:PRN pain 
RX *tramadol [Ultram] 50 mg 0.5 (One half) tablet(s) by mouth 
every 6 hours Disp #*20 Tablet Refills:*0
12. Flunisolide Inhaler 2 sprays inhalation daily 
13. peg 400-propylene glycol 0.4-0.3 % ophthalmic 1 drop each 
eye 
14. Tobramycin-Dexamethasone Ophth Susp 1 DROP BOTH EYES PRN dry 
eyes 
15. Triamcinolone Acetonide 0.1% Cream 1 Appl TP BID 
16. Docusate Sodium 100 mg PO BID 
Please take while taking Ultram. 

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
Right colon cancer

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).

 
Discharge Instructions:
Dear Ms. ___, 

You were admitted to the general surgery inpatient service after 
your surgery. You are now stable enough to continue your 
recovery at home. 

Please resume all regular home medications, unless specifically 
advised not to take a particular medication.  Also, please take 
any new medications as prescribed. Avoid driving or operating 
heavy machinery while taking pain medications. 

Please get plenty of rest, continue to ambulate several times 
per day, and drink adequate amounts of fluids. Please continue 
drinking Ensures while at home to make sure you keep up with 
your calories.  Avoid lifting weights greater than ___ lbs 
until you follow-up with your surgeon, who will instruct you 
further regarding activity restrictions.
  
Please follow-up with your surgeon as advised.
 
Incision Care:
*Please call your doctor or nurse practitioner if you have 
increased pain, swelling, redness, or drainage from the incision 
site.
*Avoid swimming and baths until your follow-up appointment.
*You may shower, and wash surgical incisions with a mild soap 
and warm water.  Gently pat the area dry.
*If you have steri-strips, they will fall off on their own.  
Please remove any remaining strips ___ days after surgery.

It was a pleasure taking care of you!
 
Followup Instructions:
___
"
10371195-DS-9," 
Name:  ___                Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: SURGERY
 
Allergies: 
Patient recorded as having No Known Allergies to Drugs
 
Attending: ___.
 
Chief Complaint:
s/p Motorcycle crash
 
Major Surgical or Invasive Procedure:
___ Epidural catheter placement

 
History of Present Illness:
Pt is ___ yr-old male adm on trauma service s/p MCC vs SUV. Pt
trans by Medflight from ___. Was unresponsive at scene,
+helmet, +ETOH w/BAL=28. No record of ETOH level from OSH. Pt 
with right pulmonary contusion, left clavicle fracture, 
bilateral rib fractures, grade II right renal laceration, grade 
V liver laceration, left L2 transverse process fracture.

 

 
Past Medical History:
none
 
Social History:
___
Family History:
NC
 
Physical Exam:
On discharge
VS: T 98.6 Hr 72 BP 106/62 RR 16 96% or Ra
GEN: A&O x 3 , NAD
___: RRR no m/r/g
Pulm: CTAB
Abdomen: Tender with palpation
Ext: WWP, R ___ cyst in popliteal fossa.

 
Pertinent Results:
___ 03:20AM BLOOD WBC-12.4* RBC-4.14* Hgb-12.8* Hct-36.8* 
MCV-89 MCH-30.8 MCHC-34.7 RDW-13.7 Plt ___
___ 03:20AM BLOOD UreaN-13 Creat-1.2
___ 05:45AM BLOOD ALT-957* AST-909* AlkPhos-84 Amylase-149* 
TotBili-1.8*
___ 05:45AM BLOOD Lipase-226*
___ 05:45AM BLOOD Albumin-4.2 Calcium-8.2* Phos-4.2 Mg-1.9
___ 03:20AM BLOOD ASA-NEG Ethanol-28* Acetmnp-NEG 
Bnzodzp-NEG Barbitr-NEG Tricycl-NEG
___ 03:31AM BLOOD pH-7.27* Comment-GREEN TOP
___ 03:31AM BLOOD Glucose-113* Lactate-2.1* Na-140 K-4.7 
Cl-104 calHCO3-21
___ 03:31AM BLOOD Hgb-14.3 calcHCT-43 O2 Sat-89 COHgb-3 
MetHgb-0
___ 03:31AM BLOOD freeCa-1.09*

___ CT Torso: Grade 5 liver lac extending to IVC, Grade 2 right 
renal lac at lower pole, Bilateral rib fx, L clavicular fx, R 
pulm contusion/aspiration bilaterally, L L2 transverse process 
fx
Small area of stranding/fluid around transverse colon. No free 
air, stable between scans
___ CT Abd/pelvis: no new fluid collection
___ CT abd: No acute pathology including no bowel obstruction 
or abscess. Stable liver and renal lacerations. Decreased amount 
of high-density fluid in the pelvis.Small bilateral pleural 
effusions and atelectasis. 
ERCP: Normal major papilla. Clear bile seen. Common bile duct, 
common hepatic duct, R+L hepatic ducts, biliary radicles + 
cystic duct filled with contrast, well visualized. Normal w/o 
evidence of extrinsic compression, no ductal abnormalities, and 
no filling defects.
___ ERCP:Normal major papilla. Clear bile seen at the major 
papilla and in the duodenum. The common bile duct, common 
hepatic duct, right and left hepatic ducts, biliary radicles and 
cystic duct were filled with contrast and well visualized. 
The course and caliber of the structures are normal with no 
evidence of extrinsic compression, no ductal abnormalities, and 
no filling defects.  
___ KUB: No evidence of bowel obstruction or ileus.
___ b/l ___ US: Negative for DVT.  Loculated ___ cyst.

 
Brief Hospital Course:
___ Pt admitted to the trauma surgical service s/p Motor cycle 
crash with positive loss of consciousness. Injuries included 
Grade 4 liver lac extending to IVC  
Grade 2 right renal lac at lower pole; Bilateral rib fx; L 
clavicular fx  ; R pulm contusion/aspiration bilaterally ; L L2 
transverse process fx  ; Small area of stranding/fluid around 
transverse colon. No free air, stable between scans.  ___ 
admitted to the TICU for observation. 
___: ___ remianed in TICU.  Acute pain service consulted for 
pain managment with bupivicaine 0.1 ___ and diluadid pca ___: Epidural IV PCA, MS ___ 15 mg po TID  
___: Epidural continued; stopped PCA; MS ___ and MSIR  PO 
meds started.
___: + ambulation w/ ___.  CT Abd/pelvis follow up examination 
performed.
___: capped and flagged epidural; foley removed with 
positive void. Aggressive bowel regimen started.  
___: Pt noted to have increased abdominal pain in the p.m. KUB 
demonstrated ileus. Foley reinserted due to incomplete voiding 
and post void residuals of 388 cc.
___ CT abd performed for continued abdominal discomfort: No 
acute pathology including no bowel obstruction.    
___ Increased LFTs and abdominal pain prompted r/o for biliary 
injury with ERCP.  ___ kept NPO  for procedure.
___ performed- normal exam.  F/u amylase and lipase not 
acutely elevated, no evidence of pancreatitis.
___ KUB: No evidence of bowel obstruction or ileus.  Pain in R 
leg with area of hardness prompted  b/l ___ US: Negative for DVT. 
 Loculated ___ cyst. Pt tolerating a regular diet.  Pain 
well controlled with PO pain meds.   Pt ambulating and cleared 
by ___.  Pt with large BM.
 
 

 
Medications on Admission:
none
 
Discharge Medications:
1. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO three 
times a day.
Disp:*90 Capsule(s)* Refills:*0*
2. Bisacodyl 5 mg Tablet, Delayed Release (E.C.) Sig: Two (2) 
Tablet, Delayed Release (E.C.) PO DAILY (Daily) as needed.  
3. Zolpidem 5 mg Tablet Sig: One (1) Tablet PO HS (at bedtime) 
as needed for insomnia.
Disp:*30 Tablet(s)* Refills:*0*
4. Tizanidine 2 mg Tablet Sig: One (1) Tablet PO QHS (once a day 
(at bedtime)).
Disp:*30 Tablet(s)* Refills:*2*
5. Morphine 30 mg Tablet Sustained Release Sig: One (1) Tablet 
Sustained Release PO Q12H (every 12 hours): take with 15 mg 
tablet to equal 45 mg.
Disp:*60 Tablet Sustained Release(s)* Refills:*0*
6. Morphine 15 mg Tablet Sustained Release Sig: One (1) Tablet 
Sustained Release PO every twelve (12) hours: take with 30 mg 
tablet to equal 45 mg.
Disp:*60 Tablet Sustained Release(s)* Refills:*0*
7. Magnesium Hydroxide 400 mg/5 mL Suspension Sig: Thirty (30) 
ML PO Q6H (every 6 hours) as needed for constiaption.  
8. Albuterol 90 mcg/Actuation Aerosol Sig: Two (2)  Inhalation 
every six (6) hours as needed for shortness of breath or 
wheezing.
Disp:*1 * Refills:*1*
9. Miralax 100 % Powder Sig: One (1) Dose PO once a day: Mix as 
directed in liquid.  
10. Senna 8.6 mg Tablet Sig: Two (2) Tablet PO at bedtime.
Disp:*60 Tablet(s)* Refills:*0*

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
s/p Motorcycle crash
Right pulmonary contusion
Left clavicle fracture
Bilateral rib fractures
Grade II right renal laceration
Grade V liver laceration
Left L2 transverse process fracture

 
Discharge Condition:
Hemodynamically stable, tolerating a regular diet, pain 
adequately controlled

 
Discharge Instructions:
It is important that you cough, deep breathe and use the 
incentive spirometer every hour that you are awake.

DO NOT participate in any contact sports of any kind for the 
next 8 weeks because of your liver injury.

If at any time you feel dizzy, weak and/or lightheaded, as if 
you are going to pass out you will needto go to the nearest 
Emergency room as this may be a sign that you may be 
experiencing internal bleeding from your liver.
Return to the Emergency room if you develop any fevers, chills, 
increased productive cough, shortness of breath, chest pain, 
abdominal pain, nausea, vomiting, diarrhea and/or any other 
symptoms that are concerning to you.

It is important that you take the pain medications as 
prescribed. A stool softener and laxative have been prescribed 
for you; it is important that you take these while on narcotics 
in order to prevent constipation.
 
Followup Instructions:
___
"
10794068-DS-18," 
Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: SURGERY
 
Allergies: 
Patient recorded as having No Known Allergies to Drugs
 
Attending: ___.
 
Chief Complaint:
___ s/p unwitnessed fall, unresponsive, with multiple L rib 
fractures and pneumothorax
 
Major Surgical or Invasive Procedure:
___: Intubated in the ED secondary to agitation and emesis 
with aspiration
___: Placement L chest tube in ED, later removed as it was 
found to be in subcutaneous space.
___: Arterial line placed
___: Insertion left-sided 3-lumen subclavian CVL
___: Percutaneous tracheostomy at ICU bedside for failure to 
wean from vent
 
History of Present Illness:
Pt is a ___ with a hx of alcohol dependence who was found down 
and unresposive by his wife after apparently ___ down 8 
concrete steps.  The pt was initially oriented x1 with a GCS of 
4 on the scene, however his GCS was 15 in the ED.  He became 
agitated in the ED, vomited, and desaturated and was therefore 
intubated for airway protection.  CT in the ED showed left sixth 
through ninth rib fractures and a small left-sided pneumothorax.
 
Past Medical History:
PMH: CAD, peripheral neuropathy, depression, gout, EtOH 
dependence, asbestosis/lung scar
PSH: CABG, aortic valve (tissue) replacement ___

 
Social History:
___
Family History:
Non-contributory
 
Physical Exam:
HR:75 BP:118/62 Resp:22 O(2)Sat:93 nrb low 
 
Constitutional: Moaning, uncomfortable, confused
HEENT: Pupils equal, round and reactive to light, Extraocular 
muscles intact, C-collar, no crepitus
Chest: Clear to auscultation, + L chest wall ttp
Cardiovascular: Regular Rate and Rhythm
Abdominal: Soft, diffuse ttp, R inguinal hernia easily 
reducible, FAST negative, stable pelvis
Extr/Back: c/o diffuse pain with vertebral palpation
Skin: R lateral thigh ecchymosis, R knee laceration, L arm 
abrasion
Neuro: Confused, follows commands, MAE, equal strength 
bilaterally, decreased sensation to l.t. in bilateral feet(which 
patient states is old)

 
Pertinent Results:
___ CT A/P: Mildly displaced multilevel left-sided rib 
fractures. At the site of rib fractures there is a chest tube, 
which does not enter into the thoracic cavity. There is 
subcutaneous emphysema with a small amount of hematoma at this 
site.  Small left basilar and apical pneumothorax.  Bibasilar 
atelectasis. Pleural calcifications may reflect asbestos 
exposure, correlate clinically. 

___ CT C-Spine: No fracture of the cervical spine. Compression 
deformity at T2 age-indeterminate but may relate to degenerative 
changes. Degenerative changes at C3-4 and C4-5 cause mild degree 
of central canal 
narrowing may predispose to cord injury in the setting of 
trauma. If there is concern for cord injury, MRI would be 
recommended. Left apical pneumothorax, seen on concurrent CT 
Torso. Patient is intubated. Nasogastric tube in the esophagus. 

___ CT Head: . No acute intracranial findings. Parenchymal 
atrophy and small vessel disease. 

___ TLS-Spine MRI: No evidence of acute fractures. Compression 
fractures involving T2, T5 and L1 are likely chronic given 
absence of marrow edema.  Mild multilevel degenerative changes 
as described above with multiple 
areas of mild to moderate foraminal stenosis and mild cord 
indentation at 
T5-T6 without cord signal intensity abnormality. 
Well-circumscribed 2-cm upper back subcutaneous lesion, most 
consistent with an epidermal inclusion cyst or a sebaceous cyst. 
Minimal marrow edema L2 and L3 and L5-S1 facets and C1-2 lateral 
mass joints , pattern most compatible with degenertive changes 
without secondary features to indicate acute trauma. Multilevel 
degenerative changes as described above. 

___ CXR: Asymmetric lucency of the left lung suggests an 
anterior pneumothorax in this supine patient. Right lower lobe 
opacity likely reflects new right pleural effusion (moderate) 
and right lower lobe consolidation. New moderately severe 
pulmonary edema. 

___ CT Chest: Bilateral moderate-sized simple pleural effusions 
and associated compressive atelectasis of the lower lobes, new 
since the prior study. Multifocal ground-glass opacities in the 
right lung may represent 
infection or aspiration. Extensive subcutaneous emphysema in the 
left anterior chest wall, has increased since the prior study. 
Interval resolution of a left-sided pneumothorax. Multiple left 
recent rib fractures and non-acute right rib fractures. 

___ CXR:  The Dobbhoff catheter is in the left main bronchus 
and should be removed. Stable severe right lower lobe pneumonia, 
bilateral pleural effusions and left lower lobe atelectasis.  

___ CXR: The Dobbhoff tube is coiled in the stomach. The tip 
projects over the middle parts of the stomach. Normal 
tracheostomy tube. No evidence of complications. Unchanged left 
subclavian vein catheter. Mild retrocardiac atelectasis. 
Unchanged size of the cardiac silhouette. The study and the 
report were reviewed by the staff radiologist. 

___ CXR: Improved ventilation at both lung bases with small 
remnant areas of atelectasis. No newly-occurred focal 
parenchymal opacities. Mild 
cardiomegaly without pulmonary edema. 

___ CXR: As compared to the previous radiograph, the Dobbhoff 
tube has been advanced. The tip of the tube now projects over 
the middle parts of the stomach. No evidence of complications. 
Otherwise, the radiograph is 
unchanged. 

___ 09:50PM BLOOD WBC-8.4 RBC-4.40* Hgb-13.8* Hct-40.1 
MCV-91 MCH-31.4 MCHC-34.4 RDW-16.2* Plt ___
___ 09:50PM BLOOD Plt ___
___ 09:50PM BLOOD ___ 04:32AM BLOOD Glucose-53* UreaN-13 Creat-0.8 Na-131* 
K-4.5 Cl-102 HCO3-19* AnGap-15
___ 09:50PM BLOOD CK(CPK)-109
___ 04:32AM BLOOD ALT-12 AST-27 CK(CPK)-304 AlkPhos-76 
TotBili-0.3
___ 04:32AM BLOOD CK-MB-12* MB Indx-3.9 cTropnT-0.02*
___ 12:54AM BLOOD CK-MB-6 cTropnT-<0.01
___ 04:32AM BLOOD Albumin-3.2* Calcium-7.6* Phos-3.5 Mg-1.8
___ 09:50PM BLOOD ASA-NEG ___ Acetmnp-NEG 
Bnzodzp-NEG Barbitr-NEG Tricycl-NEG
___ 11:09PM BLOOD Type-ART Tidal V-500 PEEP-5 FiO2-100 
pO2-501* pCO2-52* pH-7.20* calTCO2-21 Base XS--7 AADO2-182 REQ 
O2-38 -ASSIST/CON Intubat-INTUBATED
___ 02:32AM BLOOD Type-ART Temp-38.8 PEEP-10 pO2-116* 
pCO2-43 pH-7.41 calTCO2-28 Base XS-1 Intubat-INTUBATED
 
Brief Hospital Course:
Neuro:  The patient requires medication for agitation, and 
should continue oxycodone and Tylenol prn pain, as well as 
clonidine, seroquel QHS, q16:00 and prn.  Zyprexa Zydis was used 
prn as well.  For his history of EtOH dependence and previous 
episodes of complicated withdrawal he was maintained on CIWA 
protocol with thiamine, folate & multivitamin for 
neuroprotection. Benzodiazepines were stopped ___.  He has been 
in restraints intermittently for agitation and pulling at lines.

CV: The pt was initally in septic shock from his pneumonia and 
required pressors to mainatin hemodynamic stability.  These were 
discontinued on ___.  The pt has been maintained on metoprolol 
25 mg BID

Pulm: The pt was initially intubated in the Emergency Department 
for agitation, emesis and concern for aspiration.  He was found 
to have a leftsided pneumothorax and a chest tube was placed in 
the ED.  This was found to enter the subcutaneous space and was 
removed.  The pneumothorax did resolve on serial films.  The pt 
did develop a likely aspiration pneumonia and was treated 
empirically with Vancomycin and Zosyn, and completed a 10-day 
course on ___.  The pt was unable to wean from the vent and was 
very agitated by the ETT tube, a bedside percutaneous 
tracheostomy was performed in the ICU ___ with a #8 Portex.  He 
has been able to wean to CPAP and, on the day of discharge did 
have a trial with trach mask.

FEN/GI: Pt had dobhoff tube placed x3 for tube feeds.  He pulled 
out the first two and the third was carefully secured with tape. 
 Tube feeds were initiated per Nutrition recommendations and, at 
time of discharge, were running at goal (55cc/hr).

ID: The pt was initially septic from his pnemonia and completed 
a 10-day course of Vanc/Zosyn on ___, pressors d/c'ed ___.

GU: The pt has been diuresed with Lasix 20mg IV BID. He has a 
Foley catheter.

Musculoskeletal: Pt has lateral L rib fractures of ___.  He also 
has old compression deformities of T2, T5, L1.  He came off 
logroll precautions and had his C-Spine cleared ___.

Heme: Heparin SC and venodyne boots for DVT Prophylaxis, PPI for 
ulcer prophylaxis

 
Medications on Admission:
zocor, ASA, omeprazole, allopurinol, ativan, neurontin, atenolol
 
Discharge Medications:
1. Heparin (Porcine) 5,000 unit/mL Solution Sig: One (1) 
injection Injection BID (2 times a day).  
2. Albuterol Sulfate 90 mcg/Actuation HFA Aerosol Inhaler Sig: 
___ Puffs Inhalation Q4H (every 4 hours) as needed for 
wheezing.  
3. Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a 
day) as needed for constipation.  
4. Docusate Sodium 50 mg/5 mL Liquid Sig: 10 (ten) mL PO BID (2 
times a day).  
5. Folic Acid 1 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  

6. Pantoprazole 40 mg Recon Soln Sig: 40 (forty) mg Intravenous 
Q24H (every 24 hours).  
7. Quetiapine 25 mg Tablet Sig: One (1) Tablet PO HS (at 
bedtime).  
8. Quetiapine 25 mg Tablet Sig: 0.5 Tablet PO DAILY (Daily): at 
16:00.  
9. Sodium Chloride 0.9%  Flush 3 mL IV Q8H:PRN line flush 
Peripheral line: Flush with 3 mL Normal Saline every 8 hours and 
PRN. 
10. Quetiapine 25 mg Tablet Sig: 0.5 Tablet PO BID PRN () as 
needed for agitation.  
11. Acetaminophen 650 mg/20.3 mL Solution Sig: Six Hundred Fifty 
(650) mg PO Q6H (every 6 hours) as needed for fever.  
12. Oxycodone 5 mg/5 mL Solution Sig: Five (5) mL PO Q4H (every 
4 hours) as needed for pain.  
13. Multivitamin     Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
14. Thiamine HCl 100 mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
15. Metoprolol Tartrate 25 mg Tablet Sig: One (1) Tablet PO BID 
(2 times a day): Hold SBP<90, HR<50.  
16. Furosemide 20 mg IV BID 
17. HydrALAzine 10 mg IV Q6H:PRN SBP > 140 
18. Metoclopramide 5 mg IV Q6H:PRN residuals 
19. Guaifenesin 100 mg/5 mL Syrup Sig: ___ MLs PO Q6H (every 6 
hours) as needed for secretions.  
20. Clonidine 0.1 mg Tablet Sig: One (1) Tablet PO TID (3 times 
a day).  
21. Dextrose 50% 12.5 gm IV PRN hypoglycemia protocol 
22. Chlorhexidine Gluconate 0.12 % Mouthwash Sig: Fifteen (15) 
ML Mucous membrane BID (2 times a day).  
23. Glucagon (Human Recombinant) 1 mg Recon Soln Sig: One (1) mg 
Injection Q15MIN () as needed for hypoglycemia protocol.  
24. Regular Insulin Sliding Scale
FSBS Q6H 
 
Glucose         Regular Insulin Dose 
___ Proceed with hypoglycemia protocol 
71-100mg/dL   0 Units 
101-150mg/dL  2 Units 
151-200mg/dL  4 Units 
201-250mg/dL  6 Units 
251-300mg/dL  8 Units 
301-350mg/dL  10 Units 
351-400mg/dL  12 Units 
> 400mg/dL    ___ M.D. 

Instructons for NPO Patients: Evening Prior to 
Surgery/Procedure: If on glargine or detemir: give 80% of usual 
dose; If on NPH: give 100% usual dose. Morning of 
Surgery/Procedure: If on glargine or detemir: give 80% of usual 
dose; If on NPH: give 50% of usual dose; If on premix insulin 
(e.g. 70/30, 75/25): take total number of AM units ordered, 
divide by 3, and give that many units as NPH; If on sliding 
scale of short acting insulin: administer according to HS 
schedule. Hold all oral antidiabetic medications, and consider 
sliding scale coverage; If appropriate, give IVF with dextrose 
to prevent hypoglycemia. 

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
-Displaced ___ left-sided rib fractures & small pneumothorax 
s/p unwitnessed fall
-Alcohol dependence 
-Aspiration Pneumonia

 
Discharge Condition:
Mental Status: Confused - sometimes.
Level of Consciousness: Alert and interactive.
Activity Status: Out of Bed with assistance to chair or 
wheelchair has ambulated in ICU with assist

 
Discharge Instructions:
Please call your doctor or nurse practitioner or return to the 
Emergency Department for any of the following:
*You experience new chest pain, pressure, squeezing or 
tightness.
*New or worsening cough, shortness of breath, or wheeze.
*If you are vomiting and cannot keep down fluids or your 
medications.
*You are getting dehydrated due to continued vomiting, diarrhea, 
or other reasons. Signs of dehydration include dry mouth, rapid 
heartbeat, or feeling dizzy or faint when standing.
*You see blood or dark/black material when you vomit or have a 
bowel movement.
*You experience burning when you urinate, have blood in your 
urine, or experience a discharge.
*Your pain in not improving within ___ hours or is not gone 
within 24 hours. Call or return immediately if your pain is 
getting worse or changes location or moving to your chest or 
back.
*You have shaking chills, or fever greater than 101.5 degrees 
Fahrenheit or 38 degrees Celsius.
*Any change in your symptoms, or any new symptoms that concern 
you.
Please resume all regular home medications , unless specifically 
advised not to take a particular medication. Also, please take 
any new medications as prescribed.
Please get plenty of rest, continue to ambulate several times 
per day, and drink adequate amounts of fluids. Avoid lifting 
weights greater than ___ lbs until you follow-up with your 
surgeon.
Avoid driving or operating heavy machinery while taking pain 
medications.
Incision Care:
*Please call your doctor or nurse practitioner if you have 
increased pain, swelling, redness, or drainage from the incision 
site.
*Avoid swimming and baths until your follow-up appointment.
*You may shower, and wash surgical incisions with a mild soap 
and warm water. Gently pat the area dry.
*If you have staples, they will be removed at your follow-up 
appointment.
*If you have steri-strips, they will fall off on their own. 
Please remove any remaining strips ___ days after surgery.
 
Followup Instructions:
___
"
10839721-DS-9," 
Name:  ___                      Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Iodine-Iodine Containing / Amitriptyline / Amitiza / ondansetron 
/ Levaquin
 
Attending: ___.
 
Chief Complaint:
Colitis, Hematochezia
 
Major Surgical or Invasive Procedure:
Flexible sigmoidoscopy
 
History of Present Illness:
Patient seen and examined, agree with house officer admission 
note by Dr. ___ ___ with additions below

___ year old Female with a history of Irritable Bowel Syndrome, 
diverticulosis, and hemorrhoids, who presents with diarrhea, 
abdominal pain and frank hematochezia. She has IBS flares with 
abdominal pain every 3 months but notes that this pain is much 
more severe. She states the pain is crampy, intermittent and 
primarily in both lower quadrants. She has Nausea without 
vomiting. Had copious BMs since the day prior to admission which 
were watery, but in the middle of the night on the day of 
admission she had three episodes of rectal bleeding in which 
toilet was filled with bright red blood. She has not had rectal 
bleeding on any of her prior IBS flares. She felt lightheaded 
but no syncope.

In the ED initial VS were 97.9, 88, 113/46, 16, 96%RA. On exam, 
abdomen diffusely tender without rebound or guarding. The pain 
was maximal in the suprapubic region. Rectal exam showed frank 
blood in the vault. No hemorrhoids visible or palpated. EKG 
showed NSR with normal axis & intervals and no ischemic changes. 
Labs notable for WBC 14 (83%PMN), nml HCT, UA with a few 
bacteria and mod leuk esterase. 

As patient was drinking oral contrast for the CT she developed 
sharp substernal CP. Repeat EKG was unchanged and the troponin 
was negative. Patient given ASA 325mg although she was bleeding. 
Pain resolved with 2.5mg IV morphine but later returned. Bedside 
ultrasound was neg for aortic aneurysm/dissection and 
pericardial tamponade. Pain resolved with 5mg morphine. 

CT abd/pelvis showed thickened and abnormal stomach, wall 
thickening in right colon with adjacent thickening of the 
lateral conal fascia, and diverticuli, though not in the region 
of the abnormality to suggest diverticulitis as a cause. In 
addition to ASA and morphine patient was also given zosyn for 
presumed colitis. GI and surgery evaluated the patient and 
recommended admission to medicine.  

On arrival to the floor the patient is more comfortable and 
states that her pain has decreased and is almost at her baseline 
(has ___ abdominal pain at baseline). No further GI bleeding 
since coming to the ED.
 
Past Medical History:
Irritable Bowel Syndrome
Benign Hypertension
hypercholesterolemia
___ esophagus
Obstructive Sleep Apnea
TIA ___
arthritis
Brain aneurysm
Endometriosis
Diverticulosis
Hemorrhoids  
PSHx: open cholecystectomy ___ yrs ago, appendectomy, 
oopherectomy, removal of brain aneursym
 
Social History:
___
Family History:
h/o colitis in mother
 
Physical ___:
ADMISSION PHYSICAL EXAM:
VITALS: 98.6, 132/60, 75, 14, 97%RA
GENERAL: WDWN woman in NAD
HEENT: PERRL, EOMI, no icterus or pallor
NECK: Supple, no carotid bruits, no JVD
LUNGS: CTAB
HEART: RRR, ___ SEM loudest at USB, no S3/S4
ABDOMEN: Soft, TTP across lower abdomen, no guarding or rebound
EXTREMITIES: WWP, no c/c/e
NEUROLOGIC: A&Ox3, CNs grossly intact, strength and sensation 
grossly intact
.
DISCHARGE PHYSICAL EXAM:
PHYSICAL EXAM:
VS: Temp 98.5 F, BP 126/52, HR 72, R 18, 99% on cpap
GENERAL - well-appearing mildly obese woman in NAD, comfortable, 
appropriate.
HEENT - NC/AT, PERRLA, sclerae anicteric, MMM, OP clear
NECK - supple, no thyromegaly, no bruits
LUNGS - CTA bilat, no r/rh/wh, good air movement, resp 
unlabored, no accessory muscle use
HEART - RRR, systolic ejection murmur heard best over LUSB, 
radiating into L carotid
ABDOMEN - Soft, mildly distended, mild tenderness to palpation 
greatest in lower quadrants, no rebound/guarding
EXTREMITIES - WWP, no c/c/e
NEURO - awake, A&Ox3, CNs II-XII grossly intact, moving all 
extremities independently, able to stand and walk w/ normal 
gait.
 
Pertinent Results:
ADMISSION LABS: 
___ 12:30PM BLOOD WBC-14.0*# RBC-4.07* Hgb-12.7 Hct-37.7 
MCV-93 MCH-31.2 MCHC-33.6 RDW-13.4 Plt ___
___ 12:30PM BLOOD ___ PTT-33.9 ___
___ 12:30PM BLOOD Glucose-127* UreaN-25* Creat-1.1 Na-139 
K-3.4 Cl-100 HCO3-28 AnGap-14
___ 12:30PM BLOOD ALT-17 AST-29 AlkPhos-99 TotBili-0.6
___ 10:38PM BLOOD cTropnT-<0.01
___ 12:30PM BLOOD cTropnT-<0.01
___ 12:30PM BLOOD Albumin-4.6
___ 09:53AM BLOOD Calcium-8.5 Phos-2.2* Mg-1.7

___ 6:45 pm URINE

**FINAL REPORT ___
URINE CULTURE (Final ___: MIXED BACTERIAL FLORA ( >= 3 
COLONY TYPES), CONSISTENT WITH SKIN AND/OR GENITAL 
CONTAMINATION. 

DISCHARGE LABS: 
___ 06:00AM BLOOD WBC-12.2* RBC-3.49* Hgb-10.9* Hct-32.2* 
MCV-92 MCH-31.1 MCHC-33.7 RDW-12.9 Plt ___
___ 06:00AM BLOOD Plt ___
___ 06:00AM BLOOD Glucose-82 UreaN-11 Creat-0.6 Na-142 
K-3.5 Cl-108 HCO3-25 AnGap-13
___ 06:00AM BLOOD Calcium-8.9 Phos-1.7* Mg-1.8

___: C. difficile DNA amplification assay (Pending): 
FECAL CULTURE (Pending): 
CAMPYLOBACTER CULTURE (Pending): 
FECAL CULTURE - R/O VIBRIO (Pending): 
FECAL CULTURE - R/O YERSINIA (Pending): 
FECAL CULTURE - R/O E.COLI 0157:H7 (Pending): 

STUDIES: 

CHEST (PORTABLE AP) Study Date of ___ 3:39 ___ 
IMPRESSION: 
Minimal patchy opacity in the right lung base, which is 
nonspecific, and may reflect atelectasis.  Aspiration or early 
infection is not excluded. 
 
CT ABD & PELVIS W/O CONTRAST Study Date of ___ 4:36 ___ 
IMPRESSION: 
1.  Colitis of the left colon along a 14-cm segment.  This may 
reflect 
ischemic colitis, however, infectious or inflammatory etiologies 
are not 
excluded.
2.  Colonic diverticulosis without diverticulitis.
3.  Calcified 1.4 cm right renal arterial aneurysm, unchanged.
4.  7-mm hyperdense cyst in the lower pole of the left kidney, 
which could be better evaluated with ultrasound on a 
non-emergent basis.
5.  Unchanged 5-mm nodule in the right middle lobe, for which no 
further 
followup is required.

Sigmoidoscopy ___:
Impression:
Superficial ulceration, erythema, friability and abnormal 
vascularity in the splenic flexure compatible with colitis 
likely from ischemia (biopsy)
Normal mucosa in the sigmoid colon (biopsy)
Internal hemorrhoids
Otherwise normal sigmoidoscopy to transverse colon

PATHOLOGY EXAMINATION: ""DIAGNOSIS: 
Colonic mucosa, biopsies, three: 
A. Transverse:
Mildly active inflammation with regenerative changes. No chronic 
colitis seen.
B. Splenic flexure:
- Fragments of colonic mucosa with recent hemorrhage, likely 
procedural.
- Strips of surface epithelium admixed with neutrophils (not 
present on level 2 and cannot be further evaluated).
C. Sigmoid: Within normal limits.
Note: The differential diagnosis includes infection, some drugs, 
ischemia, etc. Clinical correlation is needed.""
 
Brief Hospital Course:
1. Abdominal Pain b/l lower quadrants, Acute Blood Loss Anemia, 
Ischemic Colitis, Rectal Bleeding, gastroenteritis:
Pt was were admitted with abdominal pain and bloody diarrhea. CT 
scan revealed wall thickening in the right colon in a watershed 
area pointing to ischemic colitis, although infection and 
diverticulitis were also on the differential. Pt's hematocrit 
remained low but stable. Labs notable for WBC 14 (83%PMN), nml 
HCT, UA with a few bacteria and mod leuk esterase. She was 
treated with IV fluids, and her pain controlled with morphine. A 
sigmoidoscopy was performed that also revealed evidence of 
ischemic colitis. Pt's pain resolved over the course of her 
stay, and her nausea was treated with compazine 5 mg. By day of 
discharge she was having no more bloody BMs and was able to eat. 
She was encouraged to take good PO, and to hold her high blood 
pressure meds until she follows up with her outpatient doctor. 

2. Chest Pain:
In the ED as the patient was drinking IV contrast, she developed 
substernal chest pain. An EKG was w/o ischemic changes and 3 
troponins returned negative. Ultrasound in the ED was neg for 
aortic aneurysm/dissection or pericardial tamponade. Given her 
history of ___ esophagus, her chest pain may have been GI 
related, or in the setting of acute bleeding, she may have been 
in a demand ischemia setting. Her chest pain did no recur in the 
hospital; she can discuss the merits of  an outpatient echo with 
her cardiologist. She was discharged chest pain free and 
encouraged to followup with a GI doctor. 

3. GERD. 
Continued PPI and H2 blocker.

4. Benign Hypertension. 
Antihypertensives were held due to normotension likely in 
setting of bleeding

5. Hyperlipidemia. 
Continued crestor

6. Obstructive Sleep Apnea. 
Continued CPAP on auto settings as inpatient. 

TRANSITIONAL ISSUES
====================
-- Patient had colonic biopsy taken which will need to be 
followed up; negative at discharge, returned at time of this 
writing.  
-- Patient had renal cyst seen on CT abdomen which should be 
followed up with renal ultrasound to rule out malignanacy
 
Medications on Admission:
- amlodipine 10mg daily  
- esomeprazole 40mg daily  
- lisinopril 5mg daily  
- modafinil 200mg QAM and 100mg QPM  
- ranitidine 150mg daily prn  
- rosuvastatin 40mg daily  
- triamterene-HCTZ 37.5-25mg daily  
- zolpidem 5mg daily  
- aspirin 81mg daily  
- centrum silver MVI daily  
- PB-8 probiotic; 2 tabs daily  
- methylcellulose 1 scoop BID  
- polyethylene glycol daily
 
Discharge Medications:
1. Zolpidem Tartrate 5 mg PO HS 
2. modafinil *NF* 200 mg Oral QAM Reason for Ordering: Wish to 
maintain preadmission medication while hospitalized, as there is 
no acceptable substitute drug product available on formulary.
3. modafinil *NF* 100 mg ORAL QPM Reason for Ordering: Wish to 
maintain preadmission medication while hospitalized, as there is 
no acceptable substitute drug product available on formulary.
4. Aspirin 81 mg PO DAILY 
5. methylcellulose (laxative) *NF* 1 scoop Oral BID 
6. Polyethylene Glycol 17 g PO DAILY 
7. rosuvastatin *NF* 40 mg Oral Daily 
8. Esomeprazole Magnesium *NF* 40 mg ORAL DAILY 
9. Centrum Silver *NF* (multivitamin-minerals-lutein;<br>mv with 
min-lycopene-lutein;<br>mv-min-folic acid-lutein) 400-250 mcg 
Oral Daily 
10. Ranitidine 150 mg PO DAILY:PRN Dyspepsia 
11. Loperamide 2 mg PO QID:PRN Frequent stooling 
RX *Anti-Diarrhea 2 mg 1 tabs by mouth Every ___ Hours Disp #*30 
Tablet Refills:*0

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Primary 
Ischemic Colitis

Secondary
Hypertension
Diverticuolsis
Irritable bowel syndrome
Barretts esophagus
 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
 
Discharge Instructions:
It was a pleasure taking care of you in your hospital stay at 
___. As you know, you were admitted with abdominal pain and 
bloody diarrhea. We performed a CT scan which showed findings 
consistent with decreased blood flow to the colon and colitis 
(ischemic colitis). We checked your blood level and it remained 
stable and not danerously low. We performed a sigmoidoscopy that 
also revealed evidence of ischemic colitis. 

Ischemic colitis will improve with time in the next two weeks. 
In that time, we recommend that you maintain good hydration and 
do not take your high blood pressure medication.

Please see below for changes to your medications.
 
Followup Instructions:
___
"
10848570-DS-12," 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Patient recorded as having No Known Allergies to Drugs
 
Attending: ___.
 
Chief Complaint:
Fall
 
Major Surgical or Invasive Procedure:
Endotracheal Intubation
Central Venous Line Placement
___ Dobhoff Feeding Tube Placement
 
History of Present Illness:
Mr. ___ is a ___ year old gentleman with dementia, COPD, 
HTN, CAD, PVD, seizure d/o, distant EtOH abuse admitted on 
___ from nursing home after mechanical fall from his bed.  

Per outside hospital records, he fell from bed, approximately 2 
feet to the ground.  He was found on the floor complaining of 
left hip pain. He presented to the ___ where a CT 
abdomen/pelvis revealed a left acetabular and iliac crest 
fracture with a retroperitoneal hematoma.  He was given IV 
fentanyl and dilaudid for pain and transferred to ___ for 
further management.

In the ED his VS were HR 88 BP 136/73  RR18  SpO2 99.  He had a 
distended abdomen and was tender to palpation over his right 
hip.  He has one episode of coffee ground emesis.  A CT abdoemn 
pelvis showeda comminuted, intra-articular left acetabular 
fracture with extension into left superior pubic ramus, ischium, 
and inferior left iliac bone with surrounding large 
retroperitoneal hematoma. HCt was 28 and he was given 2U of 
PRBC. He was admitted to the trauma SICU for management of his 
pelvic fracture and retroperitoneal bleed.

 
Past Medical History:
COPD
HTN
PVD, s/p fem-fem bypass
Seizure Disorder
Anemia
Dysphagia
s/p c1-c2 fusion
 
Social History:
___
Family History:
Unable to obtain 
 
Physical Exam:
VITAL SIGNS: T= 99.5 BP= 164/77 HR= 114, RR 22, SATS= 98% on 
face mask
GEN: frail elderly man, lying on bed, not in acute distress, 
follows simple commends, moaning when repositioned
HEENT: PERRL, oral mucosa dry, NG in place on tube feeding
NECK: no LAD, no JVD
CV: RRR, tachy, no mumurs
RESP: poor inspirtary effort, no wheezes, no crackles
ABD: + BS, soft, +distended, non-tender, no masses, no guarding 
or rebound
PULSES: 2+radial B, 2+ ___ B
GU: Foley catheter
EXT: no edema, no cyanosis, no clubbing
SKIN : no rash, no ulceration, no erythema in decubiti
NEURO: awake alert to person only, no tremor; no rigidity, gait= 
not assessed
CAM: A/F: Y Inat: ? Disorg: ? Consc: N total:/4
Attention test: demented, unable to test at this time 
 
Pertinent Results:
___ CT c-spine: s/p post c1-c2 fusion. metallic nail through L 
lat C2 extends w/tip in retropharnyngeal/prevertebral jxn soft 
tissues ant to C1. mild anterolisthesis of C4 over C5. very min 
retrolisthesis C5 over C6. mult-level ___ change. no acute fx 
seen. pulmonary emphysema. coarse vertebral and carotid artery 
calcs. 6mm R thyroid lobe hypodensity.
___ CT torso: 1.6 x 1.2 cm focal hypodensity in ant 
mediastinum (S2:im15). ?focal hematoma vs thymic cystic lesion. 
No overlying sternal fx or aortic injury. dense aortic calcs. 
LLL atelect/scarring. comminuted, intra-art L acetabular fx 
involv ant &post columns and ext to L sup pubic ramus. adj mod 
pelvic hematoma w/out active extrav. hematoma crosses midline, 
extends superiorly ant to L psoas muscle and iliacus. mild loss 
of ht of L2 & L3 vert bodies. Grade 1 spondylolisthesis L5/S1. 
bladder diverticula .

___ CT head: No acute ICH. opacification of inf L maxillary
sinus w/focal loss of ant inf L max sinus/ant L alveolar bone, 
adj soft tissue swelling and foci of gas. ?infectious process 
involving L alveolar process of maxilla, dental in nature vs 
chronic sinusitis vs injury. recommend direct visualization.

___ CXR: No consolidation

___ CXR (pm): Increased lung volumes c/w emphysema. 
Peribronchial cuffing and predominantly R-sided interstitial 
opacities likely fluid overload. Subtle opacity @R apex 
?superimposition of external
ventilator apparatus vs. consolidation.

___ CXR:
The Dobbhoff tube tip is in the stomach. Cardiomediastinal 
silhouette is
stable. There is no change in upper lobe interstitial opacities 
in this
patient with hyperinflated lungs. The lower lungs are 
unremarkable. There is no pleural effusion. There is no 
pneumothorax.

___ ECG:
Normal sinus rhythm. Q waves in leads V1-V2 consistent with 
prior anteroseptal myocardial infarction. Compared to the 
previous tracing of ___ there has been no diagnostic 
interim change.
 IntervalsAxes
___

Admission Labs:

___ 06:00PM BLOOD WBC-6.6 RBC-3.25* Hgb-9.7* Hct-28.3* 
MCV-87 MCH-29.8 MCHC-34.3 RDW-15.6* Plt ___
___ 06:00PM BLOOD Neuts-88.2* Lymphs-6.2* Monos-4.9 Eos-0.6 
Baso-0.1
___ 06:00PM BLOOD ___ PTT-26.9 ___
___ 06:00PM BLOOD Glucose-120* UreaN-18 Creat-0.8 Na-128* 
K-4.2 Cl-97 HCO3-22 AnGap-13
___ 02:18PM BLOOD ALT-14 AST-16 CK(CPK)-50 AlkPhos-61 
TotBili-0.6
___ 09:47PM BLOOD Calcium-8.3* Phos-4.9* Mg-1.9
___ 10:07PM BLOOD TSH-3.8
___ 07:59PM BLOOD Lactate-0.9

Discharge Labs:

___ 05:05AM BLOOD WBC-7.8 RBC-3.15* Hgb-9.3* Hct-28.3* 
MCV-90 MCH-29.4 MCHC-32.7 RDW-14.6 Plt ___
___ 05:05AM BLOOD Glucose-110* UreaN-18 Creat-0.6 Na-139 
K-3.2* Cl-105 HCO3-22 AnGap-15
___ 06:10AM BLOOD Calcium-9.0 Phos-4.5 Mg-2.3
 
Brief Hospital Course:
#. Pelvic fracture. He was initially admitted to the trauma 
surgery service.  He was seen by orthopedic surgery and a pin 
was placed through the distal femur and the leg was placed in 
traction in anticipation of possible surgery.  3d reconstructive 
CT imaging of the pelvis was performed.  Ultimately, it was 
decided to treat this fracture non operatively given his 
baseline functional status and the severity of his fracture on 
imaging.  The pin was removed. Pain was controlled with IV 
morphine and PO oxycodone.

# Retroperitoneal Bleed.  On CT, retroperitoneal and pelvic 
bleeding was discovered. Interventional radiology was consulted 
and patient was monitored clinically.  He remained 
hemodynamically stable and his hematocrit remained stable and no 
intervention was necessary. His hematocrit remained stable for 
the remainder of his hospitalization.

# Hospital Acquired Pneumonia - On ___, patient developed a 
fever, hypoxia and an infiltrate was noted on CXR.  He was 
started on empiric therapy for hospital acquired pneumonia of 
vancomycin, ciprofloxacin, and cefepime IV.  A 7 day course was 
completed with an improvement in his breathing, and a reduction 
in his oxygen requirement.  On the floor he was given standing 
albuterol and Atrovent nebs, and was had regular chest ___ with 
respiratory therapy with a significant improvement in function.  


# Tachycardia - Patient had tachycardia, alternating between 
sinus tachycardia and multifocal atrial tachycardia in the range 
of 110-140 early in his SICU course.  Cardiology was consulted 
and recommended up titration of his metoprolol. His metoprolol 
was gradually up titrated to 200mg PO tid.  As his clinical 
picture improved, this dose was gradually reduced to 50mg PO 
bid, with rates in the ___ on discharge.

# Nutrition - Initial speech and swallow evaluation found that 
it was unsafe for him to take anything PO due to aspiration 
risk. A Dobbhoff feeding tube was placed for nutrition and given 
tube feeds.  He pulled the feeding tube once, and it needed to 
be replaced.  Repeat speech/swallow evaluation with video 
swallow found him to be safe to eat pureed solids with nectar 
thickened liquids.  Feeding tube was removed and he was started 
on the recommended diet on discharge.

#. Goals of care - The patient had severe dementia, and had no 
health care proxy on admission.  Guardianship was obtained 
emergently given the patient initially tenuous clinical status.  
___ (___ has agreed to be Mr. ___ guardian.  On 
discussion with Mr. ___ tube placement was declined 
and it was decided to change Mr. ___ code status to 
DNR/DNI.
 
Medications on Admission:
metoprolol 25mg PO bid
tramadol 50mg PO tid
simvastatin 5mg PO qhs
hytrin 5mg PO qhs
celexa 30mg PO daily
cilostazol 100mg PO bid
omeprazole 20mg PO bid
colace 100mg PO bid
advair 250/50
proair 90mcg IH q4prn
keppra 500mg PO bid
asa 325 po daily
folic acid 1mg po daily
multivitamin 1 tablet daily
vitamin b1 100mg po q daily
 
Discharge Medications:
1. Levetiracetam 500 mg Tablet Sig: One (1) Tablet PO BID (2 
times a day).  
2. Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a 
day) as needed for constipation.  
3. Acetaminophen 325 mg Tablet Sig: ___ Tablets PO every six (6) 
hours as needed for pain.  
4. Olanzapine 5 mg Tablet, Rapid Dissolve Sig: 0.5 Tablet, Rapid 
Dissolve PO TID (3 times a day) as needed for agitation.  
5. Bisacodyl 10 mg Suppository Sig: One (1) Suppository Rectal 
HS (at bedtime) as needed for constipation.  
6. Metoprolol Tartrate 50 mg Tablet Sig: One (1) Tablet PO BID 
(2 times a day).  
7. Polyethylene Glycol 3350 17 gram/dose Powder Sig: One (1)  PO 
DAILY (Daily) as needed for constipation.  
8. Advair Diskus 250-50 mcg/Dose Disk with Device Sig: One (1) 
puff Inhalation twice a day.  
9. Celexa 10 mg Tablet Sig: Three (3) Tablet PO once a day.  
10. Prilosec 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) 
Capsule, Delayed Release(E.C.) PO once a day.  
11. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO twice 
a day.  
12. Oxycodone 5 mg Tablet Sig: ___ Tablets PO every ___ hours as 
needed for pain.  
13. Albuterol Sulfate 90 mcg/Actuation HFA Aerosol Inhaler Sig: 
___ puffs Inhalation every four (4) hours as needed for 
shortness of breath or wheezing.  
14. Simvastatin 5 mg Tablet Sig: One (1) Tablet PO once a day.  
15. Aspirin 325 mg Tablet Sig: One (1) Tablet PO once a day.  
16. Folic Acid 1 mg Tablet Sig: One (1) Tablet PO once a day.  
17. Multivitamin     Tablet Sig: One (1) Tablet PO once a day.  
18. Vitamin B-1 100 mg Tablet Sig: One (1) Tablet PO once a day. 
 

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
Pelvic Fracture
Retroperitoneal Bleed
Multifocal Atrial Tachycardia
Pneumonia
COPD
Dementia

 
Discharge Condition:
Baseline dementia, not oriented to place or time. Ambulating 
with assistance.  

 
Discharge Instructions:
You were admitted for a fall.  You were found to have a pelvic 
fracture, and surgery was not needed.  You developed a bleed 
into your back and pelvis that resolved.  You also developed a 
high heart rate which was controlled with medications.  You 
developed a pneumonia which was treated with intravenous 
antibiotics.  Your pain was controlled with oxycodone. 
 
Followup Instructions:
___
"
10860165-DS-24," 
Name:  ___              Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: SURGERY
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
trauma evaluation s/p fall from ladder
 
Major Surgical or Invasive Procedure:
none

 
History of Present Illness:
___ is a ___ year old male who complains of S/P FALL 
from ___ FT. He was transferred from outside hospital and 
presents to ___ ED. His fall was approximately 20 feet off of 
a ladder. He Landed on his left side. Seen in outside hospital 
and diagnosed with multiple rib fractures on the left with a 
pneumothorax and splenic laceration. CT head and neck were 
negative. Transferred here for pain control and trauma surgery 
evaluation.

 
Past Medical History:
PMH:  
Hepatitis C cirrhosis, grade 2 esophageal varices

PSH: 
ankle surgery 

Hepatitis C, genotype 3 with resultant cirrhosis
-- last VL: HCV VIRAL LOAD (Final ___: 1,270,000 IU/mL. 
-- S/P interferon & ribavirin; d/c'd for thrombocytopenia, 
relapsed
-- RUQ ultrasound ___, no lesions stable mild splenomegaly 

and tiny gallstones.  
-- EGD ___ cords superficial grade 2 varices not bleeding, 
ulcers, biopsies of which were negative; on Prilosec and 
Nadalol.
 
Social History:
___
Family History:
Mother deceased from breast cancer, father has diabetes. 
Siblings and children are healthy.

 
Physical Exam:
On admission:
Resp: 18 O(2)Sat: 94 Normal
Constitutional: Uncomfortable
HEENT: Normocephalic, atraumatic
No C-spine tenderness
Chest: No crepitus, left chest wall tenderness to palpation, 
bilateral breath sounds
Cardiovascular: Regular Rate and Rhythm
Abdominal: Tender in the left abdomen
GU/Flank: No costovertebral angle tenderness
Extr/Back: No long bone deformities
Skin: No rash
Neuro: GCS 15, moving all extremities well
Psych: Normal mood

On Discharge:
VS: 98.4F HR 62 99/50 RR 16 97%
HEENT: Normocephalic, atraumatic, no C-spine tenderness
Chest: No crepitus, left chest wall tenderness to palpation, 
bilateral breath sounds, CTAB, decreased air movement R base
Cardiovascular: RRR no MRG
Abdominal: LUQ tenderness along costal margin
GU/Flank: No costovertebral angle tenderness
Neuro: GCS 15, no focal neuro deficits 
Psych: Normal mood, happy about going home

 
Pertinent Results:
___ 09:55PM   ___ 09:55PM   PLT COUNT-56*
___ 09:55PM   ___ PTT-30.1 ___
___ 09:55PM   WBC-10.4 RBC-4.02* HGB-15.2 HCT-40.4 MCV-101* 
MCH-37.9* MCHC-37.7* RDW-14.1
___ 09:55PM   ASA-NEG ETHANOL-NEG ACETMNPHN-NEG 
bnzodzpn-NEG barbitrt-NEG tricyclic-NEG
___ 09:55PM   LIPASE-63*
___ 09:55PM   estGFR-Using this
___ 09:55PM   UREA N-15 CREAT-0.6
___ 09:59PM   freeCa-1.12
___ 09:59PM   HGB-14.9 calcHCT-45 O2 SAT-76 CARBOXYHB-4 MET 
HGB-0
___ 09:59PM   ___ PO2-48* PCO2-47* PH-7.35 TOTAL 
CO2-27 BASE XS-0 INTUBATED-NOT INTUBA
___ 11:00PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-NEG 
GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.5 
LEUK-NEG
___ 11:00PM URINE  COLOR-Yellow APPEAR-Clear SP ___
___ 11:00PM URINE  UHOLD-HOLD
___ 11:00PM URINE  HOURS-RANDOM

CT Abdomen ___:
1.  No suspicious arterially-enhancing liver lesions are 
identified. 
2. Unchanged sequela of liver cirrhosis and portal hypertension, 
including splenomegaly, paraesophageal, and splenic varices.   
3. Cholelithiasis without cholecystitis. 

CXR ___:
1.  Multiple left rib fractures and small to moderate left 
pneumothorax. 
2.  Layering left hemothorax as seen on outside CT. 

CXR: ___: Left hemopneumothorax is increased compared to ___, causing increase in tension and contralateral mediastinal 
shift. 

CXR: ___: 
1.Left chest tube has been placed since 8 hr prior. Left 
hemopneumothorax is decreased. 
2. Left hemidiaphragm is elevated, which could be due to left 
lung base 
atelectasis or diaphragm injury. 
3. Right lung base opacity could be due to atelectasis or 
aspiration. 

XR Shoulder ___:  
Unremarkable appearance of the right shoulder on these limited 
views. 

CXR: ___: Cardiomediastinal silhouette is unchanged. Left chest 
tube is in place. No pneumothorax is seen. Overall no 
substantial change since the previous study demonstrated. 

CXR: ___ In comparison with the earlier study of this date, 
with the chest tube on water seal there is possibly a tiny left 
apical pneumothorax. Otherwise, little change in the appearance 
of the heart and lungs. 

CXR ___: 
1. Interval increase in size of a small left apical 
pneumothorax. 
2. Increased left basilar opacification, likely representing a 
layering 
pleural effusion. 

CXR ___:
Left chest tube is in place. Left pneumothorax appears to be 
similar to 
previous examination, small. Right lung is well-aerated. 
Cardiomediastinal silhouette is stable 

CXR ___: Left chest tube is in place. Small left apical 
pneumothorax is unchanged. Lung volumes are lower than on the 
previous study. Elevated right hemidiaphragm is re- 
demonstrated. Cardiomediastinal silhouette is stable. Left rib 
fractures are partially imaged 

CXR ___: Left chest tube is in unchanged position.  Small left 
pneumothorax is unchanged. There is mild bibasilar atelectasis. 
Elevation of left hemidiaphragm is similar to prior. There is no 
pleural effusion. Cardiomediastinal silhouette is mildly 
enlarged. Again seen are multiple left rib fractures 
posteriorly. Small left pneumothorax is unchanged since 5 hr 
prior.

CXR ___: Small residual left pneumothorax unchanged over 24 hr. 
Large left juxtahilar
pneumatocele that grew between ___ and ___, 
subsequently stable. Bibasilar atelectasis is mild. There is no 
appreciable left pleural effusion despite multiple left rib 
fractures. Basal pleural drainage catheter place. Essentially 
normal cardiomediastinal silhouette.

CXR PA/LAT ___:  Left small pneumothorax is unchanged.  There 
is left lung volume loss and
elevation of left hemidiaphragm, similar to prior. There is 
small left pleural effusion/ hemothorax, similar to prior. 
Multiple left posterior rib fractures are again noted. No 
notable interval change since ___. Stable small left 
hemopneumothorax and left lung volume loss.
 
Brief Hospital Course:
The patient was transferred to ___ Emergency Department on 
___ from an outside hospital. Mr. ___ was evaluated by 
the acure care surgery team. Initial imaging (CT Abdomen ___ 
identified multiple rib fractures and small to moderate left 
pneumothorax and a grade 2 splenic laceration. ( 1. No 
suspicious arterially-enhancing liver lesions are identified.  
2. Unchanged sequela of liver cirrhosis and portal hypertension, 
including splenomegaly, paraesophageal, and splenic varices.  3. 
Cholelithiasis without cholecystitis.)  A same day CXR ___ 
showed again, multiple left rib fractures and small to moderate 
left pneumothorax. and layering left hemothorax. CT head and 
C-spine were negative. 

Given concern for continued hemopneumothorax, a left sided chest 
tube was placed on ___ and 200cc drained immediately, with an 
additional 800cc afterwards. Platelets were transfused prior to 
chest tube placement. The patient was restarted on his home 
rifaximin and lactulose. Home spironolactone held for 
hyperkalemia. The Acute Pain Service (APS) was consulted for an 
epidural, however the patient was deemed to not be a good 
candidate given the thromboyctopenia. Serial hematocrits 
stabilized: 40->35->36.8->35.6->33.1->33.1. Adjuncts were added 
for pain control: APAP ATC (cleared with hematology service 
given the history of liver disease) and additional pain control 
was achieved with a dilaudid PCA and lidocaine patch. The diet 
was advanced to clears and then ADAT regular. The patient was 
placed in the trauma surgical intensive care unit and a tertiary 
trauma survery was remarkable for shoulder pain. Plain films of 
shoulder were negative. The next day the patient was 
transitioned to po oxycodone, the dPCA was discontinued. 
However, the pain was poorly controlled and other adjuncts were 
adjusted: gabapentin increased, clonidine started, dilaudid 
PRNs. The chest tubes were placed to water seal and home BP 
medications were restarted. On ___, additional pain control 
was required and oxycodone was increased per APS.  The ___ CXR 
looked worse and CT was put back to suction. The patient was 
stable and transfered to the surgical care floor. The ___ CXR 
showed a persistence of PTX and thus the chest tube was kept on 
suction. Patient was demonstrating good respiratory excursion 
and using IS well. Physical therapy was consulted and 
recommended discharge to home when medically ready. 

On ___, repeat CXR continued to show a PTX and CT was kept on 
suction. Over the course of the next few days CXR imaging 
continued to show a persistent left sided apical PTX with small 
left costophrenic angle blunting. However the patient continued 
to remain afebrile, with increasingly better pain control, and 
continued to not experience any respiratory distress. On ___ 
CT output decreased to approximately less than 200cc/day and the 
CT was placed on water seal. On ___ CXR showed an unchanged 
apical PTX and the CT was pulled with stable post-pull CXR. On 
___ CXR again showed a stable PTX and Mr. ___ was 
prepared for discharge to home with close follow up with CXR 
imaging arranged. 

The patient received subcutaneous heparin and ___ dyne boots 
were used during this stay and was encouraged to get up and 
ambulate as early as possible. At the time of discharge, the 
patient was doing well, afebrile and hemodynamically stable.  
The patient was tolerating a diet, ambulating, voiding without 
assistance, and pain was well controlled.  The patient received 
discharge teaching and follow-up instructions with understanding 
verbalized and agreement with the discharge plan.
 
Medications on Admission:
Famotidine 20', furosemide 60', lactulose 30 cc BID prn 
onstipation, nadolol 20', oxycodone 5 mg q6h prn, rifaximin 550 
mg BID, sofosbuvir and 5816 one tablet once daily, Aldactone 
200', and ursodeoxycholic acid ___ BID
 
Discharge Medications:
1. Famotidine 20 mg PO DAILY 
2. Furosemide 60 mg PO DAILY 
3. Lactulose 30 mL PO BID 
4. Lidocaine 5% Patch 1 PTCH TD QAM 
RX *lidocaine [Lidoderm] 5 % (700 mg/patch) apply to affected 
chest wall QAM for 12 hours Disp #*14 Patch Refills:*0
5. Nadolol 20 mg PO DAILY 
6. OxycoDONE (Immediate Release)  ___ mg PO Q3H:PRN pain 
RX *oxycodone 5 mg ___ tablet(s) by mouth q3hrs Disp #*70 Tablet 
Refills:*0
7. Polyethylene Glycol 17 g PO DAILY 
RX *polyethylene glycol 3350 [Miralax] 17 gram/dose 1 powder(s) 
by mouth q day Refills:*0
8. Rifaximin 550 mg PO BID 
9. Senna 8.6 mg PO BID constipation 
RX *sennosides [senna] 8.6 mg 1 tab by mouth twice a day Disp 
#*50 Capsule Refills:*0
10. Sofosbuvir/___ Study Med 1 tablet ORALLY ONCE A DAY 
11. Ursodiol 300 mg PO BID 
12. Gabapentin 600 mg PO TID 
RX *gabapentin 600 mg 1 tablet(s) by mouth three times a day 
Disp #*100 Tablet Refills:*0
13. Docusate Sodium 100 mg PO BID 
RX *docusate sodium [Colace] 100 mg 1 capsule(s) by mouth twice 
a day Disp #*50 Capsule Refills:*0

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Rib fractures
Left Pneumothorax/Hemopneumothorax
Splenic laceration (grade 2)

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Mr. ___,
You were brought to the ___ ED after sustaining a fall from a 
ladder. You were found to have rib fractures, a collapses lung 
and a laceration of your spleen. You have recovered and are now 
ready to be discharged from the hospital.

Please read the following instructions:
*AVOID contact sports and/or any activity that may cause injury 
to your abdominal area for the next ___ weeks.
 
*If you suddenly become dizzy, lightheaded, feeling as if you 
are going to pass out go to the nearest Emergency Room as this 
could be a sign that you are having internal bleeding from your 
liver or spleen injury.
 
*AVOID any blood thinners such as Motrin, Naprosyn, Indocin, 
Aspirin, Coumadin or Plavix for at least ___ days unless 
otherwise instructed by the MD/NP/PA.

* Your injury caused multiple rib fractures which can cause 
severe pain and subsequently cause you to take shallow breaths 
because of the pain.
 
* You should take your pain medication as directed to stay ahead 
of the pain otherwise you won't be able to take deep breaths. If 
the pain medication is too sedating take half the dose and 
notify your physician.
 
* Pneumonia is a complication of rib fractures.  In order to 
decrease your risk you must use your incentive spirometer 4 
times every hour while awake.  This will help expand the small 
airways in your lungs and assist in coughing up secretions that 
pool in the lungs.
 
* You will be more comfortable if you use a cough pillow to hold 
against your chest and guard your rib cage while coughing and 
deep breathing.
 
* Symptomatic relief with ice packs or heating pads for short 
periods may ease the pain.
 
* Narcotic pain medication can cause constipation therefore you 
should take a stool softener twice daily and increase your fluid 
and fiber intake if possible.
 
* Do NOT smoke
 
* If your doctor allows, non-steroidal ___ drugs 
are very effective in controlling pain ( ie, Ibuprofen, Motrin, 
Advil, Aleve, Naprosyn) but they have their own set of side 
effects so make sure your doctor approves.
 
* Return to the Emergency Room right away for any acute 
shortness of breath, increased pain or crackling sensation 
around your ribs (crepitus).

 
Followup Instructions:
___
"
10912090-DS-33," 
Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Abacavir Sulfate / Aspirin / fluconazole / levetiracetam / 
morphine
 
Attending: ___.
 
Chief Complaint:
fevers, myalgias
 
Major Surgical or Invasive Procedure:
None
 
History of Present Illness:
___ is a ___ with a history of HIV/AIDS ___: CD4 
218, VL 7900, ___: CD4 nadir 8), poorly compliant with HAART 
on lamivudine, darunavir-cobicistat, dolutegavir, and multiple 
opportunistic infections including CMV retinitis/esophagitis and 
___ esophagitis presenting with 1 day of subjective fever 
and myalgias.  The patient reports full body aches and chills.  
She had one episode of emesis this AM and has had a poor 
appetite.  The patient took 3 acetaminophen without palliation 
of symptoms.  The patient denies HA, neck pain, pain with 
swallowing, SOB, CP, abdominal pain, dysuria, diarrhea.  She 
also denies history of new foods and recent travel.

 In the ED, initial vitals: 100.4 | 109 | 116/89 | 16 | 100% RA 

- Labs were significant for:
Lactate 1.0
ALT 24 AST 44 AP 116 Tbili 0.3 Alb 3.6 Lipase 130 
Na 138 K 4.6 Cl 103 HCO3 20 BUN 21 Cr 1.2 Glu 92
Ca 9.1 Mg 1.7 Phos 4.4 
Tox screen: Serum ASA, EtOH, Acetmnphn, Benzo, Barb, Tricyc, 
Negative
WBC 4.5 Hgb 10.0 Hct 31.3 Plt 168
N:52.2 L:29.7 M:13.0 E:4.0 Bas:0.4 ___: 0.7 Absneut: 2.32 
Abs lymp: 1.32 Abs mono: 0.58 Abs eos: 0.18 Abs baso: 0.02 

CSF Chem 
#2: Prot 37, Glu 49
#3: No PMN's, no microorganisms, Cryptococcal Ag: Negative
#4: WBC 1, RBC 1, Poly 0, Lymph ___ Mono 3, Eos 0

Pending labs:
CMV VL 
HSV PCR
___
CD3%,Abs-CD3
CD4%,Abs-CD4 
CD8%,Abs-CD8
CD4/CD8
Blood cx

 - Imaging showed:
CXR: Impression: Atelectasis in the right cardiophrenic region. 
No definite evidence of pneumonia. 

CT head w/o contrast (prelim): 
1. No evidence of an acute intracranial abnormality.
2. Unchanged age advanced atrophy. 
 
 - In the ED, she received: 
Acetaminophen 1000mg PO
NS IVF 50mL/hr    

 - Vitals prior to transfer:  100.4 | 96 | 140/83 | 20 | 100% RA 


 Upon arrival to the floor, the patient was in stable condition. 
 She was uncomfortable with a low-grade fever, but responsive to 
interview.   
 
 REVIEW OF SYSTEMS:  
 No night sweats or weight changes. No changes in vision or 
hearing, no changes in balance. No cough, no shortness of 
breath, no dyspnea on exertion. No chest pain or palpitations. 
No constipation. No hematuria. No hematochezia, no melena. No 
numbness or weakness, no focal deficits.  
 
Past Medical History:
# AIDS (CD4 218, VL 7900 ___ resistant disease - followed 
by ID, Dr. ___ 
 - on dolutegravir, darunavir-cobi, lamuvidine ___ on Stribild)
# esophageal candidiasis, CMV esophagitis and colitis ___    
# ___ esophagitis 
 - ___
 - ___
 - ___ s/p fluc/vori (completed ___
# CIN II-III s/p LEEP procedure  
# Strongyloidiasis infection, treated
# Bacterial meningitis, treated 
# Seizure 
# Depression  
# Gastritis secondary to H. Pylori  
# Nephrolithiasis  
# Cervical spondylosis  
# Migraines  
# Genital and vaginal condyloma  
# L CTS
# S/p open CCY
# h/o R Bell's palsy  
# diverticulitis with microperforation 

 
Social History:
___
Family History:
Sister with seizures, father with stroke.  Mother with HTN.
 
Physical Exam:
 ADMISSION PHYSICAL EXAM: (___)
 Vital Signs: 100.8 119/66 104 20 100 RA
 General: Tired, resting in bed, feeling cold, nondiaphoretic, 
NAD
 HEENT: Sclerae anicteric, MMM, oropharynx clear, EOMI, PERRL, 
neck supple, JVP not elevated, no LAD  
 CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, 
gallops  
 Lungs: Clear to auscultation bilaterally, no wheezes, rales, 
rhonchi  
 Abdomen: Soft, non-tender, non-distended, bowel sounds present, 
no organomegaly, no rebound or guarding  
 GU: No foley  
 Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or 
edema  
 Neuro: CNII-XII intact, ___ strength upper/lower extremities, 
grossly normal sensation, 2+ reflexes bilaterally, gait 
deferred. 
 Skin: No rashes.

ON DISCHARGE: (___)
 GENERAL: NAD, warm
 HEENT: anicteric sclera, pink conjunctiva, mmm
 HEART: RRR, S1/S2, no murmurs, gallops, or rubs  
 LUNGS: breathing comfortably without use of accessory muscles,
CTAB, resonant to percussion ___, no wheezes/ crackles/ rhonchi/
dullness
 ABDOMEN: nondistended, +BS, nontender in all quadrants, no
rebound/guarding, no hepatosplenomegaly, well-healed
cholecystectomy scar RUQ
 EXTREMITIES: no cyanosis, clubbing or edema, moving all 4
extremities with purpose, no pitting edema ___  
 NEURO: alert & oriented, grossly moving all 4 extremities with
purpose, strength ___ UE/ ___
 SKIN: Erythematous flush ___ cheeks- decreased, no other rashes
or skin findings elsewhere

 
Pertinent Results:
ADMISSION LABS:
=================
___ 08:42AM    WBC-4.5  LYMPH-30 ABS LYMPH-1350 CD3-48 ABS 
CD3-642 CD4-9 ABS CD4-123* CD8-35 ABS CD8-471 CD4/CD8-0.26*
___ 08:42AM   NEUTS-52.2 ___ MONOS-13.0 EOS-4.0 
BASOS-0.4 IM ___ AbsNeut-2.32 AbsLymp-1.32 AbsMono-0.58 
AbsEos-0.18 AbsBaso-0.02
___ 08:42AM   WBC-4.5 RBC-3.31* HGB-10.0* HCT-31.3* MCV-95 
MCH-30.2 MCHC-31.9* RDW-14.6 RDWSD-50.8*
___ 11:31PM   ___ PTT-26.7 ___
___ 08:42AM   GLUCOSE-92 UREA N-21* CREAT-1.2* SODIUM-138 
POTASSIUM-4.6 CHLORIDE-103 TOTAL CO2-20* ANION GAP-15
___ 08:42AM   ALBUMIN-3.6 CALCIUM-9.1 PHOSPHATE-4.4 
MAGNESIUM-1.7
___ 08:42AM   ALT(SGPT)-24 AST(SGOT)-44* ALK PHOS-116* TOT 
BILI-0.3
___ 08:42AM   LIPASE-130*
___ 08:42AM   ASA-NEG ETHANOL-NEG ACETMNPHN-NEG 
bnzodzpn-NEG barbitrt-NEG tricyclic-NEG
___ 08:58AM   LACTATE-1.0
___ 09:46AM   CMV VL-NOT DETECT
___ 10:55AM CEREBROSPINAL FLUID (CSF)  TNC-1 RBC-1 POLYS-0 
___ ___ 10:55AM CEREBROSPINAL FLUID (CSF)  PROTEIN-37 
GLUCOSE-49
___ 06:05PM URINE  COLOR-Yellow APPEAR-Hazy* SP ___
___ 06:05PM URINE  BLOOD-MOD* NITRITE-NEG PROTEIN-100* 
GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.0 
LEUK-NEG
___ 06:05PM URINE  RBC-34* WBC-4 BACTERIA-FEW* YEAST-NONE 
EPI-0
___ 06:05PM URINE  GRANULAR-1* HYALINE-5*
___ 06:05PM URINE  MUCOUS-RARE*
___ 11:31PM   PARST SMR-NEGATIVE
___ 11:31PM   OSMOLAL-288

SIGNIFICANT LABS:
=================
___ 09:07AM BLOOD Parst S-NEG
___ 05:05PM BLOOD HIV1 VL-5.6*

EBV PCR, QUANTITATIVE, WHOLE BLOOD
  
Test                          Result              Reference 
Range/Units
SOURCE                        Whole Blood         
EBV DNA, QN PCR               <200                <200 copies/mL
 
Note: Although this result was below our lower limit
of quantitation, EBV was detected. We suggest
repeat testing if clinically warranted.

B-GLUCAN
  
Test                          Result              Reference 
Range/Units
FUNGITELL(R) (___) B D        INTERFERING         pg/mL
GLUCAN ASSAY                  SUBSTANCES PRESENT  
INTERPRETATION                                    
 
Interference may be transitory. Testing of a new sample is
recommended.

STRONGYLOIDES ANTIBODY,IGG

Test                          Result              Reference 
Range/Units
STRONGYLOIDES AB IGG          NEGATIVE            
 

ASPERGILLUS GALACTOMANNAN ANTIGEN
  

Test                          Result              Reference 
Range/Units
INDEX VALUE                   0.17                <0.50
ASPERGILLUS AG,EIA,SERUM      Not Detected        Not Detected
 

Streptococcus pneumoniae Antigen Detection
  
Test                          Result              Reference 
Range/Units
S. PNEUMONIAE ANTIGENS,       Not Detected        Not Detected
URINE                                             

Influenza A by PCR NEGATIVE
Influenza B by PCR NEGATIVE

___ Blood culture - No growth (final)
___ Blood culture - No growth (final)
___ Urine culture - No growth (final)
___ Toxoplasma IgG and IgM - negative
___ Urine Legionella Urinary Antigen - negative
___ Nasal MRSA screen negative
___ Blood culture fungal/AFB - No growth to date (preliminary)
___ respiratory viral panel negative
___ blood cryptococcal antigen negative
___ stool C. diff antigen negative
___ Blood culture - No growth to date (preliminary)
___ Stool culture - No growth (final), Campylobacter negative, 
ova and parasites negative, Vibrio negative, Yersinia negative, 
E.coli O157:H7 negative, Cyclospora negative, 
Cryptosporidium/giardia negative
 
___ CSF Cryptococcal antigen - negative
___ CSF HSV PCR negative

___ 10:55 am CSF;SPINAL FLUID      Source: LP CSF TUBE #3. 

   GRAM STAIN (Final ___: 
      NO POLYMORPHONUCLEAR LEUKOCYTES SEEN. 
      NO MICROORGANISMS SEEN. 
      This is a concentrated smear made by cytospin method, 
please refer to
      hematology for a quantitative white blood cell count.. 

   FLUID CULTURE (Final ___:    NO GROWTH. 

   FUNGAL CULTURE (Preliminary):    NO FUNGUS ISOLATED. 

Anaplasma pending
Lyme pending

SIGNIFICANT IMAGING:
=================
___ Head CT without Contrast
IMPRESSION:
1. No evidence of an acute intracranial abnormality.
2. Slightly prominent ventricles and sulci for the patient's 
age, likely
related with the HIV status and unchanged since the prior study

___ CXR
IMPRESSION: 
 
In comparison with the study of ___, there are slightly 
lower lung
volumes.  Cardiomediastinal silhouette is stable.  No evidence 
of appreciable
vascular congestion, pleural effusion, or acute focal pneumonia.
Evidence of previous cholecystectomy clips in the right upper 
quadrant of the
abdomen.

___ Transthoracic Echo
CONCLUSIONS: The left atrial volume index is moderately 
increased. Left ventricular wall thicknesses and cavity size are 
normal. There is moderate global left ventricular hypokinesis. 
[Intrinsic left ventricular systolic function is likely more 
depressed given the severity of valvular regurgitation.] 
Quantitative (3D) LVEF = 37%. Right ventricular chamber size is 
normal; there is mild free wall hypokinesis. The diameters of 
aorta at the sinus, ascending and arch levels are normal. The 
aortic valve leaflets (3) appear structurally normal with good 
leaflet excursion and no aortic stenosis or aortic 
regurgitation. There is no aortic valve stenosis. The mitral 
valve leaflets are mildly thickened. No mass or vegetation is 
seen on the mitral valve. Moderate to severe (3+) mitral 
regurgitation is seen ___ 0.3 cm2, RV 35 cc/beat). There is 
mild pulmonary artery systolic hypertension. No vegetation/mass 
is seen on the pulmonic valve.

IMPRESSION: No vegetations seen. Moderate global left 
ventricular systolic dysfunction. Moderate to severe mitral 
regurgitation. Mild pulmonary hypertension.

DISCHARGE LABS:
=================

 
Brief Hospital Course:
ACTIVE ISSUES:
=============

#Fever: Initial presentation with Tm 102.9F in the setting of an 
admission CD4 of 123 in a HIV+ patient with poor HAART 
compliance.  Given her history of multiple opportunistic 
infections in the past, her presentation was most likely of 
infectious etiology with a broad differential vs ___.  Her 
hospital course began with admission to general medicine on 
___, where she began to spike fevers ___, resistant to 
acetaminophen/ibuprofen.  She was also tachycardic to the 120s, 
with a RR of 36.  She was given doses of azithromycin, 
vancomycin, and zosyn prior to transfer to the MICU on ___ 
for further medical management. In the MICU, she received two 
doses of acyclovir for HSV prophylaxis. Infectious disease was 
consulted. She had one episode of hypotension to SBPs ___ which 
was responsive to fluid bolus. She was transferred back to the 
floor on ___ when stable. Blood cultures x2 showed no growth. 
Her UA had protein and blood, and her urine culture showed no 
growth. CXR was clear, she had a negative respiratory viral 
panel, legionella urinary antigen was negative, S. pneumo 
antigen was negative, and glactomannan negative. C. diff was 
negative, stool culture was ordered for various tests and was 
negative. Cryptococcus was negative in serum and CSF. HSV was 
negative in CSF. CSF culture negative. Head CT was negative for 
toxoplasma or CNS lymphoma. Serologies were negative for 
toxoplasma. Parasite smear was negative, anaplasma is pending 
and Lyme pending. Strongyloides negative. EBV serologies were 
detected <200 (reference under 200). The patient underwent TTE 
which was negative for vegetations or myocarditis. Diagnostic 
studies were significant for EBV detection. Given negative work 
up, infectious disease believed patient had ___, antibiotics 
were discontinued and patient was monitored and remained 
hemodynamically stable and afebrile. On discharge, patient feels 
well with no localizing symptoms and back to baseline.   

#HIV: ___ CD4 218 VL7900 ___ CD4 nadir 8, found to have 
a CD4 on admission of 123. Was continued on her home 
Darunavir-Cobixistat, Doltegravur, Lamivudine.

___: attributed to hypotension, on admission 1.2, peak 1.6, 
improved after fluids to 1.4. Consider rechecking Cr in 1 week.

CHRONIC ISSUES:
================
#CHFrEF: Held metop in the setting of sepsis initially, HR after 
stabilized are in 60-70s so held on discharge.
Home hydralazine and isosorbide dinitrate were held given 
hypotension. After patient stabilized, pressures remained 
110-120s so they were held on discharge. 

#Depression: Continued home paroxetine

#Ppx: Continued home Bactrim, Azithromycin

#H/o CMV viremia: Continued home valganciclovir

TRANSITIONAL ISSUES:
===================
- Follow up pending labs
- Consider rechecking Cr, discharge Cr 1.4
- Echo in the setting of ___ with EF 37% with moderate to 
severe MR, mild pulmonary HTN, compared to prior studies, MR has 
worsened
- ___ hydralazine, metoprolol and isosorbide mononitrate 
given blood pressures stable at 110-120s

 
Medications on Admission:
The Preadmission Medication list may be inaccurate and requires 
futher investigation.
1. Acetaminophen 325-650 mg PO Q6H:PRN Pain - Mild 
2. Azithromycin 600 mg PO 2X/WEEK (WE,SA) 
3. Dolutegravir 50 mg PO DAILY 
4. LaMIVudine 150 mg PO DAILY 
5. LamoTRIgine 50 mg PO BID 
6. PARoxetine 30 mg PO DAILY 
7. ValGANCIclovir 450 mg PO Q48H 
8. HydrALAZINE 20 mg PO TID 
9. Isosorbide Dinitrate 10 mg PO Q8H 
10. Metoprolol Succinate XL 25 mg PO DAILY 
11. Multivitamins W/minerals 1 TAB PO DAILY 
12. ___ ___ UNIT PO Q8H 
13. Ondansetron ODT 4 mg PO Q8H:PRN nausea/vomiting 
14. Prezcobix (darunavir-cobicistat) 800-150 mg-mg oral DAILY 
15. Omeprazole 40 mg PO BID 
16. Sulfameth/Trimethoprim DS 1 TAB PO DAILY 

 
Discharge Medications:
1.  Acetaminophen 325-650 mg PO Q6H:PRN Pain - Mild  
2.  Azithromycin 600 mg PO 2X/WEEK (WE,SA)  
3.  Dolutegravir 50 mg PO DAILY  
4.  LaMIVudine 300 mg PO DAILY  
5.  LamoTRIgine 50 mg PO/NG BID 
Start: Upon Arrival  
6.  Ondansetron ODT 4 mg PO Q8H:PRN nausea/vomiting  
7.  PARoxetine 30 mg PO DAILY  
8.  Prezcobix (darunavir-cobicistat) 800-150 mg-mg oral DAILY  
9.  Sulfameth/Trimethoprim DS 1 TAB PO DAILY  
10.  ValGANCIclovir 450 mg PO Q48H  
11. HELD- HydrALAZINE 20 mg PO TID  This medication was held. Do 
not restart HydrALAZINE until you talk to your doctor
12. HELD- Metoprolol Succinate XL 25 mg PO DAILY  This 
medication was held. Do not restart Metoprolol Succinate XL 
until you talk to your doctor

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
Primary diagnosis
------------------
___ 
___ virus
AIDs

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___,

WHY WERE YOU ADMITTED?:
You were admitted to ___ with fevers and body aches. 

WHAT HAPPENED WHILE YOU WERE IN THE HOSPITAL?: 
- We thought you had an infection and did testing to identify a 
cause.
- You required a short stay in the ICU (Intensive Care Unit) 
when you started to look very sick with high temperatures 
(___), high heart rate (>120), and high respiratory rate (>36)
- We monitored you closely and gave you antibiotics to cover for 
any infection. The infectious team was consulted. 
- All your blood tests and scans came back negative and 
reassuring except a virus called ___ virus was detected 
in your blood 
- Your primary care doctor ___ follow up with you. It is now 
safe for you to go home. 

WHAT TO DO WHEN YOU LEAVE THE HOSPITAL: 
- We believe your symptoms of fever, fatigue and not feeling 
well was because your body was mounting a response to the 
___ virus. This can happen on HIV medications when your 
immune system becomes stronger. It is called ""Immune 
Reconstitution Inflammatory Syndrome"". Your HIV medications are 
working and you should continue taking them as prescribed. 
- Please attend all of your doctor appointments that we have 
made, listed below
- If you develop fever, body aches, shortness of breath, nausea, 
vomiting please call your doctor.  

It was a pleasure caring for you. Please follow up with your 
primary care doctor below. 

Wishing you the best,
Your ___ Team
 
Followup Instructions:
___
"
10960609-DS-16," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: ORTHOPAEDICS
 
Allergies: 
Penicillins / Neurontin
 
Attending: ___.
 
Chief Complaint:
right knee pain
 
Major Surgical or Invasive Procedure:
___ right knee resection arthroplasty and placement of 
antibiotic spacer
___ PICC placement

 
History of Present Illness:
HISTORY OF PRESENT ILLNESS:  Followup 15 or 20-minute visit with
___ today.  Bone scan results discussed with her from
___.  We see a lot of increased tracer around the total
knee prosthesis on both the femoral and the tibial component,
more on the tibia.  This is consistent with
infection/osteomyelitis since we are picking up tracer on all
three phases of the scan.  As I noted in my prior visits,
aspiration of the knee fluid has been benign in final culture
results and in the number of white blood cells but that 
certainly
cannot rule out osteomyelitis of the bone, which would be
subsynovial.  Given her persistent pain, the number of surgeries
she has been through, the progressive radiolucency seen on plain
film and now with the bone scan, we are going to move forward
with a two-stage resection arthroplasty.  We will remove her
entire prosthesis.  Because she is quite stiff and has had the
prior osteotomy of the tibial tubercle with translocation and 
has
retained hardware including some broken hardware quite possibly
at surgery, need to take down the osteotomy, remove the 
hardware,
remove all the implants, and freshen up the tibial osteotomy 
site
for a reimplantation at the time she has her total knee
replacement 8 weeks later after interim antibiotic spacer and IV
antibiotics.  Even if she comes back with negative culture on 
the
multiple tibia cultures, I probably would still want to treat 
her
long six weeks with antibiotics since there is a high suspicion
that there is infection even though it is to date eliminated,
determination/detection.  ___ understands it we cannot
guarantee that she will have a pain free knee.  It is quite
possible that she will always have trouble with this knee.  She
has arthrofibrosis now and that certainly may be a problem 
later.
Longevity of implants in the setting of prior osteomyelitis
presumptive is hard to establish.  She will not be able to
weightbear on this extremity for 8 weeks until it is
re-implanted.  She does understand and will try and maintain 
some
amount of range of motion through the knee, but I do not think
she would be a great benefit for her to have a hinged type 
insert
since.  We are able to maintain nearly as much motion with a
custom antibiotic spacer.

 
Past Medical History:
PMH: She has low-grade asthma,
non-insulin-dependent diabetes, and is hypothyroid.

Past Surgical History:  As mentioned above, six knee operations
on the right knee at ___.  
She
has had a left ankle fusion with iliac crest bone graft ___ years
ago.  She has also had a partial thyroidectomy and a partial
salivary gland excision and cholecystectomy.

 
Social History:
___
Family History:
Family History:  Positive for nonspecific cancer, diabetes, 
heart
disease including CAD and hypertension, and neuropathy.

 
Physical Exam:
Physical Exam:  On physical exam, she appears with a cane today
(she was using crutches at prior visit).  Her knee is mildly
swollen, but not significantly warm to the touch.  The incision
is well healed.  Her motion is from approximately -10 of
extension to 80 degrees of flexion.  She does have pain.  There
is some tenderness to palpation along the medial aspect of her
joint line.

 
Pertinent Results:
___ 05:34PM   PLT COUNT-296
___ 05:34PM   WBC-12.7*# RBC-3.59* HGB-11.6* HCT-32.5* 
MCV-90 MCH-32.2* MCHC-35.6* RDW-13.5
___ 05:34PM   CALCIUM-8.7 PHOSPHATE-3.9 MAGNESIUM-2.0
___ 05:34PM   estGFR-Using this
___ 05:34PM   GLUCOSE-145* UREA N-9 CREAT-0.7 SODIUM-138 
POTASSIUM-4.5 CHLORIDE-102 TOTAL CO2-24 ANION GAP-17
___ 06:11AM BLOOD Hct-28.8*
___ 06:05AM BLOOD Hct-26.9*
___ 05:50AM BLOOD WBC-10.2 RBC-2.98* Hgb-9.5* Hct-27.3* 
MCV-92 MCH-31.9 MCHC-34.8 RDW-13.1 Plt ___
___ 05:34PM BLOOD WBC-12.7*# RBC-3.59* Hgb-11.6* Hct-32.5* 
MCV-90 MCH-32.2* MCHC-35.6* RDW-13.5 Plt ___
 
Brief Hospital Course:
Pt was admitted to the hospital following the above mentioedn 
procedure - please see op report for details.

ID: Pt was started on vancomycin IV post-op, ID was consulted on 
POD1.  A UA/UCx was (-) on POD1.
Heme: Pt was transfused 2U PRBCs for a Hct of 27.3 on POD1, and 
another 2U PRBCs on POD2 for a Hct of 26.9.  Her Hct was 28.8 on 
POD3.
Activity: NWB RLE with knee locked in extension throughout 
hospitalization, and she worked with ___ while in-house
FEN/GI: tolerated regular diet in-house, no issues
TLD: Pt's foley catheter and hemovac drain were both d/c'd on 
POD2; she had aPICC line placed for long-term IV abx on POD1.
AC: pt was on lovenox for DVT prophylaxis while in-house, and 
was discharged on lovenox as well
Pain: pain was controlled post-op with a dilaudid PCA, and she 
was transitioned to po oxycodone on POD1

Pt was discharged home on IV vancomycin afebrile, with a 
well-appearing wound, stable, to follow-up with Dr. ___ 
the ___ Disease team.
 
Medications on Admission:
Paxil 20', amitryptiline 100', simvastatin 10', omeprazole 20', 
albuterol IH prn, triamcinilone cream prn, hydrocortisone cream 
prn
 
Discharge Medications:
1. Lovenox 40 mg/0.4 mL Syringe Sig: One (1) syringe 
Subcutaneous once a day for 6 weeks.
Disp:*42 syringes* Refills:*0*
2. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 
times a day).
Disp:*60 Capsule(s)* Refills:*2*
3. Ferrous Sulfate 325 mg (65 mg Iron) Tablet Sig: One (1) 
Tablet PO DAILY (Daily).
Disp:*30 Tablet(s)* Refills:*2*
4. Paroxetine HCl 20 mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily). Tablet(s) 
5. Amitriptyline 10 mg Tablet Sig: One (1) Tablet PO HS (at 
bedtime).  
6. Simvastatin 10 mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
7. Albuterol 90 mcg/Actuation Aerosol Sig: ___ Puffs Inhalation 
Q6H (every 6 hours) as needed.  
8. Oxycodone 5 mg Tablet Sig: ___ Tablets PO Q4H (every 4 hours) 
as needed for pain.
Disp:*121 Tablet(s)* Refills:*0*
9. Vancomycin in Dextrose 1 gram/200 mL Piggyback Sig: One (1) 
gram Intravenous Q 12H (Every 12 Hours) for 6 weeks.
Disp:*84 gram* Refills:*0*
 PICC LINE CARE Sig: One (1) once a day for 5 weeks: Please 
maintain picc line care as per protocol. 
 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
right knee prosthetic infection

 
Discharge Condition:
stable

 
Discharge Instructions:
You should return to the ER or call MD if you develop any of the 
following: chest pain, shortness of preath, severe 
nausea/vomiting, fever greater than 101.5F, increased redness or 
drainage from your incision, or any other concerning symptoms.

You should be non-weight bearing on your right leg with the 
___ brace on at all times, locked in extension.
Physical Therapy:
Activity:  Activity as tolerated
 Right lower extremity:  Non weight bearing
Encourage turn, cough and deep breathe q2h when awake; knee 
locked in extension @ all times in ___ brace

Treatments Frequency:
local wound care with dry sterile dressings and ACE wrap daily 
for 1 week, then dressings alone (no ACE wrap)
 
Followup Instructions:
___
"
10965697-DS-12," 
Name:  ___                    Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
lisinopril / chlorhexidine
 
Attending: ___
 
Chief Complaint:
Leukocytosis, mucosal bleeding
 
Major Surgical or Invasive Procedure:
PICC in Right Basilic Vein (Placed ___

 
History of Present Illness:
Ms. ___ is a ___ y/o woman with PMH relapsing AML, s/p multiple 
failed therapies, including allogenic stem cell transplant in 
___, most recently on Cabozatinib as part of DF/HCC 
Protocol ___: Phase 1 trial of cabozantinib in patients with 
relapsed or refractory AML. She presented for regular follow-up 
to clinic, where she was found to have worsening fatigue, 
weakness, and anorexia. Lab tests from clinic showed 
leukocytosis to 27K and thrombocytopenia to 13K. She had also 
electrolyte abnormalities likely related to her AML.
 
Past Medical History:
PAST ONCOLOGIC HISTORY:
Pertinent Oncologic history (include past therapies, surgeries,
etc): Dx with anemia in ___. Seen in follow-up in ___
and found to have a continued drop in Hct and with an elevated
LDH. BM bx revealed AML.

Induction with 7+3 regimen on ___ (daunorubicin 90 mg/m2
days ___ and cytarabine 100 mg/m2 days ___

The patient's bone marrow after induction therapy was without
evidence of leukemia; however, showed features of MDS and she
remained pancytopenic.

Allogenic stem cell transplant from a ___ matched unrelated
donor (female, CMV +/+, ABO matched), reduced intensity
conditioning with FLU-BU-ATG, day ___.

Bone marrow on ___ (D+91) - ___ blasts, chimerism 90% 
donor. BM bx showing ""hypocellular marrow with increased blast 
concerning for relapsing acute leukemia"". 

CSA taper ___ (last dose)

Bone marrow on ___ - increased blasts, however CD34 
negative, cytogenetics with a new clone with t(18;21), repeat BM 
bx shows 60% donor cells compared to 90% on previous bx. The 
blasts in her bone marrow do not have the same surface markers 
as previously, namely they are now lacking CD34 and cytogenetics 
are now showing the presence of translocation(18;21). 
Questioning either a second primary
malignancy or evolution of the prior leukemia clone C1 
Decitabine D1-10 from ___

On ___ pt had repeat BM biopsy which showed ___, 75% 
of the cells of patient origin and only 25% are donor. Given 
circulating blasts and pacytopenia, pt discussed remaining 
options w/ Dr. ___ on ___.

At that point, both pt and Dr. ___ agreed to proceed w/ 
elective re-induction w/ experimental protocol including 
lenalidomide plus MEC.
  
PAST MEDICAL/SURGICAL HISTORY:  
- HTN
- Aspergillus - On previous admission on ___, dx via CT 
chest, w/ bronch, and galatomannan, who continues on 
Voriconazole
- Latent TB - Previously declined tx until ___ admission 
when was started on INH and Pyridoxine, that was switched to 
moxifloxacin in ___. Plan to stop on ___
- Stomatococcus/Fusobacterium Bacteremia likely from dental 
source (___)

 
Social History:
___
Family History:
Per notes, negative for cancer or hematologic malignancies.
 
Physical Exam:
Physical Exam on Admission:
GENERAL: Thin Asian lady lying comfortably in bed  
CV: Regular rate and rhythm, no murmurs/rubs/gallops  
Lungs: Clear to auscultation bilaterally  
Abdomen: Soft, nontender, nondistended  
Ext: warm, well perfused, no edema 
Skin: ecchymoses of the upper and lower gingiva, associated with 
some oozing of blood from the gingiva

Physical Exam on Discharge: 
Vitals: T 97.5, Tmax 98, HR 76(76-95), BP 112/60(94/50-126/66), 
RR ___, SAT 99% RA
General: thin Asian lady lying comfortably in bed
HEENT: no oral ulcers or lesions
CV: regular rate and rhythm, no murmurs/rubs/gallops
Chest: clear to auscultation bilaterally 
Abd: soft, nontender, nondistended
Ext: warm, well perfused, no edema
Skin: no rashes
 
Pertinent Results:
ADMISSION LABS
___ 11:00AM   ___ 11:00AM   ___ PTT-32.6 ___
___ 11:00AM   PLT SMR-RARE PLT COUNT-13*#
___ 11:00AM   HYPOCHROM-OCCASIONAL ANISOCYT-2+ 
POIKILOCY-NORMAL MACROCYT-2+ MICROCYT-NORMAL POLYCHROM-NORMAL 
STIPPLED-OCCASIONAL
___ 11:00AM   NEUTS-2* BANDS-0 LYMPHS-16* MONOS-34* EOS-0 
BASOS-0 ___ MYELOS-0 BLASTS-48* NUC RBCS-9*
___ 11:00AM   WBC-27.3*# RBC-2.61* HGB-9.0* HCT-28.4* 
MCV-109* MCH-34.5* MCHC-31.8 RDW-18.6*
___ 11:00AM   T3-67* FREE T4-1.0
___ 11:00AM   TSH-6.3*
___ 11:00AM   D-DIMER-2732*
___ 11:00AM   TOT PROT-6.8 ALBUMIN-4.6 GLOBULIN-2.2 
CALCIUM-8.9 PHOSPHATE-4.4 MAGNESIUM-2.0 URIC ACID-4.9
___ 11:00AM   LIPASE-23
___ 11:00AM   ALT(SGPT)-99* AST(SGOT)-92* LD(LDH)-863* ALK 
PHOS-171* TOT BILI-0.7 DIR BILI-0.2 INDIR BIL-0.5
___ 11:00AM   UREA N-15 CREAT-1.2* SODIUM-135 
POTASSIUM-3.1* CHLORIDE-98 TOTAL CO2-26 ANION GAP-14
___ 11:00AM   GLUCOSE-148*

PERTINENT LABS
___ 12:30AM BLOOD WBC-0.7* RBC-2.54* Hgb-8.5* Hct-24.8* 
MCV-97 MCH-33.5* MCHC-34.4 RDW-17.5* Plt Ct-<5
___ 12:30AM BLOOD Neuts-2* Bands-0 Lymphs-86* Monos-4 Eos-0 
Baso-0 ___ Myelos-0 Blasts-8*
___ 01:00AM BLOOD ALT-85* AST-153* LD(LDH)-3050* 
AlkPhos-145* TotBili-1.1 DirBili-0.3 IndBili-0.8
___ 11:00AM BLOOD TSH-6.3*
___ 01:00AM BLOOD TSH-2.9
___ 02:30PM BLOOD TSH-4.1
___ 11:00AM BLOOD T3-67* Free T4-1.0
___ 02:30PM BLOOD T3-47* Free T4-0.83*
___ 12:40AM BLOOD HAV Ab-POSITIVE IgM HAV-NEGATIVE
___ 12:40AM BLOOD AMA-NEGATIVE Smooth-NEGATIVE
___ 12:40AM BLOOD ___
___ 12:40AM BLOOD tTG-IgA-___HEST WITHOUT CONTRAST ___ 2:21 ___
1.  Several new lung nodules have developed, including a 
dominant cavitary 7 mm lingular nodule with peripheral 
ground-glass halo and two solid right apical nodules measuring 
up to 5 mm.  These findings are concerning for aspergillus 
infection, but are not specific for this entity. 
2.  Near resolution of pericardial effusion but development of 
trace pleural effusions. 
3.  Unchanged indeterminate right adrenal lesion. 
4.  Ectatic ascending aorta is similar to previous exam, 
measuring approximately 3.8 cm in greatest dimension. 

CT ABD & PELVIS WITH CONTRAST ___ 3:50 ___  
1.  Colitis involving the ascending and proximal transverse 
colon, most severe in the proximal transverse colon.  Most 
likely etiology is infectious.  Ischemia is less likely. 
2.  Apparent focal gastric antrum thickening with edema.  
Endoscopy should be considered when the patient is able to 
tolerate. 
3.  1.3 cm right adrenal gland nodule, similar in size to 
___, likely an adenoma. 

CT CHEST W/CONTRAST ___ 3:51 ___
Worsening multifocal pneumonia involving the right lobe and 
lingula. The 
differential diagnosis includes atypical bacterial infection and 
fungal 
infection. Increased small bilateral pleural effusions. 
Unchanged diffuse bronchial wall thickening, likely due to 
chronic infection. 3 mm solid right middle lobe nodule which is 
stable since ___. 

DISCHARGE LABS
___ 12:00AM BLOOD WBC-1.0* RBC-2.68* Hgb-8.5* Hct-24.8* 
MCV-92 MCH-31.6 MCHC-34.2 RDW-14.9 Plt Ct-12*
___ 12:00AM BLOOD Neuts-4* Bands-0 Lymphs-60* Monos-7 Eos-0 
Baso-2 ___ Myelos-0 Blasts-27*
___ 12:00AM BLOOD Hypochr-1+ Anisocy-NORMAL Poiklo-NORMAL 
Macrocy-NORMAL Microcy-NORMAL Polychr-NORMAL
___ 10:02AM BLOOD Plt Ct-30*#
___ 12:00AM BLOOD Plt Smr-RARE Plt Ct-___*
___ 12:00AM BLOOD ___ PTT-31.4 ___
___ 12:00AM BLOOD Glucose-78 UreaN-9 Creat-0.7 Na-141 K-3.5 
Cl-104 HCO3-30 AnGap-11
___ 12:00AM BLOOD ALT-19 AST-20 LD(LDH)-204 AlkPhos-164* 
TotBili-0.7
___ 12:00AM BLOOD Albumin-3.2* Calcium-7.8* Phos-3.2 Mg-2.0
 
Brief Hospital Course:
Ms. ___ is a ___ year-old-woman with a history of 
relapsed/refractory AML, s/p multiple failed therapies including 
allogenic stem cell transplant in ___, most recently 
on cabozatinib as part of DF/HCC Protocol ___: Phase 1 trial 
of cabozantinib in patients with relapsed or refractory AML. She 
presented with leukocytosis, thrombocytopenia, fatigue, anorexia 
and weakness and was found to have toxicity from cabozatinib. 
Her hospital course was complicated by aspergillus pneumonia and 
colitis.

# AML/Leukocytosis
Upon admission, the patient was treated with hydroxyurea with 
good response, and it was discontinued on ___ when her WBC 
reached 6.1. However, her white count continued to decrease and 
remained below 1.0 until discharge. Upon admission, she had 
elevated LFTs with ALT 99, AST 92, LDH 863, and AlkPhos 171. 
They continued to trend up with a peak on ___ of ALT 85, AST 
153, and AlkPhos 145. Subsequently, her total bilirubin trended 
up to 3.8 on ___. The changes were thought to be due to 
carbozatinib toxicity, and she was removed from the study. Her 
LFTs subsequently normalized by discharge. She received a repeat 
bone marrow biopsy on ___, which the full report is pending at 
discharge.

# Febrile Neutropenia
She became febrile early in the morning on ___ while 
neutropenic. She was started on cefepime and vancomycin. Blood 
cultures eventually showed no growth. Patient was found to have 
colitis by abdominal CT on ___. Cdiff was negative. She was 
switched from cefepime to meropenem until discharge, at which 
time she was sent home with ciprofloxacin for bacterial 
prophylaxis and 5 days of metronidazole. She became afebrile on 
___ and remained afebrile until discharge.

# Hemoptysis / Aspergillus Pneumonia
The patient reported hemoptysis, and ENT was consulted on ___. 
They determined that the source of bleeding was most likely 
mucosal given thrombocytopenia as they noted clotted blood at 
the back of the right nostril, however, the scope was limited 
and they could not see superiorly with the equipment. A CT chest 
on ___, however, showed cavitations and nodules, which were 
concerning for aspergillosis. Given that she had a history of 
aspergillosis with hemoptysis, she was started on ambisome 
initially for treatment with elevated bilirubin. Once the 
bilirubin normalized, she was given voriconazole until 
discharge.

# Thrombocytopenia
She had thrombocytopenia, which was likely secondary to her AML. 
She was consistently transfusion dependent and required frequent 
platelet transfusions. She had some gingival bleeding that 
resolved by the time of discharge.
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. cabozantinib 60 mg/day (20 mg [3]/day) oral daily 
2. Acyclovir 400 mg PO Q12H 
3. Ursodiol 300 mg PO BID 
4. Pantoprazole 40 mg PO Q24H 
5. FoLIC Acid 1 mg PO DAILY 
6. Atovaquone Suspension 1500 mg PO DAILY 

 
Discharge Medications:
1. Acyclovir 400 mg PO Q12H 
RX *acyclovir 400 mg 1 tablet(s) by mouth twice a day Disp #*60 
Tablet Refills:*1
2. Ursodiol 300 mg PO BID 
RX *ursodiol 300 mg 1 capsule(s) by mouth twice a day Disp #*60 
Capsule Refills:*1
3. Pantoprazole 40 mg PO Q24H 
RX *pantoprazole 40 mg 1 tablet(s) by mouth daily Disp #*30 
Tablet Refills:*1
4. FoLIC Acid 1 mg PO DAILY 
RX *folic acid 1 mg 1 tablet(s) by mouth daily Disp #*30 Tablet 
Refills:*1
5. Atovaquone Suspension 1500 mg PO DAILY 
RX *atovaquone 750 mg/5 mL 10 mL by mouth daily Refills:*2
6. Voriconazole 200 mg PO Q12H 
RX *voriconazole 200 mg 1 tablet(s) by mouth twice a day Disp 
#*60 Tablet Refills:*1
7. Ciprofloxacin HCl 500 mg PO Q12H 
RX *ciprofloxacin 500 mg 1 tablet(s) by mouth twice a day Disp 
#*60 Tablet Refills:*0
8. MetRONIDAZOLE (FLagyl) 500 mg PO Q8H 
RX *metronidazole 500 mg 1 tablet(s) by mouth three times a day 
Disp #*15 Tablet Refills:*0

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
Primary: Acute Myelogenous Leukemia
Secondary: Cabozatinib-Induced Toxicity (Hyperbilirubinemia, 
Abnormal Liver Function Tests), Febrile Neutropenia, Infectious 
Colitis, Aspergillus Pneumonia

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___,

You were admitted to the hospital because of weakness and 
fatigue and elevated white cell count, which required treatment 
with hydroxyurea, a chemotherapy drug. During your 
hospitalization, you develop toxicity to the new chemotherapy 
drug, cabozanitib, and it was discontinued. Afterwards, we 
watched you for recovery and treated you for an infection of 
your abdomen and another infection in your lungs. Last, we gave 
you blood products for low platelets, something that helps you 
clot. It was a pleasure to take care you during your stay. 
Please do not hesitate to contact us with any questions or 
concerns.

Sincerely,

Your ___ Oncology Team
 
Followup Instructions:
___
"
11021124-DS-15," 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Codeine
 
Attending: ___.
 
Chief Complaint:
chest pain 
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
___ yo female with h/o HTN, hyperlipidemia, presents with several 
episodes of chest pain in the last 24 hours.  
Over the last three weeks, patient has feeling progressively 
weak, and has difficulty walking as far as she had in the past. 
She also decribes intermittent ""queasiness"" without chest pain, 
shortness of breath or diaphoresis. She says that at baseline 
she can climb a flight of stairs, and walk out to her mailbox 
without stopping, but that her activity is limited by leg 
pain/weakness, not shortness of breath or fatigue. She saw her 
PCP in the office on ___ who felt her weakness was related to 
hip pain and lower extremity weakness, got plain films of her 
hips which which showed mild DJD, and recommended physical 
therapy.  
.  
One night prior to admission, patient noted sudden onset of 
sharp, stabbing chest pain while carrying food to the dinner 
table. It lasted seconds and resolved spontaneously. She then 
felt fatigued, and ""not well"", and lay down on the couch. She 
then felt chest pressure ""like an iron sitting on my chest"" with 
left arm numbness and tingling. This resolved over the next 
hour. The following morning, she had another episode of dull 
chest pressure, radiating into the epigastrum, associated with 
nausea. This did not resolve. On speaking with her daughter and 
triage nurse, she came to the emergency department. 
.  
In the emergency department initial VS were T 98.5 HR 49 BP 
155/57 RR 18 99/RA. EKG showed TWI V2-V4 since here, consistent 
but different from prior. A CXR showed mild blunting of the 
costophrenic angles bilaterally. A CTA demonstrated no PE or 
dissection, but some RUL GGO. Troponin was negative x 1. She was 
given 325mg of aspirin and supplemental O2. She was given SL NTG 
x 3 without relief of her chest pain. She was given morhine IV 
2mg x 2 with relief of her chest pain. She was admitted to the 
medicine service for ___. 
.  
ASA given, oxygen. 3 SL NG, without relieve. not relieved with 
SL. Pain free with MSIV 2mg them returned, then relieved again 
with another. HR 50, 132/45, 12, sating well 99%.  
.  
On floor, initial VS were HR 50, 132/45, 12, sating 99% RA. 
Patient was asymptomatic. She denies chest pain, shortness of 
breath, nausea/vomiting or diaphoresis.  
.  
ROS: Denies fever, chills, night sweats, headache, vision 
changes, rhinorrhea, congestion, sore throat, cough, abdominal 
pain, nausea, vomiting, diarrhea, constipation, BRBPR, melena, 
hematochezia, dysuria, hematuria.  

 
Past Medical History:
- HTN  
- History of appendectomy  
- History of two laparotomies  
- Endometriosis  
- Cholelithiasis and gallstone pancreatitis  
- Spinal stenosis s/p L3-5 laminectomy  
- Shoulder impingement s/p rotator cuff tear surgery.  

 
Social History:
___
Family History:
Stroke in her mother at ___ years. Father with MI at ___ also with 
 
history of rheumatic heart disease.  

 
Physical Exam:
VS - Temp 96.1F, BP 106/50, HR 90, R 18, O2-sat 98% RA  
GENERAL - well-appearing ___ yo female in NAD, comfortable, 
appropriate  
HEENT - NC/AT, MMM, OP clear  
NECK - supple, no thyromegaly, no JVD  
LUNGS - CTA bilat, no r/rh/wh, good air movement, resp 
unlabored, no accessory muscle use  
HEART - PMI non-displaced, RRR, no MRG, nl S1-S2, TTP at lower 
sternum, pain disssimilar to pain on presentation  
ABDOMEN - NABS, soft/NT/ND, no masses or HSM, no 
rebound/guarding  
EXTREMITIES - WWP, no c/c/e, 2+ peripheral pulses  
SKIN - no rashes or lesions  
NEURO - awake, A&Ox3, face symmetric, speech fluent, muscle 
strength ___ throughout, sensation grossly intact throughout  

 
Pertinent Results:
Admission labs 

___ 08:15PM   cTropnT-<0.01
___ 02:45PM URINE  HOURS-RANDOM
___ 02:45PM URINE  GR HOLD-HOLD
___ 02:45PM URINE  COLOR-Straw APPEAR-Clear SP ___
___ 02:45PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-NEG 
GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-7.0 
LEUK-NEG
___ 01:30PM   GLUCOSE-90 UREA N-20 CREAT-0.8 SODIUM-139 
POTASSIUM-4.0 CHLORIDE-102 TOTAL CO2-29 ANION GAP-12
___ 01:30PM   estGFR-Using this
___ 01:30PM   CK(CPK)-39
___ 01:30PM   cTropnT-<0.01
___ 01:30PM   WBC-5.3 RBC-4.19* HGB-11.4* HCT-34.3* MCV-82 
MCH-27.3 MCHC-33.4 RDW-14.3
___ 01:30PM   NEUTS-73.8* ___ MONOS-4.1 EOS-3.6 
BASOS-0.5
___ 01:30PM   PLT COUNT-120*
___ 01:30PM   ___ PTT-24.9 ___
.
Discharge Labs 

___ 05:15AM BLOOD WBC-4.3 RBC-4.11* Hgb-11.4* Hct-34.0* 
MCV-83 MCH-27.7 MCHC-33.5 RDW-14.5 Plt ___
___ 07:15AM BLOOD WBC-3.5* RBC-4.13* Hgb-11.4* Hct-34.0* 
MCV-82 MCH-27.5 MCHC-33.4 RDW-14.2 Plt Ct-96*
___ 01:30PM BLOOD Neuts-73.8* ___ Monos-4.1 Eos-3.6 
Baso-0.5
___ 05:15AM BLOOD Plt ___
___ 05:15AM BLOOD ___ PTT-24.1 ___
___ 10:50AM BLOOD PTT-55.5*
___ 07:15AM BLOOD Plt Smr-LOW Plt Ct-96*
___ 07:15AM BLOOD ___
___ 05:15AM BLOOD Glucose-105* UreaN-18 Creat-0.8 Na-139 
K-3.8 Cl-102 HCO3-31 AnGap-10
___ 07:15AM BLOOD Glucose-102* UreaN-17 Creat-0.8 Na-141 
K-3.9 Cl-103 HCO3-31 AnGap-11
___ 06:00AM BLOOD Glucose-105* UreaN-17 Creat-0.7 Na-137 
K-3.7 Cl-101 HCO3-29 AnGap-11
___ 06:00AM BLOOD CK(CPK)-38
___ 01:30PM BLOOD CK(CPK)-39
___ 07:15AM BLOOD CK-MB-3 cTropnT-<0.01
___ 10:40AM BLOOD CK-MB-3 cTropnT-LESS THAN 
___ 06:00AM BLOOD CK-MB-2 cTropnT-LESS THAN 
___ 08:15PM BLOOD cTropnT-<0.01
___ 05:15AM BLOOD Calcium-9.1 Phos-3.4 Mg-2.3
___ 07:15AM BLOOD Calcium-9.1 Phos-3.3 Mg-2.4
.
Micro: None 
.
Reports 
___ Persantine Stress test 
RADIOPHARMACEUTICAL DATA: 
9.6 mCi Tc-99m Sestamibi Rest ___ 
29.1 mCi Tc-99m Sestamibi Stress ___ 
HISTORY:Progressive SOB 
  
SUMMARY FROM THE EXERCISE LAB:  
  
Dipyridamole was infused intravenously for 4 minutes at a dose 
of 0.142 
mg/kg/min.  
  
IMAGING METHOD:  
  
Resting perfusion images were obtained with Tc-99m sestamibi. 
Tracer was 
injected approximately 45 minutes prior to obtaining the resting 
images.  
  
Following resting images and two minutes following intravenous 
dipyridamole, 
approximately three times the resting dose of Tc-99m sestamibi 
was administered 
intravenously. Stress images were obtained approximately 30 
minutes following 
tracer injection.  
  
Imaging protocol: Gated SPECT.  
  
This study was interpreted using the 17-segment myocardial 
perfusion model.  
  
INTERPRETATION:  
  
The image quality is adequate with some motion artifact. 
  
Left ventricular cavity size is normal. 
  
Rest and stress perfusion images reveal uniform tracer uptake 
throughout the 
left ventricular myocardium.  
  
Gated images reveal normal wall motion.  
  
The calculated left ventricular ejection fraction is 71% with an 
EDV of 71 ml 
post stress.  
  
Compared with an exercise MIBI performed on ___ there is 
no appreciable 
interval change.  
  
IMPRESSION: 1. Normal myocardial perfusion study. 2. EF of 71% 
with an EDV of 71 
ml post stress. 
  
.
___ EKG 
Sinus bradycardia. Compared to the previous tracing there is no 
diagnostic 
change. 
Rate PR QRS QT/QTc P QRS T 
54 166 92 470/459 62 -46 34 
.
CTA Chest  ___
UNDERLYING MEDICAL CONDITION: 
   ___ year old woman with CP  
REASON FOR THIS EXAMINATION: 
   Eval AD/PE  
CONTRAINDICATIONS FOR IV CONTRAST: 
   None. 

 
 
Wet Read: ___ FRI ___ 5:31 ___ 
1. no PE detected to the subsegmental levels. 
2. No dissection. 
3. Small scattered ground glass opacities throughout both lungs 
are a non- 
specific finding and may represent small areas of inflammatory 
changes. No 
focal consolidations are seen. 

 
Final Report 
INDICATION: Chest pain. 
  
COMPARISON: Radiographs available from ___. 
  
TECHNIQUE: MDCT-acquired axial images of the chest were obtained 
with the use 
of IV contrast. Coronal and sagittal reformats were performed. 
Additional 
right and left oblique reconstructions were obtained for further 
evaluation of 
the pulmonary vasculature. 
  
CT OF THE CHEST WITH IV CONTRAST: The great vessels including 
the thoracic 
aorta are normal in caliber and patent. There is no dissection 
seen. No 
pulmonary embolus is detected at the subsegmental levels. There 
is no 
pericardial or pleural effusion. Note, there is a 
mild-to-moderate degree of 
dependent atelectasis bilaterally. Scattered centimeter 
ground-glass 
opacities, predominantly within the right upper lobe (3:44), are 
is a 
nonspecific finding and may represent small foci of inflammatory 
changes. No 
focal consolidations are seen. There is no pleural effusion. 
  
There is mild calcification of the trachea. No axillary or 
mediastinal 
lymphadenopathy is seen. A small hiatal hernia is unchanged 
since the ___, CT exam. 
  
OSSEOUS STRUCTURES: There is no acute fracture or dislocation. 
No concerning 
blastic or lytic lesions are seen. Moderate degenerative changes 
are present 
throughout the thoracic spine. 
  
IMPRESSION: 
1. No evidence of pulmonary embolus to the subsegmental levels. 
2. No evidence of aortic dissection. 
3. Scattered centimeter ground-glass opacities, predominantly 
within the 
right upper lobe, are nonspecific and most likely reflect small 
foci of 
inflammatory change or infection. No focal consolidations are 
seen. 
  
The study and the report were reviewed by the staff radiologist. 

  
 
.
___ CXR 
FINDINGS: Single AP upright portable view of the chest was 
obtained. Slight 
blunting of the left costophrenic angle may relate to overlying 
soft tissue.  
A very trace effusion or pleural thickening cannot be entirely 
excluded. No 
focal consolidation or pneumothorax is seen. The aorta is 
tortuous. The 
cardiac silhouette is top normal in size. 
  
IMPRESSION: Subtle blunting of the left costophrenic angle may 
relate to 
overlying soft tissue, although minimal pleural thickening or a 
very trace 
effusion cannot be entirely excluded. No focal consolidation or 
pulmonary 
edema. 
.
EKG ___ 
Sinus bradycardia. Compared to the previous tracing there is no 
diagnostic 
change. 
TRACING #3 
  
 
Read by: ___ 
 
  Intervals Axes 
Rate PR QRS QT/QTc P QRS T 
48 ___ 57 -24 ___ yo female with h/o HTN, hyperlipidemia, presented with 
several episodes of chest pain associated with nausea, left arm 
numbness, that improved after morphine.  
.  
#. Chest Pain: Description of pain was initially concerning for 
angina, with chest pressure, associated with nausea, left arm 
numbness. Variable nature of pain, reproducibility, lack of 
association with activity makes it less typical for angina, 
possibly GI related given h/o GERD. Per patient, she has had a 
negative stress as recently as ___. Cardiac biomarkers were 
negative with no EKG changes. Her pain returned on the floor the 
morning after admission, EKG was stable, CE negative. Pt was 
started on Heparin gtt for possible unstable angina, however she 
had no more chest pain and no EKG changes. Heparin was stopped 
AM of ___. She was continued on ASA. Persantine stress test on 
___, showed no wall motion abnormalities, with EF of 71%, and no 
ischemic ST changes. CTA ruled out PE and aortic dissection on 
admission.     
.  
#. Hypertension: BPs were elevated during admission to 170s. 
Continued BB and HCTZ and lisinopril was added at 5mg once pt 
appeared stable from a cardiac stand point. Given sinus 
bradycardia did not increase beta.
.  
#. Sinus Bradycardia: Initially had some bradycardia in ___ with 
brief episodes in high fort___ without symptoms. Appears to be 
her baseline in ___, unclear if this is related to her 
symptoms. Was continued on low dose beta blocker at discharge.  
.  
#. Restless Leg Syndrome: Continued Requip, gabapentin and 
remained well controlled.
.  
#. GERD: continued pantoprazole.  
.  
#. Anxiety/Depression: continued sertraline, clonazepam  
.  
Pt was discharged home with PCP ___.
 
Medications on Admission:
ATENOLOL 25MG PO daily  
CLONAZEPAM 0.5 mg PO bid  
GABAPENTIN 300 mg PO daily  
HYDROCHLOROTHIAZIDE 25MG PO daily  
PRAVASTATIN 20MG Tablet PO qhs  
PROTONIX 40MG Tablet PO daily  
ROPINIROLE [REQUIP] 1 mg PO TID  
SERTRALINE 50 mg PO daily  
TRAZODONE 25 mg PO qhs prn  
ASPIRIN 81 mg PO daily  

 
Discharge Medications:
1. Cholecalciferol (Vitamin D3) 400 unit Tablet Sig: Two (2) 
Tablet PO DAILY (Daily).  
2. Calcium Carbonate 500 mg Tablet, Chewable Sig: One (1) 
Tablet, Chewable PO TID (3 times a day).  
3. Multivitamin     Tablet Sig: One (1) Tablet PO DAILY (Daily). 
 
4. Trazodone 50 mg Tablet Sig: 0.5 Tablet PO HS (at bedtime) as 
needed for insomnia.  
5. Hydrochlorothiazide 25 mg Tablet Sig: One (1) Tablet PO once 
a day.  
6. Pravastatin 10 mg Tablet Sig: Two (2) Tablet PO HS (at 
bedtime).  
7. Ropinirole 1 mg Tablet Sig: One (1) Tablet PO TID (3 times a 
day).  
8. Sertraline 50 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 
 
9. Clonazepam 0.5 mg Tablet Sig: One (1) Tablet PO twice a day 
as needed for anxiety.  
10. Gabapentin 300 mg Capsule Sig: One (1) Capsule PO once a 
day.  
11. Pantoprazole 40 mg Tablet, Delayed Release (E.C.) Sig: One 
(1) Tablet, Delayed Release (E.C.) PO Q24H (every 24 hours).  
12. Aspirin 81 mg Tablet Sig: One (1) Tablet PO once a day.  
13. Atenolol 25 mg Tablet Sig: One (1) Tablet PO once a day.  
14. Lisinopril 5 mg Tablet Sig: One (1) Tablet PO once a day.
Disp:*30 Tablet(s)* Refills:*0*

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
___ Diagnosis:
Primary:
1. Chest pain
Secondary:
1. Hypertension
2. Hyperlipidemia

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
You were admitted to the hospital with chest pain and shortness 
of breath. Your EKG and blood work indicated you were not having 
an active heart attack. You underwent a stress test which was 
normal.
.
The following changes were made to your medications:
-You were started on Lisinopril for your blood pressure
 
Followup Instructions:
___
"
11134545-DS-21," 
Name:  ___.              Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
chest pain
 
Major Surgical or Invasive Procedure:
none

 
History of Present Illness:
___ M w/ HFrEF (30%), CAD, HTN, Type B Aortic dissection, CVA
___, pacemaker presenting from home with 2 days of intermittent
chest pain. Patient responds appropriately to questions but is
difficult to understand. He states the he has had intermittent
chest pain for the past ___ years, but appears to have worsened in
severity recently. The patient describes the pain as burning in
quality, waxing and waning in timing, maximum ___ in severity,
localized to the inferior left costal margin with radiating
""aching"" in the upper extremities bilaterally, and aggravated by
exertion and sitting up. He called EMS today because he got a 
new
chair at home that he thought would fix the problem but did not.
Denies fevers, dyspnea, orthopnea, pleuritic chest pain, n/v,
abdominal pain. He states that his ostomy bag has been draining
normally and that his bilateral ___ edema has not worsened.
Patient was evaluated in the ED on ___ for concern of worsening
___ edema but was discharged after ___ showed no clots. He
wonders if the pain could be due to anxiety, as he had similar
chest pain in the setting of a panic attack in the 1960s.  
 
In the ED, initial vital signs were: 
T 98.3   HR 64   BP 100/59   RR 16   ___ 99 on RA   Pain 7

 - Exam notable for:  

RRR no m/r/g/, lungs CTAB, abd soft, ostomy pink, 3+ pitting
edema to knees with overlying venous stasis changes

 - Labs were notable for...

Leukocytosis (WBC 12.3*) with normal diff
Worsened chronic anemia (Hgb 10.3* from 12.7* on ___ (baseline
~11.5))

Glucose 109*
___ (BUN 49 from baseline in ___, Cr 2.1* from baseline 0.8-1.2)
Hyperkalemia (K 5.2*)
 
Trop 0.03*
CK-MB <1

 - Studies performed include...  

Chest XR: ""no acute cardiopulmonary abnormality""
ECG: pacemaker

 - Patient was given...

Aspirin 81 mg  
HTZ 50 mg
Metop Tartrate 50 mg
Lisinopril 2.5 mg

 - Vitals on transfer:  
T 97.6   HR 76   BP 127/66   RR 23   ___ 95 on RA 

Upon arrival to the floor...

The patient reports that his chest pain has improved to ___ 
from
___ after being given nitro this morning. He denies fever,
chills, night sweats, headache, vision changes, hearing changes,
SOB, orthopnea, n/v, abdominal pain.
 
Past Medical History:
PAST MEDICAL HISTORY: 
- CAD: 3-vessel CAD ___ LAD 60%, midLAD 100%, PDA 80% 
diffusely 
diseased, ___ RCA 100% on cath ___ no intervention)
- Type B aortic dissection, treated conservatively; diagnosed 
___ 
- L-sided ischemic CVA (small L pontine), ___, with resuidual R 

arm/hand/leg weakness; had speech difficulties before
- R arm DVT ___
- chronic lymphedema with venous stasis changes
- RLE cellulitis
- Colonic volvulus s/p colectomy
- Degenerative joint disease
- Right retinal vein occlusion

PAST SURGICAL HISTORY:  
- Bilateral cataract surgery
- Cardiac cath as above
- H/O ostomy after sigmoid colectomy for volvulus, ___
- H/O exploratory laparotomy in the ___ w/o resection
- Umbilical hernia (over ___ years ago)
 
Social History:
___
Family History:
From previous notes
Father with CAD, deceased age ___, pt confirmed
Mother with ___
4 Children all healthy
 
Physical Exam:
Admission Exam:
=================================
AOx3, NAD, conversant, lying comfortably 30 degrees in
bed  
HEENT: Normocephalic, atraumatic. Blind in L eye, left-sided
RAPD. Sclera anicteric. Poor dentition, MMM, oropharynx clear
with no erythema or exudates.   
CARDIAC: RRR, distant heart sounds, S1/S2, no murmurs, rubs or
gallops. PMI palpable and visible.
LUNGS: CTAB, no wheezes, rhonchi or rales without labored
breathing
ABDOMEN: +BS, nontender, nondistended, without rigidity or
guarding. Colostomy in LLQ w/out erythema or discharge, no 
output
(changed last night, had not eaten).   
EXTREMITIES: 3+ pitting edema in BLE up to knees, no tenderness,
clubbing or cyanosis
SKIN: stage 2 pressure ulcer on coccyx, ecchymosis on posterior
right thigh, peeling dry skin on bilateral legs   
NEUROLOGIC: A&Ox3, blind in left eye, facial sensation intact 
and
symmetric, R lower facial weakness, hearing intact to finger rub
and symmetric, SCM/trapezius ___, tongue midline, ___ strength
bilateral UE, ___ strength bilateral ___, sensation to light 
touch
intact and symmetric  

Discharge Physical Exam:
=======================================
General: NAD, conversant, lying comfortably 30 degrees in bed  
HEENT: Normocephalic, atraumatic. Blind in L eye, Sclera 
anicteric. Poor dentition, MMM, oropharynx clear with no 
erythema or exudates.   
CARDIAC: RRR, distant heart sounds, nl S1/S2, no murmurs, rubs 
or
gallops. PMI palpable and visible.
LUNGS: mild B lower lobe crackles, stable
ABDOMEN: +BS, soft, NTND. Colostomy in LLQ w/o erythema or 
discharge
EXTREMITIES: 2+ pitting edema in BLE up to knees, no tenderness,
clubbing or cyanosis, chronic lymphedematous changes
SKIN: stage 2 pressure ulcer on coccyx, ecchymosis on posterior
right thigh, peeling dry skin on bilateral legs   
 
Pertinent Results:
Admission Labs:
=======================

___ 04:55AM BLOOD WBC-12.3* RBC-3.53* Hgb-10.3* Hct-31.7* 
MCV-90 MCH-29.2 MCHC-32.5 RDW-16.3* RDWSD-54.4* Plt ___
___ 04:55AM BLOOD Plt ___
___ 10:25AM BLOOD ___ PTT-24.7* ___
___ 04:55AM BLOOD Glucose-109* UreaN-49* Creat-2.1* Na-137 
K-5.2* Cl-96 HCO3-25 AnGap-16
___ 04:55AM BLOOD CK(CPK)-73
___ 04:55AM BLOOD CK-MB-<1
___ 04:55AM BLOOD cTropnT-0.03*
___ 08:10AM BLOOD cTropnT-0.02*
___ 09:25PM BLOOD proBNP-4413*
___ 10:25AM BLOOD Calcium-9.0 Phos-3.5 Mg-2.2

Discharge and Notable Labs:
==============================

___ 04:40AM BLOOD WBC-5.9 RBC-3.27* Hgb-9.6* Hct-29.9* 
MCV-91 MCH-29.4 MCHC-32.1 RDW-16.1* RDWSD-54.3* Plt ___
___ 04:40AM BLOOD Plt ___
___ 04:20AM BLOOD Ret Aut-3.0* Abs Ret-0.09
___ 04:40AM BLOOD Glucose-90 UreaN-20 Creat-0.7 Na-139 
K-4.0 Cl-97 HCO3-30 AnGap-12
___ 04:40AM BLOOD Calcium-8.5 Phos-2.0* Mg-1.8

Microbiology:
=======================
URINE CULTURE (Final ___: 
      MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), CONSISTENT 
WITH SKIN
      AND/OR GENITAL CONTAMINATION. 

Imaging:
==================
CHEST (PORTABLE AP) Study Date of ___ 5:11 AM 
FINDINGS:  
  
Unchanged cardiomegaly and pacemaker with electrodes in expected 
position.  
There is aorta is tortuous and calcified, as before.  The 
mediastinal and 
hilar contours are normal. The pulmonary vasculature is normal. 
Lungs are 
clear.  No pleural effusion or pneumothorax is seen. There are 
no acute 
osseous abnormalities. 
  
IMPRESSION:  
  
No acute cardiopulmonary abnormality. 

 
Brief Hospital Course:
___ M w/ HFrEF (30%), CAD, HTN, Type B Aortic dissection, CVA 
___, pacemaker presented from home with 2 days of intermittent 
chest pain. He was found to have ___ which resolved with IVF. 
His chest pain was felt to be angina in nature and 
improved with SLN. He is not interested in cardiac 
catheterization, so stress test was not pursued.

#Chest pain: Patient presented with chest pain felt to likely be 
angina in nature. Troponins to 0.03, downtrending and negative 
CK-MB felt to be likely from poor renal clearance rather than 
NSTEMI. ECG difficult to interpret in the setting of pacemaker. 
Pain improved with nitroglycerin. Patient felt to have 
progressive stable angina. Discussions with the patient and HCP 
indicated that patient would not be interested in cardiac 
catheterization, so stress test was not performed. Patient was 
medically optimized with lisinopril, metoprolol, and 
atorvastatin increased to 40 mg for high intensity statin 
therapy. Aspirin was continued.

___: Patient presented with Cr 2.1. This was felt to be 
pre-renal in etiology ___ poor po intake at home. This resolved 
with IVF administration. Lisinopril held initially in the 
setting ___ and restarted when Cr decreased. 

#Hypotension: Patient haad hypotension to ___ after 
receiving sublingual nitro x1 as well as likely hypovolemia. 
This improved over 24 hours. Sublingual nitro should be used 
with caution and close BP monitoring in the future.

#Leukocytosis: Patient had a leukocytosis of 12.3 on admission 
of unclear etiology. Patient was afebrile and asymptomatic, with 
no dyspnea, cough, dysuria. CXR was clear and his ostomy site 
was clean. The leukocytosis resolved without specific 
intervention.

#Anemia: Noted to have drop in H/H on this admission from 2 
weeks prior. Iron studies without iron deficiency. Had mild 
folate deficiency and was started on folate supplements. 

#Failure to thrive: Patient has been readmitted to the hospital 
many times in the last months with clear evidence of failure to 
thrive at home, intermittently refusing care and not allowing 
help with cleaning, including his urine and feces. He has 
evidence of skin breakdown related to immobility. In prolonged 
discussion with patient's son and the patient on both this 
admission and his prior (ending ___, the patient continues to 
express that his primary goal is to be home. His son hopes to 
honor these wishes and feels that his dad has the capacity to 
make this decision. While he is oriented, his insight is quite 
poor and I do not think the patient has true capacity to make 
this decision but his son, as HCP, does as long as the 
situation at home is safe. His recurrent admissions and poor 
care raise concerns about this however he has not had a true 
trial of home services (24 hours care and home visits from PCP) 
to help mimick a rehab. The family has now arranged for these 
services including PCP who will see patient on ___ at home. 
Should he continue to refuse care at home in this setting with 
poor hygeine and self neglect, will need to consider 
guardianship to help better care for patient. 

------------------
CHRONIC/STABLE PROBLEMS:
#HFrEF
#Acute on Chronic Systolic Heart Failure ExacerbationEF of 30% 
in ___. Patient has chronic lymphedema in lower extremities. He 
had crackles on exam indicative of pulmonary edema following 
administration of IV fluids for pre-renal ___ with increase in 
pro-BNP to 4413 from 1312. Diuresed ___ with 40 mg IV Lasix 
with improvement. Given intravascular depletion on admission, 
home dose of Lasix was reduced to 20 mg po daily. Can consider 
additional 20 mg po as needed for weight gain. Lisinopril held 
initially in setting ___ and ___ restarted at home dose. 
Metoprolol continued at home dose fractionated and then 
consolidated.

#Vitamin B12 deficiency
Continued B12 1000mcg PO daily. 

#Dental Caries. 
Patient has poor dentition. Nystatin mouth wash was offered four 
times daily, however patient regularly refused.

#Essential Hypertension
Continued home metoprolol fractionated. Held lisinopril 2.5 mg 
due to ___. Resumed once Cr decreased.

#CAD
Continued home ASA
Continued metoprolol fractionated. Can resume metoprolol XL on 
discharge.

#Vitamin D Deficiency
Continued vit D 50K units weekly

#Depression
Continued home dose of Citalopram 10 mg PO QD.

TRANSITIONAL ISSUES:
===========================
CHANGED Lasix to 20 mg po daily
CHANGED atorvastatin to 40 mg qhs
CHANGED meclizine to 12.5 mg daily prn for dizziness
STARTED folate supplements

[ ] PCP follow up through home visits with Dr. ___
[ ] Use caution with sublingual nitro as patient became 
hypotensive to ___
[ ] Encourage po intake at home
[ ] Would get weights at patients regularly if possible to 
assess volume status. Titrate furosemide depending on volume 
status given poor PO intake.
[ ] Patient discharged with 24hr services as well as home visits 
with ___ medicine practice. Consider palliative care 
services at home given patient's repeated decline of nursing 
care and his goals of care. 
[ ] In terms of goals of care, patient and HCP expressed 
strongly that patient wants to be at home and not at a 
facility. 

DNR/DNI. Patient has MOLST
Health Care Proxy is son ___, phone ___

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Aspirin 81 mg PO DAILY 
2. Atorvastatin 20 mg PO QPM 
3. Lisinopril 2.5 mg PO DAILY 
4. Citalopram 10 mg PO DAILY 
5. Cyanocobalamin 1000 mcg PO DAILY 
6. Docusate Sodium 100 mg PO BID 
7. Furosemide 40 mg PO DAILY 
8. Meclizine 12.5 mg PO DAILY 
9. Metoprolol Succinate XL 25 mg PO DAILY 
10. Nitroglycerin SL 0.3 mg SL Q5MIN:PRN chest pain 
11. Vitamin D ___ UNIT PO 1X/WEEK (___) 

 
Discharge Medications:
1.  FoLIC Acid 1 mg PO DAILY 
RX *folic acid 1 mg 1 tablet(s) by mouth daily Disp #*30 Tablet 
Refills:*0 
2.  Meclizine 12.5 mg PO DAILY:PRN dizziness  
3.  Atorvastatin 40 mg PO QPM 
RX *atorvastatin 40 mg 1 tablet(s) by mouth at bedtime Disp #*30 
Tablet Refills:*0 
4.  Furosemide 20 mg PO DAILY 
RX *furosemide 20 mg 1 tablet(s) by mouth daily Disp #*30 Tablet 
Refills:*0 
5.  Aspirin 81 mg PO DAILY  
6.  Citalopram 10 mg PO DAILY  
7.  Cyanocobalamin 1000 mcg PO DAILY  
8.  Docusate Sodium 100 mg PO BID  
9.  Lisinopril 2.5 mg PO DAILY  
10.  Metoprolol Succinate XL 25 mg PO DAILY  
11.  Nitroglycerin SL 0.3 mg SL Q5MIN:PRN chest pain  
12.  Vitamin D ___ UNIT PO 1X/WEEK (___)  

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
Acute Kidney Injury
Chest Pain
Acute on Chronic Systolic Heart Failure Exacerbation

 
Discharge Condition:
Mental Status: Confused - sometimes.
Level of Consciousness: Alert and interactive.
Activity Status: Bedbound.

 
Discharge Instructions:
Dear Mr. ___,

It was a pleasure taking care of you during your stay at ___.

WHY WAS I HERE?
- You were having chest pain
- Your kidneys were not working well enough

WHAT WAS DONE WHILE I WAS IN THE HOSPITAL?
- You were given fluids
- You were given nitro for your chest pain

WHAT SHOULD I DO WHEN I GO HOME?
- You should work with your new PCP at home
- You should eat and drink your regular diet

Be well!

Your ___ Care Team
 
Followup Instructions:
___
"
11161110-DS-13," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
DKA
 
Major Surgical or Invasive Procedure:
None
 
History of Present Illness:
___ history type 1 diabetes with history of alcohol use disorder 
and IVDU now sober x15 months, who presents as a transfer from 
outside hospital for DKA. 

For 4days prior to admission, he's had malaise, myalgias, nausea 
and vomiting. In this setting he stopped taking his insulin, as 
he wasn't eating. Symptoms were associated with chills, no 
fevers. He lives in a sober house and no one else had similar 
symptoms. 

The two days prior to admission he had worsening shakiness and 
fatigue, leading him to present to ___. Vital signs were  
BP 145/96, HR 113, T-99.5. Labs significant for lactate 3.9, CO2 
8, Gap 40, glu 541. Initially, 2L NS given, 10units insulin inj 
then patient was started on gtt at 4.2 units/hr and transferred 
to ___. Nausea was treated with 8 mg IV Zofran.  Last FSBG prior 
to transfer to ___ ___ was 297. 

Upon arrival to the ___ ___ , initial vitals:  Temp 98.0 F HR 
88 BP 146/94 RR 24 100% RA 
- Exam notable for  
- EKG with NSR HR 90's QTc 542 
- Labs were notable for:  FSBG 279. 
WBC 11.3K hbg 18.0K Plt 274. pH 7.18 pCO2 29 pO2 36. chem panel 
with HCO3 9, AG 20.  K:3.1 and lactate 1.9. Phos 1.1. UA with 
ketones.
- Imaging:  CXR w/o evidence of pneumonia.
- Patient was given:  insulin gtt, 20 KCl in ___.

On arrival to the MICU, he feels fatigued but improved from 
prior. His mouth feels very dry and he is thirsty. He's not had 
nausea or vomiting since arrival to ___. He denies abdominal 
pain, diarrhea, bloody or dark stools. He has not had CP, SOB, 
or dysuria. No rashes. On arrival, IVF were changed to 40 KCL in 
NS at 250 cc/hour
 

 
Past Medical History:
1. Type 1 DM
--4 to 5 hositalizations for DKA in past few years
2. H/o alcohol use disorder in remission (sober x 15 months)
3. H/o IV drug use in remission
4. Untreated hepatitis C diagnosed ___

 
Social History:
___
Family History:
Not reviewed 
 
Physical Exam:
=======================
ADMISSION PHYSICAL EXAM
=======================
Vitals:  T 97.5 HRs in ___ BP 138/83 100 RA
GEN: fatigued appearing but able to recount detailed history w/o 
difficulty
HEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva, 
very dry mucus membranes
NECK: nontender supple neck, no LAD, no JVD  
CARDIAC: RRR, S1/S2, no murmurs, gallops, or rubs  
LUNG: CTAB, no wheezes, rales, rhonchi, breathing comfortably 
without use of accessory muscles  
ABDOMEN: nondistended, +BS, nontender in all quadrants, no 
rebound/guarding, 
EXTREMITIES: no cyanosis, clubbing or edema, moving all 4 
extremities with purpose  
PULSES: 2+ DP pulses bilaterally  
NEURO: CN II-XII intact
SKIN: multiple tattoos, small healing scars on arms, no recent 
track marks

=======================
DISCHARGE PHYSICAL EXAM
=======================
Vitals: 97.9 109 / 70 58 18 98 RA 
Gen: Young male, reclined in bed, NAD 
HEENT: NCAT, EOMI, PERRLA, anicteric sclera, clear OP, MMM
CV: RRR, no r/g/m
Chest: CTAB, no w/r/r
GI: soft, NT, ND, BS+
MSK: No kyphosis. 
Skin: No rash. No jaundice. Multiple tattoos.
Neuro: AAOx3. No facial droop. Full strength all extremities. 
Psych: Full range of affect
 
Pertinent Results:
==============
ADMISSION LABS
==============
___ 03:02AM BLOOD WBC-11.3* RBC-5.84 Hgb-18.0*# Hct-50.3 
MCV-86 MCH-30.8 MCHC-35.8 RDW-12.4 RDWSD-38.5 Plt ___
___ 03:02AM BLOOD Neuts-81.4* Lymphs-10.9* Monos-6.8 
Eos-0.0* Baso-0.2 Im ___ AbsNeut-9.19* AbsLymp-1.23 
AbsMono-0.77 AbsEos-0.00* AbsBaso-0.02
___ 03:02AM BLOOD Glucose-296* UreaN-14 Creat-1.1 Na-140 
K-3.3 Cl-111* HCO3-9* AnGap-23*
___ 10:28AM BLOOD ALT-18 AST-11 AlkPhos-53 TotBili-0.5
___ 03:02AM BLOOD Calcium-8.8 Phos-1.1* Mg-2.0
___ 06:24AM BLOOD %HbA1c-14.7* eAG-375*
___ 03:17AM BLOOD ___ pO2-36* pCO2-29* pH-7.18* 
calTCO2-11* Base XS--17
___ 03:17AM BLOOD Lactate-1.9 K-3.1*
___ 03:17AM BLOOD O2 Sat-73
___ 04:15AM URINE Color-Straw Appear-Clear Sp ___
___ 04:15AM URINE Blood-SM  Nitrite-NEG Protein-100 
Glucose-1000 Ketone-150 Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-NEG
___ 04:15AM URINE RBC-<1 WBC-3 Bacteri-NONE Yeast-NONE 
Epi-<1
___ 04:15AM URINE CastGr-7* CastHy-4*
___ 04:15AM URINE Mucous-RARE
___ 04:15AM URINE bnzodzp-NEG barbitr-NEG opiates-NEG 
cocaine-NEG amphetm-NEG oxycodn-NEG mthdone-NEG

=================
PERTINENT IMAGING
=================
CXR PORTABLE (___):  
No pneumonia.

==============
DISCHARGE LABS
==============
___ 07:15AM BLOOD WBC-5.0 RBC-5.04 Hgb-15.2 Hct-41.9 MCV-83 
MCH-30.2 MCHC-36.3 RDW-12.0 RDWSD-36.6 Plt ___
___ 07:15AM BLOOD Glucose-287* UreaN-10 Creat-0.5 Na-135 
K-4.1 Cl-96 HCO3-29 AnGap-14
___ 07:15AM BLOOD Calcium-9.0 Phos-3.7 Mg-2.1
 
Brief Hospital Course:
Mr. ___ is a ___ with PMH T1DM, alcohol/IVDU abuse (sober x 
15 months), and hepatitis C who presented from outside hospital 
in ___.  Four days prior to admission, Pt had 
malaise/myalgias/nausea/vomiting that he thought was a stomach 
bug.  As he wasn't able to eat, Pt stopped taking his insulin.  
Two days prior to admission he became increasingly fatigued and 
shaky, which led him to present to ___.  Pt was started on 
insulin gtt and then transferred to ___.  

=================
___ ICU COURSE
=================
Pt was maintained on an insulin drip until his anion gap closed 
and he was able to tolerate PO, at which point he was 
transitioned to injectable insulin.  Also given brisk IV 
hydration and repletion of his hypokalemia/hypophosphatemia.  

# T1DM with # DKA:  Likely precipitated by nonadherence to 
insulin egimen in setting of GI illness.  No obvious infectious 
source on CXR or UA.  Put on insulin gtt, fluid repleted with ___ NS with K.  Transitioned to subq insulin hen anion gap 
closed.  ___ was consulted, and titrated Pt's insulin 
throughout his course. 

# NAUSEA/VOMITING:  DDx viral gastroenteritis vs. manifestation 
of Pt's DKA.  Had a borderline prolonged QTc on admission (see 
below), so antiemetics used sparingly during his course.  N/V 
improved as glycemic control improved.

# PROLONGED QTc:  No medications or drugs on board that could 
obviously prolong QTc.  Repeat EKG demonstrated QTc of 432.  

# HEPATITIS C:  Has never received Tx for same. 

# Hx ALCOHOL ABUSE and # Hx IVDU:  Patient denied recent use, no 
suggestion of intoxication, no withdrawal symptoms. 

# HYPOKALEMIA and # HYPOPHOSPHATEMIA:  In the setting of DKA and 
GI losses.  Repleted IV and PO.  

===============
HOSPITAL COURSE
===============
Patient was monitored on the hospital floor while receiving 
continued electrolyte repletion. He was seen by the ___ 
Diabetes Educator, and discharged in stable condition. 
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Levemir (insulin detemir) 35 U subcutaneous DAILY 
2. HumaLOG (insulin lispro) 100 unit/mL subcutaneous TID W/MEALS 


 
Discharge Medications:
1.  Glargine 40 Units Bedtime
Humalog 8 Units Breakfast
Humalog 8 Units Lunch
Humalog 8 Units Dinner
Insulin SC Sliding Scale using HUM Insulin
RX *insulin glargine [Lantus Solostar] 100 unit/mL (3 mL) AS DIR 
40 Units before BED; Disp #*12 Syringe Refills:*0
RX *blood-glucose meter  dispense one blood glucose monitoring 
kit including blood glucose monitor AS DIR Disp #*1 Kit 
Refills:*0
RX *insulin lispro [Humalog KwikPen] 100 unit/mL AS DIR Up to 10 
Units QID per sliding scale; 8 Units before BRKFST, LNCH and 
DINR Disp #*4 Syringe Refills:*0 

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Primary: Diabetic Ketoacidosis
Secondary: Type 1 Diabetes

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Mr ___,

You were admitted for diabetic ketoaciodosis following insulin 
non-use during a gastrointestinal illness. You were treated and 
fortunately rapidly got better; your insulin was increased and 
you will be discharged on this regimen. Please remember to take 
your insulin regardless of how you are feeling, and if you are 
concerned or have infections symptoms to call your primary care 
physician or diabetologist.

We wish you all the best,
Your ___ Care Team
 
Followup Instructions:
___
"
11180362-DS-10," 
Name:  ___                Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Glucotrol
 
Attending: ___.
 
Chief Complaint:
cough
 
Major Surgical or Invasive Procedure:
none
 
History of Present Illness:
The patient is an ___ y/o man with a history of diabetes, 
coronary disease, chronic systolic congestive heart failure s/p 
ICD placement, who is admitted to the medical service after 
presenting to the emergency department with fever and cough. 

He reports having symptoms for several days which included fever 
as high as 103 today, cough productive of yellow sputum. He was 
seen on an outpatient bases ___ and diagnosed with acute 
bronchitis and prescribed a course of azithromycin. He continued 
to feel poorly, spiking a high fever to 103 and having extreme 
weakness ___ night. He contacted his PCP who recommend that 
he present to the ED.  

In the ED, his vital signs were 98.5  88  157/66 breathing at 
24/min and sating 98%on room air. He was given combivent, 1LNS, 
and 750mg levaquin po x 1. an EKG was unchanged. 

Of note, he was recently admitted in ___ to the 
cardiology service epigastric pain. He ruled out for MI and a 
cardiac catheterization was performed and was unchanged with 
stable 3 vessel coronary disease.  
 
Past Medical History:
# CAD status post CABGx3 in ___ (first obtuse marginal to left 
anterior descending artery, saphenous vein graft to right 
coronary artery, and saphenous vein graft to obtuse 
marginal/diagonal).  
# Cath from ___: 1. Three vessel native coronary artery 
disease. 2. Mild left ventricular diastolic dysfunction. 3. 
Patent SVG to Diagonal with patent jump segment to OM2. 4. 
Patent LIMA to LAD.  
# Stress from ___: EKG: IMPRESSION: No anginal symptoms or 
ischemic EKG changes at the achieved workload. Nuclear report 
sent separately. Nuclear: IMPRESSION: 1) Severe myocardial 
perfusion defect involving the inferior wall shows partial 
reversibility in its apical region. 2) Global hypokinesis with 
estimated EF of 35%. Further evaluation by cardiac ECHO is 
recommended.  
# Chronic systolic CHF EF 35-40% ___  
# Hypertension  
# Diabetes mellitus  
# Duodenal ulcer  
# Status post appendectomy  
# Status post implantable cardioverter-defibrillator  
placement for nonsustained ventricular tachycardia  
# High cholesterol  

 
Social History:
___
Family History:
NC
 
Physical Exam:
98.3  118/78  78  20  95%RA
GEN: well appearing, not in any distress
HEENT: dry  mucus membranes, JVP not prominent
CV: Irregular s1, s2, no M/G/R
RESP: course breath sounds @ bases, but no crackles or wheezing. 

ABD: soft, protuberent, non-tender
EXT; trace pitting edema
 
Pertinent Results:
LABS ON ADMISSION:
___ 12:15PM   WBC-13.1*# RBC-3.93* HGB-12.0* HCT-34.5* 
MCV-88 MCH-30.5 MCHC-34.8 RDW-13.3
___ 12:15PM   GLUCOSE-178* UREA N-36* CREAT-1.6* SODIUM-137 
POTASSIUM-4.7 CHLORIDE-101 TOTAL CO2-27 ANION GAP-14
___ 12:15PM BLOOD WBC-13.1*# RBC-3.93* Hgb-12.0* Hct-34.5* 
MCV-88 MCH-30.5 MCHC-34.8 RDW-13.3 Plt ___
___ 06:10AM BLOOD WBC-10.8 RBC-3.66* Hgb-10.9* Hct-32.1* 
MCV-88 MCH-29.7 MCHC-33.9 RDW-12.9 Plt ___
___ 06:10AM BLOOD WBC-6.9 RBC-3.66* Hgb-10.8* Hct-32.4* 
MCV-88 MCH-29.6 MCHC-33.5 RDW-13.2 Plt ___
___ 12:15PM BLOOD Glucose-178* UreaN-36* Creat-1.6* Na-137 
K-4.7 Cl-101 HCO3-27 AnGap-14
___ 06:10AM BLOOD Glucose-135* UreaN-34* Creat-1.6* Na-136 
K-4.0 Cl-102 HCO3-24 AnGap-14
___ 06:10AM BLOOD Glucose-158* UreaN-28* Creat-1.3* Na-136 
K-3.9 Cl-103 HCO3-26 AnGap-11
___ 12:15PM BLOOD ALT-24 AST-25 AlkPhos-54 TotBili-1.1
___ 06:10AM BLOOD Calcium-8.5 Phos-2.9 Mg-1.9

STUDIES:

CXR ___: Left lower lobe pneumonia and possible additional 
involvement of right ___ lobe. Radiographic follow up in 4 
weeks after completion of antibiotics is recommended to ensure 
resolution. 

MICRO:
___ - BCX - pending at time of discharge. 
___ - UCX - pending at time of discharge.
___ - BCx - pending at tiem of discharge. 
___ - Sputum Cx - oral flora. 
___ - Urine Legionella - Negative. 
___ - BCx - pending at time of discharge. 
 
Brief Hospital Course:
This is an ___ y/o man with diabetes, coronary disease, systolic 
heart failure and chronic kidney disease admitted with pneumonia 
and acute renal failure.

1) Community Acquired Pneumonia: For pneumonia he was started on 
levofloxacin, renally dosed, and had symptomatic improvment, 
improved oxygenation, and leukocytosis rapidly. He was also 
given guaifenesin with codeine to help with cough, and nebulizer 
treatments. diagnosis supported by symptoms, white count, and 
infiltrate.  His fever curve trended down slowly, with Tmax 
101.4 on ___, and 100.6 on ___.  He was discharged home on 
___ with instructions to complete a 7 day course of 
antibiotics, with levaquin 750mg po q48hrs, last dose on ___.  

Based on his CXR on ___, repeat CXR was recommended in 4 weeks 
to ensure resolution of his infiltrate. ( IMPRESSION :  Left 
lower lobe pneumonia and possible additional involvement of 
right lower lobe. Radiographic follow up in 4 weeks after
completion of antibiotics is recommended to ensure resolution).
  

2) Acute Renal Failure: This was thought due to dehydration from 
his acute illness. He was given cautious IV fluid and his 
lisinopril and hctz were held.  His creatinine improved to 1.3 
at the time of discharge (baseline 1.2).  He was instructed to 
discuss restarting HCTZ/lisinopril with his PCP at his ___ 
appointment on ___. 

3) Chronic Systolic Congestive Heart Failure; stable, euvolemic 
to dry, he was continued on carvedilol.

4) Diabetes, type II without complications: His metformin was 
held in house with coverage by sliding scale and diabetic diet.  
He was instructed to restart metformin on ___, one day after 
his last dose of levaquin, as the combination of these 2 
medications can cause hypoglycemia. 

5) Coronary Artery Disease, native vessel and bypass graft: He 
was continued on home simvastatin, carvedilol, plavix, and 
aspirin.

6) Duodenal ulcer: He was maintained on home ppi.

7) ___ - an appointment was made with his PCP ___ ___, 
and he will be called by their office if an appointment is 
required more quickly. 
 
Medications on Admission:
Lisinopril/HCTZ 20mg/25mg po qday
Plavix 65mg po qday
Carvedilol 25mgpo qday
simvastatin 40mg po qday
folic acid ___ po qday
metformin 1000mg po qday
protonix 40mg po qday
lorazepam 0.5mg po qday prn
aspirin 81mg po qday
nitro spray prn
 
Discharge Medications:
1. Clopidogrel 75 mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
2. Carvedilol 12.5 mg Tablet Sig: Two (2) Tablet PO BID (2 times 
a day).  
3. Simvastatin 40 mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
4. Folic Acid 1 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  

5. Pantoprazole 40 mg Tablet, Delayed Release (E.C.) Sig: One 
(1) Tablet, Delayed Release (E.C.) PO Q24H (every 24 hours).  
6. Lorazepam 0.5 mg Tablet Sig: One (1) Tablet PO once a day as 
needed for anxiety/insomnia.  
7. Levofloxacin 250 mg Tablet Sig: Three (3) Tablet PO Q48H 
(every 48 hours) for 1 doses: please take on ___.
Disp:*3 Tablet(s)* Refills:*0*
8. Acetaminophen 500 mg Tablet Sig: ___ Tablets PO Q6H (every 6 
hours) as needed for pain, fever.  
9. Aspirin 81 mg Tablet Sig: One (1) Tablet PO once a day.  
10. Nitroglycerin 0.4 mg Tablet, Sublingual Sig: One (1)  
Sublingual PRN CHEST PAIN.  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Community acquired pneumonia
Diabetes melitus, type II
Chronic obstructive pulmonary disease
Acute renal failure with chronic kidney disease
Anemia
Hypertension
Coronary artery disease, native vessel and bypass graft
Hyperlipidemia
Systolic congestive heart failure

 
Discharge Condition:
afebrile, breathing comfortably on room air.

 
Discharge Instructions:
Weigh yourself every morning, call MD if weight > 3 lbs.
Adhere to 2 gm sodium diet
Fluid Restriction: 2L

You were admitted to the hospital with pneumonia. You improved 
with antibiotics. You should continue this antibiotic, 
levofloxacin, on discharge, and take your last dose on ___. 
.
You should ___ with your primary care Dr. ___ 
1 week of your discharge.  
. 
The following changes were made to your medications:
1. You were started on an antibiotic, levaquin as above. 
2. Your blood pressure medications (HCTZ and Lisinopril) were 
held because your kidney function.  Your blood pressure remained 
well controlled in the hospital.  These can be restarted as 
needed by your primary care doctor. 
3. Your metformin was held because it can cause low blood sugars 
while you are taking the levaquin.  You should restart your 
metformin on ___ after completing your course of antibiotics.  
.
You should contact your primary care doctor or return to the 
Emergency Department if you experience worsening fevers, chills, 
shortness of breath, nausea, vomitting, inability to take in 
foods or liquids.
 
Followup Instructions:
___
"
11215929-DS-4," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: OBSTETRICS/GYNECOLOGY
 
Allergies: 
Multihance / Penicillins / Bactrim
 
Attending: ___
 
Chief Complaint:
Abdominal pain
 
Major Surgical or Invasive Procedure:
___ drainage of hematosalpynx 

 
History of Present Illness:
Ms. ___ is a ___ year-old G0 with unprovoked extensive
superficial thrombophlebitis of the right thigh on ___
presents with RLQ pain starting at 2am this morning. She has 
been
feeling weak without appetite for 2 days, and has been feeling
cold for a week now, but denies any fever. Yesterday, she had
very little appetite, and started her menses which was much
heavier than she has ever experienced, requiring 10 pads
(normally uses ___. She had a lot of cramping associated with
clots. Denies any dizziness, palpitations, SOB/CP, or
bowel/bladder symptoms. This was her first menstrual period 
since
she was started on Xarelto for superficial right left 
thrombosis.
She then went to stay with her sister (who is a ___) last
night.

She had severe RLQ cramping and pulling at 2am with associated
nausea and dry heaves but no actual emesis. She tried using some
heat packs, which helped temporarily but did not completely
alleviate the pain. The pain continues to persist and is worse 
if
she lies flat, but she still cannot get comfortable. Has not
eaten anything today. Last BM was yesterday morning, passing
flatus. No abnl vaginal discharge, not sexually active for
several years due to severe dyspareunia.

 
Past Medical History:
Obstetric History: G0

Gynecologic History:
- Menses regular qmonth, lasting 7 days with heavier flow for 
___
days (using ___ pads on those days)
- Denies h/o abnormal Pap test
- Denies h/o STIs or pelvic infections
- h/o L ovarian cyst (unsure what size) which had ruptured ___
years ago

Past Medical History:
- HTN
- Sleep apnea
- Obesity (BMI 44)
- Elevated Factor VIII level (246% of normal in ___
- Iron deficiency anemia s/p iron dextran infusion in ___. 
Last
HCT 34.3 (___)

Past Surgical History:
- nasal septum surgery (age ___

 
Social History:
___
Family History:
- Father and sister with h/o DVT
- Denies family history of ovarian, uterine, cervical, or colon
cancer

 
Physical Exam:
Vitals in ED: Tmax 99.6 110 135/75 17 97% RA 
General: uncomfortable appearing woman, NAD, AxO
CV: tachycardic, no murmur
Resp: CTAB, no crackles appreciated
Abd: +BS, soft, obese, RLQ very tender to palpation, no rebound
or guarding
Pelvic: Normal external genitalia with dried blood externally,
smooth vaginal walls without lesions, ___ scopettes of blood in
the vault, no mucopurulent discharge, nulliparous cervix without
lesions. On bimanual exam, has tenderness in the right adhexal
region but no palpable mass due to limitation from pain and body
habitus. No left adnexal tenderness.
Ext: right thigh with palpable cord and erythema

On discharge:
Afebrile, normal vital signs
Gen: NAD
CV: RRR
PULM: CTAB
Abd: soft, obese, mildly distended, TTP in RLQ, no 
rebound/guarding
Extr: 1+ ___ edema bilaterally, non tender. Stable ant thigh 
ecchymosis and tenderness
 
Pertinent Results:
___ 06:25AM BLOOD WBC-8.6 RBC-4.01* Hgb-9.7* Hct-30.3* 
MCV-76* MCH-24.3* MCHC-32.1 RDW-17.7* Plt ___
___ 06:39AM BLOOD WBC-7.5 RBC-3.72* Hgb-9.3* Hct-28.4* 
MCV-76* MCH-25.0* MCHC-32.7 RDW-17.4* Plt ___
___ 03:20PM BLOOD WBC-6.9 RBC-3.81* Hgb-9.5* Hct-29.1* 
MCV-77* MCH-25.1* MCHC-32.8 RDW-17.3* Plt ___
___ 06:50AM BLOOD WBC-6.6 RBC-3.67* Hgb-9.0* Hct-27.6* 
MCV-75* MCH-24.6* MCHC-32.6 RDW-17.2* Plt ___
___ 01:30AM BLOOD WBC-7.6 RBC-3.69* Hgb-9.1*# Hct-27.0* 
MCV-73* MCH-24.8* MCHC-33.9 RDW-16.5* Plt ___
___ 06:45AM BLOOD WBC-8.6 RBC-3.14* Hgb-7.2* Hct-23.4* 
MCV-74* MCH-23.0* MCHC-30.9* RDW-16.8* Plt ___
___ 12:45AM BLOOD WBC-9.1 RBC-3.24* Hgb-7.5* Hct-23.6* 
MCV-73* MCH-23.1* MCHC-31.7 RDW-16.5* Plt ___
___ 06:20PM BLOOD WBC-10.8 RBC-3.54* Hgb-8.2* Hct-25.9* 
MCV-73* MCH-23.1* MCHC-31.5 RDW-16.2* Plt ___
___ 02:29PM BLOOD WBC-18.1* RBC-3.79* Hgb-9.1* Hct-27.4* 
MCV-72* MCH-24.0* MCHC-33.3 RDW-16.5* Plt ___
___ 06:40AM BLOOD WBC-18.7* RBC-3.77* Hgb-8.8* Hct-27.2* 
MCV-72* MCH-23.4* MCHC-32.4 RDW-16.5* Plt ___
___ 07:05AM BLOOD WBC-17.3*# RBC-4.66 Hgb-11.2* Hct-33.4* 
MCV-72* MCH-24.0* MCHC-33.5 RDW-16.3* Plt ___
___ 06:25AM BLOOD Neuts-70.7* ___ Monos-6.8 Eos-3.7 
Baso-0.3
___ 06:06AM BLOOD Neuts-71.0* Lymphs-17.7* Monos-7.4 
Eos-3.7 Baso-0.2
___ 06:39AM BLOOD Neuts-72.9* Lymphs-15.2* Monos-7.5 
Eos-4.2* Baso-0.2
___ 03:20PM BLOOD Neuts-69.4 ___ Monos-7.1 Eos-4.3* 
Baso-0.4
___ 06:50AM BLOOD Neuts-67.9 ___ Monos-6.7 Eos-3.0 
Baso-0.3
___ 06:45AM BLOOD Neuts-82.3* Lymphs-12.6* Monos-3.8 
Eos-1.3 Baso-0.1
___ 12:45AM BLOOD Neuts-87.3* Lymphs-8.4* Monos-3.4 Eos-0.8 
Baso-0.1
___ 03:00AM BLOOD Neuts-86.4* Lymphs-9.9* Monos-2.2 Eos-1.4 
Baso-0.1
___ 02:29PM BLOOD Neuts-90.1* Lymphs-6.9* Monos-2.3 Eos-0.6 
Baso-0.1
___ 06:40AM BLOOD Neuts-91.2* Lymphs-6.5* Monos-2.0 Eos-0.1 
Baso-0.1
___ 06:25AM BLOOD ___ PTT-31.7 ___
___ 06:50AM BLOOD ___ PTT-30.8 ___
___ 06:45AM BLOOD ___ PTT-29.0 ___
___ 02:29PM BLOOD ___ PTT-33.7 ___
___ 06:40AM BLOOD ___ PTT-31.2 ___
___ 07:05AM BLOOD ___ PTT-34.0 ___
___ 06:25AM BLOOD Glucose-123* UreaN-4* Creat-0.6 Na-137 
K-3.6 Cl-97 HCO3-31 AnGap-13
___ 06:06AM BLOOD Glucose-86 UreaN-6 Creat-0.6 Na-138 K-3.9 
Cl-98 HCO3-29 AnGap-15
___ 06:39AM BLOOD Glucose-94 UreaN-6 Creat-0.5 Na-138 K-3.9 
Cl-98 HCO3-28 AnGap-16
___ 03:20PM BLOOD Glucose-98 UreaN-5* Creat-0.7 Na-137 
K-3.5 Cl-98 HCO3-27 AnGap-16
___ 03:00AM BLOOD ALT-10 AST-14 AlkPhos-70 TotBili-1.2

IMAGING:

Pelvic US ___: 
1. Tubular structure in right adnexa with echogenic contents, 
consistent with  pyosalpinx.  Endometriosis and/or neoplasm 
would be other considerations, however the elevated white count 
suggest pyosalpinx would be more likely. Ascites and omental 
stranding are also presumed to be inflammatory in nature given 
patient's clinical presentation. 
2.  Left hydrosalpinx.  Normal appearance of left ovary.  
3.  Right ovary not well evaluated on this exam due to 
displacement by adnexal structures, making complete exclusion of 
right ovarian torsion, as queried, not possible on this exam. 
  
Liver US ___: 1.  Biliary sludge without evidence of acute 
cholecystitis. No cholelithiasis. 
2.  0.___ile duct, similar to MR dated ___ 
without evidence  of stone.  3.  Small volume of ascites. 

CTA Chest ___: Limited exam due to body habitus and bolus 
timing. No evidence of large  pulmonary embolism.  No acute 
findings. Bibasilar atelectasis, left greater than right. 

Lower extremity venous ultrasound ___: No evidence of deep 
venous thrombosis in the bilateral lower extremity veins. 

 
Brief Hospital Course:
Ms. ___ was admitted from the ED to the GYN service with the 
diagnosis of hematosalpynx thought to be related to 
anticoagulation from being on Xarelto. 
Please see below for detailed hospital course by system/problem:

1) Neuro: Ms. ___ had significant abdominal pain associated 
with a right hematosalpynx. She received IV pain medication 
however continued to have persistnet pain. APS was consulted who 
recommended a morphine PCA. This was continued until her diet 
was advanced to a regular diet after which she was transitioned 
to oral oxycodone and acetaminophen which controlled her pain 
adequately.

2) Hematosalypnx: This was thought to be related to beign 
anticoagulated on Xaralto. Therefore, this medication was held 
and all anticoagulation was held. The patient received multiple 
doses of Vitamin K and 2units FFP to reverse her coagulopathy 
following which her INR significantly improved. Although there 
was some suspicion for hemoperitoneum, her abdominal exam 
remained stable throughout with no hemodynamic instability or 
acute abdomen. She received 2 units pRBC for downtrending anemia 
with an appropriate response. 
The patient underwent an ___ guided drainage of right 
hematosalypnx with minimal fluid aspirated. There was no 
purulence noted at the time of drain. 

3) ID: the patient was noted to have a significant leukocytosis 
on admission. Due to some initial concern for pyosalpynx, the 
patient was started on gentamicin and clindamycin. She was 
afebrile until the day of above noted ___ drained when post 
procedurally she was triggered for a heart rate in the 130s and 
a temp of 101.4. She subsequently defevervesced with no further 
fevers. This was thought to be related to a inflammatory 
response after ___ drainage. Her antibiotics were subsequently 
discontinued given no clinical evidence of pyosalpynx or 
infection. ___ cultures did not grow anything.

4) GI: Initially, the patient had nausea, intermittent emesis 
and limited bowel function. She was maintained on a clear liquid 
diet due to concern for possible ileus and received a bowel 
regimen which significantly improved her symptoms. She was 
advanced to a regular diet without difficulty. Nutrtition was 
consulted given need for daily vitamin K who recommended Ensure 
supplementation. 

5) Heme: Patient was initially on Xaralto due to a history of 
superficial thrombosis and fam hx of DVT. Hematology was 
consulted who agreed with holding Xaralto on admission. Once 
hematocrits were stable with no evidence of ongoing bleeding 
into hematosalypnx, the patient was started on prophylactic 
anticoagulation (___ transitioned to lovenox, discharged on 
prophylactic lovenox). During her hospital stay, she had ___ 
ultrasound that was negative for a DVT (this was done to a 
complaint of lower extremity swelling)

6)Pulm: the patient had intermittent oxygen requirements. This 
was thought to be related to a combination of sleep apnea and 
fluid overload. A CTA chest was negative for a PE. A CXR showed 
possible fluid overload. Given clinical evidence of fluid 
overload (crackes on lung exam, ___ swelling) the patient 
received several doses of IV lasix and used the incentive 
spirometer following which she was weaned to room air without 
difficulty. The patient had normal ambulatory O2 sats prior to 
discharge.  

Ms. ___ was discharged home in stable condition on hospital day 
#8- ambulating independently, tolerating a regular diet and pain 
adequately controlled on oral pain regimen.  
 
Discharge Medications:
1. Acetaminophen 1000 mg PO Q6H 
RX *acetaminophen 500 mg ___ tablet(s) by mouth every six (6) 
hours Disp #*60 Tablet Refills:*1
2. Bisacodyl ___AILY:PRN constipation 
RX *bisacodyl 10 mg 1 suppository(s) rectally daily as needed 
Disp #*30 Suppository Refills:*0
3. Docusate Sodium 100 mg PO TID 
RX *docusate sodium 100 mg 1 capsule(s) by mouth twice a day 
Disp #*60 Capsule Refills:*0
4. Enoxaparin Sodium 60 mg SC DAILY 
Start: ___, First Dose: Next Routine Administration Time 
RX *enoxaparin 60 mg/0.6 mL 60 mg SC daily Disp #*14 Syringe 
Refills:*0
5. Ferrous Sulfate 325 mg PO TID 
RX *ferrous sulfate 325 mg (65 mg iron) 1 tablet(s) by mouth 
three times a day Disp #*90 Tablet Refills:*1
6. Hydrochlorothiazide 12.5 mg PO DAILY 
7. Polyethylene Glycol 17 g PO DAILY 
RX *polyethylene glycol 3350 17 gram 1 powder(s) by mouth daily 
Disp #*30 Packet Refills:*0
8. Senna 8.6 mg PO BID 
RX *sennosides [senna] 8.6 mg 1 capsule by mouth twice a day 
Disp #*30 Capsule Refills:*0
9. Valsartan 160 mg PO DAILY 
10. OxycoDONE (Immediate Release)  ___ mg PO Q3H:PRN pain 
Do not drink alcohol or drive while taking. 
RX *oxycodone 5 mg ___ tablet(s) by mouth every ___ hours Disp 
#*60 Tablet Refills:*0
11. Furosemide 20 mg PO DAILY:PRN lower extremity swelling 
Take as needed for swelling in your legs. Do not take more than 
one daily. 
RX *furosemide 20 mg 1 tablet(s) by mouth daily Disp #*10 Tablet 
Refills:*0
12. Lorazepam 0.5 mg PO Q4H:PRN anxiety, insomnia 
RX *lorazepam 0.5 mg 1 tablet(s) by mouth every 4 hours Disp 
#*20 Tablet Refills:*0
13. Ondansetron ___ mg PO Q8H:PRN nausea 
RX *ondansetron HCl 4 mg ___ tablet(s) by mouth every 8 hours 
Disp #*10 Tablet Refills:*0

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
hematosalpinx 

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___,
.
You were admitted to the gynecologic oncology service with 
hematosalpinx. You have recovered well, and the team feels that 
you are safe to be discharged home. Please follow these 
instructions: 
.   
* Take your medications as prescribed.  
* Do not drive while taking narcotics.  
* Do not combine narcotic and sedative medications or alcohol.  
* Do not take more than 4000mg acetaminophen (APAP) in 24 hrs.   

* You may eat a regular diet. 
.
To reach medical records to get the records from this 
hospitalization sent to your doctor at home, call ___.  

 
Followup Instructions:
___
"
11296936-DS-66," 
Name:  ___                Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Morphine
 
Attending: ___
 
Chief Complaint:
chest pain, dyspnea
 
Major Surgical or Invasive Procedure:
none

 
History of Present Illness:
Mr. ___ is a ___ gentleman with h/o ESRD on HD, chronic 
systolic CHF with EF 30%, AF, HTN, GIB, cocaine abuse, p/w chest 
pain X 2 days.  Pt. also complains of N/V X 2 days.  
.  
In the ED, initial vs were: 97.5   171/81   130s   38   89% RA.  
He triggered on arrival for his hypoxia and tachypnea.  EKG 
showed AFib but no evidence of ischemia.  Labs were significant 
for hypkalemia to 6.6 and negative cardiac biomarkers.  CXR was 
interpreted as showing pulmonary vascular congestion.  He was 
given diltiazem 15mg IV with improvement in his tachycardia to 
the ___.  He also received ASA 325mg.  The dialysis fellow was 
contacted and he was sent directly to hemodialysis before being 
admitted to the medical floor.  He was given Dilaudid 2mg in 
dialysis.
.
On the floor, pt. complained of ___ CP which he said was 
constant since waking the morning prior to the ___ of admission. 
 He said that he did not have this pain before.  He states he 
was asymptomatic with his MI in the past.  Pt. did have N/V at 
this time and a HR of ""200"" though when assessed his HR 
decreased to 150s.  An EKG was done which showed ST depressions 
in II, AvF, V5, V6 with were present but more pronounced than 
previous.  Pt.'s heart rate decreased spontaenously and his n/v 
resolved on it's own.  Pt.'s CP did not respond to 0.4 of SL 
Nitroglycerin.  His Cardiac enzymes were repeated at that time 
and were unchanged.  Pt. complained of left hand pain which he 
states always worsens after dialysis over the past several 
months.  He c/o constant numbness in his left hand.  Patient 
states he last used cocaine ""a few days ago"" but could not 
recall an exact date, but that he usually uses it 2x/week.
.
Patient states that he did not take any of his home medications 
today and missed dialysis because he was laid up in bed not 
feeling well since yesterday.  Pt. believes sxs started because 
of mac and cheese and steak which he has eatten over the past 2 
days.  Denies sick contacts.
 
Past Medical History:
ESRD on HD ___ at ___ Dialysis, ___, 
___  
Type 2 diabetes mellitus c/b peripheral neuropathy  
Reports h/o MI:  on review of records, he had demand ischemia in 
___ with no flow-limiting stenoses on cardiac cath 
- MIBI in ___ showed reversible defects inferior/lateral  
- baseline troponin 0.2-0.4
Chronic systolic CHF with EF ___ TEE)  
Atrial fibrillation/AFlutter s/p ablation ___  
h/o atrial tachycardia s/p EPS ___ and ablation x 2 
Hypertension  
Dyslipidemia: ___ TC 101, LDL 54, HDL 29, ___ 112  
History of GI bleed:  
- Duodenal, jejunal, and gastric AVMs s/p thermal therapy  
- diverticulosis throughout colon  
Chronic pancreatitis  
Possible Hepatitis C infection, HCV Ab + ___, but neg ___
GERD  
Gout 
s/p arthroscopy with medial meniscectomy ___  
Depression with multiple hospitalizations due to SI  
Polysubstance abuse: crack cocaine, EtOH, tobacco  
- frequent bouts of chest pain following crack/cocaine use  
Erectile dysfunction s/p inflatable penile prosthesis ___ 
h/o C diff in ___
 
Social History:
___
Family History:
Mother had ESRD on HD, died from MI at the age of ___. 4 Brothers 
and 2 sisters, nearly all with DM2
 
Physical Exam:
Vitals: 98.2  143/97  (-160/100  98-100  20 100%/3L 
General: Alert, oriented, no acute distress  
HEENT: Sclera anicteric, MMM, oropharynx clear, partially 
adentulous  
Neck: supple, JVP not elevated, no LAD  
Lungs: Clear to auscultation bilaterally, no wheezes, rales, 
ronchi; TTP along sternum-rib border on left.    
CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, 
gallops  
Abdomen: soft, non-tender, non-distended, bowel sounds present, 
no rebound tenderness or guarding, no organomegaly  
Ext: Warm, well perfused, 2+ radial pulses, no clubbing, 
cyanosis or edema. AVF in left arm strong thrill.  NL warmth in 
left hand.  
 
Pertinent Results:
Admission labs:
WBC-5.3 RBC-4.56* Hgb-12.8* Hct-39.1* MCV-86 MCH-28.0 MCHC-32.6 
RDW-17.3* Plt ___
Neuts-78.6* Lymphs-13.5* Monos-6.4 Eos-0.7 Baso-0.8
Glucose-288* UreaN-54* Creat-9.5*# Na-131* K-6.6* Cl-94* HCO3-24 
AnGap-20
CK(CPK)-71 ___ set)
CK(CPK)-55
CK(CPK)-55
cTropnT-0.22* ___ set)
cTropnT-0.31*
cTropnT-0.31* 
Calcium-10.0 Phos-5.6* Mg-2.4
PTH-468*
Lactate-2.6* K-5.5*

URINE bnzodzp-NEG barbitr-NEG opiates-NEG cocaine-POS 
amphetm-NEG mthdone-NEG

blood culture ___ pending

CXR:  Findings are most compatible with volume overload. An 
underlying
focal infiltrate cannot be entirely excluded. Repeat radiography 
recommended
after appropriate diuresis to assess for underlying infection. 
The enlarged
cardiac silhouette is stable since the prior study, but is an 
interval change
since the study of ___. A superimposed pericardial 
effusion cannot be
excluded. Correlate clinically.

EMG b/l arms:
Abnormal study. There is also evidence for severe, bilateral 
median
neuropathies at the wrist. There is evidence for a moderate, 
right ulnar
neuropathy at the elbow. There is also evidence for a 
generalized moderate
sensory motor polyneuropathy. Although the clinical history is 
worrisome for a median neuropathy at the cubital fossa, this was 
not confirmed on this study. There is no evidence for an ulnar 
neuropathy at the elbow or for a radial neuropathy on the right 
side.

TTE:
The left atrium is moderately dilated. There is mild symmetric 
left ventricular hypertrophy. The left ventricular cavity size 
is normal. There is moderate global left ventricular hypokinesis 
(LVEF = XX %). The right ventricular cavity is dilated and the 
free wall is hypokinetic. The aortic valve leaflets (3) are 
mildly thickened. No aortic regurgitation is seen. The mitral 
valve leaflets are mildly thickened. Mild (1+) mitral 
regurgitation is seen. The estimated pulmonary artery systolic 
pressure is normal. There is no pericardial effusion (does not 
exclude pericarditis).

Compared with the prior study (images reviewed) of ___, 
the left ventricle now appears less dilated and systolic 
function is improved. The images from the study of ___ 
are not available for review due to technical difficulties.  

EKG: multiple EKGs showing, Atrial tachycardia with 3:1 or 2:1 
block. Non-specific ST-T wave abnormalities.
Low limb lead voltage. 
 
Brief Hospital Course:
# Shortness of breath: CXR c/w pulmonary edema.  Given recent 
dietary indiscretion, possibly went into flash pulmonary edema 
from tachycardia.  No viral syndrome to suggest pericarditis and 
no pericardial effusion on echo (and patient not hypotensive, 
but hypertensive), and urea not elevated to extent that would 
expect to see uremic pericarditis.  Renal followed and patient 
had dialysis with UF on hospital ___ 1 and dialysis on ___ 3.  
He was also kept on a low potassium, low salt diet with fluid 
restrictions.
.  
# AFib with RVR: Patient converted with Diltiazem 15mg IV X1 in 
ED and then spontaneously on floor ___.  He was continued on 
tele without further events.  He was continued on Amiodarone per 
discussion with Dr ___.
.  
# Chest pain: Troponins elevated at baseline.  Given CP with 
palpation, most likely MSK and related to cough however could 
have been secondary to cocaine abuse.  CEs negative X3. Patient 
was started on asa, cont statin, ___, nitro prn for treatment 
and given prn pain meds.  He was CP free at d/c.
.
# cocaine use: could contribute to ischemic as although patient 
denies use in the past ___ days at admission, his urine tox ___ 
___ of admission was positive.Advised patient to quit and he 
refused SW consult.
.
# ESRD on HD: Continued dialysis as above.  Continued Sevelamer, 
started Cinacalcet.
.
# left arm pain: Etiology unclear however differential included 
neuropathy versus steal syndrome due to AV fistula.  Pulses and 
flow on exam however seemed normal.  EMG revealing for carpal 
tunel b/l.  Gabapentin was continued and splints were ordered 
along with outpatient hand f/u.
.
# DM
-Insulin s/s
.
# HLD
-cont statin
.
# HTN
-cont Lisinopril and Diltiazem
.
# pruritis: unclear etiology, possible ___ cocaine withrdawal?
- benadryl, hydroxizine used
.  
# Code: full (confirmed) 
.  
# Communication: Patient; ___ ___ son: ___
 
___ on Admission:
Medications (confirmed with pharmacy)
Glargine 14 units HS
Lispro
Lisinopril 20mg daily
Diltiazem 240mg daily
Amiodarone 200mg daily
Atorvastatin 20mg daily
Percocet ___ before dialysis prn pain
Gabapentin 100mg HS
Pantoprazole 40mg daily
Sevelamer 800mg TID
Cinacalcet 30mg daily (none this year per pharmacy)
Hydroxyzine 25mg TID prn itch
Immunocal nutrition supplement
Mupirocin 2% ointment
Albuterol inhaler Q4-6H prn wheeze
.  
Allergies:  
Morphine -- itch
 
Discharge Medications:
1. Gabapentin 100 mg Capsule Sig: Two (2) Capsule PO at bedtime.
Disp:*60 Capsule(s)* Refills:*1*
2. Oxycodone-Acetaminophen ___ mg Tablet Sig: One (1) Tablet 
PO before dialysis as needed for pain.  
3. Atorvastatin 20 mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
4. Amiodarone 200 mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
5. Diltiazem HCl 240 mg Capsule, Sustained Release Sig: One (1) 
Capsule, Sustained Release PO DAILY (Daily).  
6. Lisinopril 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 
 
7. Insulin
please see insulin sliding scale.  14units of Glargine every 
night.
8. Pantoprazole 40 mg Tablet, Delayed Release (E.C.) Sig: One 
(1) Tablet, Delayed Release (E.C.) PO Q24H (every 24 hours).  
9. Sevelamer HCl 400 mg Tablet Sig: Two (2) Tablet PO TID 
W/MEALS (3 TIMES A ___ WITH MEALS).  
10. Cinacalcet 30 mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).
Disp:*30 Tablet(s)* Refills:*2*
11. Hydroxyzine HCl 25 mg Tablet Sig: One (1) Tablet PO TID (3 
times a ___ as needed for itching.  
12. Albuterol Sulfate 90 mcg/Actuation HFA Aerosol Inhaler Sig: 
___ puffs Inhalation every ___ hours as needed for shortness of 
breath or wheezing.  
13. Percocet ___ mg Tablet Sig: One (1) Tablet PO before and 
after dialysis as needed for pain.
Disp:*24 Tablet(s)* Refills:*0*

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Primary
- chest pain, atypical, likely cocaine-related
- carpal tunnel syndrome
- volume overload, likely secondary to missing dialysis and 
food/medications noncompliance

Secondary
ESRD on HD ___ at ___ Dialysis, ___, 
___  
Type 2 diabetes mellitus c/b peripheral neuropathy  
Reports h/o MI:  on review of records, he had demand ischemia in 
___ with no flow-limiting stenoses on cardiac cath 
- MIBI in ___ showed reversible defects inferior/lateral  
- baseline troponin 0.2-0.4
Chronic systolic CHF with EF ___ TEE)  
Atrial fibrillation/AFlutter s/p ablation ___  
h/o atrial tachycardia s/p EPS ___ and ablation x 2 
Hypertension  
Dyslipidemia: ___ TC 101, LDL 54, HDL 29, ___ 112  
History of GI bleed:  
- Duodenal, jejunal, and gastric AVMs s/p thermal therapy  
- diverticulosis throughout colon  
Chronic pancreatitis  
Possible Hepatitis C infection, HCV Ab + ___, but neg ___
GERD  
Gout 
s/p arthroscopy with medial meniscectomy ___  
Depression with multiple hospitalizations due to SI  
Polysubstance abuse: crack cocaine, EtOH, tobacco  
- frequent bouts of chest pain following crack/cocaine use  
Erectile dysfunction s/p inflatable penile prosthesis ___ 
h/o C diff in ___

 
Discharge Condition:
stable, improved.

 
Discharge Instructions:
You were admitted to the hospital because of chest pain and 
shortness of breath.  While you were here you had dialysis which 
helped your shortness of breath.  You had studies of your heart 
which showed that you were not having a heart attack.  Your 
chest pain improved.  It was thought that your chest was caused 
by the use of cocaine.  You had 2 episodes of your heart going 
very fast which was likely due to the cocaine.  You should stop 
using cocaine in order to improve your health.  You can talk to 
your doctors about ___ to do this when  you decide that this is 
something you want to do.
.
While you were here you had nerve studies of your arms which 
show that you have carpal tunel syndrome.  We will refer you to 
a hand surgeon in case you want their opinion on getting this 
surgically fixed.  Sometimes this type of pain can resolve on 
its own with wrist splints.  You can speak with Dr. ___ 
this with your next visit with him.
.
While you were here your Gabapentin was increased to 200mg each 
night.  This might help with your arm pain.  You can also pick 
up wrist splints which should be waiting for you at the 
___ on the second floor of the ___ 
Building.
.
Dr. ___ that you can use Percocet 1 pill before and 
after each dialysis session for your pain.  You should not use 
this medication while driving or operating machinery.
.
You should start taking Cinacalcet per your new prescription.  
Talk to your kidney doctor if you have a problem filling it.
.
You should continue to take all other prescriptions as 
prescribed by your doctor.
.
Weigh yourself every morning, call MD if weight goes up more 
than 3 lbs.  Adhere to 2 gm sodium diet
Fluid Restriction: 1.5 Liters per ___
.
If you develop chest pain, shortness of breath, difficulty 
breathing or with any other concerning symptoms you should call 
your doctor or go to the emergency room.
 
Followup Instructions:
___
"
11392990-DS-6," 
Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
___
 
Attending: ___.
 
Chief Complaint:
Shortness of breath
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
Mr. ___ is a ___ w/ CAD s/p CABG, CHF w/ EF ___ & ICD, 
A-fib on coumadin, and extensive smoking history who presents 
with SOB.  Today he was at home in his USOH when he began 
feeling acutely dyspnic.  He called EMS, who reported that he 
was cool/pale/diaphoretic and tachypnic to the ___ and satting 
in the ___.  He did not improve with albuterol, so they placed 
him on CPAP, after which he improved.  

On arrival to the ED, he was tachypnic to the ___ and had a 
collapsable IVC on bedside US.  CXR looked more volume 
overloaded, so they did not give him IVF.  His respiratory 
status improved with duonebs, and he received solumedrol.  Also, 
he received a dose of vanc/cefepime for presumed HCAP given 
opacities on CXR and ronchorous lung exam - the patient has not 
been febrile and does not report cough.  He was also started on 
a nitro gtt for SBP in the 160s out of concern for flash 
pulmonary edema, as CXR also w/ evidence of pulm edema.  Notable 
labs include WBC 7 w/ 49% Lymphocytes, Cr 2.3 (baseline 
1.4-1.5), Lactate 5.7 -> 3.7, and BNP in the 990s (no baseline). 


On arrival to the MICU, VS were 98 71 148/51 17 97% on Venturi 
mask.  The pt was comfortable and reports his SOB has improved 
but not yet back to baseline.

REVIEW OF SYSTEMS:  
(+) Per HPI  
(-) Denies fever, chills, night sweats, recent weight loss or 
gain. Denies headache, sinus tenderness, rhinorrhea or 
congestion. Denies cough, shortness of breath, or wheezing. 
Denies chest pain, chest pressure, palpitations, or weakness. 
Denies nausea, vomiting, diarrhea, constipation, abdominal pain, 
or changes in bowel habits. Denies dysuria, frequency, or 
urgency. Denies arthralgias or myalgias. Denies rashes or skin 
changes.  

Of note, pt had workup in ___ at ___ for 
dyspnea, notable for:

- PFTs ___
FVC 78% predicted
FEV1 70% predicted
FEV1/FVC 90%
DLCO 74% predicted
maximum midexpiratory flow rate 37% predicted
ERV 24% predicted
FRC 68% predicted
""The findings suggest the presence of combined borderline 
restrictive and very mild obstructive physiology. The latter is 
at the level of the small airways. The mild reduction in the 
maximum breathing capacity suggests the possibility of mild 
neuromuscular weakness.""
Methacholine challenge: No bronchoconstrictor response to 
methacholine challenge.

- CT Chest ___
""There is minimal to moderate pleural parenchymal fibrosis noted 
in both upper lobes greater on the left side. Multiple calcified 
granulomas are also noted ranging from 2 mm to 8 mm. There are 
no noncalcified pulmonary nodules. No evidence for infiltrates 
or effusions. No evidence for bronchiectasis. Evaluation for 
mediastinal and hilar adenopathy is limited due to lack of IV 
contrast. There are no lymph nodes noted in the axillary 
regions.""
""Bilateral pleural parenchymal scarring and fibrosis within both 
upper lobes with multiple calcified granulomas. No other 
significant abnormalities.""
 
Past Medical History:
Atrial fibrillation/flutter - s/p ablation, on coumadin and 
amiodarone
CAD s/p anterior MI in ___, CABG in ___
CHF (EF ___, ICD implantation w h/o inappropriate shocks)
Non-insulin dependent diabetes mellitus
Hypertension
Hyperlipidemia
Chronic kidney disease (Cr baseline 1.4-1.5)
Distant history of TB treated with abx
 
Social History:
___
Family History:
No FH of premature CAD.
 
Physical Exam:
ADMISSION (arrival to ___):
Vitals: 98 71 117/51 17 91% on 2L NC  
General: Well appearing in no acute distress, breathing 
comfortably  
HEENT: dry mucous membranes  
Neck: JVP non-elevated (~8 cm)  
CV: Distant heart sounds Regular rate and rhythm, normal S1 S2, 
no murmurs  
Lungs: good air movement throughout, prolonged expiratory phase 
with diffuse ronchi posteriorly  
Abdomen: Soft, normoactive bowel sounds, nontender, 
nondistended, no rebound or guarding  
GU: Foley in place  
Ext: Warm, no peripheral edema peripheral pulses 2+ ___  
Neuro: alert and oriented to person, hospital, and date  

DISCHARGE:
VS: 99.2, 99.0, 128/46 (119-145/35-70), 58 (56-73), ___, 
97-98%RA.
Ambulatory sats on ___ AM: 90-93% on RA while walking
FSBS: 166, 186, 229, 220
General: NAD, not tachypneic, no increased WOB, comfortable 
lying on 2 pillows
HEENT: no oral lesions, no oropharyngeal erythema  
Neck: supple, no LAD, no carotid bruits  
CV: RRR, no m/r/g, JVP approx 8 cm, well-healed sternotomy scar, 
ICD in left chest 
Lungs: CTAB, no crackles or wheezes
Abdomen: soft, NT, ND, BS+
GU: no foley in place, no CVAT
Ext: WWP, DP and ___ 2+ bilaterally, no edema
Neuro: A&Ox3, no focal neuro deficits

 
Pertinent Results:
PERTINENT ADMISSION LABS:
___ 02:05AM   GLUCOSE-247* UREA N-35* CREAT-2.3* SODIUM-141 
POTASSIUM-4.2 CHLORIDE-97 TOTAL CO2-21* ANION GAP-27*
___ 02:05AM   CALCIUM-9.1 PHOSPHATE-7.7*# MAGNESIUM-2.2
___ 02:05AM   WBC-7.0 RBC-4.11* HGB-11.8* HCT-36.5* MCV-89 
MCH-28.7 MCHC-32.3 RDW-14.8
___ 02:05AM   PLT COUNT-293
___ 02:05AM   NEUTS-42.0* LYMPHS-49.8* MONOS-6.3 EOS-1.6 
BASOS-0.4
___ 02:05AM   ___ PTT-41.1* ___
___ 02:05AM   proBNP-995*
___ 02:12AM   LACTATE-5.7*
___ 02:29AM   LACTATE-3.7*
___ 02:27PM   LACTATE-3.6*
___ 02:39AM   Lactate-1.0
___ 02:05AM   cTropnT-<0.01
___ 10:10AM   cTropnT-0.02*
___ 02:05AM   cTropnT-<0.01
___ 02:05AM   ALT(SGPT)-35 AST(SGOT)-47* ALK PHOS-148* TOT 
BILI-0.2
___ 02:05AM   TSH-11*
___ 01:39PM   T4-8.0

PERTINENT INTERVAL LABS:
___ 01:39PM   GLUCOSE-219* UREA N-33* CREAT-1.9* SODIUM-139 
POTASSIUM-4.9 CHLORIDE-105 TOTAL CO2-23 ANION GAP-16
___ 02:19AM BLOOD Glucose-123* UreaN-31* Creat-1.6* Na-141 
K-4.5 Cl-108 HCO3-23 AnGap-15
___ 11:30AM BLOOD Glucose-158* UreaN-29* Creat-1.5* Na-139 
K-4.0 Cl-103 HCO3-27 AnGap-13
___ 08:05AM BLOOD Glucose-106* UreaN-30* Creat-1.5* Na-141 
K-3.3 Cl-103 HCO3-27 AnGap-14
___:39PM   CALCIUM-8.6 PHOSPHATE-2.4*# MAGNESIUM-1.9
___ 02:19AM BLOOD Calcium-8.4 Phos-2.3* Mg-1.9
___ 11:30AM BLOOD Calcium-8.7 Phos-2.4* Mg-2.0
___ 02:19AM BLOOD ALT-24 AST-20 AlkPhos-76 TotBili-0.2
___ 02:19AM BLOOD WBC-7.8 RBC-3.27* Hgb-9.3* Hct-29.3* 
MCV-90 MCH-28.3 MCHC-31.6 RDW-15.4 Plt ___
___ 11:30AM BLOOD WBC-8.3 RBC-3.49* Hgb-10.1* Hct-29.9* 
MCV-86 MCH-28.9 MCHC-33.8 RDW-15.3 Plt ___
___ 02:19AM BLOOD ___ PTT-42.2* ___
___ 11:30AM BLOOD ___ PTT-38.3* ___
___ 02:19AM BLOOD %HbA1c-6.2* eAG-131*
___ 02:27PM   ___ PO2-76* PCO2-40 PH-7.40 TOTAL CO2-26 
BASE XS-0
___ 02:39AM BLOOD pO2-102 pCO2-34* pH-7.46* calTCO2-25 Base 
XS-0 Comment-GREEN TOP

EKGS:
___ Normal sinus rhythm with intra-atrial conduction 
abnormality. Non-specific intraventricular conduction 
abnormality. Compared to the previous tracing of ___ the QRS 
duration has increased. Atrial fibrillation/flutter is no longer 
present. ST segment abnormalities are less marked. 
___ Sinus rhythm. Intraventricular conduction delay. Left 
atrial abnormality. Delayed R wave transition. Compared to the 
previous tracing of ___ the ventricular rate is faster and 
the Q-T interval has normalized. 

IMAGING:

___ TTE
The left atrium is mildly dilated. No atrial septal defect is 
seen by 2D or color Doppler. There is mild symmetric left 
ventricular hypertrophy. The left ventricular cavity is 
moderately dilated. There is moderate to severe regional left 
ventricular systolic dysfunction with inferior/septal/anterior 
hypokinesis and distal LV/apical akinesis. No masses or thrombi 
are seen in the left ventricle. There is no ventricular septal 
defect. Right ventricular chamber size and free wall motion are 
normal. The diameters of aorta at the sinus, ascending and arch 
levels are normal. The aortic valve is not well seen. There is 
no aortic valve stenosis. Trace aortic regurgitation is seen. 
The mitral valve leaflets are mildly thickened. Mild to moderate 
(___) mitral regurgitation is seen. The tricuspid valve 
leaflets are mildly thickened. There is moderate pulmonary 
artery systolic hypertension. There is no pericardial effusion. 
Compared with the prior study (images reviewed) of ___, LV 
systolic function has slightly improved (LVEF on prior really 
___.  

___ CXR
IMPRESSION:  Markedly enlarged cardiac silhouette with findings 
suggestive of chronic fluid overload with no evidence of acute 
pulmonary edema. 

___ CT Chest without contrast
IMPRESSION: 
1.  Prior tuberculosis/granulomatous infection evident in lung 
apices. No 
reactivation.  
2.  Posterior basilar ground glass opacification in the 
bilateral lower lobes could be pulmonary hemorrhage, drug 
reaction, or the early manifestation of chronic eosinophilic 
pneumonia, nonspecific or desquamative interstitial pneumonia.  
Supplementary prone imaging could be performed to see if this is 
unusual atelectasis or gravity dependent edema.  No evidence of 
pulmonary fibrosis. 
3.  Moderately severe emphysema. Probable pulmonary 
hypertension. 
4.  Extensive coronary and peripheral atherosclerosis detailed 
above. 

___ CXR
IMPRESSION:  AP chest compared to ___ and ___: 
Severe cardiomegaly progressed between ___ and ___, 
subsequently unchanged.  A combination of vascular engorgement 
and worsening interstitial abnormality suggests all the findings 
could be explained by cardiac decompensation.  Because of 
asymmetry in lower lobe involvement there could be concurrent 
right lower lobe pneumonia, but that diagnosis need not be 
invoked to explain the current findings.  Pleural effusions are 
small, if any. Transvenous pacer lead tip projects over the apex 
of the right ventricle. 

PERTINENT DISCHARGE LABS:
___ 08:05AM BLOOD Glucose-106* UreaN-30* Creat-1.5* Na-141 
K-3.3 Cl-103 HCO3-27 AnGap-14
___ 08:05AM BLOOD Calcium-8.5 Phos-3.4 Mg-2.0
___ 08:05AM BLOOD WBC-7.7 RBC-3.50* Hgb-9.9* Hct-29.9* 
MCV-85 MCH-28.4 MCHC-33.3 RDW-15.1 Plt ___
___ 02:00PM BLOOD ___

PENDING LABS ON DISCHARGE:
___ Blood cultures pending
 
Brief Hospital Course:
Mr. ___ is a ___ man with CAD s/p CABG, CHF (EF ___, 
afib on coumadin and amiodarone, and s/p ICD placement (h/o 
inappropriate shocks for AF), who presented to the ED with acute 
onset SOB likely secondary to exacerbation of undiagnosed COPD 
prompting admission to ICU on ___ followed by transfer to 
Medicine floor on ___.

# Shortness of breath/hypoxemia
On arrival to the MICU, VS were 98 71 148/51 17 97% on Venturi 
mask. The patient was comfortable and reported his SOB had 
improved. Empiric antibiotics and nitro drip were discontinued 
given lack of evidence for PNA or fluid overload. Respiratory 
status continued to improve with steroids and nebs for presumed 
COPD exacerbation. TTE revealed no change in his severe heart 
failure with increased EF ___. CT chest revealed prior 
tuberculosis/granulomatous infection (no reactivation), 
moderately severe emphysema, and basilar ground glass opacities 
that could be pulmonary hemorrhage, drug reaction, or the early 
manifestation of chronic eosinophilic pneumonia. Because of the 
possibility of amiodarone-related pulmonary toxicity, home 
amiodarone was held. His respiratory status continued to improve 
on steroids and duo nebs and on transfer to the floor he 
reported almost his baseline respiratory status on nasal 
cannula. On the floor, he was continued on prednisone, 
azithromycin, and nebs, with decreased SOB, no tachypnea, and 
improving O2 sat. By the day of discharge, O2 sat was stably 
>90% on room air at rest and while ambulating. Patient was 
discharged on albuterol PRN and with early pulmonary follow up 
for new possible diagnosis of COPD and the question of 
amiodarone induced lung toxicity.
   
# Acute-on-chronic kidney disease
Baseline Cr 1.4-1.5. On admission, Cr was 2.3. This was though 
likely prerenal in etiology, although no obvious history of poor 
PO intake or GI losses. In the unit patient received NS @ 100 
cc/hr. Urine lytes demonstrated a FENA <1% and his Cr returned 
to its baseline level of 1.5 on ___. Home lisinopril and 
lasix were restarted on ___ and ___, respectively. Cr 
remained baseline 1.5 on day of discharge.

# Possible amiodarone toxicity
SOB and hypoxemia with GGOs on CT Chest could be secondary to 
amiodarone toxicity. LFTs were mildly elevated on ___, and 
normalized by ___. TSH was elevated at 11.0, T4 was normal. 
Cardiology/EP was consulted and recommended continuing to hold 
amiodarone, though stated that SOB was probably not due to 
amiodarone toxicity. Patient was scheduled for outpatient 
pulmonary follow up to further assess possibility of underlying 
amiodarone toxicity, as amio toxicity would warrant longer 
course of steroids. 

# CHF (EF ___ s/p ICD)
No evidence of acute volume overload on this admission (JVP 
~8cm, no leg swelling, CXR with cardiomegaly and e/o chronic 
volume overload). Repeat TTE this admission showed no 
significant change, increased EF ___. He was continued on his 
home digoxin and started on metoprolol (instead of his home 
atenolol, which is renally cleared, in the setting of ___. 
Additionally, his home lisinopril and lasix were held in the 
setting of ___. When ___ resolved, home lisinopril, lasix, and 
atenolol were restarted.

# Afib on coumadin
Patient with longstanding history of AFib s/p failed ablation 
and s/p ICD on coumadin. Started on amiodarone in ___ due to 
increasing fatigue, possibly due to AV dyssynchrony. Amiodarone 
held during admission and on discharge as above. He was in NSR 
throughout admission. EP interrogated the ICD, which 
demonstrated no inciting event to explain the sudden onset 
dyspnea. Patient declined ablation for rhythm control. His 
coumadin was held in the setting of a supratherapeutic INR after 
receiving vanc and cefepime in the ED (INR 4.2), which decreased 
to 2.2 by discharge. Patient was restarted on coumadin 2.5 mg QD 
with instructions for early follow up of his INR with his outpt 
cardiologist's office. Patient was scheduled for appointments 
with general cardiology and EP after discharge.

# Downtrending Hct
Patient's baseline Hct appears to be ___. Hct was 36 on 
admission ___ and decreased to 29.3 on ___, normocytic. 
Unclear etiology; the decreased Hct did not appear to be 
dilutional and there was no evidence of active bleeding. Hct was 
stable at 29.9 for the remainder of the admission.

# CAD s/p CABG
Admission EKG had no signs of active ischemia, and troponins 
were negative x2. He was continued on home ASA 81 mg and statin 
during admission.  

# Diabetes Mellitus, type II
Patient is on metformin at home, with good control (HgbA1c 6.2% 
on ___. Unclear if nephropathy is a complication of DM. 
During admission, he was placed on an insulin sliding scale and 
home metformin was held. Metformin restarted on discharge. 
 
# Hypertension  
Patient's home lisinopril was initially held for ___, and 
restarted after ___ resolved on ___. Home atenolol was 
replaced by metoprolol in the setting ___ (atenolol is 
renally cleared), and restarted after ___ resolved on ___.

# Hyperlipidemia  
Patient received home statin during admission.  

# Possible Aspiration in ICU
Due to concern for possible aspiration in the ICU, speech and 
swallow was consulted. They found no evidence of obvious 
aspiration, however the patient's O2 sat decreased from 91 to 
high ___ on RA while eating. Though the desats could have been 
due to silent aspirations, they were more likely due to the 
ongoing COPD flare, and video swallow was deferred. There was no 
other concern for aspiration for the duration of the admission.

# Transitional issues
- Follow up with general cardiology (Dr. ___ and EP (Dr. 
___ about atrial fibrillation management, possibly 
restarting amiodarone versus ablation
- Follow up with pulmonary about new possible diagnosis of COPD 
and ? of whether amiodarone was causing pulmonary toxicity
- Follow up with PCP about elevated TSH
- Follow up with PCP about ___ slightly below baseline
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Atenolol 50 mg PO DAILY 
2. Atorvastatin 80 mg PO DAILY 
3. Digoxin 0.125 mg PO EVERY OTHER DAY 
4. Lisinopril 40 mg PO DAILY 
5. PrimiDONE 50 mg PO HS 
6. Sertraline 75 mg PO DAILY 
7. Tamsulosin 0.4 mg PO HS 
8. Warfarin 2.5 mg PO DAILY16 
9. Zolpidem Tartrate 5 mg PO HS 
10. MetFORMIN (Glucophage) 500 mg PO BID 
11. Amiodarone 200 mg PO DAILY 
12. Furosemide 40 mg PO DAILY 
13. Aspirin 81 mg PO DAILY 
14. Nitroglycerin SL 0.4 mg SL PRN chest pain 

 
Discharge Medications:
1. Aspirin 81 mg PO DAILY 
2. Atorvastatin 80 mg PO DAILY 
3. Digoxin 0.125 mg PO EVERY OTHER DAY 
4. Sertraline 75 mg PO DAILY 
5. Tamsulosin 0.4 mg PO HS 
6. Zolpidem Tartrate 5 mg PO HS 
7. MetFORMIN (Glucophage) 500 mg PO BID 
8. Nitroglycerin SL 0.4 mg SL PRN chest pain 
9. PrimiDONE 50 mg PO HS 
10. Atenolol 50 mg PO DAILY 
11. Furosemide 40 mg PO DAILY 
12. Lisinopril 40 mg PO DAILY 
13. PredniSONE 40 mg PO DAILY 
Take until ___, unless instructed to continue by your 
cardiologist or pulmonologist. 
RX *prednisone 20 mg 2 tablet(s) by mouth daily Disp #*8 Tablet 
Refills:*0
14. Azithromycin 250 mg PO Q24H Duration: 2 Doses 
Please take one dose on ___ and one dose on ___. 
RX *azithromycin 250 mg 1 tablet(s) by mouth Daily Disp #*1 
Tablet Refills:*0
15. Warfarin 2.5 mg PO DAILY16 
16. Albuterol Inhaler ___ PUFF IH Q6H:PRN wheezing, shortness of 
breath 
RX *albuterol sulfate 90 mcg ___ puffs inhaled every 6 hours 
Disp #*1 Inhaler Refills:*0

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
COPD exacerbation
Acute on chronic kidney injury

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Mr. ___,

It was a pleasure taking care of you at ___ 
___. You were admitted with shortness of breath, 
probably due to a flare of COPD (emphysema). You were initially 
in the Intensive Care Unit (ICU), and then you were transferred 
to a general medicine floor when your breathing improved. For 
your COPD flare, you were treated with prednisone (steroids), 
nebulizer treatments, azithromycin (antibiotic), and extra 
oxygen. Your breathing improved and by the time of discharge, 
you were breathing comfortably without extra oxygen, both at 
rest and when you were walking.

Because amiodarone may have contributed to your shortness of 
breath, it was stopped while you were in the hospital. You 
should NOT take amiodarone unless your cardiologist tells you to 
restart it. We also set up an appointment with you with a 
pulmonologist, who will assess if the amiodarone may have caused 
some lung damage. We gave you a copy of some test results from 
___ - please bring a copy of these to the 
appointment with the pulmonologist.

When you were admitted to the hospital, your INR was high, 
indicating that the coumadin had made your blood too thin. We 
stopped the coumadin until your INR was normal again. Your INR 
was 2.2 on ___. 

Because you are a reliable patient, you can restart your 
coumadin also known as warfarin at home. Take your coumadin 2.5 
mg per day at home, and call your anticoagulation service on 
___.

Please call your doctor or go to an Emergency Room if you 
develop worsening shortness of breath, fever/chills, worsening 
shortness of breath when walking, inability to lie flat, chest 
pain, dark stools, or blood in your stool. Also please weigh 
yourself every morning and call your primary care doctor if your 
weight goes up more than 3 lbs.

It was a pleasure taking care of you.
 
Followup Instructions:
___
"
11515132-DS-10," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Nsaids / Penicillins / Sulfa (Sulfonamide Antibiotics) / 
Benadryl / Aspirin / Zithromax / Quinine / shellfish derived / 
raw fruits and vegetables
 
Attending: ___.
 
Chief Complaint:
Atypical chest pain
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
    Ms. ___ is a ___ with a history of DM, HTN, HL presenting 
with chest pressure that has been off and on for the past 3 
weeks. She says that the discomfort started weeks ago, but has 
gotten somewhat more frequent and pronounced in the past few 
weeks. She typically feels the chest tightness prior to going to 
sleep, occasionally associated with some nausea. Patient also 
has associated right elbow pain, which she describes as sharp 
and located over olecranon and antecubital fossa. She has not 
had fevers and chills. She has been fatigued. Her exercise is 
swimming, but she hasn't been to the pool recently due to the 
___. She went to the pool today, and worked out 
w/out any discomfort. This evening, she had the chest pressure 
while walking up stairs, and she had to sit down after climbing 
the stairs because she was winded and absolutely fatigued. She 
called her PCP who referred her here. Pt has a hx of bronchial 
asthma, and states that her dyspnea today feels somewhat similar 
to previous episodes of asthma (triggered by allergies).  
Patient is allergic to ASA which causes difficulty breathing/ 
throat swelling / rash. She also has an allergy to IV dye.  

In the ED, initial vitals were 98.3 98 168/98 15 98% RA. Labs 
and imaging significant for EKG demonstrated sinus, RBBB with 
new LAFB, non-specific ST-T changes. UA unremarkable. CXR was 
performed which demonstrated no acute intrathoracic process. 
Urine culture was sent. The patient had nausea and some arm pain 
prior to arriving to the floor. Repeat EKG demonstrated no 
appreciable change, < 1mm ST-T elevation V2-V3. Patient was 
given small dose of IV morphine w/ relief.  
 
On arrival to the floor, patient's vitals are 98.2 156/89 74 20 
96%RA. ___ 195. Pt currently is asymptomatic, and is able to 
relay a cogent history.  

 
Past Medical History:
Past Medical History:  
1. Diabetes.  
2. Hypothyroidism.  
3. Hypertension.  
4. History of breast cancer for which she has finished a  
five-year course of tamoxifen.  
5. History of bone spurs in her heels as well as heel bursitis  
6. Gout  
7. Hysteroscopy for benign  
8. Neuropathy effecting feet.  
9. Colonoscopy ___ normal. But family history of large polyps  
needs every ___ years.  
10. Asthma  
11. Trigeminal neuralgia  
12. Pain in her right hip likely due to vertebral disc problems. 
 
13. Bronchial asthma  

Surgical History  
Knee surgery ___  
Breast surgery ___  
Back surgery ___  
Thyroid tumors ___  

 
Social History:
___
Family History:
Father: Died at age ___ from heart disease; Had first MI at age 
___ History of multiple bypass procedures and an aortic aneurysm 
 
Mother: Lung CA alive, ___  

 
Physical Exam:
Admission Physical Exam:
VS- 98.2 156/89 74 20 96%RA ___ 195  
GENERAL- AOx3, in NAD  
HEENT- NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were 
pink, no pallor or cyanosis of the oral mucosa.  
NECK- Supple, unable to appreciate JVP secondary to neck habitus 
 
CARDIAC- RR, normal S1, S2. II/VI systolic murmur, unable to 
appreciate radiation. No thrills, lifts. No S3 or S4.  
LUNGS- No chest wall deformities, scoliosis or kyphosis. Resp 
were unlabored, no accessory muscle use. CTAB, faint 
end-inspiratory squeak  
ABDOMEN- Soft, NT, obese.  
EXTREMITIES- No c/c. Bilateral trace pedal edema.  
SKIN- No stasis dermatitis.  
PULSES-  
Right: DP 1+ ___ 1+  
Left: DP 1+ ___ 1+  

Discharge Physical Exam:
VS: T= 98 BP= 156/ 89 - 173/89 HR= ___ RR=18 O2 sat= 97% on RA 
 
GENERAL: Obese female, lying comfortably in bed. Oriented x3. 
Mood, affect appropriate.  
HEENT: NCAT. Sclera anicteric. EOMI. MMM.  
NECK: Supple. Difficult to asses JVP due to girth of neck. No 
carotid bruits auscultated.  
CARDIAC: Regular rate and rhythm. Systolic murmur heard loudest 
at the LUSB. No S3, S4, thrills or gallops. 
LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp 
were unlabored, no accessory muscle use. CTAB, no crackles, 
wheezes or rhonchi.  
ABDOMEN: Soft, nondistended, nontender to palpation.  
EXTREMITIES: Warm extremities. Bilateral trace edema.     
PULSES: Radial 1+, ___ 1+ bilaterally

 
Pertinent Results:
Admission Labs:
___ 08:10PM BLOOD WBC-13.0* RBC-4.74 Hgb-13.3 Hct-41.7 
MCV-88 MCH-28.0 MCHC-31.8 RDW-13.5 Plt ___
___ 08:10PM BLOOD Neuts-66.1 ___ Monos-5.4 Eos-2.4 
Baso-0.5
___ 08:10PM BLOOD Glucose-270* UreaN-16 Creat-0.7 Na-137 
K-3.9 Cl-99 HCO3-28 AnGap-14
___ 08:10PM BLOOD cTropnT-<0.01
___ 01:55AM BLOOD CK-MB-6 cTropnT-<0.01
___ 08:10PM BLOOD Calcium-9.6 Phos-3.4 Mg-1.9
___ 08:10PM BLOOD TSH-4.2

Discharge Labs:
___ 07:45AM BLOOD WBC-12.0* RBC-4.57 Hgb-12.7 Hct-40.1 
MCV-88 MCH-27.7 MCHC-31.6 RDW-13.6 Plt ___
___ 07:45AM BLOOD Glucose-133* UreaN-15 Creat-0.8 Na-141 
K-4.3 Cl-100 HCO3-30 AnGap-15
___ 07:45AM BLOOD Calcium-9.9 Phos-4.4 Mg-2.0

CXR (___) FINDINGS:  PA and lateral views of the chest 
provided demonstrate no focal consolidation, effusion, or 
pneumothorax.  The heart and mediastinal contours appear normal. 
 Bony structures are intact. 
  
IMPRESSION:  No acute intrathoracic process. 

EKG (___): Sinus rhythm, LAD, RBBB (similar to previous 
EKGs) with ? new LAFB, non-specific ST-T changes

Persantine Stress MIBI (___):

IMPRESSION:  1. No focal myocardial perfusion defects.  2. 
Normal wall motion with LVEF 63%.  3. Top normal LV size with 
LEDV 117cc. 

IMPRESSION: Atypical anginal type symptoms in the setting of 
Persantine 
infusion. No ischemic EKG changes. Nuclear report sent 
separately. 

 
 
Brief Hospital Course:
Ms. ___ is a ___ F with DM, HTN, and HL presenting with chest 
pressure that has been on and off for the past 3 weeks, 
worsening with exertion yesterday. She had negative troponins. 
EKG showed increased LAD and questionable new LAFB. Stress MIBI 
was performed and showed no focal myocardial defects and an EF 
of 63%.

# Atypical Chest Pain, likely secondary to SVT- Patient has 
chest pressure and R arm pain, occasional nausea. Pain sometimes 
occurs with exertion, sometimes does not not. Given her risk 
factors (former smoker, hypertension, DMII, + family hx of early 
MI, central obesity) and history, there is concern for worsening 
angina. The patient is currently chest pressure free, troponins 
were negative, and EKG has some conduction disturbance, but no 
ST elevations > 1mm and is relatively unchanged from ___ EKG 
(although worsening LAD and questionable new LAFB). Patient is 
unfortunatley allergic to ASA (swelling of throat and dyspnea), 
so aspirin is deferred. Also allergic to IV dye. 
- Patient received a persantine stress MIBI as an inpatient for 
evaluation of angina with exertion
- Stress MIBI showed no focal myocardial perfusion defects and 
normal wall motion with an ejection fraction of 63%. The patient 
did have some atypical anginal symptoms with the injection of 
persantine 
- Patient recieved in patient echo prior to discharge due to new 
cardiac murmur. This showed no significant valvular abnormality, 
but did show mild LV outflow tract obstruction. She was 
hyperdynamic (EF 70%), which per attending cardiologist can 
exagerate this finding. Metoprolol was started for this reason 
as well, as rate control should reduce level of LVOT. 
- Throughout hospitalization continued outpatient meds for 
management of hypertension, with addition of lisinopril 5mg for 
improved blood pressure control in the setting of diabetes.
- Patient was also started on Metoprolol succinate 50mg for SVT 
and hypertension.
- TSH was WNL.
 
# PUMP: Pt w/ trace pedal edema which is baseline. Has 
increasing fatigue over the last three weeks.  
- Persantine stress suggested EF was 63%. 
 
# RHYTHM: Pt w/ what may be new anterior fascicular block on 
first EKG in ED, w/ existant RBBB. New EKG showed worsening LAD. 
 
 
# DMII: Slightly elevated ___ upon arrival (190s). Metformin was 
held during hospitalization and the patient was started on 
Insulin Sliding Scale. Her last HbA1C was 6.9 in ___. 
Patient was discharged on her home dose of Metformin.  
 
# HTN: Blood presures elevated during hospitalization (150s/80s 
- 170s/80s). Home blood pressure medications (clonidine and 
amlodipine) were continued. Lisinopril 5mg was added to the 
patient's hypertension regimen for improved control. Given 
benefit to patients with diabetes, ACE-I can be titrated up in 
the outpatient setting. Patient also started on Metoprolol 
Succinate 50mg daily.  

# Hypothyroidism: Stable. Patient was continued on 
levothyroximne. TSH WNL during this hospitalization.  
 
# Trigeminal Neuralgia: Stable during this hospitalization. 
Patient was continued on her home regimen.  

# Hyperlipidemia - Patient was continued on home Pravastatin 
20mg. 

# Elevated WBC count - Patient was admitted with a WBC count of 
13, down to 12 today. CXR and UA were not suggestive of 
infection. Patient has been afebrile during hospitalization, 
with no picture concerning for infection. 

Transitional Issues:
- Further consideration of potential causes of atypical chest 
pain.
- Optimize HTN medication regimen (titrate ACE-I and B-blocker).
- Control LVOT with metoprolol succinate, f/u with Cardiology 
 
Medications on Admission:
Preadmissions medications listed are incomplete and require 
futher investigation.  Information was obtained from 
PatientwebOMR.
1. Acetaminophen 500 mg PO Q6H 
2. Gabapentin 300 mg PO TID 
3. CloniDINE 0.1 mg PO TID 
4. MetFORMIN (Glucophage) 500 mg PO BID 
5. Levothyroxine Sodium 175 mcg PO DAILY 
6. Amlodipine 10 mg PO DAILY 
7. Calcium Carbonate 1000 mg PO DAILY 
8. Vitamin D 1000 UNIT PO DAILY 
9. Oxcarbazepine 300 mg PO BID 
10. pramipexole *NF* 0.25 mg Oral qhs 
11. Pravastatin 20 mg PO DAILY 

 
Discharge Medications:
1. Acetaminophen 500 mg PO Q6H 
2. Amlodipine 10 mg PO DAILY 
3. Calcium Carbonate 1000 mg PO DAILY 
4. CloniDINE 0.1 mg PO TID 
5. Gabapentin 300 mg PO TID 
6. Levothyroxine Sodium 175 mcg PO DAILY 
7. Oxcarbazepine 300 mg PO BID 
8. Pravastatin 20 mg PO DAILY 
9. Vitamin D 1000 UNIT PO DAILY 
10. MetFORMIN (Glucophage) 500 mg PO BID 
11. pramipexole *NF* 0.25 mg Oral qhs 
12. Lisinopril 5 mg PO DAILY 
Hold if SBP < 100 
RX *lisinopril 5 mg 1 tablet(s) by mouth once a day Disp #*60 
Tablet Refills:*1
13. Metoprolol Succinate XL 50 mg PO DAILY 
hold for SBP < 100 or HR < 60 
RX *metoprolol succinate 50 mg 1 tablet(s) by mouth once a day 
Disp #*60 Tablet Refills:*1

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Atypical chest pain, liking secondary to SVT 

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___,

It was a pleasure taking care of you at ___ 
___. You came in with chest pain worsening on 
exertion. You received a cardiac imaging test to help us better 
assess your chest pain, which showed no distinct abnormalities. 
Please follow up with Dr. ___ Cardiology on ___. 
 
Followup Instructions:
___
"
11532659-DS-11," 
Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
dyspnea
 
Major Surgical or Invasive Procedure:
Ultrasound-guided percutaneous cholecystostomy (___)
Trans-jugular temporary pacer wire
Screw-in pacemaker 
Hepatic artery embolization 
 
History of Present Illness:
___ year-old female with past medical history of prosthetic 
mitral ___, on warfarin, congestive heart failure, 
hypertension, yperlipidemia, diabetes presenting with dyspnea 
and abdominal pain. SOB has been ongoing for 2 weeks and has 
been getting worse. Notabyl this is associated with orthopnea 
requiring 5 pillows from 2 pillows previously. Also reports 
weight has increased and reports worsening ___ edema. She does 
report compliance with all of her medications but did not take 
her home torsemide on the day of admission.  
 She has also been complaining of RUQ pain that has been also 
ongoing for days. She initially associated it with food but is 
now constant. Reports early satiety as well. Reports 
intermittent constipation and diarrhea. Has been nauseous but no 
vomiting.  
 She went to her PCP (referral on ED dash) for an outpatient 
routine follow-up visit. She was found to be dyspneic with 
concern for volume overload. Her PCP referred her to the ED for 
further evaluation.  

 
Past Medical History:
 - Severe MR: s/p mechanical MVR in ___.  
 - Atrial fibrillation s/p DCCV ___  
 - Hypertension  
 - Hyperlipidemia  
 - Diabetes, type 2  
 - Hyperthyroidism  
 - Anxiety  
 - Asthma  
 - CHF with EF 43%  
 - GERD  

 
Social History:
___
Family History:
Family history is significant for brother with CAD in his ___. 
Her grandmother died of coronary artery disease when she was 
elderly. Reports family history of hypertension. 
 
Physical Exam:
Admission exam:
===============
VS: 97.5 137 / 81 48 24 95  
 Gen: middle aged female, uncomfortable appearing, tachypneic  
 HEENT: MMM, no scleral icterus, PERRL, EOMI. JVD to jaw  
 CV: RRR, normal S1, S2. +S3 with mechanical mitral sound.  
 Pulm: Rales in bases bilaterally; decreased BS bilaterally, no 
wheeze or rhonchi  
 Abd: soft, ND, RUQ TTP +Murphys. No appreciable ascites  
 GU: no foley  
 Ext: 2+ pitting edema to knee bilaterally  
 Skin: no rash  
 Neuro: CNII-XII intact, ___ strength in UE and ___ bilaterally, 
normal sensation to touch in UE and ___. Gait deferred.  

Discharge exam:
===============
VS: 97.7 87 122/65 23 100% on RA
GENERAL: Well developed, well nourished Hispanic female
CARDIAC: RRR. mechanical S1, S2. no gallops/rubs
NECK: Eternal pacemaker generator in place
LUNGS: breathing comfortably, in no respiratory distress, clear 
to auscultation bilaterally
ABDOMEN: Soft non-tender, obese, PCBD in place draining bile
EXTREMITIES: Warm, well perfused. Trace ___ edema. No R groin 
hematoma or bleeding noted. No neck bleeding or hematoma at 
Pacer site
 

 
Pertinent Results:
Admission labs:
===============
___ 03:30PM BLOOD WBC-7.1 RBC-3.37* Hgb-9.6* Hct-31.0* 
MCV-92 MCH-28.5 MCHC-31.0* RDW-16.6* RDWSD-56.4* Plt ___
___ 03:30PM BLOOD Neuts-70.1 Lymphs-18.0* Monos-9.7 Eos-1.7 
Baso-0.4 Im ___ AbsNeut-5.00# AbsLymp-1.28 AbsMono-0.69 
AbsEos-0.12 AbsBaso-0.03
___ 03:30PM BLOOD ___ PTT-34.6 ___
___ 03:30PM BLOOD Glucose-146* UreaN-28* Creat-1.6* Na-140 
K-5.1 Cl-102 HCO3-23 AnGap-20
___ 03:30PM BLOOD ALT-12 AST-35 AlkPhos-64 TotBili-0.9
___ 03:30PM BLOOD Lipase-96*
___ 03:30PM BLOOD cTropnT-<0.01 proBNP-2323*
___ 10:29PM BLOOD cTropnT-<0.01
___ 10:29PM BLOOD Calcium-9.3 Phos-3.8 Mg-1.4*
___ 03:30PM BLOOD Albumin-4.0
___ 10:29PM BLOOD Hapto-<10*
___ 03:38PM BLOOD Lactate-3.7*
___ 11:42PM BLOOD Lactate-2.8*

Microbiology:
=============
Blood cultures ___ pending
Urine culture ___ negative
Blood culture ___ pending
Urine culture ___ negative

___ 11:45 am BILE

                            **FINAL REPORT ___

   GRAM STAIN (Final ___: 
      NO POLYMORPHONUCLEAR LEUKOCYTES SEEN. 
      NO MICROORGANISMS SEEN. 

   FLUID CULTURE (Final ___:    NO GROWTH. 

   ANAEROBIC CULTURE (Final ___:    NO GROWTH. 

___ 9:00 pm BLOOD CULTURE      Source: Line-art 1 OF 2. 

                            **FINAL REPORT ___

   Blood Culture, Routine (Final ___:    NO GROWTH. 

___ 9:30 pm URINE      Source: Catheter. 

                            **FINAL REPORT ___

   URINE CULTURE (Final ___:    NO GROWTH.

___ 11:30 am MRSA SCREEN      Source: Nasal swab. 

                            **FINAL REPORT ___

   MRSA SCREEN (Final ___:    No MRSA isolated. 

___ 4:37 am BLOOD CULTURE      Source: Line-ALINE. 

                            **FINAL REPORT ___

   Blood Culture, Routine (Final ___:    NO GROWTH. 

___ 4:38 am URINE      Source: Catheter. 

                            **FINAL REPORT ___

   URINE CULTURE (Final ___:    NO GROWTH. 

___ 5:00 pm STOOL     CONSISTENCY: NOT APPLICABLE
      Source: Stool. 

                            **FINAL REPORT ___

   C. difficile DNA amplification assay (Final ___: 
      Negative for toxigenic C. difficile by the Cepheid nucleic 
acid
      amplification assay.. 
           (Reference Range-Negative).

___ 6:00 pm BLOOD CULTURE      Source: Line-PICC 2 OF 2. 

                            **FINAL REPORT ___

   Blood Culture, Routine (Final ___:    NO GROWTH. 

___ 10:53 am URINE      Source: Catheter. 

                            **FINAL REPORT ___

   URINE CULTURE (Final ___:    NO GROWTH. 

___ 9:43 am BILE

                            **FINAL REPORT ___

   GRAM STAIN (Final ___: 
      1+    (<1 per 1000X FIELD):   POLYMORPHONUCLEAR 
LEUKOCYTES. 
      NO MICROORGANISMS SEEN. 

   FLUID CULTURE (Final ___:    NO GROWTH. 

   ANAEROBIC CULTURE (Final ___:    NO GROWTH. 

Studies:
========
CXR ___
 - Small pleural effusions, mild to moderate pulmonary edema, 
and cardiomegaly suggest CHF. 

RUQ U/S ___
 - The gallbladder contains sludge and stones bones and is 
nondistended.  A shadowing stone is seen lodged in the neck of 
the gallbladder and the wall of the gallbladder is edematous.  
Gallbladder edema may be seen with hepatitis or heart failure, 
however in the setting of cholelithiasis with gallstone at the 
neck of the gallbladder, cannot exclude acute cholecystitis in 
the appropriate clinical setting. 

___ EXAMINATION:  Ultrasound procedure
Successful ultrasound-guided placement of ___ pigtail 
catheter into the gallbladder. Samples was sent for microbiology 
and chemistry evaluation. 5 cc of bilious secretions were 
aspirated after 10 cc of saline was instilled into the 
gallbladder.  Aspirated material was extremely thick and 
difficult to aspirate due to inspissation.

___ TTE
Endotracheal intubation performed days prior to study, and 
patient was sedated on propofol and monitored by nursing 
throughout the study. 

No spontaneous echo contrast or thrombus is seen in the body of 
the left atrium/left atrial appendage or the body of the right 
atrium/right atrial appendage. The left atrial appendage 
emptying velocity is depressed (<0.2m/s). No mass or thrombus is 
seen in the right atrium or right atrial appendage. The right 
atrial appendage ejection velocity is depressed (<0.2m/s). No 
atrial septal defect is seen by 2D or color Doppler. There are 
simple atheroma in the ascending aorta, aortic arch, and 
descending thoracic aorta. The aortic valve leaflets (3) are 
mildly thickened. There are filamentous strands on the aortic 
leaflets consistent with Lambl's excresences (normal variant). 
Trace aortic regurgitation is seen. The mitral prosthesis 
appears well seated, with normal disc motion and transvalvular 
gradient. A very small paravalvular mitral prosthesis leak is 
probably present with mild (1+) mitral regurgitation. There is 
at least moderate pulmonary artery systolic hypertension. There 
is no pericardial effusion. 

IMPRESSION: Well-seated mitral mechanical prosthesis with mobile 
discs, normal gradients and mild paravalvular mitral 
regurgitation. Mild-moderate tricuspid regurgitation. Moderate 
pulmonary artery systolic hypertension.

___ CXR
IMPRESSION:  
Unchanged severe bilateral pulmonary edema with asymmetric 
distribution in the right upper lobe.  This could be edema alone 
if the patient has mitral 
regurgitation, alternatively edema and concurrent right upper 
lobe pneumonia. 

___ EP Report
 Successful implantation of a temporary screw-in ventricular 
pacemaker (RV apical lead connected
to an external generator).
 There were no complications.
 Device interrogation in the morning.
 Continue antibiotics as per primary condition.
 PA and LAT chest X ray in AM to check lead placement.
 Permanent PPM after resolution of the infectious process/after 
surgery.

CT AP ___
IMPRESSION:  
  
1.  Small-moderate amount of intra-abdominal blood with the 
highest density blood around the liver and a small hematoma 
situated between the gallbladder and duodenum.  Active contrast 
extravasation is noted into this hematoma from a possible 
subcapsular branch arising from the right hepatic artery where a 
percutaneous cholecystostomy tube courses adjacent to the 
branch. 
2.  Percutaneous cholecystostomy tube appropriately positioned 
within the 
fundus of the gallbladder. 

CT CHEST ___
IMPRESSION:  
1.  Small-moderate amount of intra-abdominal blood with the 
highest density blood around the liver and a small hematoma 
situated between the gallbladder and duodenum.  Active contrast 
extravasation is noted into this hematoma from a possible 
subcapsular branch arising from the right hepatic artery where a 
percutaneous cholecystostomy tube courses adjacent to the 
branch. 
2.  Percutaneous cholecystostomy tube appropriately positioned 
within the 
fundus of the gallbladder.

HEPATIC ARTERIOGRAM ___
IMPRESSION:   
1. Technically successful coil and Gel-Foam embolization of the 
segment 4B 
hepatic artery branch which fills a hepatic pseudoaneurysm. 
2. LIJ central line is kinked and should not be used. 
3. Appropriate position of percutaneous cholecystostomy tube. 

FEMORAL VASCULAR US RIGHT ___ cm right inguinal pseudoaneurysm.

CT A/P ___
IMPRESSION: 
1. Hazy peribronchial nodular opacities in the right lower lobe 
and nodular consolidation in the left lower lobe consistent with 
aspiration versus pneumonia. 
2. The previously seen hematoma along the posterior inferior 
left lobe and 
medial gallbladder fossa is increased in size, with increased 
low-density 
fluid and clot. There is increased hemoperitoneum of 
intermediate density, 
with density in some places decreased from prior.  Findings are 
compatible 
with recent bleeding however ongoing bleeding cannot be 
definitively assessed on this noncontrast study. 
3. Small pseudoaneurysm in the right femoral access site seen on 
ultrasound is not well evaluated on this noncontrast study.  No 
significant right groin hematoma. 
4. The gallbladder contains previously administered contrast and 
a stone 
without contrast egress into the bile ducts, consistent with 
gallstone 
obstruction at gallbladder neck.  Recommend flushing of the 
percutaneous 
cholecystostomy tube. 

HEPATIC ARTERIOGRAM ___
IMPRESSION: 
1. No evidence of arterial extravasation on hepatic angiography. 
 Empiric 
Gel-Foam embolization of the right and middle hepatic arteries 
to stasis. 
2. Aborted thrombin injection of right common femoral 
pseudoaneurysm. 
  
RECOMMENDATION(S):  Ultrasound of the right groin should be 
performed to 
follow up the right common femoral artery pseudoaneurysm. 

FEMORAL VASCULAR US RIGHT ___

IMPRESSION:  
  
The previously noted pseudoaneurysm now appears thrombosed, 
without internal flow on Doppler interrogation. 

Discharge labs:
===============
___ 04:17AM BLOOD WBC-15.5* RBC-2.43* Hgb-7.5* Hct-23.6* 
MCV-97 MCH-30.9 MCHC-31.8* RDW-19.4* RDWSD-59.3* Plt ___
___ 09:05AM BLOOD PTT-123.5*
___ 04:17AM BLOOD Plt ___
___ 04:17AM BLOOD ___ PTT-55.1* ___
___ 04:17AM BLOOD Glucose-107* UreaN-21* Creat-1.1 Na-135 
K-4.2 Cl-105 HCO3-22 AnGap-12
___ 04:17AM BLOOD Calcium-8.3* Phos-3.0 Mg-2.___rief summary:
==============
___ year-old female with mechanical mitral valve, congestive 
heart failure (EF 46% in ___, hypertension, hyperlipidemia, 
diabetes presenting with dyspnea and abdominal pain, found to 
have cholecystitis and in an acute exacerbation of HFpEF. 

Acute issues: 
=============
#Acute cholecystitis: RUQ ultrasound revealed gallbladder edema 
and a stone in the neck of the gallbladder. ACS evaluated 
patient and recommended percutaneous chlecystotomy and to defer 
surgery for 6 weeks in setting of comorbidities, late 
presentation, and coumadin anticoagulation for a mechanical 
mitrial valve.  Patient was given unasyn which was later 
broadened to Zosyn due to fevers and worsening clinical status. 
She improved on Zosyn and was transitioned back to Unasyn. She 
was stable on Unasyn and transitioned to augmentin at time of 
discharge.  
[ ] She will need to f/u with ACS within 2 weeks of discharge to 
plan lap CCY.
 
#Heart Block: Patient was transferred to the CCU from the 
medical floor due to new heart block and prolonged QT. Her home 
nodal agents were stopped. Electrophysiology evaluated the 
patient and recommended pacemaker once she cleared her 
infection. In the interim, she underwent temporary pacemaker 
placement through a RIJ. In the setting of percutaneous drain in 
her gallbladder, she was unable to undergo permanent pacemaker 
placement until after drain can be removed (in several weeks). 
She underwent screw-in pacemaker on ___. The plan will be to 
keep the temporary pacemaker in place until her gall-bladder 
drain heals and she is able to undergo CCY. After she undergoes 
CCY, she will be able to have a permanent pacemaker placed.   
  
#Hypoxemic Respiratory Failure: Upon transfer to the CCU, the 
patient became hypoxemic. CXR showed acute pulmonary edema. 
Hypoxemia worsened despite Lasix and nitro so she was intubated 
on ___. CVVH was initiated to remove fluid in the setting of 
acute renal failure (detailed below). Her pulmonary edema 
improved with improving volume status and she was extubated 
___.     
 
#Hypotension / Septic Shock: On ___ after intubation, patient 
became hypotensive to the ___ systolic and required levophed. 
The following day she developed a fever to 100.5 on unasyn and 
increasing pressor requirement with the addition of vasopressin. 
Her antibiotics were broadened to zosyn. The patient was also 
given glucocorticoids in setting of possible adrenal 
insufficiency related to chronic prednisone use for PMR. 
Pressors were weaned off on ___.      
 
#Acute renal failure: Baseline at 1.0. On admission Cr 1.6. 
Clearly volume overloaded, likely cause ___ was cardiorenal. 
Patient's creatinine continued to increase to 2.0 and she became 
anuric despite aggressive diuresis with lasix gtt and 
metolazone. CVVH was started on ___. Several liters of fluid 
were removed and the patient began to produce urine. CVVH was 
discontinued on ___. Her UOP subsequently improved. Her Cr upon 
discharge was 1.1.  
 
#Acute decompensation of HFpEF: EF 46% in ___. Per patient, 
baseline weight is 210 at home. In system, weights have been 
between 202-210lbs this past year. 216lbs on admission. 
Clinically volume overloaded with pitting edema, elevated JVP, 
and basilar crackles. Confirmed taking torsemide daily. 
Confirmed not changing her diet. Likely cause of her 
exacerbation was cholecystitis. Aggressive diuresis was 
attempted but the patient became anuric as detailed above. She 
improved after volume removal with CVVH. Renal function 
subsequently improved and the patient became euvolemic. She was 
discharged on metoprolol XL 200mg and torsemide 20mg daily.  
 
#Atrial fibrillation: s/p DCCV ___. EKG on admission 
revealed A-fib with slow conduction. Metoprolol was held, 
however patient continued to have slow conduction. She was 
determined to have heart block requiring trans-venous pacing (as 
detailed above). Warfarin initially held in setting of hepatic 
artery hemorrhage (as described below). She was bridged with 
heparin. Warfarin restarted prior to discharge. Her warfarin 
dose on discharge was 3mg 2x/wk, 4mg 5x/wk and INR 1.3.  
 
#Hepatic Artery Hemorrhage: Patient was found to have a 
significant drop in H/H on ___ with abdominal tenderness. CT 
A/P showed hemorrhage from the hepatic artery. She received 
multiple units of PRBCs. She underwent ___ embolization on ___ 
of the bleeding site and her H/H initially stabilized. 
Unfortunately, she continued to bleed slowly from her hepatic 
artery and required daily transfusions for the following 3 days. 
On ___ she underwent repeat hepatic artery embolization and her 
hgb remained stable the remainder of her hospitalization. 
 
#Anemia/Hemolysis: On admission, H/H far below baseline of 
___. No clear evidence of bleed although on anticoagulation. 
Hemolysis work up revealed low haptoglobin, schistocytes on 
smear, and elevated LDH. Likely hemolysis from mechanical mitral 
valve iso acute illness. H/H initially stabilized and no 
evidence of bleeding during hospitalization. 
 
#Severe MR: s/p mechanical MVR in ___. On Coumadin as 
outpatient. Intially was held in anticipation of pacemaker 
placement and in setting of intra-abdominal hemorrhage (as 
above). Patient remained on heparin gtt for bridging. She was 
restarted on Coumadin prior to discharge from the hospital with 
heparin bridge.  

#HTN: Well controlled in hospital. Imdur and hydralazine held at 
discharge.
 
#Hyperlipidemia: Continued home atorvastatin
 
#Diabetes, type 2, insulin dependent: patient stated she is on 
20 detemir at home but OMR showed 26 units detemir. On 
glarginine and ISS while in hospital. Home metformin held on 
admission and restarted upon discharge.

#Asthma: Continued home regimen of albuterol, fluticasone, and 
loratidine

#GERD: Continued home regimen of omeprazole

#Insomnia: continued home regimen of trazodone

#Vitamins: continued home regimen of vitamin D 
 
#Chronic steroid use: 
#Polymalgia Rheumatica: 
Patient started on prednisone in ___ for PMR. During 
current hospitalization, patient was given stress-dose steroids 
in setting of acute illness, prednisone 40mg x3 days (___). 
Patient tapered to 10mg prednisone prior to discharge (___). 

[ ] Continue to taper prednisone as tolerated  
 
TRANSITIONAL ISSUES: 
===================
WEIGHT AT DISCHARGE: 113 KG
CREATININE AT DISCHARGE: 1.1
INR AT DISCHARGE: 1.3

MEDICATIONS TEMPORARILY HELD
[ ] Hydralazine, restart as BP tolerates
[ ] Imdur, restart as BP tolerates 

MEDICATIONS STARTED 
[ ] Amoxicillin-Clavulanic Acid ___ mg PO Q12H for gallbladder 
infection

REDOSED MEDICATIONS
[ ] Metoprolol increased

FOLLOW-UP ITEMS:
LAB FOLLOW UP:
[ ] Please repeat BMP and INR on ___, replete 
electrolytes while on torsemide and adjust warfarin dosing 
[ ] Goal INR 2.5-3.5 --overlap heparin gtt with therapeutic INR 
x 24hrs
[ ] Daily weights, adjust torsemide accordingly

APPT FOLLOW UP:
[ ] F/u with ACS within 2 weeks of discharge to plan for lap 
CCY. 
[ ] Following cholecystectomy, patient will need follow-up with 
EP to have a permanent pacemaker placed
[ ] Patient will need to follow-up with Cardiologist Dr. ___ 
in one month
[ ] Continue Augmentin for discharge until PTBD drain out / CCY. 

[ ] Patient discharged on prednisone 10mg daily for PMR. Taper 
dose as tolerated. 

 # CODE: full (presumed) 
 # CONTACT: ___ daughter ___ 
 Relationship: ___, alternate. daughter Phone: ___ 
 
___ on Admission:
The Preadmission Medication list may be inaccurate and requires 
futher investigation.
1. Acetaminophen 500 mg PO BID:PRN Pain - Mild 
2. Aspirin 81 mg PO DAILY 
3. Alcohol Pads (alcohol swabs)    topical DAILY:PRN 
4. BD Insulin Pen Needle UF Orig (pen needle, diabetic) 29 gauge 
x ___ miscellaneous ASDIR 
5. BD Insulin Syringe Ultra-Fine (insulin syringe-needle U-100) 
0.3 mL 30 gauge x ___ miscellaneous DAILY 
6. Warfarin 1 mg PO DAILY16 
7. Flovent HFA (fluticasone) 220 mcg/actuation inhalation BID 
8. FreeStyle Lite Strips (blood sugar diagnostic)    
miscellaneous TID 
9. Levemir FlexTouch (insulin detemir) 100 unit/mL (3 mL) 
subcutaneous DAILY 
10. Omeprazole 20 mg PO DAILY 
11. Guaifenesin-Dextromethorphan 5 mL PO Q6H:PRN cough 
12. Metoprolol Succinate XL 100 mg PO BID 
13. albuterol sulfate 90 mcg/actuation inhalation QID 
14. Amoxicillin 500 mg PO ONCE:PRN dental prophylaxis 
15. Atorvastatin 80 mg PO QPM 
16. Vitamin D 1000 UNIT PO DAILY 
17. ClonazePAM 0.5 mg PO BID:PRN anxiety, insomnia 
18. Fluticasone Propionate NASAL 2 SPRY NU DAILY 
19. HydrALAZINE 25 mg PO BID 
20. Isosorbide Mononitrate (Extended Release) 30 mg PO DAILY 
21. Loratadine 10 mg PO DAILY 
22. MetFORMIN (Glucophage) 1000 mg PO BID 
23. Torsemide 20 mg PO DAILY 
24. TraZODone 50 mg PO QHS 
25. Lidocaine 5% Ointment 1 Appl TP TID:PRN painful area 

 
Discharge Medications:
1.  Amoxicillin-Clavulanic Acid ___ mg PO Q12H 
RX *amoxicillin-pot clavulanate 875 mg-125 mg 1 by mouth twice a 
day Disp #*60 Tablet Refills:*0 
2.  Calcium Carbonate 500 mg PO BID Long term steroids  
3.  Heparin IV per Weight-Based Dosing Protocol
Indication: Mechanical Heart Valve
Continue existing infusion at 900 units/hr
Therapeutic/Target PTT Range: 60 - 99.9 seconds
Start: Today - ___, First Dose: 0900 hrs  
4.  Glargine 15 Units Bedtime
Insulin SC Sliding Scale using HUM Insulin 
5.  Metoprolol Succinate XL 200 mg PO DAILY  
6.  Acetaminophen 1000 mg PO BID:PRN Pain - Mild  
7.  albuterol sulfate 90 mcg/actuation inhalation QID  
8.  Alcohol Pads (alcohol swabs)    topical DAILY:PRN as needed  

9.  Aspirin 81 mg PO DAILY  
10.  Atorvastatin 80 mg PO QPM  
11.  BD Insulin Pen Needle UF Orig (pen needle, diabetic) 29 
gauge x ___ miscellaneous ASDIR  
12.  BD Insulin Syringe Ultra-Fine (insulin syringe-needle 
U-100) 0.3 mL 30 gauge x ___ miscellaneous DAILY  
13.  ClonazePAM 0.5 mg PO BID:PRN anxiety, insomnia  
14.  Flovent HFA (fluticasone) 220 mcg/actuation inhalation BID  

15.  Fluticasone Propionate NASAL 2 SPRY NU DAILY  
16.  FreeStyle Lite Strips (blood sugar diagnostic)    
miscellaneous TID  
17.  Guaifenesin-Dextromethorphan 5 mL PO Q6H:PRN cough  
18.  Levemir FlexTouch (insulin detemir) 100 unit/mL (3 mL) 
subcutaneous DAILY  
19.  Lidocaine 5% Ointment 1 Appl TP TID:PRN painful area  
20.  Loratadine 10 mg PO DAILY  
21.  MetFORMIN (Glucophage) 1000 mg PO BID  
22.  Omeprazole 20 mg PO DAILY  
23.  PredniSONE 10 mg PO DAILY  
24.  Torsemide 20 mg PO DAILY  
25.  TraZODone 50 mg PO QHS:PRN insomnia  
26.  Vitamin D 1000 UNIT PO DAILY  
27.  Warfarin 3 mg PO 5X/WEEK (___)  
28.  Warfarin 4 mg PO 2X/WEEK (___)  
29. HELD- HydrALAZINE 25 mg PO BID  This medication was held. Do 
not restart HydrALAZINE until you are told to start by your 
doctor
30. HELD- Isosorbide Mononitrate (Extended Release) 30 mg PO 
DAILY  This medication was held. Do not restart Isosorbide 
Mononitrate (Extended Release) until you are told to start by 
your doctor

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
Primary diagnoses:
==================
Acute cholecystitis
Cholelithiasis
Complete heart block
Sinus bradycardia
Acute exacerbation of HFpEF
Acute kidney injury
Blood loss anemia

Secondary diagnoses:
====================
Atrial fibrillation
Mechanical mitral valve 

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___,

It was a pleasure to care for you at ___.

Why did you come to the hospital?
 - You were concerned about your shortness of breath and 
abdominal pain

What did you receive in the hospital?
 - On imaging, you were found to have an gallstone leading to a 
gallbladder infection. You were given antibiotics. You 
eventually had a procedure that placed a tube into your 
gallbladder to relieve the pressure and clear out the infection. 
The tube in your gallbladder caused some bleeding in your 
abdomen so a procedure was performed to stop the bleeding.  
 - While we were monitoring you, your heart rate also slowed 
down significantly, a condition called complete heart block. You 
were given a temporary pacemaker to keep your heart rate up 
during the procedure. After you have your gall bladder removed, 
you will have a permanent placemaker placed. 

What should you do once you leave the hospital?
 - You will need to follow up with the surgeons who will arrange 
for removal of your your gallbladder surgically.  
 - You will need to follow-up with the cardiologists after your 
gallbladder is removed for a permanent pacemaker

We wish you the best,
Your ___ Care Team
 
Followup Instructions:
___
"
11576109-DS-15," 
Name:  ___                Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___
 
Chief Complaint:
chest pain 
 
Major Surgical or Invasive Procedure:
None 

 
History of Present Illness:
___ T2DM, CAD w/ known s/p 3VD DES to LAD, ESRD on HD, PAD s/p R 
BKA, HTN, HL, presents with chest pain.
  
- Reports substernal chest pain, similar to past, burning in 
quality, but this time radiates to back (which is new), no n/v, 
neck pain, arm pain. CP not worsened with deep breathes. reports 
subjective fever yesterday, since resolved. no cough. no abd 
pain, d/c, GU complaints.  
- Went to ___, received nitro > reports that it helped a bit 
initilly. had ? lateral changes, and transferred here for mgmt. 
 
In the ED, initial vitals were: 98.0 85 111/56 14 100% RA  
- exam: ___ pain. RRR, CTAb, no ___ swelling.  
- EKG: Sinus at ___, ___ later ST depression.  
- tropI at OSH 0.19  
- Labs notable for: WBC 10.7 (55%N), Hb 11, K 5.5, BUN/Cr 
53/9.8, trop 0.06, CKMb 3  
- CTA chest without evidence of dissection, noted bilateral 
opacities concering for multifocal PNA  
- Pt was given nothing  
- vitals prior to transfer: 64 124/60 15 97% RA  

On arrival to the floor, pt reports chest and back pain are 
fully resolved. 

 
Past Medical History:
- Type II diabetes mellitus  
- LLE neuropathy  
- ESRD on HD MWF  
- CAD with LM distal 60% stenosis, LCX ostial 90% stenosis 
before  
stent mid 60% stenosis, LAD difuse disease segmental mid 60%  
stenosis, RCA mid ___ stenosis, L to distal R collaterals  
- PAD s/p R BKA  
- Hypertension  
- Hyperlipidemia  
- Carpal tunnel syndrome  
- Breast cancer  

 
Social History:
___
Family History:
No family history of early MI.
 
Physical Exam:
Exam: 
=====
Vitals: 98.1 118/62 67 98% RA
wt: 97.4kg  
General: well appearing, middle aged, overweight female 
HEENT: PERRLA, OP clear, hirsute
Neck: no LAD
CV: RRR, S1/S2, no murmurs, gallops, or rubs    
Lungs: breathing comfortably. faint crackles at bases, no focal 
deficits 
Abdomen: nondistended, +BS, nontender in all quadrants, no 
rebound/guarding, no hepatosplenomegaly   
Extr: no edema, WWP 
Neuro: ___ strength in ___, R BKA, some stocking glove 
distribution neuropathy, but no saddle anesthesia, good rectal 
tone.
Skin: no lesions 
 
Pertinent Results:
Labs:
=====
___ 12:53PM   UREA N-17
___ 09:14AM   CK-MB-4 cTropnT-0.10*
___ 09:14AM   CALCIUM-9.3 PHOSPHATE-2.3*
___ 01:40AM   GLUCOSE-233* UREA N-53* CREAT-9.8*# 
SODIUM-133 POTASSIUM-5.5* CHLORIDE-94* TOTAL CO2-22 ANION 
GAP-23*
___ 01:40AM   estGFR-Using this
___ 01:40AM   CK(CPK)-132
___ 01:40AM   CK-MB-3 cTropnT-0.06*
___ 01:40AM   WBC-10.7* RBC-3.72* HGB-11.0* HCT-34.4 MCV-93 
MCH-29.6 MCHC-32.0 RDW-14.8 RDWSD-49.6*
___ 01:40AM   NEUTS-55.6 ___ MONOS-10.5 EOS-3.4 
BASOS-0.7 IM ___ AbsNeut-5.97 AbsLymp-3.18 AbsMono-1.13* 
AbsEos-0.36 AbsBaso-0.___ 01:40AM   PLT COUNT-223
___ 01:40AM   PLT COUNT-223

IMAGING: 
=========
# CTA chest:  
1. No evidence of aortic dissection.  
2. Bilateral patchy opacities are concerning for multifocal 
pneumonia.  
3. Compression deformities of the T10 and T11 vertebral bodies 
are of unclear chronicity, but new since ___. Linear 
sclerosis of of the T11 vertebral body may suggest a more acute 
process.  

ECG: Sinus rhythm, nl axis, nl intervals, with ST depressions in 
I, II, V5-6, unchanged from prior 
 
Brief Hospital Course:
___ T2DM, CAD w/ known s/p 3VD DES to LAD, ESRD on HD, PAD s/p R 
BKA, HTN, HL, presents with chest pain, possibly PNA.

ACUTE ISSUES: 
=============
# Chest pain: Substernal CP with exertion yesterday, radiating 
to back, which is new. Relieved somewhat with SLN. CTA at ___ 
negative for dissection or PE, but did show atypical PNA. EKG 
unchanged, trops near baseline, MB flat. Patient lacking many 
infectious symptoms (no cough, subjective fevers at home, but no 
fever or leuckocyotsis here), started on levoflox for 5 days for 
treatment of atypial PNA (renally dosed; QTc not prolonged). To 
follow up as outpatient with Dr ___ CP persists (ischemic 
CP has been managed medically as an outpatient given she is poor 
operative candidate). Continue home ranolazine and imdur. 

# T10/11 compression fractures: incidentally noted on CT, could 
explain back pain, though pain now resolved, patient has no TTP 
over spinus processes. Appear sub-acute to chronic. 
Neurologically intact. Discussed with ortho, who reviewed the 
films, felt the fractures appeared old. To follow up as 
outpatient re: minearal/bone density management in setting of 
ESRD to prevent further fractures. 

CHRONIC ISSUES: 
===============
# CAD: known 3VD, with LM distal 60% stenosis, LCX ostial 90% 
stenosis  before stent mid 60% stenosis, LAD difuse disease 
segmental mid 60%  stenosis, RCA mid ___ stenosis, L to distal 
R collaterals. Not a good candidate for C
- continue home aspirin, atorvastatin, metop, clopidogrel

# ESRD on HD: ___, went for HD today  
- renal HD consult 
- continue home cinacalcet, sevalemer 

# DM: 
- continue home insulin 
- continue home gabapentin

# HTN: 
- continue amlodipine  

# GERD: 
- continue home famotidine
 
TRANSITIONAL ISSUES: 
====================
- levofloxacin for 5 days for pneumonia (day 1= ___ 
- noted to have subacute to chronic T10/11 comrpession 
fractures, asymptomatic; should follow up with PCP ___: 
optimizing bone/mineral density
- follow up with cardiologist if chest pain persists

 
Medications on Admission:
The Preadmission Medication list may be inaccurate and requires 
futher investigation.
1. Aspirin 81 mg PO DAILY 
2. Atorvastatin 80 mg PO QPM 
3. Cinacalcet 30 mg PO DAILY 
4. Clopidogrel 75 mg PO DAILY 
5. Famotidine 20 mg PO DAILY 
6. Gabapentin 300 mg PO 3X/WEEK (___) 
7. Gabapentin 300 mg PO QHS 
8. Nephrocaps 1 CAP PO DAILY 
9. ranolazine 500 mg ORAL DAILY 
10. sevelamer CARBONATE 3200 mg PO TID W/MEALS 
11. Nitroglycerin SL 0.3 mg SL Q5MIN:PRN pain 
12. Metoprolol Succinate XL 100 mg PO DAILY 
13. Glargine 44 Units Bedtime
Insulin SC Sliding Scale using HUM Insulin

 
Discharge Medications:
1. Aspirin 81 mg PO DAILY 
2. Atorvastatin 80 mg PO QPM 
3. Cinacalcet 30 mg PO DAILY 
4. Clopidogrel 75 mg PO DAILY 
5. Famotidine 20 mg PO DAILY 
6. Gabapentin 300 mg PO 3X/WEEK (___) 
7. Gabapentin 300 mg PO QHS 
8. Glargine 44 Units Bedtime
Insulin SC Sliding Scale using HUM Insulin
9. Metoprolol Succinate XL 100 mg PO DAILY 
10. Nephrocaps 1 CAP PO DAILY 
11. Nitroglycerin SL 0.3 mg SL Q5MIN:PRN pain 
12. Ranolazine ER 500 mg PO DAILY 
13. sevelamer CARBONATE 3200 mg PO TID W/MEALS 
14. Levofloxacin 500 mg PO Q48H Duration: 5 Days 
RX *levofloxacin 500 mg 1 tablet(s) by mouth q48hrs Disp #*2 
Tablet Refills:*0

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
# Primary: Pneumonia
# Secondary: Cornonary Artery Disease, End Stage Renal Disease

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Out of Bed with assistance to chair or 
wheelchair.

 
Discharge Instructions:
Dear Ms ___, 

You were admitted with back pain and chest pain. Imaging was 
negative for anything concerning, but we did note that you might 
have a pneumonia. This could explain your pain, which has now 
improved. We started you on an antibiotic (levofloxacin) for 5 
days. You should follow up with your outpatient cardiologist if 
you continue to have chest pain. 

Weigh yourself every morning, call MD if weight goes up more 
than 3 lbs.
 
Followup Instructions:
___
"
11649745-DS-4," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: NEUROLOGY
 
Allergies: 
Novocain / lisinopril
 
Attending: ___
 
Chief Complaint:
headache
 
Major Surgical or Invasive Procedure:
none

 
History of Present Illness:
___ yo M Hx embryonal cell carcinoma of the mediastinum as a
child treated with surgery, XRT and chemotherapy, invasive 
breast
cancer leading to bilateral mastectomy ___ and subsequent
treatment with tamoxifen. who is now s/p cardiac Catheterization
and ___ for RCA occlusion ___. Pre and post cath he
received Antiplatelet therapy (Asa 81, brilinta, cangrelor gtt)
as well as intraprocedural heparin gtt.  Post Cath he developed
HAs and was noted on exam today around 2pm to have left sided
vision loss and neglect when he got up to use the commode.  Head
CT showed Right parieto-occipital IPH with IVH and antiplatelet
therapy was held.  He presents as a direct transfer to the Neuro
ICU.  Currently he denies CP, SOB.  He c/o ""migraine headache""
and light sensitivity. He feels that his vision is blurry at
times and that he is losing vision off to the left side.

According to Atrius records he was in his usual state of health
until ___ when he developed significant chest pain in the
morning while making coffee. Pain radiated to the left arm.  He
became dizzy and lost consciousness and fell to the floor.  EMS
was called and prehospital ECG showed inferior STEMI.  When he
presented to OSH heart rate was in the ___ and ECG showed
complete heart block.  He was hypotensive with a blood pressure
in the ___.  Reportedly he was mentating throughout most of
his time in the ER.  He received atropine 1 mg, Levophed and 
then
dopamine drips and was placed on transcutaneous pacing.  He
remained hypotensive and was taken emergently to cardiac
catheterization.  In the Cath Lab, he was found to have
thrombotic total occlusion of the ostial RCA and an occluded
distal RCA with thrombus, likely embolic.  DES was placed in the
RCA. His blood pressure in the CCU on both high-dose dopamine 
and
Levophed were in the 150s with heart rates in the 130s.  The
patient had no further CP, arm pain, SOB.  SBPs today have been
less than 130 and HR ___ in sinus rhythm. Please see Atrium
records for echo results.

 
Past Medical History:
Hx embryonal cell carcinoma of the mediastinum as a child 
treated
with surgery, XRT and chemotherapy, invasive breast cancer
leading to bilateral mastectomy ___ and subsequent treatment
with tamoxifen. 
STEMI ___ s/p cardiac cath thas showed occlusion of the ostial
RCA and thrombus within the distal RCA

 
Social History:
___
Family History:
no hx ICH
 
Physical Exam:
ADMISSION PHYSICAL EXAM:
O: AVSS
Gen: WD/WN, comfortable, NAD.
HEENT: normocephalic, atraumatic
Neck: Supple.
Extrem: Warm and well-perfused.

Date and Time of evaluation: ___ 23:00
___ Coma Scale:
  [ ]Intubated   [x]Not intubated

Eye Opening: 
 [ ]1 Does not open eyes
 [ ]2 Opens eyes to painful stimuli
 [ ]3 Opens eyes to voice
 [x]4 Opens eyes spontaneously

Verbal:
 [ ]1 Makes no sounds
 [ ]2 Incomprehensible sounds
 [ ]3 Inappropriate words
 [ ]4 Confused, disoriented
 [x]5 Oriented

Motor:
 [ ]1 No movement
 [ ]2 Extension to painful stimuli (decerebrate response)
 [ ]3 Abnormal flexion to painful stimuli (decorticate response)
 [ ___ Flexion/ withdrawal to painful stimuli 
 [ ]5 Localizes to painful stimuli
 [x]6 Obeys commands

 __15__ Total

ICH Score:
GCS
     [ ]2     GCS ___
     [ ]1     GCS ___
     [x]0     GCS ___
     
ICH Volume 
     [x]1     30 mL or Greater
     [ ]0     Less than 30 mL

Intraventricular Hemorrhage
     [x]1     Present
     [ ]0     Absent

Infratentorial ICH
     [ ___     Yes
     [x]0     No

Age
     [ ]1     ___ years old or greater
     [x]0     Less than ___ years old

Total Score: ___2___

Neuro:
Mental status: Awake and alert, cooperative with exam, normal
affect.
Orientation: Oriented to person, place, and date.
Language: Speech fluent with good comprehension and repetition.
Naming intact. No dysarthria or paraphasic errors.

Cranial Nerves:
I: Not tested
II: Pupils equally round and reactive to light, 3 to 2
mm bilaterally. Left homonymous hemianopsia.
III, IV, VI: Extraocular movements intact bilaterally without
nystagmus.
V, VII: Facial strength and sensation intact and symmetric.
VIII: Hearing intact to voice.
IX, X: Palatal elevation symmetrical.
XI: Sternocleidomastoid and trapezius normal bilaterally.
XII: Tongue midline without fasciculations.

Motor: Normal bulk and tone bilaterally. No abnormal movements,
tremors. Strength full power ___ throughout. No pronator drift

Sensation: Intact to light touch bilaterally.

=========================
DISCHARGE FROM ICU EXAM:
===========================
MS- Opens eyes spont, awake and alert, oriented x3, 
coverasational but headache so speaks quietly follows commands 
with all extremities. No dysarthria.  
CN- R pupil 3->2, L pupil 3->2. Decreased BTT on the left.  
EOMI without nystagmus, No facial droop, face symmetric at rest, 
tongue midline, left hemianopia. 
Motor-  
RUE: able to lift hold and resist ___,   
LUE: able to lift hold and resist ___, (Has very subtle + left 
pronator drift)
RLE: able to lift hold and resist ___ 
LLE: able to lift hold and resist ___  
 
-Sensory: No deficits to light touch, pinprick, proprioception   
throughout. Extinguishes to DSS.  
-DTRs:  
Plantar response was flexor bilaterally.  
Coordination- no dysmetria on FNF 

==================
DISCHARGE EXAM
==================

MS- awake, alert and interactive, oriented x3, conversational. 
follows commands with all extremities. No dysarthria.  

CN- Left homonomous hemianopia, EOMI slight left NLFF but no
obvious facial droop, face symmetric at rest, tongue midline

Motor- ___ in all four extremities to confrontational testing in 
b/l delt, biceps, triceps, ECR, FEx, IP, Hamstring, Quad, TA, 
Gastroc
 
-Sensory: No deficits to light touch. Does not extinguish to DSS 


-Cerebellar: mild intention tremor bilaterally. no dysmetria

 
Pertinent Results:
==============
PERTINENT LABS
==============

___ 11:58PM BLOOD WBC-16.7* RBC-3.66* Hgb-10.8* Hct-33.2* 
MCV-91 MCH-29.5 MCHC-32.5 RDW-14.8 RDWSD-49.1* Plt ___
___ 04:35AM BLOOD WBC-14.3* RBC-4.22* Hgb-12.5* Hct-36.8* 
MCV-87 MCH-29.6 MCHC-34.0 RDW-14.1 RDWSD-44.8 Plt ___
___ 11:58PM BLOOD Neuts-84.5* Lymphs-7.0* Monos-7.8 
Eos-0.1* Baso-0.2 Im ___ AbsNeut-14.14* AbsLymp-1.18* 
AbsMono-1.30* AbsEos-0.01* AbsBaso-0.04
___ 04:35AM BLOOD Plt ___
___ 05:50AM BLOOD ___ PTT-25.6 ___
___ 06:05AM BLOOD Glucose-101* UreaN-20 Creat-1.0 Na-136 
K-4.7 Cl-97 HCO3-26 AnGap-13
___ 08:33AM BLOOD ADP-DONE Collage-DONE Arach A-DONE
___ 11:58PM BLOOD CK(CPK)-82
___ 11:58PM BLOOD ALT-43* AST-74* LD(LDH)-409* CK(CPK)-254 
AlkPhos-41 TotBili-0.8
___ 11:58PM BLOOD CK-MB-12* MB Indx-4.7 cTropnT-0.98*
___ 06:05AM BLOOD Calcium-9.4 Phos-3.3 Mg-2.4
___ 12:14AM BLOOD %HbA1c-5.4 eAG-108
___ 11:58PM BLOOD Triglyc-97 HDL-34* CHOL/HD-4.4 LDLcalc-97
___ 11:58PM BLOOD TSH-0.88
___ 02:50PM URINE Color-Yellow Appear-Clear Sp ___
___ 02:50PM URINE Blood-NEG Nitrite-NEG Protein-TR* 
Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-NEG
___ 02:50PM URINE RBC-4* WBC-2 Bacteri-NONE Yeast-NONE 
Epi-<1 TransE-<1
___ 02:50PM URINE CastHy-1*

STUDIES

 
___ 12:44 am URINE      Source: ___. 

                            **FINAL REPORT ___

   URINE CULTURE (Final ___:    NO GROWTH. 

 
 
___ 2:50 pm URINE      Source: ___. 

                            **FINAL REPORT ___

   URINE CULTURE (Final ___:    NO GROWTH. 

___ 12:44 am BLOOD CULTURE      Source: Venipuncture. 

   Blood Culture, Routine (Pending): 

========
IMAGES 
========
___ NCHCT
IMPRESSION:  
  
No significant change in right parietal/occipital parenchymal 
hemorrhage.  No 
significant change in intraventricular hemorrhage allowing for 
slight 
redistribution.  Stable hydrocephalus. 

====================
MRI/MRA BRAIN ___
 
1. Stable extent of right parietal/occipital parenchymal 
hemorrhage with 
stable intraventricular extension and stable mass effect. 
2. Underlying acute to early subacute infarction in the right 
posterior 
cerebral artery territory, with involvement of the occipital and 
parietal 
lobes, and of the splenium of the corpus callosum. 
3. Several small, near punctate acute to early subacute 
infarctions in the 
head of the right caudate nucleus, in a different vascular 
territory. 
4. While the brain MRA is limited by motion artifact, there is 
apparent 
asymmetric mild-to-moderate narrowing of the distal P1 segment 
of the right 
posterior cerebral artery. 
  
===================
CTA HEAD AND NECK ___
 
1. Unchanged large right parieto-occipital intraparenchymal 
hemorrhage with 
intraventricular extension.  There is decreased hemorrhage 
within the third 
and fourth ventricles.  There is no evidence of vasospasm or 
underlying 
vascular abnormality.  9 mm of leftward midline shift is 
unchanged. 
2. The vessels of the circle of ___ and their principal 
intracranial 
branches appear normal without stenosis, occlusion, or aneurysm 
formation.  
There is no evidence of internal carotid stenosis by NASCET 
criteria. 

==================
BILATERAL LOWER EXTREMITY VENOUS ULTRASOUND
Occlusive thrombus within the right internal jugular vein.  
Otherwise no DVT within the left or right upper extremities. 

BILATERAL UPPER EXTREMITY VENOUS ULTRASOUND 
No evidence of deep venous thrombosis in the right or left lower 
extremity 
veins. 

===================
NCHCT ___
 
1. Expected evolution of right parieto-occipital 
intraparenchymal hemorrhage 
with interval decrease in degree of intraventricular extension. 
2. No new or enlarging hemorrhages.  No evidence of new 
infarction 
3. Slight interval decrease in ventricular size. 
4. Interval decrease of leftward midline shift, now minimal. 

==================

CT L SPINE ___

No acute fracture of the lumbar spine.  Mild degenerative 
changes. 

 
Brief Hospital Course:
___ yo M with history of embryonal cell carcinoma of the 
mediastinum as a child treated with surgery, XRT and 
chemotherapy, invasive breast cancer leading to bilateral 
mastectomy ___ and subsequent treatment with tamoxifen 
whopresented to ___ with a STEMI s/p DES to the RCA on 
___, subsequently developed a left visual field cut, CT showing 
IPH and transferred to ___. Patient monitored in the neuro ICU 
for edema. Here, MRI showed ischemic infarcts in the PCA 
territory and the caudate, with hemorrhagic conversion in the 
PCA territory. 
Exam was initially significant for left hemianopia, extinction 
to double simultaneous stimulation on the left, and overall 
fatigue and sensitivity to light.

Stroke etiology at this time is unclear. Patient has known risk 
factors including a large PFO and sleep apnea. Another 
possibility is periprocedural infarction from manipulation of 
the vasculature, particularly if the patient is found to have 
atherosclerosis.

#Ischemic to hemorrhagic conversion of PCA infarct, and R 
Caudate head infarct.

#ICU course
On admission to the neuro ICU, patient had MRI/MRA which showed 
PCA territory infarct as well as right head caudate infarct. MRA 
showed no vessel cutoffs. Bedside ultrasound of right IJ 
(incision at the site from OSH) showed large thrombus in right 
IJ. Cardiology was consulted regarding post-stent care, as well 
as medication recommendations. They recommended starting 
antiplatelet therapy as soon as possible, but were agreeable to 
holding for at least one week. In terms of what medication to 
start, they recommended a Plavix assay to confirm Plavix 
response, and if patient is a responder to begin with Plavix 
monotherapy, and monitor patient inpatient while the medication 
is started. They advised against continuing tamoxifen due to its 
coagulopathy side effect. In chart review, patient was found to 
have a large PFO. 

Patient experienced a flushing sensation ___ after 
administration of hydralazine, oxycodone, and Lidocaine. This 
was thought to be likely to Lidocaine, as he has an allergy to 
novacaine which also involved flushing. He experienced a similar 
flushing sensation ___ after metoprolol and acetaminophen. 
After the latter episode, the patient reported diffuse and 
moving paresthesias in his bilateral legs, back, arms, and face. 
These paresthesias did not follow a sensory distribution and 
were thought not to be a central process. On ___ platelet 
reactivity study was sent. Discussed incidentally found right IJ 
clot (seen on ultrasound ___, which could not be treated with 
anticoagulation in the ICU due to acute hemorrhage. Plan was 
made to plan for a follow up ultrasound in 3 months after 
discharge to ensure resolution. 

On the floor, Mr ___ improved quickly and had only a residual 
left homonymous hemianopsia at the time of discharge. 

Plavix was re-started on ___ and patient had repeat head CT on 
___ that was stable. If patient continue to do well, anticipate 
re-starting aspirin on ___.  Patient was otherwise started on 
atorvastatin 40mg daily. 

Stroke etiology has yet to be elucidated. Patient has known risk 
factors including a large PFO and tamoxifen is known to 
predispose patients to venous clot (though no venous clot 
identified apart from R IJ).  He also has sleep apnea as well as 
some calcification in the aortic arch seen on CTA.  Another 
possibility is ___ infarction from manipulation of 
the vasculature. Stroke risk factors evaluated TSH 0.88, A1c 5.4 
and LDL 97. He has a PFO on chart review and redemonstrated on 
our TTE. Lower extremity ultrasound was negative for venous 
clot. 

#Hypertension:
Patient has a history of hypertension. He had previously been on 
lisinopril but he developed cough.  Blood pressures were well 
controlled on metoprolol.

Patient had a few episodes of orthostatic hypotension that 
improved with increased PO intake. 

#ST-elevation MI (STEMI) on ___ cardiac cath at ___ RCA occlusion   
- TTE ___ here showed possible PFO, previous ECHOs have showed 
PFO
- Plavix resumed on ___. Plan to resume ASA on ___ if stable 
- F/U platelet aggregation assay ___ 
- Cardiology recommended restarting lisinopril 5mg daily when 
appropriate though this was held in the hospital due to episodic 
orthostatic hypotension. This should be resumed as he becomes 
less deconditioned at acute rehab. 

#Leukocytosis: now afebrile, downtrending
- continue to monitor

#Low back pain: On ___, patient developed severe low back pain. 
 Patient had CT L-spine which revealed degenerative changes but 
no acute abnormalities. Pain was controlled on tramadol and 
Tylenol.  Pain resolved prior to discharge but did occur 
intermittently throughout his stay. 

#OSA: Patient was found to have OSA.  He will need a sleep study 
as an outpatient

#Hx of breast cancer: 
Patient has been on tamoxifen since ___.  Because it has been 
associated with increased risk of venous thrombus and patient 
has a PFO, we spoke with his primary oncologist, Dr. ___, 
___ this risk.  She recommended not re-starting tamoxifen for 
now and follow up with her as an outpatient. 

#RIJ Thrombus:
Discussed incidentally found right IJ clot (seen on ultrasound 
___, which could not be treated with anticoagulation in the 
ICU due to acute hemorrhage. Plan was made to plan for a follow 
up ultrasound in 3 months after discharge to ensure resolution. 

===============================
Transitional Issues:
[ ] If clinically stable, resume aspirin on ___
[ ] Repeat US in 3 months to ensure resolution of R IJ thrombus 
[ ] Sleep study 
[ ] Tamoxifen stopped during this admission after talking with 
Dr ___. Will need follow up with Dr ___.
[ ] Resume Lisinopril 5mg daily after orthostatic hypotension 
resolves with improved deconditioning 
[ ] Neurology Follow up

===============================

AHA/ASA Core Measures for Ischemic Stroke and Transient Ischemic 
Attack  
 1. Dysphagia screening before any PO intake? (x) Yes, confirmed 
done - () Not confirmed  () No  
 2. DVT Prophylaxis administered? (x) Yes - () No  
 3. Antithrombotic therapy administered by end of hospital day 
2? () Yes - (x) No  (hemorrhagic conversion of PCA infarct)
 4. LDL documented? (x) Yes (LDL = 97) - () No  
 5. Intensive statin therapy administered? (simvastatin 80mg, 
simvastatin 80mg/ezetemibe 10mg, atorvastatin 40mg or 80 mg, 
rosuvastatin 20mg or 40mg, for LDL > 100) (x) Yes - () No [if 
LDL if LDL >70, reason not given:  
 [ ] Statin medication allergy  
 [ ] Other reasons documented by physician/advanced practice 
nurse/physician ___ (physician/APN/PA) or pharmacist  
 [ ] LDL-c less than 70 mg/dL]  
 6. Smoking cessation counseling given? () Yes - (x) No [reason 
(x) non-smoker - () unable to participate]  
 7. Stroke education (personal modifiable risk factors, how to 
activate EMS for stroke, stroke warning signs and symptoms, 
prescribed medications, need for followup) given (verbally or 
written)? (x) Yes - () No  
 8. Assessment for rehabilitation or rehab services considered? 
(x) Yes - () No  
 9. Discharged on statin therapy? (x) Yes - () No [if LDL >70, 
reason not given:  
 [ ] Statin medication allergy  
 [ ] Other reasons documented by physician/advanced practice 
nurse/physician ___ (physician/APN/PA) or pharmacist  
 [ ] LDL-c less than 70 mg/dL  
 10. Discharged on antithrombotic therapy? (x) Yes [Type: (x) 
Antiplatelet - () Anticoagulation] - () No  
 11. Discharged on oral anticoagulation for patients with atrial 
fibrillation/flutter? () Yes - () No - (x) N/A  
 
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Tamoxifen Citrate 20 mg PO DAILY 
2. Lisinopril 5 mg PO DAILY 

 
Discharge Medications:
1.  Acetaminophen ___ mg PO Q6H:PRN Pain - Mild  
2.  Atorvastatin 40 mg PO QPM  
3.  Bisacodyl 10 mg PO/PR DAILY:PRN Constipation  
4.  Clopidogrel 75 mg PO DAILY  
5.  Cyclobenzaprine 5 mg PO TID:PRN back pain  
6.  Metoprolol Succinate XL 150 mg PO DAILY  
7.  Polyethylene Glycol 17 g PO DAILY:PRN Constipation  

 
Discharge Disposition:
Extended Care
 
Facility:
___ 
 
Discharge Diagnosis:
Hemorrhagic conversion of ischemic posterior cerebral artery 
infarct

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
 Dear Mr. ___,

 You were hospitalized due to symptoms of changes in your vision 
resulting from an ACUTE ISCHEMIC STROKE WITH HEMORRHAGIC 
CONVERSION, a condition where a blood vessel providing oxygen 
and nutrients to the brain is blocked by a clot. The brain is 
the part of your body that controls and directs all the other 
parts of your body, so damage to the brain from being deprived 
of its blood supply can result in a variety of symptoms.  

 Stroke can have many different causes, so we assessed you for 
medical conditions that might raise your risk of having stroke. 
In order to prevent future strokes, we plan to modify those risk 
factors. Your risk factors are:  
- recent heart surgery
- patent foramen ovale 

 We are changing your medications as follows:  
- STOP tamoxifen
- continue PLAVIX
- do not resume aspirin until ___

 Please take your other medications as prescribed.  

 Please follow up with Neurology and your primary care physician 
as listed below.
  
 If you experience any of the symptoms below, please seek 
emergency medical attention by calling Emergency Medical 
Services (dialing 911). In particular, since stroke can recur, 
please pay attention to the sudden onset and persistence of 
these symptoms:  
 - Sudden partial or complete loss of vision  
 - Sudden loss of the ability to speak words from your mouth  
 - Sudden loss of the ability to understand others speaking to 
you  
 - Sudden weakness of one side of the body  
 - Sudden drooping of one side of the face  
 - Sudden loss of sensation of one side of the body  

 Sincerely,  
 Your ___ Neurology Team  

 
Followup Instructions:
___
"
11652327-DS-14," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: SURGERY
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
Penetrating aortic ulcer of visceral
segment of the abdominal aorta.
 
Major Surgical or Invasive Procedure:
___
1.  Realtime ultrasound-guided access to both common femoral
arteries.
2.  Fenestrated endovascular aortic aneurysm repair with three
visceral endoprostheses using a physician-modified ___,
28 x ___ mm Cook Zenith thoracic graft.
3.  Closure of both common femoral puncture sites using two
Perclose devices each in a preclose fashion.

___:
Percutaneous endoscopic gastrostomy and
tracheostomy.
 
History of Present Illness:
Mr. ___ is seen in consultation
for referral from Dr. ___ for evaluation of a
juxtarenal abdominal aortic aneurysm.  He had an infrarenal
___ repair of an abdominal aortic aneurysm in ___ ___ an ___ graft.  Dr. ___ and Dr. ___
has taken over followup and noted development of a large
penetrating aortic ulcer in the posterior wall near the level of
the renals at the top of the existing stent graft. He has no 
abdominal or back pain.
 
Past Medical History:
Notable for diabetes, hyperlipidemia, and
hypertension.   He also has a history of anxiety, and 
depression.
 
Social History:
___
Family History:
His father died of an aortic aneurysm and his
brother has one as well.  His children have all been checked. 
Notable also for diabetes and breast cancer.

 
Physical Exam:
Upon discharge:

Vitals
98.3   84 Sinus    102/59   17   97%   Trach Mask 35%
Gen: lying in bed, no acute distress
CV: sinus rhythm
Pulm: on trach mask, no respiratory distress
Abd: soft, non-tender, nondistended
___: WWP, palp b/l fem, pop and dp pulses
 
Pertinent Results:
CTA torso ___
IMPRESSION: 
  
  
1. Status post interval placement of aortic, SMA, and renal 
artery stents.  
Peripheral wedge-shaped hypoenhancement of the left lower pole 
of the kidney 
is consistent with renal infarction due to exclusion of an 
accessory lower 
pole renal artery, possibly accounting for patient's symptoms.  
No other acute 
process in the abdomen or pelvis is identified. 
2. Bilateral pulmonary ground-glass opacities are worrisome for 
developing 
infectious or inflammatory process.  Extensive mediastinal and 
hilar 
lymphadenopathy is likely reactive. 
3. Underlying chronic interstitial lung disease. 
4. Pulmonary nodules measure up to 8 mm for which CT is 
recommended as below. 
  
RECOMMENDATION(S):  For incidentally detected multiple solid 
pulmonary nodules 
measuring 6 to 8mm, a CT follow-up in 3 to 6 months is 
recommended in a 
low-risk patient, with an optional CT follow-up in 18 to 24 
months. In a 
high-risk patient, both a CT follow-up in 3 to 6 months and in 
18 to 24 months 
is recommended. 

___ CT chest:
IMPRESSION:  
  
Findings highly concerning for bilateral pneumonia on a 
background of combined 
pulmonary fibrosis and emphysema syndrome. 
  
Mediastinal adenopathy, likely reactive. 

___ CT abd/pelvis:
IMPRESSION: 
  
  
1. No acute intra-abdominal process. 

___ CT head
IMPRESSION: 
  
  
1. No evidence of acute intracranial process or hemorrhage. 
2. Opacified bilateral mastoid air cells and middle ear 
cavities.  No evidence 
of bony erosion on this nondedicated study.  Findings could 
reflect sequelae 
of chronic otitis media with bilateral mastoid effusions.  
Correlate 
clinically with patient's symptoms, including symptoms of otitis 
media. 
3. Chronic findings include age-appropriate global parenchymal 
loss and 
vascular calcifications. 

___ CT abd/pelvis
IMPRESSION: 
  
  
1. No acute process within the abdomen or pelvis.  Specifically, 
no 
intra-abdominal or intrapelvic fluid collection. 
2. Unchanged splenomegaly. 
3. Patent aorto bi-iliac stent graft, ___ stent, and bilateral 
renal artery 
stents without definite evidence of endoleak. 
4. Please see separate report performed on the same day for 
detailed 
evaluation of the chest. 

___ CT chest:
IMPRESSION: 
  
  
1. Extensive bilateral lobe consolidations suggestive of 
pneumonia or 
aspiration are overall improved compared to prior.  No 
significant change in 
likely reactive mediastinal and hilar lymphadenopathy. 
2. Worsened, small pericardial effusion. 
3. Redemonstration of chronic emphysema and bronchiectasis. 
4. 8 mm left upper lobe nodule.  Recommend follow-up chest CT as 
recommended 
in recent CTA torso dated ___. 
5. Please refer to separate report from concurrent CT abdomen 
pelvis for 
description of findings below diaphragm. 

___ CT a/p
IMPRESSION: 
  
  
-New indeterminate peripherally enhancing lesions in the muscle 
of the pelvis; 
they could represent intramuscular abscesses or myonecrosis.  
Intramuscular 
hematoma cannot be excluded especially in the right internal 
obturator muscle. 
-No intra-abdominal acute process. 
  
RECOMMENDATION(S):  Non emergent pelvic MRI 

___ CT chest
IMPRESSION: 
  
  
-Interval decrease but persistence of parenchymal opacities that 
could 
represent aspiration with superimposed infection. 

___ MRI pelvis
IMPRESSION: 
  
  
1. Multiloculated centrally nonenhancing lesion with surrounding 
enhancement 
expanding the right obturator internus muscle is likely a 
hematoma.  No 
drainable fluid collection is identified. 
2. Ill-defined area of non enhancement in the left gluteus 
maximus muscle may 
reflect myonecrosis.  This area is predominantly low signal on 
T2 suggesting 
that this is not fluid. 
3. Area of hyperenhancement with multiple internal foci of 
hypoenhancement in 
the right gluteus maximus muscle is nonspecific but may reflect 
developing 
myonecrosis. 
4. Bilateral gluteal and adductor muscle edema. 

___ TEE
CONCLUSION:
There is no spontaneous echo contrast or thrombus in the body of 
the left atrium/left atrial appendage. The
left atrial appendage ejection velocity is mildly depressed. No 
spontaneous echo contrast or thrombus is seen
in the body of the right atrium/right atrial appendage. The 
right atrial appendage ejection velocity is
depressed. There is no evidence for an atrial septal defect by 
2D/color Doppler. There are no aortic arch
atheroma with simple atheroma in the descending aorta. The 
aortic valve leaflets (3) are mildly thickened. No
masses or vegetations are seen on the aortic valve. No abscess 
is seen. There is no aortic regurgitation. The
mitral valve leaflets appear structurally normal with no mitral 
valve prolapse. No masses or vegetations are
seen on the mitral valve. No abscess is seen. There is mild [1+] 
mitral regurgitation. The tricuspid valve
leaflets appear structurally normal. No mass/vegetation are seen 
on the tricuspid valve. No abscess is seen.
There is mild [1+] tricuspid regurgitation.
IMPRESSION: No intracardiac thrombus or valvular vegetations 
seen. Mild mitral and tricuspid regurgitation.

___ CTA torso
IMPRESSION: 
  
  
1. No evidence of mesenteric ischemia.  Patent vasculature.  Due 
to metallic 
artifact, patency of a superior mesenteric artery stent is not 
well assessed 
with this technique. 
2. Interval progression of extensive bilateral ground-glass 
opacities and 
consolidations a consist with multifocal infection, ARDS, or 
both.  Underlying 
interstitial disease may also be present and a differential 
would be acute on 
chronic interstitial disease.  Associated mediastinal 
lymphadenopathy has 
slightly increased.  Differential for this also includes 
lymphoproliferative 
disorders. 
3. Interval increase in small volume ascites and small bilateral 
pleural 
effusions. 
4. New hyperdense ingested foreign body posteriorly within the 
stomach 
resembles a tooth. 

___ CT head
IMPRESSION: 
  
  
1. Late subacute to chronic right cerebral hemisphere, left 
cerebellar 
infarcts. 
2. Opacified mastoids, middle ear cavities, likely from nasal 
intubation. 

___ CT neck
IMPRESSION: 
  
  
1. Borderline neck lymph nodes, measure up to 1 cm, may be 
reactive. 
2. Refer to head CT, chest CT report from today. 

___ CT chest
IMPRESSION:  
  
1.  Extensive consolidation and ground-glass opacities 
throughout the lungs, 
most pronounced in the bilateral lower lobes, not significantly 
changed 
compared to prior CT from ___.  Findings are 
compatible with 
ARDS and/or multifocal pneumonia.. 
2.  Extensive honeycombing of the lungs, in keeping with 
background 
interstitial lung disease. 
3.  Mediastinal, bilateral hilar and supraclavicular 
lymphadenopathy is 
unchanged. 
4. Small bilateral pleural effusions, unchanged on the right and 
slightly 
increased on the left. 
4.  For evaluation of the neck and abdomen please see the 
dedicated CTs which 
were obtained at the same time. 

___ CT a/p
  
IMPRESSION: 
  
  
1. No source of infection identified in the abdomen or pelvis. 
2. Mild perisplenic and perihepatic ascites. 
3. Right obturator internus hematoma is not significantly 
changed from ___.  Previously characterized myonecrosis of the 
gluteus maximus 
muscles bilaterally is better appreciated on prior MRI. 
4. Bilateral pars defects at L5-S1 with associated mild grade 1 
anterolisthesis. 

___ MR head
IMPRESSION: 
  
  
1. In the cortex of the right posterior frontal and parietal 
regions are 
signal abnormalities which are likely chronic infarcts seen on 
the previous CT 
of ___ 
2. Leukoaraiosis is demonstrated in theperiventricular white 
matter. 
3. Increased FLAIR signal along the sulci of both cerebral 
hemispheres is a 
nonspecific finding and could be related to supplemental oxygen 
therapy or 
less likely due to meningitis.  Correlation with CSF findings 
recommended. 
4. No evidence of infarction, hemorrhage, edema, mass or mass 
effect. 

___ EEG
IMPRESSION: This is an abnormal continuous ICU EEG monitoring 
study due to: 
  
1) Frequent broad-based blunted generalized discharges with a 
triphasic 
appearance, which are often periodic and often have a rhythmic 
delta component 
(GPD+R), which can be seen in setting of etiology-nonspecific 
encephalopathies, but may be suggestive of diffuse cortical 
hyperexcitability 
with potential to evolve to seizures. 
  
2) Burst suppression pattern, slowing, and disorganization of 
the background, 
which is suggestive of a severe global encephalopathy that is 
nonspecific as 
etiology but causes can include medications/sedation, global 
hypoxic ischemic 
injuries. By the end of the recording, the background 
transitions to diffuse 
continuous slowing, which may be secondary to weaning of 
sedation but is 
suggestive of a severe encephalopathy. 
  
The pushbutton events show no changes in the EEG background or 
electrographic 
seizure correlate. No areas of focal slowing or electrographic 
seizures are 
seen. 

___ GJ
IMPRESSION:  
  
Successful placement of a ___ extension 
gastrojejunostomy tube 
with its tip in the proximal jejunum.  The catheter can be used 
immediately. 

___ CT chest
IMPRESSION:  
  
1.  Findings in keeping with diffuse alveolar damage with 
interval clearance 
of the exudative/edematous phase and is now transitioning into 
the fibrotic 
phase. 
2.  Ground-glass changes with an anterior posterior graded is 
nonspecific and 
may represent interstitial edema, or may represent active 
inflammatory changes 
(organizing phase which could progress to further fibrosis). 
3.  Multiple confluent fibrotic nodules are also noted, which 
could be 
followed to establish benignity.  No superimposed airspace 
consolidation to 
suggest pneumonia. 
4.  The trachea appears widened in the coronal diameter and 
tracheobronchomalacia should be excluded. 
5.  Relative hypodensity of the blood pool suggesting anemia. 

 
Brief Hospital Course:
Mr. ___ is a ___ year old male with history of DM, HLD, HTN, 
AAA s/p EVAR ___, ___, who presented with PAU at the 
top of the prior stent graft at level of renals.  He went to the 
OR on ___ for a PMEG.  Postoperatively, he did fine and was 
transferred to the VICU.  He had an episode of presumed 
aspiration and subsequent respiratory failure.  He was 
transferred to the ___ where he was treated for ARDS.  He 
remained intubated and sedated.  He was on intermittent 
pressors.  He was treated with CVVH. He was also treated with 
broad spectrum antibiotics for pneumonia. He went to the OR on 
___ for a trach and PEG.  

Neuro: Patient had difficulties with vent dysychrony and 
overbreathing on the ventilator, requiring multiple different 
sedation regimens, including midazolam, precedex, dilaudid, 
Haldol, propofol. He had no reliable neuro exam while on 
sedation. After he was stabilized on pressure support, he was 
weaned off of sedation and neuro exam improved to withdrawal to 
pain and some spontaneous movement of the face and left upper 
extremity. Psych was consulted for assistance in sedation 
management as patient had a significant history of anxiety. He 
also had several CT scans of the head due to poor mental status 
and ultimately an MRI, which showed an old infarct but nothing 
to explain his poor mental status. There was some questionable 
sign of meningitis on the MRI, which subsequently led to an LP 
being performed on ___, which was negative for bacterial 
and HSV infections. EEG showed moderate to severe encephalopathy 
and later on new generalized periodic discharged for which he 
was started on keppra on ___. Neurology service was 
consulted to help us manage these issues. 

During the week of ___, the patient's neuro exam was of 
spontaneous movement of all four extremities; he did not follow 
commands or track. Given agitation, he was started on Seroquel 
on ___. 

Cardiovascular: Patient had aflutter/afib requiring diltiazem 
drip and heparin drips. He was intermittently on prn metoprolol 
and was on pressors for most of his icu course, which was 
eventually weaned off. He underwent a TEE to rule out culture 
negative endocarditis, which was negative.

During the week of ___, the patient was transitioned from 
diltizem drip to po diltiazem. His po regimen was uptitrated due 
to continued Afib/flutter with rate in the 110's-130's. He had a 
brief 4 hour period where he converted to sinus rhythm on 
___, however, he went back into Afib/flutter with poor rate 
control. Hence, cardiology was reconsulted. During this week, a 
bridge from heparin gtt to Coumadin was started.  

Pulmonary: Patient experienced an aspiration event which led to 
development of ARDS and pneumonia. He subsequently reaspirated 
while in the ICU and intubated due to high tube feed residuals 
which worsened his ARDS. He received a trach/peg on ___ due 
to prolonged intubation. He required paralysis for a brief 
period due to respiratory acidosis and overbreathing on the 
ventilator while on pressure support. He was ultimately 
stabilized on pressure support. Pulmonary was consulted to help 
us with management of these issues, and predicted that he would 
have a prolonged period on the ventilator, likely several 
months. 

GI: After receiving his trach/peg, he was fed through TFs until 
he aspirated even with the Gtube to gravity on ___. TFs were 
then stopped and he was started on TPN. He was eventually 
restarted on ___ of TFs with no residuals, followed by 
an exchange to a GJ with ___ to allow for distal feeding on 
___. His tube feeds via the J-limb were increased to goal 
and were tolerated well without any aspiration events. 

Renal: Patient developed ATN and CRRT was initiated to help with 
fluid removal to optimize his pulmonary status. He was trialed 
off of CRRT twice, which was not well tolerated. He eventually 
started making more urine even while on CRRT. Renal was 
consulted to help with management.

A tunneled dialysis catheter was placed on ___ in planning 
for intermittent HD. 

ID: Patient was treated with two courses of antibiotics for 
aspiration pneumonia. He was on vanc/zosyn from ___ and 
linezolid/zosyn (___). He was briefly on micafungin, which 
was discontinued after cultures were negative and the BDglucan 
was felt to be a contaminate. Other than pneumonia, no other 
sources of infection were ultimately identified. ID consult was 
obtained to assist us with these issues.

During the week of ___, there were no infectious disease 
related issues. 

Week of ___:
- patient was found to have ___ fungemia--> lines were 
removed and micafungin was started and transitioned to 
fluconazole po once sensitivities resulted; ophthalmology was 
consulted with the following comments: ""His anterior chamber is 
quiet without evidence of anterior inflammation. Dilated exam at 
bedside limited in view of peripheral retina due to patient 
cooperation, but there is a clear view to the posterior pole. He 
does have an exudate in the macula of his right eye and a small 
spot of peripapillary hemorrhage in the left eye, which may be 
related to his HTN and T2DM.  To be safe, will follow up with 
dilated exam in 1 week; please page sooner if there is any 
change in external exam or if the patient complains of any 
visual symptoms.

- underwent TTE/cardioversion on ___ with successful 
cardioversion to sinus tachycardia

- patient tolerated increasing periods of time off of ventilator

Week of ___:
- started to follow commands, smiled when providers walked in 
and said ""hi""
- tolerated tube feeds via J tube
- stayed on trach mask with no vent requirements
- worked with speech therapy, who fitted speech valve --> not to 
be used for >10 minutes, needs to have constant healthcare 
provider supervision when speaking valve in place, MAY NOT take 
anything PO

 
Medications on Admission:
vitamin D, hydrochlorothiazide, p.r.n. lorazepam, and bupropion
 
Discharge Medications:
1.  Aspirin 81 mg PO DAILY  
2.  BuPROPion 150 mg PO BID  
3.  Fluconazole 400 mg PO Q24H  
4.  Furosemide 40 mg PO BID  
5.  Glucagon 1 mg IM Q15MIN:PRN hypoglycemia protocol  
6.  Glucose Gel 15 g PO PRN hypoglycemia protocol  
7.  Heparin Dwell (1000 Units/mL) 1000-4000 UNIT DWELL PRN 
Arterial Lumen 
Dwell to CATH Volume  
8.  Heparin Dwell (1000 Units/mL) 1000-4000 UNIT DWELL PRN 
Venous Lumen 
Dwell to CATH Volume  
9.  Insulin SC 
      Sliding Scale

Fingerstick q6
Insulin SC Sliding Scale using REG Insulin 
10.  Lansoprazole Oral Disintegrating Tab 30 mg PO DAILY  
11.  Metoprolol Tartrate 50 mg PO Q6H  
12.  Multivitamins W/minerals Chewable 1 TAB PO DAILY  
13.  QUEtiapine Fumarate 100 mg PO QHS insomnia / delirium  
14.  Simethicone 40-80 mg PO QID:PRN gas pain  
15.  Vitamin D 1000 UNIT PO DAILY  

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
Penetrating aortic ulcer
pneumonia
respiratory failure
ARDS
encephalopathy
renal failure
 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Lethargic but arousable.
Activity Status: Out of Bed with assistance to chair or 
wheelchair.

 
Discharge Instructions:
Mr. ___, we appreciate your perseverance and patience with 
us. While you came into the hospital for the repair of a 
penetrating aortic ulcer and were set to be discharge home, 
there was a complication that required you to be intubated and 
transferred to the intensive care unit. Once you were better, we 
continued your care in the ICU. Now, you are stable for 
discharge to rehab. 
 
Followup Instructions:
___
"
11783215-DS-18," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
___
 
Attending: ___.
 
Chief Complaint:
Weakness
 
Major Surgical or Invasive Procedure:
None
 
History of Present Illness:
___ with PMHx as below presents with c/f rhabdomyolysis. She 
presented to her PCP complaining of ___ 
weakness for approximately 1 week, and on ROS noted mild 
hematuria. The patient reports that over the last 9 days, she 
has developed progressive b/l shoulder weakness and hip 
weakness. She reports that up until ___ she was continuing her 
typical three days per week working out, and had not done any 
more exercise than usual. She woke up on ___ with significant 
girdle weakness so much so that it has been difficult for her to 
walk. She has denied any pain and very little stiffness. 
Otherwise no fevers/chills, cp, diarrhea, melena, rectal 
bleeding. She is on a statin which was stopped two days prior to 
this admission due to the muscle weakness.  
 She saw her nephrologist on ___, who she follows for CKD ___ 
DM, and was told that her creatinine was up from 3.0 to 3.7. In 
the setting of this weakness, her nephrologist suggested that 
she see her PCP. She saw her PCP, ___, on ___. Her PCP 
felt that this presentation was consistent with PMR, so they 
sent a set of labs including an ESR which was elevated to 58, 
and a CRP which was normal. They recommended drinking lots of 
water, stopping crestor, and calling if she did not improve. She 
did not improve, so decision as made to present to the ED.  
 In the ED, initial vitals: 99.2 99 154/71 18 99% RA  
 - Exam notable for: well-appearing, no limb swelling, mild hip 
flexor weakness but equal bilaterally t/o  
 - Labs notable for: CK 9561, creatinine 4.8 (baseline in ___ 
of 3.0), BUN 96, bicarb 16 (AG 20), H/H 9.1/30.4, WBC 8.8, UA 
mod leuk, mod blood, 27 WBC, 1 epi ALT 258, AST 280.  
 - Imaging notable for: none  
 - Patient given: IVF  
 - Vitals prior to transfer: 98.3 88 127/70 16 98% RA  
 
 On arrival to the floor, pt reports persistent hip flexor and 
shoulder weakness, strength relatively intact in other more 
distal motor groups. She denies pain or stiffness. Denies 
fevers/chills, other notable symptoms (as above)  

 
Past Medical History:
T2DM  
 ALLERGIC RHINITIS  
 ANEMIA  
 - PROB THAL MINOR  
 AORTIC SCLEROSIS  
 ASTHMA  
 BENIGN POSITIONAL VERTIGO  
 CATARACT  
 CHRONIC KIDNEY DISEASE STAGE IV
 L KIDNEY MASS (?papillary renal cell carcinoma)  
 ECZEMA  
 GOUT  
 HYPERCHOLESTEROLEMIA  
 HYPERTENSION  
 MITRAL REGURGITATION  
 OBESITY  
 OSTEOARTHRITIS  
 HIP-BILAT, LT HIP BURSITIS  
 SLEEP APNEA  
 SPINAL STENOSIS  
 VITAMIN D DEFICIENCY  
 RIGHT BUNDLE BRANCH BLOCK    
 STRESS INCONTINENCE  

 
Social History:
___
Family History:
Mother: HYPERTENSION  
Father: ___ DIABETES MELLITUS  
Sister: ___ ENDOMETRIAL CANCER at ___ yrs  

 
Physical Exam:
ADMISSION EXAM:
===============
Vitals: 0739 98.4 131/77 91 18 96% RA  
General: Alert, sitting up in bed attempting to eat breakfast, 
in no acute distress  
HEENT: Sclera anicteric, MMM, oropharynx clear, neck supple, 
EOMI grossly, PERRLA. Some periorbital swelling with mild pink 
coloration. JVP @8cm. No LAD  
Lungs: clear to auscultation bilaterally w/o wheezes, crackles, 
or rhonchi  
CV: tachycardic w/ normal rhythm, normal S1 + S2, no murmurs, 
rubs, gallops  
Abdomen: soft, non-tender, non-distended, bowel sounds present, 
no rebound tenderness or guarding, no organomegaly  
Ext: No tenderness to palpation at the thighs or shoulders. 
Warm, well perfused, no cyanosis or edema. no ___ edema.  
Neuro: CN II-XII grossly intact, strength ___ in UE and ___ 
throughout with exception of deltoid and hip flexors at ___.  
Psych: pleasant affect  

DISCHARGE EXAM:
===============
Vitals: Afebrile, BP 102-112/59-70, 74-90, ___, 96% on RA 
General: Alert, sitting in chair, looking quite  well  
HEENT: Sclera anicteric, MMM, oropharynx clear, neck supple, 
EOMI  
grossly, PERRLA. JVP @8cm. No LAD. Periorbital edema with slight 
pink discoloration of eyelids.  
Lungs: CTAB w/o wheezes, crackles, or rhonchi  
CV: RRR, with loud S2 (loudest at RUSB), with II/VI blowing 
mid-systolic murmur with no radiation, no rubs or gallops  
Abdomen: soft, non-tender, non-distended, bowel sounds present,  

no rebound tenderness or guarding, no organomegaly  
Ext: No tenderness to palpation at the thighs or shoulders. 
Warm,  
well perfused, no cyanosis or edema. no ___ edema.  
Neuro: CN II-XII grossly intact, strength ___ in UE and ___    
Psych: pleasant affect  

 
Pertinent Results:
ADMISSION RESULTS:
==================
___ 09:34PM BLOOD WBC-8.8 RBC-4.22 Hgb-9.1* Hct-30.4* 
MCV-72* MCH-21.6* MCHC-29.9* RDW-22.1* RDWSD-51.4* Plt ___
___ 11:00AM BLOOD UreaN-90* Creat-4.5* Na-142 K-3.5 Cl-103 
HCO3-20* AnGap-23*
___ 11:00AM BLOOD ALT-248* AST-280* ___ 
AlkPhos-87 TotBili-0.3
___ 05:25AM BLOOD SED RATE: 58 

RELEVANT IMAGING:
==================
___ renal US: 

FINDINGS:   
The right kidney measures 9.7 cm.  The left kidney measures 
10.1cm. Kidneys appear echogenic consistent with chronic medical 
renal disease.  Bilateral renal cysts are better assessed on 
prior MRI.  The hypoechoic left renal lesion described on prior 
MRI as ""Concerning for papillary renal cell carcinoma"" is 
visualized measuring approximately 1.9 x 1.5 x 1.8 cm.  There is 
no hydronephrosis.  Bladder is decompressed. 
  
IMPRESSION:    
Echogenic kidney most consistent with chronic medical renal 
disease.  Simple cysts and left renal interpolar lesion 
measuring 1.9 x 1.5 x 1.8 cm

___ thigh MRI:
FINDINGS:   
Muscles: Mild fluid signal is seen throughout the musculature 
bilateral 
thighs, greatest involving the rectus femoris muscles, left 
greater than 
right, as well as the right vastus lateralis and bilateral 
hamstring muscles. These findings are consist with myopathy.   
Bone marrow: No abnormal marrow signal.  
Other: Bilateral hamstring origin complexes appear grossly 
intact.   
Visualized intrapelvic soft tissues appear grossly unremarkable. 

  
IMPRESSION:  
Mild muscle edema throughout bilateral thigh musculature greater 
in the rectus femoris muscles, left greater than right. These 
findings may be seen in a statin-induced myopathy. 

DISCHARGE RESULTS:
===================
___ 05:45AM BLOOD WBC-7.4 RBC-3.92 Hgb-8.6* Hct-28.0* 
MCV-71* MCH-21.9* MCHC-30.7* RDW-22.1* RDWSD-51.8* Plt ___
___ 05:45AM BLOOD Glucose-125* UreaN-60* Creat-3.0* Na-143 
K-4.5 Cl-109* HCO3-19* AnGap-20
___ 05:45AM BLOOD ALT-130* AST-71* CK(CPK)-1256*     
 
Brief Hospital Course:
___ y/o woman with stage IV CKD ___ T2DM, and likely renal cell 
carcinoma, presentedwith 9d of proximal muscle weakness, found 
to have acute on chronic kidney injury in the setting of 
rhabdomyolysis of unclear etiology. ___ and ___ resolved with 
IVF.

#Muscle weakness: CK elevated to ~10k with elevated ALT/AST (low 
Alk Phos), both downtrended and her weakness improved with only 
d/c-ing statin and IVF. ESR was also elevated to 58 on ___, 
downtrended to 32 on ___. CRP remained normal. Rheumatology 
was consulted and felt her presentation was most likely 
statin-related myopathy, however they could not exclude 
inflammatory myopathy without a muscle biopsy. Their suspicion 
for inflammatory myopathy was increased due to her periorbital 
edema (although pt states this is chronic), as well as her 
?renal cell carcinoma. Of note, pt reports being up to date with 
colonoscopy, mammogram, and pap smear, with no reported evidence 
of malignant or premalignant lesions. She was discharged with 
improved weakness, and plan for muscle outpatient biopsy. 

___ on CKD: CKD reportedly ___ T2DM, baseline Cr ~3. ___ could 
be from myoglobinuria. FeNa ~ 60%--likely intrinsic renal given 
hx of CKD and recent myoglobinuria which could lead to ATN. 
Pre-renal cause seems unlikely given pt does not appear 
hypovolemic and increased FeNA. Post-renal obstruction seems 
unlikely given pt reports good urine output w/ no changes from 
baseline, and US with no hydronephrosis. Cr down to 3 on 
discharge.

#HTN: given ___ and ___, held HCTZ and losartan. Continued 
verapamil. BP was well-controlled (SBP 110s) on verapamil only, 
so she was instructed to continue holding HCTZ and losartan 
pending PCP ___.

#H/o gout  
- continue allopurinol at lower dose (100 mg every third day) 
due to GFR now 9.  

#Anemia: chronic, thought to be due to thal minor.  

#DM: Home glipizide was held and pt was maintained on Humalog 
sliding scale.

TRANSITIONAL ISSUES:
====================
-Losartan and HCTZ stopped. Check BP and electrolytes and 
restart as needed.
-Check chemistry to ___ on renal function
-Rheumatology recommending muscle biopsy to r/o inflammatory 
myositis. This was scheduled with surgery. Please discuss this 
with patient.
-Pt has rheumatology follow-up scheduled
-Will still need ___ MRI for known L renal mass
-If renal function worsens, may need dose adjustment of 
allopurinol

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Losartan Potassium 100 mg PO DAILY 
2. Sodium Bicarbonate 650 mg PO BID 
3. Desonide 0.05% Cream 1 Appl TP BID 
4. Hydrocortisone Cream 1% 1 Appl TP DAILY:PRN rash 
5. azelastine 0.15 % (205.5 mcg) nasal BID:PRN 
6. Allopurinol ___ mg PO DAILY 
7. Verapamil SR 240 mg PO Q24H 
8. Fluticasone Propionate NASAL 1 SPRY NU BID 
9. PrednisoLONE Acetate 0.12% Ophth. Susp. 1 DROP BOTH EYES TID 
10. darbepoetin alfa in polysorbat 150 mcg/0.3 mL injection q4-6 
weeks 
11. mometasone 200 mcg/actuation inhalation BID 
12. Fexofenadine 60 mg PO DAILY:PRN allergic symptoms 
13. GlipiZIDE 2.5 mg PO DAILY 
14. Hydrochlorothiazide 25 mg PO DAILY 
15. Calcitriol 0.25 mcg PO 1X/WEEK (___) 
16. Vitamin D ___ UNIT PO DAILY 

 
Discharge Medications:
1.  Allopurinol ___ mg PO EVERY OTHER DAY 
RX *allopurinol ___ mg 1 tablet(s) by mouth every  other day 
Disp #*30 Tablet Refills:*0 
2.  azelastine 0.15 % (205.5 mcg) nasal BID:PRN  
3.  Calcitriol 0.25 mcg PO 1X/WEEK (___)  
4.  darbepoetin alfa in polysorbat 150 mcg/0.3 mL injection q4-6 
weeks  
5.  Desonide 0.05% Cream 1 Appl TP BID  
6.  Fexofenadine 60 mg PO DAILY:PRN allergic symptoms  
7.  Fluticasone Propionate NASAL 1 SPRY NU BID  
8.  GlipiZIDE 2.5 mg PO DAILY  
9.  Hydrocortisone Cream 1% 1 Appl TP DAILY:PRN rash  
10.  mometasone 200 mcg/actuation inhalation BID  
11.  PrednisoLONE Acetate 0.12% Ophth. Susp. 1 DROP BOTH EYES 
TID  
12.  Sodium Bicarbonate 650 mg PO BID  
13.  Verapamil SR 240 mg PO Q24H  
14.  Vitamin D ___ UNIT PO DAILY  
15. HELD- Hydrochlorothiazide 25 mg PO DAILY  This medication 
was held. Do not restart Hydrochlorothiazide until you speak 
with your PCP
16. HELD- Losartan Potassium 100 mg PO DAILY  This medication 
was held. Do not restart Losartan Potassium until you speak with 
your PCP

 
___:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
Acute Renal Failure
Rhabdomyolysis

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___,

You came to the hospital with weakness and injury to your 
kidneys. We did tests that showed the most likely cause of your 
weakness and kidney dysfunction was your muscle injury. By the 
time of discharge, your kidney function had returned to its 
baseline before coming to the hospital.

We think your muscle injury is most likely related to the 
rosuvastatin (Crestor) you were taking, however, in order to be 
sure that it wasn't a different cause, we recommend that you 
consider a muscle biopsy and discuss with rheumatology what 
further treatment might be needed.

It was a pleasure being involved in your care.

Your ___ Team 
 
Followup Instructions:
___
"
11838076-DS-20," 
Name:  ___                    Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
chest pain, cough 
 
Major Surgical or Invasive Procedure:
Cardiac Catheterization (___)

 
History of Present Illness:
Mr. ___ is an ___ ___ speaking man who presented
___ to ___ with 4 days of chest pain and
cough. Patient without any known medical problems although has
not seen a doctor in decades. On presentation was afebrile, HR
___, BPs 170s/90s, O2 sat 93% RA. EKG showed STD in v4-v5, loss
of R waves in precordial leads, no prior for comparison. 
Troponin
was 0.77. which uptrended to ___ yesterday afternoon and then
2.96 this morning. He was started heparin gtt, statin, aspirin.
He had an echo that showed inferior wall hypokinesis. He also 
had
a CXR with pulmonary edema and received 20 mg IV Lasix ___ and
another 20 mg ___.

At 11AM today, patient developed respiratory distress, CP, chest
pressure with vitals: BP 190/70, O2 sat in ___, placed on 4L to
100%. Nitro paste was given and pressure and pain improved. EKG
showed blocked PACs. Patient transferred to ___ for cath. Out
of concern for imminent decompensation, he was sent to the CCU
for stabilization prior to cath. 
 
OSH studies:

___ NCHCT: Study blurred by patient motion with changes
consistent with small vessel ischemic disease with atrophy, but
no apparent acute intracranial abnormality. 

TTE reportedly with inferior wall hypokinesis but no official
read available on OMR

On arrival to the CCU, patient initially with eyes open but not
making eye contact and not speaking to ___ interpreter.
More responsive with family 30 minutes later. Conversant but
confused, stating that he believes he is in a kitchen. A&Ox3.
Family also states that believe he has new facial droop for the
past 24 hours. Neurology was STAT paged out of concern for
stroke. However, code stroke not called because out of 24 hour
window.  

 
Past Medical History:
No past medical history (had not seen physician ___ ___ years)
 
Social History:
___
Family History:
Non-contributory. 
 
Physical Exam:
ADMISSION PHYSICAL EXAMINATION:  
==============================
GENERAL: Elderly cachectic appearing man lying in bed. 
Conversant
with family at bedside. A&Ox1.  
HEENT: Normocephalic, atraumatic. Sclera anicteric. PERRL. EOMI. 

CARDIAC: Normal rate, regular rhythm. No murmurs, rubs, or
gallops. Nitro paste in place on chest.
LUNGS: No accessory muscle use. Poor air entry throughout. 
ABDOMEN: Soft, non-tender, non-distended. No palpable
hepatomegaly or splenomegaly.  
EXTREMITIES: Warm, well perfused. No clubbing, cyanosis, or
peripheral edema.  
SKIN: No significant lesions or rashes.   
NEURO: Subtle left sided facial droop. Moving all extremities
equally.  

DISCHARGE PHYSICAL EXAM
========================
24 HR Data (last updated ___ @ 1514)
    Temp: 97.4 (Tm 98.2), BP: 139/51 (117-151/51-60), HR: 53
(49-78), RR: 24 (___), O2 sat: 97% (94-97), O2 delivery: Ra,
Wt: 113.1 lb/51.3 kg  

Fluid Balance (last updated ___ @ 1450) 
  Last 8 hours No data found
  Last 24 hours  Total cumulative -75ml
    IN: Total 350ml, PO Amt 350ml
    OUT:  Total 425ml, Urine Amt 425ml      OUT:  Total 355ml,
Urine Amt 355ml, Bowel Amt 0ml  
 
General: Sitting in bed, in NAD. 
HEENT: NC/AT, sclera-nonicteric
Lungs: Clear to auscultation bilaterally, no wheezes rhonchi or
crackles
Heart: RRR, ___ systolic murmur heard best at apex
Extremities: WWP, no c/c/e
Neuro: 
- No focal abnormalities 
- Moving all 4 extremities with purpose
- Face symmetric
 
Pertinent Results:
ADMISSION LABS:
=============================
___ 01:45PM BLOOD WBC-6.9 RBC-4.79 Hgb-14.1 Hct-45.0 MCV-94 
MCH-29.4 MCHC-31.3* RDW-13.0 RDWSD-44.8 Plt ___
___ 01:45PM BLOOD ___ PTT-34.9 ___
___ 01:45PM BLOOD Glucose-178* UreaN-25* Creat-1.6* Na-144 
K-3.9 Cl-96 HCO3-35* AnGap-13
___ 01:45PM BLOOD ALT-22 AST-33 CK(CPK)-196 AlkPhos-66 
TotBili-1.2
___ 01:45PM BLOOD CK-MB-10 MB Indx-5.1 cTropnT-0.68*
___ 01:45PM BLOOD Albumin-3.7 Calcium-8.6 Phos-4.4 Mg-1.9 
Cholest-169
___ 01:45PM BLOOD VitB12-222* Folate-18
___ 01:45PM BLOOD Triglyc-102 HDL-61 CHOL/HD-2.8 LDLcalc-88
___ 01:45PM BLOOD TSH-1.0
___ 02:26PM BLOOD ___ pO2-45* pCO2-75* pH-7.32* 
calTCO2-40* Base XS-8
___ 02:26PM BLOOD Lactate-1.5

DISCHARGE LABS:
=============================
___ 05:05PM BLOOD WBC-5.4 RBC-3.97* Hgb-12.2* Hct-37.5* 
MCV-95 MCH-30.7 MCHC-32.5 RDW-13.2 RDWSD-45.3 Plt ___
___ 05:05PM BLOOD Plt ___
___ 05:05PM BLOOD Glucose-237* UreaN-27* Creat-1.5* Na-142 
K-5.1 Cl-103 HCO3-30 AnGap-9*
___ 05:05PM BLOOD Calcium-8.1* Phos-4.1 Mg-2.1

IMAGES/RESULTS:
=============================
MRI HEAD WITHOUT CONTRAST ___: 
IMPRESSION: 
1. Incomplete examination with only a few sequences obtained, 
with obtained 
sequences demonstrating severe motion degradation. 
2. Within these confines, there is no definite evidence of focal 
slowed 
diffusion to suggest large acute infarction. 
3. Repeat imaging could be attempted if/when the patient is 
better able to 
tolerate examination. 

CARDIAC CATH ___:
The coronary circulation is right dominant.
LM: The Left Main, arising from the left cusp, is a small 
caliber vessel. This vessel bifurcates into the
Left Anterior Descending and Left Circumflex systems. There is a 
60% stenosis in the proximal, mid,
and distal segments. There is severe calcification in the mid 
segment extending to the distal third of the
LAD.
LAD: The Left Anterior Descending artery, which arises from the 
LM, is a small caliber vessel. There is
mild tortuosity beginning in the proximal segment. There is a 
90% stenosis in the proximal segment.
There is a 90% stenosis in the proximal, mid segment a nd distal 
segments (serial lesions) and the
remaining of the vessel has severe diffuse disease. The vessel 
is heavily calcified.
Cx: The Circumflex artery, which arises from the LM, is a very 
small caliber vessel. There is mild tortuosity beginning in the 
mid segment. There is a 99% stenosis in the mid segment.
The Obtuse Marginal, arising from the mid segment, is a very 
small caliber vessel.
RCA: The Right Coronary Artery, arising from the right cusp, is 
a medium caliber vessel. There is a
70% stenosis in the proximal segment. There is an 80% stenosis 
in the distal segment.

TTE ___
CONCLUSION: The left atrial volume index is normal. There is 
mild symmetric left ventricular hypertrophy with a normal cavity 
size. There is moderate regional left ventricular systolic 
dysfunction with near akinesis of the inferior and inferolateral 
walls (see schematic) and preserved/normal contractility of the 
remaining segments. Quantitative biplane left ventricular 
ejection fraction is 31 %. Due to severity of mitral 
regurgitation, intrinsic left ventricular systolic function 
likely be lower. Left ventricular cardiac index is normal (>2.5 
L/min/m2). There is no resting left ventricular outflow tract 
gradient. Tissue Doppler suggests an increased left ventricular 
filling pressure (PCWP greater than 18mmHg). Normal right 
ventricular cavity size with normal free wall motion. The aortic 
sinus diameter is normal for gender with normal ascending aorta 
diameter for gender. The aortic arch diameter is normal with a 
normal descending aorta diameter. The aortic valve leaflets (3) 
are mildly thickened. There is no aortic valve stenosis. There 
is mild [1+] aortic regurgitation. The mitral valve leaflets are 
mildly thickened with no mitral valve prolapse. There is 
moderate [2+] mitral regurgitation. The tricuspid valve leaflets 
appear structurally normal. There is mild [1+] tricuspid 
regurgitation. There is moderate pulmonary artery systolic 
hypertension. There is a small circumferential pericardial 
effusion. There are no 2D or Doppler echocardiographic evidence 
of tamponade. A left pleural effusion is present. 
IMPRESSION: Mild symmetric left ventricular hypertrophy with 
mild regional systolic dysfunction most consistent with single 
vessel coronary artery disease (PDA distribution). Moderate 
mitral regurgitation most likely due to papillary muscle 
dysfunction. Moderate pulmonary artery systolic hypertension. 
Small circumferential pericardial effusion without 
echocardiographic evidence for tamponade physiology.

HEAD CT WITHOUT CONTRAST ___
FINDINGS:  
  
There is no evidence of infarction, hemorrhage, edema, or mass.  
The 
ventricles and sulci are normal in size and configuration. 
  
There is no evidence of fracture.  The visualized portion of the 
paranasal 
sinuses, mastoid air cells, and middle ear cavities are clear.  
The visualized 
portion of the orbits are unremarkable.  Multiple EEG leads 
appreciated. ICA calc.   
IMPRESSION:   
1. No evidence of infarct, hemorrhage, edema.

CAROTID SERIES ___
IMPRESSION:  
Bilateral ___ ICA stenosis 
Antegrade vertebral flow 

EEG ___
IMPRESSION: This is an abnormal continuous ICU EEG monitoring 
study because of mild background slowing that is nonspecific as 
to etiology, but Common causes are medication effect, 
infections, or toxic/metabolic disturbances. 
There was also focal intermittent slowing in the left temporal 
region, 
indicative of subcortical dysfunction in that region. Compared 
to the prior day's recording, focal intermittent slowing in the 
left temporal region is better appreciated. 

CT HEAD ___
IMPRESSION:  
No evidence of mass, hemorrhage or infarction. 
Atrophy with white matter changes suggesting chronic small 
vessel schemia. 
  

EEG ___
IMPRESSION: This is an abnormal continuous ICU EEG monitoring 
study because  of a slow background activity, consistent with a 
mild to moderate 
encephalopathy that is nonspecific as to etiology. Common causes 
are 
medication effect, infections, or toxic/metabolic disturbances. 
There was no  focal slowing, or epileptiform discharges. 

 

 
Brief Hospital Course:
PATIENT SUMMARY
=====================
___ with no known PMH, minimal medical care admitted for NSTEMI 
and echo with wall motion abnormalities. Cath ___ with 
multi-vessel disease for which he will have CABG down the road. 
Hospital course complicated by multifactorial encephalopathy 
(toxic-metabolic, UTI, ?underlying dementia). Guardianship 
pursued during this hospitalization due to confusion. 

#CORONARIES: 3v CAD, 60% ___, mid, distal LMCA, 90% ___, mid, 
distal LAD (serial lesions),diffuse LAD disease (heavily 
calcified), 70% ___ RCA, 80% distal RCA, 99% mid LCX
#PUMP: near akinesis of inferior and inferolateral walls, EF 31%
#RHYTHM: pAF, mostly NSR, intermittently bradycardic

ACUTE ISSUES
=================
#NSTEMI
#Multivessel CAD
#HFrEF (31%)
Heart failure diagnosis is new this admission, ischemic etiology 
in setting of multivessel CAD. Will be worked up as an 
outpatient for possible CABG. TTE showed near akinesis of the 
inferior and inferolateral walls, EF 31%. Cath ___: 3v CAD, 70% 
___ RCA, 80% distal RCA, 99% mid LCX up to 90% diffuse LAD 
disease. Attempted to optimize medical therapy while waiting for 
guardianship for discharge to rehab while awaing CABG. 
Unfortunately had to discontinue ___ (and cannot give ___ in 
setting of worsening kidney function. Carvedilol could not be 
uptitrated in the setting of bradycardia. Did not start 
spironolactone in setting of borderline elevated potassium. 
Uptitrated imdur as tolerated, with plan to possibly add on 
hydral for better blood pressure control. This was not started 
during the hospitalization because blood pressures were 
acceptable (130s systolic) and simplification of medications was 
emphasized. Patient also intermittently refused medications in 
the setting of delirium as below.

#pAF
Seen overnight on tele, reverted to sinus by AM of ___, and 
remained in sinus. Started on apixaban renal dosing. 

#HTN
Hypertensive to 150s-160s in setting of intermittently refusing 
medications. Tolerated uptitration of imdur as above. Could not 
start spironolactone, ___ as above in setting of kidney 
function. Considered adding hydralazine, but opted for 
toleration of higher blood pressures and simplicity of 
medication administration given patient refusal of medications. 

#UTI
#Leukocytosis
No growth on urine cultures, although urine with bacteria. S/p 7 
day course of ceftriaxone during this hospitalization. 

#Altered mental status
Negative seizure and stroke workup, felt Likely multifactorial: 
toxic/metabolic iso UTI, delirium, and unknown dementia 
baseline. Waxing and waning hypoactive to hyperactive delirium, 
and he was intermittently refusing meds. Telemetry was 
discontinued and lab draws were minimized to minimize delirium. 
Since workup of treatable causes of delirium were negative, it 
is thought that his confusion is delirium in the setting of 
hospitalization, worsened by language barrier, with a component 
of toxic metabolic due to UTI as above. Initially he did not 
have an official healthcare proxy, so guardianship was pursued 
because he would be unable to consent for necessary rehab. 
However he stablizied medically, and was able to name ___ 
healthcare proxy on ___. He was therefore discharged home with 
services, and was intermittently confused on discharge. 

___
Creatinine 1.6 on admission, baseline unclear. Initially trended 
down, nadir 1.2, max 1.7 this admission. Likely pre-renal iso 
poor PO intake and reduced EF. 

#Goals of care
Unclear if CABG is within his goals of care, and with 
intermittent confusion, difficult to elicit wishes. Healthcare 
proxy named this hospitalization. Guardianship hearing ___. 

#Hematuria
Noted on urinalysis for workup for UTI. Hemoglobin stable 
throughout hospitalization. 

TRANSITIONAL ISSUES:
====================
--- Discharge weight: 51.3 kg (113.1 lbs)
--- Discharge creatinine: 1.5
--- Discharge potassium: 5.1
(Labs drawn 3 days before discharge)

[ ] Can start lisinopril 5mg daily as outpatient once renal 
function recovers to baseline.
[ ] Has appointment for follow-up with cardiac surgeon Dr. 
___ discharge
[ ] Has appointment for urology outpatient follow-up for 
hematuria
[ ] Needs appointment for follow-up with cardiology

#Code: Full
#Contact: Daughter ___ ___ Grandson ___ 
___ Niece ___: ___ Son ___: ___
 
___ on Admission:
No preadmission medications

 
Discharge Medications:
1.  amLODIPine 10 mg PO DAILY 
RX *amlodipine 10 mg 1 tablet(s) by mouth daily Disp #*30 Tablet 
Refills:*0 
2.  Apixaban 2.5 mg PO BID 
RX *apixaban [Eliquis] 2.5 mg 1 tablet(s) by mouth twice daily 
Disp #*60 Tablet Refills:*0 
3.  Aspirin 81 mg PO DAILY 
RX *aspirin 81 mg 1 tablet(s) by mouth daily Disp #*30 Tablet 
Refills:*0 
4.  Atorvastatin 80 mg PO QPM 
RX *atorvastatin 80 mg 1 tablet(s) by mouth daily Disp #*30 
Tablet Refills:*0 
5.  Carvedilol 3.125 mg PO BID 
RX *carvedilol 3.125 mg 1 tablet(s) by mouth twice daily Disp 
#*60 Tablet Refills:*0 
6.  Isosorbide Mononitrate (Extended Release) 120 mg PO DAILY 
RX *isosorbide mononitrate 120 mg 1 tablet(s) by mouth daily 
Disp #*30 Tablet Refills:*0 
7.  Multivitamins 1 TAB PO DAILY 
RX *multivitamin  1 tablet(s) by mouth daily Disp #*30 Tablet 
Refills:*0 

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
PRIMARY DIAGNOSIS:
================
Non ST-segment elevation myocardial infarction 
Coronary artery disease

SECONDARY DIAGNOSIS:
====================
Altered mental status 
Acute kidney injury 

 
Discharge Condition:
Mental Status: Confused - sometimes.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Mr. ___,  

It was a pleasure caring for you at ___.  

WHY WAS I IN THE HOSPITAL?  
==========================  
 - You were admitted because you had a heart attack  

 WHAT HAPPENED IN THE HOSPITAL?  
==============================  
- Your heart arteries were examined (cardiac catheterization) 
which showed narrowing of multiple arteries. No stents were 
placed, because it would be better for you to have surgery on 
your heart arteries. 
- You had some confusion concerning for neurologic changes. Head 
imaging (CAT SCAN and MRI) did not show acute stroke or bleed, 
and blood tests didn't show any clear cause for your confusion. 
People often become confused in the hospital when they are in 
unfamiliar surroundings (delirium). 
 
 WHAT SHOULD I DO WHEN I GO HOME?  
 ================================  
- Please take all your prescribed medications as scheduled.
- Please attend any follow-up appointments you have. You have a 
list of appointments below. 
- Please weigh yourself every day. Your weight on day of 
discharge is 113 lbs. If your weight goes up by more than 3 lbs 
in 24 hours, call your doctor. 

Thank you for allowing us to be involved in your care, we wish 
you all the best!  
- Your ___ Healthcare Team  
 
Followup Instructions:
___
"
11997336-DS-3," 
Name:  ___            Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Codeine / Percodan / Morphine
 
Attending: ___
 
Chief Complaint:
shortness of breath
 
Major Surgical or Invasive Procedure:
___ cardiac catheterization

 
History of Present Illness:
Mrs ___ is a ___ female patient with a significant 
past medical history of hypertension, diabetes, and 
hyperlipidemia who was admitted to OSH on ___ after an 
episode of presyncope, associated with shortness of breath, 
nausea, and left-sided rib pain radiating to her back and over 
her umbilicus. The episode occurred when she was cleaning her 
house.  She described the episode as feeling dizzy and cold. On 
questioning she admits to the chest pain and shortness of 
breath.  She described the pain as sharp and ___ in intensity. 
She denies ever experiencing similar chest pain before but 
states that she had a history of injury to her left ribs. She 
admits that her ability to complete daily activities has been 
limited by her fatigue, shortness of breath, and diaphoresis 
over the last year. She believes these symptoms have progressed 
over the last ___ years.  She can no longer walk as far as 
across the street without getting worn out.  She requires daily 
afternoon naps.  She always sleeps on an incline or in a chair 
which she attributes to her shortness of breath and her chronic 
back pain. She is uncertain of recent weight gain or swelling 
but states she has gain at least 20 lbs in the last ___ years. 

In the OSH she was given Demerol and Reglan in the ED with 
relief of her pain and nausea.  She was admitted to telemetry 
and ruled in for a NSTEMI with a peak troponin of 0.40.  She 
underwent a nuclear stress test and was found to have anterior 
and anteroapical perfusion defects with documented LVEF of 74%.  
Due to a complaint of R calf pain she underwent ultrasound which 
revealed no DVT. Pt was then transferred to ___ for cardiac 
catheterization.  
.  
On arrival to the floor after cardiac catheterization, pt denied 
any feelings of chest discomfort, shortness of breath, or 
palpitations.   On her review of systems, she denies any prior 
history of stroke, TIA, deep venous thrombosis, pulmonary 
embolism, bleeding at the time of surgery, cough, hemoptysis, 
black stools or red stools. He denies recent fevers, chills or 
rigors. She denies exertional buttock or calf pain. Cardiac 
review of systems is notable for absence of paroxysmal nocturnal 
dyspnea, palpitations, ankle edema, syncope or presyncope.  

 
Past Medical History:
1) Hypertension
2) Hyperlipidemia
3) Diabetes (non-insulin dependent)
4) Anxiety disorder
5) S/P TAHBSO
6) Seasonal allergies
7) Mitral valve prolapse
8) S/P right foot surgery x 2 for osteomyletis
9) cholecystectomy
___ Rheumatic fever as a child

 
Social History:
___
Family History:
Father had extensive cardiac history. Pt denies any history of 
sudden death or premature cardiac disease in her family.
 
Physical Exam:
VS: T 98.0 BP 141/60 HR 94 RR 20 SpO2 98 %2L
Gen: WDWN middle aged male in NAD. Oriented x3. Mood, affect 
appropriate.  
HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were 
pink, no pallor or cyanosis of the oral mucosa.   
Neck: Supple; no masses, unable to assess JVP  
CV: RR, normal S1, S2. No m/r/g. No S3 or S4.  
Chest: No chest wall deformities, scoliosis or kyphosis. Resp 
were unlabored, no accessory muscle use. CTAB, no crackles, 
wheezes or rhonchi.  
Abd: Soft, NTND. 
Ext:No clubbing or cyanosis.  Trace symmetric BLE edema. 
Skin: No stasis dermatitis or ulcers.  
 
Pertinent Results:
___ Cardiac Cath: 
COMMENTS:     
1. Coronary angiography in this right dominant system 
revealed no angiographically apparent flow-limiting coronary 
artery 
disease. The LMCA, LAD and LCx had no disease. The RCA had a 30% 

proximal stenosis. 
2. Resting hemodynamics revealed elevated left sided and 
right sided filling pressures with LVEDP of 29 mmHg, mean PCW of 
31 
mmHg, and RVEDP of 19 mmHg. There was severe pulmonary arterial 
systolic 
hypertension with PASP of 61 mmHg. There was mild systemic 
arterial 
systolic hypertension with SBP of 147 mmHg. The cardiac index 
was 
preserved at 2.2 L/min/m2. 
3. Left ventriculography revealed 2+ mitral regurgitation. The 
LVEF was 
calculated to be 72% with no wall motion abnormalities. 
4. Succesful closure of femoral access with ___ Angioseal device. 

  
FINAL DIAGNOSIS:     
1. No angiographically apparent flow-limiting coronary artery 
disease. 
2. Normal ventricular function. 
3. Left ventricular diastolic dysfunction. 
4. Mild-moderate mitral regurgitation. 
5. Severe pulmonary arterial systolic hypertension. 
.
___ ECHO: 
The atria are moderately dilated. There is mild symmetric left 
ventricular hypertrophy with normal cavity size and 
regional/global systolic function (LVEF>55%). Right ventricular 
chamber size and free wall motion are normal. The aortic valve 
leaflets (3) are mildly thickened, especially towards the 
leaflet tips (charcteristic of the rheumatic valvulitis 
sequelae), but aortic stenosis is not present. Moderate (2+) 
aortic regurgitation is seen. There is moderate valvular mitral 
stenosis. Due to co-existing aortic regurgitation, the pressure 
half-time estimate of mitral valve area may be an OVERestimation 
of true mitral valve area. Mild to moderate (___) mitral 
regurgitation is seen. [Due to acoustic shadowing, the severity 
of mitral regurgitation may be significantly UNDERestimated.] 
There is moderate pulmonary artery systolic hypertension. There 
is a trivial/physiologic pericardial effusion. 

IMPRESSION: Rheumatic valvular disease with moderate mitral 
stenosis and moderate aortic regurgitation. Mild symmetric left 
ventricular hypertrophy with preserved global and regional 
biventricular systolic function. Moderate pulmonary 
hypertension.  

 
Brief Hospital Course:
___ yo f with hx of HTN, HL, and DM presents to OSH with 
worsening dyspnea on exertion and acute chest pain. She ruled in 
for NSTEMI was transferred to ___ for cardiac catheterization. 

.  
#. CAD: No known diagnosis of CAD on arrival to OSH. Pt has 
multiple risk factors for coronary disease including HTN, HL, DM 
and history of tobacco abuse. Her presentation with SOB, 
atypical chest pain, nausea and diaphoresis were concerning for 
ACS.  Reports from OSH indicate positive cardiac enzymes with a 
troponin of 0.4 (per verbal signout). Stress test also reportly 
had anterior and anterior-apical changes. Cardiac cath performed 
on arrival to ___ showed no significant coronary artery 
disease.  Catheterizations did, however, show evidence of 
elevated pressures throughout the heart.  This likely indicates 
that it was not coronary occlusion that caused the elevated 
troponin rather heart failure.  Plavix and heparin were 
discontinued after cath and pt was continued on aspirin, 
betablocker, ACEI, and statin.
.  
#. Pump: No known history of heart failure.  However, clinical 
presentation, history, and cardiac cath results support 
diagnosis of diastolic heart failure. Pt reports elevated blood 
pressure at time of dyspneic episode that would support pump 
failure. Etiology of heart failure was undetermined at time of 
admission.  Pt had known potential for significant valvular 
disease given known MVP, history of Rheumatic fever, and MR 
identified on cath. Cardiac cath performed on admission showed 
markedly elevated pressures throughout the heart. Echo was 
performed the follow morning showing diastolic dysfuction as a 
result of mitral stenosis (see results).  Pt was placed on fluid 
restriction, low salt diet and started on a lasix gtt.  Symptoms 
greatly improved overnight with diuresis.  Pt was also managed 
with heart rate control to reduce pulmonary hypertension.  
Because pt responded so well to diuresis and rate control there 
is no indication for surgical intervention at this time. Pt will 
continue to be medically managed with metoprolol tartrate 150mg 
bid for rate control (goal heart rate 60) and lasix 40mg po bid 
for afterload reduction. Pt was counseling on maintaining a low 
sodium diet, fluid restriction and weighing herself daily.  Pt 
is to follow up with her primary care provider to have her blood 
pressure, heart rate, and electrolytes monitored on her new 
regimen.  She is also instructed to have biannual 
echocardiograms to evaluate the status of her mitral stenosis.
.  
#. Diabetes: poorly controlled; Home oral hypoglycemics where 
held in setting of catheterization; Pt was monitored with fsbs 
qachs and treated with lantus 25 u qpm and sliding scale humolog 
at meal time. Pt's blood sugars remained elevated throughout 
hospitalization (range from 200-400).  Pt instructed to resume 
home hypoglycemic regimen and diabetic diet at home with 
frequent glucose monitoring.  Pt is to follow up with primary 
care doctor to discuss augmenting her regimen if elevated sugars 
persist at home.
.  
#. Hyperlipidemia: continue home meds of lipitor and tricor
.
#. Code:  FULL CODE;  Husband ___ ___ 
                      Daughter ___ ___
.  
 
___ on Admission:
glyburide 7.5 mg daily
alprazolam 1 mg  qhs
darvocet ___ tablets q6h prn
meclizine 25 mg q8h prn
Metoprolol 25 bid
lisinopril 10mg po daily
tricor 145 mg daily
buproprion 150 bid
premarin 0.625 mg daily
fexofenadine 180mg daily
lipitor 40mg daily
benedryl 25mg prn
acetaminophen 500mg prn

 
Discharge Medications:
1. Lisinopril 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 
 
2. Fexofenadine 180 mg Tablet Sig: One (1) Tablet PO once a day. 
 
3. Propoxyphene N-Acetaminophen 100-650 mg Tablet Sig: ___ 
Tablets PO Q6H (every 6 hours) as needed.  
4. Aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable 
PO DAILY (Daily).  
5. Fenofibrate Micronized 145 mg Tablet Sig: One (1) Tablet PO 
daily ().  
6. Acetaminophen 325 mg Tablet Sig: ___ Tablets PO Q6H (every 6 
hours) as needed.  
7. Bupropion 150 mg Tablet Sustained Release Sig: One (1) Tablet 
Sustained Release PO BID (2 times a day).  
8. Alprazolam 1 mg Tablet Sig: One (1) Tablet PO BID (2 times a 
day) as needed for anxiety.  
9. Metoprolol Tartrate 50 mg Tablet Sig: Three (3) Tablet PO BID 
(2 times a day).
Disp:*180 Tablet(s)* Refills:*2*
10. Furosemide 40 mg Tablet Sig: One (1) Tablet PO BID (2 times 
a day).
Disp:*60 Tablet(s)* Refills:*2*
11. Trimethoprim-Sulfamethoxazole 160-800 mg Tablet Sig: One (1) 
Tablet PO BID (2 times a day) for 4 doses.
Disp:*4 Tablet(s)* Refills:*0*
12. Outpatient Lab Work
Please have an electrolyte panel (Na, K, Cl, HCO3, BUN, Cr, and 
Mg) drawn on ___.  Results should be faxed to Dr. ___ 
___, phone number ___.
13. Metformin 1,000 mg Tablet Sig: One (1) Tablet PO twice a 
day.  
14. Glyburide 5 mg Tablet Sig: 1.5 Tablets PO once a day.  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Primary: acute diastolic CHF secondary to mitral stenosis
Secondary: DM, HTN, HL

 
Discharge Condition:
Pt is hemodynamically stable. She ambulates without assistance 
and does not require supplemental oxygen.

 
Discharge Instructions:
You were transferred to this hospital to undergo a cardiac 
catheterization.  The catheterization did not show any blockages 
in the blood vessels that supply the heart.  However, it did 
show that you have high blood pressures within your heart.  To 
determine why you have these elevated pressures you had an 
echocardiogram performed.  This showed a tight valve within your 
heart.  This is most likely the cause of your symptoms.  You 
were treated with medications to reduce the pressures within 
your heart and to make your breathing easier. You tolerated the 
medications well and it was determined that you are not in acute 
need for any surgical intervention at this time. You will need 
to continue some of these new medications after you leave the 
hospital.
.
During your hospitalization you developed a bladder infection in 
the setting of a bladder catheter.  The catheter was removed and 
you were started on a three day course of antibiotics.  You 
should complete this course at home and follow up with your 
primary care provider.
.
While inpatient your glucose was significantly elevated.  You 
were treated with insulin while inpatient.  You are advised to 
return to your home oral hypoglycemic regimen after you leave 
the hospital and to follow up with your primary care physician 
within one week to discuss changing your current regimen.  
Please check your glucose regularly and alert your primary care 
physician if you have a glucose above 400.
.
The following changes were made to your medications:
1) INCREASE Metoprolol Tartrate to 150 mg by mouth daily
2) START furosemide (lasix) 40mg by mouth twice a day.
3) START bactrim-DS 1 tablet twice a day for four doses (last 
dose on ___ morning)
4) STOP Premarin.  Please discuss the need for this medication 
with your primary care physician before restarting.
.
Please continue all other medications as previously directed.
.
Please notify your physician or return to the hospital if you 
experience worsening shortness of breath, chest pain, 
palpitations, loss of consciousness, fever, chills, or any other 
symptom that is concerning to you.
 
Followup Instructions:
___
"
12018901-DS-68," 
Name:  ___                    Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Ranitidine / Aldactone
 
Attending: ___.
 
Chief Complaint:
#Fevers and lethargy
 
Major Surgical or Invasive Procedure:
none

 
History of Present Illness:
F w/ complicated PMH significant for DM2, ESRD on HD, gout, 
sleep apnea, asthma on 3L home O2, afib not on warfarin, chronic 
L achilles wound and L breast wound, sent from primary care for 
lethargy and fever. Pt was seen in ___ clinic for urgent care 
visit at which she described feeling feverish for 1 day and 
sleeping excessively during the day for ~5 days. She denies any 
chills, cough, chest pain. Reports having RUQ colicky abdominal 
pain w/ occasional nausea and vomited up breakfast once. Also 
reports having constipation for 5 days, though she did have one 
small bowel movement today w/ some blood on paper. Her daughter 
and her ___ were concerned that she was not as talkative and was 
falling asleeping in the middle of conversations, which they 
state is a major change from her normal. Per PCP note, ___ 
clinic vitals were BP 101/49, HR 83, Temp 102.1F. Her O2 sat on 
3L was 79-83%, then up to 100% on 5L, but ___ HR would dip to 
___ when she ""fell asleep"" in clinic and then back up to ___ 
when she would wake up. Pt reportedly arousable during these 
episodes, unclear what O2 sat was during espisodes, and no RR 
was documented. Pt was sent to ED for further evaluation.  
In the ED, initial vs were: 99.6F, HR 90, 119/65, 1, 99% 3L. Pt 
had RUQ tenderness w/ + ___ sign, clear lungs, no evidence 
of bradycardia, LLE more swolen than RLE with calf tenderness, 
unchanged from note on ___ visit, same per patient, when she 
nad negative doppler. Her chronic L achilles wound and L breast 
wound were examined and seemed infected. Labs were remarkable 
for WBC 13.5k, Hct 29 (baseline), AP 120, AST 87, Lactate 1.8. 
RUQ ultrasound showed cholelithiasis but no evidence of 
cholecystitis. Her chest XR showed significant bilateral 
pulmonary edema but unchanged from prior. She reportedly had 
guaiac positive stool in ED. Pt spiked a fever in ED to 101.6F. 
Surgery consult was called regarding her left breast wound, but 
they thought it was superficial infection and did not feel this 
was the source for her fevers. Culture was obtained in ED. Pt 
was started on IV vancomycin for empiric coverage of skin 
infections. She was also given IV fluids, and HR remained in 
___ and BP ___. Pt was admitted to medicine for 
further management.  
 
On the floor, vs were: 100.6F, 134/47, 96, 20, 97% 3L, 237 lb 
(bed)  
Pt reported pain in her R lateral side, reproducible on 
palpation. States that it hurt more than her chronic breast or L 
achilles wounds. Reported constipation. Otherwise felt at 
baseline. Reports having vomited once yesterday.  
 
Past Medical History:
PMH: DM2, ESRD on HD (RUE AVF), HTN, hyperlipidemia, 
hypertrophic
cardiomyopathy w/ heart failure, Afib, h/o thalamic CVA, OSA on
home CPAP, obesity, h/o pericarditis, h/o GIB (gastric ulcer),
asthma (on home O2), depression, nephrolithiasis, positive PPD,
anemia, dysphagia, GERD, uterine fibroids, gout, low back pain,
neck pain, vitamin D deficiency, diverticulitis, breast ulcers,
lichen simplex chronicus, pulmonary nodule, h/o pericarditis

PSH: TAH, L rotator cuff repair, back cyst removal, RUE AVF,
umbilical hernia repair

 
Social History:
___
Family History:
 Mother died ___ DM.  Father died ___ cancer, unknown
type.  Brother died ___ DM.  Sister died ___ DM, also had HTN.

 
Physical Exam:
Admission physical:

PHYSICAL EXAM:  
Vitals: 100.6F, 134/47, 96, 20, 97% 3L, 237 lb  
General: elderly obese woman in bed in no acute distress  
HEENT: PERRL, EOMI, normal oropharynx  
Lungs: distant breath sounds, relatively clear  
CV: irregular rhythm, normal rate, normal s1, s2, no m/r/g  
Abdomen: obese, lateral R inferior chest wall pain to palpation. 
Mild tenderness diffusely over abdomen. No rebound, normal bowel 
sounds. No masses.  
Ext: no edema bilaterally, 2+ pulses  
Skin: L breast w/ 3 cm irregular wound w/ foul smelling pus, 
mildly tender to palpation, no surrounding erythema or warmth. L 
achilles w/ 4 x 1 cm surgical wound, foul smelling w/ some white 
fluid, mild-moderate tenderness, no surrounding erythema or 
warmth.  
Neuro: A&O x name, BI ___ floor, ___ (not date), spelled 
world forwards and backwards. CN2-12 intact. No focal deficits.  


Discharge physical:
General: elderly obese woman sitting on chair with legs raised 
on stool. in no acute distress  
HEENT: PERRL, EOMI, normal oropharynx  
Lungs: clear to auscultation
CV: irregular rhythm, normal rate, normal s1, s2, no m/r/g  
Abdomen: obese, soft and non-tender. No rebound, normal bowel 
sounds. No masses.  
Ext: no edema bilaterally, 2+ pulses  
Skin: L breast w/ 3 cm irregular wound w/ foul smelling pus, 
mildly tender to palpation, no surrounding erythema or warmth. L 
achilles w/ 4 x 1 cm surgical wound, foul smelling w/ some white 
fluid, mild-moderate tenderness, no surrounding erythema or 
warmth.  
Neuro: A&O x 3  

 
Pertinent Results:
Admission labs:

___ 03:00PM BLOOD WBC-13.5* RBC-2.69* Hgb-9.0* Hct-29.2* 
MCV-109* MCH-33.5* MCHC-30.8* RDW-18.1* Plt ___
___ 03:00PM BLOOD Neuts-86.8* Lymphs-8.4* Monos-4.4 Eos-0.3 
Baso-0.2
___ 03:00PM BLOOD Plt ___
___ 06:45AM BLOOD ESR-131*
___ 03:00PM BLOOD Glucose-186* UreaN-17 Creat-5.3*# Na-136 
K-7.2* Cl-93* HCO3-26 AnGap-24*
___ 05:00PM BLOOD Glucose-173* UreaN-17 Creat-5.4* Na-141 
K-4.7 Cl-92* HCO3-28 AnGap-26*
___ 03:00PM BLOOD ALT-20 AST-87* AlkPhos-120* TotBili-0.6
___ 03:00PM BLOOD Lipase-17
___ 03:00PM BLOOD Albumin-3.4*
___ 05:00PM BLOOD Calcium-10.0 Phos-2.1* Mg-1.5*
___ 05:00PM BLOOD CRP-74.7*
___ 06:45AM BLOOD CRP-201.6*
___ 05:08PM BLOOD ___ pO2-44* pCO2-58* pH-7.36 
calTCO2-34* Base XS-4
___ 03:17PM BLOOD Lactate-1.8 K-4.7
___ 05:08PM BLOOD K-4.6

Discharge labs and studies:

Imaging studies:

___ Liver/gallbladder US
IMPRESSION:  Cholelithiasis.

___ CXR
IMPRESSION:  
 
Limited study due to body habitus, however there is no 
significant interval
change in the diffuse bilateral pulmonary edema.
 
The study and the report were reviewed by the staff radiologist.

___ ECHO

IMPRESSION: No intracardiac thrombus identified (better excluded 
by TEE).

___ KUB
IMPRESSION:
 
Focal loops of small bowel which are stacked and dilated in the 
left lower
quadrant.  This is concerning for a partial obstruction given 
the fact that
there is air within the colon as well.
 
Findings discussed with ___ upon review of the 
study at 2:10
AM via ___
 
 ___ CT abdomen w/contrast
IMPRESSION: 
Partial small bowel obstruction with the transition occurring 
over a long
segment of hyperemic and thickened small bowel with adjacent 
mesenteric edema
and fluid. These findings are concerning for a focal area of 
ischemia versus
infection. Other considerations would be an adhesion from which 
the bowel
recently ""untwisted"". Given the patient's significant arterial 
atherosclerotic
disease and enlarged heart, ischemia is a primary concern.
 
 

___ 08:10AM BLOOD WBC-8.9 RBC-2.40* Hgb-8.1* Hct-25.9* 
MCV-108* MCH-33.6* MCHC-31.2 RDW-17.8* Plt ___
___ 08:10AM BLOOD Glucose-83 UreaN-19 Creat-4.9*# Na-140 
K-3.9 Cl-92* HCO3-27 AnGap-25*
___ 08:10AM BLOOD Calcium-9.8 Phos-2.4*# Mg-1.8

BREAST WOUND. 

                            **FINAL REPORT ___

   WOUND CULTURE (Final ___: 
      This culture contains mixed bacterial types (>=3) so an 
abbreviated
      workup is performed. Any growth of P.aeruginosa, S.aureus 
and beta
      hemolytic streptococci will be reported. IF THESE BACTERIA 
ARE NOT
      REPORTED BELOW, THEY ARE NOT PRESENT in this culture.. 
      ESCHERICHIA COLI.    MODERATE GROWTH. 
         Cefazolin interpretative criteria are based on a dosage 
regimen of
         2g every 8h. 

                              SENSITIVITIES: MIC expressed in 
MCG/ML
                      
_________________________________________________________
                             ESCHERICHIA COLI
                             |   
AMPICILLIN------------  =>32 R
AMPICILLIN/SULBACTAM--    16 I
CEFAZOLIN-------------   <=4 S
CEFEPIME--------------   <=1 S
CEFTAZIDIME-----------   <=1 S
CEFTRIAXONE-----------   <=1 S
CIPROFLOXACIN---------   0.5 S
GENTAMICIN------------   <=1 S
MEROPENEM-------------<=0.25 S
PIPERACILLIN/TAZO-----   <=4 S
TOBRAMYCIN------------   <=1 S
TRIMETHOPRIM/SULFA----  =>16 R
 
Brief Hospital Course:
___ w/ complicated PMH significant for DM2, ESRD on HD, gout, 
sleep apnea, asthma on 3L home O2, afib not on warfarin, chronic 
L achilles wound and L breast wound, sent from primary care for 
lethargy and fever.

# Lethargy: Patient had reported lethargy in clinic. In ED and 
on floor, patient had been completely awake and fully oriented. 
This was most likely from the E.coli that grew from her breast 
wound.  This was managed initially with vancomycin, 
ciprofloxacin and flagyl.  But once the cultures came back 
positive, vancomycin was discontinued as she only required 
gram-negative coverage. Her blood cultures are still pending. 
She had associated abdominal tenderness and CT imaging results 
were indicative of a small area of bowel ischemia. Given her 
A-fib without anticoagulation, it is possible she may have 
thrown a clot to her intestinal vasculature.  This was managed 
with 24 hours of bowel rest and resolved. An ECHO ruled out a 
myocardial thrombus. In-house her gabapentin was also 
discontinued due to its effects of lethargy.

 # intermittent bradycardia: Pt had reported episodes of 
bradycardia when she ""feel asleep"" in urgent care clinic, w/ HR 
down to ___, but then back up to ___ when awoken. Unclear 
what her O2 sat or RR was during these periods, but it is 
possible that her lethargy, possibly from opiate medications 
described above, led to worsening of her known obstructive 
apnea, and transient hypoxia, which may reduce heart rate. She 
refuses CPAP. In-house, her opiate dosing was decreased and 
gabapentin was discontinued.  Her heart rate was stable in the 
___. 

# atrial fibrillation: not on anticoagulation. Per daughter and 
PCP, this was due to concern that warfarin was making her breast 
and L achilles wounds worse, but her CHADS2 score is 4, which is 
high risk, though stroke was thalamic so possibly due to bleed.  
PCP to ___ with out-patient cardiologist and nephrologist to 
assess patient's current requirement for warfarin. PCP did reply 
in email explaining that he had a risk benefit conversation 
(especially given bleeding risk from calciphylaxis) about 
warfarin and that the patient and her family chose against 
warfarin after making an informed decision. 

# L achilles wound: Pt was just seen by podiatry ___, who 
felt wound had moderate amount of purulent type drainage with a 
slight odor, with fibrotic base of wound but no purulence and 
moderate exudate.  In-house managed with Aquacel Ag dressings.  
Patient has out-patient podiatry follow up.

#Left breast wound.  Chronic over a few months.  Being dressed 
by nurse at home. Slight odor. Fleshy erythema surrounding a 
crusted center. Biopsied prior to admission which was indicative 
of wound likely secondary to calcifilaixis from renal failure. 
Wound cultures also grow E.coli.  She was managed as above with 
ciprofloxacin and flagyl

Transitional issues:
-patient to continue cipro/flagyl until ___
-out-patient assessment for warfarin 
-out-patient podiatry appointment
-out-patient PCP ___ (PCP to please follow up blood 
cultures)
-out-patient cardiology appointment 

 

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Albuterol Inhaler 2 PUFF IH Q6H 
2. Allopurinol ___ mg PO EVERY OTHER DAY 
3. Aspirin 81 mg PO DAILY 
4. Collagenase Ointment 1 Appl TP DAILY 
5. Docusate Sodium 100 mg PO BID 
6. FoLIC Acid 1 mg PO DAILY 
7. Gabapentin 300 mg PO QHD 
8. Glargine 26 Units Breakfast
9. Metoclopramide 5 mg PO QIDACHS 
10. Nephrocaps 1 CAP PO DAILY 
11. Omeprazole 20 mg PO DAILY 
12. sevelamer CARBONATE 1600 mg PO TID W/MEALS 
13. Simvastatin 10 mg PO DAILY 
14. Senna 1 TAB PO BID:PRN constipation 
15. budesonide-formoterol *NF* 80-4.5 mcg/actuation Inhalation 
bid 
16. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN wheezing, dyspnea 

17. Carvedilol 6.25 mg PO BID 
hold for sbp < 90 or HR < 60 
18. Dextromethorphan-Guaifenesin (Sugar Free) ___ mL PO TID:PRN 
cough 
19. OxycoDONE (Immediate Release)  5 mg PO Q4H:PRN pain 

 
Discharge Medications:
1. Allopurinol ___ mg PO EVERY OTHER DAY 
2. Aspirin 81 mg PO DAILY 
3. Carvedilol 6.25 mg PO BID 
4. Collagenase Ointment 1 Appl TP DAILY 
5. FoLIC Acid 1 mg PO DAILY 
6. Glargine 26 Units Breakfast
7. Metoclopramide 5 mg PO QIDACHS 
8. Nephrocaps 1 CAP PO DAILY 
9. Omeprazole 20 mg PO DAILY 
10. Senna 1 TAB PO BID:PRN constipation 
11. sevelamer CARBONATE 1600 mg PO TID W/MEALS 
12. Simvastatin 10 mg PO DAILY 
13. Ciprofloxacin HCl 500 mg PO Q24H wound infection Duration: 7 
Days 
start date ___ 
RX *ciprofloxacin 500 mg 1 tablet(s) by mouth once a day Disp 
#*5 Tablet Refills:*0
14. MetRONIDAZOLE (FLagyl) 500 mg PO Q8H Duration: 7 Days 
please take this medication until ___ 
RX *metronidazole [Flagyl] 500 mg 1 tablet(s) by mouth every 
eight (8) hours Disp #*15 Tablet Refills:*0
15. Miconazole Powder 2% 1 Appl TP BID under breasts 
RX *miconazole nitrate [Anti-Fungal] 2 % please apply to the 
areas under your breast twice a day Disp #*1 Tube Refills:*0
16. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN wheezing, dyspnea 

17. Albuterol Inhaler 2 PUFF IH Q6H:PRN shortness of breath, 
wheezing 
18. budesonide-formoterol *NF* 80-4.5 mcg/actuation INHALATION 
BID 
19. Docusate Sodium 100 mg PO BID 
20. Gabapentin 300 mg PO QHD 
21. Dextromethorphan-Guaifenesin (Sugar Free) ___ mL PO TID:PRN 
cough 

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
Bowel ischemia
Wound on left breast with growth of E.coli
 
ESRD on HD
Calciphylaxis
Atrial Fibrillation with CHADS2 of 4

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).

 
Discharge Instructions:
Dear Ms. ___,

It was a pleasure caring for you at ___. You were admitted 
with fevers and lethargy. We treated you with antibiotics for 
bacteria which was growing in the wound of your left breast.  
You also had an area of bowel which was thickened on CT imaging. 
 This resolved spontaneously with resting your bowels for 24 
hours.
   
Weigh yourself every morning, call MD if weight goes up more 
than 3 lbs. 
  
Please be sure to keep up with your follow-up appointments 
below.

Thank you
 
Followup Instructions:
___
"
12050253-DS-20," 
Name:  ___                    Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Sulfa (Sulfonamide Antibiotics) / shellfish derived / ACE 
Inhibitors / Augmentin / glipizide / metformin / gluten / 
nifedipine
 
Attending: ___.
 
Chief Complaint:
Chronic Diarrhea, malnutrition
 
Major Surgical or Invasive Procedure:
___: EGD/colonoscopy 
___: Push Enteroscopy

 
History of Present Illness:
This is a ___ male with PMHx significant for afib on
warfarin, presumed diagnosis of Celiac disease presenting with ___
year history of diarrhea, failure to thrive with significant
weight loss (over 100 pounds in the past year), fatigue,
generalized weakness, sent in from GI clinic today for admission
for further workup.

Patient reports his symptoms started ___ years ago without an
identifiable precipitating event or trigger. He gradually
developed frequent diarrhea, urgency and poor bowel control
associated with abdominal bloating and flatus. At the time, he
saw his PCP and had ""extensive testing including Giardia"" which
was unrevealing. Since then, his diarrhea has been persistent.
Frequency of diarrhea varies from ___ times up to 12 times per
day. He states he sometimes gets up ___ times at night to have a
bowel movement. His diarrhea is mostly light brown and loose but
sometimes fully formed. He cannot tell if it smells particularly
bad or not. He denies ever having bloody or dark stool. He has
intermittent crampy lower abdominal pain along with the diarrhea
but cannot tell whether bowel movements make it better or worse.
He cannot identify any types of triggers (i.e. fatty food,
carbohydrates) for his diarrhea but thinks eating pasta with
tomato sauce sometimes make it worse. He denies having diarrhea
prior, significant travel outside of the ___, alcohol
or other substance use, nausea, vomiting, fevers, chills,
lightheadedness, headaches, oral ulcers, rash, abnormal 
bleeding,
palpitations, chest pain, shortness of breath, orthopnea,
dysuria, frequency, or hematuria.

In ___, he was hospitalized after becoming septic from a
perirectal abscess for which he underwent surgery. At the time,
he was told he had ""gluten antibodies in blood"" and he had a
colonoscopy and endoscopy which reportedly confirmed he had
Celiac disease. For the past ___ years, he has been careful in
avoiding gluten without any improvement in his symptoms. 

In ___, he was hospitalized for a cellulitis treated with
antibiotics. At the time he also had cholesystostomy tube placed
due to concern for cholecystitis. Since his last 
hospitalization,
he has been living at a rehab facility. For the past 1.5 months,
he has been taking loperamide and probiotics and has been having
diarrhea ___ times per day. However, he also has not been eating
much as he has poor appetite and he doesn't like the food at the
rehab. His wife brings food for him and his current diet 
includes
meat, potatoes, and vegetables. He has been feeling fatigued and
weak.

He reports losing a lot of weight over the past ___ years. He
weighed 376 lbs ___ years ago and intentionally lost weight for 
his
diabetes down to 240 lbs in ___. However, since then, 
he
has been unintentionally losing weight. His weight was 205 lbs 
in
___ and 143 lbs now. He infrequently checks his blood
sugars.

 
Past Medical History:
-Type 2 Diabetes (resolved with weight loss)
-Hypertension
-Hyperlipidemia                               
-Atrial fibrillation
-Hyperuricemia ___, left lower leg was hot and sore,
was diagnosed with gout, did not improve with antibiotics)
-Morbid obesity
-OSA
-Gallstones 
-Pulmonary hypertension (moderate to severe)
-Perirectal abscess
-Ascites
-Severe protein-calorie malnutrition
-___
-___
-Celiac disease
-Subclinical hypothyroidism 
-MRSA Bacteremia (___)

PAST SURGICAL HISTORY:
-Anal fistula and fistulotomy ___
-Perineal abscess and transphinteric anal fistula ___ 
placement
___
-Cholecystostomy tube placement ___

 
Social History:
___
Family History:
No history of Crohn's, UC, Celiac disease, autoimmune disease.
Maternal grandfather died of liver cancer, father died of
?embolism or aneurysm, mother died of stroke ___ years ago (___)
 
Physical Exam:
ADMISSION PHYSICAL EXAM:  
=========================
VS:  Temp 97.8  BP 94/64  HR 78  RR 20  O2sat 98 RA
General: Lying in bed, conversant, NAD. Cachectic.  
HEENT: NC/AT, anicteric sclera, PERRL, oral mucosa clear without
ulcers or bleeding. Dry MM
NECK: No JVD. No palpable lymph nodes. No thyromegaly.
LUNGS: CTAB no w/r/r. Breathing comfortably in room air without
accessory muscle use.
CARDIAC: distant heart sounds
ABD: cholecystostomy tube in RUQ, +BS, mildly distended and
tympanic, nontender, no palpable masses.
EXT: Warm and well perfused, pedal pulses palpable, no clubbing
or cyanosis
SKIN: Skin breakdown on forearms, lower extremity stasis
dermatitis, no other rashes or lesions noted.
NEURO: AOx3, CNII-XII grossly intact, spontaneously moving all
limbs against gravity, no asterixis 

DISCHARGE PHYSICAL EXAM:
========================
VITALS 98.2 132/86 93 18 98 Ra 
GENERAL: NAD, laying in bed waiting for breakfast
EYES: MMM, non-icteric
CV:  Irregularly irregular, no m/r/g
RESP: CTAB, diminished breath sounds at the bases
GI: abdomen very soft with minimal muscular tone, mildly
distended, non tender to palpation
MSK: Eccymosis noted on posterior thigh, superior to the knee,
improving. 2+ LLE edema improving, RLE without edema, palpable
distal pulses
SKIN: No rashes or lesions noted. Ecchymosis on arms 
NEURO: A&Ox3, moves all extremities, ___ upper and lower 
strength
RECTAL: small open lesion draining minimal pus, at top of 
gluteal cleft
 
Pertinent Results:
ADMISSION LABS
===============
___ 02:27PM BLOOD WBC-21.5* RBC-3.75* Hgb-11.7* Hct-34.7* 
MCV-93 MCH-31.2 MCHC-33.7 RDW-15.9* RDWSD-53.9* Plt ___
___ 02:27PM BLOOD Neuts-86.9* Lymphs-4.3* Monos-6.7 
Eos-0.8* Baso-0.6 Im ___ AbsNeut-18.71* AbsLymp-0.92* 
AbsMono-1.45* AbsEos-0.17 AbsBaso-0.14*
___ 02:30PM BLOOD ___ PTT-35.9 ___
___ 02:27PM BLOOD Glucose-98 UreaN-20 Creat-1.4* Na-134* 
K-4.4 Cl-104 HCO3-16* AnGap-14
___ 02:27PM BLOOD ALT-10 AST-19 AlkPhos-132* TotBili-0.4
___ 02:27PM BLOOD Lipase-9
___ 02:27PM BLOOD Albumin-1.9* Calcium-7.7* Phos-3.5 
Mg-1.4*
___ 04:35AM BLOOD calTIBC-124* VitB12-PND Hapto-106 
Ferritn-142 TRF-95*
___ 02:27PM BLOOD Osmolal-290
___ 04:35AM BLOOD TSH-6.3*
___ 04:35AM BLOOD Free T4-0.9*
___ 02:27PM BLOOD CRP-9.5*
___ 04:35AM BLOOD PEP-PND IgG-995 IgA-623* IgM-95
___ 04:35AM BLOOD HIV Ab-NEG
___ 02:27PM BLOOD tTG-IgA-9

IMAGING
=========
___ EGD
- Normal mucosa was noted in the whole esophagus.
- Diffuse erythema of the mucosa with no bleeding was noted in 
the stomach. These findings are compatible with gastritis. 
Multiple cold forceps biopsies were performed for histology in 
the stomach. ___ protocol).
- Normal mucosa was noted in the whole examined duodenum. 
Multiple cold forceps biopsies were performed for histology in 
the duodenum. 

___ COLONOSCOPY
- A fistula was found in the anus
- A few diverticula were seen in the whole colon. Diverticulosis 
appeared to be of mild severity. 
- Normal mucosa was noted in the whole colon and 10cm into the 
terminal ileum. Multiple cold forceps biopsies were performed 
for histology in the random colon and terminal ileum. 
- Abnormal digital rectal exam (external hemorrhoids). 
** Note: colonoscopy incomplete, will need to repeat as an 
outpatient due to poor prep.

___ CXR
1. Repositioning of the left-sided PICC line, now with tip 
terminating at the
mid SVC.  No pneumothorax is seen.
2. Small to moderate left pleural effusion with left basilar 
atelectasis is
unchanged.

+ ___ CT ENTEROGRAPHY
IMPRESSION:
1. Multiple discontiguous inflamed segments of jejunum, with 
areas of
suspected inflammatory stricturing but no high-grade mechanical 
obstruction. 
Findings are most in keeping with an infectious or inflammatory 
jejunitis.
2. No focal fluid collection or fistula.
3. Small volume ascites.  Moderate left and small right pleural 
effusion.
4. Diffusely decreased bone mineral density with multilevel 
compression
fractures.  Please refer to the body of the report for further 
details on
osseous findings.

___ ABDOMINAL XRAY
IMPRESSION:
1. New marked distention of the stomach which could represent 
gastric outlet
obstruction.
2. Possible small bowel ileus or small-bowel obstruction.
3. Near complete opacification of the left thorax likely related 
to pleural
effusion.  Please refer to chest performed concomitantly.

MICRO
=====
___ 1:10 am STOOL     CONSISTENCY: SOFT      Source: Stool. 

                            **FINAL REPORT ___
   C. difficile DNA amplification assay (Final ___: 
      Negative for toxigenic C. difficile by the Cepheid nucleic 
acid
      amplification assay.. 

PATHOLOGY
==========
+ ___ GI BIOPSIES:

1. Stomach, biopsy:
-Antral mucosa with chronic inactive gastritis.
-Corpus mucosa with edema, otherwise within normal limits.
- Immunohistochemical stain for Helicobacter will be performed 
and reported in a revised report.
** 1. Stomach: Immunohistochemical stain for Helicobacter is 
negative with adequate
controls. 

2. Duodenal bulb, biopsy:
-Duodenal mucosa with surface foveolar metaplasia suggestive of 
mild peptic injury, otherwise within
normal limits.

3. Duodenum, biopsy:
-Duodenal mucosa within normal limits.

4. Terminal ileum, biopsy:
-Small intestinal mucosa within normal limits.

5. Random colon, biopsy:
-Colonic mucosa within normal limits. 

+ ___ SMALL INTESTINE BIOPSIES
Chronic severely active enteritis with non-necrotizing 
granulomas

MRI PELVIS ___.  Complex trans sphincteric perianal fistula within 
intersphincteric 
component and multiple branches, one of which terminates into a 
1.7 cm fluid collection which is unchanged since ___ and 
located 0.7 cm deep to the skin. 
2.  Extensive anasarca, deep tissue and presacral edema, 
including severe 
muscular edema, worse than on prior. 
3.  3.5 cm right proximal femoral chondroid lesion without 
cortical 
breakthrough.  This could be followed on subsequent exams. 
4.  Diffuse fatty marrow throughout the osseous structures with 
focal red 
marrow conversion within the proximal right femur. 

DISCHARGE LABS
===============
___ 06:25AM BLOOD WBC-18.7* RBC-2.82* Hgb-8.7* Hct-27.7* 
MCV-98 MCH-30.9 MCHC-31.4* RDW-16.8* RDWSD-60.3* Plt ___
___ 06:25AM BLOOD Glucose-184* UreaN-43* Creat-1.3* Na-146 
K-3.6 Cl-117* HCO3-18* AnGap-11
___ 06:25AM BLOOD Calcium-7.9* Phos-3.1 Mg-1.___ male with PMHx significant for afib on warfarin, 
presumed diagnosis of Celiac disease presenting with ___ year 
history of diarrhea of unclear etiology, failure to thrive with 
significant weight loss (over 100 pounds in the past year), 
fatigue, generalized weakness, here for workup. He underwent 
___ on ___ (unrevealing), then push enteroscopy on ___, 
which showed chronic inflammation consistent with Crohn's 
disease. 

ACUTE ISSUES:
================
# Crohn's disease
# Chronic diarrhea and weight loss
# Perirectal abscess and fistula
He presented with a compelling story of weight loss and chronic 
diarrhea. Has had large workup, which has thus far been notable 
for positive Celiac markers HLA-DQ2/DQ8 without pathologic 
diagnosis of Celiac disease (including normal tTG-IgA) although 
he has been adherent to a gluten free diet. He has been told he 
has Celiac disease in the past. Push enteroscopy revealing for 
discontinguous and strictured jejunum which, in the setting of 
perirectal abscesses was consistent with Crohn's disease. Final 
path from push enteroscopy showed non-necrotizing granulomas and 
chronic enteritis. Old pathology report also suggestive of 
Crohns without intraepithelial leukocytes. He likely has had 
Crohns disease all along. Per gastroenterology, he was taken off 
gluten free diet and tolerated a regular diet in house without 
any issues. He was started on prednisone 40mg daily which he is 
to remain on until his follow up outpatient appointment with 
gastroenterology Dr. ___.

Regarding perirectal fistula, this was evaluated by our 
colorectal surgery team and with an MRI pelvis.  There is no 
drainable pocket for now.  He should be scheduled for outpatient 
colorectal surgery follow up in ___.  Recommend Dr. ___ 
___ this.

# Anorexia
# Severe Malnutrition
# Protein Losing Enteropathy 
# Hypoalbuminemia
Unintentional weight loss of ~60 lbs since ___ in the 
setting of poor PO intake and intermittent diarrhea. Low albumin 
of 1.9 consistent with severe malnutrition. Nutrition was 
consulted. Electrolytes were checked frequently and patient was 
monitored on telemetry for re-feeding syndrome and 
electrolyte-related arrhythmias. He temporarily required TPN to 
boost his nutrition and then was discontinued shortly 
thereafter. He tolerated a regular diet and was given vitamin 
supplementation daily.  He does NOT require a gluten-free diet.

# Cholecystostomy tube
Placed at ___ in ___ for conservative 
management of suspected cholecystitis (positive ___ sign, 
gallbladder distention of RUQUS, though no CBD dilation or 
pericholecystic fluid). Patient is a poor candidate for surgery 
given his overall deconditioning and poor nutritional status. 
Surgery was consulted and they recommended T tube cholangiogram 
which showed patent biliary tree and patent cystic duct. Surgery 
removed the percutaneous cholecystostomy tube without any 
further issues.

# Neutrophilic leukocytosis
Patient remained afebrile, HD stable, and normoxemic in room air 
without any localizing symptoms. Infectious workup negative. 
Likely leukemoid reaction vs demarginalization in setting of 
starting steroids.  WBC count on day prior to discharge 18.7.

# ___
Baseline Cr of 0.9 in ___, up to 1.4 on admission. 
Suspected to be pre-renal azotemia in the setting of poor PO 
intake and diarrhea. Resolved with TPN and fluids. Renal was 
consulted for additional assistance and they also recommended 
IVF.  Cr day prior to discharge is 1.3, likely his new baseline.

#LLE swelling: has had this for many years. Likely ___ 
hypoalbuminea and venous insufficiency. Low suspicion for 
cardiac etiology given unilaterality. Bilateral LENIs were 
negative for DVT. He was recommended to elevate the leg and wear 
compression stockings. His swelling improved with resolution of 
home Lasix and aldactone.

#Anemia: 
Normocytic, likely related to anemia of chronic disease, not 
iron deficient. No evidence of hemolysis.

# Atrial fibrillation
INR of 2.7 on admission. Decision made to stop anticoagulation 
with warfarin given CHADS2VASC of 1 (1 point for age). He was 
started on aspirin during this admission. He had intermittent 
tachycardia with movement thought to be the result of 
deconditioning rather than poorly controlled afib. He was rate 
controlled on metoprolol succinate 50mg daily and digoxin (dose 
reduced to 0.625 in setting of renal function).

#Hyperglycemia: developed in setting of steroids. Was controlled 
with minimal ISS.

#Melena: Developed following push enteroscopy procedure. 
Stabilized without intervention. He had no further episodes of 
melena thereafter.

#Transudative left pleural effusion: etiology appears to be 
consistent with hypoalbuminemic state. No clinical signs of 
heart failure. His nutritional status was optimized as above. He 
underwent a thoracentesis with IP to have 1L of fluid removed. 
Repeat CT showed reinflation of the lung with resolution of the 
pleural effusion. He will need continued follow up given 
likelihood of reaccumation.

TRANSITIONAL ISSUES:
====================
[ ] We are working on scheduling him with outpatient GI Dr. 
___ at ___.  His number is listed in 
discharge paperwork.  We will call ___ with 
details.
[ ] Needs outpatient colorectal surgery follow up
[ ] New meds: Prednisone 40 daily, Pantoprazole 40 daily, 
vitamin D 50,000 units weekly x 8 weeks, metoprolol succinate 50 
daily, Asa 81 daily
[ ] Stopped meds: metoprolol tartrate, warfarin
[ ] Changed dosing: digoxin 0.0625 daily (from 0.125 daily)
[ ] Non-immune to hep B
[ ] Supplementation of Vitamin D3 at 50,000 units/week over an 8 
week period, with transition to 800 units daily of D3 afterward
[ ] Outpatient DEXA scan
[ ] Consider repeat CXR as outpatient to re-eval for 
reaccumulation of prior pleural effusion
[ ] Follow-up ultrasound in 1 month is also recommended to 
ensure resolution of echogenic material within the bladder. 
[ ] Was hyperglycemic on steroids in house. Will need ongoing 
evaluation and assessment of his blood glucose readings
[ ] Evaluation of sacrum, other pressure sites at risk for 
injury given immobility
[ ] Consider atovaquone for PCP prophylaxis following 
hospitalization (no Bactrim due to anaphylaxis allergy)
[ ] Needs repeat quantiferon gold as outpatient prior to 
initiating (attempts here were insufficient for analysis)
[ ] Recommend repeat WBC count and Cr in ___ days after 
discharge from ___

#CODE: Full (presumed)  
#CONTACT: ___ ___ (son) 
 
Medications on Admission:
The Preadmission Medication list may be inaccurate and requires 
futher investigation.
1. Allopurinol ___ mg PO DAILY 
2. Floranex (Lactobacillus acidoph-L.bulgar) 4 tabs oral DAILY 
3. Digoxin 0.125 mg PO DAILY 
4. Furosemide 40 mg PO BID 
5. Ipratropium Bromide MDI 1 PUFF IH Q6H 
6. LOPERamide 2 mg PO QID:PRN diarrhea 
7. Warfarin 1 mg PO DAILY16 
8. Spironolactone 25 mg PO DAILY 
9. Metoprolol Tartrate 50 mg PO BID 
10. Mirtazapine 30 mg PO QHS 

 
Discharge Medications:
1.  Aspirin 81 mg PO DAILY  
2.  Metoprolol Succinate XL 50 mg PO DAILY  
3.  Multivitamins W/minerals 1 TAB PO DAILY  
4.  Pantoprazole 40 mg PO Q24H  
5.  PredniSONE 40 mg PO DAILY  
6.  Vitamin D ___ UNIT PO 1X/WEEK (FR) Duration: 8 Weeks  
7.  Digoxin 0.0625 mg PO DAILY  
8.  Allopurinol ___ mg PO DAILY  
9.  Floranex (Lactobacillus acidoph-L.bulgar) 4 tabs oral DAILY  

10.  Furosemide 40 mg PO BID  
11.  Levothyroxine Sodium 25 mcg PO DAILY  
12.  LOPERamide 2 mg PO QID:PRN diarrhea  
13.  Mirtazapine 30 mg PO QHS  
14.  Spironolactone 25 mg PO DAILY  

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
PRIMARY DIAGNOSIS
=================
Crohns Disease

SECONDARY DIAGNOSES
====================
Severe Malnutrition
Acute Kidney Injury
Atrial Fibrillation
Anemia
Melena
Transudative pleural effusion

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).

 
Discharge Instructions:
Dear Mr. ___,

It was a pleasure taking part in your care here at ___!

Why was I admitted to the hospital?
- You were admitted to the hospital for work-up of your chronic 
diarrhea. 

What was done for me in the hospital?
- You had an endoscopy and a colonoscopy on ___. The 
endoscopy showed some irritation in your stomach, called 
gastritis. The colonoscopy showed a fistula (an irritated hole 
that connects two parts of the intestines) in your rectum.  
- You had a ""push enteroscopy"", a special kind of endoscopy that 
looked at your small bowel. It showed some abnormalities, and 
biopsies were taken. These biopsies showed Crohn's disease. You 
were started on steroids to reduce the inflammation.
- You had a liter of fluid removed from your left lung.
- You were seen by a nutritionist, and you were given vitamin 
replacement for your vitamin deficiencies.
- You had your percutaneous cholecystostomy tube removed after 
we ensured there weren't any blockages in your gallbladder.

What should I do when I leave the hospital?
- Please take all medicines as prescribed.
- Please attend all doctors ___. You will be following 
up with ___ at ___ for the Crohns 
Disease.

We wish you the best of luck in your health!

Sincerely,
Your ___ Treatment Team

 
Followup Instructions:
___
"
12128814-DS-15," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: SURGERY
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
Trauma:

gunshot wound to abdomen ( entry)
Left flank wound (exit)
 
Major Surgical or Invasive Procedure:
___
Exploratory laparotomy, small bowel resection

 
History of Present Illness:
This patient is a ___ year old male who came in as a trauma STAT 
with a
gunshot wound to the right upper quadrant and was evaluated
briefly in the trauma bay where he was hemodynamically fairly
stable with systolic blood pressure above 100 after some
volume and blood resuscitation.  He had evidence of a gunshot
wound in the right upper quadrant and another wound in the
left lower flank.  On quick evaluation there was a copious
hemoperitoneum seen on ultrasound. Given the transabdominal
nature of this wound, was brought to the operating room for
laparotomy.  No consent was obtained given the emergency
nature.

 
Past Medical History:
none
 
Social History:
___
Family History:
none
 
Physical Exam:
Temp 95.9  HR 114  BP  89/67  RR 15  intubated  O2 sat 89%
 
Constitutional: intubated and sedated
PERRLA
Chest clear, equal BS
Abdominal: Soft, gsw right and left abd
Extr/Back: No cyanosis, clubbing or edema
Skin: No rash

 
Pertinent Results:
___ 05:35AM BLOOD WBC-11.7* RBC-3.41* Hgb-10.3* Hct-30.2* 
MCV-89 MCH-30.2 MCHC-34.0 RDW-14.0 Plt ___
___ 04:40AM BLOOD WBC-11.1* RBC-3.14* Hgb-9.7* Hct-28.1* 
MCV-89 MCH-30.9 MCHC-34.5 RDW-13.6 Plt ___
___ 05:00AM BLOOD WBC-11.5* RBC-3.31* Hgb-10.4* Hct-29.3* 
MCV-89 MCH-31.4 MCHC-35.5* RDW-14.0 Plt ___
___ 11:40PM BLOOD WBC-31.1* RBC-4.26* Hgb-12.9* Hct-37.9* 
MCV-89 MCH-30.2 MCHC-33.9 RDW-13.2 Plt ___
___ 11:40PM BLOOD Neuts-84.4* Lymphs-10.3* Monos-2.6 
Eos-2.3 Baso-0.5
___ 05:35AM BLOOD Plt ___
___ 04:40AM BLOOD Plt ___
___ 05:00AM BLOOD Plt ___
___ 01:58PM BLOOD ___ PTT-21.9* ___
___ 03:22AM BLOOD ___ PTT-19.7* ___
___ 12:55AM BLOOD ___ PTT-23.4 ___
___ 12:55AM BLOOD ___ 05:35AM BLOOD Glucose-93 UreaN-7 Creat-0.8 Na-139 K-3.9 
Cl-101 HCO3-30 AnGap-12
___ 04:40AM BLOOD Glucose-110* UreaN-8 Creat-0.9 Na-138 
K-4.0 Cl-101 HCO3-30 AnGap-11
___ 11:40PM BLOOD Glucose-154* UreaN-16 Creat-1.1 Na-142 
K-3.5 Cl-107 HCO3-26 AnGap-13
___ 11:40PM BLOOD ALT-26 AST-22 AlkPhos-40 TotBili-0.4
___ 01:58PM BLOOD Lipase-13
___ 11:40PM BLOOD Lipase-28
___ 05:35AM BLOOD Calcium-8.6 Phos-3.8 Mg-2.1
___ 04:40AM BLOOD Calcium-8.5 Phos-3.6 Mg-2.1
___ 02:16PM BLOOD Lactate-1.8
___ 07:01AM BLOOD Lactate-3.3*
___ 01:04AM BLOOD Glucose-189* Lactate-2.6* Na-139 K-4.5
___ 01:04AM BLOOD freeCa-1.28

___:  chest x-ray:

An ET tube ends 4.4 cm above the carina at the thoracic inlet. 
An NG tube 
ends in the fundus of the stomach. 
Lung volumes are low. There is no focal consolidation, no 
pleural effusion 
and no pneumothorax. The cardiomediastinal silhouette is normal. 

No displaced fractures are visualized in the thorax. 
  
PELVIS:  
No fracture 

___: chest x-ray:

 
The ET tube tip is 6 cm above the carina. NG tube tip is in the 
stomach. The patient is after recent abdominal surgery. Right 
internal jugular line tip is at the level of mid SVC. There is 
no pneumothorax. Minimal bibasilar atelectasis is noted but 
there is overall improvement of the right lung aeration, may be 
consistent with resolution of contusion

___:  Chest CTA:

 IMPRESSION: 
  
1. Within limitation of suboptimal contrast bolus, there is no 
evidence of 
acute central pulmonary embolism. 
  
2. No evidence of acute aortic injury. 
  
3. Trace left pleural effusion. Bilateral opacification of lungs 
with some 
air bronchograms may represent compressive atelectasis; however, 
acute 
infectious process cannot be completely excluded and should be 
considered in the correct clinical setting. 

 
Brief Hospital Course:
___ year old gentleman admitted to the Acute Care service s/p 
gunshot wound to his abdomen.  Initially admitted to an OSH, 
where he was intubated,  required intravenous fluids and blood 
products.  
 
Upon admission, he was found to have a hemo-peritoneum.  He was 
urgently taken to the operating room where he underwent an 
exploratory laparotomy and small bowel resection.  During his 
operative course, he required additional blood products.  He had 
an 1800cc blood loss.  He was monitored in the intensive care 
unit after his surgery where he required pressors for blood 
pressure support. Once his blood pressure stabilized, his 
pressors were weaned.   He was extubated on POD #1 and was 
maintained on antibiotics for 48 hours.
Social work services were consulted once he was extubated.

He was transferred to the regular floor on POD #2.  His 
post-operative pain was managed with Dilaudid PCA. He did have 
an isolated episode of decreased oxygen saturation related to 
his abdominal discomfort and his pain regimen was readjusted. He 
did experience abdominal distention with slow return of bowel 
function and received methylnaltrexone with passage of flatus.  
His PCA was discontinued once clear liquids were tolerated and 
his diet was gradually advanced.  He had adequate pain relief 
with oral Dilaudid and Tylenol.

He ambulated with some difficulty initially and required walking 
with a walker. Currently he is walking independently on his own 
but will be sent home with a walker if he needs it. His surgical 
wound is healing well.  His vital signs are stable and he is 
afebrile.  After an uncomplicated recovery he was discharged to 
his mothers home on ___ and will follow up in the Acute Care 
Clinic in 2 weeks.

 
Medications on Admission:
none
 
Discharge Medications:
1. Colace 100 mg Capsule Sig: One (1) Capsule PO twice a day: 
hold for diarrhea.  
2. acetaminophen 325 mg Tablet Sig: Two (2) Tablet PO Q6H (every 
6 hours) as needed for pain.  
3. hydromorphone 2 mg Tablet Sig: ___ Tablets PO every ___ hours 
as needed for pain: Decrease the amount or increase the interval 
as your pain improves.
Disp:*100 Tablet(s)* Refills:*0*
4. senna 8.6 mg Tablet Sig: Two (2) Tablet PO once a day as 
needed for constipation.  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
1. Gunshot wound to the abdomen, and multiple small bowel injury 
as well as mesenteric vessel injury.
2. Acute blood loss anemia

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
You were admitted to the hospital with a gunshot wound to the 
abdomen. You also had injury to your left flank.  You were taken 
to the operating room for a resection of your bowel.  You are 
now preparing for discharge home with the following 
instructions:

Please call your doctor or nurse practitioner or return to the 
Emergency Department for any of the following:

*You experience new chest pain, pressure, squeezing or 
tightness.

*New or worsening cough, shortness of breath, or wheeze.

*If you are vomiting and cannot keep down fluids or your 
medications.

*You are getting dehydrated due to continued vomiting, diarrhea, 
or other reasons. Signs of dehydration include dry mouth, rapid 
heartbeat, or feeling dizzy or faint when standing.

*You see blood or dark/black material when you vomit or have a 
bowel movement.

*You experience burning when you urinate, have blood in your 
urine, or experience a discharge.

*You have shaking chills, or fever greater than 101.5 degrees 
Fahrenheit or 38 degrees Celsius.

*Any change in your symptoms, or any new symptoms that concern 
you.

Please resume all regular home medications , unless specifically 
advised not to take a particular medication. Also, please take 
any new medications as prescribed.

Please get plenty of rest, continue to ambulate several times 
per day, and drink adequate amounts of fluids. Avoid lifting 
weights greater than ___ lbs until you follow-up with your 
surgeon.

Avoid driving or operating heavy machinery while taking pain 
medications.

Incision Care:

*Please call your doctor or nurse practitioner if you have 
increased pain, swelling, redness, or drainage from the incision 
site.

*Avoid swimming and baths until your follow-up appointment.

*You may shower, and wash surgical incisions with a mild soap 
and warm water. Gently pat the area dry.

*If you have staples, they will be removed at your follow-up 
appointment.

*If you have steri-strips, they will fall off on their own. 
Please remove any remaining strips ___ days after surgery

 
Followup Instructions:
___
"
12247014-DS-9," 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: SURGERY
 
Allergies: 
Patient recorded as having No Known Allergies to Drugs
 
Attending: ___.
 
Chief Complaint:
___ YOM who fell and hit head on car tire, sustaining  C6-7 
ligamentous injury
 
Major Surgical or Invasive Procedure:
___ C4-7
Tracheostomy
Percutaneous Endoscopic Gastrostomy
IVC filter

 
History of Present Illness:
___ s/p fall while carrying a mattress in the garage, fell on 
his car, and hyperextended his neck against the tire. Found by 
his family unable to move his extremities. Pt was intubated on 
scene by EMS and medflighted to ___.
 
Past Medical History:
CAD
Htxn
hypercholesterolemia
DM2
seizure disorder
allergic rhinitis
prostate CA s/p radiation ___
prior mechanical fall
 
Social History:
___
Family History:
n/c
 
Physical Exam:
T95.7 P55 90/40 100% intubated CPAP 0.5 PS 15 PEEP 5
intubated but awake, alert, responding to questions
PERRLA
sensation impaired below C5
UE bicep/tricep strength intact
___ b/l flaccid
lower ext w/o reflex
RR S1 S2 no m/r/g
CTA b/l
soft ND NT no peritonitis
 
Pertinent Results:
___ 12:45PM   WBC-8.2 RBC-3.43* HGB-10.3* HCT-29.7* MCV-87 
MCH-30.0 MCHC-34.6 RDW-14.2
___ 12:45PM   PLT COUNT-239
___ 12:45PM   NEUTS-74.2* ___ MONOS-4.5 EOS-2.8 
BASOS-0.3
___ 12:45PM   ___ PTT-23.0 ___
___ 12:45PM   ___ 12:48PM   GLUCOSE-93 LACTATE-2.9* NA+-138 K+-5.1 
CL--106 TCO2-23
___ 12:45PM   UREA N-22* CREAT-1.1
___ 12:45PM   CALCIUM-8.3* PHOSPHATE-2.7 MAGNESIUM-1.8
___ 12:45PM   CK(CPK)-267* AMYLASE-52
___ 12:45PM   CK-MB-5
___ 12:45PM   cTropnT-<0.01

___ 12:45PM   ASA-NEG ETHANOL-NEG ACETMNPHN-NEG 
bnzodzpn-NEG barbitrt-NEG tricyclic-NEG
___ 01:15PM URINE  bnzodzpn-NEG barbitrt-NEG opiates-NEG 
cocaine-NEG amphetmn-NEG mthdone-NEG

___ 01:15PM URINE  BLOOD-LG NITRITE-NEG PROTEIN-NEG 
GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-5.0 
LEUK-NEG
___ 01:15PM URINE  ___ BACTERIA-FEW YEAST-NONE 
EPI-0

___-SPINE: There is visualization of the skull base through T1. 
There is no evidence of acute fracture. However, anterior 
splaying of the intervertebral disc space at the C6-7 level is 
concerning for ligamentous injury. There is no 
spondylolisthesis. There is no paravertebral hematoma seen. 
  
Multilevel degenerative changes are seen. There is mild 
narrowing of the spinal canal due to posterior osteophytes at 
the C5-6 level and also due to disc osteophyte complex at the 
C7-T1 level. Uncovertebral hypertrophy and facet hypertrophy 
cause severe narrowing of the right neural foramen at the C4-5 
level. Uncovertebral hypertrophy causes moderate bilateral 
neural foramen narrowing at the C5-6 level. Uncovertebral and 
facet joint hypertrophy cause severe neural foraminal narrowing 
at the C6-7 level. 

CT HEAD: No evidence of intracranial hemorrhage. Hypodensity in 
subcortical and periventricular white matter in right 
occipital/parietal region may represent chronic small vessel 
ischemia. MR may be performed for more sensitive evaluation of 
acute infarct if of clinical concern. 
  
CTA head/neck: Bilateral partially calcified plaques at carotid 
bifurcations, with at least 50% stenosis on the right. Left 
vertebral artery dominant, with intermittent flow seen in 
diminuitive right vertebral. Intracranial arteries patent; small 
basilar with patent PComs bilaterally. 3D reformats pending. 
Scattered rounded pulmonary opacities and atelectasis. Anterior 
splaying of C5-6. ETT/NGT. Ethmoid mucosal thickening & fluid in 
nasopharynx. 

CT Torso:
1. Multifocal pulmonary opacities concerning for multifocal 
pneumonia, although there is also likely a component of 
aspiration. Atelectasis involving right upper and bilateral 
lower lobes. ETT slightly low. 
2. No evidence of acute intra-abdominal pathology. Colonic 
diverticula, without evidence of diverticulitis. 

___ Radiologic Studies
MR/MRA brain:
1. A small subcentimeter focus of increased signal on the 
diffusion-weighted image, which may represent a small acute 
infarct versus T2 shine-through artifact. As this is not 
definitely identifiable on other sequences, a followup study, 
can be considered to assess stability of this finding and 
confirming its nature. 
  
2. Very small caliber of the distal vertebral and basilar 
arteries, which is grossly unchanged since ___. Prominent 
posterior communicating arteries, supplying the posterior 
circulation. This appearance may relate to atherosclerotic 
disease, as described previously.

MR ___ spine:
The axial GRE sequence is limited due to motion artifacts. 
However, confirming the findings of the recent CT of the 
cervical spine, there is widening of the disc space anteriorly 
at the level of C6-C7 with disruption of the anterior 
longitudinal ligament, anterior disc herniation with increased 
signal within the disc, which can relate to edema. In addition, 
there is also evidence of injury to the anterior longitudinal 
ligament at the level of C5-6 with widening of the disc space 
anteriorly with increased signal of the disc, representing 
edema. There is also diffuse disc bulge with posterior central 
disc extrusion with superior migration. Theposterior 
longitudinal ligament is displaced anteriorly and has some 
increased signal within which can relate to edema or injury. 
There is effacement of the ventral thecal sac at this level, 
with moderate- severe compression on the cord. There is 
increased signal within the cord extending from the level of C4 
to C7 from cord edema versus contusion. This linear focus of 
increased signal noted posterior to the C5 body (___) can 
represent small edpidural hematoma. 
  
At C2-3, small central focal disc protrusion is noted. 
  
At C3-4 moderate-sized central disc extrusion is noted causing 
mild indentation on the ventral thecal sac. 
  
At C4-5, there is posterior spondylotic ridge with uncovertebral 
osteophyte causing mild indentation on the ventral thecal side 
and bilateral neural foraminal narrowing. At C4-5, there is also 
increased signal in the disc, with anterior disc herniation and 
possible injury to the anterior longitudinal ligament at this 
level as well. 
  
At C7-T1, the disc space is grossly unremarkable but not 
adequately assessed due to artifacts on the axial sequences. 
  
There is moderate amount of increased signal in the prevertebral 
soft tissues, representing edema versus hemorrhagic contusion. 
  
On the STIR sequence, there is also increased signal in the 
interspinous and the posterior spinous soft tissue at the level 
of C5 and C6, representing possible edema or injury to the 
interspinous and supraspinous ligaments (series 5, image 10). 
Patient is intubated, with increased signal from fluid in the 
sphenoid and the maxillary sinuses. 
  
In the left lobe of the thyroid, there are areas of increased 
signal intensity seen on the sagittal T2 (series 5, image 10; 
series 6, image 27), which represent cysts or adenoma, not 
adequately assessed.  

 
Brief Hospital Course:
Patient was initially admitted to ___ for critical care 
support.
Pt was evaluated by Ortho Spine service (Dr ___ and 
underwent 

___ 1. Fusion C4-C7.
        2. Anterior diskectomies at C4-5, C5-6 and C6-7.
        3. Anterior instrumentation C4-C7.
        4. Structural allograft.

___ 1. Total laminectomy of C4, 5, 6 and 7.
        2. Fusion C4-C7.
        3. Posterior instrumentation C4-7.
        4. Autograft.
<please see op report for details>

Given his neurologic deficit due to C5 spinal cord injury, he 
underwent

___ 1. Tracheostomy. (#8 perfit, cuffed, non-fenestrated)
        2. Percutaneous endoscopic gastrostomy.
        3. Placement of inferior vena cava filter. (Bard G2)

Pt was trasferred to Trauma Service/TSICU for postop care and 
vent support. He continued on heparin 5000 units SC TID.

___ early AM febrile to 102. Defervesced over the course of 
the day. Pt was pan cultured (blood x2, tracheal Aspirate)and 
started on broad-spectrum IV antibiotic coverage with Vancomycin 
and Zosyn. 
___ Pt has been afebrile for 24 hours. At this time feel that 
patient is ready for discharge to extended care facility. 
Patient seen by psychiatry and at this time does not want to 
begin antideppressant therapy.  Psych recommends counseling 
during rehabilitation 

 
Medications on Admission:
Lisinopril 40 mg qday
enalapril 20 mg q day
Simvastatin 20 mg
Isosorbide mono 30 mg q day
phenytoin 100mg bid
metformin 1000mg BID
amlodipine 10mg q day
atenolol 100mg q day
 
Discharge Medications:
1. Acetaminophen 325 mg Tablet Sig: ___ Tablets PO Q6H (every 6 
hours) as needed.  
2. Atorvastatin 20 mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
3. Insulin Lispro 100 unit/mL Solution Sig: One (1) injection 
Subcutaneous ASDIR (AS DIRECTED).  
4. Albuterol 90 mcg/Actuation Aerosol Sig: ___ Puffs Inhalation 
Q6H (every 6 hours) as needed.  
5. Famotidine 20 mg Tablet Sig: One (1) Tablet PO BID (2 times a 
day).  
6. Bisacodyl 10 mg Suppository Sig: One (1) Suppository Rectal 
DAILY (Daily) as needed.  
7. Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a 
day) as needed.  
8. Oxycodone-Acetaminophen ___ mg/5 mL Solution Sig: ___ MLs 
PO Q4H (every 4 hours) as needed.  
9. Colace 50 mg/5 mL Liquid Sig: Five (5) mL PO twice a day.  

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
Cervical stenosis and multi-level cervical spine fracture with 
C5 spinal cord injury
 
Discharge Condition:
Stable

 
Discharge Instructions:
You must wear the Cervical collar at all times when out of bed 
until follow-up.  You do not need to wear the collar when in 
bed.

Monitor for skin breakdown under collar. Keep incision clean and 
dry, cover with dry gauze dressing as needed. Call your doctor 
for any concerns about the wound, fevers/chills, or new 
neurologic symptoms.

You are able to shower, but do not submerge the incisions under 
water.

Do not lift anything heavier than a gallon of milk (about 10 
lbs).  Do not bend or twist your neck.
 
Followup Instructions:
___
"
12304719-DS-18," 
Name:  ___               Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: NEUROLOGY
 
Allergies: 
Biaxin
 
Attending: ___.
 
Chief Complaint:
Left hand clumsiness and left leg stiffness.
 
Major Surgical or Invasive Procedure:
None.

 
History of Present Illness:
Mr. ___ is a ___ right-handed male with a past 
medical history significant for hypertension, panhypopituitarism 
since a benign pituitary adenoma in ___, panic and anxiety, and 
BPH, who presents with an episode of left hand 
weakness/clumsiness this morning followed by an episode of left 
leg weakness this afternoon.
 
The patient was in his usual state of health this morning when 
he was trying to put an earring in his wife's ear.  While he was 
doing this, he noticed a sudden onset of a strange feeling in 
his left hand.  He is a little unclear about what this feeling 
was.  He believes there was perhaps some tingling or the 
sensation that the hand was asleep.  He also felt that he might 
be having some difficulty with coordination trying to get the 
earring in his wife's ear.  He is unsure if there was any actual 
weakness.  He stopped doing what he was doing and proceeded to 
shake the hand for a brief period of time.  He believes the 
sensation lasted for about a minute and then resolved.  After 
the episode had ceased, he was able to then put the earring in 
his wife's ear, a task which apparently requires some degree of 
dexterity. 
 
After that episode, he did not think anything of it and he 
continued to go about his day.  According to both he and his 
wife, the rest of the day was uneventful until the early 
afternoon when he went to fill a prescription at his pharmacy.  
The patient was driving in his car and he noticed when he was 
attempting to get out of the car, his left leg was both stiff 
and weak.  The patient has had a number of problems with left 
leg stiffness in the past; however, this was unlike other 
episodes.  He felt his left leg was dragging and he was unable 
to put any weight on it.  He was barely able to take a few steps 
before he felt he was going to give out and fall down.  However, 
someone in the pharmacy caught him and laid him down on the 
floor.  The patient felt that he would have fallen due to the 
lack of power in the left leg.  There was no pain with this 
episode.  The people in the pharmacy insisted that he stay on 
the floor for approximately ___ minutes.  During that time, 
the patient did not test the leg, so he is not completely sure 
how long the episode lasted.  After the ___ minutes had 
passed, he insisted that he could get up and was able to do so.  
At this point, he believes he was walking normally, although he 
did feel that his left leg was somewhat stiff.  However, at this 
point, the stiffness was not significantly different than his 
usual left leg stiffness.  He spoke with his PCP who recommended 
that the patient come into the emergency room.  The patient was 
able to walk to his car, get in his car, and drove to the ___ 
Emergency Room.  He believes he is back at baseline, although 
feels his left leg is slightly stiff currently.
 
The patient has never had anything like this happen before.  He 
has never had any problems with carpal tunnel syndrome or 
tingling or numbness in his hands either left or right.  The 
patient has for many years, although he is not clear for how 
long, had difficulty with his left leg and left leg stiffness.  
However, he has never experienced significant weakness like this 
in the past.  He does report that sometimes he has some 
difficulty lifting up his leg and needs to lower his pants down 
to get his leg into it and sometimes when getting out of a car 
will aid leg in lifting it out of the car.  The patient 
otherwise has not had any headaches.  He has had no other focal 
numbness or weakness besides the above-mentioned problems.  He 
had no difficulties with speech.  He has never experienced any 
episode like this before.  He has never had episodes of focal 
weakness in the past before either.
 

On neuro ROS, the pt denies headache, loss of vision, blurred 
vision, diplopia, dysarthria, dysphagia, lightheadedness, 
vertigo, tinnitus or hearing difficulty. Denies difficulties 
producing or comprehending speech.   No bowel or bladder 
incontinence or retention. Denies difficulty with gait.
  
On general review of systems, the pt denies recent fever or 
chills.  No night sweats or recent weight loss or gain. Denies 
cough, shortness of breath.  Denies chest pain or tightness, 
palpitations.  Denies nausea, vomiting, diarrhea, constipation 
or abdominal pain.  No recent change in bowel or bladder habits. 
 No dysuria.  Denies arthralgias or myalgias. Denies rash.
 
Past Medical History:
- HTN
- hypopituitarism s/p adenoma and radiation in ___
- BPH
- glaucoma
- hemorrhoids
- depression/anxiety
 
Social History:
___
Family History:
Father with prostate CA and a stroke later in life. Some HTN in 
his family as well.
 
Physical Exam:
Vitals: T: 97.8 P:52  R: 16  BP:235/69 -> 185/70  SaO2:99 
General: Awake, cooperative, NAD. 
HEENT: NC/AT, no scleral icterus noted, MMM, no lesions noted in
oropharynx 
Neck: Supple, no carotid bruits appreciated. No nuchal rigidity,
limited horizontal rotation of neck 
Pulmonary: Lungs CTA bilaterally without R/R/W 
Cardiac: RRR, nl. S1S2, no M/R/G noted 
Abdomen: soft, NT/ND, normoactive bowel sounds
Extremities: No C/C/E bilaterally, 2+ radial, DP pulses
bilaterally. 
Skin: no rashes or lesions noted. 
 
Neurologic: 
-Mental Status: Alert, oriented x 3.  Able to relate history
without difficulty.  Attentive, able to name ___ backward 
without
difficulty.  Language is fluent with intact repetition and
comprehension.  Normal prosody.  There were no paraphasic 
errors.
Pt. was able to name both high and low frequency objects.  Able
to read without difficulty.  Speech was not dysarthric. Able to
follow both midline and appendicular commands. Pt. was able to
register 3 objects and recall ___ at 5 minutes.  The pt. had 
good
knowledge of current events.  There was no evidence of apraxia 
or
neglect. 

-Cranial Nerves: 
I: Olfaction not tested.  
II: PERRL 3 to 2mm and brisk.  VFF to confrontation.  
III, IV, VI: EOMI without nystagmus.  Normal saccades. 
V: Facial sensation intact to light touch. 
VII: No facial droop, facial musculature symmetric. 
VIII: Hearing intact to finger-rub bilaterally.  
IX, X: Palate elevates symmetrically.  
XI: ___ strength in trapezii and SCM bilaterally. 
XII: Tongue protrudes in midline.
 
-Motor: Normal bulk, slightly increased tone in left leg/arm,
Slight curling of left arm on pronator No adventitious 
movements,
such as tremor, noted. No asterixis noted. 
  Delt Bic Tri WrE FFl FE IO IP Quad Ham TA ___ 
L  5    ___   ___  4+  5    5- 4+    5     5-  5- 
R  5    ___   ___  5   5    5  5     5     5   5 
RAM a little slower on left, but he is left handed. 

-Sensory: No deficits to light touch, pinprick, cold sensation,
vibratory sense, proprioception throughout. No extinction to 
DSS.

 
-DTRs: 
  Bi Tri ___ Pat Ach 
L  3  3    3    3   2 
R  2  2    2    2   1 
Plantar response was flexor bilaterally. 
 
-Coordination: No intention tremor, no dysdiadochokinesia noted.
No dysmetria on FNF or HKS bilaterally. 
 
-Gait: Good initiation. Narrow-based, normal stride and arm
swing.  Able to walk in tandem without difficulty. Romberg
absent.
 
Pertinent Results:
___ 07:50AM BLOOD WBC-11.3* RBC-4.35* Hgb-13.8* Hct-39.5* 
MCV-91 MCH-31.7 MCHC-35.0 RDW-14.5 Plt ___
___ 01:00PM BLOOD Neuts-73.9* Lymphs-17.9* Monos-4.6 
Eos-2.9 Baso-0.6
___ 07:45AM BLOOD ___ PTT-21.5* ___
___ 07:50AM BLOOD Glucose-77 UreaN-26* Creat-1.2 Na-142 
K-3.5 Cl-110* HCO3-25 AnGap-11
___ 07:45AM BLOOD ALT-15 AST-18 AlkPhos-51 TotBili-0.6
___ 07:45AM BLOOD Albumin-3.8 Calcium-9.3 Phos-3.6 Mg-2.1 
Cholest-224*
___ 07:45AM BLOOD %HbA1c-5.6 eAG-114
___ 07:45AM BLOOD Triglyc-124 HDL-55 CHOL/HD-4.1 
LDLcalc-144
___ 07:45AM BLOOD TSH-<0.02*
___ 01:00PM BLOOD ASA-NEG Acetmnp-NEG Bnzodzp-NEG 
Barbitr-NEG Tricycl-NEG
 
___ 05:20AM URINE Color-Yellow Appear-Clear Sp ___
___ 05:20AM URINE Blood-NEG Nitrite-NEG Protein-TR 
Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-5.5 Leuks-NEG
___ 05:20AM URINE RBC-1 WBC-1 Bacteri-NONE Yeast-NONE Epi-0
URINE CULTURE (Final ___:    NO GROWTH. 
 
EKG
Sinus bradycardia. Right bundle-branch block. Since the previous 
tracing of ___ the axis is more vertical and right 
bundle-branch block is new. Clinical correlation is suggested.
___
___
 
MRI Brain
IMPRESSION:
1. The non-contrast MRI of the brain demonstrates no acute 
intracranial
process. There are multiple T2 hypointense lesions which 
demonstrate gradient
signal artifact within the bilateral frontal lobes and the right 
pons which
are unchanged compared with the prior study in ___ and 
most
certainly represent occult vascular malformations
2. There is a severe short segment stenosis of the proximal 
right A1 segment
of the anterior cerebral artery. There are also other foci of 
intracranial
arterial stenoses to include the right MCA M2 branch and 
bilateral PCA
branches which are not typical for atheromatous disease. Even 
though these
are atypical in appearance for atheromatous disease, given the 
high incidence
of this disease, atheromatous etiology is still on the 
differential. Another
possibility is a vasculitis. Clinical correlation recommended.
 
MRI C-spine
IMPRESSION:
Multilevel cervical spondylosis with mild to moderate spinal 
canal narrowing
from C3-C4 through C6-C7 worst at C5-C6 as described above 
without abnormal
signal of the spinal cord. There is severe neural foraminal 
narrowing at the
right C4-C5 and C5-C6.
 
CT C-spine
IMPRESSION: Moderate degenerative disease of the cervical spine, 
without
""critical"" spinal canal stenosis.
 
Brief Hospital Course:
Cervical Spondylosis/Canal Stenosis
Exam and history most consistent with this. Some confusion 
initially given left sided weakness in the context of a cavenoma 
in the right basis pontis, but cervical disease much more 
consistent with overall picture. Exam actually worsened after 
admission with increased leg stiffness/tone, left patella 
clonus, bilateral upgoing toes. Has not previously had neck 
pain. Exam worse than MRI, but flexion extension imaging not 
performed owing to worsening and concern for exacerbation. MRI 
c- and t- spine was performed, along with CT c-spine. 
Neurosurgery was consulted and recommended Medrol steroid dose 
taper, rigid collar and muscle relaxants. Thus, hydrocortisone 
10 mg BID was held while Medrol started and will need to be 
restarted wihen Medrol completed. This resulted in hypertension 
which will need to be followed closely as below. Typical 5 mg 
diazepam daily was rescheduled as 2 mg q8h. His exam improved 
somewhat in rigid collar and with Medrol, but we felt that he 
was not sufficiently independent to return home. Thus, he is 
discharged to rehabilitation. We expect that further clinical 
improvement will be seen. He should be seen by Neurosurgery in 
clinic in two weeks. He should remain in an Aspen rigid collar 
until that time. 
 
Hypertension
Amlodipine was increased to 10 mg QD from 5 mg, enalapril to 20 
mg BID from QD and atenolol was changed to carvedilol given 
blood pressures around 200 systolic. This began prior to steroid 
treatment, but uptitration of these medications in part occurred 
during steroid treatment. It will be essential to follow his 
blood pressure closely and down-titrate medications if there is 
a fall in his blood pressure with steroid taper. 
  
Hypopituitarism
After adenoma and radiation in ___. Radiation is the likely 
cause of cavernomas, of which he has several (see MRI report). 
Testosterone and levothyroxine were continued. Hydrocortisone 
was held in the context of methylprednisolone treatment, but 
will need to be restarted immediately on completion of last dose 
Medrol, lest he become Addisonian. This is very important. 
 
BPH
Continued to exhibit urgency and small volume urination, with 
some worsening due to spinal disease. Condom catheter was used 
for much of the admission. Finasteride was continued.
  
Glaucoma
Ophthalmic medicatons were continued. 
  
Depression/Anxiety
Buspirone and celexa, along with diazepam were continued. He was 
quite anxious about his new gait difficulties, but this was 
appropriate and understandable. Thus, these longer-standing 
problems were not really active issues during the admission. 
 
Leukocytosis
Attributable to steroid dosing. No bands.
 
Medications on Admission:
- Timolol 0.25% once a day left eye
- Xalatan .005%  once a day left eye
- Citalopram 15mg qd 
- Protonix 40mg qd
- ASA 81g qd
- Vit D3 1000U qd
- Omega 3 fatty acid ___ qd
- Valium 5mg qd
- Enalapril 20mg qd
- Finasteride 5mg qd
- Hydrocortisone 10mg BID
- AndroGel 1.25g/actuation Gel Pump (8 pumps on abd daily)
- Metoprolol 50mg BID
- Synthriod 125mcg qd
- Terazosin 5mg qd
- Buspirone 15mg BID
 
Discharge Medications:
1. timolol maleate 0.25 % Drops Sig: One (1) Drop Ophthalmic 
DAILY (Daily): Left eye.  
2. latanoprost 0.005 % Drops Sig: One (1) Drop Ophthalmic HS (at 
bedtime): Left eye.  
3. pantoprazole 40 mg Tablet, Delayed Release (E.C.) Sig: One 
(1) Tablet, Delayed Release (E.C.) PO Q24H (every 24 hours).  
4. omega-3 fatty acids     Capsule Sig: One (1) Capsule PO DAILY 
(Daily).  
5. finasteride 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 
 
6. hydrocortisone 20 mg Tablet Sig: 0.5 Tablet PO BID (2 times a 
day): Restart on ___ - very important to restart after done 
with Medrol dose pack given hypopituitarism. .  
7. levothyroxine 125 mcg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
8. metoprolol tartrate 50 mg Tablet Sig: One (1) Tablet PO BID 
(2 times a day).  
9. terazosin 5 mg Capsule Sig: One (1) Capsule PO HS (at 
bedtime).  
10. Methylprednisolone 6 mg BID on ___, 4 mg BID on ___, 2 mg 
BID on ___, then restart hydrocortisone 10 mg BID on ___.
11. testosterone 1 %(50 mg/5 gram) Gel in Packet Sig: One (1)  
Transdermal daily ().  
12. carvedilol 6.25 mg Tablet Sig: One (1) Tablet PO BID (2 
times a day).  
13. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID 
(2 times a day).  
14. senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a 
day) as needed for consiptation.  
15. diazepam 2 mg Tablet Sig: One (1) Tablet PO Q8H (every 8 
hours).  
16. enalapril maleate 20 mg Tablet Sig: One (1) Tablet PO twice 
a day.  
17. amlodipine 10 mg Tablet Sig: One (1) Tablet PO once a day.  
18. aspirin 81 mg Tablet, Delayed Release (E.C.) Sig: One (1) 
Tablet, Delayed Release (E.C.) PO once a day.  
19. Vitamin D-3 1,000 unit Tablet, Chewable Sig: One (1) Tablet, 
Chewable PO once a day.  
20. Celexa 10 mg Tablet Sig: 1.5 Tablets PO once a day.  
21. buspirone 15 mg Tablet Sig: One (1) Tablet PO twice a day.  

 
Discharge Disposition:
Extended Care
 
Facility:
___ 
 
Discharge Diagnosis:
Primary
Cervical stenosis with myelopathy
 
Secondary
Hypertension
Panhypopituitarism

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
You were admitted after a brief episode (that lasted for a few 
seconds) of left hand clumsiness and a few minutes of left leg 
stiffness. Your brain MRI did not show any stroke but did show 
small cavernomas which are vascular malformations. Your clinical 
condition worsened after admission and clinical findings were 
consistent with spinal stenosis with myelopathy. This was 
confirmed on imaging of your spine. You were seen by 
Neurosurgery who recommended against surgery at this time, and 
that you follow-up with them as an outpatient. Physical therapy, 
along with your Neurology Team, recommended a stay in 
rehabilitation.  
 
Followup Instructions:
___
"
12314513-DS-16," 
Name:  ___                Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Penicillins / NSAIDS (Non-Steroidal Anti-Inflammatory Drug)
 
Attending: ___.
 
Chief Complaint:
Positive PPD
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
Ms. ___ is a ___ with PMH of iron deficiency secondary to 
menorrhagia, NSAID gastritis, and bipolar disorder presenting 
for evaluation of +PPD and concern for active TB exposure.  
To explain the current scenario, one of pt's roommate beginning 
in ___ developed a severe cough associated with fever or 
chills. These symptoms continued through ___. Pt. never sought 
medical intention. In this time period, pt. was traveling around 
___ interviewing for grad school. Prior to ___, pt. had 
traveled to ___ ___ years prior, but otherwise no recent 
travel. No known risk factors for HIV in this person as far as 
the pt. is aware. This individual then traveled to Malaise and 
___ in ___ and then returned to live with the pt.  
Pt. also lives with multiple other roommates, 2 of which have 
positive PPDS recently. One of these roommates has been coughing 
and feeling unwell for several weeks.  
Pt. wanted to go to the minute clinic to have a ppd placed. Pt. 
found out about positive ppd on ___ (20mm). She made an 
urgent care appt here to have a CXR. Pt. presented to ___ 
urgent care in ___ and was referred to the ED.  
Pt. recently began feeling generalized malaise and weak over the 
last several weeks. She has noted an on and off cough over the 
same time period, typically in the mornings. Denies sputum 
production, fevers, chills, weight gain (intentional weight loss 
of 7lbs since ___, chest pain, SOB, nausea, vomiting. Pt. 
does note ___ year of abdominal pain associated with loose stools. 
No significant change in this recently. Denies ever having a BCG 
vaccine. Pt. has traveled to ___, 
Hungry, ___, and ___. Last travel 
was ___ in ___ working in a hospital (sanitizine and 
autoclaving parts).  
In the ED, initial VS were 98.2 76 113/75 16 100% RA  
-Labs showed normal CBC, BMP, normal lactate at 1.2, UA 
unremarkable, UCx and BCx pending  
-Imaging showed CXR without acute cardiopulmonary process. No 
findings to suggest active tuberculosis.  
-Transfer VS were 98.2 72 118/72 16 100% RA  
-Decision was made to admit to medicine for further management.  

-On arrival to the floor, patient reports...  
REVIEW OF SYSTEMS:  
As documented in HPI  

 
Past Medical History:
# Iron Deficiency Anemia: hx of heavy menses, checking for 
___'s disease  
# Bipolar Type II with hypomanic episodes  
# UGIB ___ Erosive Gastropathy (___) - unclear etiology, no 
evidence of hpylori  
# Positive PPD (___), 20mm  

 
Social History:
___
Family History:
She notes that her mother has an arrhythmia and her grandmother 
died of complications of heart disease in her ___.  

 
Physical Exam:
ADMISSION PHYSICAL EXAM:  
VS: 98.0, 116/75, 61, 18, 99% on RA  
GENERAL: NAD  
HEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva, 
MMM, good dentition  
NECK: nontender supple neck, no LAD, no JVD  
CARDIAC: RRR, S1/S2, no murmurs, gallops, or rubs  
LUNG: CTAB, no wheezes, rales, rhonchi, breathing comfortably 
without use of accessory muscles  
ABDOMEN: nondistended, +BS, nontender in all quadrants, no 
rebound/guarding, no hepatosplenomegaly  
EXTREMITIES: no cyanosis, clubbing or edema, moving all 4 
extremities with purpose  
PULSES: 2+ DP pulses bilaterally  
NEURO: CN II-XII intact  
SKIN: warm and well perfused, no excoriations or lesions, no 
rashes 

DISCHARGE PHYSICAL EXAM:
VS: 97.7, 94/57, 52, 18, 99% on RA  
General: alert, oriented, no acute distress  
HEENT: sclera anicteric, MMM, oropharynx clear  
Neck: supple, JVP not elevated, no LAD  
Lungs: clear to auscultation bilaterally, no wheezes, rales, 
ronchi  
CV: regular rate and rhythm, normal S1 + S2, no murmurs, rubs, 
gallops  
Abdomen: soft, non-tender, non-distended, bowel sounds present, 
no rebound tenderness or guarding, no organomegaly  
GU: no foley  
Ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis or 
edema  
Neuro: CNs2-12 intact, motor function grossly normal  
 

 
Pertinent Results:
***ADMISSION LABS***
___ 02:00PM BLOOD WBC-6.0 RBC-4.30 Hgb-12.5 Hct-35.9 MCV-84 
MCH-29.1 MCHC-34.8 RDW-12.0 RDWSD-36.6 Plt ___
___ 02:00PM BLOOD Neuts-61.0 ___ Monos-8.5 Eos-0.8* 
Baso-0.5 Im ___ AbsNeut-3.66 AbsLymp-1.74 AbsMono-0.51 
AbsEos-0.05 AbsBaso-0.03
___ 02:00PM BLOOD Glucose-97 UreaN-10 Creat-0.8 Na-139 
K-3.6 Cl-104 HCO3-26 AnGap-13
___ 02:17PM BLOOD Lactate-1.2

***DISCHARGE LABS***
___ 07:25AM BLOOD WBC-6.1 RBC-4.61 Hgb-13.0 Hct-39.0 MCV-85 
MCH-28.2 MCHC-33.3 RDW-12.3 RDWSD-37.2 Plt ___
___ 07:25AM BLOOD Glucose-86 UreaN-8 Creat-0.7 Na-138 K-4.1 
Cl-104 HCO3-24 AnGap-14
___ 07:25AM BLOOD Calcium-9.2 Phos-3.9 Mg-1.8

***OTHER LABS***
___ 07:17AM BLOOD HIV Ab-Negative

***IMAGING***
___ CXR
FINDINGS:  
The lungs are hyperinflated and clear.  No pleural effusion or 
pneumothorax is seen. The cardiac and mediastinal silhouettes 
are unremarkable. 
  
IMPRESSION:    
No acute cardiopulmonary process.  No findings to suggest active 
tuberculosis.

***MICROBIOLOGY***
___ 12:25 am SPUTUM      Source: Induced. 

   ACID FAST SMEAR (Final ___: 
      NO ACID FAST BACILLI SEEN ON CONCENTRATED SMEAR.

___ 9:02 am SPUTUM      Source: Induced. 

   ACID FAST SMEAR (Final ___: 
      NO ACID FAST BACILLI SEEN ON CONCENTRATED SMEAR. 

___ 5:23 pm SPUTUM      Source: Induced (noted as 
expectorated in lab report, but actually induced per respiratory 
therapist, will be corrected in future records)

   ACID FAST SMEAR (Final ___: 
      NO ACID FAST BACILLI SEEN ON CONCENTRATED SMEAR. 

 

 
Brief Hospital Course:
Ms. ___ was admitted to rule out active pulmonary 
tuberculosis.

ACTIVE ISSUES  
==============  
#Positive PPD: Pt. has had generalized malaise with a mild cough 
recently, however she is largely asymptomatic, no fevers, 
chills, hemoptysis. Negative CXR (if reactivation TB, would 
expect positive CXR). Pt. without risk factors for HIV, negative 
test within the last ___ years.  Induced sputum x3 was preformed 
with no AFB on gram stain, culture results and MTB direct 
amplification pending at time of discharge.  HIV ab negative.  

CHRONIC ISSUES  
===============  
#Iron Deficiency anemia: due to menorrhagia, pt s/p IV iron 
___, not on oral iron supplement per last outpatient note.  
Recommend continued outpatient monitoring.  
 
#Bipolar Type II: stable per last outpatient note, patient not 
on any medications  

#Seasonal Allergies: Continue fluticasone PRN  

TRANSITIONAL ISSUES:
======================
[ ] Final acid fast sputum cultures pending at discharge.
[ ] Patient is planning to move to ___ in two weeks. We 
recommend that she find an Infectious Disease specialist in ___ 
___ to start treatment for latent TB, and she is agreeable. We 
counseled her on the types of medications, side effects, etc. 
She plans to f/u with PCP at ___ prior to moving as well.
 
Medications on Admission:
1. Fluticasone Propionate NASAL 1 SPRY NU DAILY:PRN Nasal 
Congestion 

 
Discharge Medications:
1. Fluticasone Propionate NASAL 1 SPRY NU DAILY:PRN Nasal 
Congestion 

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
PRIMARY DIAGNOSIS:
===================
Positive PPD

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___,

It was a pleasure caring for your during your hospitalization at 
___.  You were admitted to rule 
out active tuberculosis given your positive PPD.  The initial 
sputum tests are negative, so we are discharing you home.  You 
should follow-up with your primary care physician as scheduled.  
We recommend that you find an Infectious Disease specialist 
after you move to ___ to start treatment for latent 
tuberculosis.

We wish you the best!

Sincerely,
Your ___ Team
 
Followup Instructions:
___
"
12545016-DS-17," 
Name:  ___                     Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
Chest Pain
 
Major Surgical or Invasive Procedure:
___ Coronary Angiography without stent or POBA

 
History of Present Illness:
Ms. ___ (***NEW NAME IS ___ is a ___ with a PMHx of 
mood d/o, fibromyalgia, and s/p gastric bypass who presented as 
an OSH transfer for evaluation of NSTEMI. 
  The patient notes that 1d PTA that she was in her USOH when 
she developed crushing substernal chest pain while walking. She 
sat down and it took approximately 20 minutes for the pain to 
ablate spontaneously. She also endorsed some SOB and 
lightheadedness with this episode. Unfortunately, later in the 
evening her chest pain recurred while at rest and was then a/w L 
arm numbness- after which her boyfriend encouraged her to 
present to the ED.  She has no recent history of DOE, CP with 
exertion or rest, orthopnea, leg swelling, or PND.  She is a 
smoker. She has never had chest pain like this before.   
  She received a full strength ASA at the OSH ED and was started 
on a heparin gtt. 

In the ED initial vitals were: 96.8 74 116/81 14 96% RA  
EKG: Sinus rate 72, normal axis, normal intervals, Q in III, TWI 
in V1  
Labs/studies notable for:  
 141 | 105 | 23  
 --------------- Anion gap = 15, hemolyzed sample  
 5.7 | 21 | 1.1  
WBC 9.7 Hgb 13.7 Plt 299  
INR 1.0  
K 4.8  
U/A 127 WBC, few bacteria, large leuk, positive nitrite  
Imaging with CTA which was negative for aortic pathology or PE. 
 
Patient was given:  IV NS and heparin gtt continued
 
REVIEW OF SYSTEMS:  
Cardiac review of systems is notable for absence of paroxysmal 
nocturnal dyspnea, orthopnea, ankle edema, palpitations, 
syncope, or presyncope.  

On further review of systems, denies any prior history of 
stroke, TIA, deep venous thrombosis, pulmonary embolism, 
bleeding at the time of surgery, myalgias, joint pains, cough, 
hemoptysis, black stools or red stools. Denies exertional 
buttock or calf pain. Denies recent fevers, chills or rigors. 
All of the other review of systems were negative.  
 
Past Medical History:
1. CARDIAC RISK FACTORS  
 - none per history

2. CARDIAC HISTORY  
 - CABG: None  
 - PERCUTANEOUS CORONARY INTERVENTIONS: None  
 - PACING/ICD: None  

3. OTHER PAST MEDICAL HISTORY  
Fibromyalgia
Mood disorder- depression/anxiety
Chronic LBP 
s/p gastric bypass in ___
 
Social History:
___
Family History:
Father- CAD, died in ___
Mother- ""bad heart"", unsure of details
2 brothers and two sons without known cardiac disease. One 
granddaughter with congenital heart defect.
 
Physical Exam:
==============================
ADMISSION PHYSICAL EXAMINATION
============================== 
VS: Reviewed in POE- stable 
GENERAL: WDWN female in NAD. Oriented x3. Mood, affect 
appropriate.  
HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were 
pink, no pallor or cyanosis of the oral mucosa. No xanthelasma.  

NECK: Supple with  
CARDIAC: PMI located in ___ intercostal space, midclavicular 
line. RRR, normal S1, S2. Soft ___ systolic murmur best at LUSB. 
No thrills, lifts.  
LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp 
were unlabored, no accessory muscle use. No crackles, wheezes or 
rhonchi.  
ABDOMEN: Soft, NTND. No HSM or tenderness.  
EXTREMITIES: No c/c/e. No femoral bruits.  
SKIN: No stasis dermatitis, ulcers, scars, or xanthomas.  
PULSES: Distal pulses palpable and symmetric  

==============================
DISCHARGE PHYSICAL EXAMINATION
==============================
GENERAL: Well appearing woman sitting up in bed speaking to me. 
Not in any apparent distress. 
HEENT: Pupils equal and reactive. No scleral icterus or 
injection. Moist mucous membranes. 
NECK: JVP visible only at the base of the neck at 30 degrees. 
CARDIAC: S1/S2 regular. Soft ___ systolic murmur best at LUSB. 
LUNGS: Lungs clear to auscultation bilaterally without crackles, 
wheezing or rhonchi. No use of accessory muscles or evidence 
ABDOMEN: Soft, non-tender, non-distended. 
EXTREMITIES: Warm extremities with trace edema up to mid-shin 
bilaterally.  
SKIN: No stasis dermatitis, ulcers, scars, or xanthomas.  
PULSES: Distal pulses palpable and symmetric  
 
Pertinent Results:
============================
ADMISSION LABORATORY STUDIES
============================
___ 04:15AM URINE  BLOOD-NEG NITRITE-POS* PROTEIN-NEG 
GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.0 
LEUK-LG*
___ 04:15AM URINE  RBC-6* WBC-127* BACTERIA-FEW* YEAST-NONE 
EPI-2
___ 04:55AM   WBC-9.7 RBC-4.54 HGB-13.7 HCT-43.4 MCV-96 
MCH-30.2 MCHC-31.6* RDW-15.3 RDWSD-53.1*
___ 04:55AM   cTropnT-0.21*
___ 04:55AM   GLUCOSE-93 UREA N-23* CREAT-1.1 SODIUM-141 
POTASSIUM-5.7* CHLORIDE-105 TOTAL CO2-21* ANION GAP-15
___ 06:08AM   K+-4.7
___ 10:35AM   CK-MB-2 cTropnT-0.19*

==========================================
DISCHARGE AND PERTINENT LABORATORY STUDIES
==========================================
___ 06:15AM BLOOD WBC-6.7 RBC-3.90 Hgb-11.9 Hct-37.7 MCV-97 
MCH-30.5 MCHC-31.6* RDW-15.4 RDWSD-54.3* Plt ___
___ 06:15AM BLOOD Glucose-101* UreaN-17 Creat-1.0 Na-141 
K-4.4 Cl-106 HCO3-21* AnGap-14
___ 04:55AM BLOOD cTropnT-0.21*
___ 10:35AM BLOOD CK-MB-2 cTropnT-0.19*
___ 10:30AM BLOOD CK-MB-2 cTropnT-0.09*
___ 06:15AM BLOOD proBNP-122
___ 06:15AM BLOOD Calcium-8.4 Phos-3.3 Mg-1.8

===========================
REPORTS AND IMAGING STUDIES
===========================
------------------
___ CTA Chest 
------------------
IMPRESSION:  
1.  No aortic dissection or other acute abnormality. 
2.  No pulmonary embolism through the segmental level. 
3.  No acute pulmonary parenchymal process. 

___ Coronary Angiography
Left dominant
LM: No disease.
LAD: No obstructive disease.
LCx: No obstructive disease.
RCA: No obstructive disease.
Impressions:
No coronary artery disease.
Normal EF without wall motion abnormalities.

------------
___ TTE
------------
The left atrium is normal in size. Left ventricular wall 
thickness, cavity size and regional/global systolic function are 
normal (LVEF = 70%). Tissue Doppler imaging suggests a normal 
left ventricular filling pressure (PCWP<12mmHg). The right 
ventricular free wall thickness is normal. The right ventricular 
cavity is moderately dilated with depressed free wall 
contractility. The diameters of aorta at the sinus, ascending 
and arch levels are normal. The aortic valve leaflets (3) appear 
structurally normal with good leaflet excursion and no aortic 
stenosis or aortic regurgitation. The mitral valve appears 
structurally normal with trivial mitral regurgitation. The 
estimated pulmonary artery systolic pressure is normal. There is 
no pericardial effusion. 

No intracardiac shunt identified on agitated saline contrast 
injection with maneuvers.

IMPRESSION: dilated, hypokinetic right ventricle 

============
MICROBIOLOGY
============
URINE CULTURE (Final ___: 
MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), CONSISTENT WITH 
FECAL
CONTAMINATION. 
ESCHERICHIA COLI.    >100,000 CFU/mL.  PREDOMINATING ORGANISM.
INTERPRET RESULTS WITH CAUTION. 
                       
                     ESCHERICHIA COLI
                             |   
AMPICILLIN------------  =>32 R
AMPICILLIN/SULBACTAM--  =>32 R
CEFAZOLIN-------------   <=4 S
CEFEPIME--------------   <=1 S
CEFTAZIDIME-----------   <=1 S
CEFTRIAXONE-----------   <=1 S
CIPROFLOXACIN---------<=0.25 S
GENTAMICIN------------   <=1 S
MEROPENEM-------------<=0.25 S
NITROFURANTOIN--------  <=16 S
PIPERACILLIN/TAZO-----   <=4 S
TOBRAMYCIN------------   <=1 S
TRIMETHOPRIM/SULFA----  =>16 R
 
Brief Hospital Course:
=================
SUMMARY STATEMENT
=================
Ms. ___ is a ___ with a limited past cardiac history who 
presented with NSTEMI found to have clean coronary arteries on 
LHC and a dilated, hypokinetic RV on TTE. Ms. ___ presented 
with typical anginal symptoms with mild troponin elevation and 
no ischemic EKG changes. She had a coronary angiography that did 
not show significant disease and an ECG that demonstrated RV 
dilation with depressed free wall contractility with a normal PA 
systolic pressure. She did not have any other anginal symptoms 
after presentation. The differential for her RV hypokinesis 
includes thrombus (through no intracardiac shunt), microvascular 
disease, vasospasm or focal myocarditis. Given resolution of her 
symptoms and improvement of her cardiac enzymes, she was 
discharge home with plan for follow up TTE in several months. 

====================
ACUTE MEDICAL ISSUES
====================
# NSTEMI/Chest pain 
# RV Dysfunction
Ms. ___ presented with crushing substernal chest pain on two 
occasions in the 24 hours prior to presentation, occurring once 
while walking and once at rest. By presentation, she was chest 
pain free. However, she was found to have troponin-T elevation 
that peaked at 0.21 (her first lab drawn here) before 
downtrending. She did not have associated EKG changes 
(non-specific T wave inversions). LHC without CAD- making 
working diagnosis myocardial infarcation with non-obstructive 
coronary aterties (MINOCA), etiologies include myocarditis, 
thrombus, microvascular disease or vasospasm.

Etiology of isolated RV dilation and hypokinesis is unknown, 
though it is likely an incidental finding not related to her 
presentation. She did not have a intracardiac shunt that could 
help explain her findings. It is possible the etiology is 
secondary to a myocarditis, though it would be somewhat atypical 
to see isolated RV dysfunction. Vasospasm or transient thrombus 
are also on the differential. Primary pulmonary disease is less 
likely given her PASP was not elevated. She will be treated for 
primary prevention of CAD with ASA/statin. 

Of note, the patient experienced hypotension on two separate 
occasions shortly after oral Metoprolol. She should not be 
placed on beta blockade for that reasons. 
- ASA 81mg daily
- Atorvastatin 80mg daily
- D/c Metoprolol 12.5mg bid given hypotension with 
administration
- Repeat TTE in ___ to re-evaluate for RV dysfunction 

# Urinary tract infection
- U cx originally with mixed flora, subsequently grew >100k 
units E. coil resistant to Bactrim and ampicillin/augmentin. 
Treated for 3 d with IV CTX 1g. 
- CTX 1g ___ -> ___

=====================
CHRONIC/STABLE ISSUES 
===================== 
# Depression
- Continued wellbutrin and trazodone

# Fibromyalgia
- Continued home lyrica and tizanidine

===================
TRANSITIONAL ISSUES
===================
- New Meds: Aspirin 81mg; Atorvastatin 80mg 
- Stopped/Held Meds: Held molixacam 15mg held during admission
- Changed Meds: None
- Post-Discharge Follow-up Labs Needed: None
- Incidental Findings: RV dilation, as above
- Discharge weight: ___ 108.1kg 238.32lbs 

[ ] Repeat TTE around ___ to evaluate for change in RV 
function
[ ] Patient should not be placed on beta-blockers as she became 
symptomatically hypotensive on this medication on two instances 
while hospitalized
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Pregabalin 150 mg PO TID 
2. Diazepam 5 mg PO Q8H:PRN anxiety 
3. Tizanidine 2 mg PO TID:PRN spasms 
4. rOPINIRole 1 mg PO QHS 
5. TraZODone 100 mg PO QHS 
6. BuPROPion (Sustained Release) 300 mg PO QAM 
7. BuPROPion (Sustained Release) 150 mg PO QPM 
8. meloxicam 15 mg oral DAILY 

 
Discharge Medications:
1.  Aspirin 81 mg PO DAILY 
RX *aspirin 81 mg 1 tablet(s) by mouth daily Disp #*30 Tablet 
Refills:*0 
2.  Atorvastatin 80 mg PO QPM 
RX *atorvastatin 80 mg 1 tablet(s) by mouth daily Disp #*30 
Tablet Refills:*0 
3.  BuPROPion (Sustained Release) 300 mg PO QAM  
4.  BuPROPion (Sustained Release) 150 mg PO QPM  
5.  Diazepam 5 mg PO Q8H:PRN anxiety  
6.  meloxicam 15 mg oral DAILY  
7.  Pregabalin 150 mg PO TID  
8.  rOPINIRole 1 mg PO QHS  
9.  Tizanidine 2 mg PO TID:PRN spasms  
10.  TraZODone 100 mg PO QHS  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
=================
PRIMARY DIAGNOSIS
=================
Non-ST elevation myocardial infaraction

===================
SECONDARY DIAGNOSES
===================
Right heart dilation 

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___, 

It was a pleasure caring for you while you were admitted to ___ 
___. 

WHY WERE YOU ADMITTED TO THE HOSPITAL?
- You were having chest pain and when you came to the hospital 
we found that you had evidence of damage to your heart, which 
made us worried you had blockages in the vessels of the heart. 

WHAT HAPPENED WHILE YOU WERE IN THE HOSPITAL?
- We did a coronary angiography (catheterization) that did not 
show any significant blockages in your heart. 
- We did an ultrasound of the heart (echocardiogram) that showed 
some stretching of the right side of your heart. This does not 
require us to do anything now, but you will have another 
ultrasound in several months to ensure there are no changes. 

WHAT SHOULD YOU DO WHEN YOU GO HOME?
- Please carefully review the medication list that we provided 
to you, as we changed some of your medications. 
- Continue to be active and get regular exercise. 
- Call your doctor or go to an emergency room right away if you 
have chest pain again. 

Sincerely, 
___ Cardiology Team
 
Followup Instructions:
___
"
12549331-DS-3," 
Name:  ___                Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
Dypsnea
 
Major Surgical or Invasive Procedure:
Intubation, extubation
___
Central line ___

 
History of Present Illness:
Mr. ___ is a ___ with PMH of asthma, sleep apnea on CPAP, 
and recent treatment for pneumonia (___) presenting with 
respiratory distress. History limited by patient intubation. 

Per ED signout, patient presented to ED on ___. CXR during 
past ED visit suggestive of left lung base early pneumonia. Was 
discharged from ED during that visit with instructions to 
complete 4 day course of azithromycin and prednisone, and to 
continue albuterol inhaler. Patient has been having persistence 
of the cough since his pneumonia in ___ despite completing 
the full course of antibiotics. His child has the flu and he has 
been having worsening symptoms including fever and nausea for 
the past two days. 

Patient presented to ___ saying he ""could 
not breath."" Wearing CPAP nightly. Using ICS daily and albuterol 
___. At ___, patient found to have 
RR 20, HR 140, O2 Sat 94% on 2 L O2. 

Sent to ___ ED for further management of respiratory distress. 

At ___, patient endorses significant difficulty breathing, but 
denies chest pain, abdominal pain or vomiting.
 
In ED initial VS: 
Temp 101.8 HR 138 BP 143/93 RR 35 POx 99% nrb 
 
Exam was notable for: Tachycardic, regular rhythm. Poor air 
movement bilaterally, diffuse expiratory wheezing.  

Labs significant for:  
FluAPCR: Positive
Lactate: 2
WBC 9.9
VBG 15:27: pH 7.37 pCO2 43 pO2 96 HCO3 26 
VBG 18:30: pH 7.21 pCO2 66 pO2 298 HCO3 28
VBG 20:12: pH 7.11 pCO2 85 pO2 166 HCO3 29
VBG 00:09 (___): pH 7.13 pCO2 76 pO2 121 HCO3 27

SPUTUM GRAM STAIN
>25 PMNs and <10 epithelial cells/100X field
1+ (<1 per 1000X FIELD): /GRAM POSITIVE COCCI
 /IN PAIRS/AND/SINGLY

Blood cx pending 

Patient was given:  
PO Acetaminophen 1000 mg 
PO Ibuprofen 600 mg 
IH Albuterol 0.083% Neb Soln 1 NEB 
IH Ipratropium Bromide Neb 1 NEB 
IV MethylPREDNISolone Sodium Succ 125 mg  
PO/NG OSELTAMivir 75 mg 
IH Albuterol 0.083% Neb Soln 1 NEB   
IH Ipratropium Bromide Neb 1 NEB 
IVF  NS ( 1000 mL ordered) 
IH Albuterol 0.083% Neb Soln 1 NEB 
IH Ipratropium Bromide Neb 1 NEB 
IV LORazepam .25 mg 
IV Magnesium Sulfate  
IH Albuterol 0.083% Neb Soln
IH Albuterol 0.083% Neb Soln  
IV Etomidate 20 mg 
IV Succinylcholine 100 mg 
IV Azithromycin  
IV CefTRIAXone (1 g ordered) 
IV DRIP Fentanyl Citrate ___ mcg/hr ordered) Started 50 
mcg/hr 
IV DRIP Propofol ___ mcg/kg/min ordered)Started 50 mcg/kg/min 
IV Rocuronium 60 mg 
IV Piperacillin-Tazobactam   
IV Azithromycin 500 mg 

Imaging notable for:  
CXR ___
Decreased conspicuity of previous left basal opacity suggests a 
resolving pneumonia. 

Consults:  
Respiratory Therapy:
Placed pt on HFNC at 100% and 40L, pt tolerated fairly well, but 
pt became more labored and somnolent over time. ABG showed a 
respiratory acidosis. Pt intubated with a 7.5ETT with a 
glidescope. ETCO2 had a + color change. Initial settings VT 500; 
RR 18; FiO2 80%; PEEP 8cm. Pt had very high PIPs of 40-50cm 
initially with low exhaled VT 100-200ccs. VT lowered to 370cc 
and RR increased to 24 than 30 - PEEP and FiO2 remained the 
same. Pt given Albuterol MDI 6 puffs for wheezing and was 
suctioned for small amts of thick, yellow secretions. Sputum 
sample obtained and sent to lab. s/p VBG 7.___/121/27 -5. Vent 
settings changed to vT:500 RR:24 PEEP:8 Fio2:60%. Etco2:41mmHg. 
With change in vent settings MV increased 10.5L --> 12L

Initially treated respiratory distress with nebs then advanced 
to BiPAP. Patient intubated after failing BiPAP for increasing 
hypercarbia and respiratory acidosis. Decision was made to admit 
patient to MICU for management of severe asthma exacerbation, 
flu, and pneumonia. 

VS prior to transfer:  
Temp 98.5 HR 108 BP 99/57 RR 24 POx 97% vent 
 
On arrival to the MICU, patient found to be hypotensive with 
SBPs ___. Given 1L bolus LR and started on norepinephrine 
drip. 

 
Past Medical History:
Asthma 
Hypothyroidism
HTN
Gout
GERD
Sleep Apnea
 
Social History:
___
Family History:
Several family members with flu, otherwise noncontributory
 
Physical Exam:
ADMISSION PHYSICAL EXAM
=======================
VITALS:  Reviewed in MetaVision
GENERAL: Intubated, NAD 
HEENT: Head AT NC, Sclera injected, Pupils 2mm and RLA
LUNGS: On ventilator, poor air movement throughout with 
scattered expiratory wheezes and rhonchi
CV: RRR, although difficult to appreciate   
ABD: soft, non-tender, non-distended, bowel sounds present, no 
rebound tenderness or guarding, no organomegaly  
EXT: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or 
edema
GU: Foley in place   
NEURO: Patient sedated 

DISCHARGE PHYSICAL EXAM
=======================
Vitals:
T:98 BP: 151/88 HR:85 18 94 RA
GENERAL: Alert, NAD, breathing room air comfortably and speaking 
in full sentences
EYES: Anicteric, PERRL
ENT: OP clear, MMM
CV: NR/RR, no m/r/g
RESP: Clear B/L auscultation without wheezes or rhonchi
GI: Abdomen soft, non-distended, non-tender to palpation.  Bowel
sounds present.
GU: No suprapubic fullness or tenderness to palpation
MSK: Neck supple, moves all extremities, strength grossly full
and symmetric bilaterally in all limbs, no ___ edema
SKIN: No rashes or ulcerations noted
NEURO: Alert, oriented, face symmetric, gaze conjugate with 
EOMI,
speech fluent, moves all limbs
PSYCH: pleasant, appropriate affect

 
Pertinent Results:
ADMISSION LABS
==============
___ 03:10PM BLOOD WBC-9.9 RBC-4.33* Hgb-14.7 Hct-43.6 
MCV-101* MCH-33.9* MCHC-33.7 RDW-13.6 RDWSD-50.4* Plt ___
___ 03:10PM BLOOD Neuts-91.7* Lymphs-3.2* Monos-4.0* 
Eos-0.4* Baso-0.3 Im ___ AbsNeut-9.04* AbsLymp-0.32* 
AbsMono-0.39 AbsEos-0.04 AbsBaso-0.03
___ 03:10PM BLOOD Plt ___
___ 03:10PM BLOOD Glucose-125* UreaN-14 Creat-1.1 Na-138 
K-4.0 Cl-100 HCO3-24 AnGap-14
___ 03:10PM BLOOD ALT-20 AST-23 AlkPhos-86 TotBili-0.4
___ 03:10PM BLOOD Albumin-4.2 Calcium-8.8 Phos-3.2 Mg-2.3
___ 03:27PM BLOOD ___ Temp-38.8 Rates-/28 pO2-96 
pCO2-43 pH-7.37 calTCO2-26 Base XS-0
___ 03:27PM BLOOD Lactate-2.0

MICRO
=====
Influenza A by PCR POSITIVE*
  Reported to and read back by 
___, 16:23 ___ 
Influenza B by PCR NEGATIVE

S. PNEUMONIAE ANTIGENS,       Not Detected        Not Detected
URINE                                             
 
___ URINE URINE CULTURE-FINAL INPATIENT 
___ URINE Legionella Urinary Antigen -FINAL 
INPATIENT 
___ MRSA SCREEN MRSA SCREEN-FINAL INPATIENT 
___ SPUTUM GRAM STAIN-FINAL; RESPIRATORY 
CULTURE-FINAL EMERGENCY WARD 
___ BLOOD CULTURE Blood Culture, Routine-PENDING 
EMERGENCY WARD 
___ BLOOD CULTURE Blood Culture, Routine-PENDING 
EMERGENCY WARD 

IMAGING
=======
___ CXR
IMPRESSION:  
Decreased conspicuity of previous left basal opacity suggests a 
resolving 
pneumonia. 

DISCHARGE LABS
==============
___ 07:45AM BLOOD WBC-6.2 RBC-3.80* Hgb-12.9* Hct-38.9* 
MCV-102* MCH-33.9* MCHC-33.2 RDW-13.5 RDWSD-51.5* Plt ___
___ 07:45AM BLOOD Glucose-112* UreaN-24* Creat-1.0 Na-143 
K-4.8 Cl-103 HCO3-27 AnGap-13
___ 03:30AM BLOOD ALT-14 AST-21 LD(LDH)-191 AlkPhos-57 
TotBili-<0.2
 
Brief Hospital Course:
Mr. ___ is a ___ male with asthma, OSA on CPAP, 
CAD with prior MI, HTN, and GERD who was recently treated for 
CAP (___) who presented in respiratory distress ___ influenza 
A and status asthmaticus.

#Influenza A
#Status Asthmaticus
#Hypoxemic respiratory failure
He initially presented to ___ urgent care 
wheezing and saying he ""could not breathe,"" found to be in 
respiratory distress with HR 140s, RR 20, and SpO2 94% on 2L and 
was transferred to the ___ ED for further management. In the 
ED
he was found to be febrile to 101.8, tachycardic in the 130s, 
slightly hypertensive, and tachypneic at RR 35 requiring a NRB 
to maintain SpO2 in the ___. He was placed on HFNC at 100% and 
40L which he tolerated well initially but his breathing became 
more labored and he became more somnolent. BiPAP was placed. 
Despite this, he developed a worsening respiratory acidosis with 
VBG: pH 7.11, pCO2 85, HCO3 29 and was intubated for hypercarbic 
respiratory failure. For his hypercarbic respiratory failure he 
was started on oseltamivir, methylprednisolone, Duonebs, and 
antibiotics (ceftriaxone, azithromycin, and Zosyn x1). He was 
started on broad spectrum antibiotics with vancomycin and 
ceftriaxone. These were discontinued on ___ as he had no overt 
evidence of bacterial pneumonia. He also received 3L IVF.  He 
was then admitted to the MICU. On arrival to the MICU he was 
hypotensive with SBPs in the ___. His lactate increased from 
2 to 17, although this was likely type B insetting of albuterol 
nebs. He was given 2L LR bolus and was started on 
norepinephrine. He was weaned off pressors within 24 hours. Due 
to high PIP due to breath stacking, he was paralyzed to optimize 
ventilation. He was extubated on ___. Called out to the floor on 
___, stable on room air. He was no longer wheezing and felt 
comfortable using nebulizers as needed at home.  He continued to 
improve and was discharged on a prednisone taper over 2 weeks. 
he was advised to follow up with his PCP ___ ___ weeks of 
discharge.

# Acute renal failure
Patient developed acute renal failure in setting of acute 
illness. Cr peaked at 1.4, now back to baseline of 1.0 on 
discharge.

# Hypertension
Labetalol was started in the ICU due to recent ___ preventing 
use of home ACEi after improvement in renal function his home 
lisinopril was resumed. He was discharged on both ACEI and 
labetolol and advised to follow up with PCP to determine if 
labetolol was still needed. 

# Macrocytic anemia
Hgb ___ during admission from a baseline normal Hgb (14.7). 
Likely partially some dilutional/iatrogenic anemia from blood 
draws and volume resuscitation. LFTs wnl. EtOH use is moderate. 
B12 and folate both normal
- recommend  repeat CBC as outpatient and if persists, consider 
additional work up

# Hypothyroidism
 - Continued home levothyroxine

# GERD
 - Was on IV PPI while intubated; resumed home omeprazole 20 mg 
daily after extubation and continued on discharge

# Gout
 - Continued home allopurinol ___ mg daily

# OSA
Home CPAP ordered.

# Tobacco use disorder
Patient reports he is planning to quit smoking after his severe 
illness.

Transitional issues:
- discharged on prednisone ___ call PCP to schedule 
follow up
- labetolol added to antihypertensive regimen
- recommend  repeat CBC as outpatient and if anemia persists, 
consider additional work up
Code: Full
HCP: HCP is daughter
___ ___ Wife- ___ (___)

 
Medications on Admission:
The Preadmission Medication list may be inaccurate and requires 
futher investigation.
1. Chantix (varenicline) 0.5 mg oral daily 
2. Sildenafil 20 mg PO Frequency is Unknown 
3. Omeprazole 20 mg PO DAILY 
4. Colchicine 1.2 mg PO PRN with flares 
5. Levothyroxine Sodium 275 mcg PO DAILY 
6. Allopurinol ___ mg PO DAILY 
7. Lisinopril 20 mg PO DAILY 
8. Ibuprofen 600 mg PO Q8H:PRN Pain - Mild 
9. Albuterol Inhaler 2 PUFF IH Q6H:PRN wheeze 
10. Fluticasone Propionate 110mcg 2 PUFF IH BID 

 
Discharge Medications:
1.  Albuterol 0.083% Neb Soln 1 NEB IH Q4H:PRN wheezing 
RX *albuterol sulfate 2.5 mg/3 mL (0.083 %) 1 neb INH Q4hrs Disp 
#*42 Vial Refills:*0 
2.  Ipratropium-Albuterol Neb 1 NEB NEB Q4H 
RX *ipratropium-albuterol 0.5 mg-3 mg (2.5 mg base)/3 mL 1 neb 
INH Q4hrs Disp #*42 Ampule Refills:*0 
3.  Labetalol 100 mg PO BID 
RX *labetalol 100 mg 1 tablet(s) by mouth twice a day Disp #*60 
Tablet Refills:*0 
4.  PredniSONE 50 mg PO DAILY Duration: 2 Doses 
This is dose # 1 of 5 tapered doses
RX *prednisone 10 mg ___ tablet(s) by mouth daily as directed 
Disp #*30 Tablet Refills:*0 
5.  PredniSONE 40 mg PO DAILY Duration: 2 Doses 
Start: After 50 mg DAILY tapered dose 
This is dose # 2 of 5 tapered doses 
6.  PredniSONE 30 mg PO DAILY Duration: 2 Doses 
This is dose # 3 of 5 tapered doses 
7.  PredniSONE 20 mg PO DAILY Duration: 2 Doses 
Start: After 30 mg DAILY tapered dose 
This is dose # 4 of 5 tapered doses 
8.  PredniSONE 10 mg PO DAILY Duration: 2 Doses 
This is dose # 5 of 5 tapered doses 
9.  Sildenafil 20 mg PO 1X:ASDIR  
10.  Albuterol Inhaler 2 PUFF IH Q6H:PRN wheeze  
11.  Allopurinol ___ mg PO DAILY  
12.  Colchicine 1.2 mg PO PRN with flares  
13.  Fluticasone Propionate 110mcg 2 PUFF IH BID  
14.  Ibuprofen 600 mg PO Q8H:PRN Pain - Mild  
15.  Levothyroxine Sodium 275 mcg PO DAILY  
16.  Lisinopril 20 mg PO DAILY  
17.  Omeprazole 20 mg PO DAILY  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Influenza
Status asthmaticus
Macrocytic anemia
 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
 
Discharge Instructions:
Mr. ___,

It was a pleasure taking care of you during your admission to 
___. You were admitted with the flu and developed a severe 
asthma exacerbation. You were treated in the ICU on a breathing 
machine and were given steroids, nebulizers and medication to 
treat the flu and you improved.  You were monitored on the 
general medical floor and you improved. You should continue to 
take nebulizers once you are at home.

You will be discharged on a tapering dose of steroids.

Take Prednisone 50mg daily ___
Take Prednisone 40mg daily ___
Take Prednisone 30mg daily  ___
Take Prednisone 20mg daily ___
Take Prednisone 10mg daily ___

You were also noted to have high blood pressure. We have added a 
blood pressure medication to your regimen and you should follow 
up with your primary care doctor to determine if you still need 
this medication.  You were also noted to have anemia. This may 
be due to your infection but please have your doctor recheck 
your blood counts when you follow up.

We wish you the best,
Your ___ Care team
 
Followup Instructions:
___
"
12612379-DS-23," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Tetracycline / Horse Blood Extract / Minocycline / Lipitor / 
adhesive tapa
 
Attending: ___.
 
Chief Complaint:
Ground level fall
 
Major Surgical or Invasive Procedure:
- Right intertrochanteric hip fracture status post repair with 
trochanteric femoral nail
- Left subclavian artery occlusion status post thrombectomy

 
History of Present Illness:
Ms. ___ is an ___ s/p mechanical fall while at home earlier 
today sustaining an injury to her right hip, denies hitting her 
head or LOC. She noted immediate pain in her RLE, denies any 
numbness or tingling in the right leg. Patient is an independent 
ambulator at baseline, denies premorbid hip pain. She volunteers 
at ___. She denies any dizziness, difficulties with balance, 
or syncope. 
 
Past Medical History:
1. Recurrent lymphocyte predominant right sided pleural effusion 

s/p pleuroscopy and pleurX placement on ___
2. COPD
3. Atrial fibrillation with RVR on coumadin
4. History of RML lung nodules likely NSCLC, s/p RFA treatment 
in ___ PET scan showed FDG avidity, biopsied under CT guidance 
but cytology showed no malignancy 
5. Abnormal CT scan with multiple stable nodules and a few areas 

of inflammatory ___ nodules.
6. History of breast cancer treated ___ years s/p R lumpectomy 
and XRT
7. Fat necrosis R breast
8. Hypothyroidism
9. Hypertension
10. Osteoporosis
11. Hyperlipidemia
12. COPD
13. Colon polyps
14. History of basal cell carcinoma
15. Urinary incontinence
16. s/p Left Total Hip Replacement
17. s/p carpal tunnel repair ___
 
Social History:
___
Family History:
No history of cancer or heart disease 
 
Physical Exam:
On admission:
In general, the patient is in NAD, elderly female  
Vitals: VSS  
Right upper extremity:  
Skin intact  
Soft, non-tender arm and forearm  
Full, painless PROM of shoulder, elbow, wrist, and digits  
+Motor exam grossly intact  
+sensation grossly intact  
+Radial pulse  
Left upper extremity:  
Skin intact  
Soft, non-tender arm and forearm  
Full, painless PROM of shoulder, elbow, wrist, and digits  
+Motor exam grossly intact  
+sensation grossly intact  
+Radial pulse  
Right lower extremity:  
Skin intact, TTP along the proximal femur  
___ fire  
+SILT SPN/DPN/TN/saphenous/sural distributions  
___ pulses, foot warm and well-perfused  
Left lower extremity:  
Skin intact  
Soft, non-tender thigh and leg  
Full, painless PROM of hip, knee, and ankle  
___ fire  
+SILT SPN/DPN/TN/saphenous/sural distributions  
___ pulses, foot warm and well-perfused  

At discharge:
VS: 98.3  HR 60-90s (afib)  BP 100-120s/50-60s (103/49)  RR 18 
Sa02 100% 2L
GEN: Lying in bed in NAD
NEURO: Alert, answering questions approriately. Face symmetric, 
PERRL, EOMI. 4+ strength with wrist flexion/extension, elbow 
flexion/extension
HEENT: Nasal canulae in place 
CV: Irreg, normal rate, no murmurs or rubs
PULM: Clear, poor air movement with mild wheezes
EXT: R hip with mild induration and swelling, but no large 
ecchymosis around surgical site; L arm with medial ecchymosis; 
2+ L radial pulse

 
Pertinent Results:
On admission:
___ 11:45AM BLOOD WBC-11.9*# RBC-3.74* Hgb-11.4* Hct-35.1* 
MCV-94 MCH-30.5 MCHC-32.6 RDW-13.6 Plt ___
___ 11:45AM BLOOD Neuts-93.4* Lymphs-3.2* Monos-3.0 Eos-0.2 
Baso-0.2
___ 11:45AM BLOOD ___ PTT-26.1 ___
___ 11:45AM BLOOD Glucose-127* UreaN-35* Creat-1.4* Na-139 
K-3.5 Cl-91* HCO3-34* AnGap-18
___ 06:45AM BLOOD Calcium-8.4 Phos-2.8 Mg-1.7
___ 12:06PM BLOOD Lactate-2.7*

At discharge:
___ 07:15AM BLOOD WBC-5.7 RBC-3.15* Hgb-9.7* Hct-30.2* 
MCV-96 MCH-30.8 MCHC-32.1 RDW-15.1 Plt ___
___ 07:15AM BLOOD ___ PTT-71.4* ___
___ 06:30AM BLOOD Glucose-85 UreaN-13 Creat-0.6 Na-138 
K-4.2 Cl-99 HCO3-37* AnGap-6*

Microbiology: NONE

Imaging: 
CT HEAD ___:
IMPRESSION:  No evidence for an acute intracranial abnormality.

RIGHT FEMUR AP AND LATERAL ___:
IMPRESSION:  Comminuted and displaced intertrochanteric fracture 
of the right hip with varus angulation.  No fracture is 
identified elsewhere.  Severe osteopenia. 

CXR ___:
IMPRESSION:  Interval improvement of patchy opacities in the 
right lower lung compared with ___ ___s probable 
decrease in size of right effusion given supine position on the 
current exam.  Background emphysema and coarse interstitial 
markings likely related to fibrotic changes. 

CTA HEAD & NECK ___:
IMPRESSION:  
1. No evidence of acute intracranial hemorrhage or large 
territorial 
infarction. 
2. No evidence of aneurysm > 3mm or dissection. 
3. Complete occlusion of the left subclavian artery at the level 
of the left vertebral artery origin.
4. Diffuse large vessel partially calcific atherosclerosis with 
severe 
stenosis of the proximal right subclavian artery. 
5. 7 mm right upper lobe pulmonary nodule, not definitively 
identified on the previous Chest CTA. 
6. Bilatratal lobulated pleural effusions with adjacent 
atelectasis, 
bronchiectasis, airway secretions, and scattered airspace 
opacities. 

___ MRI HEAD W/O CONTRAST:
MRI HEAD:  There is no evidence of acute infarction or 
hemorrhage. There is no mass effect, edema, or hydrocephalus.  
Prominent ventricles and sulci are compatible with mild global 
age-related atrophy. FLAIR hyperintensities in the subcortical 
and periventricular white matter likely sequelae of chronic 
microvascular ischemic disease. Old infarct with volume loss is 
noted within the right temporal lobe. Principal vascular flow 
voids are preserved.  Globes and soft tissues are unremarkable. 
Visualized paranasal sinuses and mastoid air cells are well 
aerated. 
  IMPRESSION:  
No evidence of acute infarction or hemorrhage 

___ TTE:
The left atrium is elongated. No left atrial mass/thrombus seen 
(best excluded by transesophageal echocardiography). The right 
atrium is moderately dilated. The estimated right atrial 
pressure is at least 15 mmHg. Left ventricular wall thickness, 
cavity size, and global systolic function are normal (LVEF>65%). 
The right ventricular cavity is mildly dilated with borderline 
normal free wall function. The aortic root is mildly dilated at 
the sinus level. The number of aortic valve leaflets cannot be 
determined. The aortic valve leaflets are moderately thickened. 
Mild (1+) aortic regurgitation is seen. The mitral valve 
leaflets are mildly thickened. There is no mitral valve 
prolapse. Trivial mitral regurgitation is seen. The tricuspid 
valve leaflets are mildly thickened. There is moderate pulmonary 
artery systolic hypertension. There is no pericardial effusion. 
  Compared with the prior study (images reviewed) of ___ 
the findings are similar.

___ ECG:
Atrial fibrillation with moderate ventricular response. Modest 
diffuse  
ST-T wave changes that are non-specific. Poor R wave progression 
suggests 
anteroseptal myocardial infarction of indeterminate age. 
Compared to the 
previous tracing of ___ wave changes 
appear to be 
improved. Otherwise, no other significant diagnostic change. 

 
Brief Hospital Course:
___ year old woman with diastolic CHF, atrial fibrillation who 
presented 3 days ago with R intertrochanteric fracture due to 
mechanical fall, now status post trochanteric-femoral nail whose 
post-op course was complicated by blood loss anemia, 
hypotension, and left subclavian arterial thrombus requiring 
thrombectomy. 

#Left subclavian arterial thrombus: Likely cardioembolic source 
given subtherapeutic INR. No history of arterial thrombi in 
past. Thrombocytopenia of new onset may suggest HITT, but she 
has clear other reasons and I feel that HITT would be much less 
likely than cardiac embolus. Additionally, platelets rebounded 
while on heparin. Transthoracic echo showed no ___. A 
hypercoaguable workup was not pursued as an inpatient, thinking 
that it would be low yield. She was restarted on home warfarin 
that she had been non-compliant with (admission INR 1.3), and 
bridged with heparin drip. 
   Of note, in the setting of her left arm arterial thrombus, 
stroke evaluation was undertaken before it was clear her arm was 
ischemic. She had no evidence of large vessel aneurysm or 
dissection on CTA of head/neck and, after her thrombectomy, an 
MRI of the head showed no acute infarct. 

#R hip fracture: Suffered from a mechanical fall at home landing 
on her right hip. She had trochanteric femoral nail placed on 
___. Post-op orders were for weight bearing as tolerated. 
Physical therapy saw the patient and recommended rehab for acute 
___. She has orthopedics follow up in ~2 weeks for repeat hip 
imaging. 

#Behavioral Changes: The family (3 children) were present for 
much of the admission. They expressed concern over their 
mother's perceived chronic to subacute personality changes. She 
had in the past months to ___ years become more forgetful and 
started not taking medications, such as warfarin, that she had 
been on for years. Their concern is that she still resides alone 
and is independent in ADLs, IADLs. However, she reportedly is 
not able to do tax papers reliably any longer, which is a change 
from previous years. The description of her slow decline sounds 
most consistent with incipient dementia. We had this 
conversation with the family and patient. Her neurologic exam 
was intact, though behaviorally she demonstrated inability to 
retain some basic facts of her hospital care. Neurocognitive 
evaluation was not undertaken.   
   Reversible causes were not investigated during this acute 
hospitalization, though she should have reversible causes of 
dementia ruled out as an outpatient. 

#Acute blood loss anemia: Hemoglobin was 11mg/dL on admission, 
but was near 15 last month. Much of this is likely acute blood 
loss from hip surgery in addition to left subclavian arterial 
thrombectomy. Her MCV is normal. She had a colonoscopy in ___ 
with polyps and diverticuli and EGD ___ that was normal. She 
would benefit from serial monitoring every month or so to 
demonstrate return to baseline. 

#Thrombocytopenia: Normal at 159 on admission, then dropped down 
to nadir of 108. Her platelets were 145 on day of discharge. 
Though HITT was considered and discussed extensively by Dr. ___ 
___ vascular surgery, and discussed again with Dr. ___ 
Dr. ___ likely represents consumption from blood loss and 
surgery, with HITT being quite unlikely given rebound of 
platelets while on continuous heparin infusion. Drop and timing 
of rebound is also typical of post-opereative recovery.  Have 
recommended that CBC be monitored at rehab for the next ___ 
days.

#Diastolic CHF: TTE showed findings similar to prior with normal 
LVEF, moderate PA systolic hypertension, and 1+ AR. She had been 
getting both Lasix 20mg daily and developed low blood pressure 
post-operatively, likely from some bleeding. Therefore, her 
Lasix was held. This should be given if she develops any signs 
of hypervolemia, worsened respiratory status, or elevated 
jugular veins. She appeared euvolemic at discharge.

#AFib with RVR: History of atrial fibrillation for years. She is 
on diltiazem for rate control and warfarin. Her CHADS2 score is 
2. She has been non-adherent per family for unclear reasons, 
though possibly related to early dementia. She was started 
emergently on heparin gtt for subclavian arterial thrombus. 
Heart rates were well controlled in 90-110s. Her diltiazem ER 
360mg dose was lowered for a few days because of borderline 
blood pressures (90s-100s). This should be titrated back up to 
her home dose of 360 mg.

CHRONIC/STABLE ISSUES:
#COPD: Home 2 liters O2. Chemistries showed elevated HCO3 
consistent with chronic CO2 retention. Continued home inhalers 
and O2.

#Left pleural effusion: Seen on imaging. Unclear etiology. Of 
note she has a history of RML lung nodules thought to be likely 
___ s/p radiofrequency ablation in ___. Subsequently she 
has had a history of bilateral effusions R>L. She has had 
extensive workup, including pleural biopsy in ___ ___s 
pleural cytology, both of which were negative for malignancy. 
Prior to that in ___ she had work up of pleural fluid that 
was negative for lymphoma/leukemia cells. Additionally, she had 
cytology in ___ that was likewise negative. 

#Pulmonary nodules: History of multiple CTs for past few years 
with multiple pulmonary nodules bilaterally. Last CTA chest in 
___ showed a stable 12 mm ground-glass nodule in right lower 
lobe since ___ and yearly followup was recommended. This 
admission, CTA neck showed a new 7 mm, not definitively 
identified on the previous Chest CTA. These should be evaluated 
with chest CT in ___ year.

#Hypothyroidism - Continued levothyroxine supplement.

TRANSITIONAL ISSUES:
-FULL CODE
[]continue heparin drip until INR >2, then discontinue
[]check CBC everyday for 1 week for monitoring since on heparin 
drip (platelets and Hgb)
[]left upper extremity arterial US in 1 month, vascular surgery 
follow up ___
[]orthopedic surgery follow up ___
[]outpatient reversible dementia workup and/or neurocognitive 
evaluation
[]repeat chest CT ___
[]consideration of home health aide to assist with medication 
compliance
[]uptitration of rate control agents (diltiazem) to home dose of 
360mg
[]reinitiation of furosemide 20mg as volume assessment dictates
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Diltiazem Extended-Release 360 mg PO DAILY 
2. Furosemide 20 mg PO DAILY 
3. Levothyroxine Sodium 75 mcg PO DAILY 
4. Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID 
5. Tiotropium Bromide 1 CAP IH DAILY 
6. Warfarin 4 mg PO ASDIR 
7. Mirtazapine 15 mg PO HS 
8. Vitamin D 1000 UNIT PO DAILY 
9. Biscolax (bisacodyl) 10 mg rectal prn constipation 
10. PreserVision AREDS 2 (vit C,E-Zn-coppr-lutein-zeaxan) 
250-200-40-1 mg-unit-mg-mg oral daily 
11. ProAir HFA (albuterol sulfate) 90 mcg/actuation inhalation 
q4hrs wheezing 
12. Acetaminophen 325 mg PO Q6H:PRN pain 
13. Docusate Sodium 200 mg PO BID 
14. Multivitamins 1 TAB PO DAILY 
15. Senna 8.6 mg PO DAILY:PRN constipation 

 
Discharge Medications:
1. Diltiazem Extended-Release 180 mg PO DAILY 
2. Acetaminophen 650 mg PO Q6H 
3. Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID 
4. Senna 8.6 mg PO DAILY 
5. Tiotropium Bromide 1 CAP IH DAILY 
6. Heparin IV per Weight-Based Dosing Guidelines
Continue existing infusion at 900 units/hr
Start: ___, First Dose: 1600 
Target PTT: 60 - 100 seconds
7. OxycoDONE (Immediate Release)  5 mg PO Q6H:PRN Pain Duration: 
16 Doses 
8. Multivitamins 1 TAB PO DAILY 
9. PreserVision AREDS 2 (vit C,E-Zn-coppr-lutein-zeaxan) 
250-200-40-1 mg-unit-mg-mg oral daily 
10. ProAir HFA (albuterol sulfate) 90 mcg/actuation inhalation 
q4hrs wheezing 
11. Vitamin D 1000 UNIT PO DAILY 
12. Biscolax (bisacodyl) 10 mg rectal prn constipation 
13. Docusate Sodium 100 mg PO BID 
14. Levothyroxine Sodium 75 mcg PO DAILY 
15. Warfarin 4 mg PO ASDIR 
16. Mirtazapine 15 mg PO HS 
17. Furosemide 20 mg PO DAILY 

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
Primary:
Right intertrochanteric hip fracture
Acute blood loss anemia
Left subclavian artery thrombus

Secondary:
Atrial fibrillation
Chronic obstructive pulmonary disease
Likely dementia

 
Discharge Condition:
Mental Status: Confused sometimes
Level of Consciousness: Alert and interactive.
Activity Status: Out of Bed with assistance to chair or 
wheelchair.

 
Discharge Instructions:
Dear Ms. ___,

It was a pleasure taking part in your care during your admission 
to ___. As you know, you were 
admitted after you fell and were noted to have a hip fracture, 
which was repaired. You developed weakness in your left arm that 
was found to be due to a blood clot in one of the blood vessels 
that supplies your arm, prompting removal of the clot and 
improvement in your symptoms. Although there was initial concern 
that arm weakness was due to a stroke, MRI of your brain was 
ultimately reassuring that you did NOT have a stroke. 
Nevertheless, it is very important that you take warfarin 
(Coumadin) as directed to prevent future blood clots like the 
one you had in your left arm.
 
Followup Instructions:
___
"
12626414-DS-32," 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___
 
Chief Complaint:
Transaminitis
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
Mr. ___ is a ___ h/o ETOH cirrhosis c/b HRS, s/p 
liver-kidney transplant in ___, course c/b chronic rejection of 
liver w/ repeat liver transplant ___ on tacro, MMF and 
prednisone, gunshot wound in ___ s/p multiple bowel 
surgeries resulting in short gut syndrome, chronic metabolic 
acidosis, post-transplant CKD with Cr 2.2-2.3 (with DSAs) who 
presents at the advice of Dr. ___ with elevated LFTs and 
biopsy showing
mild acute cellular rejection ___.

Patient reports that he is feeling well overall. He states that 
for 2 weeks about a month ago he missed the morning doses of his 
immunosuppressive medications because he thought that if he 
didn't take them on time, he should not take them at all. He has 
since become compliant again. He denies any alcohol use for
years, no MJ use since the New Year. His only new medication is 
losartan, started early ___. He reports flu-like symptoms a 
month ago but no other recent illnesses. He has otherwise been 
healthy. He has not had any recent travel or new foods. Has 
remained active making furniture and chopping wood. He denies 
any nausea, vomiting, diarrhea, constipation, shortness of 
breath, chest pain, fevers, chills, dizziness.

REVIEW OF SYSTEMS: Per HPI, otherwise negative
 
Past Medical History:
___ gunshot wounds in ___ status post exploratory  
laparotomy and colostomy.  
___ colostomy was reversed.  
___, he had a history of small-bowel obstruction with multiple  
surgeries that retrieved most of his small bowel.  
___, laparotomy again had multiple surgeries again for small  
bowel obstruction.  
___, he had a right knee arthroscopy.  
___, diagnosis of cirrhosis and bleeding varices.  
___, he had hepatorenal syndrome and liver failure and he   
had his combined liver and kidney transplant at ___.  
H/o cholangitis, multiple ERCP with plastic/metal stents.  
___ cystoscopy to remove a stent that was placed that was  
causing urosepsis (this resulted in a lawsuit against ___ 
___).  
___, he underwent a lysis of adhesions at ___.  
___ cholangitis/ s/p ERCP and stent placement.  
___. Hepaticojejunostomy with Roux-en-Y.  
___ PTC and liver biopsy with chronic rejection.  
___ Orthotropic Deceased Donor Liver Transplant  
Hepatic encephalopathy  
Gout  
Depression  
Insomnia  
Possible Short Gut Syndrome due to prior bowel resection
Chronic metabolic acidosis from frequent stools i/s/o short gut  
syndrome and possible RTA from immunosuppressants
 
Social History:
___
Family History:
Per Prior notes:
Mother - dementia (___)
Father - diabetes/prostate cancer (___)
2 Children, 3 Grandchildren all healthy
 
Physical Exam:
ADMISSION PHYSICAL EXAM:
======================
VS: 98.2 PO 134/73 R Lying 76 18 99% RA 
GENERAL: NAD  
HEENT: AT/NC, EOMI, PERRL, anicteric sclera, MMM  
NECK: supple, no LAD, no JVD  
HEART: RRR, S1/S2, ___ systolic murmur, no gallops or rubs   
LUNGS: CTAB, no wheezes, rales, rhonchi, breathing comfortably 
without use of accessory muscles  
ABDOMEN: nondistended, nontender in all quadrants, no 
rebound/guarding, multiple surgical scars on abdomen, no TTP 
over liver and transplant kidney 
EXTREMITIES: no cyanosis, clubbing, or edema  
PULSES: 2+ DP pulses bilaterally  
NEURO: A&Ox3, moving all 4 extremities with purpose  
SKIN: warm and well perfused, no excoriations or lesions, no 
rashes

DISCHARGE PHYSICAL EXAM:
=======================
VS: ___ 0020 Temp: 97.9 PO BP: 168/83 R Lying HR: 70 RR: 18
O2 sat: 99% O2 delivery: RA 
GENERAL: Older man in NAD  
HEENT: Anicteric sclera, MMM  
HEART: RRR, S1/S2, ___ systolic murmur, no gallops or rubs   
LUNGS: CTAB - no wheezes, rales, rhonchi
ABDOMEN: +BS, S, NT, ND, multiple surgical scars on abdomen
EXTREMITIES: no cyanosis, clubbing, or edema  
PULSES: 2+ DP pulses bilaterally  
NEURO: A&Ox3, moving all 4 extremities with purpose  
SKIN: WWP, no excoriations or lesions, no rashes
 
Pertinent Results:
ADMISSION LABS:
===============
___ 08:10AM BLOOD WBC-4.4 RBC-3.35* Hgb-10.9* Hct-33.3* 
MCV-99* MCH-32.5* MCHC-32.7 RDW-11.8 RDWSD-42.5 Plt ___
___ 08:10AM BLOOD ___ PTT-27.5 ___
___ 08:10AM BLOOD Glucose-89 UreaN-29* Creat-2.2* Na-141 
K-4.8 Cl-105 HCO3-24 AnGap-12
___ 08:10AM BLOOD ALT-63* AST-43* AlkPhos-161* TotBili-0.7
___ 08:10AM BLOOD Albumin-4.3 Calcium-8.2* Phos-3.3 Mg-1.7 
Iron-93
___ 08:10AM BLOOD calTIBC-281 Ferritn-76 TRF-216
___ 11:35AM BLOOD tacroFK-3.9*
___ 09:04AM URINE Color-Straw Appear-Clear Sp ___
___ 09:04AM URINE Blood-NEG Nitrite-NEG Protein-30* 
Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-7.0 Leuks-NEG
___ 09:04AM URINE RBC-1 WBC-8* Bacteri-NONE Yeast-NONE 
Epi-0

INTERVAL LABS:
=============
___ 10:35AM BLOOD CMV VL-NOT DETECT

___ 11:35AM BLOOD tacroFK-3.9*
___ 05:00AM BLOOD tacroFK-4.6*
___ 04:54AM BLOOD tacroFK-4.0*
___ 04:57AM BLOOD tacroFK-4.2*

___ 08:10AM BLOOD ALT-63* AST-43* AlkPhos-161* TotBili-0.7
___ 05:00AM BLOOD ALT-59* AST-35 AlkPhos-172* TotBili-0.5
___ 04:54AM BLOOD ALT-55* AST-29 LD(LDH)-164 AlkPhos-148* 
TotBili-0.4
___ 04:57AM BLOOD ALT-79* AST-36 LD(LDH)-151 AlkPhos-138* 
TotBili-0.4

MICROBIOLOGY:
=============
___ BCx x2: Pending, no growth to date
___ UCx: No growth
___ Monospot: Negative

IMAGING/STUDIES:
===============
___ Liver Biopsy PATHOLOGY:
1) Changes consistent with mild acute cellular rejection 
demonstrating:
- Focal, mild portal venous endothelialitis.
- Mild portal, predominately mononuclear inflammation (including 
focally activated lymphocytes). - Focal lymphocytic cholangitis 
with rare, mild bile duct damage.
2) No significant steatosis, ballooning degeneration or 
intracytoplasmic hyalin identified.
3) Trichrome stain demonstrates no definitive fibrosis.
4) Iron stain is negative for iron deposition.

DISCHARGE LABS:
==============
___ 04:57AM BLOOD WBC-5.1 RBC-3.34* Hgb-10.9* Hct-32.6* 
MCV-98 MCH-32.6* MCHC-33.4 RDW-11.4 RDWSD-40.1 Plt ___
___ 04:57AM BLOOD ___ PTT-23.4* ___
___ 04:57AM BLOOD Glucose-125* UreaN-44* Creat-2.3* Na-143 
K-4.5 Cl-108 HCO3-21* AnGap-14
___ 04:57AM BLOOD ALT-79* AST-36 LD(LDH)-151 AlkPhos-138* 
TotBili-0.4
___ 04:57AM BLOOD Albumin-3.7 Calcium-7.6* Phos-4.4 Mg-1.9
___ 04:57AM BLOOD tacroFK-4.2*
 
Brief Hospital Course:
Mr ___ is a ___ h/o ETOH cirrhosis c/b HRS s/p liver-kidney 
transplant ___, w/ subsequent chronic liver rejection s/p liver 
transplant ___ on MMF, tacro, and prednisone who was admitted 
for mild acute liver rejection on biopsy and transaminitis - 
thought to be due to missed doses of immunosuppressants. While 
hospitalized, he had a steroid burst with high dose IV 
Methylprednisolone. He was subsequently transitioned to PO 
Prednisone 20mg daily, and is to be slowly tapered in clinic. He 
tolerated the increased doses of steroids well. 

# ETOH cirrhosis c/b HRS s/p liver-kidney transplant ___, c/b 
chronic liver rejection
# S/P liver transplant ___:
# Mild acute transplant rejection:
Mild acute rejection on biopsy ___ with new elevations in LFTs. 
No obvious trigger other than medication non-compliance. Issue 
with timing of medications discussed at length with patient. 
Notable studies that were negative included: EBV mono spot, CMV 
VL, infectious work up including UCx (BCx pending at discharge). 
As such, he was given a steroid burst with IV Solumedrol 1g 
daily x3 day ___ and was transitioned to a higher dose 
of PO Prednisone 20mg qd afterwards. He is to take 20mg 
Prednisone from ___ - ___, and then 17.5mg Prednisone from ___ 
- ___, and then Prednisone 15mg from there after. He was also 
started on Valgancyclovir for CMV prophylaxis, as well as 
continued on Bactrim DS QOD for PCP/Toxo prophylaxis. He was 
continued on MMF 500mg BID and Tacrolimus (daily levels 
monitored and doses were adjusted accordingly). His Tacrolimus 
level at discharge was 4.2 and he was discharged on Tacrolimus 
5.5mg BID. His transaminitis initially improved with the steroid 
burst, and at discharge were AST 36 and ALT 79. 

# ESRD s/p liver-kidney transplant
Cr baseline most recently ~2.2-2.6 with evidence of stable but 
present DSAs. His creatinine was monitored daily, and ultimately 
his home Losartan was held during his hospitalization (as well 
as at discharge). 

#Chronic metabolic acidosis:
Secondary to ongoing diarrhea due to short gut syndrome and MMF. 
Continued home Bicarbonate 1950mg BID supplementation. 

#Short gut syndrome
Continue home Loperamide PRN. Held home Lomotil during his 
hospitalization, but this was restarted at discharge. 

#Hypertension 
Held home Losartan in the setting of ESRD, however continued his 
home Nifedipine. 

TRANSITIONAL ISSUES:
===================
- New Meds: ValGANCIclovir 450 mg PO Q48H 6 weeks (___) 
- Stopped/Held Meds: Losartan Potassium 50 mg PO DAILY
- Changed Meds: Prednisone to 20mg daily ___ - ___ then 
transition to Prednisone 17.5mg from ___ - ___ then 
transition to Prednisone 15mg from ___ onwards), Tacrolimus to 
5.5mg BID 
- Post-Discharge Follow-up Labs Needed: Chem-10/LFTs/Tacrolimus 
on ___ and ___ (ordered)
- Incidental Findings: None
- Discharge weight: 69.31 kg (152.8 lb) 

# CODE: Presumed FULL
# CONTACT: ___ 
 ___: wife 
 Phone number: ___ 
 Cell phone: ___ 
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Diphenoxylate-Atropine 1 TAB PO Q6H:PRN diarrhea 
2. Mycophenolate Mofetil 500 mg PO BID 
3. NIFEdipine (Extended Release) 30 mg PO DAILY QAM 
4. NIFEdipine (Extended Release) 60 mg PO DAILY QPM 
5. PredniSONE 5 mg PO DAILY 
6. Sulfameth/Trimethoprim DS 1 TAB PO EVERY OTHER DAY 
7. Tacrolimus 4.5 mg PO Q12H 
8. tadalafil ___ mg oral PRN 
9. Vitamin D ___ UNIT PO DAILY 
10. LOPERamide 2 mg PO Q3H:PRN diarrhea 
11. Multivitamins 1 TAB PO DAILY 
12. Sodium Bicarbonate ___ mg PO BID 
13. Losartan Potassium 50 mg PO DAILY 
14. TraZODone 50 mg PO QHS 
15. Cyanocobalamin 1000 mcg IM/SC QMONTH 

 
Discharge Medications:
1.  LORazepam 0.5 mg PO QHS:PRN insomnia 
Do not drink alcohol or operate machinery while using this 
RX *lorazepam [Ativan] 0.5 mg 1 tablet by mouth at bedtime Disp 
#*5 Tablet Refills:*0 
2.  ValGANCIclovir 450 mg PO Q48H 
RX *valganciclovir [Valcyte] 450 mg 1 tablet(s) by mouth every 
48 hours Disp #*15 Tablet Refills:*0 
3.  PredniSONE 20 mg PO DAILY 
RX *prednisone 20 mg 1 tablet(s) by mouth daily Disp #*6 Tablet 
Refills:*0
RX *prednisone 10 mg 1 tablet(s) by mouth daily Disp #*7 Tablet 
Refills:*0
RX *prednisone 5 mg 1 tablet(s) by mouth daily Disp #*7 Tablet 
Refills:*0
RX *prednisone 2.5 mg 1 tablet(s) by mouth daily Disp #*7 Tablet 
Refills:*0 
4.  Tacrolimus 5.5 mg PO Q12H 
RX *tacrolimus 5 mg 1 capsule(s) by mouth daily Disp #*15 
Capsule Refills:*0
RX *tacrolimus 0.5 mg 1 capsule(s) by mouth daily Disp #*15 
Capsule Refills:*0 
5.  Cyanocobalamin 1000 mcg IM/SC QMONTH  
6.  Diphenoxylate-Atropine 1 TAB PO Q6H:PRN diarrhea  
7.  LOPERamide 2 mg PO Q3H:PRN diarrhea  
8.  Multivitamins 1 TAB PO DAILY  
9.  Mycophenolate Mofetil 500 mg PO BID  
10.  NIFEdipine (Extended Release) 60 mg PO DAILY QPM  
11.  NIFEdipine (Extended Release) 30 mg PO DAILY QAM  
12.  Sodium Bicarbonate ___ mg PO BID  
13.  Sulfameth/Trimethoprim DS 1 TAB PO EVERY OTHER DAY  
14.  tadalafil ___ mg oral PRN  
15.  TraZODone 50 mg PO QHS  
16.  Vitamin D ___ UNIT PO DAILY  
17. HELD- Losartan Potassium 50 mg PO DAILY  This medication was 
held. Do not restart Losartan Potassium until discussing further 
with the Liver Transplant team
18.Outpatient Lab Work
Labs to collect ___: Chem-10, LFTs, Tacrolimus
ICD-9 Code: V42.7
Followed up by: Liver ___ fax: 
___
19.Outpatient Lab Work
Labs to collect ___: Chem-10, LFTs, Tacrolimus
ICD-9 Code: V42.7
Followed up by: Liver ___ fax: 
___

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Mild acute cellular rejection of liver transplant
EtOH cirrhosis s/p transplant
ESRD s/p kidney transplant
Chronic metabolic acidosis
Short gut syndrome
Hypertension

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Mr. ___,

You were admitted to the hospital because your liver blood tests 
were elevated and there was concern for rejection

WHAT HAPPENED WHILE YOU WERE IN THE HOSPITAL?
- We gave you high dose steroids for three days, and then 
transitioned you to a higher dose of Prednisone pills
- You improved and were ready to leave the hospital. 

WHAT DO YOU NEED TO DO WHEN YOU LEAVE THE HOSPITAL?
- Please take your Tacrolimus dose twice every day (even if one 
of the doses is a little late)
- You will have repeat labs on this upcoming ___ and ___
- Take all of your medications as prescribed (listed below)
- Keep your follow up appointments with your doctors
- Seek medical attention if you have new or concerning symptoms 
or you develop

It was a pleasure participating in your care. We wish you the 
best!
 - Your ___ Care Team

 
Followup Instructions:
___
"
12884747-DS-9," 
Name:  ___                     Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Morphine
 
Attending: ___.
 
Chief Complaint:
chest pain  
 
Major Surgical or Invasive Procedure:
None
 
History of Present Illness:
This is a ___ hx of 10 cardiac stents per pt report, 
esophageal spasms, HTN, HLD, prior CVA per epic records, 
depression on Prozac, DM (HBA1C 12.1% on ___ who presents to 
___ ED with report of chest pain.  

Patient states that he was sitting at his sister's home at 4pm 
sitting at rest, reading a screenplay, when he had substernal 
squeezing chest pain. Sometimes he has similar pain with 
esophageal spasms, but this chest pain became asso with numbness 
in his left hand and left jaw discomfort and progressively 
worsened. States it does not feel entirely like his esophageal 
spasms and that it is similar to prior angina asso with 
catherization albeit less pronounced. Took SLN at home with no 
effect, just SLN asso headache. No asso with 
nausea/vomiting/diphoreisis, but ""pronounced"" SOB per his 
report. Denies lightheadedness, dizziness, nausea, sweats, 
peripheral edema, URI sx, fever, abdominal pain, palpitations. 
He states that his chest pain did not improve until Dilaudid 
administered in the ED.  

According to Partners records, he initially presented on ___ 
to ___ ED. There, his EKG was remarkable only for SR 110 
inferior/apical TWF similar to prior studies, labs with negative 
trop x 2, transaminitis in 70-80 rang, c/w prior, CXR 
unremarkable. Per the ED note ""...I do not see any obvious 
explanation for the pain, certainly there is nothing specific in 
the history of exam to indicate PE, ACs, PNA, etc. It is 
suppose, posssible that opiate dependence is playing a role 
here. He was certainly quite insistent regarding pain relief, 
and specifically 2mg of Dilaudid IV and 1 mg of Ativan IV. He 
became quite irate when I told him that this was not an option 
for us this evening. I have counseled the pt in this regard. We 
contacted his cardiology, ___, here at the ___ to 
apprise her of his visit here ...""  

Shortly thereafter, he presented to the ___ ED for further 
management.  
In the ED, initial vital signs were: 97.7 100 155/89 19 99%RA  
- Exam was notable for: AA&o3, nontoxic RRR; CTAB; abd s/nt/nd; 
no ___ edema; skin + psoriasis  
- Labs were notable for: anemia 11.0/34.1; glucose 213. Trop neg 
x 1  
- Imaging: CXR clear  
- The patient was given: SLN x1, dilaudid 0.5 x 2; GI cocktail.  

As the patient stated in the ED that he had taken a full aspirin 
prior to arrival, he was not administerd further ASA.  

Upon arrival to the floor, patient complaining of chest pain, 
jaw discomfort and left hand tingling. Repeat EKG on floor 
unchanged from prior. Trialed another SLN with no improvement. 
Given diluadid with improvement. On medication reconciliation, 
it was found that he only takes a baby ASA, and therefore was 
given a full 325mg of ASA on arrival.  

In regards to his rash, he states that this is his baseline and 
attributes this to psoriasis. Has prior history of malignant 
melanoma and therefore not a candidate for light therapy. Not on 
MTX. He states that whenever he gets pain, his rash worsens. 
Slightly pruritic, but overall the pt is not bothered by this 
rash.  
 
Past Medical History:
HTN  
HLD  
DM  
CVA  
Psoriasis  
Esophageal spasm  
s/p Nissen fundoplication  
s/p CCY  

 
Social History:
___
Family History:
No significant history of coronary artery diseae 
 
Physical Exam:
VITALS - Tmax 98.5 100-110s/60-70s 50-70s 16 98 %RA  
Weight 111.3 kg  
GENERAL - Middle age male, NAD, sleeping comfortably in bed. 
HEENT - NC/AT  
NECK - supple, no LAD, no thyromegaly, JVP 2 cm above clavicle 
at 30 degrees. 
CARDIAC - regular rate & rhythm, normal S1/S2, no murmurs rubs 
or gallops appreciated  
PULMONARY - clear to auscultation bilaterally, without wheezes 
or rhonchi  
ABDOMEN - normal bowel sounds, soft, non-tender, non-distended, 
no organomegaly  
EXTREMITIES - warm, well-perfused, no cyanosis, clubbing or 
edema  
SKIN - diffuse salmon colored patchy diffusely throughout, from 
head to toe. Back exam s/f midline incisional scar and red 
violaceous rash.  
NEUROLOGIC - A&Ox3, CN II-XII grossly normal, normal sensation, 
with strength ___ throughout. 
PSYCHIATRIC - listen & responds to questions appropriately
 
Pertinent Results:
___ 06:15AM BLOOD WBC-5.3 RBC-4.09* Hgb-11.0* Hct-35.6* 
MCV-87 MCH-26.9 MCHC-30.9* RDW-14.1 RDWSD-44.9 Plt ___
___ 12:50AM BLOOD Neuts-47.7 ___ Monos-7.0 Eos-5.1 
Baso-0.9 Im ___ AbsNeut-2.24 AbsLymp-1.84 AbsMono-0.33 
AbsEos-0.24 AbsBaso-0.04
___ 06:15AM BLOOD ___ PTT-31.1 ___

___ 06:15AM BLOOD Glucose-216* UreaN-11 Creat-0.8 Na-136 
K-3.4 Cl-98 HCO3-28 AnGap-13
___ 06:15AM BLOOD Calcium-8.7 Phos-3.3 Mg-2.1
___ 06:15AM BLOOD ALT-66* AST-45* AlkPhos-67 TotBili-0.4

___ 12:50AM BLOOD cTropnT-<0.01
___ 06:23AM BLOOD CK-MB-2 cTropnT-<0.01
___ 11:06PM BLOOD CK-MB-<1 cTropnT-<0.01

CARDIAC CTRESS ___
INTERPRETATION: This ___ yo NIDDM man with h/o CAD, s/p multiple 
PCIs, was referred to the lab from the inpatient floor following 

negative serial cardiac enzymes for evaluation of chest 
discomfort and 
dyspnea on exertion. The patient exercised for 6 minutes of a 
Modified 
___ protocol and was stopped at the patient's request for 
shortness of 
breath. The estimated peak MET capacity was 4.6, which 
represents a poor 
exercise tolerance for his age. The patient presented to the lab 
with a 
___ central chest discomfort that increased to ___ in late 
exercise 
and remained at that level throughout recovery. Progressive 
dyspnea was 
reported by the patient during exercise and early recovery. 
There were 
no significant ST changes noted during exercise or recovery. 
Rhythm was 
sinus with one VPB in recovery. There was a blunted heart rate 
and blood 
pressure response to exercise in the presence of beta blockade. 
IMPRESSION: Atypical symptoms in the absence of ischemic EKG 
changes. 
Poor functional capacity limited by dyspnea. Blunted hemodynamic 

response. Nuclear report sent separately. 

CARIAC PERFUSION ___ IMPRESSION: 1. Normal myocardial perfusion 
with no reversible defects at the level of exercise achieved.  
2. Slightly increased left ventricular cavity size and decreased 
left ventricular ejection fraction of 50%, previously 59%. 

ECG ___
Sinus rhythm. Inferior wall myocardial infarction of 
indeterminate age. 
Possible prior anteroseptal myocardial infarction of 
indeterminate age. 
Non-specific ST segment changes. Compared to the previous 
tracing of ___  the ventricular rate is slower  

CXR ___ FINDINGS:  
Cardiomediastinal silhouette including mild cardiomegaly is 
unchanged.  Lungs are clear.  There is no pleural effusion or 
pneumothorax.  Bones are grossly unremarkable. IMPRESSION:  No 
acute intrathoracic abnormality. 

 
Brief Hospital Course:
___ hx of HTN, HLD, DM2 and CAD s/p PCI and esophageal spasms 
admitted for ACS rule out. 
# Chest pain: S/p ASA 325 mg x 1. Chest pain atypical in 
presentation-- did not start with exertion, not relieved by SLN. 
EKG without new ischemic changes and troponin negative x 2. Of 
note, per Partner's ___ review, pt was seen in ED and also ruled 
out for ACS at ___. Aditionally, pt had repeat episode of chest 
pain overnight. EKG once again unchanged and troponin/CK-MB 
negative. However, given that pt endorses new DOE, concern for 
progression of CAD and therefore underwent stress/MIBI. Stress 
test with atypical symptoms in the absence of ischemic EKG 
changes. Poor functional capacity limited by dyspnea. Imaging 
notable for normal myocardial perfusion with no reversible 
defects at the level of exercise achieved, though slightly 
increased left ventricular cavity size and decreased left 
ventricular ejection fraction of 50%, previously 59%. No 
evidence of heart failure on exam and therefore encouraged to 
follow-up with outpatient cardiologist. 

#Esophageal spasms: Likely a contributor to chest pain. CCB 
considered for hx of esophageal spasm, however pt has tried 
diltiazem without relief in past, and is already on amlodipine. 
Home nitrate was uptitrated: imdur 120 mg QD increased to imdur 
180 mg QD, and he was encouraged to follow up with outpatient 
GI. 

===transitional issues====
-IMDUR 150 increased to IMDUR 180 QD to improve esophageal 
spasms. 
-LFTs mildly elevated: AST 45, ALT 66. Nml alk phos and t.bili. 
Likely ___ fatty liver. Pls continue to monitor as outpt
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Gabapentin 400 mg PO TID 
2. Amlodipine 10 mg PO DAILY 
3. Fluoxetine 60 mg PO DAILY 
4. Mirtazapine 30 mg PO QHS 
5. Atorvastatin 80 mg PO QPM 
6. Metoprolol Tartrate 50 mg PO BID 
7. Bisacodyl 5 mg PO DAILY 
8. Isosorbide Mononitrate (Extended Release) 120 mg PO DAILY 
9. MetFORMIN (Glucophage) 500 mg PO BID 
10. Pantoprazole 40 mg PO Q12H 
11. Clopidogrel 75 mg PO DAILY 
12. Aspirin 81 mg PO DAILY 

 
Discharge Medications:
1. Amlodipine 10 mg PO DAILY 
2. Aspirin 81 mg PO DAILY 
3. Atorvastatin 80 mg PO QPM 
4. Bisacodyl 5 mg PO DAILY 
5. Clopidogrel 75 mg PO DAILY 
6. Fluoxetine 60 mg PO DAILY 
7. Gabapentin 400 mg PO TID 
8. Metoprolol Tartrate 50 mg PO BID 
9. Mirtazapine 30 mg PO QHS 
10. Pantoprazole 40 mg PO Q12H 
11. MetFORMIN (Glucophage) 500 mg PO BID 
12. Isosorbide Mononitrate (Extended Release) 180 mg PO DAILY 
RX *isosorbide mononitrate 60 mg 3 tablet(s) by mouth daily Disp 
#*90 Tablet Refills:*0

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Atypical chest pain, hypertension, hyperlipidemia, diabetes type 
II, esophageal spasm
 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
 
Discharge Instructions:
Dear Mr. ___,

You came to the hospital because you were having chest pain. The 
largest thing we worry about is a heart attack, particularly in 
you since you have had prior stents placed in your coronary 
arteries before. Thankfully, your EKGs did not show any evidence 
of a heart attack, nor did the markers for cardiac dysfunction 
in your blood, even after a repeated episode of chest pain you 
had overnight. Therefore, your symptoms are not from a heart 
attack. Unfortunately, we are unable to tell you what is causing 
them exactly; likely it is a component of your esophageal 
spasms, and therefore we have uptitrated your home nitrate. We 
have increased the dose of your isosorbide mononitrate from 120 
mg to 180 mg daily. Please follow-up with your outpatient 
gastroenterologist since he knows your esophageal spasm history 
the best, as well as your PCP to maintain overall good health. 

We wish you the best,
-Your ___ care team
 
Followup Instructions:
___
"
12962702-DS-14," 
Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: SURGERY
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
Left eye vision loss
 
Major Surgical or Invasive Procedure:
___ - left carotid endarterectomy

 
History of Present Illness:
History Present Illness: ___ reports that on ___ he had a 
partial
loss of vision in his left eye. The top eye of his left eye
became cloudy/dark grey and the bottom half was clear.  He
reports that he went to his optomotrist who after assessing his
eyes referred him to an opthalmologist who, on report noticed a
cotton wool spot in the left inferotemporal retina which
suggested ischemia.

The opthalmologist then contacted his neurologist ___
referred him to ___ ED.  Dr. ___ been following him 
for
asymptomatic carotid stenosis first noted as a carotid bruit on
physical exam.  This is his first episode of vision changed and
he denies a previous history of CVA.  The patient reports that
his vision has been almost completely restored although he does
have a residual deficit at the superior aspect of his visual
field.

He denies headache, dizziness, weakness, changes in sensorium, 
or
problems moving his extremities.  He also denies fevers, chills,
nausea, vomiting, diarrhea and hematochezia. He denies rest pain
and claudication and is able to walk ~1.5 miles without his legs
tiring.

 
Past Medical History:
PAST MEDICAL HISTORY: Hypertension, Hyperlipidemia, MI in ___,
cataracts, benign Parotid Tumor
 
PAST SURGICAL HISTORY: Tonsillectomy, Right hip replacement,
Bilateral Benign Parotid Tumor

 
Social History:
___
Family History:
Mother with emphysema, lung cancer, and abdominal
aorta problem and tremor.  Father with emphysema.  Maternal
grandmother with tremor.

 
Physical Exam:
Vital Signs: Temp: 98.5 RR: 16 Pulse: 67 BP: 180/63  
Neuro/Psych: Oriented x3, Affect Normal, NAD, abnormal:
Visual defect resolved. 
Neck: No masses, Trachea midline, Thyroid normal size,
non-tender, no masses or nodules, abnormal: Bilateral carotid
bruit left>right. 
Nodes: No clavicular/cervical adenopathy, No inguinal 
adenopathy.

Skin: No atypical lesions. 
Heart: Regular rate and rhythm. 
Lungs: Clear, Normal respiratory effort. 
Gastrointestinal: Non distended, No masses, Guarding or rebound,
No hepatosplenomegally, No hernia, No AAA. 
Extremities: No popiteal aneurysm, No femoral bruit/thrill, No
RLE edema, No LLE Edema, No varicosities, No skin changes. 
 
Pulse Exam (P=Palpation, D=Dopplerable, N=None)
RUE Radial: P. Ulnar: P. Brachial: P. 
LUE Radial: P. Ulnar: P. Brachial: P. 
RLE Femoral: P. Popiteal: P. DP: D. ___: D. Other: Diphasic
signals ___. 
LLE Femoral: P. Popiteal: P. DP: D. ___: D. Other: Diphasic
signals ___. 
 
DESCRIPTION OF WOUND: Incision C/D/I 

 
Pertinent Results:
___ 05:15PM   WBC-7.2 RBC-4.09* HGB-13.7* HCT-39.9* MCV-98 
MCH-33.4* MCHC-34.2 RDW-15.1
___ 05:15PM   GLUCOSE-111* UREA N-48* CREAT-1.3* SODIUM-138 
POTASSIUM-5.1 CHLORIDE-110* TOTAL CO2-16* ANION GAP-17
___ 08:20PM   ___ PTT-20.1* ___

___ MRI head/neck: No significant abnormalities on MRA of the 
head. 
  
No acute infarct seen. Areas of low signal in the right frontal 
sulci 
indicate of superficial siderosis from previous subarachnoid 
hemorrhage. MRA of the neck demonstrates diffuse atherosclerotic 
disease with approximately 60-70% narrowing at the narrowest 
portions in both carotid arteries.  Intracranial MRA is 
unremarkable.

 
Brief Hospital Course:
Mr. ___ was admitted on ___ with superior visual field 
defect of the left eye.  MRA revealed approximately 75% stenosis 
of his left carotid bifurcation.  He was taken to the operating 
room on ___ for a left carotid endarterectomy.  Please see 
operative report dictated on ___ for further details of the 
operation.  The procedure was uncomplicated and he was 
transferred to the VICU in stable condition.  His diet was 
advanced the next day and he was restarted on home medications.  
His foley was removed on POD#1, but he developed urinary 
retention.  He was straight cathed once, but again failed to 
void, so he was started on Flomax and a foley catheter was 
replaced.  His wound staples and JP drain were removed in the 
morning of POD#2.  He will be discharged to home with a leg bag 
and followup with a urologist.
 
Medications on Admission:
allopurinol ___
amlodipine 10'
atorvastatin 80'
clopidogrel 75'
lisinopril 40'
metoprolol succinate 25''
niacin 1000'
aspirin 162'

 
Discharge Medications:
1. atorvastatin 80 mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
2. amlodipine 5 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily).  

3. allopurinol ___ mg Tablet Sig: Two (2) Tablet PO DAILY 
(Daily).  
4. clopidogrel 75 mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
5. lisinopril 40 mg Tablet Sig: One (1) Tablet PO once a day.  
6. metoprolol succinate 25 mg Tablet Extended Release 24 hr Sig: 
One (1) Tablet Extended Release 24 hr PO DAILY (Daily).  
7. niacin 500 mg Capsule, Extended Release Sig: Two (2) Capsule, 
Extended Release PO DAILY (Daily).  
8. aspirin 81 mg Tablet, Chewable Sig: Two (2) Tablet, Chewable 
PO DAILY (Daily).  
9. oxycodone 5 mg Tablet Sig: One (1) Tablet PO every four (4) 
hours as needed for pain.
Disp:*30 Tablet(s)* Refills:*0*
10. tamsulosin 0.4 mg Capsule, Ext Release 24 hr Sig: One (1) 
Capsule, Ext Release 24 hr PO HS (at bedtime).
Disp:*30 Capsule, Ext Release 24 hr(s)* Refills:*2*
11. Colace 100 mg Capsule Sig: One (1) Capsule PO twice a day: 
while taking pain medications.
Disp:*60 Capsule(s)* Refills:*2*

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Left carotid artery stenosis

 
Discharge Condition:
Awake alert, oriented x3
Ambulating independently

 
Discharge Instructions:
What to expect when you go home:
1. Surgical Incision:
 It is normal to have some swelling and feel a firm ridge along 
the incision
 Your incision may be slightly red and raised, it may feel 
irritated from the staples

2. You may have a sore throat and/or mild hoarseness
 Try warm tea, throat lozenges or cool/cold beverages

3. You may have a mild headache, especially on the side of your 
surgery
 Try ibuprofen, acetaminophen, or your discharge pain 
medication
 If headache worsens, is associated with visual changes or 
lasts longer than 2 hours- call vascular
surgeons office

4. It is normal to feel tired, this will last for ___ weeks
 You should get up out of bed every day and gradually increase 
your activity each day
 You may walk and you may go up and down stairs
 Increase your activities as you can tolerate- do not do too 
much right away!

5. It is normal to have a decreased appetite, your appetite will 
return with time
 You will probably lose your taste for food and lose some 
weight
 Eat small frequent meals
 It is important to eat nutritious food options (high fiber, 
lean meats, vegetables/fruits, low fat, low
cholesterol) to maintain your strength and assist in wound 
healing
 To avoid constipation: eat a high fiber diet and use stool 
softener while taking pain medication

What activities you can and cannot do:
 No driving until post-op visit and you are no longer taking 
pain medications
 No excessive head turning, lifting, pushing or pulling 
(greater than 5 lbs) until your post op visit
 You may shower (no direct spray on incision, let the soapy 
water run over incision, rinse and pat
dry)
 Your incision may be left uncovered, unless you have small 
amounts of drainage from the wound,
then place a dry dressing over the area that is draining, as 
needed
 Take all the medications you were taking before surgery, 
unless otherwise directed
 Take one full strength (325mg) enteric coated aspirin daily, 
unless otherwise directed
 Call and schedule an appointment to be seen in 2 weeks for 
staple/suture removal

What to report to office:
 Changes in vision (loss of vision, blurring, double vision, 
half vision)
 Slurring of speech or difficulty finding correct words to use
 Severe headache or worsening headache not controlled by pain 
medication
 A sudden change in the ability to move or use your arm or leg 
or the ability to feel your arm or leg
 Trouble swallowing, breathing, or talking
 Temperature greater than 101.5F for 24 hours
 Bleeding, new or increased drainage from incision or white, 
yellow or green drainage from incisions
 
Followup Instructions:
___
"
12970259-DS-4," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: SURGERY
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
s/p fall
 
Major Surgical or Invasive Procedure:
None
 
History of Present Illness:
___ male with history of alcohol abuse, aortic surgery, 
presenting as a trauma transfer from ___ for evaluation of 
multiple rib fractures and a scapular fracture after a 
intoxicated fall. Patient fell in the bathroom
landed on the toilet on his right side. He was seen at ___ 
where he had multiple rib fractures and concern for possible 
pulmonary contusion as well as a right scapular fracture.

 
Past Medical History:
Past Medical History: High Cholesterol, HTN, ETOH, aortic 
surgery

 
Social History:
___
Family History:
Non-contributory
 
Physical Exam:
Admission Physical Exam:
Temp: 98.3 HR: 100 BP: 219/112 Resp: 22 O(2)Sat: 100 Normal
Constitutional: Patient is in obvious discomfort
HEENT: Normocephalic, atraumatic, Pupils equal, round and
reactive to light, Extraocular muscles intact
No midline C-spine tenderness
Chest: Right lateral chest wall tenderness
Cardiovascular: Tachycardic
Abdominal: Soft, Nontender, Nondistended
Extr/Back: No cyanosis, clubbing or edema
Skin: No rash, Warm and dry
Neuro: Speech fluent, moving all extremities
Psych: Normal mentation

Discharge Physical Exam:
VS: 97.9, 188/102, 86, 17, 96 Ra 
GEN: A&O, mild discomfort with activity
HEENT: wnl
CV: HRR
PULM: LS diminished on right side, fine crackles. TTP over right 
chest wall.
ABD: soft, NT/ND
EXT: No edema
 
Pertinent Results:
LABS:
___ 11:00PM   GLUCOSE-131* UREA N-18 CREAT-0.7 SODIUM-125* 
POTASSIUM-4.5 CHLORIDE-86* TOTAL CO2-27 ANION GAP-12
___ 11:00PM   CALCIUM-8.3* PHOSPHATE-2.9 MAGNESIUM-2.2
___ 04:10PM   GLUCOSE-137* UREA N-16 CREAT-0.6 SODIUM-125* 
POTASSIUM-4.1 CHLORIDE-84* TOTAL CO2-28 ANION GAP-13
___ 04:10PM   CALCIUM-8.8 PHOSPHATE-2.8 MAGNESIUM-2.3
___ 11:20AM   CORTISOL-11.2
___ 09:45AM   GLUCOSE-122* UREA N-13 CREAT-0.7 SODIUM-124* 
POTASSIUM-4.0 CHLORIDE-84* TOTAL CO2-27 ANION GAP-13
___ 09:45AM   CALCIUM-8.3* PHOSPHATE-2.7 MAGNESIUM-2.0
___ 04:55AM   GLUCOSE-119* UREA N-13 CREAT-0.7 SODIUM-120* 
POTASSIUM-4.4 CHLORIDE-83* TOTAL CO2-25 ANION GAP-12
___ 04:55AM   CALCIUM-8.6 PHOSPHATE-3.0 MAGNESIUM-1.8
___ 04:55AM   WBC-10.6* RBC-3.14* HGB-10.2* HCT-27.8* 
MCV-89 MCH-32.5* MCHC-36.7 RDW-11.9 RDWSD-38.5
___ 04:55AM   PLT COUNT-168
___ 09:29PM   PO2-91 PCO2-40 PH-7.45 TOTAL CO2-29 BASE XS-3
___ 09:29PM   GLUCOSE-121* LACTATE-2.7* NA+-120* K+-4.4 
CL--77*
___ 09:29PM   HGB-12.2* calcHCT-37 O2 SAT-94 CARBOXYHB-2 
MET HGB-0
___ 09:29PM   freeCa-0.97*
___ 09:14PM   UREA N-17 CREAT-0.7
___ 09:14PM   LIPASE-22
___ 09:14PM   ASA-NEG ETHANOL-NEG ACETMNPHN-NEG 
bnzodzpn-NEG barbitrt-NEG tricyclic-NEG
___ 09:14PM   WBC-14.8* RBC-3.53* HGB-11.4* HCT-31.2* 
MCV-88 MCH-32.3* MCHC-36.5 RDW-11.9 RDWSD-38.5
___ 09:14PM   PLT COUNT-208
___ 09:14PM   ___ PTT-25.0 ___
___ 09:14PM   ___ 06:36AM BLOOD WBC-8.0 RBC-3.35* Hgb-10.8* Hct-31.6* 
MCV-94 MCH-32.2* MCHC-34.2 RDW-12.1 RDWSD-41.8 Plt ___
___ 06:36AM BLOOD Glucose-112* UreaN-13 Creat-0.6 Na-135 
K-4.2 Cl-96 HCO3-26 AnGap-13

Radiology: 
___ R shoulder: Mildly comminuted fracture lateral inferior
right scapular blade is seen. No fracture or dislocation or 
signs
of osteomyelitis in the right glenohumeral joint are found.
Multiple right-sided rib fractures are present. 

___ CT chest: Acute mildly displaced fx of lateral R ___, posterior and lateral 7th rib, non-displaced fx post
R8-9 ribs. Multiple lateral and posterior R sided rib fractures
producing flail chest syndrome are seen. Extensive posterior
right lower lobe consolidation, compatible with atelectasis 
mixed
with lung hemorrhage and moderate right pleural effusion, small
anterior and medial lower right pneumothorax are present. No
thoracic aortic aneurysm or dissection is seen. Bilateral
gynecomastia, much more prominent on the right side are seen. 

___ Abdomen/Pelvis: Extensive posterior right lung base 
airspace
disease and moderate right pleural effusion are present. No
abdominal hematoma or internal organ injury could be seen. No
pelvic hematoma or internal organ injury could be seen. Left
adrenal tumor is found, follow-up MRI is recommended. Right mid
renal cortical simple cyst and relatively high density left
lateral inferior renal cortical lesion are seen. Right
parasagittal ventral hernia containing partial circumference of
transverse colon, small periumbilical hernia seen.

 
Brief Hospital Course:
Mr. ___ is a ___ y/o M who was transferred to ___ from 
___ s/p fall while intoxicated, found to have 
multiple right-sided rib fractures and a right displaced 
scapular fracture. The patient was also found to be hyponatremic 
with a sodium level of 120.  The patient was admitted to the 
Trauma Surgery service for further management. He was maintained 
on a ___ protocol for alcohol withdrawal. 

The patient received NS and salt tabs for hyponatremia. On ___, 
sodium was normalized to 135 and salt tabs were discontinued. 
The patients home HCTZ was restarted.  He worked with Physical 
and Occupational Therapy.  He was seen by social work for ___. 
Orthopedic Surgery was contacted for the scapula fracture, they 
recommended WBAT and outpatient follow-up. During this 
hospitalization, the patient ambulated early and frequently, was 
adherent with respiratory toilet and incentive spirometry, and 
actively participated in the plan of care. The patient received 
subcutaneous heparin and venodyne boots were used during this 
stay.

At the time of discharge, the patient was doing well, afebrile 
with stable vital signs. The patient was tolerating a regular 
diet, ambulating, voiding without assistance, and pain was well 
controlled.  The patient was discharged home without services. 
The patient received discharge teaching and follow-up 
instructions with understanding verbalized and agreement with 
the discharge plan.

 
Medications on Admission:
atorvastatin 80, HCT 25 mg, metop tartrate 100 mg, ASA 81 mg 
 
Discharge Medications:
1.  Acetaminophen ___ mg PO Q6H:PRN Pain - Mild  
2.  Docusate Sodium 100 mg PO BID 
hold for loose stool  
3.  FoLIC Acid 1 mg PO DAILY  
4.  Gabapentin 300 mg PO BID  
5.  Lidocaine 5% Patch 1 PTCH TD QAM right rib fx's  
6.  OxyCODONE (Immediate Release) ___ mg PO Q4H:PRN Pain - 
Moderate 
  Reason for PRN duplicate override: Alternating agents for 
similar severity
Take lowest effective dose. Patient may request partial fill. 
RX *oxycodone 5 mg ___ tablet(s) by mouth every four (4) hours 
Disp #*20 Tablet Refills:*0 
7.  Polyethylene Glycol 17 g PO DAILY:PRN Constipation - First 
Line 
  Reason for PRN duplicate override: Alternating agents for 
similar severity 
8.  Senna 8.6 mg PO BID:PRN Constipation - First Line  
9.  Thiamine 100 mg PO DAILY  
10.  Aspirin 81 mg PO DAILY  
11.  Atorvastatin 80 mg PO QPM  
12.  Hydrochlorothiazide 25 mg PO DAILY  
13.  Metoprolol Tartrate 100 mg PO DAILY  

 
Discharge Disposition:
Extended Care
 
Facility:
___ 
 
Discharge Diagnosis:
[] Fall while intoxicated
[] Right displaced scapula fracture
[] Right-sided rib fractures ___ and moderate right pleural 
effusion
[] Alcohol withdrawal
[] Hyponatremia (resolved)

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Mr. ___,

You were admitted to ___ after 
a fall and were found to have a right scapular (shoulder blade) 
fracture and multiple right-sided rib fractures.  Your scapular 
fracture will heal on it's own and you have an appointment in 
the outpatient ___ clinic for repeat imaging.  Your rib 
fractures will heal on their own and it is important to use your 
incentive spirometer to prevent pneumonia.  

You have worked with Physical Therapy who recommend you be 
discharged to rehab to regain your strength. 

You are now ready to be discharged from the hospital.  Please 
note the following discharge instructions:

* Your injury caused right-sided rib fractures which can cause 
severe pain and subsequently cause you to take shallow breaths 
because of the pain.
 
* You should take your pain medication as directed to stay ahead 
of the pain otherwise you won't be able to take deep breaths. If 
the pain medication is too sedating take half the dose and 
notify your physician.
 
* Pneumonia is a complication of rib fractures.  In order to 
decrease your risk you must use your incentive spirometer 4 
times every hour while awake.  This will help expand the small 
airways in your lungs and assist in coughing up secretions that 
pool in the lungs.
 
* You will be more comfortable if you use a cough pillow to hold 
against your chest and guard your rib cage while coughing and 
deep breathing.
 
* Symptomatic relief with ice packs or heating pads for short 
periods may ease the pain.
 
* Narcotic pain medication can cause constipation therefore you 
should take a stool softener twice daily and increase your fluid 
and fiber intake if possible.
 
* Do NOT smoke
 
* If your doctor allows, non-steroidal ___ drugs 
are very effective in controlling pain ( ie, Ibuprofen, Motrin, 
Advil, Aleve, Naprosyn) but they have their own set of side 
effects so make sure your doctor approves.
 
* Return to the Emergency Room right away for any acute 
shortness of breath, increased pain or crackling sensation 
around your ribs (crepitus).

 
Followup Instructions:
___
"
12991484-DS-15," 
Name:  ___       ___ No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: ORTHOPAEDICS
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___
 
Chief Complaint:
right knee osteoarthritis/pain
 
Major Surgical or Invasive Procedure:
___: right total knee arthroplasty

 
History of Present Illness:
___ year old male w/right hip osteoarthritis/pain who failed 
conservative measures, now admitted for right total knee 
arthroplasty. 
 
Past Medical History:
HTN, dyslipidemia, OSA, T2DM ___ A1C 7.1), BPH, LUE chemical 
burn requiring hospitalization & laser surgeries, shingles, s/p 
L THA ___, Dr. ___ 
 
Social History:
___
Family History:
Family history of DM. 
 
Physical Exam:
Well appearing in no acute distress  
 Afebrile with stable vital signs  
 Pain well-controlled  
 Respiratory: CTAB  
 Cardiovascular: RRR  
 Gastrointestinal: NT/ND  
 Genitourinary: Voiding independently  
 Neurologic: Intact with no focal deficits  
 Psychiatric: Pleasant, A&O x3  
 Musculoskeletal Lower Extremity:  
 * Incision healing well with staples  
 * Scant serosanguinous drainage  
 * Thigh full but soft  
 * No calf tenderness  
 * ___ strength  
 * SILT, NVI distally  
 * Toes warm  
 
Pertinent Results:
___ 08:03AM BLOOD WBC-11.9* RBC-3.50* Hgb-11.3* Hct-33.0* 
MCV-94 MCH-32.3* MCHC-34.2 RDW-13.2 RDWSD-45.9 Plt ___
___ 07:55AM BLOOD WBC-12.7* RBC-3.80* Hgb-12.4* Hct-35.4* 
MCV-93 MCH-32.6* MCHC-35.0 RDW-13.1 RDWSD-44.8 Plt ___
___ 08:02AM BLOOD WBC-9.9 RBC-4.00* Hgb-12.8* Hct-37.3* 
MCV-93 MCH-32.0 MCHC-34.3 RDW-13.0 RDWSD-44.7 Plt ___
___ 08:03AM BLOOD Plt ___
___ 07:55AM BLOOD Plt ___
___ 08:02AM BLOOD Plt ___
___ 08:02AM BLOOD Glucose-149* UreaN-14 Creat-1.0 Na-135 
K-4.0 Cl-102 HCO3-23 AnGap-14
___ 08:02AM BLOOD Calcium-9.1 Phos-3.5 Mg-1.6
 
Brief Hospital Course:
The patient was admitted to the Orthopaedic surgery service and 
was taken to the operating room for above described procedure. 
Please see separately dictated operative report for details. The 
surgery was uncomplicated and the patient tolerated the 
procedure well. Patient received perioperative IV antibiotics.

Postoperative course was remarkable for the following:
Overnight on POD#0, the patient was unable to void and had to be 
straight cath'ed x1.  He was able to void thereafter.  On POD#2, 
the patient was complaining of calf tenderness.  He was sent to 
rule out a blood clot.  His LENIs were negative for blood clots. 
 Urines were also collected on POD#2 when his white count and 
temp were elevated.  His urinalysis was negative and urine 
culture was pending at time of discharge.  He will be contacted 
if the urine culture comes back positive.

Otherwise, pain was controlled with a combination of IV and oral 
pain medications.  The patient received Lovenox for DVT 
prophylaxis starting on the morning of POD#1.  The surgical 
dressing was changed and the SIlverlon dressing was removed on 
POD#2. The surgical incision was found to be clean and intact 
without erythema or abnormal drainage. The patient was seen 
daily by physical therapy. Labs were checked throughout the 
hospital course and repleted accordingly. At the time of 
discharge the patient was tolerating a regular diet and feeling 
well.  The patient was afebrile with stable vital signs.  The 
patient's hematocrit was acceptable and pain was adequately 
controlled on an oral regimen. The operative extremity was 
neurovascularly intact and the wound was benign.

The patient's weight-bearing status is weight bearing as 
tolerated on the operative extremity. Please use walker or 2 
crutches at all times for 6 weeks.

Mr. ___ is discharged to home with services in stable 
condition.
 
Medications on Admission:
1. GlipiZIDE 10 mg PO DAILY 
2. Ibuprofen 800 mg PO Q8H:PRN Pain - Moderate 
3. Glargine 10 Units Bedtime
4. Lisinopril 20 mg PO DAILY 
5. MetFORMIN (Glucophage) 1000 mg PO BID 
6. Pravastatin 20 mg PO QPM 
7. Aspirin 81 mg PO DAILY 

 
Discharge Medications:
1.  Acetaminophen 1000 mg PO Q8H 
2.  Docusate Sodium 100 mg PO BID 
Hold for loose stools 
3.  Enoxaparin Sodium 40 mg SC DAILY 
Start: ___, First Dose: Next Routine Administration Time 
4.  OxyCODONE (Immediate Release) ___ mg PO Q4H:PRN Pain 
5.  Senna 8.6 mg PO BID 
Hold for loose stools 
6.  Glargine 10 Units Bedtime 
7.  GlipiZIDE 10 mg PO DAILY  
8.  Lisinopril 20 mg PO DAILY  
9.  MetFORMIN (Glucophage) 1000 mg PO BID  
10.  Pravastatin 20 mg PO QPM  
11. HELD- Aspirin 81 mg PO DAILY  This medication was held. Do 
not restart Aspirin until Lovenox course completed.
12. HELD- Ibuprofen 800 mg PO Q8H:PRN Pain - Moderate  This 
medication was held. Do not restart Ibuprofen until you have 
completed lovenox

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
right knee osteoarthritis/pain

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).

 
Discharge Instructions:
1. Please return to the emergency department or notify your 
physician if you experience any of the following: severe pain 
not relieved by medication, increased swelling, decreased 
sensation, difficulty with movement, fevers greater than 101.5, 
shaking chills, increasing redness or drainage from the incision 
site, chest pain, shortness of breath or any other concerns.

2. Please follow up with your primary physician regarding this 
admission and any new medications and refills. 

3. Resume your home medications unless otherwise instructed.

4. You have been given medications for pain control. Please do 
not drive, operate heavy machinery, or drink alcohol while 
taking these medications. As your pain decreases, take fewer 
tablets and increase the time between doses. This medication can 
cause constipation, so you should drink plenty of water daily 
and take a stool softener (such as Colace) as needed to prevent 
this side effect.  Call your surgeons office 3 days before you 
are out of medication so that it can be refilled.  These 
medications cannot be called into your pharmacy and must be 
picked up in the clinic or mailed to your house.  Please allow 
an extra 2 days if you would like your medication mailed to your 
home.

5. You may not drive a car until cleared to do so by your 
surgeon.

6. Please call your surgeon's office to schedule or confirm your 
follow-up appointment.

7. SWELLING: Ice the operative joint 20 minutes at a time, 
especially after activity or physical therapy. Do not place ice 
directly on the skin. You may wrap the knee with an ace bandage 
for added compression. Please DO NOT take any non-steroidal 
anti-inflammatory medications (NSAIDs such as Celebrex, 
ibuprofen, Advil, Aleve, Motrin, naproxen etc).

8. ANTICOAGULATION: Please continue your  Lovenox for four (4) 
weeks to help prevent deep vein thrombosis (blood clots).  If 
you were taking Aspirin prior to your surgery, you should hold 
this medication while taking anticoagulation medication.   

9. WOUND CARE: Please keep your incision clean and dry. It is 
okay to shower five days after surgery but no tub baths, 
swimming, or submerging your incision until after your four (4) 
week checkup. Please place a dry sterile dressing on the wound 
each day if there is drainage, otherwise leave it open to air. 
Check wound regularly for signs of infection such as redness or 
thick yellow drainage. Staples will be removed by at follow-up 
appointment approximately two weeks after surgery. 

10. ___ (once at home): Home ___, dressing changes as 
instructed, and wound checks.

11. ACTIVITY: Weight bearing as tolerated on the operative 
extremity. Two crutches or walker at all times for 6 weeks. 
Mobilize.  ROM as tolerated. No strenuous exercise or heavy 
lifting until follow up appointment. 
Physical Therapy:
WBAT RLE
No range of motion restrictions
Assistive device x 6 weeks (i.e., 2 crutches, walker)
Mobilize frequently
Treatments Frequency:
daily dressing changes as needed for drainage
wound checks daily
ice
staple removal and replace with steri-strips (at follow up 
visit)
 
Followup Instructions:
___
"
13016981-DS-27," 
Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Demerol
 
Attending: ___.
 
Chief Complaint:
RUQ Pain, Fever
 
Major Surgical or Invasive Procedure:
 
___ percutaneous cholangiogram with biliary drain exchange. 
___ biliary drain exchange, upsized to 10 ___. 

 
History of Present Illness:
___ with metastatic cholangiocarcinoma who presents with RUQ 
pain and fever to ___. 

For the past few days, the patient has been having RUQ pain and 
fevers as high as 102.2F, along with occasional night sweats. He 
has a chronic percutaneous biliary drain in place, however it 
has remained capped recently. He has one episode of non-bloody 
emesis the day prior to admission. He also endorses a mild cough 
productive of white sputum which he attributes to allergies 
after cutting his lawn recently.

He initially presented to the ___ ED where Tbili was 
elevated to 2.7, alk phos elevated to 343. RUQ US there showed 
thickened gallbladder and biliary ductal dilation. He received 
IVF, vanc/Zosyn and was transferred to the ___ ED. 

In the ___ ED, ERCP was consulted. Labs showed persistent 
elevation of Tbili. He was admitted to ___.
 
Past Medical History:
ONCOLOGIC HISTORY:  ___ initially presented with
diarrhea ___, but then became jaundiced in ___, prompting medical evaluation.  He underwent two ERCP
procedures at ___, at which time
biliary stents were placed.  Cytology was initially inconclusive
but on followup study showed adenocarcinoma.  He was referred 
for
surgical exploration and planned resection on ___. 

The procedure was aborted, however, as peritoneal metastases 
were
identified intraoperatively.  Biopsy confirmed the finding of
metastatic adenocarcinoma morphologically consistent with
pancreaticobiliary primary.  His postoperative course was
complicated by E. coli bacteremia.  He began
gemcitabine/cisplatin systemic chemotherapy on ___. 
Treatment was held in ___ after he was hospitalized with
cholangitis, and he continued off treatment until ___ when CT
showed progression associated with increased abdominal pain.  He
was also diagnosed with right hydronephrosis.  He resumed single
agent gemcitabine ___, and then combination
gemcitabine/cisplatin ___ after ureteral stenting. 

Past Medical History:  
1. Cholangiocarcinoma, stage IV, as above.
2. Portal vein thrombosis

 
Social History:
___
Family History:
The patient's mother has hypertension. His father died with  
NASH cirrhosis at ___ years. His brother has no health concerns.  

He has three children, a son with irritable bowel syndrome and  
a daughter with ___ disease.  
 

 
Physical Exam:
ADMISSION PHYSICAL EXAM
=======================
PHYSICAL EXAM:
VITAL SIGNS: T 98.0 BP 108/62 HR 60 RR 18 SpO2 94/RA
General:  NAD
HEENT:  MMM, no OP lesions, 
Neck: supple, no JVD
CV:  RR, NL S1S2 no S3S4 or MRG
PULM:  CTAB
ABD:  BS+, soft, TTP in the RUQ. PTBD in place and is capped
EXT:  warm well perfused, no edema
SKIN:  No rashes or skin breakdown
NEURO:  alert and oriented x 4, no focal deficits appreciated

DISCHARGE PHYSICAL EXAM
=======================
VS: 98.0, 108/72, 49, 18, 97%/RA, TFB -875
GEN: Conversant gentleman, frustrated.   
HEENT: PERRLA. MMM. no LAD. no JVD. neck supple. No cervical, 
supraclavicular, or axillary LAD  
Cards: RR S1/S2 normal. no murmurs/gallops/rubs.  
Pulm:  CTAB no crackles. Bilateral squeaking wheezes in mid lung 
fields
Abd: TTP at RUQ, with minimal guarding. BS+, soft, no HSM, no 
___ sign. Biliary drainage drain in place, capped clean 
dressing, no biliary fluid leakage.
Extremities: WWP, PPP, no ___ edema
Skin: no rashes or bruising, no noticeable jaundice

 
Pertinent Results:
ADMISSION LABS
==============
___ 12:00AM   GLUCOSE-83 UREA N-12 CREAT-0.8 SODIUM-139 
POTASSIUM-3.4 CHLORIDE-107 TOTAL CO2-22 ANION GAP-13
___ 12:00AM   estGFR-Using this
___ 12:00AM   ALT(SGPT)-61* AST(SGOT)-38 ALK PHOS-286* TOT 
BILI-2.8* DIR BILI-2.4* INDIR BIL-0.4
___ 12:00AM   LIPASE-19
___ 12:00AM   ALBUMIN-3.3*
___ 12:00AM   WBC-4.7 RBC-2.81* HGB-9.4* HCT-29.1* MCV-104* 
MCH-33.5* MCHC-32.3 RDW-14.7 RDWSD-54.9*
___ 12:00AM   NEUTS-50.2 ___ MONOS-20.1* EOS-1.5 
BASOS-0.2 IM ___ AbsNeut-2.34# AbsLymp-1.30 AbsMono-0.94* 
AbsEos-0.07 AbsBaso-0.01
___ 12:00AM   HYPOCHROM-1+ ANISOCYT-1+ POIKILOCY-NORMAL 
MACROCYT-1+ MICROCYT-NORMAL POLYCHROM-OCCASIONAL
___ 12:00AM   PLT SMR-LOW PLT COUNT-72*#
___ 12:00AM   ___ PTT-28.0 ___

MICROBIOLOGY RESULS
===================
Blood culture ___: pending
Bile culture ___: 

                       SENSITIVITIES: MIC expressed in MCG/ML
                      
_________________________________________________________
                             PROTEUS SPECIES
                             |          KLEBSIELLA OXYTOCA
                             |          |          ENTEROBACTER 
CLOACAE COMPLE
                             |          |          |          
PROTEUS SPECIES
                             |          |          |          |  
        ENTER
                             |          |          |          |  
        |   
AMPICILLIN------------  =>32 R                           =>32 R  
    <=2 S
AMPICILLIN/SULBACTAM--  =>32 R        8 S                =>32 R
CEFAZOLIN-------------  =>64 R      <=4 S                =>64 R
CEFEPIME--------------       S      <=1 S      <=1 S       16 R
CEFTAZIDIME-----------   <=1 S      <=1 S        2 S        8 I
CEFTRIAXONE-----------  =>64 R      <=1 S      <=1 S        8 R
CIPROFLOXACIN---------<=0.25 S   <=0.25 S   <=0.25 S   <=0.25 S
GENTAMICIN------------   <=1 S      <=1 S      <=1 S      <=1 S
MEROPENEM-------------<=0.25 S   <=0.25 S   <=0.25 S   <=0.25 S
PENICILLIN G----------                                           
      2 S
PIPERACILLIN/TAZO-----   <=4 S      <=4 S          S
TOBRAMYCIN------------   <=1 S      <=1 S      <=1 S      <=1 S
TRIMETHOPRIM/SULFA----   <=1 S      <=1 S      <=1 S      <=1 S
VANCOMYCIN------------                                           
      1 S

   ANAEROBIC CULTURE (Final ___: 
      CLOSTRIDIUM PERFRINGENS.    SPARSE GROWTH. 

DISCHARGE LABS
===============
___ 06:00AM BLOOD WBC-9.0 RBC-3.60* Hgb-12.0* Hct-37.2* 
MCV-103* MCH-33.3* MCHC-32.3 RDW-14.3 RDWSD-54.4* Plt ___
___ 06:00AM BLOOD Plt ___
___ 06:00AM BLOOD Glucose-90 UreaN-23* Creat-1.0 Na-134 
K-4.8 Cl-99 HCO3-24 AnGap-16
___ 06:00AM BLOOD estGFR-Using this
___ 06:00AM BLOOD ALT-23 AST-27 LD(LDH)-263* AlkPhos-209* 
TotBili-0.5
___ 06:00AM BLOOD Calcium-9.4 Phos-4.4 Mg-1.___SSESSMENT AND PLAN:  ___ with metastatic cholangiocarcinoma 
(gemcitabine/cisplatin/ with internal/external stent, who p/w 
RUQ pain and fever to 102, found to have elevated Tbili, AlkP, 
RUQ revealed thickened gallbladder and biliary ductal dilation 
found to have biliary drain obstruction during drain exchange, 
bile culture growing multiple 

Acute Issues:
=======
#Cholangitis/Drain Obstruction. RUQ Pain likely ___ biliary 
pathology given RUQ pain, fever, elevated Tbili, AlkP, ALT, and 
thickened gallbladder with dilated biliary duct seen on US at 
OSH. Found to have distal drain obstruction during ___ drain 
exchange ___. C/f bile drain obstruction given increased pain 
on ___ and AlkP uptrending to 208 iso pale stools. On 
cipro/augmentin per ID consulted based on bile culture 
sensitivities for 14 days from first drain exchange (last day 
___ second drain change and upsize to 10 ___. 
 
#Cholangiocarcinoma. Currently on cycle 31 of 
cisplatin/gemcitabine
- Continue home ursodiol 300 mg BID

#Portal Vein Thrombosis. Hx of portal vein thrombosis, on 
lovenox.
- Continue lovenox 

#Pain. Significant RUQ pain, improved since drain exchange and 
antibiotics. 
- IV dilaudid 0.5 mg -1.0 mg Q4 PRN pain 
- Restart home oxycodone ___ ___ mg Q6 PRN pain upon DC

___ Cyst. R knee medial popliteal ___ cyst noted on 
physical exam, confirmed on U/S
- Monitor 

#Panctyopenia. Likely ___ cis/gem chmtx restarted ___. 
- Continue to monitor

Chronic Issues
======== 

#Constipation
- Continue home Colace, senna, miralax PRN

#Anxiety
- Continue home lorazepam 0.5 mg Q8 PRN

#Nausea
- continue home Zofran 8 mg PO Q8 PRN
- Continue home prochlorperazine 10 mg PO Q6 PRN 

#GERD:
- continue home pantoprazole 40 mg PO Q12

Transitional Issues
===================
- Continue Cipro/augmentin for 14 days after drain exchange 
(last day ___ 
- f/u with Dr. ___ ___
- f/u with ___ in ___ weeks

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Enoxaparin Sodium 100 mg SC DAILY 
Start: ___, First Dose: Next Routine Administration Time 
2. Lactulose 15 mL PO Q4H:PRN constipation 
3. LORazepam 0.5 mg PO Q8H:PRN anxiety 
4. Ondansetron 8 mg PO Q8H:PRN nausea 
5. OxyCODONE (Immediate Release) ___ mg PO Q6H:PRN Pain - 
Moderate 
6. Pantoprazole 40 mg PO Q12H 
7. Prochlorperazine 10 mg PO Q6H:PRN nausea 
8. Ursodiol 300 mg PO BID 
9. Docusate Sodium 100 mg PO BID 
10. Polyethylene Glycol 17 g PO DAILY 
11. Senna 8.6 mg PO BID 
12. OxyCODONE SR (OxyconTIN) 10 mg PO Q12H 

 
Discharge Medications:
1.  Amoxicillin-Clavulanic Acid ___ mg PO Q12H 
RX *amoxicillin-pot clavulanate 875 mg-125 mg 1 tablet(s) by 
mouth twice a day Disp #*15 Tablet Refills:*0 
2.  Ciprofloxacin HCl 500 mg PO Q12H 
RX *ciprofloxacin HCl 500 mg 1 tablet(s) by mouth twice a day 
Disp #*15 Tablet Refills:*0 
3.  Docusate Sodium 100 mg PO BID  
4.  Enoxaparin Sodium 100 mg SC QD 
Start: ___, First Dose: Next Routine Administration Time  
5.  Lactulose 15 mL PO Q4H:PRN constipation  
6.  LORazepam 0.5 mg PO Q8H:PRN anxiety  
7.  Ondansetron 8 mg PO Q8H:PRN nausea  
8.  OxyCODONE (Immediate Release) ___ mg PO Q6H:PRN Pain - 
Moderate  
9.  OxyCODONE SR (OxyconTIN) 10 mg PO Q12H  
10.  Pantoprazole 40 mg PO Q12H  
11.  Polyethylene Glycol 17 g PO DAILY  
12.  Prochlorperazine 10 mg PO Q6H:PRN nausea  
13.  Senna 8.6 mg PO BID  
14.  Ursodiol 300 mg PO BID  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
PRIMARY DIAGNOSIS: 
Cholangitis 
Biliary Drain Obstruction

SECONDARY DIAGNOSES:
Metastatic cholangiocarcinoma
Portal vein thrombosis 

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Mr. ___,

It was a pleasure to be part of your care.

You were admitted to the hospital because you were having fevers 
and right upper abdominal pain. You were found to have an 
obstruction and infection of your biliary drain. Your drain was 
replaced and you were started on antibiotics (now 
ciprofloxacin/augmentin) to treat your infection. Later during 
your stay the drain replacement was found to be partially 
clogged, so you underwent a second drain exchange and a larger 
drain was place. 

Please continue taking the antibiotics for a total 14 days 
(dating from your drain exchange), so your last day of 
antibiotics will be ___. 

If you experience any further infectious symptoms such as fever 
or chills or any symptoms related to your drain site such as 
redness or pus around your drain site, please contact your 
primary doctor.

It was a pleasure to be part of your care,
Your ___ Team
 
Followup Instructions:
___
"
13164440-DS-18," 
Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: ORTHOPAEDICS
 
Allergies: 
Penicillins / Sulfa(Sulfonamide Antibiotics) / sea food
 
Attending: ___.
 
Chief Complaint:
foot drop nd numbness right side
 
Major Surgical or Invasive Procedure:
1. L3 bilateral hemilaminotomy.
2. Diskectomy.

 
History of Present Illness:
HPI: ___ with h/o LBP and RLE radicular symptoms with recent
exacerbation. ___ years ago she had LBP and RLE radicular pain 
that
improved after ___ and lumbar steroid injections. She was symptom
free for ___ years until 1 month ago when her symptoms returned. 
In
the beginning of ___ she had a couple steroid injections that
relieved her back pain and radicular pain. She continued to have
subjective numbness below the knee on the RLE. She started ___
again last week and following a session developed a right foot
drop 6 days ago. She has required the use of crutches for the
last 6 days to walk. She currently denies back pain, radicular
pain, bowel/bladder problems.

PMH: kidney stones, LBP

PSH: 2 c-sections

MED: naproxen PRN, nexium, advair PRN, OCP's

ALL: penicillin and sulfa

PE: 

96.8 119 119/97 18 100% 

Anxious, but in NAD

Sensory:
UE C5 C6 C7 C8 T1
(lat arm)  (thumb) (mid fing) (sm finger) (med arm)
R intact      intact        intact        intact        intact
L intact      intact        intact        intact        intact

T2-L1 (Trunk) intact

___       L2     L3   L4   L5 S1 S2
(Groin) (Knee)    (Med Calf) (Grt Toe) (Sm Toe) (Post Thigh)
R intact intact dec dec       intact intact
L intact  intact intact intact       intact intact 

Motor:
UE Dlt(C5) Bic(C6) WE(C6) Tri(C7) WF(C7) FF(C8) FinAbd(T1)
R    5    5     5     5     5    5    5
L    5    5     5     5     5    5    5

___   Flex(L1) Add(L2)  Quad(L3) TA(L4) ___ Per(S1) 
___
R    5    5    5     0     0     4+       4+      
L    5     5       5     5     5     5     5

Reflexes 
Bic(C4-5) BR(C5-6) Tri(C6-7) Pat(L3-4) Ach(L5-S1)
R    2     2     2     0      0
L    2     2     2     2      2
             
Hoffmans: neg

Babinski: downgoing

Clonus: ___ beats bilaterally

Perianal sensation: intact

Rectal tone: intact

Straight Leg Raise: Does not reproduce radicular symptoms

Estimated Level of Cooperation: good
Estimated Reliability of Exam: good

IMAGING:Imaging: From OSH per report MRI L-spine from ___
showing L4-5 right paramedian disc herniation with moderate
foraminal stenosis. This MRI, however, was performed before she
developed the foot drop.

 
Past Medical History:
see HPI
 
Social History:
___
Family History:
nc
 
Physical Exam:
see HPI for details

Preop neurology

Right side 
L5 root ___
S1 root ___

Sensory numbness over L5 root distribution
No perianal numbness
Voiding normally. 
 
Pertinent Results:
___ 08:50PM   ___ PTT-27.4 ___
___ 06:45PM URINE  HOURS-RANDOM
___ 06:45PM URINE  HOURS-RANDOM
___ 06:45PM URINE  GR HOLD-HOLD
___ 06:45PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-NEG 
GLUCOSE-NEG KETONE-10 BILIRUBIN-NEG UROBILNGN-NEG PH-5.5 
LEUK-NEG
___ 06:30PM   GLUCOSE-106* UREA N-13 CREAT-0.8 SODIUM-141 
POTASSIUM-3.6 CHLORIDE-105 TOTAL CO2-21* ANION GAP-19
___ 06:30PM   WBC-7.3 RBC-4.70 HGB-13.8 HCT-41.7 MCV-89 
MCH-29.4 MCHC-33.1 RDW-12.3
 
Brief Hospital Course:
Patient was admitted to the ___ Spine Surgery Service and 
taken to the Operating Room for the above procedure.  Refer to 
the dictated operative note for further details.  The surgery 
was without complication and the patient was transferred to the 
PACU in a stable condition.  TEDs/pnemoboots were used for 
postoperative DVT prophylaxis.  Intravenous antibiotics were 
continued for 24hrs postop per standard protocol. Initial postop 
pain was controlled with a PCA.  Diet was advanced as tolerated. 
 The patient was transitioned to oral pain medication when 
tolerating PO diet.  Foley was removed on POD#2.  

Physical therapy was consulted for mobilization OOB to ambulate. 

Occupational therapy were consulted. AFO was used for the right 
foot drop. 

Hospital course was otherwise unremarkable.  On the day of 
discharge the patient was afebrile with stable vital signs, 
comfortable on oral pain control and tolerating a regular diet.
 
Medications on Admission:
 naproxen PRN, nexium, advair PRN, OCP's

 
Discharge Medications:
1. fluticasone-salmeterol 250-50 mcg/dose Disk with Device Sig: 
One (1) Disk with Device Inhalation DAILY (Daily).  
2. acetaminophen 650 mg Tablet Sig: One (1) Tablet PO Q6H (every 
6 hours) as needed for fever or pain.  
3. hydromorphone 2 mg Tablet Sig: ___ Tablets PO Q3H (every 3 
hours) as needed for breakthrough pain .
Disp:*100 Tablet(s)* Refills:*0*
4. docusate sodium 50 mg/5 mL Liquid Sig: ___  PO BID (2 times a 
day) as needed for constipation.  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
1. L4-5 herniated nucleus pulposus.
2. Large disk extrusion, from L3-L to L4-L, with severe
    neurologic compression.
3. Acute foot drop with progressive weakness.

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
You have undergone the following operation: Minimally Invasive 
Microdiscectomy
 
Immediately after the operation:
 
-        Activity: You should not lift anything greater than 10 
lbs for 2 weeks. You will be more comfortable if you do not sit 
or stand more than ~45 minutes without moving around.
 
-        Rehabilitation/ Physical Therapy: 
o   ___ times a day you should go for a walk for ___ minutes 
as part of your recovery.  You can walk as much as you can 
tolerate.
o   Limit any kind of lifting.
 
-        Diet: Eat a normal healthy diet. You may have some 
constipation after surgery.
 
-        Brace: You do not need a brace for your back.
 
-        Wound Care: Remove the dressing in 2 days.  If the 
incision is draining cover it with a new sterile dressing.  If 
it is dry then you can leave the incision open to the air.  Once 
the incision is completely dry (usually ___ days after the 
operation) you may take a shower. Do not soak the incision in a 
bath or pool.  If the incision starts draining at anytime after 
surgery, do not get the incision wet. Cover it with a sterile 
dressing.  Call the office.
 
-        You should resume taking your normal home medications.
 
-        You have also been given Additional Medications to 
control your pain.  Please allow 72 hours for refill of narcotic 
prescriptions, so please plan ahead.  You can either have them 
mailed to your home or pick them up at the clinic located on 
___.  We are not allowed to call in narcotic prescriptions 
(oxycontin, oxycodone, percocet) to the pharmacy.  In addition, 
we are only allowed to write for pain medications for 90 days 
from the date of surgery.
 
-        Follow up: 
o   Please Call the office and make an appointment for 2 weeks 
after the day of your operation if this has not been done 
already.
o   At the 2-week visit we will check your incision, take 
baseline X-rays and answer any questions. We may at that time 
start physical therapy.
o   We will then see you at 6 weeks from the day of the 
operation and at that time release you to full activity.
 
Please call the office if you have a fever>101.5 degrees 
Fahrenheit and/or drainage from your wound 
 
Followup Instructions:
___
"
13227028-DS-12," 
Name:  ___.               Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: NEUROSURGERY
 
Allergies: 
Ms ___ / Fentanyl / Lipitor / Oxycontin / Hydrochlorothiazide 
/ Rofecoxib
 
Attending: ___.
 
Chief Complaint:
Falls
 
Major Surgical or Invasive Procedure:
Burr Hole/Crani for ___ evacuation
 
History of Present Illness:
This is a ___ year old female who presents with a two day history 
of diplopia and Nausea and vomitting that. Patient is a good 
historian and provides a history of a syncopal episode on 
___ for which she had a full cardiac workup and a head CT at 
that time which was negative.  She started having
headaches in mid ___ and also some ataxia, but denies fall. 
Yesturday she noticed she was having some diplopia with her 
right eye closed and has been nautious and vomitting all day 
today. Again, patient denies any head trauma since ___.

 
Past Medical History:
HTN
Hypercholestrolemia
DDD lumbar spine
Diverticulosis
IBS
Alopecia
Osteoarthritis
GI Bleed ___
Diverticulitis ___
Osteopenia
RA
Syncope ___

 
Social History:
___
Family History:
n/c
 
Physical Exam:
PHYSICAL EXAM:
T:98.1  BP:188 /73      HR: 77   R 18      O2Sats: 100% RA
Gen: WD/WN, comfortable, NAD.
HEENT: Pupils: 2 to 1.5        EOMs: Intact
Neck: Supple.

Cardiac: RRR. S1/S2.
Abd: Soft, NT

Extrem: Warm and well-perfused.
Neuro:
Mental status: Awake and alert, cooperative with exam, normal
affect.
Orientation: Oriented to person, place, and date.

Language: Speech fluent with good comprehension and repetition.
Naming intact. No dysarthria or paraphasic errors.

Cranial Nerves:
I: Not tested
II: Pupils equally round and reactive to light,2 to 1.5
mm bilaterally. Visual fields are full to confrontation.
III, IV, VI: Extraocular movements intact bilaterally without
nystagmus.
V, VII: Facial strength and sensation intact and symmetric.
VIII: Hearing intact to voice.
IX, X: Palatal elevation symmetrical.
XI: Sternocleidomastoid and trapezius normal bilaterally.
XII: Tongue midline without fasciculations.

Motor: Normal bulk and tone bilaterally. No abnormal movements,
tremors. Strength full power ___ throughout. Slight left 
pronator
drift.

Sensation: Intact to light touch, propioception, pinprick and
vibration bilaterally.

Coordination: normal on finger-nose-finger

ON DISCHARGE: As above - neurologically intact. Incisions clean, 
dry and intact
 
Pertinent Results:
ADMISSION LABS:

___ 05:00PM   WBC-11.5* RBC-4.16* HGB-13.6 HCT-38.0 MCV-91 
MCH-32.7* MCHC-35.8* RDW-14.7
___ 05:00PM   GLUCOSE-107* UREA N-15 CREAT-0.6 SODIUM-133 
POTASSIUM-4.6 CHLORIDE-93* TOTAL CO2-27 ANION GAP-18
___ 05:00PM   ___ PTT-24.6 ___

DISCHARGE LABS:
___ 06:20AM BLOOD WBC-6.8 RBC-3.17* Hgb-10.8* Hct-31.0* 
MCV-98 MCH-34.0* MCHC-34.7 RDW-18.2* Plt ___
___ 06:20AM BLOOD Glucose-96 UreaN-10 Creat-0.5 Na-140 
K-4.4 Cl-102 HCO3-31 AnGap-11
___ 06:20AM BLOOD Calcium-8.6 Phos-2.9 Mg-1.9

IMAGING:
CT Head ___ - Bilateral Acute on Chronic SDH Left greater than 
right 8mm MLS.

CT Head ___: Status post surgical evacuation of bilateral 
subdural hematomas, with bilateral subdural surgical drains and 
expected pneumocephalus. The degree of mass effect has somewhat 
decreased, with decreased sulcal effacement, particularly on the 
left. There is no evidence for new hemorrhage, including no 
intraparenchymal, subarachnoid or intraventricular blood. There 
is no CT evidence for acute large vascular territory infarction. 


CT Head ___ post surgical evacuation of bilateral 
subdural hematomas with stable-appearing residual subdural 
collections with residual hemorrhage, bilateral surgical drains 
and mildly decreased pneumocephalus as compared to prior study, 
with about 4 mm shift of midline structures. No new foci of 
hemorrhage. 

CT Head ___ bilateral subdural collections overlying the 
frontal lobes, with unchanged appearance of left SDH. no new 
areas of acute hemorrhage. 

  

 
Brief Hospital Course:
The patient was admitted to the ___ service, and on the 
evening of her admission, she went to the operating room for an 
evacuation of these hematomas.  She underwent bilateral 
craniotomy for ___ evacuation and bilateral subdural drains were 
placed. She tolerated the prodecure well.  Her right pronator 
drift resolved after the procedure.  The subdural drains were 
removed on POD 2 and 3. There after, her HOB was slowly raised 
to >30, and then higher throughout the day.  She tolerated this 
transition well and ultimately ambulated without difficulty.

Her repeat head CT on ___ was stable. She was seen by ___, 
who determined that she was safe to home, but with ___ services. 
She was discharged to home on ___
 
Medications on Admission:
Tylenol,LeVETiracetam 750""/Calcium Carbonate 500'/Vitamin D
400'/FoLIC Acid 1'/Levothyroxine Sodium ?dose/Atorvastatin
20'/Metoprolol Tartrate 50""/ Methotrexate 5 mg PO
QWED/Polyethylene Glycol 17'/Mvi'/ Omeprazole 20'/Quinapril
40'/Travatan Z *NF* 0.004 % ___ hs

 
Discharge Medications:
1. Levetiracetam 250 mg Tablet Sig: Three (3) Tablet PO BID (2 
times a day) for 1 weeks: Take for total of 2 weeks (1 week 
remaining).
Disp:*180 Tablet(s)* Refills:*0*
2. Calcium Carbonate 500 mg Tablet, Chewable Sig: One (1) 
Tablet, Chewable PO DAILY (Daily).  
3. Cholecalciferol (Vitamin D3) 400 unit Tablet Sig: One (1) 
Tablet PO DAILY (Daily).  
4. Folic Acid 1 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  

5. Levothyroxine 50 mcg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
6. Atorvastatin 20 mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
7. Metoprolol Tartrate 50 mg Tablet Sig: One (1) Tablet PO BID 
(2 times a day).  
8. Methotrexate Sodium 2.5 mg Tablet Sig: Two (2) Tablet PO QWED 
(every ___.  
9. Polyethylene Glycol 3350 17 gram/dose Powder Sig: One (1)  PO 
DAILY (Daily).  
10. Multivitamin     Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
11. Quinapril 20 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily). 
 
12. Acetaminophen 500 mg Tablet Sig: ___ Tablets PO Q6H (every 6 
hours) as needed for pain fever.  

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
___ Diagnosis:
bilateral subdural hematomas

 
Discharge Condition:
Neurologically stable

 
Discharge Instructions:
.General Instructions

Have a friend/family member check your incision daily for 
signs of infection.
Take your pain medicine as prescribed.
Exercise should be limited to walking; no lifting, straining, 
or excessive bending.
You may wash your hair only after sutures and/or staples have 
been removed. If your wound closure uses dissolvable sutures, 
you must keep that area dry for 10 days. 
You may shower before this time using a shower cap to cover 
your head.
Increase your intake of fluids and fiber, as narcotic pain 
medicine can cause constipation. We generally recommend taking 
an over the counter stool softener, such as Docusate (Colace) 
while taking narcotic pain medication.
Unless directed by your doctor, do not take any 
anti-inflammatory medicines such as Motrin, Aspirin, Advil, and 
Ibuprofen etc. 
 If you have been discharged on Keppra (Levetiracetam), you 
will not require blood work monitoring.
Clearance to drive and return to work will be addressed at 
your post-operative office visit.
Make sure to continue to use your incentive spirometer while 
at home, unless you have been instructed not to. 

NO WIG FOR 1 MONTH

 
Followup Instructions:
___
"
13272597-DS-24," 
Name:  ___                      Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Erythromycin Base / Cephalosporins / Sulfonamides / Latex / 
Ceclor / Tegretol / Trileptal / Dilantin / Diltiazem / Reglan / 
Percocet / Darvocet-N 50 / Lamictal
 
Attending: ___.
 
Chief Complaint:
left buttock pain 
 
Major Surgical or Invasive Procedure:
Left Buttock Incision and Drainage
 
History of Present Illness:
 The patient is a ___ female with extensive PMH 
including common variable immunodeficiency and a history of 6 
PE, presenting with worsening swelling in left buttock 3 days 
after discharge from OSH for large hematoma in same site after 
mechanical fall and supratherapeutic INR on ___. She presented 
to Dr. ___ in ___ today who was concerned about some 
overlying cellulitis so she was sent to the ED. In the ED, she 
was seen by surgery who performed  I+D after an U/S showed a 
fluid collection. The wound was packed and she was given keflex 
and bactrim with plans for obs and then d/c. However, while in 
obs, she developed her typical chest pain which has been 
extensively worked up in the past. She states that she was 
unable to afford her medications since ___ and only 
recently restarted them. Since discharge from the OSH she has 
been noticing more CP, up to 20 times per day, worse with 
exertion and alleviated by rest with mild associated SOB. No N/V 
or diaphoresis. The episodes last <5min and she has not taken 
her nitroglycerin for it. She was also briefly hypotensive to 
83/41 with chest pain but responded well to 200cc of IVF. Her 
abx coverage was then broadened to vanc/unasyn. She was then 
moved out of obs and admitted for further work up given her 
complexity.
.
ED: VS were 99, 104, 132/90, 98% RA. Received Dilaudid 2mg PO, 
Zofran x 3, Morphine 4mg IV x 2, Keflex, bactrim, percocet x2, 
vanc, unasyn, fentanyl 25mcg IV x2, and 3L NS. 
 
Past Medical History:
Recurrent PEs and Lupus anticoagulant  
Question of restrictive cardiomyopathy  
Common variable immunodeficiency s/p port- a-cath  
Asthma  
GERD
Obstructive sleep apnea  
Borderline Personality Disorder  
Somatoform Disorder  
Fibromyalgia  
Sexual abuse  
Posttraumatic stress disorder.  
Multiple psychiatric hospitalizations for suicide attempts and 
depression.  

 
Social History:
___
Family History:
Noncontributory 
 
Physical Exam:
Vital Signs: Temp 98.4F, HR 98, BP 106/80, RR 16, Oxygen 
Saturation 98% on 2L NC 
GEN: In no acute distress. Alert and fully oriented to person 
/place/time. Pale complexion, obese habitus.  
HEENT: NC/AT, PERRLA, EOMI, anicteric sclerae, OP clear, moist 
mucosal membranes
NECK: supple, JVD of 4cm, no lymphadenopathy
CV: S1/S2 regular, no murmurs/rubs/gallops noted
PULM: Clear to auscultation bilaterally. 
ABD: (+)BS throughout all quadrants, soft, obese, NT/ND.
EXTREMITIES: left buttock dressing in place with serosanguinous 
stained guauze packing noted, no evidence of pus. Large hematoma 
that covers nearly the entire buttock and top of left thigh. 
Edges of bruise yellowish to light purple signifying healing but 
central areas deeper reddish-purple. Incision of 1"" noted at 
medial aspect of left buttock, open, not actively bleeding but 
difficult to assess well given a thick pressure bandage with 
packing guauze in place.  
Pedal pulses warm, 2+ bilaterally, trace edema at ankles noted.  

SKIN: pallid complexion, no rashes, large left buttock hematoma 
as described above 
 
Pertinent Results:
CARDIAC ENZYMES:
___ 05:12AM  CK(CPK)-121
___ 05:12AM  CK-MB-2 cTropnT-<0.01
___ 07:20PM  CK(CPK)-133
___ 07:20PM  CK-MB-2 cTropnT-<0.01
___ 01:20PM  CK(CPK)-166*
___ 01:20PM  cTropnT-<0.01
___ 01:20PM  CK-MB-2
.
ADMISSION LABS:
___ 03:26PM   LACTATE-0.8
___ 01:20PM   GLUCOSE-85 UREA N-16 CREAT-0.8 SODIUM-136 
POTASSIUM-4.1 CHLORIDE-101 TOTAL CO2-28 ANION GAP-11, WBC-5.3 
RBC-3.09* HGB-10.0* HCT-27.4* MCV-89 MCH-32.5* MCHC-36.7* 
RDW-15.1
___ 01:20PM   NEUTS-69.3 ___ MONOS-7.2 EOS-2.8 
BASOS-0.6
___ 01:20PM   PLT COUNT-265
___ 01:20PM   ___ PTT-26.6 ___
.
IMAGING:
___ CTA: The airways are patent to the subsegmental level. 
Right
supraclavicular catheter tip is in the proximal right atrium. 
There are no
filling defects to suggest pulmonary embolism. There are no 
enlarged
mediastinal, hilar, or axillary lymph nodes. Minimal coronary 
calcifications are in the LAD. The aorta is normal in caliber. 
3-mm nodule in the right upper lobe was present in ___. 
Scattered atelectases are in the right middle lobe, lingula, and 
lower lobes bilaterally. There is no pleural or pericardial 
effusion.A soft tissue nodular opacity in the left breast 
measures approximately 10 mm. There are no bone findings of 
malignancy. Of note,there is mild splenomegaly.IMPRESSION: No 
evidence of PE.Minimal coronary calcification in the LAD.Left 
breast nodule should be correlated with mammography. 
Splenomegaly.
. 
___ AP CXR: Portable AP chest radiograph was compared to 
___ right central line tip is in mid low SVC. The 
radiograph was obtained in portable semi-upright position and 
lordotic projection, thus there is some exaggeration of heart 
size, although the lungs are essentially clear. No appreciable 
pleural effusion is demonstrated.
.
EKGs:
___ EKG: rate 84-86, sinus rhythm with low precordial lead 
QRS voltages, nonspecific. Otherwise normal EKG. 
.
___ EKG: rate ___, sinus rhythm. Low precordial voltage. 
Since the previous tracing precordial voltage is somewhat less.
.
MICROBIOLOGY:
___ Blood Cultures x 2 negative to date at time of discharge
___ 11:34 am SWAB      Source: left buttock incision site. 
**FINAL REPORT ___
 GRAM STAIN (Final ___: 
 NO POLYMORPHONUCLEAR LEUKOCYTES SEEN. 
 NO MICROORGANISMS SEEN. 

WOUND CULTURE (Final ___: 
STAPH AUREUS COAG +.    SPARSE GROWTH. 
Staphylococcus species may develop resistance during prolonged
therapy with quinolones.   Therefore, isolates that are 
initially
susceptible may become resistant within three to four days after
initiation of therapy.  Testing of repeat isolates may be
warranted. 

    SENSITIVITIES: MIC expressed in MCG/ML
_________________________________________________________
              STAPH AUREUS COAG +
                             |   
CLINDAMYCIN-----------<=0.25 S
ERYTHROMYCIN----------<=0.25 S
GENTAMICIN------------ <=0.5 S
LEVOFLOXACIN----------  0.25 S
OXACILLIN-------------<=0.25 S
PENICILLIN G---------- =>0.5 R
TRIMETHOPRIM/SULFA---- <=0.5 S

   ANAEROBIC CULTURE (Final ___:    NO ANAEROBES ISOLATED. 


 
Brief Hospital Course:
In summary, the patient is a ___ female with history of 
recurrent pulmonary emboli, lupus anticoagulant, asthma, common 
variable immunodeficiency and longstanding depression/PTSD, who 
was admitted after having a fall off of her desk chair with a 
resulting painful left buttock hematoma. This event occurred in 
the  setting of a recent supratherapeutic INR. After ED 
presentation, the patient also complained of some additional 
atypical chest pain of unclear etiology. Hospital course details 
outlined more fully below:
.
# Questionable Cellulitis/Abscess: Given her MRSA history and 
CVID, the ED staff was intially concerned with infection. 
However, she had no leukocytosis or fevers. ED staff consulted 
surgery service who opted to perform a left buttock I&D due to 
concerns that there may be an underlying abscess after there was 
a questionable collection noted on ultrasound. The 1 inch 
incision site drained blood but no observable pus or discharge. 
Later, after her transfer to the floor the patient was seen by 
the surgical service who re-dressed the wound and took a wound 
culture. Because she had no fevers or WBC elevations antibiotics 
were not continued. Initially it was felt that she just had a 
deep hematoma. She was discharged with ___ and daily wound care 
instructions. Blood cultures at time of discharge were negative 
to date. Wound culture final results were pending but wound gram 
stain showed no microorganisms, no leukocyes/PMNs. 
Unfortunately, the day after discharge she had cultures that 
grew out MSSA. PCP was contacted with update as the patient has 
a scheduled follow up planned for ___. The patient may need 
to be placed on an antibiotic regimen, particularly given her 
open wound and CVID history.  
.
#Left Buttock Hematoma: The patient had been placed on long term 
Warfarin therapy for recurrent PE history and known lupus 
anticoagulant. Of note, her most recent INR was supratherapeutic 
at 5.42 on ___. Around the same time, a week before her 
admission she explained that she fell out of her desk chair in 
her kitchen. She developed a large, expanding left buttock 
hematoma soon afterwards and had a brief admission to ___ 
___ and a few doses of her Warfarin were held. Upon 
admission to ___ she had an INR of 1.9 so the medicine team 
decided to continue her daily doses while she was an inpatient. 
She had a decline in her Hct from initial 27 down to 24 range 
after a lot of IVFs and bleeding in the setting of her I & D 
procedure. She also arrived to the medical floor with systolic 
blood pressures in the ___ range. She was asymptomatic despite 
fleeting hypotension. This was likely because of the multiple 
pain medications she had received in the ED. However, in the 
setting of a recent I& D and bleeding the team transfused her 
with 2 Units of blood. After this her Hct rose from 24 to 33 and 
then stabilized to about 30 by the time of discharge.  For pain 
management she was ultimately switched from all IV narcotics 
which were promoting bouts of hypotension to a lidocaine patch 
and then to PO Dilaudid by hospital day #2 which worked very 
well and achieved excellent pain relief according to the 
patient. Thus, she was continued on an additional 10 days of PO 
Dilauded upon discharge. She had her wound dressing changed BID 
and ice packs were given for additional comfort. ___ services 
were arranged for ongoing outpatient dressing changes, wound 
checks and INR lab draws.  
.
# Hypotension: The patient had some intermittent episodes of 
hypotension soon after transfer to the medical floor from the 
ED. There were some initial concerns for sepsis but in the 
absence of fevers, normal lactate levels and no leukocytosis 
this seemed unlikely. She was given Morphine, Fentanyl, 
Percocet, and Dilaudid within hours of each other. Thus, her low 
blood pressures were mainly a result of multiple pain 
medications. She responded very well to IVFs and her blood 
pressure medications and IV narcotics were all held until her BP 
stabilized. Fortunately, she remained asymptomatic and was in no 
distress despite SBPs in the mid to high ___ at times. She 
recovered gradually and by hospital day 2 she was normotensive. 
By hospital day 3 and 4 she was restarted back on her home 
Lasix. The rest of her blood pressure medications were restarted 
after discharge. 
.
# Atypical Chest Pain:  Per OMR noted the patient has been noted 
to have a chest pain syndrome of unclear etiology. She 
complained of chest pain that was at her lower sternum and 
radiating towards her back that oscillated between sharp pains 
and dull aches and lasted ""hours"" and sometimes days. A CTA was 
negative for PE/dissection and she was continued on Coumadin for 
her history of PE. She maintained healthy oxygen saturation 
levels between 93-97% on room air during her hospital stay. 
Three sets of cardiac enzymes returned negative, so ACS 
essentially ruled out. Follow up EKGs and telemetry were benign. 
CXR also unremarkable. She was written for  SL nitroglycerin but 
had no acute CP episodes after arrival to the floor. An exercise 
stress test was postponed given her negative cardiac workup to 
date and her inability to exercise without a lot of left buttock 
pain given her extensive hematoma. Thus, she was set up for an 
outpatient cardiac follow up with Dr. ___ at  ___ in 
___ who will review her complaints in more detail in the 
outpatient setting. She was continued on her usual Aspirin and 
her beta blocker was eventually restarted. 
.
# Anemia: Hematocrit baseline in low ___ and went to ___, then 
24. Gave patient 2 Units of blood on ___ and Hct rose to 33 
again, and was 30 at time of discharge. Blood loss was likely 
from the initial I&D of her hematoma site. Some of her Hct drop 
was related to pure dilutional effects with generous IVFs given 
in the setting of her low BPs after a plethora of pain 
medications.  Serial Hcts were monitored, and her wound site was 
assessed several times daily for any active bleeding. 
.
# Common variable immunodeficiency (CVID): Chronic condition. 
Splenomegaly noted on CTA. She has ongoing IVIG monthly 
infusions for managment. 
.
# Question of diastolic CHF : It is unclear whether patient 
actually has history of congestive heart failure per cardiology 
notes. However, she states that she has diastolic dysfunction. 
She was continued on her usual home lasix dosing after her blood 
pressures stabilized on hospital day ___. She will plan to 
follow up with her new cardiologist in a few weeks to explore 
additional testing and management. 
.
# Pulmonary Embolism history: Admission INR subtherapeutic at 
1.9. She was continued on her usual Coumadin therapy. Oxygen 
saturations were typically >95% on room air and she had no 
shortness of breath complaints. Moreover, CTA was negative for 
any pulmonary embolisms. Daily INR /___ levels were monitored and 
she was discharged with instructions for BID ___ checks 
through her home ___ services. 
.
#Depression: According to records the patient has a history of 
sexual abuse and PTSD as well as multiple psychiatric 
hospitalizations for despression and suicide attempts. She 
denied a history of borderline personality disorder and asked 
that it be eliminated from her PMH. This was addressed and she 
was advised to discuss this with her PCP as the medical team had 
limited background on this diagnosis. She had no signs of 
tearfulness or labile mood changes during this hospital stay. 
She also denied suicidal thoughts. She was continued on her 
usual doses of fluoxetine, klonopin, trazodone. 
.
#Obstructive Sleep Apnea: Despite this label per medical records 
she stated that she does not use any CPAP or BIPAP at home. 
Therefore she was monitored with oxygen saturation checks with 
vital signs but otherwise no additional interventions taken on 
this admission. 
.
#CTA breast finding : A small soft tissue nodular opacity was 
noted in the left breast measuring approximately 10 mm. Prior 
mammogram reports from ___ note a right sided region that had 
been biopsied and fibroadenoma identified but no left sided 
pathology noted. Thus, this new area of nodularity in left 
breast warrants follow-up with her PCP as outpatient (notified). 
No appreciable axillary lymphadenopathy on physical exam but 
full breast exam was not performed during this inpatient stay.  
.
# Fluids, Electrolytes and Nutrition: Electrolytes were 
monitored and repleted daily as needed, she was placed on a 
cardiac healthy diet PO, IVFs were also given for low blood 
pressures as needed for any fleeting hypotension with pain 
medications.
.
# Prophylaxis:
-She was continued on Warfarin anticoagulation therapy and 
PE/DVT prevention
-She was continued on her usual home PPI (Omeprazole BID)for now 
for her history of gastroesophageal reflux disease. 
-PO Dilaudid for pain control
-Senna/Colace were provided for a bowel regimen.
. 
#Code Status/Communication - Lastly, the patient was maintained 
as a full code status for the entirety of her hospital course 
and communication occurred on a daily basis directly with the 
patient. 
 
Medications on Admission:
ALBUTEROL 90 mcg Aerosol - 2puffs INH q4-6 hours as needed
ADDERALL XR 10 mg daily
CLONAZEPAM 0.5mg at bedtime as needed for insomnia
FLUOXETINE 40 mg daily
FLUTICASONE 220 mcg 2 (Two) puffs inhaled twice a day
FUROSEMIDE 40mg BID
IVIG monthly infusions
LEVALBUTEROL HCL Dosage uncertain
METHOCARBAMOL 750 mg Q ___ hrs
METOPROLOL SUCCINATE 25 mg daily
MONTELUKAST 10 mg qpm
NITROGLYCERIN SL PRN
OMEPRAZOLE 20 mg twice a day
POTASSIUM CHLORIDE - 20 mEq Tab Sust.Rel. Particle/Crystal - 1
(One) Tab(s) by mouth three times a day /40 meq q am and 20 meq 
q
pm
SUMATRIPTAN [IMITREX] - 50 mg PRN Migraine
TRAZODONE 200 mg at bedtime
Coumadin 3mg PO daily
LORATADINE - 10 mg once a day 
 
Discharge Medications:
1. Albuterol 90 mcg/Actuation Aerosol Sig: ___ Puffs Inhalation 
Q4H (every 4 hours) as needed.  
2. Amphetamine-Dextroamphetamine 5 mg Capsule, Sust. Release 24 
hr Sig: Two (2) Capsule, Sust. Release 24 hr PO daily ().  
3. Clonazepam 0.5 mg Tablet Sig: One (1) Tablet PO QHS (once a 
day (at bedtime)) as needed.  
4. Fluoxetine 20 mg Capsule Sig: Two (2) Capsule PO DAILY 
(Daily).  
5. Fluticasone 220 mcg/Actuation Aerosol Sig: Two (2)  
Inhalation twice a day.  
6. Furosemide 40 mg Tablet Sig: One (1) Tablet PO twice a day: 
Take 1.5 tablets (60mg ) every morning and then 1 tablet (40mg) 
every night.  .  
7. IVIG  Sig: One (1)   AS DIR for 1 months: take as previously 
directed , once monthly .  
8. Warfarin 2 mg Tablet Sig: Two (2) Tablet PO Once Daily at 4 
___: Please follow up with ___ as directed for 
ongoing monitoring.  
9. Levalbuterol HCl  Inhalation
10. Methocarbamol 500 mg Tablet Sig: 1.5 Tablets PO q4-6 hours 
as needed for muscle pain/cramps.  
11. Metoprolol Succinate 25 mg Tablet Sustained Release 24 hr 
Sig: One (1) Tablet Sustained Release 24 hr PO once a day.  
12. Montelukast 10 mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
13. Nitroglycerin 0.3 mg Tablet, Sublingual Sig: One (1) Tablet, 
Sublingual Sublingual PRN (as needed).  
14. Omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) 
Capsule, Delayed Release(E.C.) PO every twelve (12) hours.  
15. Potassium Chloride 20 mEq Tab Sust.Rel. Particle/Crystal 
Sig: One (1) Tab Sust.Rel. Particle/Crystal PO three times a 
day: Please take two tablets (40mEq total) in the morning and 
one tablet in the evening(20mEq) -12 hours apart. .  
16. Sumatriptan Succinate 50 mg Tablet Sig: One (1) Tablet PO 
once a day as needed for headache for 1 days: take 1 tablet at 
onset symptoms of migraine as previously prescribed .  
17. Trazodone 100 mg Tablet Sig: Two (2) Tablet PO HS (at 
bedtime).  
18. Loratadine  Oral
19. Dilaudid 4 mg Tablet Sig: One (1) Tablet PO every six (6) 
hours for 10 days: Please be aware this medication causes 
drowsiness. Do not drive or operate any skilled equipment or 
machinery while taking this medicine.
Disp:*40 Tablet(s)* Refills:*0*
20. Outpatient Lab Work
Outpatient Lab Work: Please check ___ on ___, and again on ___ and call results to ___ 
___ at ___, report will be forwarded to 
primary care physician, ___ ___

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
Primary:
Left Buttock Hematoma
Atypical Chest Pain 
.
Secondary:
Common Variable Immunodeficiency  
Asthma.  
Obstructive Sleep Apnea  
Borderline Personality Disorder.  
Somatoform Disorder.  
Multiple PEs on chronic coumadin  
Lupus anticoagulant.  
Fibromyalgia.  
Sexual abuse history 
Posttraumatic stress disorder.  
Multiple psychiatric hospitalizations for suicide 
attempts/depression.  
Chest Pain/Dyspnea Syndrome of unclear etiology  

 
Discharge Condition:
Good. At time of discharge the patient's pain was well 
controlled and her vital signs were stable. 

 
Discharge Instructions:
It was a pleasure taking care of you here at ___ 
___ during your hospitalization.
.
You were admitted with a large hematoma on your left buttock. 
The area was drained due to initial concerns over a possible 
abscess. You were given oral and intravenous medications for 
pain control. The area did not appear to be infected but there 
was a small amount of bleeding. Please continue to cover the 
open wound site with sterile dry dressings twice daily.
.
You also had some chest pain which was evaluated with monitoring 
and blood tests. These lab tests showed no abnormalities 
consistent with a heart attack. Chest imaging was also done and 
showed no signs of any pulmonary embolisms. 
.
Please return to the emergency room or call your primary care 
doctor if you have any fevers, chills, joint pains, bleeding at 
hematoma site on left buttock, chest pain, shortness of breath, 
dizziness, weakness or any other health concerns. 
.
  
 
Followup Instructions:
___
"
13602608-DS-6," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Penicillins / latex / morphine / aspirin / eggs / shellfish 
derived
 
Attending: ___.
 
Chief Complaint:
chest pain
 
Major Surgical or Invasive Procedure:
none 

 
History of Present Illness:
___ PMH of Sarcoidosis, Clotting Disorder (Unclear Type, c/b 
PEs, CVAs, LLE infarct s/p amputation), DM (HbA1c 11.8), who 
presented to ED w/ pleuritic CP, found to have large PE and 
Hyperglycemia and was admitted to medicine for further workup.  
In looking at pt's visit notes from ___, pt noted right 
sided abdominal pain radiating to the chest, and her PCP was ___ 
PE given clotting hx, so rec'd CT Chest but was not completed. 
Today, she presented to ED c/o pleuritic left sided chest pain 
of sudden onset starting at 6pm a/w SOB, left sided chest pain, 
diaphoresis, same as symptoms a/w prior PE's so was concerned 
and came to ED. Of note, pt is active tobacco user, and had a 
recent flight from ___ to ___ 2 days ago.  
W/ regard to clotting disorder, has a family history with father 
and grandmother who had multiple clots including CVA/PE. She 
reports extensive w/u of which we dont have records but said 
they concluded it was due to her sarcoid, despite the fact that 
she is the only member in her family with both sarcoid and 
clotting issues. As per her report, had initial clot ___ yrs ago, 
was on coumadin for ppx, but then had CVA while INR therapeutic 
so was siwtched to lovenox. She continued on lovenox for several 
years without issue and providers weaned her in ___ given that 
she had no events. <6 months after weaning, experienced a 
arterial thrombus in LLE requiring 6 surgeries and eventual 
amputation. She was then restarted on lovenox given prior 
success but experienced PE ___ year later and had to be switched 
to Fondaparinux. She has continued on the Fondaparinux until 
now.  
In ED, initial VS were: 98.3 112 126/77 28 100% 2L Nasal Cannula 
but was quickly weaned to room air. On EKG was noted to have NSR 
@ 120, LAD, no TWI, 1mm ST depressions II. Labs significant for 
WBC 12.9, HCO3 20 (AG 16), Lactate 1.5, GLC 436, +Ketones in 
urine, but otherwise negative UA. Coags normal. CTA chest 
identified large central pulmonary embolus within the main 
pulmonary artery, extending  
to the left main, left upper lobar, lingular, and left lower 
lobar pulmonary w/ mild straightening of the intraventricular 
septum ___ right heart strain, and mild pulmonary edema.  
Given her PE, pt was started on IV UFH w/ bolus and given 2L NS. 
She was given IV dilaudid for pain. For hyperglycemia, pt was 
given 8U of humalog. Repeat Labs showed pH of 7.37 (VBG) HCO3 24 
but Glc still >300 so given 10 units humalog  
On the floor: pt noted that she has continued pleuritic chest 
pain which hurts when coughing or taking deep breath. 
 
Past Medical History:
DM - Per last ___ note from ___, Lantus is 55 a night, 
sliding scale 12 for 100, 14 for 150 etc  
Sarcoidosis  
Seizure Disorder  
Clotting Disorder (Unclear Type, c/b PEs, CVAs, LLE infarct s/p 
amputation)  
Depression  
HTN  
Asthma  
Chronic Pancreatitis  
Moderate Nonproliferative Diabetic Retinopathy  
 
Social History:
___
Family History:
ather has had clotting issues, arterial thrombi in legs, ESRD on 
HD, DM  
Grandmother w/ clotting issues, CVA  
No one with sarcoid  
 
Physical Exam:
Admission Physical:
------------------
Vitals 97.5, 134/87, P95, R20, O293RA FSG 240  
GENERAL: NAD, pleasant, sitting in bed, slightly lethargic  
HEENT: AT/NC, EOMI, PERRL but constricted pupils, anicteric 
sclera, pink conjunctiva, MMM  
NECK: nontender supple neck, no LAD  
CARDIAC: RRR, S1/S2, no murmurs, gallops, or rubs  
LUNG: CTAB w/ exception of bibasilar rales, unlabored breathing, 
no accessory muscle use.  
ABDOMEN: nondistended, +BS, nontender in all quadrants, no 
rebound/guarding, no hepatosplenomegaly  
EXTREMITIES: no cyanosis, clubbing or edema, has left BKA. legs 
are symmetrical  
NEURO: CN II-XII intact, AOx3, fluent speech  
SKIN: warm and well perfused, no excoriations or lesions, no 
rashes 

Discharge Physical:
------------------]Vitals 98.6 145/89 52 19 04% RA
___ 205-330
GENERAL: NAD, pleasant, standing, alert and orientated. HEENT: 
AT/NC, EOMI, PERRL but constricted pupils, anicteric sclera, 
pink conjunctiva, MMM
NECK: nontender supple neck, no LAD
CARDIAC: RRR, S1/S2, no murmurs, gallops, or rubs
LUNG: Bibasilar rales, unlabored breathing, no accessory muscle 
use.
ABDOMEN: nondistended, +BS, nontender in all quadrants, no 
rebound/guarding, no hepatosplenomegaly
EXTREMITIES: no cyanosis, clubbing or edema, has left BKA. legs 
are symmetrical
NEURO: CN II-XII grossly intact, AOx3, fluent speech
SKIN: warm and well perfused, no excoriations or lesions, no 
rashes 

 
Pertinent Results:
Admission Labs:
--------------
___ 09:50PM   PTT-102.6*
___ 07:20PM   cTropnT-<0.01
___ 07:20PM   WBC-10.7 RBC-4.30 HGB-14.3 HCT-39.3 MCV-91 
MCH-33.1* MCHC-36.3* RDW-13.1
___ 07:20PM   PLT COUNT-292
___ 04:40AM   GLUCOSE-329* UREA N-4* CREAT-0.5 SODIUM-134 
POTASSIUM-3.8 CHLORIDE-102 TOTAL CO2-19* ANION GAP-17
___ 04:40AM   CK(CPK)-31
___ 04:40AM   CK-MB-1 cTropnT-<0.01 proBNP-40
___ 10:49PM   LACTATE-1.5
___ 10:45PM   cTropnT-<0.01
___ 10:45PM   WBC-12.9* RBC-4.73 HGB-15.4 HCT-43.3 MCV-91 
MCH-32.6* MCHC-35.6* RDW-13.2
___ 10:45PM   NEUTS-72.4* ___ MONOS-3.6 EOS-1.2 
BASOS-0.3
___ 10:45PM   PLT COUNT-278
___ 10:45PM   ___ PTT-29.0 ___

Discharge Labs:
--------------
___ 09:10AM BLOOD WBC-16.1* RBC-4.24 Hgb-13.9 Hct-40.6 
MCV-96 MCH-32.8* MCHC-34.3 RDW-14.1 Plt ___
___ 06:30AM BLOOD Glucose-219* UreaN-9 Creat-0.6 Na-136 
K-4.4 Cl-96 HCO3-25 AnGap-19

Imaging:
-------
CTA- IMPRESSION: 
 
1. Large central pulmonary embolus within the main pulmonary 
artery, extending
to the left main, left upper lobar, lingular, and left lower 
lobar pulmonary
arteries. Mild straightening of the intraventricular septum is 
concerning for
right heart strain. An echocardiogram may be helpful for further 
evaluation.
 
2. Mild pulmonary edema.
 
3.  Subpleural cystic changes in an apico-basal gradient with 
reticulation in
a peribronchovascular distribution raises concern for early 
fibrotic lung
disease such as NSIP.  Recommend pulmonology consult for further 
evaluation.

Echo- The left atrial volume index is normal. A right-to-left 
shunt across the interatrial septum is seen after intravenous 
injection of agitated saline injection at rest. Left ventricular 
wall thickness, cavity size and regional/global systolic 
function are normal (LVEF >55%). Right ventricular chamber size 
and free wall motion are normal. The diameters of aorta at the 
sinus, ascending and arch levels are normal. The aortic valve 
leaflets (3) appear structurally normal with good leaflet 
excursion and no aortic stenosis or aortic regurgitation. The 
mitral valve appears structurally normal with trivial mitral 
regurgitation. Moderate [2+] tricuspid regurgitation is seen. 
There is mild pulmonary artery systolic hypertension. There is 
no pericardial effusion.

IMPRESSION: Right-to-left shunt at rest. Mild pulmonary artery 
systolic hypertension. Moderate tricuspid regurgitation. Normal 
biventricular cavity sizes with preserved regional and global 
biventricular systolic function.

CLINICAL IMPLICATIONS:
Based on ___ AHA endocarditis prophylaxis recommendations, the 
echo findings indicate prophylaxis is NOT recommended. Clinical 
decisions regarding the need for prophylaxis should be based on 
clinical and echocardiographic data. 

Imaging:
-------

___ 09:10AM BLOOD ALT-129* AST-116* AlkPhos-248* 
TotBili-0.2
___ 06:30AM BLOOD Calcium-10.0 Phos-4.6* Mg-1.___ woman PMH of Sarcoidosis, Clotting Disorder (Unclear Type, 
c/b PEs, CVAs, LLE infarct s/p amputation), DM (HbA1c 11.8), who 
presented to ED w/ pleuritic CP, found to have large PE and 
hyperglycemia and was admitted to medicine for further workup.  
She was started on heparin drip and then bridged to warfarin 
with INR goal of 2.5 to 3.5.  

#Pulmonary Embolism: Submassive given right heart strain noted 
on CT but not noted on echo. Patient with history of both venous 
and arterial clots, with family history of multiple clotting 
disorders.  In review of her work-up from ___, she has not been 
off anticoagulation to allow for work-up of her clotting 
disorder.  Per review of records, she has clotted through plavix 
and fondaparinux despite reported adherence.  Also clotted 
through warfarin that was at goal (however, INR goal unknonw). 
Patient with additional risk factors including DM and smoking 
but likely patient has underlying familial clotting disorder. 
Given history of multiple spontaneous abortions, concominant 
sarcoid, anti-phospholipid syndrome high on differential.  
Heme-onc was consulted.  She was started on heparin and bridged 
to warfarin with goal INR 2.5-3.5. She also continued on plavix. 
 

# Hematuria: Patient complaining of assymptomatic hematuria. U/A 
with RBCs but not clean catch.  She will need hematuria work-up 
as outpatient.  

#Hyperglycemia/DM uncontrolled: ___ 220-225. Pt w/ difficult to 
control diabetes w/ recent HbA1c of ~11%, on BID lantus and 
large HISS as per last ___ note. Most likely complicated by 
concurrent prednisone use. Given elevated AG, Ketones in Urine 
and Glc >400, ___ DKA but later VBG showed pH of 7.37 and HCO3 
of 24. Given 8U in ED initially, then 10U thereafter and 2L NS 
to restore intravascular volume as above. Her ___ remained 
elevated 200-300 during stay. Her lantus was not changed but 
increased sliding scale during stay.  Januvia was held. 

# Chest pain: Presented with chest pain, negative troponins, 
stable EKG. Unclear etiology. Could be from sarcoid. Unlikely 
further PEs as patient anticoagulated. 
Pain control with: 
- oxycodone 5 mg q 4 PRN(with hold parameter for sedation, 
RR<12)
- tylenol ___ mg q 4 PRN
-  tramadol PRN

# Hepatitis:Patient with elevated LFTs during stay. No right 
upper quadrant pain. RUQ deferred during stay but should be done 
as outpatient if LFTs remain elevated. 

CHRONIC ISSUES:

#Sarcoidosis
Unclear severity, previously cared for at ___, has not 
established care w/ rheumatologist at ___.
-Continued prednisone/MTX at home dose
-Continued inhalers, prn albuterol

#HTN: Intially, held antihypertensive in patient with right 
heart strain as she is preload dependent.

#Depression
Continue home meds (abilify)

#Seizure Disorder
Unclear etiology, outpt notes suggest that it is ___ sarcoidosis
-Continued home vimpat, gabapentin 

TRANSITIONAL ISSUES:
------------------
-patient came in on 15 mg prednisone for sarcoid. Unclear how 
long she has been on this dose and if necessary. Would recommend 
taper in future. Consider calcium, vitamin D as an outpatient 
for bone health
- Hyperglycemia continues to be issue and patient's insulin 
regimen may need to be further changed.
- If patient continues on steroids, needs to be started on 
bactrim ppx
- Patient had leukopenia during admission with no signs of 
infection, please trend CBC
- Patient with RBCs in urine, should be worked up as oupatient
- Patient had elevated LFTs, her simvastatin was stopped. She 
should have labs rechecked and RUQ and further lab testing 
should be performed if she does not improve
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN SOB 
2. Albuterol Inhaler 2 PUFF IH Q4H:PRN SOB 
3. Amlodipine 5 mg PO DAILY 
4. Aripiprazole 10 mg PO DAILY 
5. Clopidogrel 75 mg PO DAILY 
6. Fluticasone Propionate NASAL 1 SPRY NU DAILY 
7. Fluticasone-Salmeterol Diskus (250/50)  1 INH IH BID 
8. Fondaparinux 7.5 mg SC DAILY 
9. Gabapentin 600 mg PO DAILY 
10. Glargine 55 Units Dinner
11. LACOSamide 100 mg PO DAILY 
12. Methotrexate 15 mg PO 1X/WEEK (MO) 
13. Metoprolol Tartrate 25 mg PO ONCE 
14. OxycoDONE (Immediate Release)  5 mg PO Q6H:PRN pain 
15. Pantoprazole 40 mg PO Q24H 
16. PredniSONE 15 mg PO DAILY 
17. Simvastatin 20 mg PO QPM 
18. Januvia (sitaGLIPtin) 100 mg oral qday 
19. Zolpidem Tartrate 5 mg PO QHS 
20. Acetaminophen 500 mg PO Q4H:PRN pain 

 
Discharge Medications:
1. Acetaminophen 500 mg PO Q4H:PRN pain 
2. Aripiprazole 10 mg PO DAILY 
3. Fluticasone Propionate NASAL 1 SPRY NU DAILY 
4. Fluticasone-Salmeterol Diskus (250/50)  1 INH IH BID 
5. Gabapentin 600 mg PO DAILY 
6. LACOSamide 100 mg PO DAILY 
7. OxycoDONE (Immediate Release)  5 mg PO Q6H:PRN pain 
RX *oxycodone 5 mg 1 tablet(s) by mouth every 6 hours Disp #*12 
Tablet Refills:*0
8. Pantoprazole 40 mg PO Q24H 
9. PredniSONE 15 mg PO DAILY 
10. Clopidogrel 75 mg PO DAILY 
11. Albuterol Inhaler 2 PUFF IH Q4H:PRN SOB 
12. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN SOB 
13. Warfarin 7.5 mg PO DAILY16 
RX *warfarin [Coumadin] 7.5 mg 1 tablet(s) by mouth daily Disp 
#*30 Tablet Refills:*0
14. Amlodipine 5 mg PO DAILY 
15. Januvia (sitaGLIPtin) 100 mg oral qday 
16. Metoprolol Tartrate 25 mg PO ONCE 
17. Methotrexate 15 mg PO 1X/WEEK (MO) 
18. Zolpidem Tartrate 5 mg PO QHS 
19. Outpatient Lab Work
Please draw INR, AST, ALT, Total bilirubin, Alkaline phosphatase
ICD9: 573.3, 415.1
Please send to: Dr. ___: ___
20. Glargine 55 Units Dinner

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Pulmonary embolus
Liver injury

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___,
It was a pleasure taking care of you at ___.

Why was I here?
You had a blood clot in your lung.
You had liver injury.

How was it treated?
You were given a blood thinning medicine (heparin).
We asked the hematology doctors to make ___ on what 
was best to prevent future clots.
You were started on Warfarin.
You will go home on Warfarin.
Your simvastatin was stopped as it can worsen your liver.

What do I need to do when I get home?
Take your warfarin everyday. 
Quit smoking.
Eat the same type of foods everyday. 

Thank you,
Your ___ Team 
 
Followup Instructions:
___
"
14055839-DS-15," 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
vancomycin / ceftriaxone
 
Attending: ___
 
Chief Complaint:
nausea, fatigue
 
Major Surgical or Invasive Procedure:
none
 
History of Present Illness:
Pt is a ___ Y F with ___ stage IV adenocarcinoma EGFR wild type 
diagnosed ___ s/p carboplatin pemetrexed x6 completed on 
___ with disease progression in the neck and chest as well 
as new brain mets s/p WBRT and XRT to an obstructing lung lesion 
presents to the ER with fever.  She most recently underwent 
taxotere infusion on ___ with neulasta dose on ___. Since 
that time, she has had nausea, faticue, anorexia, vomiting 
(non-bloody), and generalized weakness.  For the past 5 days she 
reports a runny nose; the day prior to admission, she had a 
temperature of 102.7 and a cough (cannot remember if the sputum 
had color) without sick contacts or recent travel.  She also 
reports mild, crampy abdominal pain for a few days ___ in 
intensity, not if it related to eating, since she has no 
appetite.  

In the ER, she received Tylenol 1g, Levofloxacin, and Zosyn.  
RUQ U/S was negative for cholecystitis.  On arrival to the 
floor, she feels tired and nauseous, and depressed (no SI/HI).  
She states that she is not sure if receiving chemotherapy is 
worth it anymore and thinks that she may have had ""enough of all 
this.""

Review of Systems:  
(+) Per HPI and myalgias; diarrhea for one day sometime this 
week (cannot recall which day), no BMs in the past 2 days
(-) Denies chills, night sweats, recent weight gain. Denies 
blurry vision, diplopia, loss of vision, photophobia, neck 
stiffness. Denies headache, sinus tenderness, sore throat. 
Denies chest pain or tightness, palpitations, lower extremity 
edema. Denies shortness of breath, or wheezes. Denies melena, 
hematemesis, hematochezia. Denies dysuria, stool or urine 
incontinence. Denies arthralgias. Denies rashes or skin 
breakdown. No numbness/tingling in extremities. All other 
systems negative.

 
Past Medical History:
Past Oncologic Hx:
___ stage IV adenocarcinoma EGFR wild type
- ___ began to experience a productive cough, 
shortness
of breath, and increased fatigue. 
- ___ CXR revealed a right lung mass as well as some
concern for lymphangitic spread 
- ___ chest CT, images of which are not available for
review, but by report revealed a right upper lobe spiculated 
mass
with associated paraesophageal, retrotracheal, supraclavicular,
and mediastinal adenopathy. There was narrowing of the secondary
bronchi in the right, but no clear occlusion as multiple
bilateral pulmonary nodules were noted as well as a small right
effusion. There was no clear bony involvement. 
- ___ EBUS/BX: revealed non-small cell carcinoma in biopsies
of the 4L and station 7 lymph nodes. Tumor cells positive for
cytokeratin cocktail (keratin AE1/AE3, Cam 5.2), CK7, and TTF-1
and negative for CK20, CK5/6, and P63. No evidence of
keratinization is seen. 
- ___onfirmed multiple enlarged FDG avid
supraclavicular nodes with SUV max of 11. In the chest, there 
was
extensive FDG avid mediastinal adenopathy with bulky nodes in 
the
paratracheal, precarinal, and subcarinal locations with an SUV
max up to 11. The spiculated right upper lobe lesion had an SUV
max of 5.6 ___s the multiple pulmonary nodules were mildly
FDG avid. There was no FDG-avid disease in the abdomen or pelvis
or clear bony lesions. 
- ___ MRI brain was negative for enhancing brain lesions 
and
commented only on early small vessel changes. 
- ___ CT Chest with further interval progression. 
- ___ C1D1 Carboplatin AUC 5, Pemetrexed 500 mg/m2 
- ___ C2D1 Carboplatin AUC 5, Pemetrexed 500 mg/m2 
- ___ CT Chest with interval decrease in adenopathy,
pulmonary masses, and resolution of effusion. 
- ___ C3D1 Carboplatin AUC 5, Pemetrexed 500 mg/m2 
- ___ C4D1 Carboplatin AUC 5, Pemetrexed 500 mg/m2 
- ___ CT with stable disease 
- ___ C5D1 Carboplatin AUC 5, Pemetrexed 500 mg/m2 
- ___ C6D1 Carboplatin AUC 5, Pemetrexed 500 mg/m2 
- ___ Completed carboplatin pemetrexed x6
- ___ CT torso with possible progression of RUL lesions but
overall stable disease, CT neck with significant reduction in
supraclavicular disease
- ___ CT chest and neck showed progressive disease
- ___ C1D1 single agent palliative pemetrexed 500 mg/m2 IV 
- ___ to ___ Admission for PNA, syncope. Found to have
new brain mets
- ___ to ___ WBRT, chest XRT 
- ___ CT torso with progressive disease
- ___ Brain MRI with improved disease
- ___ C1D1 docetaxel 75 mg/m2 with Neulasta support on D2

Other Past Medical History:
- History of uterine fibroids, status post embolization in
___ obesity

 
Social History:
___
Family History:
- Mother: CVA
- Father: Unknown to patient
- Half sister: COPD
 
Physical ___:
ADMISSION PHYSICAL EXAM:
VS: 98.9  bp 104/54  HR 104 RR 18  SaO2 95 RA
GEN: Slightly tearful, conversant, awake, tired  
HEENT: EOMI, sclera anicteric, conjunctivae clear, OP dry and 
without lesion
NECK: Supple, no JVD  
CV: Reg rate, normal S1, S2. No m/r/g.   
CHEST: Resp unlabored, no accessory muscle use. right-sided 
breath sounds distant, no crackles, wheezes or rhonchi.  
ABD: Soft, mildly distended and diffusely tender, no HSM, bowel 
sounds present, no rebound or guarding
MSK: normal muscle tone and bulk
EXT: No c/c/e, 2+ ___ bilaterally
SKIN: No rash, warm skin
NEURO: normal attention, no focal deficits, follows commands
PSYCH: appropriate
.
DISCHARGE PHYSICAL EXAM:
VS: Tmax 98.5 Tc 97.4 BP 140/90 (108-140/60-90) HR 106 RR 20 O2 
Sat 94% RA (93-96% RA)
GEN: Patient sitting up in bed in NAD
HEENT: EOMI, sclera anicteric, conjunctivae clear
NECK: Supple. Supraclavicular node on the right appreciated.  
CV: Reg rate, normal S1, S2. No M/R/G.   
CHEST: BS clear b/l though distant
ABD: Soft, NT, ND, no HSM, bowel sounds present, no rebound or 
guarding
EXT: No clubbing, cyanosis, or edema, 2+ DP bilaterally

 
Pertinent Results:
ADMISSION LABS:
___ 07:20PM   GLUCOSE-94 UREA N-14 CREAT-0.8 SODIUM-129* 
POTASSIUM-4.4 CHLORIDE-93* TOTAL CO2-28 ANION GAP-12
___ 07:20PM   ALT(SGPT)-63* AST(SGOT)-41* ALK PHOS-104 TOT 
BILI-0.3
___ 07:20PM   LIPASE-19
___ 07:20PM   WBC-15.0*# RBC-3.68* HGB-11.0* HCT-32.7* 
MCV-89 MCH-29.8 MCHC-33.5 RDW-15.0
___ 07:20PM   NEUTS-88.5* LYMPHS-7.3* MONOS-3.7 EOS-0.3 
BASOS-0.2
___ 07:20PM   PLT COUNT-263
___ 08:03PM   LACTATE-1.5
.
DISCHARGE LABS:
___ 06:57AM BLOOD WBC-10.0 RBC-3.25* Hgb-10.0* Hct-29.2* 
MCV-90 MCH-30.9 MCHC-34.4 RDW-15.9* Plt ___
___ 06:57AM BLOOD Glucose-91 UreaN-5* Creat-0.8 Na-135 
K-4.6 Cl-102 HCO3-26 AnGap-12
___ 06:57AM BLOOD Calcium-8.8 Phos-3.2 Mg-2.0
.
IMAGING:
Gallbladder U/S Wet read ___: Small amount of gallbladder 
sludge. No cholecystitis

CXR ___: Stable appearance of right upper lobe opacity 
compatible with known malignancy. No definite signs of 
superimposed pneumonia. 
.
MICROBIOLOGY:
URINE CULTURE: NO GROWTH
BLOOD CULTURE PENDING
VIRAL RESPIRATORY SWAB: No respiratory viruses isolated. Culture 
screened for Adenovirus, Influenza A & B, Parainfluenza type 1,2 
& 3, and Respiratory Syncytial Virus.. 

 
Brief Hospital Course:
#Viral illness - Upon presentation, the patient had a fever with 
abdominal pain. She was initially started on Levaquin, and 
Falgyl was added out of nursing concern for aspiration. A RUQ 
ultrasound on admission did not show evidence of cholecystitis. 
During the hospitalization, she had a max temperature of 100.3. 
After this peak in temperature, the patient did not have any 
more temperature spikes. During the hospitalization, the patient 
noticed her symptoms of facial congestion improved. Her symptoms 
were thought to be due to a viral illness and antibiotics were 
discontinued. Blood and urine cultures and nasopharyngeal swab 
were collected and followed during the admission. Urine culture 
had no growth; blood cultures were still pending. Nasopharyngeal 
swab was negative. The patient was discharged home without 
antibiotics.   
.
#NSCLC stage IV EGFR wild type: Treating with palliative intent. 
The patient last received a cycle of chemotherapy ___ 
(Docetaxel) with Neulasta support on day 2. The patient's folic 
acid was discontinued during this hospitalization. She met with 
palliative care to discuss symptom management and goals of care. 
The patient expressed that she felt pretty clearly that she is 
not interested in more chemotherapy. During her discussion with 
palliative care, the patient acknowledged that her mood is low, 
but feels that she is just being honest with her situation. The 
patient's primary oncology team was made aware of the patient's 
decision and was fully on board with the patient's decision. She 
is being discharged home on hospice. During this 
hospitalization, the patient was started on Morphine SR 30mg 
every 12 hours for pain control. The patient was tolerating this 
medication well prior to discharge. 
.
#Metastatic brain lesions: Patient is status post whole brain 
radiation therapy. Ther was no indication for acute steroids 
during this admission.
.
#Leukocytosis - The patient leukocytosis was thought to be 
attributed to infection as with clinical improvement of the 
patient's symptoms, her white count was trended downward. 
.
#Nausea - Patient had Zofran available to her during the 
admission. Per palliative care recs, the patient was transition 
to three times daily dosing of Reglan with instructions to stop 
taking Compazine as the side effect profile of these two 
medications is similar. 
.
#Constipation - The patient was continued on scheduled senna and 
colace; she had lactulose available to her as needed for 
constipation. The patient did have a bowel movement prior to 
discharge. 
.
#Anemia - The patient did not require any blood transfusions 
during this admission.
.
#Hyponatremia - This has been a chronic issue for the patient 
with a likely component of SIADH given the patient's known 
history of brain metastasis.
.
#Transaminitis - Unclear etiology. Transaminitis was trended and 
the patient's AST was noted to be trending downward on day of 
discharge.  
.
#Adjustment disorder with depressed features secondary to 
general medical condition: The patient had ativan available as 
needed. No other medications were started for this during this 
hospitalization. 
.
#Transition of Care:
- Focus of the patient's care will now focus on comfort given 
her decision to be discharged home to home hospice. 
- Follow-up of pending blood cultures. 

 
Medications on Admission:
Medications - Prescription
DEXAMETHASONE - 4 mg Tablet - 2 Tablet(s) by mouth twice a day
starting the day prior to chemo, then for 3 days after chemo
FOLIC ACID - 1 mg Tablet - 1 Tablet(s) by mouth daily
LORAZEPAM - 0.5 mg Tablet - 1 to 2 Tablet(s) by mouth every four
(4) hours as needed for insomnia, anxiety, nausea
MORPHINE - 15 mg Tablet - ___ Tablet(s) by mouth every four (4)
hours as needed for pain take with Colace and Senna
ONDANSETRON -  (Prescribed by Other Provider) - 8 mg Tablet,
Rapid Dissolve - 1 Tablet(s) by mouth three times a day as 
needed
for nausea
PROCHLORPERAZINE MALEATE -  (Prescribed by Other Provider) - 10
mg Tablet - 1 Tablet(s) by mouth four times a day as needed for
nausea
 
Medications - OTC
DOCUSATE SODIUM - 100 mg Capsule - 1 Capsule(s) by mouth twice a
day while on pain meds
SENNOSIDES - 8.6 mg Tablet - 1 Tablet(s) by mouth twice a day
while on pain meds
 
Discharge Medications:
1. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 
times a day).
Disp:*60 Capsule(s)* Refills:*2*
2. senna 8.6 mg Tablet Sig: Two (2) Tablet PO BID (2 times a 
day).
Disp:*60 Tablet(s)* Refills:*2*
3. metoclopramide 10 mg Tablet Sig: One (1) Tablet PO TID (3 
times a day).
Disp:*90 Tablet(s)* Refills:*0*
4. lorazepam 0.5 mg Tablet Sig: One (1) Tablet PO Q4H (every 4 
hours) as needed for anxiety, nausea, insomnia.
Disp:*120 Tablet(s)* Refills:*0*
5. morphine 15 mg Tablet Sig: ___ Tablets PO Q2H (every 2 hours) 
as needed for pain.
Disp:*200 Tablet(s)* Refills:*0*
6. lactulose 10 gram/15 mL Syrup Sig: Thirty (30) ML PO DAILY 
(Daily) as needed for constipation.
Disp:*qs mL* Refills:*2*
7. magnesium hydroxide 400 mg/5 mL Suspension Sig: Thirty (30) 
ML PO Q6H (every 6 hours) as needed for constipiation.
Disp:*qs mL* Refills:*2*
8. ranitidine HCl 150 mg Tablet Sig: One (1) Tablet PO BID (2 
times a day).
Disp:*60 Tablet(s)* Refills:*2*
9. morphine 30 mg Tablet Extended Release Sig: One (1) Tablet 
Extended Release PO Q12H (every 12 hours).
Disp:*60 Tablet Extended Release(s)* Refills:*2*
10. morphine concentrate 100 mg/5 mL (20 mg/mL) Solution Sig: 
___ mg SL PO Q1H PRN as needed for pain.
Disp:*30 mL* Refills:*0*

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
Viral illness
Metastatic Adenocarcinoma of the Lung

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear ___,

It was a pleasure taking care of you during your recent 
hospitalization at ___.

You were hospitalized with fever, which was thought to be due to 
a viral illness. Through your hospital course, your symptoms 
improved. During this hospitalization, you and the ___ 
care team discussed future goals surrounding your care. You have 
decided to go home with hospice; arrangements were made for this 
during your hospitalization.

You were also started on a long-acting pain medication call 
Morphine Sustained Release to be taken twice daily every 12 
hours. Do not miss any doses of this medication.  However, you 
should contact your doctor if you notice increased lethargy or 
somnelence on this medication. You have Morphine immediate 
release available to you every 4 hours as needed for 
breakthrough pain. Please do not drink alcohol while taking 
these medication as the combination of the pain medicaion and 
alcohol can slow your breathing. Also, please do not drive or 
operate heavy machinery while first taking these medications 
until you are aware of how these medications affect you.

Please take all medications as prescribed. Please note the 
following medication changes:
- START morphine SR 30mg twice daily by mouth. Do not skip any 
doses.  Notify your doctor if you get increased lethargy or 
somnelence with this medication.
- CONTINUE morphine ___ 15mg ___ tabs every 4 hours as needed for 
breakthrough pain.
- START lacutlose 30mg daily as needed for consptipation
- START Reglan 10mg three times daily to help with symptoms of 
nausea
- START Ranitidine 150mg twice daily for acid indigestion
- TAKE senna and colace TWICE daily
- Do NOT take compazine for symptoms of nausea when at home

Please keep all follow-up appointments. Your upcoming 
appointments are listed below.
 
Followup Instructions:
___
"
14102739-DS-16," 
Name:  ___               Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Patient recorded as having No Known Allergies to Drugs
 
Attending: ___.
 
Chief Complaint:
Altered mental status 
 
Major Surgical or Invasive Procedure:
Paracentesis

 
History of Present Illness:
___ with a history of HTN, DM2, HCV cirrhosis c/b hepatocellular 
carcinomas (dx'd in ___ and SBP (___), who now p/w AMS. 
His mother accompanied him to the ED and reports he has slowly 
been declining x 5 days, and that he has had poor medication 
complicance since his recent discharge ___. He denies fevers, 
abd pain, cough, URI sx, urinary sx. Of note, he was recently 
admitted ___ for altered mental status after not 
taking lactulose and rifaxamin.  
.  
In the ED: Vitals were 98.1 168/94, 63, 17 100RA. Exam was 
notable for a softly distended abd which was non tender. + flap. 
CXR was notable for ? retrocardiac opacity; he was given CTX and 
azithromycin. He was given lactlulose (30 ml) and admitted to 
___.  
.  
On the floor he was initially confused with asterixis but 
improved overnight with lactulose and rifaximin. A long 
discussion about the consquences of missing lactulose and 
rifaximin was had with the patient.  

 
Past Medical History:
#. Multiple gallbladder stones w/o cholecystitis  
#. Hepatocellular Carcinoma  
- two bx lesions c (+) path  
- s/p RFA ___  
#. Recent hospitalization x2 over last ___ months for severe  
cellulitis of lower extremities  
#. Hep C Genotype 1  
- Pegylated interferon, ribavirin (___): Viral relapse  
- Liver bx (___): Stage 3 fibrosis, grade 2 inflammation  
- EGD (___): Esophagitis, varices  
- AFP 9.8  
#. Hypertension  
#. DMII: c/b neuropathy  
#. Psoriasis  
#. Anxiety  
#. GERD  
#. Chronic anemia  
#. s/p laminectomy (___)  
#. Chronic pain ___ laminectomy managed by methadone  
#. s/p right ankle surgery (___)  

 
Social History:
___
Family History:
Denies hx Ca, CAD, Liver Px, + DM.
 
Physical Exam:
GEN: NAD, calmer, A&Ox2  
VS: 97.7 157/90 72 20 100RA  
HEENT: anicteric sclera, MMM, poor dentition, neck supple  
CV: RR, NL S1S2 no S3S4 MRG  
PULM: CTAB  
ABD: BS +, soft, NT, distended with evidence of ascites  
LIMBS: 1+ ___ edema R>L, hyperpigmented and thickened skin 
consistent with chronic venous insufficiency  
NEURO: + asterixis. CN II-XII intact. A+O X name and place only. 
 
.  

 
Pertinent Results:
Admission labs:
___ 03:57PM BLOOD WBC-7.3 RBC-3.05* Hgb-9.2* Hct-28.5* 
MCV-93 MCH-30.0 MCHC-32.2 RDW-16.9* Plt ___
___ 03:57PM BLOOD ___ PTT-32.2 ___
___ 03:57PM BLOOD Glucose-196* UreaN-66* Creat-4.0* Na-135 
K-4.3 Cl-102 HCO3-21* AnGap-16
___ 03:57PM BLOOD ALT-42* AST-98* AlkPhos-111 Amylase-134* 
TotBili-1.7*
___ 06:15AM BLOOD Albumin-3.9 Calcium-9.5 Phos-3.7# Mg-1.9
.
Discharge labs:
___ 06:30AM BLOOD WBC-8.2 RBC-2.47* Hgb-7.6* Hct-23.2* 
MCV-94 MCH-30.8 MCHC-32.7 RDW-16.6* Plt ___
___ 06:30AM BLOOD ___ PTT-56.7* ___
___ 06:30AM BLOOD Glucose-192* UreaN-53* Creat-3.2* Na-134 
K-4.0 Cl-101 HCO3-23 AnGap-14
___ 06:30AM BLOOD ALT-29 AST-66* LD(LDH)-198 AlkPhos-95 
TotBili-1.3
___ 06:30AM BLOOD Albumin-4.4 Calcium-8.9 Phos-3.9 Mg-1.6
.
ASCITES LABS:
___ 05:15PM ASCITES WBC-1500* ___ Polys-14* 
Lymphs-39* ___ Mesothe-21* Macroph-26*
___ 05:15PM ASCITES Albumin-2.5
.
IMAGING;
ABDOMEN U.S. (COMPLETE STUDY) Study Date of ___ 9:23 AM 
COMPARISON: Compared to ultrasound from ___ and 
MRI from ___. FINDINGS: The liver remains coarse 
and heterogeneous, consistent with known cirrhosis. The cystic 
and solid lesion within segment IV is similar in comparison to 
the prior study and now measures 3.6 x 4.3 x 4.2 cm. Echogenic 
lesion within segment III is similar in appearance, and now 
measures 4.6 x 3.4 x 2.6 cm. These lesions were previously seen 
on MRI from ___, and correspond to areas of prior 
RFA treatment. There is an unchanged small calcification within 
the right lower lobe of the liver. There are numerous gallstones 
layering dependently within the gallbladder, with no evidence of 
cholecystitis. There is no gallbladder wall edema. The common 
bile duct measures 7 mm in diameter. There is no intrahepatic 
bile duct dilatation. There is a moderate amount of ascites, 
unchanged. The spleen is of normal size, measuring 11.6 cm. 
Doppler examination demonstrates patency of the main, right and 
left portal veins. Within the left portal vein, again 
arterialized waveform is demonstrated, which may reflect known 
arteriovenous fistula which was demonstrated on MRI of ___. The hepatic arteries are patent and demonstrate normal 
flow. Mark for paracentesis in the LLQ was placed by Dr. ___ 
___. IMPRESSION: 1. Cirrhosis, focal liver lesion consistent 
with s/p RFA treatment. 2. Moderate ascites. 3. Cholelithiasis. 
4. Patent main, right and left veins. Abnormal waveform of the 
left portal vein which suggests an arteriovenous fistula 
identified on MRI of ___. 
 
Brief Hospital Course:
___ with a history of HTN, DM2, HCV cirrhosis c/b HCC (dx in 
___ and ? SBP (___), who presented with AMS. Was found to 
have SBP an and was treated with antibiotics as well as 
lactulose and rifaximin. He improved clinically and was 
discharged with close follow up. 
.  
# Hepatic encephalopathy: In setting of medication noncompliance 
and SBP. Poor social supports. CXR with ? retrocardiac opacity 
per ED read, but no fever, cough, leukocytosis. Received 
ceftriaxone and azithromycin x1 in ED. This covered for SBP as 
well. Diagnostic para after ABx was positive with >200PMN. 
Culture is pending but is unlikely to be positive now that 
already received antibiotics. UCx negative to date. BCx negative 
to date. ParaCx negative to date. Para fluid consistent with 
SBP. Treated as below. Continue Rifaximin 400 mg PO TID and 
Lactulose 30 mL PO TID.
.  
# Spontaneous bacterial peritonitis: Pt received azithromycin 
and ceftriaxone in the ED but did not have a diagnostic 
parecentesis. Diagnostic para the following day was positive for 
SBP with >200PMN per uL and 1500WBC/uL. Received ceftriaxone 1g 
IV daily for 3 days (___). Received 125g albumin IV x1 
(1.5g/kg) on ___ and an additional 75g (1g/kg) on ___ 
per protocol. Discharged on Cefpodoxime Proxetil 200 mg PO Q24H 
for 4 days to complete treatment of SBP.  
.  
# ESLD ___ HCV cirrhosis + HCC s/p RFA in ___: HCV s/p failed 
Ribavarin and interferon treatments. Has known grade I/II 
varices. Not a transplant candidate due to non-compliance and 
inadequate social supports. Continue rifaximin + lactulose for 
hepatic encephalopathy. Continue Nadolol 40 mg PO DAILY for 
varices. Discontinue ciprofloxacin 750 mg PO weekly and treat 
with ceftriaxone and cefpodoxime as above. Will DC on 
ciprofloxacin 250mg PO daily for SBP PPx.  
.  
# Acute on chronic kidney failure: Admitted with acute on 
chronic renal failure last admission (baseline had been 1.7, 
admitted at 5.6, discharged at 4.7, re-admitted at 4.0). CKD was 
felt to be likely due to DM and HTN, unclear why recent decline. 
Discontinued diuretics for the moment for renal failure. ___ 
restart as an outpatient. 
.  
# Anemia/Thrombocytopenia: Down trending HCT this admission 
likely due to a combination of phlebotomy and poor production of 
RBC from renal failure. Guaiac negative. Iron studies are 
essentially WNL with depressed retic count consisdent with 
anemia of renal insufficiency. 
.  
# DM2: Continue insulin regimen (Lantus 60 + HISS)
.  
# Chronic RLE pain and back pain: Continue home doses of 
Methadone 40 mg PO QAM and Methadone 30 mg PO QPM  
.  
# Hypertension: On dilatiazem SR 120mg PO daily at home. 
Received short acting equivalent in house of Diltiazem 30 mg PO 
QID. 
 
Medications on Admission:
Rifaximin 400 mg TID  
Lactulose 30 TID  
Nadolol 40 mg daily  
Methadone 40 mg qAM, 30 mg qPM  
Pantoprazole 40 mg q12h  
Diltiazem HCl 120 mg daily  
Clonazepam 0.5 mg TID  
Lispro sliding scale  
Glargine 60 units qHS.  
Ciprofloxacin 750 mg every ___ as ppx for SBP  

 
Discharge Medications:
1. Rifaximin 200 mg Tablet Sig: Two (2) Tablet PO TID (3 times a 
day).
Disp:*180 Tablet(s)* Refills:*2*
2. Lactulose 10 gram/15 mL Syrup Sig: Thirty (30) ML PO TID (3 
times a day): take an extra dose if less than 3 bowel movements 
daily.
Disp:*2700 ML(s)* Refills:*2*
3. Nadolol 20 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily).
Disp:*60 Tablet(s)* Refills:*2*
4. Methadone 10 mg Tablet Sig: Three (3) Tablet PO QPM (once a 
day (in the evening)).  
5. Methadone 40 mg Tablet, Soluble Sig: One (1) Tablet, Soluble 
PO QAM (once a day (in the morning)).  
6. Pantoprazole 40 mg Tablet, Delayed Release (E.C.) Sig: One 
(1) Tablet, Delayed Release (E.C.) PO Q12H (every 12 hours).
Disp:*60 Tablet, Delayed Release (E.C.)(s)* Refills:*2*
7. Diltia XT 120 mg Capsule,Degradable Cnt Release Sig: One (1) 
Capsule,Degradable Cnt Release PO once a day.
Disp:*30 Capsule,Degradable Cnt Release(s)* Refills:*2*
8. Clonazepam 0.5 mg Tablet Sig: One (1) Tablet PO TID (3 times 
a day): do not drive after taking this medication.
Disp:*90 Tablet(s)* Refills:*0*
9. Lantus 100 unit/mL Solution Sig: Sixty (60) U Subcutaneous at 
bedtime.
Disp:*3 bottles* Refills:*2*
10. Insulin Lispro 100 unit/mL Insulin Pen Sig: As directed per 
sliding scale U Subcutaneous four times a day: See attached 
scale.
Disp:*3 pens* Refills:*2*
11. Cipro 250 mg Tablet Sig: One (1) Tablet PO once a day: To 
start on ___.
Disp:*30 Tablet(s)* Refills:*2*
12. Cefpodoxime 100 mg Tablet Sig: Two (2) Tablet PO Q24H (every 
24 hours) for 4 days.
Disp:*8 Tablet(s)* Refills:*0*

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
Spontaneous bacterial peritonitis, improved
Hepatitis C cirrhosis complicated by hepatocellular carcinoma

Secondary:
Diabetes mellitus
Hypertension
Gastroesophageal reflux
Anemia

 
Discharge Condition:
Afebrile, ambulating, comfortable on room air

 
Discharge Instructions:
You have been evaluated for your confusion. You were found to 
have an infection in the fluid in your abdomen (ascites). You 
were treated with intravenous antibiotics. We have changed this 
to antibiotics by mouth. You should continue this for four more 
days and then resume your daily prophylactic (preventative) 
antibiotic, ciprofloxacin.

Please take all of your medications as prescribed. 

We have changed your ciprofloxacin to a daily pill (250 mg) 
instead of weekly dosing.

Please continue cefpodoxime daily to treat your ascites 
infection for the next four days (to end on ___.

Please contact your primary care physician or return to the 
emergency room should you develop any of the following symptoms: 
fever > 101, chills, worsening abdominal pain, difficulty 
breathing, worsening leg swelling, weight gain > 3 pounds, 
throwing up blood or blood in the stools, or any other concerns.
 
Followup Instructions:
___
"
14280440-DS-8," 
Name:  ___           Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
shortness of breath
 
Major Surgical or Invasive Procedure:
___ Coronary angiogram
 
History of Present Illness:
___ yr old woman with a PMH of poorly controlled Type 2 DM,  
hypertension and hyperlipidemia, who presented to the ER on 
___ with 2 weeks of progressive SOB with ambulation. The pt 
reports that she began experiencing SOB while walking her child 
to school. The SOB starts after about 5 mins, and resolves with 
rest. She denies any CP, palpitations, dizziness, diaphoresis, 
or nausea. In the ER, her trops were neg x 2 and her CXR was 
normal. On ___, she underwent a ETT, which was notable for 1.___levation in avR and V1 with reciprocal 1-1.5 mm ST 
segment depression in leads I,II, V5-6.  She was brought to the 
___ holding area  for a coronary angiogram. She is in stable 
condition.

 
Past Medical History:
Poorly controlled Type 2 DM
Hypertension
Hyperlipidemia

 
Social History:
___
Family History:
Mother: ___ and DM Type 2
 
Physical Exam:
Admission Exam:
Pt seen and examined upon arrival to ___ Holding area
General: ___ yr old woman in NAD
VS: 140/75 85 NSR 18 99% RA
EKG: NSR 85, Symmetrical TWI V2, non-sym TWI AVL
Lungs: CTAb, no wheezing, rhonchi
Heart: S1S2 regular, noted systolic murmur
Neck: No JVD
Abd: soft, non-tender, BS + 
PV: Radial pulses: 2+ b/l. ___: 2+ b/l. No clubbing, cyanosis
or edema
Neuro: Alert and oriented x 3. No focal deficits or asymmetries
noted

Discharge Exam:
General: sitting on side of bed ready to eat breakfast
VS: 98.4, BP 112/69, HR 75, RR 16, 02 sat 100%RA, (SBP range 
101-138, HR range 75-99)
Orthostatics done: 112/69,75 lying; 111/67, 89 sitting; 121/76, 
99 standing
Lungs: CTAb, no wheezing, rhonchi
Heart: S1S2 regular, noted systolic murmur
Neck: No JVD
Abd: + bowel sounds,soft, non-tender
PV: Radial pulses: 2+ b/l. ___: 2+ b/l. No clubbing, cyanosis
or edema
Neuro: Alert and oriented x 3. No focal deficits or asymmetries
noted

 
Pertinent Results:
Cath report: ___
Coronary Anatomy
Dominance: Right
LMCA: The LMCA was long with mild ostial plaquing.
LAD: The mildly calcified proximal LAD tapered gradually to an 
80% stenosis with TIMI 2 pulsatile flow
beyond. The mid-distal LAD was very straight, but did not appear 
on a pseudo-lateral view to be intramyocardial. D1 had mild 
proximal disease. D2 was another large branch. LCX: The CX gave 
off a patent very high OM1 (functionally a ramus intermedius 
branch). The proximal
and mid AV groove CX had mild plaquing to 20%. The terminal 
segments of all the OMs were tortuous, suggestive of 
hypertensive heart disease. OM2 was small and OM3 was of modest 
caliber. OM4/LPL had a hairpin turn prior to its terminal 
tortuosity. The distal CX provided collaterals to a bifurcation 
that was likely the distal AV groove RCA and a RPL2. Flow in the 
OMs was pulsatile, consistent with microvascular dysfunction.
RCA: The RCA gave off a very early RV branch arising from a 
slightly angulated segment. The RPDA appeared to be stump 
occluded with filling of the apical segment via the high early 
RV branch. RPL1 appeared to be a branching vessel with its first 
two bifurcating sidebranches running laterally and the main pole 
running parallel to the absent RPDA. The distal AV groove RCA 
beyond this RPL appeared to be occluded, filling via 
left-to-right collaterals.
Intra-procedural Complications: None
Impressions:
1. Severe proximal LAD and likely totally occluded distal RCA 
disease (terminal AV groove RCA and
RPDA proper) in a young woman with poorly controlled diabetes 
mellitus.
2. Normal left ventricular diastolic pressures.

ECHO ___
The left atrium and right atrium are normal in cavity size. The 
estimated right atrial pressure is ___ mmHg. Mild symmetric left 
ventricular hypertrophy with normal cavity size, and 
regional/global systolic function (biplane LVEF = 68 %). The 
estimated cardiac index is normal (>=2.5L/min/m2). Right 
ventricular chamber size and free wall motion are normal. The 
aortic arch is mildly dilated. The aortic valve leaflets (3) 
appear structurally normal with good leaflet excursion and no 
aortic stenosis or aortic regurgitation. The mitral valve 
appears structurally normal with trivial mitral regurgitation. 
There is no mitral valve prolapse. The estimated pulmonary 
artery systolic pressure is normal. There is a 
trivial/physiologic pericardial effusion. 

 IMPRESSION: Mild symmetric left ventricular hypertrophy with 
preserved regional and global biventricular systolic function. 
No valvular pathology or pathologic flow identified.

 Compared with the prior study (images reviewed) of ___, 
the findings are similar.

___ 06:40AM BLOOD WBC-7.3 RBC-4.71 Hgb-11.9 Hct-37.1 
MCV-79* MCH-25.3* MCHC-32.1 RDW-14.6 RDWSD-40.9 Plt ___
___ 03:35PM BLOOD WBC-8.5 RBC-4.14 Hgb-10.2* Hct-33.0* 
MCV-80* MCH-24.6* MCHC-30.9* RDW-14.4 RDWSD-41.2 Plt ___
___ 08:48PM BLOOD WBC-7.6 RBC-4.59 Hgb-11.6 Hct-36.4 
MCV-79* MCH-25.3* MCHC-31.9* RDW-14.6 RDWSD-41.4 Plt ___
___ 03:35PM BLOOD Neuts-62.2 ___ Monos-5.2 Eos-1.9 
Baso-0.5 Im ___ AbsNeut-5.28 AbsLymp-2.53 AbsMono-0.44 
AbsEos-0.16 AbsBaso-0.04
___ 08:48PM BLOOD Neuts-57.3 ___ Monos-5.5 Eos-1.7 
Baso-0.5 Im ___ AbsNeut-4.34 AbsLymp-2.63 AbsMono-0.42 
AbsEos-0.13 AbsBaso-0.04
___ 06:40AM BLOOD ___ PTT-26.1 ___
___ 06:40AM BLOOD Ret Aut-1.3 Abs Ret-0.06
___ 06:40AM BLOOD Glucose-171* UreaN-8 Creat-0.4 Na-134 
K-4.4 Cl-100 HCO3-24 AnGap-14
___ 03:35PM BLOOD Glucose-208* UreaN-7 Creat-0.4 Na-135 
K-3.7 Cl-101 HCO3-21* AnGap-17
___ 08:48PM BLOOD Glucose-316* UreaN-9 Creat-0.7 Na-132* 
K-4.1 Cl-96 HCO3-24 AnGap-16
___ 08:48PM BLOOD estGFR-Using this
___ 06:40AM BLOOD ALT-8 AST-12 LD(LDH)-169 AlkPhos-95 
TotBili-0.4
___ 03:04AM BLOOD cTropnT-<0.01
___ 08:48PM BLOOD cTropnT-<0.01
___ 08:48PM BLOOD proBNP-29
___ 06:40AM BLOOD Albumin-3.9 Calcium-9.2 Phos-4.5 Mg-2.0 
Iron-34
___ 08:48PM BLOOD Calcium-10.0 Phos-3.4 Mg-2.2
___ 06:40AM BLOOD calTIBC-325 VitB12-585 Folate-15.2 
TRF-250
___ 06:40AM BLOOD %HbA1c-12.0* eAG-298*
___ 03:35PM BLOOD %HbA1c-12.2* eAG-303*
___ 06:40AM BLOOD TSH-0.___dmit ___ for coronary angiogram. Cath showed a right 
dominant system with normal left main, ___ LAD 80%, normal 
circumflex, right PDA likely chronically occluded with 
left-right collaterals, and a likely occluded small 
posterolateral branch. Cardiac surgery consulted and will follow 
up as outpatient. Her pravastation was changed to atorvastatin 
80mg daily. She was started on metoprolol succinate and imdur. 
She tolerated these new medications well. Her lisinopril dose 
was decreased to 10mg QHS. She remained chest pain free and 
denied any shortness of breathe while admitted.

___ did consult for uncontrolled DM. They recommended to 
continue lantus 40 units QHS and fixed doses of Humalog 10units 
with meals. Adding a sliding scale as an outpatient was deferred 
to endocrinology as she has an appointment with them tomorrow 
___.

Discharge time 25 min
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Lisinopril 40 mg PO DAILY 
2. MetFORMIN (Glucophage) 1000 mg PO BID 
3. Pravastatin 80 mg PO DAILY 
4. Glargine 40 Units Bedtime
Humalog 10 Units Breakfast
Humalog 10 Units Lunch
Humalog 14 Units Dinner
5. Aspirin 81 mg PO DAILY 

 
Discharge Medications:
1.  Atorvastatin 80 mg PO QPM  
2.  Isosorbide Mononitrate (Extended Release) 30 mg PO DAILY  
3.  Metoprolol Succinate XL 75 mg PO DAILY  
4.  Mupirocin Ointment 2% 1 Appl NU BID Duration: 5 Days 
apply pea size on tip, apply it to one nostril and repeat other 
nostril with new swab  
5.  Glargine 40 Units Bedtime
Humalog 10 Units Breakfast
Humalog 10 Units Lunch
Humalog 10 Units Dinner 
6.  Lisinopril 10 mg PO QHS  
7.  Aspirin 81 mg PO DAILY  
8.  MetFORMIN (Glucophage) 1000 mg PO BID  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
CAD
Uncontrolled Type 2 DM
Hypertension
Hyperlipidemia

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
You were admitted to the hospital for a heart catheterization to 
evaluate your shortness of breath and your abnormal stress test. 
You were found to have blockages in your left anterior 
descending artery and right coronary artery. You were given a 
choice to consider having stents placed to open the blockages, 
or to have bypass surgery. You were seen by Cardiac Surgery, and 
you and your family decided to proceed with heart surgery. You 
had pre-op testing done when you were in the hospital. You will 
be called at home when a surgical date has been decided. 

The following medications have been changed:
-Pravastatin was changed to Atorvastatin for improved treatment 
of your heart disease. Sent to pharmacy
-Lisinopril dose was decreased from 40mg to 10mg daily. Sent to 
pharmacy!
-Started on metoprolol succinate 75mg twice a day. (this will 
help your heart relax) Sent to pharmacy!
-Started on imdur (isosorbide) 30mg daily (this helps dilate 
your vessels, and may alleviate your shortness of breath caused 
by your blocked coronary arteries.)Sent to pharmacy!
-**5 days prior to surgery, start mupirocin topical ointment,1 
smear nasal twice a day.** Sent to pharmacy.

Your echocardiogram was similar to previous imaging done in ___ 
and your heart valves were working fine.

It is very important to follow up at ___ Diabetes ___ with 
Dr. ___ tomorrow at 8:30AM

I gave you a work note until ___, if you need longer, please 
contact the Cardiac Surgery Team for additional time off.

Activity restrictions and care of your wrist site will be 
included in your discharge instructions

 
Followup Instructions:
___
"
14631997-DS-13," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
hypotension
 
Major Surgical or Invasive Procedure:
RIJ central line placed ___
___ central line removed ___

 
History of Present Illness:
___ with pmhx HIV (CD4 362, VL<20 ___, chronic abdominal 
pain on opiates and EtOH abuse who presents from ___ office for 
evaluation of hypotension. At ___ noted found to be hypotensive 
to systolics in ___-70s. He was pallid in appearance and states 
that he felt very poorly at that time. The patient endorsed 
feeling poorly, and said he had several falls which he 
attributes to the low BP. He has a history of many falls. Before 
the falls yesterday there were no prodromal symptoms. At other 
times he feels lightheaded but this does not necessarily result 
in a fall. He has also had a cough and felt chills with low 
grade temperatures of 99-100. He has chronic intermittent 
diarrhea/constipation, and urinary frequency/retention both of 
which had no changes recently.  
 The patient reports having low BPs, sometimes ___, without 
many symptoms. During multiple prior admissions he has had bouts 
of asymptomatic hypotension without signs of tissue 
hypoperfusion that was not thought to be in shock of any 
etiology. Etiology was attributed to medication side effects. 
Chart review shows inpatient BPs at the last admission ranging 
from 70-170s/40s-90s. Outpatient BP range of ___.  
 He reports usage of 30mg extended release morphine at home 
which has not treated his pain adequately, so he has been 
supplementing with 500ml vodka per day, down from 750ml 
previously. He was referred by PCP to ___ for management of 
hypotension and EtOH abuse treatment  
 
 In ED initial VS: 97.5 88 82/59 16 96% RA. He was initially 
fluid responsive after 2L, though became hypotensive again. ED 
staff thought possibly due to oxycodone He as given 4L NS, 
peripheral levophed, vancomycin, cefepime. IJ CVL was placed. 
Imaging notable for CXR showing hyperinflated lungs without 
acute process.  
 
 On arrival to the MICU, he was still on levophed with vital 
signs WNL.  

 
Past Medical History:
HIV ___ CD4 362 VL <20) ___ CD4 116)
history of syphilis, chlamydia, HSV genitalis, shingles
history of c.diff colitis 
chronic pain syndrome
essential tremor
Anxiety
chronic insomnia
?fibromyalgia
chronic constipation/diarrhea
urinary retention
recent SBO ___
diverticulosis
cholelithiasis
COPD
right inguinal hernia
HTN
history of chronic bowel discomfort, constipation/diarrhea, 
currently undergoing outpatient work up in ___ clinic
PAST SURGICAL HISTORY: Remarkable for appendectomy and
testicular surgery.
 
Social History:
___
Family History:
father having died due to probable CAD at age ___
mother died at age ___ postoperative after a brain surgery.

 
Physical Exam:
ADMISSION PHYSICAL EXAM:
========================
VITALS: Reviewed in Metavision  
 GENERAL: Tremulous, lying flat in bed, conversing easily, 
intermittently wincing in pain  
 HEENT: Sclera anicteric, MMM, oropharynx clear  
 NECK: supple, no LAD palpated but tenderness to palpation in 
submandibular chain  
 LUNGS: Clear to auscultation bilaterally, no wheezes, rales, 
rhonchi  
 CV: Very diminished heart sounds, barely audible to 
auscultation, no murmurs  
 ABD: soft, diffusely tender to palpation particularly in LUQ 
where area of mild ecchymosis is present, NABS  
 EXT: Cool, 2+ pulses, no cyanosis or edema  
 NEURO: Grossly ___ strength throughout, moving all extremities 
with purpose, PERRL  
ACCESS: R IJ, PIVs  

DISCHARGE PHYSICAL EXAM:
========================
VS: 98.7 101/56 65 18 96%RA  
 GENERAL: pale gentleman in NAD, lying flat in bed, conversing 
easily  
 HEENT: Sclera anicteric, MMM, oropharynx clear  
 NECK: supple, no LAD palpated but tenderness to palpation in 
submandibular chain  
 LUNGS: Clear to auscultation bilaterally, no wheezes, rales, 
rhonchi  
 CV: RRR, nl s1/s2 without m/r/g  
 ABD: soft, diffusely tender to palpation particularly in LUQ 
where area of mild ecchymosis is present, NABS  
 EXT: Cool, 2+ pulses, no cyanosis or edema  
 NEURO: Grossly ___ strength throughout, moving all extremities 
with purpose, PERRL  

 
Pertinent Results:
ADMISSION LABS:
===============
___ 03:35PM BLOOD WBC-4.2 RBC-3.34* Hgb-11.6* Hct-33.3* 
MCV-100* MCH-34.7* MCHC-34.8 RDW-14.6 RDWSD-53.5* Plt ___
___ 03:35PM BLOOD Neuts-42.0 ___ Monos-6.0 Eos-3.8 
Baso-0.5 Im ___ AbsNeut-1.75 AbsLymp-1.98 AbsMono-0.25 
AbsEos-0.16 AbsBaso-0.02
___ 04:22AM BLOOD ___ PTT-32.0 ___
___ 03:35PM BLOOD Glucose-82 UreaN-5* Creat-1.6* Na-137 
K-4.4 Cl-96 HCO3-26 AnGap-19
___ 03:35PM BLOOD ALT-17 AST-59* AlkPhos-76 TotBili-0.3
___ 04:22AM BLOOD Albumin-3.3* Calcium-8.5 Phos-3.4 Mg-1.6
___ 04:22AM BLOOD Cortsol-16.3
___ 12:00PM BLOOD Cortsol-10.5
___ 12:30PM BLOOD Cortsol-17.9
___ 01:00PM BLOOD Cortsol-22.1*
___ 02:00AM BLOOD TSH-1.2
___ 04:10PM BLOOD Lactate-2.2*
___ 04:44AM BLOOD Lactate-0.8

MICRO:
===============
___ SPUTUM GRAM STAIN-FINAL; RESPIRATORY 
CULTURE-FINAL; LEGIONELLA CULTURE-PRELIMINARY; Immunoflourescent 
test for Pneumocystis jirovecii (carinii)-FINAL; FUNGAL 
CULTURE-PRELIMINARY {YEAST} INPATIENT 
___ SPUTUM GRAM STAIN-FINAL; RESPIRATORY 
CULTURE-FINAL INPATIENT 
___ BLOOD CULTURE Blood Culture, Routine-FINAL 
EMERGENCY WARD 
___ URINE URINE CULTURE-FINAL {ESCHERICHIA COLI} 
EMERGENCY WARD 
___ BLOOD CULTURE Blood Culture, Routine-FINAL 
EMERGENCY WARD 
___ URINE URINE CULTURE-FINAL {ESCHERICHIA COLI} 
EMERGENCY WARD 

STUDIES:
===============
___ Imaging CHEST (PA & LAT) 
No acute cardiopulmonary abnormality.

___BD & PELVIS WITH CO 
1. No specific evidence of infection in the abdomen or pelvis. 
2. Moderate congestion of the mesentery without ascites is 
likely from fluid resuscitation. 
3. Two gallstones in a nondistended gallbladder, with no 
evidence of 
cholecystitis. 

___ Imaging DX CHEST PORT LINE/TUBE 
Interval placement of a right internal jugular venous catheter, 
its tip 
terminating over the upper superior vena cava.  No pneumothorax. 


___ Cardiovascular ECHO 
Normal biventricular cavity sizes with preserved regional and 
global biventricular systolic function. Mildly dilated ascending 
aorta. No valvular pathology or pathologic flow identified.
Compared with the prior study (images reviewed) of ___, 
the findings are similar.

___ Imaging CHEST (PORTABLE AP) 
In comparison with the study of ___, there is little 
interval change.  No pneumonia, vascular congestion, or pleural 
effusion.  Right IJ catheter again extends to the midportion of 
the SVC. 

DISCAHRGE LABS:
===============
___ 05:41AM BLOOD WBC-5.7 RBC-2.87* Hgb-9.8* Hct-29.3* 
MCV-102* MCH-34.1* MCHC-33.4 RDW-15.0 RDWSD-56.3* Plt ___
___ 05:41AM BLOOD Glucose-87 UreaN-8 Creat-1.0 Na-143 K-3.5 
Cl-109* HCO3-24 AnGap-14
___ 04:22AM BLOOD ALT-11 AST-26 LD(LDH)-164 AlkPhos-67 
TotBili-0.3
___ 05:41AM BLOOD Calcium-8.8 Phos-2.8 Mg-2.___ with pmhx HIV (CD4 362, VL<20 ___, chronic abdominal 
pain on opiates and EtOH abuse who presented with intermittent 
hypotension requiring intermittent pressor support, likely 
related to medication side effect in combination with alcohol 
vs. underlying autonomic dysfunction. 

MICU Course: ___
Patient was admitted to the MICU for hypotension that required 
pressers. He was placed on broad spectrum antibiotics 
(Vancomycin, Cefepime, and Azithromycin). He was a taken off 
pressers immediately after coming to the MICU and was stable. 
After taking his medications in the morning he did drop his 
blood pressures and was ultimately needed fluid bolus and the 
restarting of pressers. Pressors were again switched off and he 
remained stable. He was called out and discharged to the floor 
on ___. At this time we believe his hypotensive episodes are 
more likely autonomic/neurologic or medication related or 
cardiac and unlikely related to infection.

Upon transfer to the medical floor on ___, chronic pain service 
reviewed patient's home regimen, and suggested patient resume 
his home pain medications. Patient was monitored on this 
regimen, and remained stable hemodynamically.

# Hypotension: 
Intermittent hypotension most likely related to medication side 
effect vs. autonomic dysfunction in the setting of HIV 
infection. No infectious symptoms, though treated for UTI given 
E. coli becteruria. Patient completed a 3 day course of 
ceftriaxone for UTI. Patient was initially treated for possible 
CAP with ctx/azithro, though no evidence of infiltrate on CXR, 
and CAP course was abbreviated. Endocrine workup negative for 
adrenal insufficiency. Patient is on multiple medications that 
can contribute to somnolence, including opioids, 
benzodiazepines, and tizanidine, but none should cause 
hypotension. Autonomic neuropathy is common in HIV, and occurs 
more commonly with increasing burden of disease. Patient was 
arranged with neurology follow-up to address possible autonomic 
dysfunction.

# Chronic pain/opioid use:
Upon admission, many of home pain medications were held out of 
concern for contribution to hypotension. He was treated with 
oxycodone while holding home medications, which did not provide 
adequate analgesia. Spoke with chronic pain, who noted that home 
opioids, tizanidine, and lyrica can all be sedating, though 
unlikely to cause hypotension. Patient was resumed on home 
regimen without new prescriptions. Upon review of records, PCP 
was reluctant to continue to prescribe opioids going forward, 
given concurrent alcohol use. Patient was encouraged to abstain 
from alcohol, and expressed understanding. He has follow-up 
arranged with PCP as well as chronic pain clinic next week. 

# Alcohol use: 
Last drink AM ___. No history of withdrawal seizures. Patient 
was monitored on CIWA scale, and was continue on home clonazepam 
for anxiety.

CHRONIC ISSUES 
# HIV: continued Triumeq (abacavir-dolutegravir-lamivud) 
600-50-300 mg oral daily
# Chronic constipation/diarrhea: continued miralax, bisacodyl, 
senna 
# HTN: Held home lisinopril and Lasix 
# Anxiety: Continue ClonazePAM 0.5 mg PO/NG TID:PRN 

=====================
TRANSITIONAL ISSUES:
=====================
[ ] HELD: Lasix, lisinopril, and tamsulosin during admission(and 
DID NOT restart upon discharge given concern for hypotension. 
Consider resuming these medications cautiously as clinically 
indicated.
[ ] Consider trial of finasteride rather than tamsulosin, given 
less effect on blood pressure.
[ ] Continue to encourage patient to abstain from alcohol
[ ] Autonomics testing with neurology
[ ] Encourage patient to continue being seen in chronic pain 
clinic
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. ClonazePAM 0.5 mg PO TID anxiety 
2. Maraviroc 300 mg PO BID 
3. Mirtazapine 30 mg PO QHS anxiety 
4. Multivitamins 1 TAB PO DAILY 
5. Ondansetron ODT 8 mg PO Q8H:PRN nausea 
6. Pregabalin 150 mg PO TID fibromyalgia 
7. Tamsulosin 0.4 mg PO WITH EVENING MEAL urinary retention 
8. Tizanidine 4 mg PO TID muscle spasm 
9. Triumeq (abacavir-dolutegravir-lamivud) 600-50-300 mg oral 
daily 
10. Vitamin D ___ UNIT PO DAILY 
11. Morphine SR (MS ___ 30 mg PO Q12H 
12. ClonazePAM 0.5 mg PO Q72H PRN anxiety 
13. Lisinopril 5 mg PO DAILY high blood pressure 
14. Furosemide 20 mg PO DAILY edema 
15. Bisacodyl 5 mg PO DAILY 
16. Polyethylene Glycol 17 g PO DAILY 

 
Discharge Medications:
1.  Cyanocobalamin 1000 mcg PO DAILY 
RX *cyanocobalamin (vitamin B-12) [Vitamin B-12] 1,000 mcg 1 
tablet(s) by mouth once a day Disp #*39 Tablet Refills:*0 
2.  FoLIC Acid 1 mg PO DAILY 
RX *folic acid 1 mg 1 tablet(s) by mouth once a day Disp #*30 
Tablet Refills:*0 
3.  Ramelteon 8 mg PO QHS:PRN insomnia 
Should be given 30 minutes before bedtime. Do not take at the 
same time as Morphine SR. 
RX *ramelteon [Rozerem] 8 mg 1 tablet(s) by mouth at bedtime 
Disp #*15 Tablet Refills:*0 
4.  Bisacodyl 5 mg PO DAILY  
5.  ClonazePAM 0.5 mg PO Q72H PRN anxiety  
6.  ClonazePAM 0.5 mg PO TID anxiety  
7.  Maraviroc 300 mg PO BID  
8.  Mirtazapine 30 mg PO QHS anxiety  
9.  Morphine SR (MS ___ 30 mg PO Q12H  
10.  Multivitamins 1 TAB PO DAILY  
11.  Ondansetron ODT 8 mg PO Q8H:PRN nausea  
12.  Polyethylene Glycol 17 g PO DAILY  
13.  Pregabalin 150 mg PO TID fibromyalgia  
14.  Tizanidine 4 mg PO TID muscle spasm  
15.  Triumeq (abacavir-dolutegravir-lamivud) 600-50-300 mg oral 
daily  
16.  Vitamin D ___ UNIT PO DAILY  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Primary Diagnosis:
Intermittent hypotension
Possible autonomic dysfunction

Secondary Diagnoses:
Chronic pain
Chronic pain/opioid use
Alcohol use
HIV
Chronic constipation/diarrhea
hypertension
anxiety

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Mr. ___,

You were admitted to ___ 
because you were having periods of very low blood pressure. We 
looked into many possible causes of your low blood pressure. One 
thing that may have contributed to your low blood pressure was 
an infection in your urine. We started you on treatment for this 
urinary infection. We also reviewed your pain medications, and 
ultimately resumed your home doses, but encourage you to stop 
drinking alcohol and follow up with your primary care doctor as 
well as your chronic pain clinic. 

Another possible cause of your low blood pressure is something 
called ""autonomic dysfunction."" This can occur in people with 
HIV, and it is caused by a problem with the nerves that control 
your blood vessels and your blood pressure. We are recommending 
that you see a neurologist for testing to further evaluate this. 


It was a pleasure caring for you,
Your ___ Care Team
 
Followup Instructions:
___
"
14719866-DS-37," 
Name:  ___              Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Ambien / Cipro
 
Attending: ___.
 
Chief Complaint:
Lightheadedness
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
Ms. ___ is an ___ year old female with PMH CAD (s/p 6 
stents), HTN, paroxysmal afib on coumadin and dronedarone, and 
aortic stenosis s/p porcine AVR ___ who presents with an 
episode from lightheadedness.  

Of note, pt. had recent AVR w/ 21mm Trifecta tissue valve and
___ ligation on ___.  Prior to her surgery pt. endorsed 
frequent lightheadedness, dyspnea on exertion, and orthopnea.  
She has tolerated the post-procedure course very well, finishing 
a 2 week stay at rehab, and has been at home working with ___.  
She continues to be deconditioned, experiencing DOE, but is 
improving as her rehab progresses.  Overall, she has been 
asymptomatic until the day of presentation.

On day of presentation, pt. was feeling well in the AM.  She 
stood from a seated position and felt lightheaded.  She sat back 
down and felt better.  She denies any frank dizziness, chest 
pain, palpitations, worsening SOB, abdominal pain, N/V/D, 
changes in voiding or stooling patterns, 
numbness/tingling/weakness of the extremities.  Later in the 
day, ___. arrived and took her vital signs.  Per report, her HR 
were in the ___ and SBP 80 (baseline per pt. 100-120).  At 
this time, her PCP was contacted who recommended pt. call ___.  
EMS arrived and confirmed above vital signs.  She was then 
transferred to the ___ ED.

In the ED, initial vitals 97.2 82 121/66 18 94%.  
- Labs were significant for: WBC 6.1, Hgb 9.7, Plt 230, INR 2.3, 
Na 135, K 3.9, CL 98, HCO3 25, BUN 19, Cr 1.2 (baseline 0.9), 
U/A with few bacteria, small leuk esterace, 2 WBCs, 3 epithelial 
cells  
- CXR showed no acute process  
- ECG showed normal sinus rhythm at a rate in the ___ in 
ventricular bigeminy without ischemic changes or evidence of AV 
block QTC calculated at 408 manually  
- She continued to be lightheaded. Her heart rates and blood 
pressures remained stable, and she was admitted to the CMED 
service.  
Vitals prior to transfer were 75 114/88 18 99% RA.
  
On the floor, she reports feeling well and no longer feels 
lightheaded. 
 
Past Medical History:
- Aortic Stenosis s/p porcine AVR (w/ 21mm Trifecta tissue valve 
and ___ ligation on ___
- Coronary artery disease  
* ___: s/p 3 overlapping Endeavour stents (3x12, 3x24, 3x30) 
to the proximal, mid and distal RCA  
* ___: s/p two Xience (3x12 and 3x23) stents for proximal &  
mid-RCA in-stent restenosis  
* ___: s/p PTCA & stenting of mid RCA ___ restenosis 
was performed w/ a 3.0 x 12 Taxus Liberte DES which was 
postdilated using a 3.5 mm balloon  
* ___ cath showed patent stents  
* ___ cath showed no obstructive disease & patent stents  
- Hypertension  
- Paroxysmal atrial fibrillation on dronaderone in sinus rhythm; 
on  
warfarin  
- Mixed dyslipidemia  
- Anxiety  
- Hysterectomy & appendectomy  
- Cholecystectomy, lap  
- Bilateral cataract surgery  
 
Social History:
___
Family History:
Brother has ___, had CVA in his ___. Mother lived until  
age ___, father died in his ___ of ruptured gallbladder.  No 
hx. of arrhythmia.
 
Physical Exam:
ADMISSION PHYSICAL EXAM:
============================
Vitals: T 98.9 BP 120/62 HR 82 RR 18 SaO2 99% onRA  
Weight 70.9  
Orthostatics: pending  
GENERAL: Pleasant elderly woman in no apparent distress  
HEENT: EOMI  
NECK: No JVD  
CARDIAC: Regular, with coupled heartbeats. Second of paired 
heartbeats demonstrate cannon A waves. No m/r/g.  
LUNG: CTAB  
ABDOMEN: Soft, nontender  
EXT: Trace edema bilaterally  
NEURO: A&Ox3. Able to do serial 7s. Nonfocal  

ADMISSION PHYSICAL EXAM:
============================  
Unchanged
 
Pertinent Results:
ADMISSION LABS
=================

___ 03:00PM BLOOD WBC-6.1 RBC-3.35* Hgb-9.7* Hct-31.9* 
MCV-95 MCH-28.9 MCHC-30.5* RDW-14.3 Plt ___
___ 03:00PM BLOOD Neuts-65.4 ___ Monos-8.4 Eos-3.5 
Baso-0.4
___ 03:00PM BLOOD ___ PTT-33.3 ___
___ 03:00PM BLOOD Glucose-98 UreaN-19 Creat-1.2* Na-135 
K-3.9 Cl-98 HCO3-25 AnGap-16
___ 03:00PM BLOOD Calcium-9.3 Phos-4.1 Mg-2.0
___ 03:26PM BLOOD Lactate-1.6

NOTABLE LABS
================

___ 07:27AM BLOOD ___ PTT-33.9 ___
___ 05:14AM BLOOD ___ PTT-34.9 ___

DISCHARGE LABS
===================

___ 06:50AM BLOOD WBC-8.9 RBC-3.27* Hgb-9.8* Hct-30.5* 
MCV-93 MCH-29.8 MCHC-32.0 RDW-14.0 Plt ___
___ 06:50AM BLOOD ___ PTT-36.9* ___
___ 06:50AM BLOOD Glucose-96 UreaN-14 Creat-1.0 Na-141 
K-4.7 Cl-104 HCO3-26 AnGap-16

STUDIES
============
ECG (___):  Sinus rhythm with ventricular bigeminy. Compared 
to the previous tracing of ___ the ventricular ectopy is 
new.

CXR (___):  IMPRESSION:  No acute cardiopulmonary process, 
moderate cardiomegaly.  

ECHO (___):  The left atrium is moderately dilated. The 
right atrium is moderately dilated. There is mild symmetric left 
ventricular hypertrophy with normal cavity size and 
regional/global systolic function (LVEF 70%). Right ventricular 
chamber size and free wall motion are normal. A bioprosthetic 
aortic valve prosthesis is present. The aortic valve prosthesis 
appears well seated, with normal leaflet/disc motion and 
transvalvular gradients. The mitral valve leaflets are mildly 
thickened. Mild (1+) mitral regurgitation is seen. There is no 
pericardial effusion. 

Compared with the prior study (images reviewed) of ___ a 
bioprosthetic aortic valve is now present. It is functioning 
normally. There is slightly more mitral regurgitation. The 
pulmonary artery pressures are slightly higher. Other findings 
are similar. 

 
Brief Hospital Course:
BRIEF SUMMARY STATEMENT:  Ms. ___ is an ___ year old female 
with ___ CAD (s/p 6 stents), HTN, paroxysmal afib on coumadin 
and dronedarone, and aortic stenosis s/p porcine AVR ___ who 
presents with an episode from lightheadedness who was found (per 
report) to be with symptomatic bradycardia and hypotension. Pt. 
was without any repeat episodes of bradycardia or hypotension. 
Her lisinopril was held given low-normal BPs. She was noted to 
be in nearly continuous APC bigeminy/trigeminy pattern. It was 
thought that pt. was possibly pre-load dependent, may have been 
mildly hypovolemic resulting in symptomatic lightheadedness. We 
attempted to start pt. on beta blockade with metoprolol, however 
she refused given prior tolerance issues. We also noted pt. to 
be with infrequent paroxysmal runs of multifocal atrial 
tachycardia. For this, we began the pt. on low dose diltiazem to 
possibly help both conditions. She was discharged home with a 
___ of Heart's monitor and close cardiology follow-up.

ACTIVE ISSUES
================

# Bigeminy/Trigeminy:  Pt. presented with lightheadedness.  
According to her home healthcare workers, pt. was bradycardia 
and hypotensive.  There were no available EKGs or strips 
documenting bradycardia.  Pt. with recent AVR on ___ with 
___.  Pt. had TTE on admission which revealed a well-seated AVR. 
 There was no evidence of bradycardia on telemtry on admission.  
Pt. was noted to be in a bigeminy pattern with periods of 
trigeminy possibly triggered by an APC.  Her lightheadedness was 
attributed to hypovolemia in the setting of ventricular 
bigeminy/trigeminy.  She remained asymptomatic on admission.  
Pt. refused metoprolol as she reports not tolerating medication 
well in the past.  As such, she was discharged on her home 
dronaderone and diltiazem to maintain sinus rhythm and reduce 
the frequency of bigeminy.  She also was sent with ___ of 
hearts monitor.    

#) Paroxysmal Multifocal atrial tachycardia:  Pt. noted to have 
infrequent runs of MAT.  This possibly was contributing to pt's 
symptoms.  As such, she was initiated on diltiazem.

#) Acute Kidney Injury:  Pt. presented with creatinine to 1.2 up 
from baseline 0.9.  Likely pre-renal azotemia in the setting of 
slight volume depletion.  Her orthostatics were negative.  
Creatinine returned to baseline.

#) Anemia:  Pt. noted to have a normocytic anemia since time of 
surgery.  Anemia work-up with iron was unrevealing.  Would 
continue  Possibly related to anemia of acute/sub-acute blood 
loss. 
- anemia work-up
- retic count

Normocytic anemia since time of surgery.  Possibly related to 
anemia of acute/sub-acute blood loss.  Anemia work-up revealed 
normal iron studies, normal B12 and folate levels.

CHRONIC ISSUES
==================
#) Atrial Fibrillation:  Stable in sinus rhythm.  Continued on 
dronaderone.  Warfarin held in the setting of supratherapeutic 
INR on day of discharge.  

#) Dyslipidemia: Continued atorvastatin

#) Coronary Artery Disease:  Continued aspirin, atorvastatin.

TRANSITIONAL ISSUES
===================
# New Medications: Pt. started on diltiazem ER to possibly help 
with control of both MAT and ventricular bigeminy. 

# Lisinopril held on admission for low normal BPs in the setting 
of lightheadedness. If BP tolerate, can resume. However, her 
lightheadedness may be related to hypotension.

# Multifocal Atrial Tachycardia: Pt. noted to have brief 
asymptomatic runs of multifocal atrial tachycardia. Given not 
related to symptoms, unlikely cause of her presentation.

# Question of Bradycardia: Pt. sent to ___ for eval of 
symptomatic bradycardia. Not witnessed on hospitalization. 
Discharged with ___ to be sent to Dr. ___.

# Bigeminy/Trigeminy triggered by APCs: ___ result in pre-load 
dependent state resulting in lightheadedness. Pt. recommended 
metoprolol but not started on admission bc/ pt. refused ___ 
previous side effects. Consider beta blockade as outpatient to 
decrease occurrence of bigemeny.

# Anemia: Pt. with normocytic anemia. Vit B12 550 (nl), folate > 
than assay, ferritin 41, transferrin 266, TIBC 346 (all normal). 
Possibly related to recent surgery. Recommend outpt. follow-up 
in ___ weeks. 

# INR: Please do not take coumadin on ___ or ___. Have INR 
checked on ___ and dose per your normal ___ clinic.

# Communication: ___ (son) ___ 

# Code: Full code (confirmed) 
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Aspirin 81 mg PO DAILY 
2. Dronedarone 400 mg PO BID 
3. Ranitidine 300 mg PO DAILY:PRN GERD 
4. Warfarin 1.5 mg PO DAILY16 
5. estradiol 0.01 % (0.1 mg/gram) vaginal 2x/week 
6. ___ Oil (Omega 3) 1000 mg PO DAILY 
7. Multivitamins 1 TAB PO DAILY 
8. ALPRAZolam 0.125 mg PO DAILY:PRN anxiety 
9. Atorvastatin 20 mg PO DAILY 
10. Lisinopril 2.5 mg PO DAILY 

 
Discharge Medications:
1. Aspirin 81 mg PO DAILY 
2. Dronedarone 400 mg PO BID 
3. ___ Oil (Omega 3) 1000 mg PO DAILY 
4. Multivitamins 1 TAB PO DAILY 
5. Ranitidine 300 mg PO DAILY:PRN GERD 
6. Warfarin 1 mg PO DAILY16 
7. Ferrous Sulfate 325 mg PO DAILY 
RX *ferrous sulfate 325 mg (65 mg iron) 1 tablet(s) by mouth 
Daily Disp #*30 Tablet Refills:*0
8. estradiol 0.01 % (0.1 mg/gram) vaginal 2x/week 
9. Atorvastatin 20 mg PO DAILY 
10. Diltiazem Extended-Release 120 mg PO DAILY 
RX *diltiazem HCl 120 mg 1 tablet(s) by mouth Daily Disp #*30 
Tablet Refills:*0
11. ALPRAZolam 0.125 mg PO DAILY:PRN anxiety 
12. Docusate Sodium 100 mg PO BID 
RX *docusate sodium 100 mg 1 capsule(s) by mouth twice a day 
Disp #*60 Capsule Refills:*0

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
PRIMARY DIAGNOSES
======================
# Multifocal Atrial Tachycardia
# Ventricular Bigeminy
# Acute Kidney Injury
# Anemia

SECONDARY DIAGNOSES
=======================
# Atrial Fibrillation
# Dyslipidemia
# Coronary Artery Disease

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Ms. ___,

It was a pleasure meeting and caring for you during your 
hospitalization.  You were admitted with lightheadedness and 
slow heart rate.  The slow heart rate was suspected by your home 
physical therapist.  We did not see evidence of a slow heart 
rate during your hospital stay.  We felt that your symptoms were 
related to dehydration and an ongoing abnormal heart rhythm 
called ""ventricular bigeminy.""  This is not a dangerous rhythm.  
You were also noted to have short periods of a fast abnormal 
heart rhythm.  You were started on a medication, diltiazem, to 
help your abnormal heart beat conditions.  In case your 
lisinopril was making your blood pressure too low, we stopped 
this medication at this time.  

You were given ___ of Heart's Monitor at discharge.  Please 
remember that when you are feeling strange, please be sure to 
transmit information from the monitor to Dr. ___.  You will be 
seen by Dr. ___ to continue to manage your heart medications.

All the best,

Your ___ Care Team
 
Followup Instructions:
___
"
14975962-DS-19," 
Name:  ___                Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Penicillins / Gluten
 
Attending: ___.
 
Chief Complaint:
Sore throat
Rash
 
Major Surgical or Invasive Procedure:
Skin biopsy

 
History of Present Illness:
This is a ___ Year old male with history of celiac disease,
psoriasis, and HTN who presented to the ED with multiple painful
& erythematous cutaneous lesions that began on ___. He
also had a severe sore throat as well as a cough. His other pain
complaint is profound lower extremity weakness which has 
resulted
in a fall and him being afraid to walk. 

The patient reported the sudden onset of a red painful indurated
nodule on his extensor forearm two days prior to presentation.
Shortly thereafter he noted similar lesions developing on his
left arm, left knee and left ankle. He had no associated fevers
or chills. Of note, the patient has had no known exposures,
though he works as ___ and has been doing ___ in
debris filled buildings. No travel (including to any areas where
coccidiomyocosis or histoplasmosis is endemic). No antibiotics.
No new medications, detergents, soaps, etc. Monogamous with his
wife, no hx or risk factors for STIs including syphilis, HIV, 
GC,
or chlamydia. The patient does have a dog (has had for ___ years)
and denies any recent bites or scratches. No exposures to birds,
cattle, cats, rabbits or other wildlife. 

He states that this rash has also been associated with a sore
throat and cough that developed over this time period. The cough
is non-productive, but he reports that it feels ""very deep"" and
that he has been more short of breath over the past week.

Additionally, on the morning of presentation, he reports that he
was so weak that his legs gave out from under him as he was
standing up. Since the initial fall, he has been ambulating
without assistance, but continues to report profound weakness 
and
is afraid to walk. He had a fall years ago where he ""fractured""
his spine and needed to have back surgery. Since then he has had
chronic pain which has been getting progressively worse over the
past 6 weeks. No new trauma to his back/legs. Denies bowel
incontinence, urinary retention or incontinence, or genital
numbness.

ED COURSE: 
In the ED his exam showed multiple palpable erythematous tender
and warm lesions on the extremities. The patient was also
tachycardic to 117 on presentation but otherwise without fevers
or signs of systemic illness. His lab work was notable for an
elevated CRP >100, WBC 11.4, and a lactate of 2.3, but was
otherwise unremarkable. UA was unremarkable. He had blood
cultures drawn. Dermatology was consulted and per conversation
with ED resident they were concerned about strep throat causing
erythema nodosum. They recommended biopsy (they will do), CTX,
and cultures. The patient received CTX, Ketorolac, 1L IVF.

On arrival to the floor, the patient confirms the above history.
Says his pain and the size of nodule swelling on his right arm
has improved after Toradol.

REVIEW OF SYSTEMS:
==================
Complete ROS obtained and is otherwise negative.
 
Past Medical History:
-Celiac disease, EGD ___ biopsies showed active celiac
disease.
-psoriasis
-hand surgery, 
-previous surgery to his nose for fracture,
-broke his back in ___
-Stress test ___.  Exercised 9:45, max hr 176. normal
-Colonoscopy ___ normal.
-Neck pain advised to have surgery but livable
-foreign body excision of upper lip ___.
-Chest pain cardiac catheterization ___: 1. Normal coronary
arteries and normal LV systolic function.
-Sleep apnea on homestudy ___.  Positive.
-low B12 ___ started 1000 mcg daily
 
Social History:
___
Family History:
His mother(breast cancer) and father (stomach cancer) both had
MI/CABG's. 
Sister with RA and diabetes.
 
Physical Exam:
ADMISSION PHYSICAL EXAM:
========================
___ 1703 Temp: 99.5 PO BP: 164/95 R Sitting HR: 99 RR: 16 
O2
sat: 94% O2 delivery: Ra 
Gen: Well-appearing, NAD
HEENT: mallampati 4. Difficult to assess tonsils/posterior
pharynx, but did appear erythematous. 
Neck: Tender left sided anterior cervical lyphadenopathy.
Pulm: CTAB, no wheezes or crackles
CV: RRR, no murmurs 
Abd: soft, nontender, nondistended, BS+, no hepatosplenomegaly
Skin: Multiple tender, erythematous nodules on bilateral upper
and lower extremities, including hands/feet (palms and soles).
Neuro: A&O x3, CN II-XII intact. ___ bilateral upper and lower
extremity strength. Symmetric ___ reflexes.

DISCHARGE PHYSICAL EXAM:
========================
Vitals:
24 HR Data (last updated ___ @ 2309)
    Temp: 98.7 (Tm 99.6), BP: 132/79 (107-153/69-92), HR: 99
(90-107), RR: 16 (___), O2 sat: 96% (91-97), O2 delivery: RA  
General: comfortable, not in acute distress
HEENT: clear oropharynx with moist mucosae.
Neck: Supple
Lungs:  CTAB with no wheezes or crackles. 
CV: RRR, no m/r/g. Radial pulses 2+ bilaterally.
GI: soft, non-distended, non-tender. Bowel sounds present. No
peritoneal signs.
Ext: warm, well-perfused, no edema. 
Skin: multiple blanching erythematous nodules scattered on the
left and right forearms, bilateral knees, bilateral shins, and
feet (mostly over the heel, toes and other bony prominences).
Slightly tender to palpation. No bleeding or active drainage, no
fluctuance. 
Neuro: A&Ox3. Normal speech and mentation. Moving all 
extremities
equally.
 
Pertinent Results:
====ADMISSION LABS====
___ 12:00PM   WBC-11.0* RBC-6.02 HGB-16.6 HCT-51.4* MCV-85 
MCH-27.6 MCHC-32.3 RDW-13.2 RDWSD-40.4
___ 12:00PM   NEUTS-78.1* LYMPHS-10.9* MONOS-9.2 EOS-1.0 
BASOS-0.3 IM ___ AbsNeut-8.57* AbsLymp-1.20 AbsMono-1.01* 
AbsEos-0.11 AbsBaso-0.03
___ 12:00PM   CRP-100.3*
___ 12:00PM   ALT(SGPT)-16 AST(SGOT)-20 CK(CPK)-75 ALK 
PHOS-76 TOT BILI-0.6
___ 12:00PM   GLUCOSE-117* UREA N-14 CREAT-1.1 SODIUM-136 
POTASSIUM-4.9 CHLORIDE-100 TOTAL CO2-21* ANION GAP-15
___ 12:06PM   LACTATE-2.3*

====PERTINENT LABS====

___ 02:28PM BLOOD HBsAg-NEG HBsAb-NEG HBcAb-NEG
___ 09:15PM BLOOD ANCA-NEGATIVE B
___ 09:15PM BLOOD ___ Titer-1:40*
___ 12:00PM BLOOD CRP-100.3*
___ 09:15PM BLOOD HIV Ab-NEG
___ 02:28PM BLOOD HCV Ab-NEG

====DISCHARGE LABS====
___ 05:57AM BLOOD WBC-9.1 RBC-5.21 Hgb-14.5 Hct-45.0 MCV-86 
MCH-27.8 MCHC-32.2 RDW-13.0 RDWSD-40.3 Plt ___
___ 05:57AM BLOOD Glucose-112* UreaN-17 Creat-1.0 Na-138 
K-4.3 Cl-100 HCO3-24 AnGap-14
___ 05:57AM BLOOD Calcium-8.7 Phos-3.9 Mg-2.2

====IMAGING====
##CXR ___
FINDINGS: 
PA and lateral views of the chest provided.  The lungs are 
clear.
There is no focal consolidation, effusion, or pneumothorax.  
There are no signs of congestion or edema.  The 
cardiomediastinal silhouette is normal. Imaged osseous 
structures are intact.  No free air below the right 
hemidiaphragm is seen.
 
IMPRESSION: 
No acute intrathoracic process.

 
Brief Hospital Course:
___ male with a history of celiac disease, psoriasis, 
and hypertension who presents with sore throat for 1.5 weeks and 
painful rash for 4 days.

# Suspected erythema nodosum
The patient reported that on ___, he had new onset of a 
painful, nodular, erythematous rash. The rash first began on his 
right arm with a painful red nodule that later spread to the 
left arm, bilateral knees, bilateral shins, and bilateral bony 
prominences of the feet. The appearance of the rash is 
consistent with erythema nodosum, however, the presence of 
nodules on the arms was atypical. As a result, dermatology was 
consulted and performed a tissue biopsy, which showed findings 
consistent with erythema nodosum. Infectious workup was notable 
for negative hepatitis B serologies, negative HIV antibody, 
negative hepatitis C antibody, negative urine culture, negative 
Monospot, negative RPR, and unremarkable EBV serologies. Of 
note, Strep was pending at discharge a rheumatologic workup was 
also performed and was notable for a CRP of 100.3, borderline 
positive ___ (1: 40), negative ANCA. At the time of discharge, 
the patient's rash improved, and the pain from the rash was 
well-controlled with over-the-counter NSAIDs and acetaminophen. 
He was discharged with instructions to follow-up with 
dermatology pending formal tissue biopsy results.

# Sore throat
# Cough
The patient reported having about 2 weeks of sore throat 
associated with non-productive cough. Throughout his 
hospitalization, the patient had normal O2 saturations on room 
air. A chest x-ray performed in the emergency department did not 
show any evidence of pneumonia. On discharge, his sore throat 
was improved and his breathing remained at baseline. Etiology of 
the sore throat is most likely viral. Given that the sore throat 
preceded erythema nodosum, there was concern that the sore 
throat was caused by streptococcal pharyngitis. As a result, the 
patient received 2 g of ceftriaxone during his hospitalization. 
However, on ___, ceftriaxone was discontinued as it was 
determined that the patient had a very low risk of streptococcal 
pharyngitis given his age.

# Bilateral leg weakness
He has long-standing weakness that he reports is from previous 
back injuries. He was seen by physical therapy he felt that he 
was safe to go home without any more needs.

====CHRONIC ISSUES====
# Hypertension:
Continued on home metoprolol and amlodipine.

# Celiac disease:
Continued on a gluten-free diet.

# Psoriasis:
Betamethasone cream as needed.

# GERD:
Continued on home omeprazole.

# Depression:
Continued on home Celexa and amitriptyline.

====TRANSITIONAL ISSUES====
[] Please follow-up with dermatology following results of the 
biopsy.
[] Elevated CRP likely in setting of acute infectious illness 
and erythema nodosum. 
[] ASO pending at time of discharge. 
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Metoprolol Succinate XL 25 mg PO DAILY 
2. Omeprazole 20 mg PO DAILY 
3. Amitriptyline 50 mg PO DAILY 
4. Citalopram 20 mg PO DAILY 
5. amLODIPine 5 mg PO DAILY 
6. clotrimazole-betamethasone ___ % topical BID:PRN itching 
7. Betamethasone Dipro 0.05% Oint 1 Appl TP DAILY 
8. Cyanocobalamin 1000 mcg PO DAILY 

 
Discharge Medications:
1.  Guaifenesin-Dextromethorphan 5 mL PO Q6H:PRN cough  
2.  Ibuprofen 600 mg PO Q8H:PRN Pain - Moderate  
3.  Amitriptyline 50 mg PO DAILY  
4.  amLODIPine 5 mg PO DAILY  
5.  Betamethasone Dipro 0.05% Oint 1 Appl TP DAILY  
6.  Citalopram 20 mg PO DAILY  
7.  clotrimazole-betamethasone ___ % topical BID:PRN itching  

8.  Cyanocobalamin 1000 mcg PO DAILY  
9.  Metoprolol Succinate XL 25 mg PO DAILY  
10.  Omeprazole 20 mg PO DAILY  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Erythema nodosum
Sore throat

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
======================  
DISCHARGE INSTRUCTIONS  
======================  

Dear Mr. ___,  
It was a pleasure caring for you at ___ 
___.

WHY WAS I IN THE HOSPITAL?  
- You were seen in the hospital for sore throat and a new rash.

WHAT HAPPENED TO ME IN THE HOSPITAL?  
- You had a biopsy performed of the rash which showed erythema 
nodosum.
 You had lab tests performed to evaluate for possible 
infectious sources of sore throat, including strep throat, all 
of which were unremarkable.*****
- You were seen by physical therapy for your leg weakness.

WHAT SHOULD I DO AFTER I LEAVE THE HOSPITAL?
- Continue to take all your medicines and keep your 
appointments.

We wish you the best!

Sincerely,  
Your ___ Team  

 
Followup Instructions:
___
"
15259244-DS-19," 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Penicillins / Imuran / Cephalosporins / Sulfonamides / Reglan / 
Latex / Ampicillin / Lactose
 
Attending: ___
 
Chief Complaint:
fevers, rigors
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
___ s/p cadaveric kidney transplant in ___ and pancreas 
transplant in ___ who presented to the ED with with fatigue, 
fever at home to ___, and chills. The patient states that she 
initially felt chills the evening PTA, then had a fever up to 
___ the morning PTA. She had been feeling generally unwell at 
home for ___ days, with symptoms of lethargy and fatigue. Given 
her symptoms, she took Macrobid as she had a few extra tablets 
that had been previuosly prescribed. However, the morning of PTA 
she still felt ill and spiked a fever. She is currently on 
rapamune, prograf and prednisone for immunosuppression for her 
kidney/pancreas transplants.  
.  
Of note, a month ago the patient was admitted to ___ with 
similar symptoms and was found to have pyelonephritis and 
treated with Macrobid per UCx sensitivities and her allergy 
profile (EColi resistant to FQ, Bactrim, and PCN). However, this 
admission she denies noticing any decreased UOP or flank pain 
which she had experienced with her pyelonephritis. She does 
admit to noticing a urinary odor. Approximately one week ago, 
the patient was seen in ___ clinic and a repeat UA/UCx was 
sent to confirm that her recent UTI had been adequately treated. 
The UCx on ___ returned negative.  
.  
In the ED, the patient's VS were: T-98.7 (not febrile in ED), HR 
- 82, BP - 186/83-->165/74, RR- 16, 100% on RA. The patient was 
given Vancomycin, Flagyl, and Levaquin given as well as 1L NS 
for her fevers in the ED. She was also given 6.25mg of Captopril 
for her hypertension.  
.  
On arrival to the floor, pt's VS: T: 101.2 BP: 162/70 HR: 106 
RR: 12 O2 97 % RA. She complained of shaking chills, nausea, but 
no vomiting. She denied any shortness of breath, cough, chest 
pain, or symptoms of a URI. She denied abdominal pain, diarrhea, 
melenea, or BRBPR. She complained of mild myalgias in her thighs 
and lower back bilaterally and also stated that her chronic ___ 
edema was slightly worse as she had not taken any Lasix 
recently. She denied any skin rashes or erythema and mainly 
complained of feeling fatigued and extremely drowsy.  
.  
REVIEW OF SYSTEMS: Per HPI, all other ROS negative.  

 
Past Medical History:
- Diabetes mellitus, type 1 c/b neuropathy, retinopathy, and 
nephropathy on no meds since pancreas transplant  
- s/p renal transplant ___ and ___ (due to chronic rejection). 
Baseline creatinine 1.3-1.5 as of ___  
- s/p pancreatic transplant ___ c/b hyperacute rejection and  
repeat pancreatic transplant ___  
- Osteoporosis  
- Hypothyroidism  
- Pernicious anemia  
- Cataracts and glaucoma  
- Colonic adenoma  
- Right foot fracture c/b RLE DVT  
- Chronic ___ edema, L>R  
- Recurrent  Ecoli pyelonephritis
 
Social History:
___
Family History:
Father with lung cancer, mother with leukemia, DM II, 
hypothyroidism 
 
Physical Exam:
GEN: Uncomfortable appearing with rigors and dyspnea  
VS: T: 101.2 BP: 162/70 HR: 106 RR: 12 O2 97 % RA  
HEENT: Exophthalmus, anicteric sclera, dry MM, OP clear without 
evidence of thrush, neck supple, no LAD. JVP 12cm  
CV: Tachycardic, NL S1S2, III/VI holosystolic murmur best at 
LLSB without rubs.  
LUNGS: Bilat crackles to the apices with no wheezes or ronchi  
ABD: BS+, soft, NTND. Bilat graft sites non-tender, No HSM  
LIMBS: Very warm skin, 1+ pitting edema bilaterally L>R with 
skin hyperpigmentation due to chronic edema more prominent on 
the LLE. No thigh or calf tenderness. No evidence of erythema or 
cellulitis.  
NEURO: A&Ox3. Appropriate. CN ___ grossly intact. Preserved 
sensation throughout. ___ strength throughout.  

 
Pertinent Results:
Admission labs:
___ 03:45PM BLOOD WBC-5.2 RBC-2.97* Hgb-9.2* Hct-28.6* 
MCV-96 MCH-30.9 MCHC-32.0 RDW-15.4 Plt ___
___ 03:45PM BLOOD ___ PTT-29.4 ___
___ 03:45PM BLOOD Glucose-117* UreaN-66* Creat-1.9* Na-144 
K-4.1 Cl-105 HCO3-29 AnGap-14
___ 06:15AM BLOOD Calcium-8.4 Phos-3.2 Mg-1.9
___ 06:15AM BLOOD tacroFK-4.0* rapmycn-4.2*
.
Discharge labs:
___ 06:25AM BLOOD WBC-3.1* RBC-3.16* Hgb-9.7* Hct-30.3* 
MCV-96 MCH-30.8 MCHC-32.0 RDW-15.1 Plt ___
___ 06:25AM BLOOD Glucose-87 UreaN-39* Creat-1.3* Na-145 
K-3.9 Cl-113* HCO3-24 AnGap-12
___ 06:25AM BLOOD Calcium-8.7 Phos-2.9 Mg-1.9
___ 06:25AM BLOOD tacroFK-2.4* rapmycn-7.6
.
Admission UA:
___ 05:05PM URINE ___ Bacteri-MOD Yeast-NONE 
___ 05:05PM URINE Blood-NEG Nitrite-NEG Protein-TR 
Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-7.0 Leuks-TR
.
Repeat UA after treatment:
___ 11:18PM URINE ___ Bacteri-FEW Yeast-FEW 
___ 11:18PM URINE Blood-NEG Nitrite-NEG Protein-TR 
Glucose-NEG Ketone-TR Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-TR
.
MICROBIOLOGY:
___ 5:05 pm URINE     Site: CLEAN CATCH
URINE CULTURE (Final ___: 
ESCHERICHIA COLI.    10,000-100,000 ORGANISMS/ML OF TWO COLONIAL 
MORPHOLOGIES.  
SENSITIVITIES: MIC expressed in MCG/ML
                        ESCHERICHIA COLI
AMPICILLIN------------  =>32 R
AMPICILLIN/SULBACTAM--     4 S
CEFAZOLIN-------------   <=4 S
CEFEPIME--------------   <=1 S
CEFTAZIDIME-----------   <=1 S
CEFTRIAXONE-----------   <=1 S
CEFUROXIME------------     4 S
CIPROFLOXACIN---------   =>4 R
GENTAMICIN------------   <=1 S
MEROPENEM-------------<=0.25 S
NITROFURANTOIN--------  <=16 S
PIPERACILLIN/TAZO-----   <=4 S
TOBRAMYCIN------------   <=1 S
TRIMETHOPRIM/SULFA----  =>16 R
.
IMAGING: 
CHEST (PA & LAT) Study Date of ___ 4:33 ___ COMPARISON: 
Multiple priors, the most recent dated ___. 
FINDINGS: The lungs are well expanded and clear. The mediastinum 
is unremarkable. The cardiac silhouette is within normal limits 
for size. No effusion or pneumothorax is noted. The bones are 
diffusely osteopenic but otherwise unremarkable. IMPRESSION: No 
acute pulmonary process.
.
TTE (Complete) Done ___ at 11:55:56 AM The left atrium is 
normal in size. There is mild symmetric left ventricular 
hypertrophy with normal cavity size. Right ventricular chamber 
size and free wall motion are normal. The aortic valve leaflets 
(3) are mildly thickened but aortic stenosis is not present. No 
masses or vegetations are seen on the aortic valve, but cannot 
be fully excluded due to suboptimal image quality. No aortic 
regurgitation is seen. The mitral valve leaflets are mildly 
thickened. There is no mitral valve prolapse. No masses or 
vegetations are seen on the mitral valve, but cannot be fully 
excluded due to suboptimal image quality. Mild (1+) mitral 
regurgitation is seen. There is mild pulmonary artery systolic 
hypertension. There is a trivial/physiologic pericardial 
effusion. IMPRESSION: no echo evidence of vegetation or abscess. 
Mild mitral regurgitation. Mild symmetric LVH with normal 
regional and global biventricular function.If clinically 
suggested, the absence of a vegetation by 2D echocardiography 
does not exclude endocarditis. Compared with the report of the 
prior study (images unavailable for review) of ___, the 
findings are similar.  
.
RENAL TRANSPLANT ___. Study Date of ___ 1:11 ___ FINDINGS: 
The left lower quadrant renal transplant measures 11.3 cm. No 
evidence of hydronephrosis, renal stones, or perinephric fluid. 
In the superior pole of the left lower quadrant transplant 
kidney, there is a prominent calix which is unchanged when 
compared to the prior study dated ___. Normal 
color and waveforms are seen in the interlobular renal arteries 
in the upper, mid and lower poles of the transplanted left lower 
quadrant kidney. The resistive indices are mildly elevated and 
range from 0.65-0.78. The main renal artery and main renal vein 
are patent with appropriate waveforms. The bladder is partially 
distended and is grossly unremarkable. IMPRESSION: 1. No 
evidence of hydronephrosis, renal stones, or perinephric fluid 
collections. 2. Mildly elevated resistive indices (0.65-0.78) of 
the transplant kidney in the left lower quadrant. This finding 
is not significantly changed since the prior study dated 
___.
 
Brief Hospital Course:
___ s/p renal & pancreas transplants on ___, prednisone, 
and Prograf who presented to the ED with fevers, chills, and 
fatigue. She was recently treated for pyelonephritis but seems 
to have cleared that infection based on follow up culture. On 
admission she had a positive UA and a new systolic murmur. 
Initially there was concern for endocarditis but her fevers 
quickly resolved with antibiotics, a UCx was positive for the 
same strain of Ecoli as her recent UTI, and no blood cultures 
were positive. Once the hyperdynamic state of her acute 
infection resolved her cardiac murmur improved. A TTE was 
negative for vegetations. Ultimately it seems that the present 
illness is due to a recurrence of pyelonephritis. She was 
discharged on a prolonged course of Macrobid for a total of 
three weeks of treatment. 
.  
# Pyelonephritis: Likely source of fevers is pyelonephritis. A 
UA on admission showed ___, with UCx pending. BCx also 
pending. CXR showed no evidence of acute cardiopulmonary process 
and the patient has no pulmonary symptoms at present. CBC showed 
no leukocytosis but elevated compared to baseline on tripple 
agent immune suppression. On acyclovir prophylactically. On 
physical exam she had no obvious localizing symptoms or 
tenderness over her kidney graft site. However, she was found to 
have a loud systolic murmur on exam not previously noted in OMR. 
The patient does state she has been told of a murmur in the 
past. Given this, the most likely source of fever is a 
UTI/pyelo. Nevertheless, she was also worked up for 
endocarditis. Of note, the Pt have multiple drug allergies which 
complicate antibiotic choice. Initial UA positive with ___. UCx 
grew Ecoli similar to her last UTI. BCx were negative. CXR with 
no evidence of PNA. TTE showed no evidence of vegetations. 
Intially she was treated with broad spectrum antibiotics with 
aztreonam for Gram negatives, vancomycin for Gram positives, and 
metronidazole for anaerobes starting on ___. Once the UCx 
grew the same Ecoli as the previous infection she was DCed home 
on a 3 week course of Macrobid with close follow up. Will need 
urologic workup if infection recurs. 
.  
# Renal/Pancreatic transplant: Baseline Cr 1.3-1.5, but 
admission Cr 1.9. Improved with hydration and holding captopril. 
She was a baseline and back on captopril at discharge. Ulytes 
pre-renal. Continue PredniSONE 5 mg PO DAILY. Continue Sirolimus 
3 mg PO DAILY. Continue Tacrolimus 2 mg PO QAM and 1 mg PO QHS. 
Continue prophylactic Acyclovir 400 mg PO Q12H (initially on 
800mg). Continue furosimide 20 mg PO DAILY. 
.  
# Hypertension: Pt on captopril 6.25 mg BID with an additional 
3.125mg QHS:PRN for HTN at home.
.  
# Hypothyroidism: Continue Levothyroxine Sodium 100 mcg PO QOD 
at home dose. Will not check TSH in the setting of an acute 
infection.  
.  
# Hyperlipidemia: Continue Atorvastatin 10 mg PO DAILY at home 
dose  
.  
# Anemia: Patient has been on Vitamin B12 and Epo injections for 
her anemia of chronic disease with stable Hct within range for 
her. Continue Folic acid daily and Vitamin B12, Epo per 
outpatient regimen  
.  
# Cataracts and glaucoma: continue travoprost, 
dorzolamide/timolol, Pred-mild, and Alphegan brimonidine at home 
doses.  
.  
# Osteoporosis: Continue home vitamin D and calcium.  
 
Medications on Admission:
ACYCLOVIR - 800 mg Tablet po BID  
AMYLASE-LIPASE-PROTEASE [CREON 10] - ___ Capsule(s) po TID  
ATORVASTATIN - 10MG Tablet po daily  
CAPTOPRIL - 6.25 mg po BID  
CYANOCOBALAMIN - 1,000 mcg IM Qmonth  
ARANESP - 100mcg q 14 days  
FUROSEMIDE - 40 mg po daily prn edema  
LEVOTHYROXINE 100 mcg alternating with 112 mcg po daily  
METHAZOLAMIDE - 50MG Tablet BID  
RISEDRONATE - 35 mg Tablet po q weekly  
PREDNISONE - 5 mg Tablet po daily  
SIROLIMUS 3 mg po daily  
TACROLIMUS - 2mg po QAM, 1mg po QPM  
Dorzolamide-Timolol ___ % Drops BID  
Brimonidine 0.15 % Drops BID  
Travoprost 0.004 % Drop QHS  
Pred-Mild 0.12% Drops QHS  
Folic acid 0.8mg po daily  
ASA 325mg po daily  
Vitamin D 1000mg po daily  
Calcium w/D: 650/400 daily  
Omega-3: 1200mg po BID  
Mag Oxide 400 mg po BID  
Niacin 250 mg po daily  
Vitamin C 500 mg po daily  
MVI daily  

 
Discharge Medications:
1. Amylase-Lipase-Protease 33,200-10,000- 37,500 unit Capsule, 
Delayed Release(E.C.) Sig: Three (3) Cap PO TID W/MEALS (3 TIMES 
A DAY WITH MEALS).  
2. Atorvastatin 10 mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
3. Cyanocobalamin 1,000 mcg/mL Solution Sig: 1000 (1000) mcg 
Injection once a month.  
4. Levothyroxine 100 mcg Tablet Sig: One (1) Tablet PO EVERY 
OTHER DAY (Every Other Day): To alternate with 112 mcg daily.  
5. Levothyroxine 112 mcg Tablet Sig: One (1) Tablet PO EVERY 
OTHER DAY (Every Other Day): To alternate with 100 mcg daily.  
6. Methazolamide 50 mg Tablet Sig: One (1) Tablet PO BID (2 
times a day).  
7. Risedronate 35 mg Tablet Sig: One (1) Tablet PO once a month. 
 
8. Prednisone 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  

9. Sirolimus 1 mg Tablet Sig: Three (3) Tablet PO DAILY (Daily). 
 
10. Tacrolimus 1 mg Capsule Sig: Two (2) Capsule PO QAM (once a 
day (in the morning)).  
11. Tacrolimus 1 mg Capsule Sig: One (1) Capsule PO QPM.  
12. Aranesp (Polysorbate) 100 mcg/0.5 mL Syringe Sig: One 
Hundred (100) mcg Injection q14 days.  
13. Dorzolamide-Timolol ___ % Drops Sig: One (1) Drop 
Ophthalmic BID (2 times a day).  
14. Brimonidine 0.15 % Drops Sig: One (1) Drop Ophthalmic twice 
a day.  
15. Travoprost 0.004 % Drops Sig: One (1) drop Ophthalmic at 
bedtime.  
16. Prednisolone Acetate 0.12 % Drops, Suspension Sig: One (1) 
Drop Ophthalmic at bedtime.  
17. Folic Acid ___ mcg Tablet Sig: One (1) Tablet PO once a day. 
 
18. Aspirin 325 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  

19. Vitamin D 1,000 unit Capsule Sig: One (1) Capsule PO once a 
day.  
20. Calcium 600 + D(3) 600-400 mg-unit Tablet Sig: One (1) 
Tablet PO once a day.  
21. Omega-3 Fatty Acids     Capsule Sig: 1200 (1200) mg PO BID 
(2 times a day).  
22. Magnesium Oxide 400 mg Tablet Sig: One (1) Tablet PO BID (2 
times a day).  
23. Niacin 250 mg Capsule, Sustained Release Sig: One (1) 
Capsule, Sustained Release PO DAILY (Daily).  
24. Ascorbic Acid ___ mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
25. Multivitamin     Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
26. Acyclovir 800 mg Tablet Sig: One (1) Tablet PO twice a day.  

27. Captopril 12.5 mg Tablet Sig: 0.5 Tablet PO twice a day: and 
prn as per prior regimen.  
28. Furosemide 20 mg Tablet Sig: ___ Tablets PO DAILY (Daily) as 
needed for swelling.  
29. Nitrofurantoin Macrocrystal 100 mg Capsule Sig: One (1) 
Capsule PO BID (2 times a day) for 17 days.
Disp:*34 Capsule(s)* Refills:*0*

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
E. coli pyelonephritis

Secondary:
Type I diabetes mellitus status post pancreatic transplant
Osteoporosis
Hypothyroidism
Pernicious anemia
Chronic lower extremity edema
Chronic renal insufficiency following renal transplant
Hypertension

 
Discharge Condition:
Afebrile, comfortable on room air, ambulating

 
Discharge Instructions:
You have been evaluated for your fever and fatigue. You were 
again found to have a bacterial urinary tract infection. This 
was treated with IV antibiotics which were converted to 
antibiotics to take by mouth to complete a 3-week course. You 
will continue antibiotics until ___. 

Please take your medications as prescribed. You will continue on 
nitro
 
Followup Instructions:
___
"
15531886-DS-12," 
Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___
 
Chief Complaint:
shortness of breath
 
Major Surgical or Invasive Procedure:
flexible bronchoscopy with EBUS guided tissue biopsy ___

 
History of Present Illness:
Mrs. ___ is a ___ year old female, with h/o stage IV SCLC of 
neuroendocrine origin, known to be metastatic to liver and 
abdominal LN, s/p 6 cycles of carboplatin/etoposide (last dose 
___ who presents with dyspnea.  She describes predominantly 
orthopnea symptoms but also progressive exertional shortness of 
breath, and generalized fatigue.  This started pretty acutely on 
___ night.  She also describes a pain in her epigastrium 
and bilateral shoulders, which is worse with deep breaths, and 
feels like a pressure sensation.  She continues to have a cough, 
not changed from prior, nonproductive.  She has a poor appetite 
but has not lost weight.  The patient otherwise denies any 
fevers or chills, no lower extremity swelling.

The patient was seen at an outside hospital emergency department 
last week on ___, at that time she underwent a CT angiogram of 
the chest which showed worsening of a known right upper lobe 
cancer. There was no pulmonary embolism.

In ED, initial vitals were:  97.6 76 155/74 16 95% RA. 
Labs were normal.  Patient was not given any medications.  

 
Past Medical History:
PAST ONCOLOGIC HISTORY:  
___: Presents to ___ complaining of pleuritic 
chest pain, chest film done which showed right sided lung 
parenchymal lesion. CT chest done which showed RUL mass encasing 
PA, with extensive LAD and possible liver mets.  
___: Intake appointment with IP. Scheduled for PET scan and 
MRI brain for staging.  
___: MRI brain showed no evidence of bony lesions or brain 
mets. PET scan showed suprahilar RUL mass, innumerable liver 
mets with porta-hepatic and retroperitoneal ___ and widespread 
osseous lesions concerning for mets in the axial and 
appendicular skeleton.  
___: Seen again in IP suite to discuss prognosis and 
treatment options. Patient sent directly from clinic to 
inpatient OMED service for initiation of chemotherapy 
(palliative given extent of mets).  

PAST MEDICAL HISTORY:  
GERD  
IBS  
Hiatal hernia  
L4-5 disc issues  
Carrier of hemophilia  
s/p CCY  
s/p TAH  

 
Social History:
___
Family History:
Son, hemophilia,  
Sister, SLE  
___ grandmother, deceased, breast cancer  

 
Physical Exam:
ADMISSION PHYSICAL EXAM:
Vitals: afebrile, BP 130s/80s, HR ___, saturation 95% RA
GENERAL: NAD, sitting in bed, normal conversation without 
conversational dyspnea
CARDIAC: RRR, no m/r/g
LUNG: decreased breath sounds on the right lung, no crackles or 
wheezes
ABDOMEN: soft, NT, ND  
EXTREMITIES: no edema
PULSES: 2+ bilateral lower extremities
NEURO:  CN ___ intact, ___ strength in bilateral upper and 
lower extremities
SKIN:  + roseacea, no other rashes

DISCHARGE PHYSICAL EXAM:
VS 98.1, 124/90, 88, 18, 93% on RA
exam unchanged
 
Pertinent Results:
ADMISSION LABS
___ 03:00PM BLOOD WBC-7.8 RBC-3.67* Hgb-11.6* Hct-35.9* 
MCV-98 MCH-31.7 MCHC-32.4 RDW-13.9 Plt ___
___ 03:00PM BLOOD ___ PTT-32.6 ___
___ 03:00PM BLOOD Glucose-88 UreaN-15 Creat-0.6 Na-134 
K-4.1 Cl-98 HCO3-29 AnGap-11
___ 03:00PM BLOOD Calcium-9.2 Phos-3.5 Mg-2.1

DISCHARGE LABS
___ 08:40AM BLOOD WBC-7.6 RBC-3.49* Hgb-10.9* Hct-33.7* 
MCV-97 MCH-31.3 MCHC-32.4 RDW-13.7 Plt ___
___ 08:40AM BLOOD Glucose-102* UreaN-15 Creat-0.5 Na-133 
K-3.8 Cl-95* HCO3-30 AnGap-12
___ 08:40AM BLOOD Calcium-9.4 Phos-3.4 Mg-1.7

No microbiology data. 
Pathology from ___ bronch with FNA and biopsy PENDING

IMAGING:
___ CT ABD/PELVIS FOR RE-STAGING: 
IMPRESSION: 
1. Multiple hepatic lesions have increased in size and number 
from the prior study consistent with worsening metastatic 
disease 
2. There has been interval progression of osseous metastases 
with a new lesion at T10 and an enlarged lesion involving T12. 
3. Right hilar/ infrahilar mass adjacent to the right heart 
border is only partially imaged but appears increased in size 
from the recent chest CT. 

___ CXR AFTER BRONCH AND STENT PLACEMENT:
FINDINGS:  In comparison with study of ___, there is little 
overall change.  Again there is a large perihilar mass with 
extension along the right paratracheal region.  Continued 
elevation of the right hemidiaphragmatic contour with minimal 
atelectatic changes.  The left lung remains essentially clear. 

BRONCHOSCOPY REPORT: ___
Airways examined with flexible bronchoscope revealing 
moderate-severe compression of distal trachea and proximal LMSB 
and RMSB. RUL was completely occluded. Flexible bronchoscope 
removed and flexible scope with EBUS inserted and advanced to 
paratracheal mass where multiple TBNA were performed using 
21gauge and 18 gauge needles. Next proximal tracheal and distal 
RMSB borders of mass were marked using TBNA needle via EBUS 
scope. Finally a 16X13X13mm silicone Y stent was deployed with 
following ___ - tracheal limb = 4cm, LMSB limb = 2.5cm, 
RMSb limb = 3.5cm with RUL take off @ 2.5cm. Rigid scope removed 
and exchanged for ETT.  
 
Brief Hospital Course:
___ year old female, with h/o stage IV SCLC of neuroendocrine 
origin, known to be metastatic to liver and abdominal LN, s/p 6 
cycles of carboplatin/etoposide (last dose ___ who presented 
with dyspnea and cancer progression. 
 
# Dyspnea: Likely related to progression of her lung cancer, 
since it appears to be larger on ___ CT chest and partially 
obstructing the upper airways/trachea.  She underwent 
bronchoscopy on ___ and they placed a stent in her trachea 
to relieve the compression.  Re-staging CT abdomen/pelvis showed 
increased size and new liver mets and additional new mets in the 
vertebra as well.  Given the progression of her cancer, she was 
set up to start erlotinib with her local oncologist, Dr. ___.  
She was discharged with n-acetylcysteine nebulizers BID for 1 
week to help her secretions get out past the new stent.
 
# GERD: continued home PPI  
# Lumbar disc disease:  continued home pain control regimen with 
ultram prn 
# Anxiety: continued home sertraline
# constipation: continued docusate, senna, MOM

TRANSITIONAL ISSUES:
- Needs to start on erlotinib for EGFR+ lung cancer.  
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Aspirin 81 mg PO DAILY 
2. Docusate Sodium 100 mg PO DAILY 
3. Lorazepam 0.5 mg PO DAILY 
4. Omeprazole 20 mg PO DAILY 
5. Sertraline 25 mg PO DAILY 
6. albuterol sulfate 90 mcg/actuation inhalation 2 puffs every 
___ hours 
7. Guaifenesin-CODEINE Phosphate ___ mL PO Q6H:PRN cough 
8. Metoprolol Tartrate 25 mg PO BID 

 
Discharge Medications:
1. albuterol sulfate 90 mcg/actuation inhalation 2 puffs every 
___ hours 
2. Docusate Sodium 100 mg PO DAILY 
3. Omeprazole 20 mg PO DAILY 
4. Sertraline 25 mg PO DAILY 
5. Milk of Magnesia 30 mL PO Q6H:PRN constipation 
RX *magnesium hydroxide [Milk of Magnesia] 400 mg/5 mL 30 ml by 
mouth every six (6) hours Refills:*0
6. Senna 8.6 mg PO BID 
RX *sennosides [senna] 8.6 mg 1 capsule by mouth twice a day 
Disp #*60 Capsule Refills:*0
7. Guaifenesin ER 1200 mg PO Q12H stent 
RX *guaifenesin 600 mg 2 tablet(s) by mouth every twelve (12) 
hours Disp #*60 Tablet Refills:*0
8. Aspirin 81 mg PO DAILY 
9. Guaifenesin-CODEINE Phosphate ___ mL PO Q6H:PRN cough 
10. Acetylcysteine Inhaled  For interventional pulmonary use 
only ___ mL NEB 2X/DAY stent 
RX *acetylcysteine 100 mg/mL (10 %) ___ ml twice a day Disp 
#*14 Vial Refills:*0
11. nebulizers    miscellaneous BID as directed 
Use with inhaled acetylcysteine 
RX *nebulizers  use twice a day Disp #*1 Each Refills:*0
12. TraMADOL (Ultram) 50 mg PO Q6H:PRN pain 
RX *tramadol 50 mg 1 tablet(s) by mouth every six (6) hours Disp 
#*120 Tablet Refills:*0
13. HYDROmorphone (Dilaudid) 2 mg PO Q6H:PRN pain 
RX *hydromorphone 2 mg 1 tablet(s) by mouth every six (6) hours 
Disp #*120 Tablet Refills:*0
14. Metoprolol Tartrate 25 mg PO BID 
15. Lorazepam 0.5 mg PO Q8H:PRN anxiety 
RX *lorazepam 0.5 mg 1 tablet by mouth every eight (8) hours 
Disp #*90 Tablet Refills:*0
16. Allopurinol ___ mg PO DAILY 
Start taking when you start taking your new chemotherapy. 
RX *allopurinol ___ mg 1.5 tablet(s) by mouth daily Disp #*30 
Tablet Refills:*0
17. Codeine Sulfate 30 mg PO Q4H:PRN cough 
RX *codeine sulfate 30 mg 1 tablet(s) by mouth every four (4) 
hours Disp #*120 Tablet Refills:*0

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
stage IV small cell lung cancer

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___,

It was a pleasure caring for you at ___ 
___.  You were admitted to the hospital because of 
worsening shortness of breath.  Your labs and chest x-ray showed 
no evidence of infection.  Your last CT image showed progression 
of your lung mass and obstruction of your airway.  You were 
evaluated by the Interventional Pulmonary team who placed a 
stent in your airway and performed a biopsy.

You will be going home with inhaled mucomyst.  Please make sure 
to do each treatment for as long as you can and to take deep 
breaths in and out during each treatment.  We also started you 
on pain medications while in the hospital.  You should not take 
these medications if you feel sleepy, with alcohol, or when 
operating any machinery.  Because these pain medications can 
cause constipation, you will also need to continue stool 
softeners when you return home.

Please follow-up with your outpatient providers as instructed 
below.

Thank you for allowing us to participate in your care.  All best 
wishes for your recovery.

Sincerely,
Your ___ medical team
 
Followup Instructions:
___
"
15807359-DS-28," 
Name:  ___                    Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: NEUROLOGY
 
Allergies: 
Ibuprofen / Aleve / Naprosyn
 
Attending: ___.
 
Chief Complaint:
Posterior neck pain/headache, metastatic rectal cancer.
 
Major Surgical or Invasive Procedure:
C2-C5 Laminectomy with tumor decompression
___ Omaya placement for intrathecal chemotherapy.

 
History of Present Illness:
Mr. ___ is a ___ year old male with metastatic rectal CA to 
brain and lung admitted for posterior neck pain/headache.  The 
pain has worsened over one week and radiates down both 
shoulders.  It is worsened by movement including sneezing or 
coughing.  The pain has failed to respond to acetaminophen, 
aspirin, ibuprofen, and low doses of oxycodone.  He denies any 
difficulty going to the bathroom other than chronic urinary 
hesitancy.  Past brain mets have been treated with resection, 
cyberknife, and whole brain radiation.  The last MRI brain 
___ was concerning for progression.  He notes a subtle 
worsening of diplopia due to a VI nerve palsy.  He is also 
unsteady, but this is chronic.  He is no longer taking steroids. 
 In the ED, he was afebrile, HR 139-->85, 121/90, RR 18, O2 sat 
99%.  He was given ondansetron 2mg, morphine 5mg IV, 
hydromorphone 1mg IV, and 1L IV normal saline.  CT head showed 
unchanged extracranial occipital soft tissue and pre-pontine 
cistern masses consistent with metastatic disease and no 
evidence for new metastatic disease.
.
ROS: He denies F/C/S, dizziness, hearing changes, nasal 
congestion, rhinorrhea, sore throat, dysphagia, chest pain, 
dyspnea, cough, abdominal pain, constipation, diarrhea, 
hematochezia, melena, hematuria, other urinary symptoms (besides 
urinary hesitancy), paresthesias (except slight numbness on ___ 
two finger tips from chemo), or rash.  A full review of systems 
was performed and is otherwise unremarkable except as noted 
above.
 
Past Medical History:
ONCOLOGIC HISTORY:
___ Colonoscopy showed a circumferential mass extending from
2cm from the anal verge to 15cm.  Biopsy of this mass was
consistent with adenocarcinoma.  His tumor is T3N2 by MRI
staging.
___ Started concurrent ___ and XRT.
___ Underwent resection of the mass. Pathology from the
resection demonstrated a T3 N0 low grade adenocarcinoma.
___ Started adjuvant FOLFOX. He completed six cycles (12
infusions) with infusional ___ omitted in the last cycle due to
insurance reasons.
___ Colonoscopy showed a reddish lesion distal to the
anastomosis; biopsy could not be obtained because he was taking
Coumadin.
___ Sigmoidoscopy disclosed a large ulcerated lesion; 
multiple
biopsies were taken and were consistent with recurrent
adenocarcinoma.  A full body PET-CT revealed two FDG-avid lung
lesions, as well.
___: EBUS/FNA of 12R lymph node non-diagnostic.
___: EBUS/FNA of 12R lymph node positive for metastatic
rectal carcinoma.
___: Re-excision of neo-rectum and anus revealed local
recurrence with a positive posterior margin.  This was
complicated by wound dehiscence/infection (Bacteroides, GBS)
requiring antibiotics, WoundVac, debridement on ___, and eventually reconstructive surgery, on ___: C1D1 FOLFIRI  
___: C2D1 FOLRIRI with bevacizumab 5mg/kg added.  Did not
receive d15 doses of either due to Cyberknife x 5 given from
___. 
___: C3D1 FOLFIRI (Avastin held until day 15)
___: C4D1 FOLFIRI + Avastin.  CT scan after this cycle 
showed
a partial response.
___: C5D1 FOLFIRI + Avastin
___: C6D1 FOLFIRI; Avastin held due to neuropathy.
___: C7D1 FOLFIRI; Avastin held due to neuropathy.
___: C8D1 FOLFIRI; Avastin held due to neuropathy.
___: Underwent RLL lobectomy, by Dr. ___.  A 1.8cm
solitary metastasis was removed with negative margins.  At the
time a small nodule was palpated in the RUL and fiducials were
placed in this for subsequent CyberKnife x5, completed on 
___ developed headache and was found to have a large 
solitary
metastasis in the cerebellum with obstructive hydrocephalus. He
was subsequently admitted and underwent urgent resection, which
disclosed metastatic rectal adenocarcinoma
___:  Completed CyberKnife radiosurgery to the left
cerebellar resection cavity 500 cGy x5 fractions at 2500 cGy
total of 96% isodose line 63.33 cc total tumor volume.
___: Brain MRI: small ring-enhancing lesion in the left
cerebellar hemisphere and leptomeningeal enhancement, suspicious
for leptomeningeal carcinomatosis.
___: WBXRT to a total dose of 3000cGy
___: CK treatment to new brainstem lesion
.
Other PMHx:
- Rectal adenocarcinoma s/p neoadjuvant chemoXRT followed by 
proctectomy then APR for recurrence, cyberknife to chest.
- Bilateral myringostomy, uses hearing aids.
 
Social History:
___
Family History:
No family history of colorectal carcinoma.  His mother passed 
away of liver disease, alcohol related, and an uncle passed away 
of an MI at age ___.
 
Physical Exam:
Admission Physical Examination:
VS: T 98.1F, BP 104/82, HR 98, RR 16, O2 sat 100% RA, wght 168.9 
lbs, ht 67in, Ins/Outs .
GEN: A&O, NAD.
HEENT: Sclerae anicteric, PEARLA, right ___ CN palsy, left 
facial palsy, o/p clear, MMM, hearing aids in place.
Neck: Supple, no JVD, no thyromegaly, C-spine non-tender.
Lymph nodes: No cervical, supraclavicular, or inguinal LAD.
CV: S1S2, reg rate and rhythm, no MRG.
RESP: Good air movement bilaterally, diffuse wheezing.
BACK: No spine, rib, or iliac tenderness.
ABD: Soft, NT, ND, no HSM, + bowel sounds, colostomy in place.
EXTR: No lower leg edema, no calf tenderness.
DERM: No rash.
Neuro: Strength ___ throughout, sensation normal to touch, 
hyper-reflexive +3 throughout especially petellar reflexes, 
positive right Babinski, down-going left plantar reflex, 
non-focal.
PSYCH: Appropriate and calm.

Discharge:
 T:98.8 BP:98-110/66-74 HR:86-116 RR:18 02 sat:99% RA  
GENERAL: NAD. Lying in bed comfortably.
HEENT: AT/NC, MMM. OP clear. Right eye CN6 deficit. Neck with 
incision on back c/d/i
CARDIAC: RRR, normal  S1/S2
LUNG: CTAB, no wheezes, rales, rhonchi, breathing comfortably. 
Left portacath visible with no signs of infection.
ABDOMEN: Nontender. Nondistended, +BS, left colostomy bag with 
gas  
EXTREMITIES: RUE weaker than LUE. RLE and LLE appear similar in 
strength. Moving all extremities well, no cyanosis, clubbing or 
edema 
PULSES: 2+ DP pulses bilaterally  
NEURO: R Cranial Nerve 6 deficit.  
SKIN: warm and well perfused,  no rashes  

 
Pertinent Results:
ADMISSION LABS:
___ 06:45AM BLOOD WBC-7.9 RBC-4.60 Hgb-14.9 Hct-43.6 MCV-95 
MCH-32.3* MCHC-34.1 RDW-13.5 Plt ___
___ 06:45AM BLOOD Neuts-76.4* Lymphs-13.9* Monos-6.6 
Eos-2.3 Baso-0.8
___ 06:45AM BLOOD ___ PTT-39.7* ___
___ 06:45AM BLOOD Glucose-99 UreaN-14 Creat-0.8 Na-137 
K-3.5 Cl-98 HCO3-21* AnGap-22*
___ 06:55AM BLOOD Lactate-1.9
.
___ MRI BRAIN: IMPRESSION:
1.  Patient with known history of metastatic rectal cancer, 
status post resection of a left cerebellar metastasis, nodular 
meningeal-based enhancing soft tissue in the resection bed 
consistent with recurrent tumor is unchanged since ___.
2.  Prepontine cisternal and upper cervical intradural enhancing 
lesions have slightly increased in size, compared to the prior 
study, with no new lesion.
.
___ CT HEAD: IMPRESSION:
1) Unchanged extracranial occipital soft tissue and pre-pontine 
cistern masses consistent with metastatic disease.
2) No evidence for new metastatic disease on this nonenhanced 
study.
.
___ MRI Head: IMPRESSION:  Motion-degraded study, 
particularly the post-contrast MP-RAGE sequence, with: 
1.  No acute intracranial abnormality; there is no evidence of 
acute intra- or extra-axial hemorrhage. 
2.  Relatively unchanged appearance to the known intracranial 
metastatic disease, including in the left cerebellar hemispheric 
resection bed, with no new metastatic lesion identified. 
3.  Evidence of radiotherapy-related change. 
.  
___ C spine MRI w & w/o contrast: IMPRESSION:  Intradural 
extramedullary C2-C3 lesion along the posterior aspect of the 
spinal canal, causing mass effect and compressing the spinal 
cord, which appears anteriorly displaced.  Signal within the 
cord is difficult to evaluate due to significant motion. 
.
___ pCXR: Impression: The left Port-A-Cath catheter tip is 
at the level of cavoatrial junction.  Heart size and mediastinum 
are grossly unchanged.  Lungs are essentially well aerated with 
no evidence of consolidative process.  Surgical clips are 
projecting over the right hemithorax. 
.
___ x-ray C-spine: 
 
A single limited intraoperative fluoroscopic image of the 
lateral cervical 
spine is submitted for review.  Only the C2 and C3 vertebral 
bodies are imaged in their entirety.  A localizing device is 
present overlying the posterior elements at the C2-C3 level.  
For procedural details, please see the operative report.  

___ CXR:
FINDINGS:  Interval placement of endotracheal tube, with tip 
terminating 
approximately 5.5 cm above the carina.  Small amount of 
pneumomediastinum is likely related to recent cervical spine 
surgery with extension of gas from the lower neck into the 
mediastinum.  The heart size is normal.  Within the lungs, a 
note is made of surgical clips in the right mid lung region as 
well as mild right-sided volume loss, likely postoperative.  
Right costophrenic sulcus is less well demonstrated and could 
reflect a small right pleural effusion.  The left lung and 
pleural surfaces are grossly clear. 

___ MRI C-SPINE W/WO CONTRAST: 
A single limited intraoperative fluoroscopic image of the 
lateral cervical spine is submitted for review.  Only the C2 and 
C3 vertebral bodies are imaged in their entirety.  A localizing 
device is present overlying the posterior elements at the C2-C3 
level.   

___ NON CONTRAST HEAD CT:
IMPRESSION: 
  
1.  New pneumocephalus, likely post-operative in the setting of 
recent 
cervical spine intradural tumor resection.   
  
2.  Prepontine cisternal and extracranial occipital soft tissue 
lesions, 
consistent with known metastatic disease.   

___ NON CONTRAST HEAD CT:
IMPRESSION: 
1. Decreased postsurgical pneumocephalus. 
2. No evidence of acute abnormalities. Grossly stable mild left 
cerebellar 
edema related to known metastases, and stable right prepontine 
mass. 
3. Unchanged mild diffuse ventriculomegaly. 

___: CXR
 
The Port-A-Cath catheter tip is at the level of mid-to-low SVC.  
Heart size and mediastinum are unremarkable.  The elevated right 
hemidiaphragm is unchanged.  Lungs are essentially clear.  The 
patient was extubated in the meantime interval.  No apparent 
pneumothorax is demonstrated. 

___ CT Head
  
Interval placement of a shunt  with its tip terminating in the 
right lateral ventricle at the level of the foramen of ___.  
No other significant changes compared to the prior study.  

___ MRI T Spine

No evidence of metastatic disease or cord compression.  No 
abnormal enhancement.  Mild degenerative changes. 

 
Brief Hospital Course:
A/P: ___ man with recurrent metastatic rectal adenocarcinoma to 
lung and CNS diagnosed in ___ s/p left suboccipital craniectomy 
in ___, cyberknife, and whole brain XRT admitted for posterior 
neck pain, headaches, bilateral UE weakness right greater than 
left, and paresthesias in both fingers. Repeat brain MRI ___ 
this admission was negative for progression. On ___ the patient 
developed rapidly progressive RUE weakness and was started on 
empiric dexamethasone out of concern for cord compression. A C 
spine MRI confirmed  large C2-3 posterior epidural lesion with 
significant canal stenosis. On ___ had C2-C5 laminectomy with 
tumor decompression. On ___ patient had omaya placement for 
intrathecal chemotherapy. Patient subsequently started C1D1 of 
Cytarabine on ___.  ___ hospital course is summarized 
by problems below:

#. Recurrent Rectal adenocarcinoma metastatic to lungs and 
brain: Patient had omaya placed on ___ and started C1D1 of 
cytarabine on ___. Patient was started on
dexamethasone taper. His pain was adequately controlled with: 
acetaminophen 650 q8, fentanyl patch 25 mcg q72, gabapentin 100 
TID, and oxycodone ___ mg po q 3prn pain. Patient will be 
discharged home on steroid taper and continue cytarabine 
therapy.

# Posterior neck pain/headache with RUE weakness/RLE weakness 
and C2/C3 cord compression: Patient had worsened deterioration 
on ___ which was  worrisome for cord compression at level of C 
spine. MRI ___ shows cord compression C2/C3. RUE weakness 
worsened with new LUE pain and weakness over the next days 
despite steroids while a treatment plan was developed. Radiation 
oncology advised that THERE WAS NO ROLE FOR XRT. Surgical 
decompression remained the only option but was extremely high 
risk AND tumor was likely to recur rapidly. After full 
discussion of risks, patient proceeded with surgery on ___. 
On ___ the patient went to the OR with Dr. ___ a C2-5 
posterior decompression of intradural tumor. The patient 
tolaterated the procedure well. He was taken to ___ following 
the operation for observation. On post operative exam the 
patient had right tricep weakness but was otherwise full motor 
strength to all extremities. The patient was confused following 
the procedure, head CT scan showed no new intracranial 
abnormailities. He was started on steriod taper and transferred 
to SDU. On ___ the patient continued to improve, he was 
transferred to the floor. Patient will need continued physical 
therapy as an outpatient.

#UTI:Patient was found to have a positive urinalysis on ___ 
and completed 7 day course of ciprofloxacin. 

#Urinary retention: Patient had episode of urinary retention on 
___. MRI of thoracic spine showed no acute changes and 
urinary retention self resolved with patient being able to void 
well on his own.

Chronic Issues:

#Disposition: Patient was evaluated by physical therapy and will 
be discharged to rehabilitation physical therapy to include: 
balance in sitting and standing, coordination exercises, gait 
training with RW and 2 assist. 

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Acetaminophen 325 mg PO Q4H:PRN Pain 
2. OxycoDONE (Immediate Release)  10 mg PO BID:PRN Pain
 
Discharge Medications:
1. OxycoDONE (Immediate Release)  ___ mg PO Q3H:PRN pain 
RX *oxycodone 10 mg ___ tablet(s) by mouth every 3 hours Disp 
#*120 Tablet Refills:*1
2. Docusate Sodium 100 mg PO BID 
3. Famotidine 20 mg PO Q12H 
4. Gabapentin 200 mg PO Q8H 
5. Heparin Flush (10 units/ml) 5 mL IV PRN line flush 
6. Senna 1 TAB PO BID:PRN constipation 
7. Acetaminophen 325 mg PO Q4H:PRN Pain 
8. Heparin 5000 UNIT SC TID 
9. Fentanyl Patch 25 mcg/h TD Q72H 
10. Dexamethasone 2 mg PO DAILY 
Please take 4 mg on morning of appointment for chemotherapy 
(___) 
11. Hydrocortisone 25 mg IT Days 1, 8, 15 and 22. ___, 
___ and ___
 (25 mg) 
12. Cytarabine 50 mg IT Days 1, 8, 15 and 22. ___, 
___ and ___
 (50 mg) 

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
Cervical cord compression, resected C2-C3 mass, rectal
cancer, left cerebellar metastasis, right prepontine cistern
mass, right CN6 palsy, intrathecal chemotherapy

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Out of Bed with assistance to chair or 
wheelchair.

 
Discharge Instructions:
Dear Mr. ___,

It was a pleasure caring for you during your most recent 
hospitalization. You were admitted for pain at the back of your 
head and neck.  A brain MRI showed no change in your previously 
treated brain metastases. You developed partial paralysis of 
your right arm, left arm, and right leg. An MRI of your spine 
showed this was caused by cancer pressing on your spinal cord. 
You were treated initially with dexamethasone (decadron) and 
then underwent C2-C5 posterior laminectomy for decompression 
with resection of intradural extramedullar tumor. On ___ you 
underwent placement of right frontal resovior for intra-thecal 
chemotherapy and on ___ started intrathecal chemotherapy 
treatment.

Please take all of your medications as prescribed. Please 
followup with your physician ___.

 
Followup Instructions:
___
"
15853461-DS-4," 
Name:  ___               Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Tylenol-Codeine #3 / NSAIDS (Non-Steroidal Anti-Inflammatory 
Drug) / Elavil / trazodone / Spiriva with HandiHaler / aspirin / 
lisinopril / any sedating Rx
 
Attending: ___.
 
Chief Complaint:
s/p Fall, Back Pain 
 
Major Surgical or Invasive Procedure:
1. Posterior arthrodesis T5 through T7.
2. Posterior instrumentation T5 through T7.
3. Open treatment, posterior fracture, T8.
4. Open treatment, posterior fracture, T7.
5. Autograft, same incision.
6. Allograft, morselized.
7. Laminectomy T6-T7, T7-T8.

 
History of Present Illness:
 Ms. ___ is a ___ year old woman with history of diastolic 
CHF, DM2, GERD, pulm hypertension, memory loss, fibromyalgia, 
migraines, who presents with lightheadedness and fall.  
 Patient reports while going out with friends earlier this week 
she had a fall on the way to bingo, no headstrike, no LOC. This 
morning she got up to urinate and when she stood up from the 
toilet she felt sweaty, lightheaded and then fell. She does not 
remember the events surrounding the fall, and is unclear if she 
hit her head or had LOC. She was found by her son, who lives on 
the first floor of their 3-family home. He called EMS and she 
was  
 sent to ___ for further evaluation  
 In the ED, initial vitals were:  
 96.7 56 156/77 18 100% RA  
 Labs notable for anemia at baseline, normal chemistry, negative 
UA, negative troponin, ECG with poor baseline but no ischemic 
changes  
 Imaging notable for  
 CXR:Moderate cardiomegaly unchanged from ___. No focal 
airspace opacity.  
 CT Head:  
 No acute intracranial abnormality.  
 CT C ___:  
 1. No fracture or traumatic malalignment.  
 2. Right-sided thyroid nodule measuring up to 2.5 cm.  
 CT T ___:  
 1. Minimally displaced, fracture of the anterior two columns of 
the T7 vertebral body without evidence of spinal canal 
narrowing. No additional thoracic fracture identified.  
 2. DISH throughout the thoracic ___.  
 3. Probable scarring at the left lung apex and several 
calcified granulomas. 1 nodule in particular measuring 5 mm is 
not calcified.  
 CT L ___:  
 No lumbar ___ fracture or malalignment  
 Patient was given  
 17:18 PO Acetaminophen 650 mg  
 17:57 PO OxyCODONE (Immediate Release) 5 mg  
 Patient was seen by ortho ___ who recommended TLSO brace, 
logroll precautions at all times, NO intubation without 
discussing with ___ (if needed), keep NPO pending MRI, and MRI 
T ___ without contrast given evidence of DISH on CT.  
 Decision was made to admit to medicine for workup for syncope 
as well as pain control, treatment of T7 fracture  
 Vitals on transfer  
 97.8 63 158/64 18 98% RA  
 
 On the floor, she complains of ___ pain in her back, worse 
with movement. No decreased sensation in arms, legs. No fecal or 
urinary incontinence. Aside from fall earlier this week she has 
not had any falls. She walks with a cane at baseline. She has 
been taking only torsemide 20mg daily instead of 40mg as it 
makes her urinate too much. She is hoping to leave tomorrow to 
celebrate New Years at home with her 17 family members.  
 
 Review of systems:  
 (+) Per HPI  
 (-) Denies fever, chills, night sweats, recent weight loss or 
gain. Denies headache, sinus tenderness, rhinorrhea or 
congestion. Reports chronic cough which she takes albuterol for. 
Denies chest pain or tightness, palpitations. Denies nausea, 
vomiting, diarrhea, constipation or abdominal pain. No recent 
change in bowel or bladder habits. No dysuria. Denies 
arthralgias or myalgias. 
 
Past Medical History:
 ASTHMA  
 BACK PAIN  
 DIASTOLIC CONGESTIVE HEART FAILURE  
 DIABETES TYPE II  
 GASTROESOPHAGEAL REFLUX  
 HYPERTENSION  
 MIGRAINES  
 PAIN MANAGEMENT  
 ANEMIA  
 SLEEP APNEA  
 MICROALBUMINURIA  
 PULMONARY HYPERTENSION  
 OSTEOPENIA  
 DIABETIC NEUROPATHY  
 MEMORY LOSS  
 
Social History:
___
Family History:
 Grandson deceased, homicide, ___, GSW/drive-by/mistaken ID  
 no neurodegenerative disorders  
 
Physical Exam:
ADMISSION PHYSICAL EXAM
=======================
VS: 98.2 PO 175 / 81 L Lying 70 20 99 RA  
Gen: very pleasant older woman lying in bed speaking in full 
sentences in NAD  
HEENT: PERRL, MMM, no scleral icterus  
CV: RRR, S1, S2 with holosystolic murmur, no rubs or gallops  
Pulm: anterior exam, scattered wheezing, no crackles or rhonchi  

Abd: obese, soft, non distended, non tender +BS  
GU: no foleu  
Ext: warm, well perfused, 1+ edema to shins  
Skin: warm. well perfused, no rashes  
Neuro: alert and oriented, moving all 4 extremities without 
deficit, ___ strength upper and lower extremities, sensation to 
light touch intact  

DISCHARGE PHYSICAL EXAM
=======================
Vitals 98.5-99.3, 128-151/67-73, 62-85, 18, 96-98% on 1L. 
Gen: Laying in bed comfortably. 
HEENT: PERRL, MMM, no scleral icterus  
CV: RRR, holosystolic murmur noted throughout 
Pulm: anterior exam, bibasilar crackles.  
Abd: obese, soft, non distended, non tender, normoactive bowel 
sounds.  
Ext: warm, well perfused, no edema  
Skin: no rashes, spinal drain removed.   
Neuro: alert and oriented, moving all 4 extremities without 
deficit, ___ strength upper and lower extremities, sensation to 
light touch intact. Alert and oriented to person place and time 
which is improved from day prior.
 
Pertinent Results:
ADMISSION LABS
==============
___ 04:44PM BLOOD WBC-6.7 RBC-4.10 Hgb-10.8* Hct-34.0 
MCV-83 MCH-26.3 MCHC-31.8* RDW-16.0* RDWSD-49.1* Plt ___
___ 04:44PM BLOOD Neuts-80.2* Lymphs-15.5* Monos-3.7* 
Eos-0.1* Baso-0.1 Im ___ AbsNeut-5.39 AbsLymp-1.04* 
AbsMono-0.25 AbsEos-0.01* AbsBaso-0.01
___ 04:44PM BLOOD Plt ___
___ 04:44AM BLOOD ___ PTT-29.7 ___
___ 04:44PM BLOOD Glucose-135* UreaN-16 Creat-1.0 Na-143 
K-3.7 Cl-100 HCO3-29 AnGap-18
___ 04:44AM BLOOD Calcium-9.1 Phos-4.0 Mg-1.9

DISCHARGE LABS
==============
___ 06:10AM BLOOD WBC-8.1 RBC-2.96* Hgb-7.8* Hct-24.2* 
MCV-82 MCH-26.4 MCHC-32.2 RDW-15.5 RDWSD-46.3 Plt ___
___ 06:10AM BLOOD Glucose-141* UreaN-7 Creat-0.7 Na-141 
K-4.1 Cl-101 HCO3-27 AnGap-17
___ 06:10AM BLOOD Calcium-8.7 Phos-3.6 Mg-2.2

CARDIOLOGY LABS
===============
___ 04:44PM BLOOD cTropnT-<0.01
___ 04:44AM BLOOD CK-MB-2 cTropnT-<0.01

URINE STUDIES
=============
___ 03:30PM URINE Color-Straw Appear-Clear Sp ___
___ 03:30PM URINE Blood-NEG Nitrite-NEG Protein-TR 
Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-TR
___ 03:30PM URINE RBC-1 WBC-2 Bacteri-NONE Yeast-NONE 
Epi-<1 TransE-<1
___ 03:30PM URINE CastHy-14*

MICROBIOLOGY
============
___ 3:30 pm URINE
                            **FINAL REPORT ___
URINE CULTURE (Final ___:    < 10,000 CFU/mL. 

IMAGING
=======
___: CHEST X-RAY (PA AND LATERAL)
IMPRESSION: Moderate cardiomegaly unchanged from ___.  
No focal airspace opacity. 

___: CT ___ WITHOUT CONTRAST
IMPRESSION:
1. Minimally displaced, fracture of the anterior two columns of 
the T7 
vertebral body without evidence of spinal canal narrowing.  No 
additional 
thoracic fracture identified.
2. DISH throughout the thoracic ___. 
3. Probable scarring at the left lung apex and several calcified 
granulomas. 1 nodule in particular measuring 5 mm is not 
calcified. 
  
RECOMMENDATION(S):  Correlation with prior chest imaging to 
document stability of the left apical changes and nodules 
suggested. If not available, followup is suggested and can be 
performed in 6 months.

___: CT ___ WITHOUT CONTRAST
IMPRESSION: 
1. No fracture or traumatic malalignment. 
2. Right-sided thyroid nodule measuring up to 2.5 cm. 
  
RECOMMENDATION(S):  Nonemergent thyroid ultrasound is 
recommended for thyroid nodule evaluation. 

___: CT HEAD WITHOUT CONTRAST
IMPRESSION: No acute intracranial abnormality. 

___: CT ___ WITHOUT CONTRAST
IMPRESSION: No lumbar ___ fracture or malalignment. 

___: MR THORACIC ___ WITHOUT CONTRAST
IMPRESSION:   
1. Examination is mildly limited by motion. 
2. Stable obliquely oriented fracture of the T7 vertebral body 
involving the anterior 2 columns with adjacent anterior 
longitudinal ligament rupture and mild associated prevertebral 
soft tissue edema, and with no definite extension to the 
posterior column. 
3. Nonspecific epidural fat prominence at T5 through T9 levels, 
most 
pronounced posterior T7, where fat results in at least mild 
vertebral canal narrowing. 
4. No other fracture or alignment abnormality. 
5. No cord signal abnormality. 
6. No definite moderate to severe spinal canal or neural 
foraminal narrowing. 
7. Trace bilateral pleural effusions. 

___: TRANSTHORACIC ECHOCARDIOGRAM
The left atrial volume index is normal. The estimated right 
atrial pressure is ___ mmHg. There is mild symmetric left 
ventricular hypertrophy with normal cavity size and 
regional/global systolic function (LVEF>55%). There is no left 
ventricular outflow obstruction at rest or with Valsalva. Right 
ventricular chamber size and free wall motion are normal. The 
ascending aorta is mildly dilated. The aortic valve leaflets (3) 
are mildly thickened but aortic stenosis is not present. No 
aortic regurgitation is seen. The mitral valve appears 
structurally normal with trivial mitral regurgitation. The 
tricuspid valve leaflets are mildly thickened. Moderate [2+] 
tricuspid regurgitation is seen. There is moderate pulmonary 
artery systolic hypertension. There is no pericardial effusion. 

IMPRESSION: No structural cardiac cause of syncope seen. 
Symmetric LVH with normal global and regional biventricular 
systolic function. Moderate functional tricuspid regurgitation. 
Moderate pulmonary hypertension. 
 
Brief Hospital Course:
___ yo F with history of chronic diastolic CHF, T2DM, pulm 
hypertension who presents s/p fall and found to have oblique 
fracture through the T7 vertebral body. 

Investigations/Interventions:
# Oblique T7 fracture: s/p fall, with ligamentous instability 
(MRI on ___ showed anterior longitudinal ligament rupture with 
mild associated prevertebral soft tissue edema). Patient went to 
OR ___ for the following interventions:
1. Posterior arthrodesis T5 through T7.
2. Posterior instrumentation T5 through T7.
3. Open treatment, posterior fracture, T8.
4. Open treatment, posterior fracture, T7.
5. Autograft, same incision.
6. Allograft, morselized.
7. Laminectomy T6-T7, T7-T8.

Post-operatively, pain was controlled with oxycodone 7.5 mg PO 
Q4H:PRN and she worked with ___ who recommended discharge to 
rehab. She also had a spinal drain that drained less than 40 cc 
and was removed on ___. The provided TLSO brace is required when 
seated, standing, or ambulating. She will have follow-up with 
Ortho ___ within two weeks following discharge from the 
hospital where she will have staples removed. She should be 
continued with Mepilex dressing which should stay on (can shower 
with it) until follow up appointment.   

# Fall: most likely vasovagal given symptoms started right after 
urination.  EKG, tele, troponin unremarkable.  She did have a 
murmur on exam without previous documentation on OMR. An echo 
was obtained on ___. Results of the TTE showed ""no 
structural cardiac cause of syncope. There was symmetric LVH 
with normal global and regional biventricular systolic function. 
Moderate tricuspid regurgitation. Moderate pulmonary 
hypertension."" 

# Chronic Diastolic CHF: Was not volume overloaded throughout 
hospitalization. Her torsemide 40 mg PO daily was held. On ___, 
she was re-started on 20 mg PO torsemide. She should be followed 
at rehab with daily weights and I/O with uptitration of 
torsemide as needed. 

# Type II DM: held metformin while inpatient and started on 
Humalog sliding scale. She was re-started on metformin at the 
time of discharge. 

# Asthma: continued on albuterol inhaler, fluticasone-salmeterol 
250/50, fluticasone propionate 1 spray BID, cetirizine 10 mg PO 
daily. 

# Hypertension: Continued on amlodipine 10 mg PO daily. 
Continued metoprolol succinate 200 mg PO daily.

# Hyperlipidemia: Continued on atorvastatin 40 mg PO QPM.

# Dementia: continued on donepezil 10 mg PO QHS.

# Fibromyalgia: continued on duloxetine 40 mg PO daily. 
Continued pregabalin 75 mg PO BID.    

# Rehabilitation: Anticipated length of rehab stay will be less 
than 30 days. 

TRANSITIONAL ISSUES
===================
-Please schedule appointment with ___ 2 weeks 
following surgery (please schedule for ___. Please 
schedule with Dr. ___ Dr. ___. Please call ___ to 
schedule this appointment.
-Staples will be removed at the follow-up appointment with 
___.
-Please continue with Mepilex dressing which should stay on (can 
shower with it) until follow up appointment.      
-Needs TLSO brace required when seated, standing, or ambulating. 
 
-patient should have repeat CBC and chemistry panel on ___ for 
evaluation of creatinine and H/H given that she was re-started 
on torsemide at discharge and had anemia following the 
procedure. 
-please follow up final read of ___ X-ray. 
-CT ___ without contrast. RECOMMENDATION(S):  Correlation 
with prior chest imaging to document stability of the left 
apical changes and nodules suggested.  If not available, 
followup is suggested and can be performed in 6 months.
-CT ___ without contrast. RECOMMENDATION(S):  Nonemergent 
thyroid ultrasound is recommended for thyroid nodule evaluation.
#CODE: full, confirmed  
#CONTACT: daughter ___ ___ 
 
___ on Admission:
The Preadmission Medication list is accurate and complete.
1. Albuterol Inhaler ___ PUFF IH Q4H:PRN sob, wheeze 
2. amLODIPine 10 mg PO DAILY 
3. Atorvastatin 40 mg PO QPM 
4. Donepezil 10 mg PO QHS 
5. DULoxetine 40 mg PO DAILY 
6. Fluticasone Propionate NASAL 2 SPRY NU DAILY 
7. Lidocaine 5% Ointment 1 Appl TP DAILY 
8. MetFORMIN (Glucophage) 1500 mg PO QAM 
9. MetFORMIN (Glucophage) 1000 mg PO QPM 
10. Metoprolol Succinate XL 200 mg PO DAILY 
11. Pantoprazole 40 mg PO Q12H 
12. Pregabalin 75 mg PO BID 
13. Torsemide 40 mg PO DAILY 
14. Calcium Carbonate 500 mg PO BID 
15. Cetirizine 10 mg PO DAILY 
16. Magnesium Citrate 300 mL PO DAILY:PRN constipation 
17. Vitamin E 1000 UNIT PO DAILY 
18. fluticasone-salmeterol 230-21 mcg/actuation inhalation 2 
puffs inhaled BID via spacer then rinse and gargle with water 

 
Discharge Medications:
1.  Docusate Sodium 100 mg PO BID  
2.  Heparin 5000 UNIT SC BID  
3.  OxyCODONE (Immediate Release) 7.5 mg PO Q4H:PRN Pain - Mild  

4.  Polyethylene Glycol 17 g PO DAILY  
5.  Senna 8.6 mg PO BID  
6.  Torsemide 20 mg PO DAILY  
7.  Albuterol Inhaler ___ PUFF IH Q4H:PRN sob, wheeze  
8.  amLODIPine 10 mg PO DAILY  
9.  Atorvastatin 40 mg PO QPM  
10.  Calcium Carbonate 500 mg PO BID  
11.  Cetirizine 10 mg PO DAILY  
12.  Donepezil 10 mg PO QHS  
13.  DULoxetine 40 mg PO DAILY  
14.  Fluticasone Propionate NASAL 2 SPRY NU DAILY  
15.  fluticasone-salmeterol 230-21 mcg/actuation inhalation 2 
PUFFS INHALED BID VIA SPACER THEN RINSE AND GARGLE WITH WATER  
16.  Lidocaine 5% Ointment 1 Appl TP DAILY  
17.  Magnesium Citrate 300 mL PO DAILY:PRN constipation  
18.  MetFORMIN (Glucophage) 1500 mg PO QAM  
19.  MetFORMIN (Glucophage) 1000 mg PO QPM  
20.  Metoprolol Succinate XL 200 mg PO DAILY  
21.  Pantoprazole 40 mg PO Q12H  
22.  Pregabalin 75 mg PO BID  
23.  Vitamin E 1000 UNIT PO DAILY  

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
PRIMARY DIAGNOSIS
=================
-Oblique fracture of T7
-Fall

SECONDARY DIAGNOSIS
===================
-Chronic Diastolic Heart Failure
-Asthma/Allergic Rhinitis
-Hypertension
-Hyperlipidemia
-Dementia
-Fibromyalgia
-Type II DM

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).

 
Discharge Instructions:
Ms. ___,

You were hospitalized after a fall.  You were admitted to the 
medicine service to evaluate cause of the fall, and workup 
revealed that you most likely had a very common reaction called 
vasovagal syncope that can occur after using the bathroom.  In 
the future, please stand up slowly to avoid this happening 
again.

Because of the fall you sustained a spinal injury that required 
surgery with our orthopedics team.  You will follow up with the 
___ surgeons within the next two weeks following discharge 
from the hospital.

Please see below regarding the discharge instructions from the 
___ Surgeons.  

___ D/C Instructions:
Lumbar Decompression With Fusion:
You have undergone the following operation: Lumbar Decompression 
With Fusion
Immediately after the operation:
 Activity: You should not lift anything greater than 10 lbs for 
2 weeks.You will be more comfortable if you do not sit or stand 
more than~45 minutes without getting up and walking around.
 Rehabilitation/ Physical Therapy: ___ times a day you should 
go for a walk for ___ minutes as part of your recovery.You can 
walk as much as you can tolerate. Limit any kind of lifting.
 Diet: Eat a normal healthy diet.You may have some constipation 
after surgery.You have been given medication to help with this 
issue.
 Brace:You have been given a brace,this brace is to be worn 
when you are walking or out of bed. You may take it off while 
lying in bed.
 Wound Care:Keep the dressing in place until your follow up 
appointment. You may take a shower with this dressing. Please do 
not soak the incision in a bath or pool. If the incision begins 
to drain at any time, please call the ___. 
Follow up: Please Call the office and make an appointment for 2 
weeks after the day of your operation if this has not been done 
already. At the 2-week visit we will check your incision,take 
baseline X-rays and answer any questions.We may at that time 
start physical therapy. We will then see you at 6 weeks from the 
day of the operation and at that time release you to full 
activity.

Please call the office if you have a fever>101.5 degrees 
Fahrenheit and/or drainage from your wound.

It was a pleasure taking care of you during your 
hospitalization! We wish you all the best!

Sincerely,
Your ___ Care Team 
 
Followup Instructions:
___
"
16345916-DS-17," 
Name:  ___                    Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: SURGERY
 
Allergies: 
Maxzide / Norvasc / Erythromycin Base / Amoxicillin
 
Attending: ___.
 
Chief Complaint:
Non-healing below the knee amputation incsion with pain and 
contracture. 
 
Major Surgical or Invasive Procedure:
Right lower extremity above the knee amputation

 
History of Present Illness:
The patient is an elderly ___ year-old female with severe 
vascular disease presenting with pain of the right lower 
extremity. She has undergone previous intervention and 
revascularization to include, Right ___ metatarsal head excision 
and closure, right lower extremity angiogram and angioplasty of 
proximal anterior tibial artery, and right below the knee 
amputation. Despite our best efforts the patient has been unable 
to heal her below-knee amputation.  At this point she has no 
additional options of revasculaization. The patient, family and 
practitioner agree have decided to proceed with above-knee 
amputation.

 
Past Medical History:
PMH: PVD, Ovarian cancer, endometrial cancer, breast cancer,  
HTN, HL, hypothyroid, pulmHTN, DM, CKD, acute chole, chronic 
urinary retention - indwelling foley 

___ diagnostic angio,R fem bypass (___), 
cholestostectomy ___ , R iliofemoral endarterectomy w patch 
 angioplasty ___, R ___ toe amp (___), ,  L 
patella ORIF ___,

 
Social History:
___
Family History:
Noncontributory
 
Physical Exam:
Physical Exam:
Alert and oriented x 3 
VS:BP  150/62  HR   75   RR   16   96%RA 
Carotids: 2+, no bruits or JVD
Resp: Lungs clear
Abd: Soft, non tender, well healed scars
Ext: Pulses:  Left  Femoral p , DP ___ d 
Left foot warm, well perfused.  No open areas
Right stump warm and well perfused, with incision clean dry and 
intact

 
Pertinent Results:
___ 02:25PM BLOOD WBC-18.3* RBC-2.85* Hgb-8.9* Hct-28.6* 
MCV-100* MCH-31.1 MCHC-31.1 RDW-23.1* Plt ___
___ 05:50AM BLOOD WBC-10.4 RBC-2.33* Hgb-7.2* Hct-23.5* 
MCV-101* MCH-30.9 MCHC-30.6* RDW-23.1* Plt ___
___ 05:10AM BLOOD WBC-8.0 RBC-2.30* Hgb-7.1* Hct-23.1* 
MCV-100* MCH-30.8 MCHC-30.7* RDW-22.4* Plt ___
___ 12:34AM BLOOD Hct-30.5*#
___ 05:05AM BLOOD WBC-8.3 RBC-3.29*# Hgb-10.3*# Hct-31.4* 
MCV-96 MCH-31.3 MCHC-32.8 RDW-21.0* Plt ___
___ 05:10PM BLOOD Hct-29.0*
___ 07:30AM BLOOD WBC-9.5 RBC-3.16* Hgb-9.8* Hct-31.0* 
MCV-98 MCH-30.9 MCHC-31.6 RDW-20.9* Plt ___
___ 06:45AM BLOOD WBC-7.9 RBC-3.01* Hgb-9.1* Hct-29.3* 
MCV-98 MCH-30.4 MCHC-31.1 RDW-21.2* Plt ___
___ 02:25PM BLOOD Neuts-81.1* Lymphs-12.4* Monos-4.2 
Eos-2.1 Baso-0.3
___ 05:40AM BLOOD Plt ___
___ 06:45AM BLOOD Plt ___
___ 05:05AM BLOOD ___ PTT-29.8 ___
___ 05:40AM BLOOD Glucose-102* UreaN-11 Creat-0.4 Na-139 
K-4.3 Cl-102 HCO3-27 AnGap-14
___ 05:05AM BLOOD Glucose-98 UreaN-10 Creat-0.4 Na-139 
K-3.7 Cl-103 HCO3-26 AnGap-14
___ 05:40AM BLOOD Calcium-8.6 Phos-2.8 Mg-2.0
___ 07:30AM BLOOD Calcium-8.4 Phos-2.5* Mg-1.8
 
Brief Hospital Course:
Ms. ___ was admitted to ___ on ___ for pain, contracture 
and gangrene of a previous right BKA the patient underwent on 
___. On ___ the patient was seen by a nutritionist, was 
given 2 units of packed red blood cells for a HCT of 2100. The 
patient was brought to the operating room on ___ and 
underwent right lower extremity below the knee amputation.  The 
procedure was without complications. The patient was closely 
monitored in the PACU and then transferred to the floor in 
stable condition where she remained hemodynamically stable. The 
patient's diet was gradually advanced. She worked with physical 
therapy and occupational therapy who recommended continued 
treatment within a rehabilitation facility. She was discharged 
to rehab on ___, POD #3 in stable condition.  Follow-up to 
be arranged with Dr. ___ office in approximately 1 month to 
have her incision site evaluated and possible staple removal.  
 

 
Medications on Admission:
atorvastatin 10', lasix 20', gabapentin 300', levothyroxine 88 
mcg'; lisinopril 10'; aspirin 81'; CaVit D 600-400'; vitD3 1k'; 
glucosamine-chondroitin; Miralax 17g', mvi'; Boniva 150 mg qmo; 
hydromorphone ___ q4prn (for rest pain in foot)

 
Discharge Medications:
1. Aspirin 81 mg PO DAILY 
2. Atorvastatin 10 mg PO DAILY 
3. Furosemide 20 mg PO DAILY 
4. Gabapentin 300 mg PO DAILY 
5. Lisinopril 10 mg PO DAILY 
6. Levothyroxine Sodium 88 mcg PO DAILY 
7. Acetaminophen 500 mg PO Q6H pain 
8. Docusate Sodium 100 mg PO BID 
9. Polyethylene Glycol 17 g PO DAILY 
10. Insulin SC 
      Sliding Scale

Fingerstick QACHS
Insulin SC Sliding Scale using REG Insulin
11. Heparin 5000 UNIT SC TID 
To be managed by Rehab. D/C with appropriate ambulation.  
12. OxycoDONE (Immediate Release)  ___ mg PO Q3H:PRN pain 
RX *oxycodone 5 mg ___ tablet(s) by mouth every three hours Disp 
#*50 Tablet Refills:*0
13. Senna 17.2 mg PO HS 
14. TraMADOL (Ultram) 50 mg PO Q6H:PRN pain 
RX *tramadol 50 mg 1 tablet(s) by mouth every six hours Disp 
#*50 Tablet Refills:*0

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
Peripheral Arterial Disease

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Out of Bed with assistance to chair or 
wheelchair.

 
Discharge Instructions:
DIVISION OF VASCULAR AND ENDOVASCULAR SURGERY
AMPUTATION DISCHARGE INSTRUCTIONS

ACTIVITY: 
On the side of your amputation you are non weight bearing for 
___ weeks. 
You should keep this amputation site elevated when ever 
possible. 
You may use the opposite foot for transfers and pivots.
No heavy lifting greater than 20 pounds for the next 3 weeks. 

BATHING/SHOWERING: 
You may shower when you get home
No tub baths or pools / do not soak your foot for 4 weeks from 
your date of surgery 
WOUND CARE:
Sutures / Staples may have been removed before discharge. If 
they are not, an appointment will be made for you to return for 
staple removal. 
When the sutures are removed the doctor may or may not place 
pieces of tape called steri-strips over the incision. These will 
stay on about a week and you may shower with them on. If these 
do not fall off after 10 days, you may peel them off with warm 
water and soap in the shower.
CAUTIONS:
If you smoke, please make every attempt to quit.  Your primary 
care physician can help with this.  Smoking causes narrowing of 
your blood vessels which in turn decreases circulation.  
DIET:
Low fat, low cholesterol / if you are diabetic  follow your 
dietary restrictions as before 

 
Followup Instructions:
___
"
16393593-DS-5," 
Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: CARDIOTHORACIC
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___
 
Chief Complaint:
sternal drainage
 
Major Surgical or Invasive Procedure:
sternal debridement and washout ___
cardiac cath ___ and cath with stent to LAD on ___
exploratory lap ___
 
History of Present Illness:
Very nice ___ year old gentleman with type 2 diabetes on an 
insulin pump, hypertension, stroke, atrial fibrillation, 
hyperlipidemia and idiopathic thrombocytopenia purpura who 
developed an area of drainage along his sternotomy this past 
___. He was seen by his primary who promptly referred him to
Dr. ___ cultured the wound and involved Dr. ___ in his 
evaluation. Mr. ___ underwent CABGx3 and redo aortic valve 
replacement in ___ at ___ in ___, 
___.  He had a complicated post-op course, including sternotomy 
wound dehiscence and infection which was treated with IV
antibiotics and wet to dry dressing changes. His surgery was 
also complicated by stroke, deep vein thrombosis and need for a 
feeding tube. He had been recovering well over the last few 
weeks however on ___ morning (___) he developed a small, 
raised, fluid-filled pocket towards mid portion of his incision 
just above the prior infection site. His temperature orally at 
the
time was 99.7F. He denies any current fever/chills but does note 
pain over the area, dyspnea and fatigue. He reports no trauma to 
the area over the last few days. He also notes that his former 
feeding tube site has begun draining. He presents for surgical 
evaluation.

 
Past Medical History:
AORTIC STENOSIS s/p AVR bioprosthetic                            


BASAL CELL CARCINOMA                                            
DIABETES MELLITUS                                               
EOSINOPHILIA                                                    
HYPERTENSION                                                    
SARCOIDOSIS                                                     
needs ___ yr cxrs                                                
SHINGLES                                                        
SLEEP APNEA                                                     
STEATORRHEA                                                     
RHINITIS                                                        
LOW BACK PAIN                                                   
LYMPHADENOPATHY                                                 
SQUAMOUS CELL CARCINOMA      

PSH
Trigger finger release surgery on right hand ___
Knee arthroscopy ___
Cholecystectomy

 
Social History:
___
Family History:
Family History: 
Mother : melanoma
Father: unknown
Sister: diabetes
 
Physical ___:
BP: 112/52. Heart Rate: 69. Weight: 171.2. BMI: 23.9.
Temperature: 97.6.

Height: 71""     Weight: 171lb

General: Appears pale, frail and mildly deconditioned. 
Skin: Warm, dry and intact
Sternotomy: Small opening at mid/upper sternotomy measuring 2cm 
x
1.5cm. There is yellow/shite thickened discharge. Mild erythema.
Bone feels relatively stable but there is an appreciable void
superiorly. 
HEENT: NCAT, PERRL, sclera anicteric, OP benign. 
Neck:  Supple [X] Full ROM [X]
Chest: Lung sounds decreased at bases
Heart: Irregular rhythm, no m/r/g 
Abdomen: Soft [X] non-distended [X] non-tender [X]  bowel sounds
+[X] There is mild drainage from former feeding tube site. No
significant erythema. 
Extremities: Warm [X], well-perfused [X] ___ ___ Edema 
Varicosities: None on right, Left EVH
Neuro: Grossly intact [X] A+Ox3, no focal deficits noted. Using 
a
walker to walk.
Pulses:
Femoral      Right:2   Left:2
DP           Right:1   Left:1
___           Right:1   Left:1
Radial       Right:2   Left:2

Carotid Bruit:      Did not appreciate

 
Pertinent Results:
___ 05:13PM BLOOD WBC-13.5* RBC-3.15* Hgb-9.4* Hct-30.6* 
MCV-97 MCH-29.8 MCHC-30.7* RDW-15.7* RDWSD-55.0* Plt ___
___ 06:24PM BLOOD ___ PTT-114.0* ___
___ 05:13PM BLOOD Glucose-124* UreaN-16 Creat-1.5* Na-146 
K-6.0* Cl-108 HCO3-6* AnGap-32*
___ 05:13PM BLOOD ALT-562* AST-3780* CK(CPK)-408* 
AlkPhos-255* Amylase-9 TotBili-0.8
___ 05:13PM BLOOD CK-MB-50* MB Indx-12.3* cTropnT-3.12*
___ 05:13PM BLOOD Calcium-13.7* Phos-9.4* Mg-2.3
___ 11:15PM BLOOD Type-ART pO2-101 pCO2-32* pH-7.13* 
calTCO2-11* Base XS--17

Echocardiographic Measurements ___:  

Left Ventricle - Ejection Fraction:   45% to 50%   >= 55%   
Left Ventricle - Stroke Volume:   53 ml/beat       
Left Ventricle - Peak Resting LVOT gradient:   2 mm Hg   <= 10 
mm Hg   
Left Ventricle - Peak Inducible LVOT gradient:   1 mm Hg       
Aortic Valve - Peak Velocity:   1.3 m/sec   <= 2.0 m/sec   
Aortic Valve - Peak Gradient:   14 mm Hg   < 20 mm Hg   
Aortic Valve - Mean Gradient:   7 mm Hg       
Aortic Valve - LVOT VTI:   17       
Aortic Valve - LVOT diam:   2.0 cm       
Mitral Valve - Peak Velocity:   1.2 m/sec       
Mitral Valve - Mean Gradient:   2 mm Hg       
Mitral Valve - Pressure Half Time:   70 ms       
Mitral Valve - MVA (P ___ T):   3.1 cm2       
Mitral Valve - MVA (2D):   3.1 cm2       
Mitral Valve - E Wave:   0.9 m/sec       
Mitral Valve - A Wave:   0.2 m/sec       
Mitral Valve - E/A ratio:   4.50       
Mitral Valve - E Wave deceleration time:   *373 ms   140-250 ms  
 
  
Findings   
 Multiplanar reconstructions were generated and confirmed on an 
independent workstation.   

LEFT ATRIUM: Moderate ___. No mass/thrombus in the ___ 
___. Depressed ___ emptying velocity (<0.2m/s) 

RIGHT ATRIUM/INTERATRIAL SEPTUM: Normal RA size. No ASD by 2D or 
color Doppler. 

LEFT VENTRICLE: Low normal LVEF. 

RIGHT VENTRICLE: Normal RV chamber size and free wall motion. 

AORTA: Normal diameter of aorta at the sinus, ascending and arch 
levels. Simple atheroma in ascending aorta. Complex (>4mm) 
atheroma in the descending thoracic aorta. No thoracic aortic 
dissection. 

AORTIC VALVE: Bioprosthetic aortic valve prosthesis (AVR). No 
AS. No AR. 

MITRAL VALVE: Moderate mitral annular calcification. No MS. 
___ (2+) MR. 

___ VALVE: Normal tricuspid valve leaflets with trivial 
TR. 

PULMONIC VALVE/PULMONARY ARTERY: Normal pulmonic valve leaflet. 
No PS. Physiologic PR. 

PERICARDIUM: Trivial/physiologic pericardial effusion. 

GENERAL COMMENTS: Written informed consent was obtained from the 
patient. A TEE was performed in the location listed above. I 
certify I was present in compliance with ___ regulations. The 
patient was under general anesthesia throughout the procedure. 
No glycopyrrolate was administered. No TEE related 
complications.   

REGIONAL LEFT VENTRICULAR WALL MOTION:   

Basal InferoseptalBasal AnteroseptalBasal Anterior
Basal InferiorBasal InferolateralBasal Anterolateral  Mid 
InferoseptalMid AnteroseptalMid Anterior
Mid InferiorMid InferolateralMid Anterolateral  Septal 
ApexAnterior Apex
Inferior ApexLateral Apex  Apex  
 
     N = Normal, H = Hypokinetic, A = Akinetic, D = Dyskinetic   

Conclusions   
Echo probe placed in the setting of possible LIMA injury to 
assess LV function given history of bypass. 

 ___:
 The left atrium is moderately dilated. No mass/thrombus is seen 
in the left atrium or left atrial appendage. The left atrial 
appendage emptying velocity is depressed (<0.2m/s). 

 IAS:
 No atrial septal defect is seen by 2D or color Doppler. 

 LV:
 The LV has borderline normal function with EF 50-55%. Anterior 
wall and septal function was normal throughout the exam.

 RV:
 Right ventricular chamber size and free wall motion are normal. 


 Aorta:
 The diameters of aorta at the sinus, ascending and arch levels 
are normal. There are simple atheroma in the ascending aorta. 
There are complex (>4mm) atheroma in the descending thoracic 
aorta. No thoracic aortic dissection is seen. 

 AV:
 A bioprosthetic aortic valve prosthesis is present. There is no 
aortic valve stenosis. No aortic regurgitation is seen. 

 MV:
 Moderate (2+) mitral regurgitation is seen. There is moderate 
MAC.

 TV:
 Normal leaflets, trivial TR.

 Pericardium:
 There is a trivial/physiologic pericardial effusion.   

CONCLUSION: echo  ___:
There is normal left ventricular wall thickness with a normal 
cavity size. There is SEVERE regional left ventricular systolic 
dysfunction with akinesis of the mid and distal anteroseptal 
wall, the distal ___ of the left ventricle, and severe 
hypokinesis of most other segments with the exception of the 
basal anterior, septal and lateral walls (see schematic). No 
thrombus or mass is seen in the left ventricle. Overall left 
ventricular systolic function is severely depressed. Mildly 
dilated right ventricular cavity with mild global free wall 
hypokinesis. An
aortic valve bioprosthesis is present. The prosthesis is well 
seated with normal gradient. There is minimal aortic valve 
stenosis. There is no aortic regurgitation. The mitral valve 
leaflets are severely thickened. There is moderate [2+] mitral 
regurgitation. Due to acoustic shadowing, the severity of mitral 
regurgitation could be UNDERestimated. There is an eccentric, 
interatrial sepal directed jet of mild to moderate [___] 
tricuspid regurgitation. Due to acoustic shadowing, the severity 
of tricuspid regurgitation may be UNDERestimated.
There is a trivial pericardial effusion.
IMPRESSION: Suboptimal image quality. Severe and extensive 
regional wall motion abnormalities c/w multivessel CAD. MIld 
right ventricular dilation with mild global hypokinesis. Mild to 
moderate tricuspid
regurgitation. Moderate mitral regurgitation. Well seated and 
normally functioning bioprosthetic AVR.
Compared with the prior TTE ___, extensive regional left 
ventricular dysfunction is new. The severity of valvular 
regurgitation has increased.
MEASUREMENTS:
LEFT VENTRICLE (LV)
Septal Thickness: 1.0cm (nl M<1.1;F<1.0)
Inferolateral Thickness: 0.9cm (nl M<1.1;F<1.0)
End-diastolic (ED) Dimension: 4.9cm (nl M<5.9;F<5.3)
Resting Visual Ejection Fraction:
RIGHT VENTRICLE (RV)
Basal Diameter: 4.3cm (nl<4.2)
PERICARDIUM
Max Effusion: 0.4cm (<0.3)
AORTIC VALVE (AV)
Peak Velocity: 2.1m/sec (nl<=2.0)
Peak Gradient:18mmHg
FINDINGS:
RIGHT ATRIUM (RA)/INTERATRIAL SEPTUM/INFERIOR VENA CAVA (IVC): 
Catheter in RA
LEFT VENTRICLE (LV): Normal wall thicknesses. Normal cavity 
size. Severe focal systolic dysrfunction (see
schematic). No LV thrombus/mass. SEVERELY depressed ejection 
fraction.
RIGHT VENTRICLE (RV): Mild cavity enlargement. Mild global free 
wall hypokinesis.
AORTIC VALVE (AV): Bioprosthesis. Well seated prosthesis. Normal 
prosthesis gradient. Minimal stenosis.
No regurgitation.
MITRAL VALVE (MV): Severely thickened leaflets. Moderate [2+] 
regurgitation. Regurgitation severity could
be UNDERestimated due to acoustic shadowing.
PULMONIC VALVE (PV): PV not well seen
TRICUSPID VALVE (TV): Mild-moderate [___] regurg

 
Brief Hospital Course:
The patient was seen in clinic and admitted for sternal 
debridement. On ___ he underwent sternal debridement and 
during the procedure the LIMA was transected. The sternum was 
left open and the patient went immediately to the cath lab from 
the OR.  He was found to have native LAD disease but he was not 
stented because he was going to need further OR procedures, 
including pectoralis flaps, and it would have been problematic 
to have the pt. on Plavix.
His was treated with Vanco/Meropenem/Micafungin and Tobramycin. 
He went for a sternal washout on ___ and required some PRBC 
after the procedure. On ___ he was having ventricular 
arrhythmias which were treated with Lido and Amiodorone.  He was 
progressively acidotic over the day and had a rising lactate. He 
was seen by EP and the interventional cardiologists.  ___ he 
required a bicarb gtt and his lactate was rising despite volume. 
He underwent an exploratory laparotomy which was negative. When 
he was being moved from the OR table to the bed he coded and was 
shocked and had ROSC. He was then taken to the cath lab and had 
a stent placed to the LAD.  He again became unstable in the cath 
lab and had VT which resolved with epi.
He was transferred back to the CVICU and continued to 
deteriorate. He required increased pressors and went up to 0.6 
of levo, 0.2 of epi, and was also on maximum doses of 
vasopressin and neo.  
His family was present for most of the day and Dr. ___ them 
fully informed. He remained on multiple drips and CRRT was 
started.  He did not improve and since the cath lab his pupils 
were fixed and dilated.
He became asystolic at 3:35 on ___ and had no blood pressure. 
The family and Dr. ___ informed of the patient's demise. 
The family did not want an autopsy and the medical examiner 
declined the case.
 
Medications on Admission:
BRIMONIDINE [ALPHAGAN P] - Alphagan P 0.1 % eye drops. 1 gtt per
eye twice daily -  (Prescribed by Other Provider)
DABIGATRAN ETEXILATE [PRADAXA] - Pradaxa 150 mg capsule. 1
capsule(s) by mouth twice a day
DULOXETINE - duloxetine 60 mg capsule,delayed release. TAKE ONE
CAPSULE(S) BY MOUTH ONCE A DAY-DOSE INCREASED FROM 30 MG TO 60 
MG
FLUTICASONE - fluticasone 50 mcg/actuation nasal
spray,suspension. 2 sprays(s) IN once a day
FUROSEMIDE - furosemide 20 mg tablet. 1 tablet(s) by mouth every
other day -  (Prescribed by Other Provider)
GABAPENTIN - gabapentin 300 mg capsule. ___ capsule(s) by mouth
three times a day
INSULIN ASPART U-100 [NOVOLOG U-100 INSULIN ASPART] - Novolog
U-100 Insulin aspart 100 unit/mL subcutaneous solution. 1 daily
sq via pump patient uses 7 vials/3 months
LEVOTHYROXINE - levothyroxine 125 mcg tablet. 1 tablet(s) by
mouth once a day take on an empty stomach
METOPROLOL TARTRATE - metoprolol tartrate 25 mg tablet. 0.5 (One
half) tablet(s) by mouth twice a day
PANTOPRAZOLE - pantoprazole 40 mg tablet,delayed release. 1
tablet(s) by mouth once a day
POTASSIUM CHLORIDE - potassium chloride ER 20 mEq 
tablet,extended
release. 1 tablet(s) by mouth once a day
SIMVASTATIN - simvastatin 20 mg tablet. TAKE 1 TABLET EVERY DAY
 
Medications - OTC
ASPIRIN - aspirin 81 mg chewable tablet. 1 tablet(s) by mouth
once a day
MULTIVIT WITH MIN-FA-LYCOPENE [ONE-A-DAY MEN'S] - One-A-Day 
Men's
0.4 mg-600 mcg tablet. Tablet(s) by mouth  -  (OTC)

 
Discharge Medications:
none
 
Discharge Disposition:
Expired
 
Discharge Diagnosis:
Primary: 
Sepsis 
sternal wound infection 
NSTEMI 
 
Secondary: 
Aortic stenosis s/p AVR in ___ and ___ 
CAD 
Myocardial infarction 
Basal cell and squamous cell carcinoma 
Diabetes - Insulin pump 
Hypertension 
Hyperlipidemia 
Sarcoidosis 
Shingles 
Sleep apnea 
Stroke ___ - Memory issues as a residual 
DVT ___ - Left 
ITP 
?Empyema drained by chest tube 
Past Surgical History: 
CABG X 3 and AVR ___ in ___  
Surgery scheduled with: Dr. ___ 
___ 
AVR ___ Dr. ___ 
___ cholecystectomy ___ - Also complicated by infection 
Feeding tube placement 
Back surgery x2  

 
Discharge Condition:
expired

 
Discharge Instructions:
expired
 
Followup Instructions:
___
"
16867446-DS-13," 
Name:  ___                        Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
Nausea, vomiting, abdominal pain
 
Major Surgical or Invasive Procedure:
none
 
History of Present Illness:
___ w/PMHx IDDM, heavy EtOH use who presented to ___ 
with nausea, emesis and abdominal pain found to be in DKA.  He 
reported that he developed nausea after eating a sandwich on his 
night shift 1.5 days ago.  Subsquently he has vomited >15 
producing nb/nb emesis.  He denies fevers.  He reports 
suprapubic abdominal pain that was well controled with advil.  
He denies changes in his bowels or bladder habbits.  After 
arriving to ___, initially had a lactate of 15, WBC 
15.8 with potassium of 5.7 and AG metabolic acidosis of 39. 
Received 3L IV NS, Insulin gtt started and Vanc, Zosyn IV 
received. Last FSG 328 mg/dL.  His lipase was nearly 1100. He 
was then transferred to ___ for futher management.

On arrival to ___, he was continued on Insulin gtt per ___ 
protocol, D5 NS +40 mEq and electrolytes were repleted.  He was 
quickly transfer to the MICU for futher managmenet of his DKA, 
presume pancreatitis, and alcohol withdrawal. His inital vitals 
in the ED were 99.8 110 138/78 18 98% RA.
 
Past Medical History:
1.  Diabetes mellitus type 2.
2.  Dyslipidemia.
3.  Psoriasis.
4.  Gout.
5.  Elevated transaminases.
6.  Anemia (macrocytic)
7.  Vitamin D deficiency.
8.  History of right rotator cuff injury.
9.  History of carpal tunnel syndrome.
10. Last colonoscopy in ___ at which time the patient was 
noted to have a colon polyp and diverticulosis.  Pathology was 
consistent with a hyperplastic polyp.      
11.  Status post right and left inguinal hernia repairs.
 
Social History:
___
Family History:
The patient's mother died from ovarian cancer he believes in her 
early ___.  The patient's father died from heart disease in his 
___.  The patient has 4 sisters who he believes are in 
goodhealth.  He is not aware of any family history of iron 
overload.

 
Physical Exam:
MICU EXAM
T 37.7 HR: 104 BP: 132/66 RR: 25 SpO2: 96% 
General: Alert, oriented, no acute distress 
HEENT: Sclera anicteric, horizontal nystamus MMM, oropharynx 
clear 
Neck: supple 
CV: Regular rate normal S1 + S2, no murmurs, rubs, gallops  
Lungs: Clear to auscultation bilaterally, no wheezes, rales, 
ronchi  
Abdomen: soft, ttp suprapubic, non-distended, bowel sounds 
present, no organomegaly  
GU: no foley  
Ext: warm, well perfused, 2+ pulses, tremor in hands bilaterally

Discharge Exam:
VS: 98.8 117/97 90 18 100 ra 
General: Sitting up in bed, NAD, aoX3  
HEENT: Sclera anicteric, PERRL, OP clear  
Neck: supple, no JVD  
CV: RRR, no murmurs, rubs, gallops  
Lungs: Clear to auscultation bilaterally, no wheezes, rales, 
ronchi  
Abdomen: soft, nontender, nondistended, no rebound/guarding, no 
CVA tenderness  
Ext: WWP, 2+ ___, no edema, psoriasis patches on 
wrists, and left calf, no asterixis  
Neuro: CNII-XII intact, moving all extremities, no asterixis, 
AOx3, ___ recall, gait not observed  

 
Pertinent Results:
Admission Labs:
___ 11:55PM BLOOD WBC-5.5 RBC-2.30* Hgb-7.8* Hct-23.8* 
MCV-104* MCH-34.0* MCHC-32.8 RDW-12.8 Plt ___
___ 11:55PM BLOOD Neuts-90.6* Lymphs-4.6* Monos-4.5 Eos-0.2 
Baso-0.1
___ 11:55PM BLOOD ___ PTT-26.6 ___
___ 11:55PM BLOOD Glucose-236* UreaN-29* Creat-1.7* Na-138 
K-4.0 Cl-103 HCO3-17* AnGap-22*
___ 02:50AM BLOOD ALT-61* AST-96* AlkPhos-55 Amylase-511* 
TotBili-1.8*
___ 02:50AM BLOOD Lipase-1251*
___ 06:39AM BLOOD CK-MB-3 cTropnT-<0.01
___ 11:55PM BLOOD Calcium-5.9* Phos-1.6* Mg-1.1*
___ 02:50AM BLOOD VitB12-1273*
___ 02:50AM BLOOD Triglyc-77
___ 12:12AM BLOOD ___ Temp-37.1 O2 Flow-2 pO2-35* 
pCO2-30* pH-7.39 calTCO2-19* Base XS--5 Intubat-NOT INTUBA 
Vent-SPONTANEOU
___ 12:02AM BLOOD Lactate-3.6*
___ 03:07AM BLOOD Lactate-2.2*
___ 04:33AM BLOOD Lactate-1.1
___ 11:55PM URINE Color-Yellow Appear-Hazy Sp ___
___ 11:55PM URINE Blood-TR Nitrite-NEG Protein-30 
Glucose-300 Ketone-80 Bilirub-NEG Urobiln-2* pH-5.5 Leuks-NEG
___ 11:55PM URINE RBC-1 WBC-6* Bacteri-FEW Yeast-NONE Epi-1
___ 11:55PM URINE CastHy-17*

Relevent MICU Labs:
___ 03:55AM BLOOD WBC-5.2 RBC-2.97* Hgb-10.4* Hct-30.2* 
MCV-102* MCH-34.8* MCHC-34.3 RDW-13.0 Plt ___
___ 04:17AM BLOOD WBC-3.8* RBC-2.60* Hgb-8.8* Hct-28.0* 
MCV-107* MCH-33.7* MCHC-31.4 RDW-12.7 Plt ___
___ 03:55AM BLOOD ___ PTT-27.7 ___
___ 03:55AM BLOOD Plt ___
___ 04:17AM BLOOD ___ PTT-30.3 ___
___ 04:17AM BLOOD Plt ___
___ 03:55AM BLOOD Glucose-152* UreaN-18 Creat-1.1 Na-135 
K-3.8 Cl-98 HCO3-23 AnGap-18
___ 04:17AM BLOOD Glucose-546* UreaN-9 Creat-1.0 Na-132* 
K-3.1* Cl-97 HCO3-25 AnGap-13
___ 03:55AM BLOOD ALT-53* AST-72* LD(LDH)-251* CK(CPK)-104 
AlkPhos-62 Amylase-517* TotBili-1.0
___ 04:17AM BLOOD ALT-57* AST-86* LD(___)-218 AlkPhos-75 
TotBili-1.0
___ 03:55AM BLOOD Lipase-1303*
___ 04:17AM BLOOD Lipase-1337*

Discharge Labs;
___ 08:00AM BLOOD WBC-4.2 RBC-2.99* Hgb-10.2* Hct-30.5* 
MCV-102* MCH-34.0* MCHC-33.3 RDW-13.1 Plt ___
___ 08:00AM BLOOD Glucose-176* UreaN-16 Creat-1.0 Na-137 
K-3.4 Cl-103 HCO3-25 AnGap-12
___ 08:00AM BLOOD Calcium-8.1* Phos-2.7 Mg-1.6
___ 07:00AM BLOOD %HbA1c-8.3* eAG-192*

Micro:  
Blood culture ___- PENDING x 2

Imaging:
EKG ___: Sinus tachycardia. RSR' pattern in lead V1 (normal 
variant). Left atrial abnormality. Non-specific ST segment 
changes. No previous tracing available for comparison. Rate 114, 
QTc 424
  
CXR ___: Lung volumes are low and there are patchy bibasilar 
opacities which may reflect patchy lower lobe atelectasis, 
although aspiration or pneumonia cannot be entirely excluded.  
Clinical correlation is advised.  No pneumothorax.  No evidence 
of pulmonary edema.  No acute bone abnormality appreciated. 

CT abd/pelvis ___: 1.  Peripancreatic fluid and fat 
stranding suggestive of pancreatitis.  No evidence of organized 
fluid collection. 
2.  Hepatic steatosis. 3.  Diverticulosis without evidence of 
diverticulitis 
 
Brief Hospital Course:
___ yo Male with history of poorly controlled DM, transferred 
from ___ for managment of DKA, pancreatitis and EtOH 
withdrawal

#DKA- came in with gap of 18, glucose of 230s.  Patient endorse 
medication non-compliance.  While in the ICU, patient was 
treated with fluid and electrolyte resuscitation and 
subcutaneous insulin, with good response. ___ 
was consulted. His insulin drip was stopped on ___. He was 
called out to the medicine floor where he remained quite stable. 
He was seen by ___ on whose recommendation he was dc-ed to rehab. 


# Acute pancreatitis- Nausea and abdominal pain were present on 
admission, as well as a lipase to 1098 at ___ 1251 at 
___. He was treated conservatively with NPO diet, pain control 
with tylenol.  A CT abdomen showed uncomplicated pancreatitis, 
without pseudocyst, necrosis, or fluid collection. Pt improved 
quickly and was toelrating regular diet, with pain controlled on 
tylenol at ___ to rehab. 

# Alcohol withdrawal- Patient reports his last drink was on 
___ morning before admission.  Patient reports that he drinks 
___ hard alcoholic drinks daily. He denies any withdrawal 
symptoms in the past, however while in the ICU he required more 
than 100mg of PRN Diazepam on a CIWA scale.  He was treated with 
Diazepam and breakthrough lorazepam per ___ protocol, and given 
thiamine and multivitamin supplementation.  A social work 
consult was placed regarding his substance abuse, as well. He 
did not score on CIWA after transfer to floor. 

#Anemia: HCT has remained stable throughout MICU stay.  Has 
macrocytic anemia consistent with history of alcohol abuse. He 
did not require transfusion, and had guaiac negative stools. We 
continued home b12 and added on folate supplementation.
 
___- Presented with serum Cr of 1.9 on admission, which is 
elevated from baseline.  Was given aggressive fluid 
resuscitation and responded well with normalization of serum Cr. 
Normalised at time of dc. 
 

Transitional Issues:
- Will need ETOH abuse council if amenable  
- f/u with ___ as outpt-set up as high risk through care 
connection seen w/in 2 days of discharge; decision to refer to 
___ deferred to PCP

 
___ on ___:
Lisinopril 10 mg daily  
simvastatin 40 mg daily  
Levemir Flexpen BID (10 units, but patient is unsure)  
___ Senior multivitamin  

 
Discharge Medications:
1. Simvastatin 40 mg PO DAILY 
2. Lisinopril 10 mg PO DAILY 
3. FoLIC Acid 1 mg PO DAILY 
4. Multivitamins W/minerals 1 TAB PO DAILY 
5. Levimir 8 Units Bedtime
6. Insulin SC 
      Sliding Scale
Insulin SC Sliding Scale using HUM Insulin

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
PRIMARY DIAGNOSIS:
1. ACUTE PANCREATITIS
2. DIABETIC KETOACIDOSIS

SECONDARY DIAGNOSIS:
1. TYPE 2 DIABETES MELLITUS
2. HYPERLIPIDEMIA
3. PSORIASIS

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Mr ___,

It was a pleasure participating in your care while you were 
admitted to ___. As you know 
you were admitted because you were experiencing abdominal pain 
and were ultimately found to have pancreatitis. This was caused 
by drinking too much alcohol and it is very important that you 
decrease the amount you are drinking.  Your blood sugars were 
also extremely high and you develop a condition called Diabetic 
Ketoacidosis. This can be extremely dangerous and it is very 
important that you take insulin as instructed.  
 
Followup Instructions:
___
"
16867779-DS-14," 
Name:  ___.                Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Corgard / Lasix
 
Attending: ___.
 
Chief Complaint:
Scrotal swelling and tenderness
 
Major Surgical or Invasive Procedure:
None
 
History of Present Illness:
Mr ___ is a ___ y/o gentleman with a past medical history 
significant for Hypertension, Diabetes Mellitus Type 2 (last 
A1c-13), mild chronic kidney disease, Hyperlipidemia, Coronary 
Artery Disease s/p drug eluting stent to right coronary and left 
circumflex who comes in with 4 day history of scrotal pain and 
tenderness.  
.  
Mr ___ reports that for the past 2 weeks he has had 
genitourinary issues. 2 weeks ago he noted a sore on his penis 
for which he was seen and his PCP treated him with two doses of 
fluconazole. Patient reports that this seems to have since 
resolved over the weekend. In what appears to be an unrelated 
process, patient notes that he began having scrotal tenderness 
and pain. He describes his pain as 12 out of 10, non-radiating 
and worsened with movement. He has never had these symptoms 
before.  
.  
Patient denies having any associated fevers, chills, night 
sweats or penile discharge during this period. He also denies 
any sexual contacts. He also denies any new lotions, creams or 
underwear. 

 
Past Medical History:
Diabetes Mellitus type II  
Hypertension  
Hyperlipedemia  
History of Skin Cancers  
Coronary Artery Disease s/p drug eluting stent to right coronary 
artery and Left Circumflex  
Anemia  
Diabetic peripheral neuropathy  
___ Disease  
Chronic Back pain  
Polyclonal Gammopathy
 
Social History:
___
Family History:
Father deceased at age ___ from ___. Brother deceased of ___ in ___
 
Physical Exam:
ON ADMISSION:

VS: T 97.6, BP 128/64, HR 92, RR 18, 97% RA, ___ 277
GENERAL: Well-appearing man in NAD, complains of testicular 
pain, laying in bed.
HEENT: NC/AT, PERRLA, EOMI, sclerae anicteric, OP clear.
NECK: Supple, no thyromegaly, no JVD, no carotid bruits.
HEART: RRR, no MRG, nl S1-S2.
LUNGS: CTA bilat, no r/rh/wh, good air movement, resp unlabored.
ABDOMEN: Soft/NT/ND, no masses or HSM, no rebound/guarding.
EXTREMITIES: WWP, no c/c/e, 2+ peripheral pulses.
GU: No CVAT, difficulty to retract foreskin, scrotum TTP, 
erythematous, no fluctuance. Also erythema over groin folds 
bilaterally.
SKIN: Erythematous papules over bilateral medial thighs.
LYMPH: No cervical LAD.

ON DISCHARGE:
Exam unchanged except for decreased scrotal tenderness to 
palpation as well as an improvement in degree of scrotal eythema
 
Pertinent Results:
ON ADMISSION:

Chemistries: 
___ 09:00PM   GLUCOSE-276* UREA N-18 CREAT-1.0 SODIUM-131* 
POTASSIUM-4.3 CHLORIDE-95* TOTAL CO2-26 ANION GAP-14
___ 09:00PM BLOOD Calcium-9.1 Phos-2.8 Mg-1.9

Hematology:
___ 09:00PM BLOOD WBC-11.1* RBC-3.44* Hgb-11.3* Hct-32.0* 
MCV-93 MCH-33.0* MCHC-35.5* RDW-13.9 Plt ___
___ 09:00PM BLOOD Neuts-50 Bands-0 ___ Monos-5 Eos-3 
Baso-0 ___ Myelos-0
___ 09:00PM BLOOD ___ PTT-25.8 ___

ON DISCHARGE:

Chemistries:
___ 05:25AM BLOOD Glucose-135* UreaN-16 Creat-0.9 Na-131* 
K-3.8 Cl-97 HCO3-26 AnGap-12

Hematology:
___ 05:25AM BLOOD WBC-10.0 RBC-3.56* Hgb-11.8* Hct-33.5* 
MCV-94 MCH-33.2* MCHC-35.2* RDW-14.2 Plt ___

CT PELVIS WITH ___:
Probable small peripheral calcification vs. residual contrast 
along the left testicle is noted and there is a mild amount of 
fluid within the scrotal sac, however, no subcutaneous gas or 
significant skin thickening is present to suggest early 
necrotizing fasciitis. Please note, the images of the scrotal 
region were obtained in the different sequences after the 
administration of intravenous contrast.
 
Included solid organs within the pelvis including the bladder 
and large bowel and prostate appear unremarkable. No 
pathologically enlarged lymph nodes are seen. Mild 
atherosclerotic calcification is present within the vasculature 
with no flow-limiting stenosis noted.
 
BONE WINDOWS: Osteoarthritic changes involving both hips, 
slightly greater on the left side is noted with some lucencies 
within the right ilium adjacent to the SI joint, likely related 
to focal osteopenia. No aggressive osseous lesions are present. 
Degenerative changes are noted within the visualized lumbar 
spine.
 
IMPRESSION:
No CT findings to suggest necrotizing fasciitis.

**PENDING ON DISCHARGE**
___ blood cultures x 2, urine culture
 
Brief Hospital Course:
___ y/o gentleman with a past medical history significant for 
Hypertension, Diabetes Mellitus Type 2 (last A1c-13), mild 
chronic kidney disease, Hyperlipidemia, Coronary Artery Disease 
s/p drug eluting stent to right coronary and left circumflex who 
comes in with 4 day history of scrotal pain and tenderness.
.
#Testicular pain/swelling
Admitted overnight on ___ with complaints of marked scrotal 
tenderness and erythema. Patient was afebrile with stable vital 
signs. His exam showed erythema over scrotal skin as well as 
erythematous skin within his groin folds bilaterally. WBC was 
11.1. There was concern for a deeper perineal infection, so 
General Surgery and Urology were consulted. Based on these 
services' recommendations, the patient was initially started on 
empiric antibiotic therapy with vancomycin, zosyn, & 
clindamycin. However, a CT pelvis showed no signs of necrotizing 
fascitis, and with low suspicion for fournier's gangrene, the 
zosyn and clindamycin were discontinued. He received a 1 time 
dose of 2mg IV morphine for pain control, but by the following 
morning, was no longer having any pain or tenderness to 
palpation. Further, his WBC count had normalized. He was felt to 
have a topical fungal infection with possibly an associated 
cellulitis. Given the clinical improvement, we discharged the 
patient home on PO bactrim DS BID 7-day course and miconazole 
cream bid. Patient was encouraged to maintain good perineal 
hygiene and to take tylenol for potential perineal discomfort. 
Blood and urine cultures are negative to date. He will f/u in 
___ clinic on ___.
.
#. HTN: 
Given uncertainty of infection and possible susceptibility to 
hemodynamic compromise home antihypertensives was initially 
held. Patient remained normotensive throughout hospital course. 
.
#. DM2/Hyperglycemia: 
Patient reports a recent hospitalization at ___ for elevated 
glucose to 800. He is followed at the ___ and ___ glargine 
at home. In the hospital, his finger sticks ranged from 140s to 
low 200s.
.
#. HLD: 
We continued his home regimen of Lipitor.
.
#. Thigh rash: 
Previously noted by PCP and felt to be heat rash or 
excoriation-related although could not exclude leukocytoclastic 
vasculitis. Improving without intervention per patient and can 
be followed up as outpatient.
.
#. Pending results:
- ___ Blood cultures x ___ Urine culture
 
Medications on Admission:
ATORVASTATIN [LIPITOR] 10mg daily
CARBIDOPA-LEVODOPA [SINEMET] 10 mg-100 mg Tablet 1 tablet tid
GABAPENTIN 300mg prn daily; 600mg QHS
ASPIRIN 81 mg daily
MULTIVITAMIN
NPH INSULIN HUMAN RECOMB [HUMULIN N] 74 units in the morning / 
15 each p.m.
VITAMIN D
AMLODIPINE 5 mg daily
VALSARTAN [DIOVAN] 160 mg daily
TAMSULOSIN 0.4 mg daily
 
Discharge Medications:
1. Bactrim DS 800-160 mg Tablet Sig: One (1) Tablet PO twice a 
day for 7 days.
Disp:*14 Tablet(s)* Refills:*0*
2. gabapentin 300 mg Capsule Sig: Two (2) Capsule PO HS (at 
bedtime).  
3. gabapentin 300 mg Capsule Sig: One (1) Capsule PO DAILY 
(Daily) as needed for pain.  
4. cholecalciferol (vitamin D3) 400 unit Tablet Sig: Two (2) 
Tablet PO DAILY (Daily).  
5. multivitamin     Tablet Sig: One (1) Tablet PO DAILY (Daily). 
 
6. carbidopa-levodopa ___ mg Tablet Sig: One (1) Tablet PO 
TID (3 times a day).  
7. atorvastatin 10 mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
8. acetaminophen 325 mg Tablet Sig: Two (2) Tablet PO Q6H (every 
6 hours) as needed for pain.  
9. miconazole nitrate 2 % Cream Sig: One (1) Appl Topical BID (2 
times a day).
Disp:*1 tube* Refills:*2*
10. valsartan 160 mg Tablet Sig: One (1) Tablet PO once a day.  
11. tamsulosin 0.4 mg Capsule, Ext Release 24 hr Sig: One (1) 
Capsule, Ext Release 24 hr PO once a day.  
12. amlodipine 5 mg Tablet Sig: One (1) Tablet PO once a day.  
13. Insulin Humulin N (NPH)  Sig: As directed   twice a day: 74 
units qAM, 15 units qPM.  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
PRIMARY: 
Possible cellulitis 
___ intertrigo 
 
SECONDARY: 
Hypertension 
Diabetes Mellitus Type 2 
___ Disease 
 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
It was a pleasure taking care of you at the ___.

You were admitted because you had pain and redness in your groin 
and scrotum. We gave you broad coverage antibiotics overnight in 
case you had a deeper infection, but this was not seen on the CT 
scan of your pelvis. While here with us overnight your pain 
improved considerably. We will discharge you on oral antibiotics 
to treat a skin infection. We think that you also have a fungal 
infection in your groin and scrotum. It is important that you 
take the medications listed below and also maintain good hygiene 
in your groin area.

We made the following changes to your medications:
1. Please apply Miconazole 2% Cream 1 Appl twice a day to your 
groin folds and scrotum.
2. Please take Bactrim DS 1 Tab twice a day by mouth for 7 days.
 
Followup Instructions:
___
"
16991646-DS-11," 
Name:  ___                      Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
headache, blurred vision, hypertension

 
Major Surgical or Invasive Procedure:
None this hospitalization

 
History of Present Illness:
This is a ___ year-old Female with a PMH significant for 
ulcerative colitis and remote history of migraine headache who 
presented with 1-day of headache and right-sided neck pain that 
progressed gradually starting the afternoon of ___ found to 
be hypertensive.
.
The patient notes the headache pain was bilateral and constant 
with a throbbing quality that gradually progressed since the 
afternoon of ___, while she was at work. She took Ibuprofen 
without significant benefit, and while her headache failed to 
worsen, it remained into the evening. The patient awoke the day 
of admission with a right, posterior neck and shoulder pain that 
radiating anteriorly. She checked her blood pressure at home and 
it was 180/112 mmHg so she called her primary care physician. 
This was associated with a transient blurry vision which 
resolved within minutes. She was referred to the ED given her 
hypertension and vision concerns. 
.
She has no documented history of hypertension but did have a 
blood pressure of 150/90 mmHg on routine PCP ___ 1-month ago. 
Given that finding, she was told to discontinue her OCP (Aviane) 
medication (which she has been on for ___ for dysmenorrhea). 
She takes no other medications and no anti-hypertensives. She 
denies meningismus, fevers or chills. No current vision changes 
or diplopia. She denies chest pain or shortness of breath. She 
has no leg swelling. She denies dysuria or hematuria. She has no 
nausea, emesis or abdominal pain and denies decreased appetite. 
She has no numbness, weakness or tingling. She also denies 
seziure history, but has a notable history of remote migraine 
headaches without episodes for many years.
.
On arrival to the ED, initial VS 98.6 88 ___ RA. Her 
exam was notable for TTP over the right trapezius muscle with 
normal fundoscopic exam and no papilledema. She had no visual 
field deficits and her neurologic exam was non-focal. She was 
having some restlessness and reported muscle twitching of her 
neck and right shoulder. Her laboratory data were notable for 
WBC 7.7, HCT 44.0. Creatinine 0.8. Urine hCG and urinalysis were 
negative. An EKG showed NSR @ 81, NA/NI, concern for LVH without 
ST-changes or evidence of ischemia. A CTA of the head and neck 
demonstrated no acute intracranial process, with the exception 
of left sphenoidal sinus disease. There was no evidence of 
dissection, aneurysm or vascular malformation. She was started 
on a Labetalol infusion and given Diazepam 5 mg PO x 1 for 
twitching and her BP improved to 179/111 mmHg with a HR of 80 
and improvement in her headache.
.
On arrival to the FICU, she had no chest pain or shortness of 
breath. She has no vision changes or headaches. Her right neck 
and shoulder spasm improved with Diazepam.
.
ROS: Denies vision changes. No cough or upper respiratory 
symptoms. Denies chest pain, dizziness or lightheadedness; no 
palpitations. Denies shortness of breath. No nausea or vomiting, 
denies abdominal pain. No dysuria or hematuria. Denies muscle 
weakness, myalgias or neurologic complaints.

 
Past Medical History:
1. Ulcerative colitis (diagnosed in ___, few episodic flares; 
sigmoidoscopy in ___ showing only left-sided colitis)
2. Spasmodic dysphonia (requiring Botox injections, followed by 
Dr. ___ ENT surgery)
3. Migraine headache with aura (remote history, no recent 
episodes)
4. Endovenous laser ablation of the left greater saphenous vein 
(___)

 
Social History:
___
Family History:
Father deceased from esophageal cancer; mother with lung cancer 
and breast cancer is still living. Maternal side with early 
cardiac death in two males of unknown circumstance. No cardiac 
dysrrhythmia or early MIs of note.

 
Physical Exam:
ADMISSION EXAM:
.
VITALS:  80  154/101  17  96% RA
GENERAL: Appears in no acute distress. Alert and interactive.
HEENT: Normocephalic, atraumatic. EOMI. PERRL. Nares clear. 
Mucous membranes moist. 
NECK: supple without lymphadenopathy. JVD not elevated.
___: Regular rate and rhythm, without murmurs, rubs or gallops. 
S1 and S2 normal. No carotid bruits.
RESP: Clear to auscultation bilaterally without adventitious 
sounds. No wheezing, rhonchi or crackles. Stable inspiratory 
effort.
ABD: soft, non-tender, non-distended, with normoactive bowel 
sounds. No palpable masses or peritoneal signs. No audible 
abdominal bruit.
EXTR: no cyanosis, clubbing or edema, 2+ peripheral pulses
NEURO: CN II-XII intact throughout. Alert and oriented x 3. DTRs 
2+ throughout, strength ___ bilaterally, sensation grossly 
intact. Gait deferred.
.
DISCHARGE EXAM: unchanged
 
Pertinent Results:
ADMISSION LABS:
.
___ 09:50AM BLOOD WBC-7.7 RBC-4.98 Hgb-15.5 Hct-44.0 MCV-88 
MCH-31.2 MCHC-35.3* RDW-12.8 Plt ___
___ 09:50AM BLOOD Neuts-79.3* Lymphs-13.9* Monos-3.7 
Eos-1.8 Baso-1.3
___ 09:50AM BLOOD Glucose-101* UreaN-13 Creat-0.8 Na-138 
K-6.2* Cl-102 HCO3-22 AnGap-20
___ 09:50AM BLOOD CK(CPK)-155
___ 09:50AM BLOOD CK-MB-3 cTropnT-<0.01
___ 09:50AM BLOOD Calcium-9.3 Phos-3.2 Mg-2.2 Cholest-242*
___ 02:59PM BLOOD %HbA1c-PND
___ 09:50AM BLOOD Triglyc-100 HDL-89 CHOL/HD-2.7 
LDLcalc-133*
___ 09:50AM BLOOD ASA-NEG Acetmnp-NEG Bnzodzp-NEG 
Barbitr-NEG Tricycl-NEG
___ 11:38AM BLOOD K-3.7
___ 09:50AM URINE Color-Straw Appear-Clear Sp ___
___ 09:50AM URINE Blood-NEG Nitrite-NEG Protein-NEG 
Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-NEG
___ 09:50AM URINE UCG-NEGATIVE
___ 09:50AM URINE bnzodzp-NEG barbitr-NEG opiates-NEG 
cocaine-NEG amphetm-NEG mthdone-NEG
.
DISCHARGE LABS:
.
___ 04:29AM BLOOD WBC-6.8 RBC-4.41 Hgb-13.4 Hct-40.1 MCV-91 
MCH-30.4 MCHC-33.4 RDW-13.1 Plt ___
___ 04:29AM BLOOD Glucose-99 UreaN-19 Creat-0.8 Na-139 
K-3.9 Cl-106 HCO3-24 AnGap-13
___ 04:29AM BLOOD Calcium-8.7 Phos-3.5 Mg-2.1
.
MICROBIOLOGIC DATA: 
___ MRSA screen - pending
.
IMAGING STUDIES:
.
___ CTA HEAD W&W/O C & RECO - No CT evidence of acute 
intracranial process. Aerosolized secretion in the left 
sphenoidal sinus suggest sinusitis. Futher details to be 
provided with CTA report. CTA: No evidence of dissection, 
aneurysm, vascular malformation or flow-limiting stenosis. Intra 
and extracranial anterior and posterior circulation arteries are 
patent. Left cavernous carotid is slightly smaller than right. 
Mild degenerative changes with disc space narrowing and 
disc-osteophyte complexes at C4/5, ___, and ___. No significant 
spinal canal 
narrowing. Awaiting 3D reformations. 
.
___ MR HEAD W/O CONTRAST - No evidence of acute infarction. 
Fluid in the sphenoid sinus with aerosolized secretions 
consistent with acute sinusitis.
.
___ CHEST (PA & LAT) - No acute findings. No mediastinal 
widening.
  

 
Brief Hospital Course:
IMPRESSION: ___ with a PMH significant for ulcerative colitis 
and remote history of migraine headache who presented with 
headache and transient vision changes found to be hypertensive 
to 200/100 mmHg with reassuring CTA head and neck imaging 
concerning for hypertensive urgency vs. emergency.
.
# HYPERTENSIVE URGENCY VS. EMERGENCY - The patient presented 
with a blood pressure of 150/90 mmHg on routine PCP ___ 
1-month ago with no prior history of hypertension, certainly a 
prior history of uncontrolled essential hypertension is 
plausible. She has few modifiable risk factors, she is not 
obese, denies excessive alcohol intake, and is physically active 
with aerobic activity. She is not on anti-hypertensive 
medications and recently discontinued her OCP (Aviane). Her 
blood pressure has ranged from ___ mmHg over 2-days 
with symptoms of posterior headache and neck pain, involuntary 
muscle spasm vs. distal extremity parathesias and twitching as 
well as transient vision concerns - despite normal renal 
function, no cardiac ischemic changes on EKG, encephalopathy, 
papilledema or retinal hemorrhaging. Given this symptomatology, 
hypertensive emergency was the concern. Overall her work-up was 
reassuring with a negative head and neck CTA and negative head 
MR imaging. She also had a reasurring laboratory work-up, 
although her EKG did show some chronic LVH changes and 
ultimately we attributed her condition to undiagnosed and 
uncontrolled essential hypertension. A Labetalol gtt was started 
in the ED and she was quickly weaned to PO Labetalol and then 
started Lisinopril 10 mg PO daily which will continue as an 
outpatient. She will follow-up with her PCP ___ 1-week for 
electrolyte monitoring.
.
# NECK SPASM, CERVICAL DYSTONIA - The patient presented with 
features of right neck and shoulder pain that has occurred 
before, per her daughter. The physical exam findings and 
clinical history indicate a primary focal dystonia or cervical 
dystonia. Half of patients describe pain in the setting of these 
findings. Her CTA did note some degenerative changes with disc 
space narrowing and disc-osteophyte complexes at C4/5, ___, and 
___ but the symptomatology seemed unrelated. This likely 
represents a separate process from her hypertensive urgency and 
there is no evidence of a medication-induced effect. She 
responded to Tylenol and PRN Valium with symptomatic relief.
.
# ULCERATIVE COLITIS - History of ulcerative colitis that has 
been left-colon predominant diagnosed in ___. She has had prior 
flares a few times yearly with rectal bleeding and last 
sigmoidoscopy in ___ showed left-sided colitis only. She has 
never been on corticosteroid treatment. She was previously on 
5-ASA (Rewasa) therapy only intermittently. She has no active 
rectal bleeding or abdominal pain symptoms to suggest active 
flare.
.
TRANSITION OF CARE ISSUES:
1. Follow-up scheduled with PCP ___ 1-week with electrolyte 
monitoring.

 
Medications on Admission:
None
 
Discharge Medications:
1. Tylenol ___ mg Tablet Sig: ___ Tablets PO every ___ hours as 
needed for fever or pain.  
2. lisinopril 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Disp:*30 Tablet(s)* Refills:*1*
3. Outpatient Lab Work
Please have your sodium, potassium and BUN, creatinine checked 
as an outpatient, which can be followed by your primary care 
physician. PCP: ___ ___, FAX: ___

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Primary Diagnoses:
1. Hypertensive urgency vs. emergency
2. Cervical dystonic reaction, muscle spasm
.
Secondary Diagnoses:
1. Ulcerative colitis
2. Hypertension
3. Migraine headaches

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Patient Discharge Instructions:
.
You were admitted to the Critical Care Unit service at ___ 
___ on the ___ floor of the ___ 
___ Care Unit regarding management of you critically high 
blood pressure, headache and neck pain. You were treated with IV 
blood pressure medications, pain medications and muscle 
relaxants with improvement in your symptoms. You were discharged 
on a low dose of Lisinopril for blood pressure management and 
will follow-up with your primary care physician ___ 1-week with 
electrolyte monitoring in clinic.
.
Please call your doctor or go to the emergency department if:
* You experience new chest pain, pressure, squeezing or 
tightness.
* You develop new or worsening cough, shortness of breath, or 
wheezing.
* You are vomiting and cannot keep down fluids, or your 
medications.
* If you are getting dehydrated due to continued vomiting, 
diarrhea, or other reasons. Signs of dehydration include: dry 
mouth, rapid heartbeat, or feeling dizzy or faint when standing.
* You see blood or dark/black material when you vomit, or have a 
bowel movement.
* You experience burning when you urinate, have blood in your 
urine, or experience an unusual discharge.
* Your pain is not improving within 12 hours or is not under 
control within 24 hours.
* Your pain worsens or changes location.
* You have shaking chills, or fever greater than 101.5 degrees 
Fahrenheit or 38 degrees Celsius.
* You develop any other concerning symptoms.
.
CHANGES IN YOUR MEDICATION RECONCILIATION:
.
* Upon admission, we ADDED:
START: Lisinopril 10 mg by mouth daily
START: Acetaminophen 325-650 mg by mouth every ___ hours as 
needed for pain or headache
.
* The following medications were DISCONTINUED on admission and 
you should NOT resume: NONE
.
* You should continue all of your other home medications as 
prescribed, unless otherwise directed above.
 
Followup Instructions:
___
"
17348831-DS-20," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___
 
Chief Complaint:
Shortness of breath and cough
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
___ with hx of schizoaffective disorder, afib on warfarin,
htn, NIDDM2, hypothyroidism, seizure disorder, OSA presenting
from ___ with SOB, cough x2 weeks. History is obtained
from review of records and from patient, who provides limited
details. He reports that he began to develop cough productive of
yellow sputum 2 weeks prior to presentation, which he attributes
to getting a ""cold"" from his AC unit. He denies chest pain, F/C,
nausea, vomiting, diarrhea, but endorses occasional 
constipation.
He is not aware of having any sick contacts. He denies 
orthopnea,
___ edema. 

Pt was brought to ED by EMS for reported SaO2 84%. 

In the ___ ED:
T 100.2, 99, 138/78, 98% Non-Rebreather-> 94% on 3L NC
Exam described as:
Lungs CTAB, abdomen soft, NT, ND, negative ___ sign
Labs notable for WBC 12.0, Hb 12.9, Cr 1.0, INR 2.6, proBNP 
2387,
TnT<0.01, lactate 2.0, Ddimer 226, VBG 7.42/42

No medications were administered

On arrival to the floor, pt is sleeping comfortably, easily
arouses to verbal stimuli, denies chest pain. He endorses
persistent productive cough.

 
Past Medical History:
1.  Atrial fibrillation, in sinus rhythm since ___.
2.  Probable CAD (probable prior IMI with inferior Q-waves and 
inferior wall motion abnormality on echo).
3.  Chronic right bundle-branch block.
4.  Hypertension.
5.  Dyslipidemia.
6.  Glucose intolerance
7.  Obesity.
8. Depression 
9. Anxiety
10. Hypothyroidism
11. Obstructive sleep apnea (non compliant with BIPAP)
12. BPH
13. Schizophrenia/schizoaffective disorder, depressive type
14. Impaired cognitive state
15. Former tobacco use
16. h/o GI bleed

 
Social History:
___
Family History:
Father with alcohol abuse. Pt reported history of MI in his 
mother around ___ years of age.

 
Physical Exam:
Admission physical exam:
VS: 97.4 PO 136 / 87 95 18 93 2 LNC 
GEN: elderly male, nontoxic appearing, sleeping comfortably, 
then
alert and interactive, no acute distress
HEENT: PERRL, anicteric with copious yellow discharge from R 
eye,
conjunctiva pink, oropharynx without lesion or exudate, moist
mucus membranes
LYMPH: no anterior/posterior cervical, supraclavicular 
adenopathy
CARDIOVASCULAR: Irregularly irregular without murmurs, rubs, or
gallops
LUNGS: clear to auscultation bilaterally without rhonchi,
wheezes, or crackles
GI: soft, trace TTP at LLQ only, without rebounding or guarding,
nondistended with normal active bowel sounds, no hepatomegaly
appreciated
EXTREMITIES: no clubbing, cyanosis, or edema
GU: no foley
SKIN: no rashes, petechia, lesions, or echymoses; warm to
palpation
NEURO: grossly intact
PSYCH: blunted affect

Discharge physical exam:
VITALS: 97.4 120/77 102 20 94% on 2L (ambulatory sat with ___ 
down
to 90% on 1L)
GEN: elderly male, nontoxic appearing, alert and interactive, no
acute distress sitting in chair
HEENT: PERRL, anicteric with no/resolved yellow discharge from R
eye, conjunctiva pink on  R eye (improved from day prior),
oropharynx without lesion or exudate, moist mucus membranes
LYMPH: no anterior/posterior cervical, supraclavicular 
adenopathy
CARDIOVASCULAR: Irregularly irregular without murmurs, rubs, or
gallops
LUNGS: CTAB, no crackles or rhonchi.
GI: soft, without rebounding or guarding, nondistended with
normal active bowel sounds, no hepatomegaly appreciated
EXTREMITIES: no clubbing, cyanosis, LLE slightly larger than RLE
(baseline per patient with trace edema)
GU: no foley
SKIN: no rashes, petechia, lesions, or echymoses; warm to
palpation
NEURO: grossly intact
PSYCH: pleasant and appropriate affect

 
Pertinent Results:
Admission labs
___ 08:42PM BLOOD WBC-12.0*# RBC-4.27* Hgb-12.9* Hct-39.5* 
MCV-93 MCH-30.2 MCHC-32.7 RDW-13.2 RDWSD-44.5 Plt ___
___ 08:42PM BLOOD ___ PTT-41.3* ___
___ 08:42PM BLOOD Glucose-153* UreaN-22* Creat-1.0 Na-139 
K-4.1 Cl-100 HCO3-22 AnGap-21*
___ 08:42PM BLOOD proBNP-___*
___ 08:42PM BLOOD cTropnT-<0.01
___ 06:38AM BLOOD Calcium-9.0 Phos-3.0 Mg-1.8
___ 02:38AM BLOOD %HbA1c-6.1* eAG-128*

Discharge labs:
___ 06:20AM BLOOD WBC-13.4* RBC-4.13* Hgb-12.8* Hct-39.3* 
MCV-95 MCH-31.0 MCHC-32.6 RDW-12.8 RDWSD-44.0 Plt ___
___ 06:20AM BLOOD Glucose-132* UreaN-34* Creat-0.9 Na-139 
K-4.5 Cl-100 HCO3-23 AnGap-21*
___ 06:38AM BLOOD ___ PTT-44.7* ___
___ 06:20AM BLOOD Calcium-8.8 Phos-4.3 Mg-2.1
___ 08:45PM BLOOD Lactate-2.0

Imaging:
Cxray ___
FINDINGS:  
PA and lateral views of the chest provided.  Overlying EKG leads 
are present. The lungs are clear bilaterally.  No evidence of 
pneumonia or edema.  No large effusion or pneumothorax.  Mild 
hilar congestion difficult to exclude.  
Cardiomediastinal silhouette appears stable.  Bony structures 
are intact 

Micro 
Sputum
GRAM STAIN (Final ___: 
      ___ PMNs and >10 epithelial cells/100X field. 
      Gram stain indicates extensive contamination with upper 
respiratory
      secretions. Bacterial culture results are invalid. 
      PLEASE SUBMIT ANOTHER SPECIMEN. 

   RESPIRATORY CULTURE (Final ___: 
      TEST CANCELLED, PATIENT CREDITED. 

 
Brief Hospital Course:
___ with hx of schizoaffective disorder, afib on warfarin, htn, 
NIDDM2, hypothyroidism, seizure disorder, OSA presenting from 
___ with coughx2 weeks and presentation likely consistent 
with COPD exacerbation.

# Cough:
# Dyspnea:
# Acute exacerbation of COPD: Symptoms improved after treatment 
with Prednisone and azithromycin (day 1- ___, end date 
___.  He was briefly on 2L of oxygen. He has a history of 
COPD from prior PFTS. He was discharge on steroid and albuterol 
inhalers. His ambulatory O2 on day of discharge was 90% on 1L. 
His O2 sat on room air was 94% on RA prior to discharge. For his 
COPD, we would tolerate O2 sat between 88%-92%.
Workup done was negative for PE (low d-dimer), CHF (BNP stable 
from prior), Pneumonia (no fevers). Cxray was reassuring.

# R eye discharge: Significantly improved prior to discharge 
with
resolution of thick discharge. No pruritus or eye pain. Though 
likely started as viral etiology, given presentation and
chronicity with increased discharge during admission will treat
as bacterial infection. Discharged on erythromycin ointment.

# Afib:
Continued home metoprolol with holding parameters
Continued home warfarin with INR monitoring. INR on ___ was 2.8

# Seizures: Stable. no evidence of seizure activity. 
Continued home Keppra.   

# Schizoaffective Disorder: stable. 
Continued home risperdol, duloxetine, ativan  

# HTN: stable. 
Continued home Lisinopril with hold parameters

# CAD: No CP or other sxs of ACS. 
Continued home Atorvastatin, ASA  

# Hypothyroid: 
Continued home Synthroid 
 
# DM: Recent A1c 6.1 (pre-diabetes). Continued home Metformin

# BPH: stable. 
Continued home Finasteride  

# OSA:
Continued bipap  

TRANSITIONAL ISSUES
===================
# New Medications
- Albuterol inhaler PRN
- Fluticasone
- Azithromcyin (end date ___
- Prednisone (end date ___

# Changed Medications
- None

# Stopped Medications
- None

To dos:
===========
- Ensure has Pulmonary follow up
- Discharged with inhalers (fluticasone and albuterol inhalers)
- On Azithromycin and prednisone (day 1- ___, End date 
___

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Triamcinolone Acetonide 0.1% Ointment 1 Appl TP BID:PRN 
itching 
2. MetFORMIN (Glucophage) 500 mg PO BID 
3. Warfarin 5 mg PO DAILY16 
4. Vitamin D 1000 UNIT PO DAILY 
5. RisperiDONE 2 mg PO QHS 
6. Omeprazole 20 mg PO DAILY 
7. Metoprolol Succinate XL 100 mg PO DAILY 
8. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild 
9. Aspirin 81 mg PO DAILY 
10. Atorvastatin 20 mg PO QPM 
11. DULoxetine 120 mg PO DAILY 
12. Finasteride 5 mg PO DAILY 
13. LevETIRAcetam 750 mg PO BID 
14. Levothyroxine Sodium 100 mcg PO DAILY 
15. Lisinopril 2.5 mg PO DAILY 
16. LORazepam 0.5 mg PO BID 
17. Milk of Magnesia 30 mL PO DAILY:PRN constipation 

 
Discharge Medications:
1.  Albuterol Inhaler 1 PUFF IH Q6H:PRN For shortness of breath 
RX *albuterol sulfate [ProAir HFA] 90 mcg 90 mcg inhalation 
Every 6 hours as needed for shortness of breath Disp #*2 Inhaler 
Refills:*0 
2.  Azithromycin 500 mg PO Q24H 
RX *azithromycin 500 mg 1 tablet(s) by mouth Daily (end date 
___ Disp #*2 Tablet Refills:*0 
3.  Erythromycin 0.5% Ophth Oint 0.5 in BOTH EYES QID 
RX *erythromycin 5 mg/gram (0.5 %) 1 application eye Upto 4 
times a day for infection for 3 more days Refills:*0 
4.  Fluticasone Propionate 110mcg 2 PUFF IH BID 
RX *fluticasone [Flovent HFA] 110 mcg/actuation 2 Puffs 
inhalation 2 puffs twice a day Disp #*5 Inhaler Refills:*0 
5.  PredniSONE 40 mg PO DAILY Duration: 2 Doses 
RX *prednisone [Deltasone] 20 mg 2 tablet(s) by mouth Daily (end 
date ___ Disp #*2 Tablet Refills:*0 
6.  Acetaminophen 650 mg PO Q6H:PRN Pain - Mild  
7.  Aspirin 81 mg PO DAILY  
8.  Atorvastatin 20 mg PO QPM  
9.  DULoxetine 120 mg PO DAILY  
10.  Finasteride 5 mg PO DAILY  
11.  LevETIRAcetam 750 mg PO BID  
12.  Levothyroxine Sodium 100 mcg PO DAILY  
13.  Lisinopril 2.5 mg PO DAILY  
14.  LORazepam 0.5 mg PO BID  
15.  MetFORMIN (Glucophage) 500 mg PO BID  
16.  Metoprolol Succinate XL 100 mg PO DAILY  
17.  Milk of Magnesia 30 mL PO DAILY:PRN constipation  
18.  Omeprazole 20 mg PO DAILY  
19.  RisperiDONE 2 mg PO QHS  
20.  Triamcinolone Acetonide 0.1% Ointment 1 Appl TP BID:PRN 
itching  
21.  Vitamin D 1000 UNIT PO DAILY  
22.  Warfarin 5 mg PO DAILY16  

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
Primary diagnosis:
Acute COPD exacerbation
Bronchitis
Bacterial conjunctivitis

Secondary diagnosis
Atrial fibrillation

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Mr ___,

You were admitted due to cough and shortness of breath which has 
improved. We felt this was likely a COPD exacerbation due to a 
viral infection or bronchitis.

You significantly improved and were discharged back to your 
facility with inhalers to use in the event of future symptoms of 
shortness of breath.

It was a pleasure being part of your care
Your ___ team
 
Followup Instructions:
___
"
17692355-DS-9," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: OBSTETRICS/GYNECOLOGY
 
Allergies: 
Nuts-pistachio and cashew only 
 
Attending: ___
 
Chief Complaint:
increasing left sided pelvic pain
 
Major Surgical or Invasive Procedure:
none

 
History of Present Illness:
Ms. ___ is a ___ G0 who was initially 
evaluated on ___ in clinic for 3 weeks of worsening 
intermittent sharp nonradiating left lower quadrant pain. 
Patient states that for the past week she has experienced this 
___ pain occurring several times a day, lasting ___ hours. Her 
exam was remarkable for tenderness in LLQ, however no rebound or 
guarding and a normal pelvic exam. She was found to have a 
normal white count of 7.6 with no left shift, negative UA, 
GC/chlamydia, BV and uhCG, and sent to OBGYN triage for further 
evaluation after imaging. In OBGYN triage, she was afebrile with 
normal HR 81. She had a pelvic US which showed ovaries normal in 
size with normal Doppler flow, no free fluid, and appropriately 
positioned Mirena IUD, and was discharged home.

Patient represented to clinic the following morning ___. 
Per clinic note, she was tearful, visibly uncomfortable, and had 
tenderness to palpation in left lower quadrant with voluntary 
guarding but without rebound tenderness. She had a repeat pelvic 
ultrasound at this time which showed normal sized ovaries and no 
free fluid, and was sent to triage. 

In OBGYN triage on ___,  patient reports that this pain has 
now been constant. She reports the pain is ___ ___nd 
___ with movement. Patient states that she has been taking 
Ibuprofen and Tylenol ""a few times a day,"" which has not 
improved her pain. She reports 2 episodes of emesis this morning 
in the context of ___ pain and continued nausea throughout the 
day. Denies further episodes of emesis. She reports decreased PO 
intake today due to nausea and pain. Last ate at 9am.

She denies fevers/chills, HA, CP, SOB, dizziness with 
ambulation. She denies dysuria, abnormal malodorous discharge, 
and hematuria. Denies diarrhea, constipation, blood in stool. 
She reports daily bowel movements this past week that are 
unchanged in consistency and frequency. Denies trauma, recent 
fall, new sexual partners.
 
Past Medical History:
PMH:
- anxiety
- pyelonephritis ___

PSH:
- LSC appendectomy at ___ c/b SBO, conservatively managed 
- LSC R ovarian cystectomy, ___
- Left triceps tendon repair ___

OB Hx: G0

GYN h/x:
- menarche age ___
- Amenorrheic since Mirena placed in ___
- Denies menorrhagia, dysmenorrhea
- H/o 4cm hemorrhagic cyst ___ s/p LSC R ovarian cystectomy
- Sexually active
- Reports possible PID in ___ denies other STIs
- Denies h/o abnormal paps
 
Social History:
___
Family History:
noncontributory
 
Physical Exam:
PHYSICAL EXAMS:

___ ___:
Gen: tearful in pain, presents alone
 HEENT:  normal
 Thyroid:  no thyromegaly, no nodules
 Resp:  CTABL no crackles or wheezes appreciated
 CV:  RRR, no murmurs, rubs, gallops
 Abd:  soft, active bowel sounds, tender to palpation in LLQ, 
non-radiating, no rebound or guarding
 Musculoskeletal: grossly normal
 Extremities:  good perfusion, no edema, calves nontender
 Neuro:  grossly wnl
 Pelvic:
 - External Genitalia: normal, no lesions or cysts
 - Urethra: meatus < 5mm, no lesions
 - Vagina: normal mucosa, no discharge, or lesions
 - Cervix: no CMT, discharge, lesions or bleeding. nulliparous, 
IUD strings in place
 - Uterus: antevertex, small, non tender, mobile
 - Adnexa: no palpable masses bilaterally, tenderness with 
palpation of left adnexal space
 - Anus/Perineum: normal appearance, no lesions

OBGYN TRIAGE ___:
Vitals: 98.7, HR 81, BP 143/70, RR 18
Gen: NAD, sitting comfortably in the bed and able to hold
conversation throughout history without appearing uncomfortable
Abd: soft, NTTP, mildly TTP in LLQ, no rebound/guarding
SSE: deferred as this was performed in clinic and found to be 
normal
SVE: no CMT, +TTP in LLQ though not palpably over the adnexa. no 
fundal TTP or RLQ pain.

TCC8 ___
BP: 122/74, Weight: 198 (With Clothes), Height: 68, BMI: 30.1, 
LMP: # (Mirena)
Gen: tearful, visibly uncomfortable
Abdomen: soft, TTP in the LLQ, no rebound, voluntary guarding
SSE: normal, IUD strings in placed
SVE: no CMT, +TTP in the LLQ, no RLQ pain, no fundal tenderness, 
rectovaginal exam unremarkable

OBGYN TRIAGE ___:
T99.1, BP 110/51, HR 80, Pain score ___
Gen: lying in bed, appears mildly uncomfortable
CV: RRR
Pulm: LCTAB
Abdomen: soft, +BS, nontender in LUQ, RUQ and RLQ. Reports 
severe tenderness focally in LLQ, however is able to speak 
through exam. No rebound or guarding. No left flank pain or CVA 
tenderness.
Pelvic: deferred given lack of symptoms and two recent normal 
pelvic exams within past 24 hours

DAY OF DISCHARGE, HOSPITAL DAY 2, ___:
Gen: lying in bed, appears comfortable on approach by provider
___: RRR, no murmurs, rubs, or gallops
Pulm: LCTAB, no wheezes or crackles appreciated
Abdomen: soft, +BS, nontender in LUQ, RUQ and RLQ. Reports 
severe tenderness focally in LLQ, however is able to speak 
through exam. Voluntary guarding. No rebound. No left flank pain 
or CVA tenderness.
 
Pertinent Results:
___ 05:40PM   UREA N-13 CREAT-0.8
___ 05:40PM   estGFR-Using this
___ 05:40PM   CRP-0.8
___ 05:40PM   WBC-7.6 RBC-4.04 HGB-12.1 HCT-36.5 MCV-90 
MCH-30.0 MCHC-33.2 RDW-12.8 RDWSD-42.4
___ 05:40PM   PLT COUNT-226
 
Brief Hospital Course:
Ms. ___ is a ___ G0 with h/o lsc right ovarian cystectomy and 
questionable PID in ___, ___ IUD in place, who presented to 
OBGYN triage on ___ with 3 weeks of intermittent left lower 
quadrant pain and new onset nausea and isolated episode of 
emesis who was admitted for observation.

Of note, she was evaluated in ___ clinic on ___ for this 
pain. She was afebrile with normal vital signs. had an abdominal 
exam remarkable for tenderness in LLQ without rebound or 
guarding, and a normal pelvic exam. She was found to have a 
normal white count of 7.6 with no left shift, negative UA, 
GC/chlamydia, BV and uhCG. She was ordered for a pelvic US which 
showed ovaries normal in size with normal Doppler flow, no free 
fluid, and appropriately positioned Mirena IUD.

In triage on ___, her pain was controlled with IV Dilaudid. 
She had normal vitals and a normal repeat pelvic ultrasound 
which showed ovaries normal in size and appearance, no ovarian 
cysts or evidence of torsion, and IUD properly positioned. 
Repeat CBC/differential and CRP were normal. Given worsening 
abdominal pain with unclear etiology, patient was admitted for 
observation the evening of ___.

Overnight, patient slept comfortably overnight per nursing 
report. On hospital day 1 (___), patient was sleeping 
comfortably in bed when approached by provider. After awakening 
from sleep, she reported persistent ___ left lower pain. Upon 
medication review, patient had received, 1 dose of IV Dilaudid, 
1 Tylenol and 1 since admission. Her nausea was controlled with 
Zofran, and she was tolerating regular diet without nausea or 
vomiting. She had normal vital signs and benign physical exam 
with soft abdomen and voluntary guarding in left lower quadrant. 
She reported severe tenderness focally in LLQ, however was able 
to speak through exam. Preliminary read for CT abdomen/pelvis 
was negative for any acute intraabdominal process.

Patient had normal vital signs and stable physical exam >24 
hours total in ___/triage/hospital floor with negative labs and 
imaging. Given the low concern for ovarian torsion and GYN 
source of pain, and no clear acute GI or MSK etiology for pain, 
patient was discharged home in stable condition with outpatient 
GYN follow up appointment scheduled and recommended primary care 
followup for additional workup of pain, should it persist.
 
Medications on Admission:
Sertraline, Zyrtec
 
Discharge Medications:
1.  Acetaminophen 1000 mg PO Q6H 
Do not take more than 4000mg in 24 hours.  
RX *acetaminophen 500 mg ___ tablet(s) by mouth every 6 hours 
Disp #*50 Tablet Refills:*1 
2.  Ibuprofen 600 mg PO Q6H 
Take with food. Do not take more than 2400mg in 24 hours. 
RX *ibuprofen 600 mg 1 tablet(s) by mouth every 6 hours Disp 
#*50 Tablet Refills:*1 

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
abdoiminal pain

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___,

You were admitted to the gynecology service after presenting 
with abdominal pain concerning for ovarian torsion. You 
underwent imagine that has shown no evidence of ovarian torsion 
or appendicitis. You have recovered well and the team believes 
you are ready to be discharged home. Please call schedule an 
outpatient appointment with your primary care doctor for further 
evaluation of your abdominal pain.  Please follow the 
instructions below. 
* Take your medications as prescribed.
* Do not take more than 4000mg acetaminophen (APAP/tylenol) in 
24 hrs.
* Do not take more than 2400mg ibuprofen in 24 hours. 

 
Followup Instructions:
___
"
17739994-DS-31," 
Name:  ___                Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: OBSTETRICS/GYNECOLOGY
 
Allergies: 
Penicillins / Reglan / Phenergan / Prochlorperazine
 
Attending: ___.
 
Chief Complaint:
nausea, vomiting, abdominal pain
 
Major Surgical or Invasive Procedure:
none
 
History of Present Illness:
___ yo G5P0 at ___ with hyperemesis gravidarum who presented to 
GYN triage with nausea and vomiting. Her emesis is non-bloody, 
non-bilious. She has had multiple episodes of vomiting since 
waking up this morning and has been unable to hold anything 
down. She has voided ""all day"" despite persisitent vomiting 
after trying foods and liquids.  

From a hyperemesis standpoint, she had been doing well for 2 
weeks after her discharge from the ___ service ___ for 
hyperemesis. Her nausea and vomiting then worsened significantly 
on ___ and improved somewhat on ___. However, she has 
been vomiting since then even when drinking tea, which usually 
helps, and using her Zofran three times a day.

She c/o epigastric abdominal pain and reflux pain. No CP/SOB. No 
HA. No fevers/chills. + constipation. No VB or LOF. No 
contractions.
 
Past Medical History:
PRENATAL COURSE
- EDC ___ by LMP c/w first trimester u/s
- O+/Ab-/RPRNR/RI/HBsAg-/HIV-/TSH 2.4/UCx-
- CF negative, nl hgb electrophoresis ___

OBSTETRIC HISTORY
G5P0
G1-G3 TAB x3, all complicated by severe hyperemesis, requiring 
multiple hospitalizations, resulting in elective termination due 

to intolerable hyperemesis. Most recent at 18wga.
G4 SAB x1, complicated by severe hyperemesis, with multiple
hospitalizations, PICC/TPN; complicated by pulmonary embolism on
Lovenox; complicated by SAB s/p ___ for megacystis
G5 current

GYNECOLOGIC HISTORY
- Did not resume regular menses after her D&E ___
- Irregular menses
- History of abnl Pap: LSIL Pap ___, had colpo ___ showing
squamous metaplasia.  She is scheduled for repeat postpartum s/p
Gardasil vaccine
- Remote history of chlamydia
- 5 x 3cm anterior fibroid noted

PMH:
Pulmonary embolism, diagnosed ___. Was on lovenox and then 
transitioned to coumadin which was discontinued prior to 
conception. She is now on prophylactic lovenox.

PSH: D&E x 4
 
Social History:
___
Family History:
non-contributory
 
Physical Exam:
(on admission)
VS: 98.3 ___ 18
Gen: Uncomfortable in bed, spitting in basin
Card: RRR
Resp: CTAB
Abd: Soft, mild diffuse tenderness in upper abdomen, no
rebound/guarding, +BS, fundus 4cm below umbilicus
Pelvic: Deferred
Ext: NT, NE

TAUS: SIUP with FHR 158. Subjectively normal fluid and movement. 
Posterior placenta.
 
Pertinent Results:
___ WBC-10.2 RBC-3.75 Hgb-10.5 Hct-30.9 MCV-82 Plt-286

___ Glu-79 BUN-7 Creat-0.5 Na-138 K-3.8 Cl-106 HCO3-22
___ Lipase-32 Calcium-9.4 Phos-4.3 Mg-1.___ G5P0 admitted at 16w3d with hyperemesis gravidarum. She was 
observed in triage for quite some time and given IVFs and 
antiemetics. Electrolytes were normal. Although she felt 
somewhat better, she continued to complain of persistent nausea 
and the decision was made to observe her overnight. On hospital 
day #2, her symptoms improved and she was tolerating both fluids 
and solids. She was discharged home in stable condition and will 
have close outpatient followup. 
 
Medications on Admission:
zofran
lovenox
 
Discharge Medications:
1. diphenhydramine HCl 25 mg Capsule Sig: One (1) Capsule PO Q6H 
(every 6 hours).  
2. pyridoxine 25 mg Tablet Sig: One (1) Tablet PO Q6H (every 6 
hours).  
3. enoxaparin 40 mg/0.4 mL Syringe Sig: One (1)  Subcutaneous 
DAILY (Daily).  
4. Zofran 4 mg Tablet Sig: One (1) Tablet PO every eight (8) 
hours as needed for nausea.
 
Discharge Disposition:
Home
 
Discharge Diagnosis:
nausea, vomitting, pregnancy
 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
 
Discharge Instructions:
Please continue eating a bland diet (bananas, apple sauce, rice, 
toast). Call our office if you are unable to hold fluids or food 
down or if you have any other concerning symptoms. 
 
Followup Instructions:
___
"
18046197-DS-13," 
Name:  ___                Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Keflex / Orencia / Remicade
 
Attending: ___.
 
Chief Complaint:
headache
 
Major Surgical or Invasive Procedure:
Procedure this AM: informed consent obtained, proper timeout 
taken, sterile etoh prep and technique, Bilateral GONB and TPI 
to Bilateral splenius capitis and occipitalis with 14 cc 0.25% 
bupivicaine PF and 10 mg MPA without complications 
 
History of Present Illness:
Mr. ___ is a ___ year old male with h/o psoriatic arthritis 
and spondylitis involving his neck/back who presents with 
headache. Notes headache came on ___ afternoon at which point 
he tried to treat it with prn morphine ___ 15 mg po and morphine 
SR 30 mg po (took X 2 on ___. He notes that the pain is the 
same as multiple prior episodes that occur when his disease 
flares, usually when he is on less immunosuppression. He has 
been treated with remicade, enbrel, and orencia in the past but 
either had side effects or found the medication to be unhelpful 
after a time. He reports no fevers or neck stiffness and no 
photophobia. He is now on imuran 100 mg bid and prednisone 50 mg 
daily (has been on prednisone for over one year per report). On 
___, he tried morphine SR 60 mg twice (AM & ___ and 
morphine ___ 15 mg X 2 but did not have relief of pain; he 
contacted the rheumatology attending on call at that point who 
advised ED evaluation. He denies any visual changes, nausea, or 
vomiting. Pain started in occipital region yesterday but now 
generalized over entire head (his usual pattern). He denies any 
slurred speech, seizures, syncope, or numbness in either arm or 
leg. He reports chronic weakness in the right hand.  
.  
He has also noted increased swelling in his hands and feet, 
which also happens when his immunosuppression is lowered. He is 
awaiting approval for humira but this has not yet been done. He 
also sees the pain clinic for potential botox injections but 
this has not yet been approved either. Of note he started 
augmentin 875 mg bid for axillary abscess (happens recurrently 
per his report) on ___.  
.  
In the ED, initial vitals T 98.8, HR 85, BP 144/63, RR 18, 99% 
on RA. He was treatd with morphine 4 mg IV X 2 for pain relief 
with good result. He also received 125 mg IV solumedrol due to 
concern for worsening joint disease. He also received humalog 19 
U SC X 1 and azathioprine 100 mg PO X 1. Labs were remarkable 
for lactate 2.7.  
.  
Of note, the patient was last admitted ___ for 
headache. His headache was attributed in the past to his 
cervical spine psoriatic arthritis, which was initially treated 
with Botox injections by Dr. ___ in the pain clinic, but 
subsequently completely resolved with the initiation of 
Remicade, which he has developed an allergy to. Last admission 
the patient was treated initially with IV narcotics and then 
discharged with PO morphine SR and ___ as needed for pain, and 
scheduled for pain consult as an outpatient for consideration of 
Botox injections. In the interim, he did not need the morphine 
___ or SR per his report (until ___. The patient also had a 
recent admission for salivary obstruction/abscess and completed 
a course of clindamycin ___.  
.  
On arrival to the floor, the patient states the pain is improved 
but still present. Denies fever, chills, visual changes, 
dysphagia, abdominal pain, nausea, vomiting, dysuria, leg 
swelling, dyspnea, or chest pain.  

 
Past Medical History:
1. Psoriatic arthritis
2. Inflammatory bowel disease
3. HTN
4. DM2
5. Peripheral neuropathy
6. bilateral corneal transplant
 
Social History:
___
Family History:
Mother who has hypertension, elevated cholesterol and ulcerative 
colitis. His father has hypertension and asthma. He has a male 
sibling with ulcerative colitis and psoriasis and a female 
sibling who is alive and well.
 
Physical Exam:
VS: T 98.6 BP 152/92 HR 84 RR 18 97% on RA FSBS 168  
GEN: NAD, comfortable and conversant, obese + moon facies  
HEENT: MMM, anicteric sclera, no OP lesions, neck is supple, no 
LAD or thyromegaly, + posterior cervicodorsal fat pad  
CV: distant, RRR, no appreciable murmur  
PULM: distant but no crackles or wheezing  
ABD: Obese, BS+, nontender to palpation throughout  
EXT: No clubbing, tremor, or edema, some mild edema of the DIP, 
PIP and MCP joints bilaterally on the hand, IP joints of feet 
with slight swelling, abrasion over r knee  
NEURO: CN II-XII intact, strength ___ in right intrinsic hand 
muscles, shoulder shrug, and wrist extension; otherwise, ___ in 
bilateral leg hip flexion, ankle dorsiflexion & plantarflexion 
and left intrinsic hand muscles, wrist extension and shoulder 
shrug; sensation intact to light touch bilaterally on arms & 
legs, reflexes 2+ at bilateral patellae and biceps  
 
Pertinent Results:
___ 07:35PM   NEUTS-89.6* LYMPHS-8.2* MONOS-1.6* EOS-0.4 
BASOS-0.2
___ 07:35PM   WBC-9.9 RBC-4.69 HGB-13.7* HCT-40.3 MCV-86 
MCH-29.3 MCHC-34.0 RDW-14.2
___ 07:35PM   GLUCOSE-188* UREA N-19 CREAT-0.9 SODIUM-139 
POTASSIUM-4.2 CHLORIDE-103 TOTAL CO2-23 ANION GAP-17
___ 08:20PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-NEG 
GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-7.0 
LEUK-NEG

 
Brief Hospital Course:
Patient is a ___ year old male with history of psoriatic 
arthritis and IBD presenting with exacerbation of cervicogenic 
headache.  
.  
#. Cervicogenic headache, acute on chronic: Patient has a 
history of these headaches which he describes as chronic daily 
headaches, from bilateral occipital region
radiating to temporal and frontal areas, lasting from hours to 
days, with some visual blurring, without mitigating factors. He 
has a history of positive tenderness on pressure over the 
greater occipital nerve region as well as over the temporal 
region. Patient was diagnosed with cerviogenic headache and 
myofascial pain, with question of his psoriatic arthritis 
affecting his cervical spine as part of
the etiology. Patient reports this headache has the same 
characteristics of prior headaches and unfortunately, he has as 
yet been unable to obtain humeria on an outpatient basis. No 
meningismus, fever or altered mental status to suggest 
infection. Left shift from chronic steroids. No mechanical 
trauma or point tenderness. Patient transitioned from IV 
morphine back to ___ morphine + Ms ___. Given solumedrol x1 IV 
in ED, prednisone 50mg PO on the floor. Patient was seen by 
rheumatology who felt that increasing the steroids would not be 
an effective intervention. Patient was evaluated by pain service 
and an occipital nerve block was done. Bilateral GONB and TPI to 
Bilateral splenius capitis and occipitalis with 14 cc 0.25% 
bupivicaine PF and 10 mg MPA without complications 
.  
#. PSORIATIC ARTHRITIS: The patient has disease which seems to 
worsen on his current regimen of imuran and prednisone. Awaiting 
humira as above and this appears to have been quite a 
complicated process unfortunately. Currently somewhat 
symptomatic with some joint pain and swollen hands and knees. 
Rheumatology felt that the headache exacerbation was not related 
to the arthitis. They did not recommend any change in 
management. Continue Ca, VitD, and Bactrim as PPx against AEs 
from steroids  
should have PCP ppx with ___ SS daily. Continue home regimen 
of azathioprine 100mg PO BID.
.  
#. DIABETES: Hold glyburide for now. Continue outpatient 
glargine 50 units QAM plus 30 U QHS, fingersticks four times 
daily.
.  
# Axillary cyst: Continue augmentin 875 mg bid for 7d ending 
___
.
# Peripheral neuropathy but no new neuro symptoms  
.
#. HTN: Continue home regimen with HCTZ, Toprol XL and 
lisinopril.  
.  
#. HYPERLIPIDEMIA: Continue home regimen of pravastatin.  
.  
# s/p submandibular sialoadenitis- completed clida course
- continue lemon drops
.
FULL CODE
 
Medications on Admission:
Dicyclomine 20 mg PO QID  
Hydrochlorothiazide 25 mg PO DAILY  
Metoprolol Succinate 100 mg PO BID  
Lisinopril 40 mg PO DAILY  
Pravastatin 20 mg PO DAILY  
Alendronate 35 mg PO QSUN  
Azathioprine 100 mg PO BID  
Calcium Carbonate 500 mg PO BID  
Cholecalciferol 800 unit PO DAILY  
Montelukast 10 mg PO DAILY  
Trimethoprim-Sulfamethoxazole 160/800 mg PO DAILY  
Prednisone 50 mg PO DAILY  
Insulin Glargine 50 units SC QAM, 30 U QHS  
Insulin humalog sliding scale (counts carbs)  
Morphine Sustained Release 30 mg PO BID  
Morphine Immediate Release 15 mg PO Q6H:PRN pain  
glyburide 5 mg bid  
augmentin 875 mg bid (since ___ 
 
Discharge Medications:
1. Dicyclomine 10 mg Capsule Sig: Two (2) Capsule PO QID (4 
times a day).  
2. Amoxicillin-Pot Clavulanate 875-125 mg Tablet Sig: One (1) 
Tablet PO BID (2 times a day) for 4 days.  
3. Metoprolol Succinate 50 mg Tablet Sustained Release 24 hr 
Sig: Two (2) Tablet Sustained Release 24 hr PO BID (2 times a 
day).  
4. Hydrochlorothiazide 12.5 mg Capsule Sig: Two (2) Capsule PO 
DAILY (Daily).  
5. Lisinopril 20 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily). 
 
6. Pravastatin 20 mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
7. Alendronate 70 mg Tablet Sig: 0.5 Tablet PO QSUN (every 
___.  
8. Azathioprine 50 mg Tablet Sig: Two (2) Tablet PO BID (2 times 
a day).  
9. Calcium Carbonate 500 mg Tablet, Chewable Sig: One (1) 
Tablet, Chewable PO BID (2 times a day).  
10. Cholecalciferol (Vitamin D3) 400 unit Tablet Sig: Two (2) 
Tablet PO DAILY (Daily).  
11. Montelukast 10 mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
12. Trimethoprim-Sulfamethoxazole 80-400 mg Tablet Sig: One (1) 
Tablet PO DAILY (Daily).  
13. Prednisone 50 mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
14. Morphine 30 mg Tablet Sustained Release Sig: ___ Tablet 
Sustained Releases PO Q12H (every 12 hours).
Disp:*60 Tablet Sustained Release(s)* Refills:*0*
15. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID 
(2 times a day) as needed for constipation.  
16. Insulin Glargine 100 unit/mL Cartridge Sig: One (1) 50 units 
SC QAM, 30 U QHS Subcutaneous twice a day: 50 units SC QAM, 30 U 
QHS.  
17. Morphine 15 mg Tablet Sig: ___ Tablets PO Q4H (every 4 
hours) as needed for pain.
Disp:*30 Tablet(s)* Refills:*0*
18. Glyburide 5 mg Tablet Sig: One (1) Tablet PO twice a day.  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Primary:
cerviogenic headache
s/p occipital nerve block
Psoriatic arthritis 
.
Secondary:
Inflammatory bowel disease  
HTN  
DM2  
Peripheral neuropathy  

 
Discharge Condition:
stable, pain well controlled on PO meds at the time of discharge

 
Discharge Instructions:
You were admitted for exacerbation of your headache. You were 
intially treated with IV steroids and IV morphine. Your pain was 
better controlled and you were transitioned to PO medications. 
You were evaluated by rheumatology and no change in management 
was recommended in regards to your steroid dose. You underwent 
an occipital nerve block by the pain service.
.
Your dose of morphine ___ was increased to achieve better pain 
control. Please take all medications as prescribed and do not 
drive while taking pain medication as they have sedating 
effects. Please go to all scheduled follow up appointments.
.
Please contact your physician if you have headaches that are not 
controlled with your PO medication. Please follow up in pain 
clinic as your headaches do not appear to be significantly 
influenced by your rheumatologic condition.
 
Followup Instructions:
___
"
18059545-DS-17," 
Name:  ___                    Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: SURGERY
 
Allergies: 
Morphine
 
Attending: ___.
 
Chief Complaint:
Right lower extremity DVT
 
Major Surgical or Invasive Procedure:
none

 
History of Present Illness:
Mr. ___ is a ___ y/o male who presented to the ___ ER after 
being diagnosed with a right lower extremity DVT at an outside 
hospital.  He states last weekend he was on a 20-hour flight 
back from ___ and in the next few
days afterward he began to experience pain in his right leg.  
Initially the pain was in the right thigh and has now become 
most severe in the calf.  He noted a moderate amount of swelling 
as well.  For this reason he presented to his local emergency 
department where he was diagnosed with a DVT.  Per reports the 
thrombus extends from his calf up to his groin.  He was started 
on lovenox BID and discharged to home, with the plan to return 
on ___ for thrombolysis.  However the patient reports he was 
uncomfortable with this plan and his brother who is a ___ 
recommended he be seen for a second opinion.  He was referred to 
Dr. ___ the vascular surgery department here at ___.

Today in the ED the patient appears well and states he is 
feeling fine with the exception of his right leg pain.  He 
denies chest pain, shortness of breath, fevers, chills, nausea 
or vomiting.

 
Past Medical History:
paroxysmal SVT diagnosed many years ago and never treated
 
Social History:
___
Family History:
mother with ___ in her ___, sister with ___ in her ___
 
Physical Exam:
VSS, Afebrile

GEN WDWN male in NAD
CV RRR no M/R/G
CHEST CTAB
ABD soft/nontender, nondistended
EXT WWP; RLE with ___ stocking on, skin without errythema, no 
edema, minimal tenderness to palpation of calf/thigh, Full ROM 
of extremity;  strenght/sensation intact and equal b/l; 
___ pulses palpable b/l

 
Pertinent Results:
Admission Labs:
WBC-5.9 RBC-5.17 Hgb-14.7 Hct-42.8 MCV-83 MCH-28.4 MCHC-34.3 
RDW-13.4 Plt ___ PTT-33.5 ___
Glucose-99 UreaN-13 Creat-1.0 Na-140 K-4.3 Cl-103 HCO3-29 
AnGap-12

Discharge Labs:

___ 07:20AM BLOOD WBC-4.9 RBC-4.95 Hgb-14.1 Hct-41.6 MCV-84 
MCH-28.5 MCHC-33.8 RDW-13.1 Plt ___
___ 07:20AM BLOOD ___ PTT-49.7* ___
___ 01:35PM URINE Color-Yellow Appear-Clear Sp ___
___ 01:35PM URINE Blood-NEG Nitrite-NEG Protein-NEG 
Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-0.2 pH-7.0 Leuks-NEG

Radiology Report CTA LOWER EXT W/&W/O C & RECONS BILAT Study 
Date of ___ 12:08 ___ 

HISTORY: ___ male who had presented to outside hospital 
with right 
leg pain after travel from ___, with extensive right 
lower extremity 
DVT in thigh and calf by outside hospital ultrasound yesterday. 
Here to 
assess extent of DVT in the IVC and lower extremity prior to 
possible 
thrombectomy. 
  
COMPARISON: None available. 
  
TECHNIQUE: MDCT axial imaging was performed through the abdomen, 
pelvis and 
bilateral lower extremities including the Inferior Vena Cava to 
the veins of 
the ankles after administration of 150 mL of IV Optiray 350. 
Multiplanar 
reformatted images were then obtained. 
  
CTV ABDOMEN: Dependent atelectatic changes are noted in the lung 
bases.  
There is no pleural or pericardial effusion. The liver, 
gallbladder, 
pancreas, adrenal glands, kidneys and ureters are unremarkable. 
The spleen is 
enlarged, measuring 14.6 cm, without focal lesion. The 
non-opacified stomach, 
small bowel, colon, and appendix appear unremarkable. No free 
air, free fluid 
or adenopathy is noted by size criteria. The abdominal aorta is 
of normal 
caliber. No filling defect is seen in the splenic, superior 
mesenteric, or 
portal veins. Also no filling defect is seen in the IVC to 
suggest thrombus. 
  
CTV PELVIS: The urinary bladder and the distal ureters are 
unremarkable. The 
prostate is not enlarged. Note is made of a 9-mm utricle cyst in 
the midline 
prostate. Additionally, there is 1.3 x 2.5 cm left seminal 
vesicle cyst.  
Trace fluid is noted in the pelvis (2:141), of indeterminate 
significance.  
Non-opacified pelvic loops of bowel and rectosigmoid colon are 
unremarkable.  
There is no free air or adenopathy within the pelvis. The lower 
IVC and 
bilateral common, internal, and external veins are patent, with 
no filling 
defect to suggest thrombosis. 
  
CTV BILATERAL LOWER EXTREMITIES: There is nearly occlusive 
thrombus seen in 
the right superficial femoral vein, which is expanded and has 
surrounding 
stranding consistent with acute thrombosis. The superior extent 
of the 
thrombus is seen in the right common femoral vein, extending 
just above the 
confluence with the greater saphenous vein. Thrombus extends 
contiguously 
into the popliteal vein and into the proximal anterior tibial, 
posterior 
tibial and peroneal veins. Nonvisualization of these veins more 
distally in 
the calf, when compared with the normal left side, is consistent 
with 
thrombosis. The right deep femoral vein and the greater 
saphenous vein are 
patent. There is no evidence of left lower extremity deep venous 
thrombosis.  
Note is made of tiny right ___ cyst (2:337). 
  
OSSEOUS STRUCTURES: No region of bony destruction or acute 
fracture is seen 
in the visualized osseous structures. Degenerative endplate 
changes are noted 
along the visualized thoracolumbar spine, without 
spondylolisthesis. Lucent 
lesion with surrounding sclerosis along the inferior iliac 
aspect of the right 
sacroiliac joint may represent degenerative change (2:141). 
  
IMPRESSION: 
  
1. Acute right lower extremity DVT extends from the right common 
femoral vein 
through the superficial femoral vein, popliteal vein and through 
the right 
calf veins.  
  
2. Tiny right ___ cyst. 
  
3. Splenomegaly. 
  
4. Trace pelvic fluid, of indeterminate etiology. 
  
5. Incidentally noted utricle cyst and left seminal vesicle 
cyst. 
  

 
Brief Hospital Course:
Mr ___ was admitted to the vascular surgery team on ___.  
He was started on a therapeutic heparin drip and a ___ stocking 
placed on his right leg with right lower extremity elevation.  A 
CT-V was obtained upon admission. This showed an acute right 
lower extremity DVT extending from the right common femoral vein 
through the superficial femoral vein, popliteal vein and through 
the right calf veins.  The heparin gtt was continued and 
coumadin therapy initiated.  Mr. ___ did well and remained 
stable throughout his hospital course. On ___ his right lower 
extremity had no swelling and minimal tenderness.  Given the 
location of the dvt, and the patients physical exam, Dr. ___ 
___ that operative thrombolysis was not neccessary.  Mr. 
___ was transitioned from a heparin gtt to therapeutic 
lovenox injections and continued on coumadin. He was out of bed, 
ambulating short distances in his room. He did have quite a bit 
of pain with ambulation, but said oxycodone was helping.  He was 
discharged on ___ once ambulating independently and adequate 
pain control had been achieved.
 
Medications on Admission:
Lovenox BID (started ___
Vicodin prn leg pain (started ___
 
Discharge Medications:
1. Acetaminophen 325 mg Tablet Sig: Two (2) Tablet PO four times 
a day as needed for pain/headache.  
2. Camphor-Menthol 0.5-0.5 % Lotion Sig: One (1) Appl Topical 
QID (4 times a day) as needed for itching.  
3. 4 pronged cane
use as needed for stability 

Dx: right lower extremity DVT
4. Percocet ___ mg Tablet Sig: ___ Tablets PO every four (4) 
hours as needed for pain.
Disp:*60 Tablet(s)* Refills:*0*
5. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO twice 
a day as needed for constipation: Use while taking percocet.
Disp:*60 Capsule(s)* Refills:*0*
6. Warfarin 2 mg Tablet Sig: Two (2) Tablet PO Once Daily at 4 
___.
Disp:*60 Tablet(s)* Refills:*2*
7. Lovenox ___ mg/mL Syringe Sig: ___ (85) mg 
Subcutaneous twice a day: Use until INR 2.0.  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Right Lower Extremity DVT

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
You were admitted with a DVT (deep venous thrombosis) of your 
right lower extremity.  It was determined that based on your 
physical exam and ct scan, a surgical thrombolytic therapy would 
not be beneficial at this time.  

You will be discharged on anticoagulation for 6 months. You will 
go home on Lovenox injections and oral coumadin therapy.  
Coumadin therapy required frequent blood draws to check the INR 
(international normalized ratio).  Your PCP, ___ be 
following this for you and adjust your coumadin dose as needed.  
Once the INR is 2.0 or greater you will be able to stop your 
lovenox injections.  The goal INR is 2.0-3.0 .  You should take 
your coumadin at the same time every day and tell your PCP if 
you take antibiotics at any time during the course of therapy. 

You have also been given a thigh high ___ stocking to wear on 
your right leg.  You should wear this daily until your follow up 
appointment with the vascular surgeon.  

You may resume normal daily activities such as walking, and 
driving. Do not drive while taking narcotic medications. You 
will need to elevate your right leg, above the level of your 
heart as much as possible over the next few weeks.  

Please call your doctor or return to the ER for any of the 
following:
* You experience new chest pain, pressure, squeezing or 
tightness.
* New or worsening cough or wheezing.
* If you are vomiting and cannot keep in fluids or your 
medications.
* You are getting dehydrated due to continued vomiting, 
diarrhea or other reasons. 
* Signs of dehydration include dry mouth, rapid heartbeat or 
feeling dizzy or faint when standing.
* You see blood or dark/black material when you vomit or have a 
bowel movement.
* Your skin, or the whites of your eyes become yellow.
* Your pain is not improving within ___ hours or not gone 
within 24 hours. Call or return immediately if your pain is 
getting worse or is changing location or moving to your chest or 

back.
* You have shaking chills, or a fever greater than 101.5 (F) 
degrees or 38(C) degrees.
* Any serious change in your symptoms, or any new symptoms that 
concern you. 
* Please resume all regular home medications and take any new 
meds 
as ordered. 
* Do not drive or operate heavy machinery while taking any 
narcotic pain medication.  You may have constipation when taking 
narcotic pain medications (oxycodone, percocet, vicodin, 
hydrocodone, dilaudid, etc.); you should continue drinking 
fluids, you may take stool softeners, and should eat foods that 
are high in fiber.  
* Continue to ambulate several times per day.
 
Followup Instructions:
___
"
18454624-DS-16," 
Name:  ___               Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: PSYCHIATRY
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
""I am fine""
 
Major Surgical or Invasive Procedure:
None
 
History of Present Illness:
From Dr. ___ ED ___, ___:
This is ___ yo resident of ___, w/ hx.o Bipolar do I,
dementive process, p/w fall from house. Psychiatry is consulted
per request of outpatient psychiatrist Dr. ___, who is
concerned that patient may be manic, and medication adjustment
has been difficult in the ___ setting. The patient is
aware that ""things have been difficult"" at ___, but 
cannot
provide further information about how. She denies Low
mood/SI/HI/AH/VH/IOR/anxiety. She confirms her memory ""is not
what it used to be"". She confirms a history of Bipolar dx.,
denies feeling manic ""that is more when you are energic in a bad
way. I am not.""  No Cp, sob. Denies HA.  

Per Dr. ___, RN, she recently has been
undergoing congnitive decline. Over the past severeal months has
been more agitated, hypersexual, making inappropriate comments,
intermittent SIB (Slapping self, punching self, pulling hair),
decreased po intake, losing weight, approximately 12 lbs. There
is a some concern that she is manic, rather than solely
disinhibited. No episodes of suicidality or homicidality. 
Several
days ago, had a discrete episode of agitation in her room, but
was not sectioned, situation was de-escalated w/o verbal
intervention by staff.  

Spoke with Daughter, ___, ___. Who is
concerned for notable weight loss, over the past 6 mo, increased
confusional behavior, calling daughter ___ daily, increased
irritability. She has multiple prior psychiatric
hospitalizations, most recently ___ years ago. No acute safety
concerns. Last time manic episode ___ years ago, screaming, led 
to
hospitalization.  

Medication adjustment has have been difficult, she came to Dr.
___ on Effexor and Klonopin. Recently started on lamictal, 
and
effexor slowly tapered. During the process of medication 
changes,
pt. had a fall (___). As a result, staff has kept pt. bound
to house, which in turn has increased agitation in patient. Dr.
___ is concerned that it is difficult to adjust medications 
in
the resting home context d/t risk of fall, limited staff 
support.
As result of increased agitation and agression and difficulty in
changing medication in her current setting Would like for her to
be admitted, with plan of adjusting of medication.
 
Past Medical History:
ospitalizations: Multiple prior, most recently ___ years.
Current treaters and treatment: ___, Director of 
Nursing
of ___ ___
Dr. ___ ___. 
Medication and ECT trials: Clonazepam, effexor (now being
downtitrated, with goal of dc'ing) 
Self-injury: when agitated has been slapping her legs, pulling 
at
hair. 
Harm to others: Denies
Access to weapons: denies. 
 
Social History:
___
Family History:
Reports mother with ___, now deceased. Denies history of
bipolar d/o, schizophrenia, substance abuse in the family.  
 
Physical Exam:
BP:112/72 HR:80 temp:98.0 resp:16  O2 sat:99% ht:5'5"" wt: 146.6

General: Awake, cooperative, NAD.
HEENT: Laceration from fall on nose, no scleral icterus noted,
MMM, edentulous, no lesions noted in oropharynx
Neck: Supple, no carotid bruits appreciated. No nuchal rigidity
Pulmonary: Lungs CTA bilaterally without R/R/W
Cardiac: RRR, nl. S1S2, no M/R/G noted
Abdomen: soft, NT/ND, normoactive bowel sounds
Extremities: No C/C/E bilaterally, 2+ radial, DP pulses
bilaterally.
Skin: Lac as mentioned above. Ecchymoses on ___ knee caps.
 
Neurologic:
-Cranial Nerves:
II: PERRL 3 to 2mm and brisk. VFF to confrontation.
III, IV, VI: EOMI without nystagmus. Normal saccades.
V: Facial sensation intact to light touch.
VII: No facial droop, facial musculature symmetric.
VIII: Hearing intact to finger-rub bilaterally.
IX, X: Palate elevates symmetrically.
XI: ___ strength in trapezii and SCM bilaterally.
XII: Tongue protrudes in midline.

*Motor- Normal bulk and tone bilaterally. No abnormal movements,
tremors. Strength full power ___ throughout. No pronator drift.  

*Sensation- Intact to light touch and vibration bilaterally.
*Reflexes- 2+ throughout and equal b/l.
*Coordination- Normal on finger-nose-finger, rapid alternating
movements, heel to shin. Unsteady gait; +Romberg, unable to
tandem gait, walk on toes, or walk on heels.
 
Pertinent Results:
___ 01:55PM   GLUCOSE-125* UREA N-9 CREAT-0.7 SODIUM-143 
POTASSIUM-4.3 CHLORIDE-104 TOTAL CO2-26 ANION GAP-17
___ 01:55PM   WBC-10.9 RBC-4.81 HGB-14.6 HCT-43.9 MCV-91 
MCH-30.4 MCHC-33.4 RDW-12.3
___ 01:55PM   NEUTS-60.0 ___ MONOS-4.7 EOS-3.0 
BASOS-1.4
___ 01:55PM   PLT COUNT-297
___ 01:55PM   TSH-3.8
___ 22:14PM   URINE WBC 17, NEG Nitrites, Leuks
___ 11:00AM   ALT-11  AST-20  ALK PHOS-72   TotBili-0.5
___ 11:00AM   VITB12-720 FOLATE- Greater TH1

 
Brief Hospital Course:
Legal: ___
Psychiatric:
Patient presented in disorganized state, exhibiting symptoms of 
pressured speech, tangential behavior, elevated mood, SIB 
(slapped self), and hypersexuality. Patient also had notable 
cognitive deficits, particularly in memory (note patient has 
already had formal Neuro-Psych testing in ___ which showed 
gross executive functional impairment of unknown etiology). 
Patient evaluated medically in the unit for other underlying 
organic causes (see below), but no significant organic 
explanation of symptoms. 

Upon admission medications were: Clonezepam 0.5 mg QHS, 
Lamotrigine 200 mg PO QHS, Trazodone 75 mg PO HS, Venlafaxine 
150 mg PO daily, Zolpidem tartrate 10 mg PO HS. We continued 
Lamotrigine 200 mg PO QHS, discontinued the trazadone and 
zolpidem tartarate and discontinued venlafaxine via a gradual 
taper. We initiated and tapered quietapine up to 150 mg QHS and 
held steady at this dose. We initially tapered and discontinued 
Clonezepam but due to patient report nightly panic attacks we 
restarted Clonezepam 0.5 mg QHS, with good effect and subsequent 
dramatic improvement in sleep.

With medication adjustments and individual, group, and milieu 
therapy, the patient slowly and steadily improved. With a 
significant improvement in her degree of mood lability, 
organization, and degree of disinhibition. Her insight into her 
condition and judgement also significantly improved. Her panic 
attacks resolved and her sleep also greatly improved.  At no 
point during her hospitalization did she demonstrate suicidal 
thoughts or self injury. She was always cooperative and help 
seeking. 

By the time of discharge the patient's acute mania resolved and 
appeared close to her baseline. She participated appropriately 
with her peers and in groups.  She is able to dress herself, 
groom, and take regular showers. Her gait has improved 
dramatically, at times needed reminders to use her cane early on 
in admission. By time of discharge, she demonstrated good safety 
awareness and care when changing positions. She was not 
orthostatic by frequent vital sign checks. The patient exhibited 
no self-injurious behavior while hospitalized nor did she voice 
any intent to harm herself during this hospitalization. Ms. 
___ is stable to go home to a supervised environment that 
___ can provide in addition to structure provided by a 
day treatment program. She will continue to have regular follow 
up by her outpatient providers.       
 
Medical:
#) Neurological workup: CT Head ordered by team showed enlarged 
ventricles and evidence of hypodensities indicating some small 
vessel ischemic disease but no gross abnormality. Patient had 
laboratories (CBC, electrolytes) which were within normal 
limits. UA showed +WBC but no nitrates.

#) Nutrition/Weight Loss: Nutrition consult revealed patient is 
low nutrition risk. Diet supplemented with ensure in unit. 
Patient to follow up with PCP for further evaluation for medical 
causes of weight loss. Patient ate all of her meals during her 
hospitalization without difficulty. 

#) Hair loss: Patient reported hair loss over the past ~6 
months. Initial ___ including CBC, BMP, TSH, B12, Folate was 
negative for a revealing etiology. The patient showed no 
evidence of self inflicted hair loss during hospitalization. 
Patient instructed to follow-up with her PCP for further ___ 
of her hair loss. 

#) Fall risk: ___ assessment determined patient is a low fall 
risk but encouraged patient to use cane at all times for safety. 
Patient was able to follow these recommendations well by the end 
of her hospitalization 

#) Orthostasis: Patient initially experienced orthostasis early 
on during hospitalization when her seroquel was being titrated, 
this resolved and she tolerated 150mg seroquel well by time of 
dischagre. . 

#) Sacral Folliculitis: Evaluated by wound nurse in hospital. 
Dressing placed. Per wound nurse evaluation, does not appear to 
be related to picking behavior or prolonged sitting. The patient 
remained appropriately mobile and active through out 
hospitaization. Patient to follow-up with PCP.

#) Borderline UA: Urine culture was likely contaminated but 
positive for gardinella. Patient denied any symptoms of vaginal 
discharge or pain. No symptoms of dysuria. As a result, there 
was no further follow-up or treatment.

Family/Social Work: Patient lives at a ___, a facility 
without nighttime care but nursing and staff throughout the day. 
She also enjoys attending a geriatric day program. Her care was 
coordinated with her children by socialwork and the patient 
remained in frequent contact with them through out her stay. 
___ house was also coordinated with at time of discharge. 
Initally requesting transfer to rehab, but ultimately accepting 
her transfer back to them. 

Groups/Milieu: Patient enjoyed attending groups, particularly 
music therapy. Adjusted well to milieu. 

Risk Assessment: At no point during her hospitalization was self 
injury or suicidality an active clinical concern. The patient 
always expressed enthusiasm for her life and her family. Given 
her history of bipolar disorder, there is some chronic risk 
through time of suicidality or self injury. However this risk is 
reduced now that her mood has been stabilized and she continues 
to have ongoing structure and support outside of the hospital. 
Currently the patient is a low to moderate fall risk due to her 
history of orthostasis and recent falls prior to her 
hospitalization, however she is currently  ambulating well with 
a w cane and is conscious of need to take her time in standing 
up and adjust from dizziness. She demonstated a good awareness 
of this through out her hospitalization. Currently, there is no 
evidence of inability to care for herself in her current 
supported living situation.  
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Venlafaxine 150 mg PO DAILY 
2. ClonazePAM 0.5 mg PO QHS 
3. Zolpidem Tartrate 10 mg PO HS 
4. LaMOTrigine 200 mg PO QHS 
5. TraZODone 75 mg PO HS 

 
Discharge Medications:
1. ClonazePAM 0.5 mg PO QHS 
RX *clonazepam 0.5 mg 1 tablet(s) by mouth at bedtime Disp #*30 
Tablet Refills:*0
2. LaMOTrigine 200 mg PO QHS 
RX *lamotrigine [Lamictal] 200 mg 1 tablet(s) by mouth at 
bedtime Disp #*30 Tablet Refills:*0
3. Aspirin 325 mg PO DAILY 
RX *aspirin 325 mg 1 tablet(s) by mouth Daily Disp #*30 Tablet 
Refills:*0
4. Docusate Sodium 100 mg PO DAILY 
RX *docusate sodium [Colace] 100 mg 1 capsule(s) by mouth Daily 
Disp #*30 Capsule Refills:*0
5. Fexofenadine 60 mg PO BID 
RX *fexofenadine 60 mg 1 tablet(s) by mouth twice a day Disp 
#*60 Tablet Refills:*0
6. Levothyroxine Sodium 25 mcg PO DAILY 
RX *levothyroxine 25 mcg 1 tablet(s) by mouth Daily Disp #*30 
Tablet Refills:*0
7. QUEtiapine Fumarate 150 mg PO QHS 
RX *quetiapine [Seroquel] 100 mg 1.5 tablet(s) by mouth at 
bedtime Disp #*45 Tablet Refills:*0
8. Senna 1 TAB PO BID 
RX *sennosides [senna] 8.6 mg 1 tablet by mouth twice a day Disp 
#*60 Capsule Refills:*0
9. Simvastatin 20 mg PO DAILY 
RX *simvastatin 20 mg 1 tablet(s) by mouth Daily Disp #*30 
Tablet Refills:*0

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
Bipolar Affective Disorder; Cognitive disorder NOS

 
Discharge Condition:
VS: T 98.2, BP 147/77, HR 93, RR 16, O2 SAT 98%

MSE:
Appearance: Thin caucasian female appearing approximately stated
age, sitting upright in chair.
Behavior/motor: Cooperative, good eye contact. No psychomotor
retardation or agitation.  
Speech: Normal rate, normal rhythm, normal volume.
Mood: 'Good'
Affect: Full range. Euthymic. Laughs appropriately.
Thought Process: mostly linear, at times tangential.
Thought Content: Appropriately concerned with regard to where 
she
will be going next. Introspective about coping with person's she
doesn't like.
No AVH; no SI.   
Safety: does not voice any concerns
Perceptions: No AVH
Insight: Fair
Judgement: Fair 

Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).

 
Discharge Instructions:
-Please follow up with all outpatient appointments as listed - 
take this discharge paperwork to your appointments.
-Please continue all medications as directed.
-Please avoid abusing alcohol and any drugs--whether 
prescription drugs or illegal drugs--as this can further worsen 
your medical and psychiatric illnesses.
-Please contact your outpatient psychiatrist or other providers 
if you have any concerns.
-Please call ___ or go to your nearest emergency room if you 
feel unsafe in any way and are unable to immediately reach your 
health care providers.
-It was a pleasure to have worked with you, and we wish you the 
best of health.
 
Followup Instructions:
___
"
18570237-DS-10," 
Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Patient recorded as having No Known Allergies to Drugs
 
Attending: ___.
 
Chief Complaint:
PCP: Dr. ___ (___)

CC: ___ pain
 
Major Surgical or Invasive Procedure:
ERCP on ___

 
History of Present Illness:
Ms. ___ is a ___ yo F with no significant past medical 
history. She presented to the ED today for intermittent 
epigastric pain since ___.

She first noted pain while at work (she works in the ___ lab) 
on ___ (___). She specifically noted 
substernal/epigastric, sharp, ___ pain, radiating to her back 
that relieved with food. She also noted significant belching. 
She had no fevers, chills, nausea, vomitting, or change in bowel 
movements.

The above symptoms returned on ___ and she presented to ___ 
___. She reports having normal LFTs, normal cardiac 
biomarkers x 1, and a normal ECG. She was discharged to home 
from the ___ ED with a new prescription for oral 
Dilaudid. The pain returned in the middle of the night on ___ 
and she re-presented to ___ where a RUQ ultrasound 
revealed cholelithiasis with no cholecystitis , a stone in the 
common bile duct at the level of pancreatic head, and her CBD 
was 0.6 cm diameter.  She was discharged to home with plan to 
follow-up with a surgeon as an outpatient.

She had repeat episodes of pain over the next few days. These 
typically were precipitated by food and relieved with Vicodin. 
On ___, her pain was ___ while at work. She felt dizzy, 
reportedly looked pale, and had to lay on the floor to keep from 
passing out. She presented to the ___ ED.

In the ___ ED, initial vitals were: T 98.2, P 58, BP 91/42, 
97% on RA. Her evaluation was notable for a guaiac negative 
rectal exam, WBC 11.1, ALT 61, AST 97, Alk Phos 97, total bili 
0.4, lipase 53, and a RUQ ultrasound that revealed a 10mm common 
bile duct and a contracted gall bladder with no evidence of 
cholecystitis. In the ED she received ciprofloxacin and Flagyl.

Currently her pain is a ___. She continues to have a lot of 
belching.

Review of Systems: No recent illnesses though she did have a 
prolonged course of diarrhea in the ___. No jaundice. 
No fevers, chills, or night sweats. Appetite is good. No SOB, 
cough, or chest pain. No urinary symptoms. Other systems 
reviewed in detail and all otherwise negative.

 
Past Medical History:
 - tonsillectomy at age ___
 - severe motor vehicle accident in ___ with a concussion and 
hospitalization
 - resection of a pilonidal cyst in ___
 - chronic bilateral knee pain after a fall; she uses a cane to 
ambulate up stairs
 - seasonal allergies
 - esophagitis in ___ thought to be from high-dose NSAID use; 
she had no endoscopy at that time
 
Social History:
___
Family History:
No family history of gallstones or gall bladder disorders.
 
Physical Exam:
Vital Signs: T 97.1, P 75, BP 127/74, and 98% on RA.

Physical examination:
- Gen: Well-appearing in NAD.
- HEENT: Conj/sclera/lids normal without icterus, PERRL, EOM 
full, and no nystagmus. Hearing grossly normal bilaterally. 
Sinuses non-tender. Nasal mucosa and turbinates normal. 
Oropharynx clear w/out lesions.
- Neck: Supple.
- Chest: Normal respirations and breathing comfortably on room 
air. Lungs clear to auscultation bilaterally.
- CV: Regular rhythm. Normal S1, S2. No murmurs or gallops. JVP 
<5 cm. 
- Abdomen: Normal bowel sounds. She had mild epigastric and RUQ 
tenderness with deep paplation. Negative ___ sign.
- Extremities: No ankle edema.
- MSK: Joints with no redness, swelling, warmth, tenderness. 
Normal ROM in all major joints.
- Skin: No lesions, bruises, rashes.
- Neuro: Alert, oriented x3. Good fund of knowledge. Able to 
discuss current events and memory is intact. CN ___ intact. 
Speech and language are normal. 
- Psych: Appearance, behavior, and affect all normal. 
 
Pertinent Results:
ADMISSION LABORATORY STUDIES:
 - ___ 11:45AM   GLUCOSE-108* UREA N-18 CREAT-0.6 
SODIUM-144 POTASSIUM-4.3 CHLORIDE-107 TOTAL CO2-25 ANION GAP-16 
LACTATE-1.1 ALT(SGPT)-61* AST(SGOT)-97* ALK PHOS-97 TOT BILI-0.4 
LIPASE-53
 - ___ 11:45AM   WBC-11.1* (NEUTS-86.2* LYMPHS-11.0* 
MONOS-1.7* EOS-0.7 BASOS-0.4) RBC-3.85* HGB-12.2 HCT-36.1 MCV-94 
MCH-31.6 MCHC-33.7 RDW-13.9 PLT COUNT-287
___ 08:20AM BLOOD WBC-5.1# RBC-3.56* Hgb-11.1* Hct-32.1* 
MCV-90 MCH-31.2 MCHC-34.6 RDW-13.6 Plt ___
___ 07:00AM BLOOD UreaN-10 Creat-0.6
___ 08:20AM BLOOD ALT-28 AST-25 AlkPhos-75 TotBili-0.4
___ 08:20AM BLOOD Lipase-34

ECG: sinus rhythm at 52 with normal axis and intervals. She has 
no old or new ischemic changes. No ECG available for comparison.

RUQ ULTRASOUND:
 - FINDINGS: 3 x 2.1 cm hypoechoic lesion in the anterior right 
liver lobe is consistent with a simple cyst. 1 x 1 cm 
heterogenous lesion in the anterior right lobe, too small to 
characterize. The gallbladder is contracted and contains 
shadowing stones. No intrahepatic biliary duct dilation. The 
common bile duct is dilated measuring 1 cm at the porta hepatis. 
No evidence of proximal CBD stones. The distal CBD cannot be 
evaluated secondary to overlying bowel gas. The pancreas appears 
normal; 
however, evaluation is limited secondary to overlying bowel gas. 
The portal vein is patent with normal hepatopetal flow. No 
evidence of right 
upper quadrant ascites. 
 - IMPRESSION: 1. Contracted gallbladder with gallstones. 2. 
Dilated common bile duct without evidence of proximal CBD stone. 
The CBD is difficult to evaluate, and if clinically indicated, 
CT or MRCP might be 
considered. 3. 1 x 1 cm indeterminate liver lesion. Liver MRI is 
recommmended for further work-up. 

ERCP ___: 
Cannulation of the biliary duct was performed with a 
sphincterotome using a free-hand technique 
A moderate diffuse dilation was seen at the CBD with the CBD 
measuring 11 mm.  
The gallbladder was filled with contrast and numerous stones 
were noted within the gallbladder 
A single 7 mm round stone that was causing partial obstruction 
was seen at the biliary tree.  
A sphincterotomy was performed in the 12 o'clock position using 
a sphincterotome over an existing guidewire.  
The stone was extracted successfully using a balloon catheter 
Final occlusion cholangiogram did not reveal any further filling 
defects 
Otherwise normal ercp to third part of the duodenum

 
Brief Hospital Course:
CHOLELITHIASIS/CHOLEDOCHOLITHIASIS WITH POSSIBLE LOW GRADE 
CHOLANGITIS: treated with cipro/flagyl and ERCP with 
sphincterotomy.  Common duct stone removed and the patient was 
noted to have significant cholelithiasis.  Symptoms initially 
resolved but had minimal pain in her epigastrium 60 minutes post 
prandial which was short lived.  This is likely related to 
cholelithiasis.  no recurrent fevers or nausea vomiting.  
Warning signs of worsened pain, pain lasting more than 2 hours 
or fevers or any other concerning symptoms (vomiting, fevers, 
abdominal swelling, etc) and she was told to return if these 
should occur.  Seen by general surgery consult inpatient who 
recommened outpt f/u with Dr. ___ days after discharge 
to evaluate for cholecystectomy which she will likely require. 
She was discharged with an additional 5 days of antibiotics for 
a total 7 day course.  
 
Medications on Admission:
-list confirmed with patient on admission-
Omeprazole 40mg daily
Glucosamine/Chondroitin daily
Motrin 800mg PRN knee pain
Tylenol #3 PRN knee pain
 
Discharge Medications:
1. metronidazole 500 mg Tablet Sig: One (1) Tablet PO Q8H (every 
8 hours) for 5 days.
Disp:*15 Tablet(s)* Refills:*0*
2. ciprofloxacin 500 mg Tablet Sig: One (1) Tablet PO Q12H 
(every 12 hours) for 5 days.
Disp:*10 Tablet(s)* Refills:*0*
3. Glucosamine-Chondroitin DS  Oral
4. Tylenol-Codeine #3  Oral
5. omeprazole 40 mg Capsule, Delayed Release(E.C.) Sig: One (1) 
Capsule, Delayed Release(E.C.) PO once a day.  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Primary Diagnosis:
Choledocholithiasis
Cholelithiasis

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
You were admitted to the hospital with pain your abdomen and 
found to have gallstones. You will need to have your gallbladder 
removed surgically.

Please make your scheduled appointments and take your 
medications as prescribed.

DO NOT take any ibuprofen, motrin, aleve, advil or aspirin for 
the next 5 days.
 
Followup Instructions:
___
"
18752997-DS-9," 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: SURGERY
 
Allergies: 
Tetanus / Morphine / Dilaudid
 
Attending: ___.
 
Chief Complaint:
abdominal pain
 
Major Surgical or Invasive Procedure:
Status Post Ventral Hernia Repair with mesh and Panniculectomy

Excision of umbilical stalk and skin.

 
History of Present Illness:
Mr. ___ is a ___ gentleman who is
status post open Roux-en-Y gastric bypass in ___.
He subsequently lost a great deal of weight total (a total of
86.3 pounds representing 60% excess weight loss). His current
body mass index is 33.2 kg per meter squared. He
unfortunately developed an incisional hernia as well as some
excess skin. The risks and benefits of surgery were

 
Past Medical History:
HTN
Diabetes
PE s/p gastric bypass ___ PE, on Coumadin for 6 months 
thereafter
S/p colon polyp surgery / partial colonectomy
S/p carpal tunnel release bilat
Migraines

ALLERGY: Horse tetanus serum
 
Social History:
___
Family History:
Mother: ___ bilat
 
Physical Exam:
 heart rate is 61, blood pressure is 122/84,
saturation 98% on room air.  He currently weighs 238 pounds,
which represents about 2-pound increase since his last visit 6
months ago but overall, about 80 pounds lost since his surgery. 
In general, he is alert and oriented x3.  His mood, affect,
judgment, insight, and memory are within normal limits.  Eyes: 
His conjunctivae are pink.  His sclerae are anicteric.  His
pupils are equal, round and reactive to light and accommodation. 

Ears, nose, mouth, and throat:  Normal hearing, normal nose,
normal mouth, and oropharynx was pink and moist.  Tongue is
midline.  Neck:  There are no masses.  Respiratory:  Breath
sounds clear to auscultation.  Heart:  Regular rate and rhythm,
S1 and S2 are normal.  Abdomen:  Soft, nontender, nondistended. 
There is a large easily reducible midline hernia in the upper
midline.  Several defects are appreciated upon palpation.  They
are all reducible.  Shaft and testes are within normal limits. 
No inguinal hernias are noted.  He has a large amount of
redundant skin overhanging his waistline.  There is no obvious
evidence of skin irritation.  Cranial nerves II through XII are
grossly intact.  Musculoskeletal:  He has full range of motion 
in
his upper extremities, lower extremities, head, neck, spine,
ribs, and pelvis.  His gait is normal.  Skin:  There are no
rashes.  There is no evidence of abnormality.

 
Pertinent Results:
___ 03:40PM BLOOD Hct-34.6*
___ 07:30AM BLOOD WBC-6.4 RBC-3.53* Hgb-10.4* Hct-31.3* 
MCV-88 MCH-29.6 MCHC-33.4 RDW-13.1 Plt ___
___ 07:30AM BLOOD Glucose-138* UreaN-15 Creat-1.2 Na-136 
K-4.4 Cl-97 HCO3-26 AnGap-17
___ 07:30AM BLOOD Calcium-8.6 Phos-1.4*# Mg-1.7
 
Brief Hospital Course:
Patient admitted and underwent an incisional hernia repair with 
mesh, Abdominal panniculectomy, and Repair of internal hernia at 
the jejunojejunostomy anastomosis. Postoperatively patient's 
umbilicus became very dark and patient was taken back to the 
operating room on postoperative day one to have that removed.

Patient did well with progression to a bariatric stage 5 diet. 
He will be discharged today with follow up appointment with Dr. 
___ in one week. He will go home with his jp drains in 
place with monitoring from ___. Recommended that patient follow 
up with his endocrinologist regarding decreasing his diabetic 
medication regimen. He will hold his glyburide for now. Also 
discussed with patient need to follow up with his primary care 
provider to decrease his cholesterol and hypertensive 
medications.

 
Medications on Admission:
GLYBURIDE -  (Prescribed by Other Provider) - 5 mg Tablet - 2
Tablet(s) by mouth twice a day
INSULIN GLARGINE [LANTUS] -  (Prescribed by Other Provider) - 
100
unit/mL Solution -  10units a day
METFORMIN -  (Prescribed by Other Provider) - 1,000 mg Tablet - 
1
Tablet(s) by mouth twice a day
SIMVASTATIN -  (Prescribed by Other Provider) - 80 mg Tablet - 1
Tablet(s) by mouth once a day
VALSARTAN [DIOVAN] -  (Prescribed by Other Provider) - 80 mg
Tablet - 1 Tablet(s) by mouth once a day
 
Medications - OTC
CALCIUM CITRATE-VITAMIN D3 [CALCIUM CITRATE +] -  (Prescribed by
Other Provider) - 315 mg-200 unit Tablet - 2 Tablet(s) by mouth
daily
CYANOCOBALAMIN [VITAMIN B-12] -  (OTC) - 1,000 mcg Tablet,
Sublingual - ___ Tablet(s) sublingually daily
ERGOCALCIFEROL (VITAMIN D2) [VITAMIN D] -  (Prescribed by Other
Provider; OTC) - Dosage uncertain
MULTIVITAMINS WITH MINERALS -  (Prescribed by Other Provider) -
Dosage uncertain

 
Discharge Medications:
1. glyburide
Please hold glyburide until your blood sugar stabilizes.
2. Oxycodone-Acetaminophen ___ mg/5 mL Solution Sig: ___ MLs 
PO Q4H (every 4 hours) as needed for pain.
Disp:*500 ML(s)* Refills:*0*
3. Metformin 500 mg Tablet Sig: Two (2) Tablet PO BID (2 times a 
day).
Disp:*120 Tablet(s)* Refills:*2*
4. Valsartan 80 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  

5. Simvastatin 40 mg Tablet Sig: Two (2) Tablet PO DAILY 
(Daily).  
6. Keflex ___ mg Capsule Sig: One (1) Capsule PO three times a 
day.
Disp:*30 Capsule(s)* Refills:*1*
7. Lantus 100 unit/mL Solution Sig: Ten (10) unit Subcutaneous 
at bedtime.  

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
Ventral hernia repair with panniculectomy
Ischemic umbilicus

 
Discharge Condition:
Stable

 
Discharge Instructions:
You are being discharged on medications to treat the pain from 
your operation. These medications will make you drowsy and 
impair your ability to drive a motor vehicle or operate 
machinery safely. You MUST  refrain from such activities while 
taking these medications.
 
 
Please call your doctor or return to the emergency room if you 
have any of the following:
 
 * You experience new chest pain, pressure, squeezing or 
 tightness.
 
* New or worsening cough or wheezing.
 
* If you are vomiting and cannot keep in fluids or your 
 medications.
 
* You are getting dehydrated due to continued vomiting, 
 diarrhea or other reasons. Signs of dehydration include dry 
 mouth, rapid heartbeat or feeling dizzy or faint when standing.
 
* You see blood or dark/black material when you vomit or have a 
 bowel movement.
 

* You have shaking chills, or a fever greater than 101.5 (F) 
 degrees or 38(C) degrees.
 
* Any serious change in your symptoms, or any new symptoms that 
 concern you. 
 
* Please resume all regular home medications and take any new 
meds 
 as ordered.  
Activity:
No heavy lifting of items ___ pounds for 6 weeks. You may 
resume moderate
exercise at your discretion, no abdominal exercises.

Wound Care:
You may shower, no tub baths or swimming. 
If there is clear drainage from your incisions, cover with 
clean, dry gauze. 
Your steri-strips will fall off on their own. Please remove any 
remaining strips ___ days after surgery.
Please call the doctor if you have increased pain, swelling, 
redness, or drainage from the incision sites.

JP Drain Care:

*Please look at the site every day for signs of infection 
(increased redness or pain, swelling, odor, yellow or bloody 
discharge, warm to touch, fever).

*Maintain suction of the bulb.

*Note color, consistency, and amount of fluid in the drain. Call 
the doctor, ___, or ___ nurse if the amount 
increases significantly or changes in character.

*Be sure to empty the drain frequently. Record the output, if 
instructed to do so.

*You may shower; wash the area gently with warm, soapy water.

*Keep the insertion site clean and dry otherwise.

*Avoid swimming, baths, hot tubs; do not submerge yourself in 
water.

*Make sure to keep the drain attached securely to your body to 
prevent pulling or dislocation.

General Drain Care:

*Please look at the site every day for signs of infection 
(increased redness or pain, swelling, odor, yellow or bloody 
discharge, warm to touch, fever).

*If the drain is connected to a collection container, please 
note color, consistency, and amount of fluid in the drain. Call 
the doctor, ___, or ___ nurse if the amount 
increases significantly or changes in character. Be sure to 
empty the drain frequently. Record the output, if instructed to 
do so.

*Wash the area gently with warm, soapy water.

*Keep the insertion site clean and dry otherwise.

*Avoid swimming, baths, hot tubs; do not submerge yourself in 
water.

*Make sure to keep the drain attached securely to your body to 
prevent pulling or dislocation.

 
Followup Instructions:
___
"
18847983-DS-6," 
Name:  ___              Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Patient recorded as having No Known Allergies to Drugs
 
Attending: ___.
 
Chief Complaint:
Bright red blood per rectum
 
Major Surgical or Invasive Procedure:
Colonoscopy and EGD, ___
 
History of Present Illness:
Mr. ___ is  a ___ male with hx of prostate 
cancer s/p brachytherapy and resection, who presented to ED 
after having a bloody, loose bowel movement in the morning of 
___, which was described as bright red, no melena, and not 
associated with abdominal pain or cramping. He has never had 
similar episodes in the past. He also denies lightheadedness or 
dizziness. No history of hemorrhoids. Patient denies taking 
NSAID and aspirin. He has never had colonoscopy in the past.
.  
Over the last several weeks patient has been experiencing 
urinary discomfort and urinary retention, as well as fevers, 
chills and sweats. He was seen in the ED on ___ for urinary 
retention and was found to have urinary tract infection. He was 
prescribed Ciprofloxacin and Foley was placed. He was seen by a 
urologist on ___ who changed the antibiotic from Ciprofloxacin 
to Levofloxacin given culture grew out coag-postive staph 
aureus. At that time, he successfully passed voiding trial.
.
In the ED, initial vital signs were stable. In the ED, patient 
was seen to have one bowel movement with mixed bright red blood. 
Again, patient denied abdominal pain or cramping. 

 
Past Medical History:
# PROSTATE CANCER ___, s/p brachytherapy
# URINARY RETENTION, s/p TURP in ___
# CORONARY ARTERY DISEASE S/P CABG three vessels in ___, stent 
___ L Cx   
# CHOLELITHIASIS, asymptomatic
# NEPHROLITHIASIS
# ___ SYNDROME   
# GASTROESOPHAGEAL REFLUX
# PEPTIC ULCER DISEASE  with GI bleeding over ___ years ago, 
received transfusion at that time, was treated medically, 
Patient unsure if associated with H. pylori.
# ANXIETY   
# HYPERTENSION, patient reports home BP is in 130-140/60-70
# HYPERCHOLESTEROLEMIA
# LUMBAR RADICULOPATHY ___
# SCIATICA, bilateral leg pain, patient feels pain is 
well-controlled on dilaudid
# AORTIC ULCERATION ___ 
# NORMOCYTIC ANEMIA, has never been worked up as far as the 
patient's aware
 
Social History:
___
Family History:
Heart disease on Father's side of the family. No history of 
sudden cardiac death. No family history of colon cancer or other 
cancers.

 
Physical Exam:
Vitals: T: 98.7 BP: 142/62 P:69 R:18  O2:99%RA  
General: Alert, oriented, pleasant elderly in no acute distress, 
affect is euthymic.  
HEENT: Sclera anicteric, but pale, MMM, oropharynx clear  
Neck: supple, JVP not elevated, no LAD  
Lungs: Clear to auscultation bilaterally, no wheezes, rales, 
ronchi  
CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, 
gallops  
Abdomen: soft, non-tender, non-distended, bowel sounds present, 
no rebound tenderness or guarding, no organomegaly  
Rectal: deferred; but no stool, no blood on exam per night float 
and no blood in vault, guaiac positive in ED. 
Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or 
edema 
Neuro: CNs intact, normal strength throughout. Gait not 
assessed.

 
Pertinent Results:
LABS ON ADMISSION:
___ 08:20PM URINE  HOURS-RANDOM
___ 08:20PM URINE  GR HOLD-HOLD
___ 08:20PM URINE  COLOR-Straw APPEAR-Clear SP ___
___ 08:20PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-NEG 
GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-7.0 
LEUK-NEG
___ 07:29PM   LACTATE-1.3 K+-4.7
___ 07:29PM   HGB-9.3* calcHCT-28
___ 07:20PM   GLUCOSE-125* UREA N-18 CREAT-1.3* SODIUM-138 
POTASSIUM-4.0 CHLORIDE-102 TOTAL CO2-26 ANION GAP-14
___ 07:20PM   WBC-4.5 RBC-2.91* HGB-8.5* HCT-24.9* MCV-86 
MCH-29.2 MCHC-34.0 RDW-16.2*
___ 07:20PM   NEUTS-74.0* LYMPHS-17.5* MONOS-8.2 EOS-0 
BASOS-0.2
___ 07:20PM   PLT COUNT-184
___ 07:20PM   ___ PTT-29.0 ___
___ 04:25PM   GLUCOSE-112* UREA N-17 CREAT-1.2 SODIUM-138 
POTASSIUM-3.8 CHLORIDE-101 TOTAL CO2-26 ANION GAP-15
___ 04:25PM   estGFR-Using this
___ 04:25PM   WBC-5.7 RBC-3.15* HGB-9.4* HCT-27.6* MCV-88 
MCH-29.7 MCHC-33.9 RDW-16.2*
___ 04:25PM   NEUTS-76.3* LYMPHS-14.9* MONOS-7.9 EOS-0.6 
BASOS-0.2
___ 04:25PM   PLT COUNT-225#
LABS ON DISPOSITION
___ 10:30AM BLOOD ALT-90* AST-67* AlkPhos-117 TotBili-1.4 
DirBili-0.4* IndBili-1.0
___ 06:48AM BLOOD PSA-0.1
___ 06:48AM BLOOD HCV Ab-PND
___ 06:48AM BLOOD WBC-4.6 RBC-3.11* Hgb-9.5* Hct-27.6* 
MCV-89 MCH-30.4 MCHC-34.3 RDW-16.0* Plt ___
___ 06:48AM BLOOD Plt ___
___ 06:48AM BLOOD Glucose-110* UreaN-11 Creat-1.1 Na-141 
K-4.2 Cl-105 HCO3-26 AnGap-14

STUDIES
AP chest radiograph (___), compared to ___: 
Impression: Borderline cardiomegaly is unchanged. Linear scar at 
the right lung base is slightly more extensive today than 
previously. No other focal pulmonary abnormality is present. 
Mild upper lobe vascular cephalization slightly more pronounced, 
but no edema or pleural effusion is present. 

Colonoscopy, (___):
Findings: Normal mucosa was noted. Protruding Lesions Three 
polyps of benign appearance were found. One sessile and one 
pedunculated polyp in the ascending colon and one pedunculated 
polyp in the transverse colon. The polyps ranged from 0.5 cm to 
0.8 cm Single-piece polypectomy was performed using a cold 
snare. The polyps were completely removed. Minimal oozing was 
noted at the polypectomy site at one of the polyps in the 
ascending colon. A single clip was attached and hemostasis was 
achieved.  
Impression: Polyps in the ascending colon and transverse colon 
(polypectomy). Normal mucosa in the colon. Otherwise normal 
colonoscopy to cecum. 

RUQ ultrasound, (___):
1. Echogenic liver consistent with fatty infiltration. Other 
forms of liver disease and more advanced liver disease including 
significant hepatic fibrosis/cirrhosis cannot be excluded on 
this study. 2. Gallstones with no signs of cholecystitis. 3. 
Simple bilateral renal cysts. Small left renal crystal within a 
calyceal diverticulum. 
 
Brief Hospital Course:
Mr. ___ was admitted to Medicine service after having 
two episodes of bright red blood per rectum.
.
# GI bleeding: This bleeding was thought to be most likely from 
the distal GI tract given the description of bright red blood 
and the absence of epigastric pain, nausea or hematemesis. He 
was given IV fluid on the day of admission. His antihypertensive 
medications were held. He was evaluated by Gastrointestinal 
service who recommended colonoscopy and 
esophagogastroduodenoscopy especially because the patient has 
never had colonoscopy in the past and he has a history of 
chronic anemia. Colonoscopy revealed three benign-appearing, 
non-bleeding polyps, one in the transverse colon, and two in the 
ascending colon. There was no evidence of new or recent 
bleeding. Capsule endoscopy is recommended as further work up, 
to be done by the patient's PCP as outpatient.He did not have 
any further episodes of bleeding after he was admitted to 
Medicine survice. His hematocrit remained stable during this 
admission. Metroprolol 12.5 mg BID was resumed on the day of 
disposition. Other antihypertensive medications were stopped. 
The patient is to be followed up by his PCP, ___ on 
___.
.
# Normocytic anemia: The patient was found to have chronic 
anemia which has not been investigated as far as the patient's 
awared. His B12 and folate levels were both normal. Iron studies 
suggested that there may be a component of anemia of chronic 
disease. Acute bleeding would not totally account for this 
especially given that only a small to moderate amount of blood 
was noted with his bowel movements. The plan to further evaluate 
GI bleeding is capsule endoscopy as discussed above.
.  
# Coag-positive S. aureus UTI: Prior to this admission, the 
patient has already been treated with a full course of 
fluroquinolone (Ciprofloxacin followed by Levofloxacin). His 
urinalysis on admission was negative. He remained afebrile. His 
blood culture had NGTD at discharge.
.
# Elevated ESR and CRP: ESR is 108 (was 60 in ___ and ___, 
CRP 89.8 (CRP was 4 in ___. Differential diagnoses of elevated 
ESR and CRP include inflammation, infection or malignancy. 
Causes could be recent UTI, bacteremia, autoimmune processes or 
malignancy. PSA level was checked and was normal (0.1). ESR and 
CRP should be repeated at follow-up visit with Dr. ___.
.
# Transaminitis: AST 81-82, ALT 52-56. Last ALT in ___ was 
normal. Simvastatin was held on the day of admission. Tylenol 
level was checked, which was negative. Hepatitis serologies are 
pending at the time of disposition. His only new medication was 
levofloxacin, which may cause transaminis, but less likely in 
this case because AST and ALT levels remained elevated after he 
finished the course of antibiotic. The patient denied recent 
alcohol use. Other differential diagnoses include non-alcoholic 
fatty liver disease, infectious, malignant or metastatic 
processes. LFTs should be repeated in ~1 week by his PCP as 
outpatient.
.
# Elevated direct bilirubin: Patient was found to have elevated 
direct bilirubin of 0.4, concerning for cholestatic proceses. On 
exam, he was afebrile and there was no RUQ or abdominal 
tenderness to palpation. No jaundice noted. RUQ ultrasound was 
obtained which showed fatty liver and gallstones but no evidence 
of inflammation or cholestasis. 
.
# Bilateral leg pain: Chronic issue. He was kept on dilaudid prn 
pain. His pain was well-controlled during this admission.
.
# Hypertension: Antihypertensive medications were held on the 
day of admission for GI bleeding and because patient was 
normotensive. His blood pressures during this admission ranged 
from 120-140's/60-70's. On disposition, only metoprolol was 
resumed with dose changed to 12.5 mg BID.  
.
# Right ankle pain: The patient developed ankle pain over the 
right medial malleolus. He reported that he has had many 
episodes of acute ""gout"" attacks in the past that lasted about 
___ days, the last episode happend about ___ years ago. He denied 
having had arthrocentesis. He reported that he went to the ED 
last time he had this type of pain but was told there was no 
treatment for his condition. He reported having had similar pain 
in both ankles and on the bottom of his feet several years ago. 
On exam, he was afebrile. There was minimal erythema over the 
right medial malleolus that was moderately tender to palpation 
and with passive range of movement. No swelling appreciated. 
Gout in differential. Patient already has a follow-up 
appointment with his PCP the day after disposition. In the 
meantime, he is instructed to take pain regimen as prescribed 
and to apply ice pack as needed.
 
Medications on Admission:
Amlodipine 5 mg daily
Citalopram 10 mg daily
HCTZ 25 mg daily
Hydromorpkone 4 mg TID
Metoprolol tartrate 50 mg BID
Nitro sl prn
Omeprazole 20 mg daily
Simvastatine 40 mg daily
Valsartan 320 mg daily
Tylenol prn 
 
Discharge Medications:
1. Citalopram 10 mg Tablet Sig: One (1) Tablet PO once a day.  
2. Hydromorphone 4 mg Tablet Sig: One (1) Tablet PO three times 
a day as needed for pain.  
3. Nitroglycerin 0.3 mg Tablet, Sublingual Sig: One (1)  
Sublingual as directed: use as previously directed, please 
contact EMS if you find the need to use this medication.  
4. Omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) 
Capsule, Delayed Release(E.C.) PO once a day.  
5. Metoprolol Tartrate 25 mg Tablet Sig: 0.5 Tablet PO twice a 
day.
Disp:*30 Tablet(s)* Refills:*0*

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Primary diagnosis: 
1. GI bleed
2. Anemia
3. Transaminitis

Secondary diagnosis:
1. Hypertension
2. Sciatic
3. GERD

 
Discharge Condition:
Mental Status: Clear and coherent
Level of Consciousness: Alert and interactive
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane)

 
Discharge Instructions:
You were admitted with blood per your rectum. You had no further 
episodes of bleeding while you were in the hospital. Your red 
blood cell count increased indicating that the bleeding has 
stopped. You had a colonoscopy to evaluate for the source of the 
bleed. They found a polyp which was removed, however, they did 
not see any signs of new or recent bleeding. You will need to 
follow up with your primary care physician for ___ capsule 
endoscopy. Also, some of your lab work was abnormal. Your liver 
tests and inflammation tests were elevated and your red blood 
cell count was low and need to be followed closely by your 
primary care physician. You also had a biopsy of the polyp which 
will need to be followed by your primary care physician. You had 
an ultrasound which showed evidence of ""fatty liver"" and 
gallstones but no signs of inflammation of cholestasis. As far 
as your ankle pain you should take your pain regimen as 
previously prescribed and use ice packs as needed. Please 
discuss this pain tomorrow with Dr. ___. An appointment 
was made for you for this upcoming ___ with Dr. 
___.

The following medications where changed:
1. DECREASE metoprolol tartrate 12.5mg by mouth twice a day
2. STOP amlodipine - please discuss this with Dr. ___
3. STOP hydrochlorothiazide - please discuss this with Dr. 
___
4. STOP valsartan -  please discuss this with Dr. ___
5. STOP simvastatin -  please discuss with Dr. ___

___ follow up with your primary care physician. An 
appointment was set up and is listed below.
 
Followup Instructions:
___
"
19297319-DS-11," 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
Post-RFA ablation  
 
Major Surgical or Invasive Procedure:
Radiofrequency Ablation 

 
History of Present Illness:
___ year old man with DM, HTN, and NASH/ETOH cirrhosis 
complicated by HCC, admitted after RFA on ___ for 
post-procedure monitoring. The procedure went well, but he was 
bradycardic during the procedure as well as in the PACU, and so 
was admitted for observation. He was asymptomatic during these 
episodes, and had similar bradycardia during a prior TACE 
procedure, evaluated by EP at that time who felt it was 
vaso-vagal. His HCC was first diagnosed ___ by MRI. He 
underwent TACE on ___ to the segment 4 lesion, however 
subsequent follow-up imaging in ___ showed a 2.2 cm segment 
8 lesion and 1.8 cm segment 3 lesion, both meeting OPTN criteria 
for HCC.  

On the floor, pt is tired/sleeping, with minimal pain, no 
dizziness, no chest pain, no nausea.  
 
Review of systems: (+) Per HPI.
 
Past Medical History:
Diabetes mellitus
Hypertension
Prior alcohol abuse (sober for the last ___ years, since diagnosis
of cirrhosis)
Liver cirrhosis complicated by HCC.
Peripheral neuropathy
Squamous cell skin ca, recent resection""
 
Social History:
___
Family History:
Mother with lung cancer. Father died of heart disease at the age 
of ___.
 
Physical Exam:
========================
Admission Physical Exam: 
========================
Vitals: 98.3 126/69 87 16 98% RA  
General: initially sleeping, then very pleasant, A+Ox3, NAD  
HEENT: PERLL, anicteric sclera, dry MM  
Neck: Supple, JVP not elevated, no LAD  
CV: RRR, ___ systolic murmur  
Lungs: CTAB  
Abdomen: obese, soft, mild tenderness in RLQ (where procedure 
occurred), + BS, no rebound, no guarding  
Ext: WWP, trace edema to mid-shin  
Neuro: symmetrical facial features, clear speech, moving all 
limbs appropriately (gait deferred) 
========================
Discharge Physical Exam: 
========================
Vitals: 98.2  BP 135/60  HR 87  RR 18  96% RA
General: Alert, oriented. Appropriate mood and affect. 
HEENT: Sclera anicteric, MMM, PERRL.    
Lungs: crackles at R lung base, otherwise clear, no wheezes or 
rhonchi  
CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, 
gallops  
Abdomen: Protuberant abdomen, soft. RUQ with minimal tenderness 
to palpation. No guarding or rebound tenderness. +BS.   
Ext: Warm, well perfused, 1+ pitting edema to mid shin.   
Neuro: CN2-12 grossly intact. Movement of upper and lower 
extremities bilaterally grossly intact. Sensation grossly intact
 
Pertinent Results:
===============
Admission Labs: 
===============
___ 07:54AM BLOOD WBC-8.1 RBC-4.44* Hgb-13.5* Hct-42.0 
MCV-95 MCH-30.4 MCHC-32.1 RDW-13.2 RDWSD-45.4 Plt Ct-76*
___ 07:54AM BLOOD Glucose-263* UreaN-50* Creat-1.7* Na-140 
K-5.3* Cl-107 HCO3-24 AnGap-14
___ 07:54AM BLOOD ALT-135* AST-253* AlkPhos-68 TotBili-1.4
___ 07:54AM BLOOD Calcium-8.7 Phos-3.3 Mg-1.6
=====================================
Pertinent Labs During Hospital Stay: 
=====================================
___ 01:59AM URINE RBC-7* WBC-1 Bacteri-FEW Yeast-NONE Epi-0
___ 01:59AM URINE Blood-TR Nitrite-NEG Protein-TR 
Glucose-TR Ketone-NEG Bilirub-NEG Urobiln-NEG pH-5.5 Leuks-NEG
___ 01:59AM URINE Color-Yellow Appear-Clear Sp ___
___ 02:30PM URINE Hours-RANDOM Creat-122 Na-18 K-33 Cl-19
___ 12:02PM URINE Hours-RANDOM UreaN-803 Creat-119 Na-26 
K-26 Cl-10
___ 02:30PM URINE Osmolal-473
___ 12:02PM URINE Osmolal-466
===============
Discharge Labs: 
===============
___ 07:50AM BLOOD WBC-5.2 RBC-4.03* Hgb-12.3* Hct-37.3* 
MCV-93 MCH-30.5 MCHC-33.0 RDW-13.2 RDWSD-44.6 Plt Ct-69*
___ 07:50AM BLOOD Plt Ct-69*
___ 07:50AM BLOOD ___ PTT-30.6 ___
___ 07:50AM BLOOD Glucose-150* UreaN-56* Creat-1.8* Na-137 
K-4.7 Cl-104 HCO3-23 AnGap-15
___ 07:50AM BLOOD ALT-105* AST-77* AlkPhos-92 TotBili-1.2
___ 07:50AM BLOOD Calcium-8.5 Phos-2.0* Mg-2.3
=============
Microbiology:
=============
___ 2:12 am BLOOD CULTURE

   Blood Culture, Routine (Pending): 

___ 1:59 am URINE      Source: ___. 

                            **FINAL REPORT ___

   URINE CULTURE (Final ___:    NO GROWTH. 
___ 8:00 am BLOOD CULTURE

   Blood Culture, Routine (Pending): 
========
Imaging: 
========
___ CT interventional procedure: Technically-successful 
radiofrequency ablation of segment III and segment VIII 
concerning hepatic lesions.
 
___ LIVER OR GALLBLADDER US (SINGLE ORGAN) + DUPLEX 
1. Patent hepatic vasculature with appropriate waveforms. 
2. Cirrhotic liver with hypoechoic lesion in segment III which 
correlates to patient's recent RFA site. 
3. Sequela of portal hypertension including splenomegaly and 
trace ascites. 

 
Brief Hospital Course:
=========
Summary: 
=========
___ year old man with EtOH/NASH cirrhosis complicated by ___, 
admitted for monitoring after elective RFA procedure on ___. 
Subsequently complicated by bradycardia, urinary retention, 
leukocytosis/fever, and acute kidney injury. 

==============
Acute Issues: 
==============
#Acute on chronic kidney injury: 
Patient with baseline creatinine of ~1.5. Was 1.7 post procedure 
on ___ AM and bumped to 2.1 on ___ AM. Acute kidney injury was 
thought to be pre-renal in etiology given FeNa calculated to 
0.23%. Held home furosemide and enalapril. Received fluid 
boluses with NS and administration of Albumin 25% (12.5g / 50mL) 
50 g IV. Improved to 1.8 at time of discharge. 
 
# Temperature: Patient spiked temperature to 102.1 on ___ ___ 
with associated leukocytosis to 13.5 in AM ___. No localizing 
signs or symptoms and patient denied cough/dysuria. UA with few 
bacteria and negative leuk esterase/nitrites and was felt to be 
asymptomatic bacteruria. Differential diagnosis included post-op 
atelectasis versus RFA post ablation syndrome versus portal vein 
thrombosis given concomitant elevation in LFTs and ___ 
(described above). RUQ Doppler US performed with no evidence of 
portal vein thrombosis. No further febrile episodes and 
leukocytosis resolved ___ thus likely secondary to resolving 
atelectasis versus RFA post ablation syndrome.

# Urinary retention: Patient with urinary retention following 
procedure on ___. Felt to be secondary to anesthetic/opioid 
(oxycodone) effect. Required straight cath for 800 cc 1AM ___ 
and was straight cath'd for another 550cc at 3PM ___. 
Tamsulosin 0.4 mg PO DAILY started ___ and low dose Tylenol 
added prn (max 2g/day given liver disease) to try to reduce 
amount of oxycodone required. Subsequently with improved 
urination on his own. Discharged on Tamsulosin. 

# ___ s/p RFA: Per ___, procedure itself went well but was 
subsequently complicated by transient, asymptomatic bradycardia. 
Patient with similar episode following TACE in ___. During 
that admission, patient was evaluated by EP who felt vasovagal 
in etiology. Was monitored on telemetry with no alarms for 
bradycardia. Pain controlled with Tylenol and oxycodone. 

# Sinus bradycardia: Patient with several episodes of 
asymptomatic bradycardia during and after the RFA procedure per 
___ report. He experienced this in ___ after his TACE 
procedure, which was evaluated by EP who felt this was a vagal 
response in setting of the procedure. Patient felt improved with 
no bradycardia on telemetry during hospital stay.

# EtOH/NASH cirrhosis: Complicated by grade I varices on EGD in 
___ and HCC as above. Patient to follow up in the ___ 
after discharge. Limited acetaminophen to 2g/day. 

# HTN: Patient on enalapril, amlodipine and furosemide at home. 
These medications were held prior to procedure and subsequently 
restarted. Enalapril and furosemide subsequently held due to 
___. Continued on amlodipine at discharge but discharged off 
enalapril and furosemide with plan to restart as outpatient. 

# DM: Complicated by neuropathy. Patient on glyburide, 36 units 
of glargine QHS and 24 units of Humalog with dinner. Continued 
Gabapentin 600 mg PO/NG TID during hospital stay. Maintained on 
ISS and 36 glargine QHS during hospital stay. 

# Vitamin D: Continued Vitamin D ___ UNIT PO/NG DAILY 

# Primary prevention: Restarted Aspirin 81 mg PO/NG DAILY post 
RFA; was holding for past few weeks for procedure. Continued 
simvastatin. 

=====================
Transitional Issues: 
=====================
- Started on Flomax for urinary retention. Please follow up as 
outpatient and titrate as clinically warranted. 
- Discharged with oxycodone and prn Tylenol (max dose 2g/day) 
for pain control. DO NOT TAKE MORE THAN 2 GRAMS PER DAY. 
- Blood cultures pending at time of discharge. Please follow up 
results. 
- Home enalapril and furosemide held during hospital stay due to 
___ resolved (discharge Creatinine was 1.8, baseline 
1.6-1.8). Enalapril and Furosemide were held on discharge, 
recommend restarting pending lab check upon dc follow up 
appointment with PCP on ___.
- Will require follow up with PCP and ___
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Aspirin 81 mg PO DAILY 
2. Gabapentin 600 mg PO TID 
3. Amlodipine 5 mg PO DAILY 
4. Enalapril Maleate 20 mg PO DAILY 
5. glimepiride 2 mg oral DAILY 
6. Omeprazole 20 mg PO DAILY 
7. Simvastatin 20 mg PO QPM 
8. Vitamin D ___ UNIT PO DAILY 
9. Glargine 36 Units Bedtime
Humalog 24 Units Dinner
10. Furosemide 10 mg PO DAILY 

 
Discharge Medications:
1. Amlodipine 5 mg PO DAILY 
2. Aspirin 81 mg PO DAILY 
3. Gabapentin 600 mg PO TID 
4. Glargine 36 Units Bedtime
Humalog 24 Units Dinner
5. Omeprazole 20 mg PO DAILY 
6. Simvastatin 20 mg PO QPM 
7. Vitamin D ___ UNIT PO DAILY 
8. Tamsulosin 0.4 mg PO DAILY 
RX *tamsulosin 0.4 mg 1 capsule(s) by mouth once a day Disp #*30 
Capsule Refills:*0
9. glimepiride 2 mg ORAL DAILY 
10. OxycoDONE (Immediate Release)  5 mg PO Q6H:PRN pain 
11. Acetaminophen 650 mg PO Q8H:PRN pain 
RX *acetaminophen 650 mg 1 tablet(s) by mouth every eight (8) 
hours Disp #*30 Tablet Refills:*0

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Primary:
Radiofrequency ablation 
Sinus bradycardia 
Urinary retention 
Acute Kidney Injury 

Secondary: 
Hepatocellular carcinoma
Cirrhosis 
Chronic Kidney Disease
Hypertension 
Diabetes Mellitus  

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Mr. ___, 

It was our pleasure caring for you during your hospital stay at 
___. 

You were admitted to the hospital after your RFA procedure due 
to some episodes of low heart rates during the procedure and 
because you were feeling dizzy after the procedure. We monitored 
you on the cardiac monitor and noted no additional periods of 
low heart rates. 

You had some difficulty urinating after the procedure that we 
think was due to a combination of the anesthesia and the pain 
killers (oxycodone) you were receiving. We started you on a new 
medication called tamsulosin that can help with difficulty 
urinating and that you should continue as an outpatient. We also 
gave you low dose Tylenol to decrease the amount of oxycodone 
you required for pain control. At the time of discharge, you 
were urinating on your own without difficulty. 

You additionally spiked a temperature while you were in the 
hospital but we did not detect any signs of infection. We think 
that the temperature may have been due to ""atelectasis"" or 
improper inflation of portions of your lung (a normal occurrence 
after procedures requiring anesthesia) or potentially due to the 
inflammation caused by the RFA procedure. We performed an 
ultrasound of your liver and we did not see anything concerning. 
You had no temperature and were breathing well on room air at 
the time of your discharge. 

Finally, your kidney function was a little worse following the 
procedure. We think that this was due to dehydration and it 
improved with the fluids and albumin we gave you.  We held your 
home Enalapril and Furosemide (Lasix) as these can affect your 
kidney function.  You should not restart these until you have 
your labs checked by your primary care physician at your next 
appointment.

You should follow up with your primary care physician and liver 
team after you leave the hospital. 

We wish you the best! 
Your ___ Care Team
 
Followup Instructions:
___
"
